<SEC-DOCUMENT>0001808805-22-000081.txt : 20220802
<SEC-HEADER>0001808805-22-000081.hdr.sgml : 20220802
<ACCEPTANCE-DATETIME>20220802160350
ACCESSION NUMBER:		0001808805-22-000081
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		68
CONFORMED PERIOD OF REPORT:	20220630
FILED AS OF DATE:		20220802
DATE AS OF CHANGE:		20220802

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nautilus Biotechnology, Inc.
		CENTRAL INDEX KEY:			0001808805
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39434
		FILM NUMBER:		221128590

	BUSINESS ADDRESS:	
		STREET 1:		2701 EASTLAKE AVE EAST
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102
		BUSINESS PHONE:		206-333-2001

	MAIL ADDRESS:	
		STREET 1:		2701 EASTLAKE AVE EAST
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ARYA Sciences Acquisition Corp III
		DATE OF NAME CHANGE:	20200408
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>naut-20220630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:9cc3a1fd-7e26-418c-9538-c00b184efabf,g:ab9b2c40-7a18-466f-af91-0013c7c3cb4b,d:92b3c97ce8934bb7b7ab6ca5e08b3121--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:naut="http://www.nautilus.bio/20220630" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:srt="http://fasb.org/srt/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>naut-20220630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80L2ZyYWc6YzE3ODBmYWUzNWIwNDQ0NzhhYmE5ZGMzODNlOTRlODMvdGFibGU6YzFhMTNkYjYyYjliNDUwMWIyM2FiZGE4MmI2MGJhYzkvdGFibGVyYW5nZTpjMWExM2RiNjJiOWI0NTAxYjIzYWJkYTgyYjYwYmFjOV8xLTEtMS0xLTgzNDE0_2bccc42c-c518-44f0-8a2a-79280920bfca">0001808805</ix:nonNumeric><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80L2ZyYWc6YzE3ODBmYWUzNWIwNDQ0NzhhYmE5ZGMzODNlOTRlODMvdGFibGU6YzFhMTNkYjYyYjliNDUwMWIyM2FiZGE4MmI2MGJhYzkvdGFibGVyYW5nZTpjMWExM2RiNjJiOWI0NTAxYjIzYWJkYTgyYjYwYmFjOV8yLTEtMS0xLTgzNDE0_e77186ee-0055-46f8-96c6-541d4d763a7a">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80L2ZyYWc6YzE3ODBmYWUzNWIwNDQ0NzhhYmE5ZGMzODNlOTRlODMvdGFibGU6YzFhMTNkYjYyYjliNDUwMWIyM2FiZGE4MmI2MGJhYzkvdGFibGVyYW5nZTpjMWExM2RiNjJiOWI0NTAxYjIzYWJkYTgyYjYwYmFjOV8zLTEtMS0xLTgzNDE0_08f37a3b-36df-4cf6-9373-dc838717cc94">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80L2ZyYWc6YzE3ODBmYWUzNWIwNDQ0NzhhYmE5ZGMzODNlOTRlODMvdGFibGU6YzFhMTNkYjYyYjliNDUwMWIyM2FiZGE4MmI2MGJhYzkvdGFibGVyYW5nZTpjMWExM2RiNjJiOWI0NTAxYjIzYWJkYTgyYjYwYmFjOV80LTEtMS0xLTgzNDE0_8ca3a271-621c-46b9-a8a2-6b82341cc29c">2022</ix:nonNumeric><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80L2ZyYWc6YzE3ODBmYWUzNWIwNDQ0NzhhYmE5ZGMzODNlOTRlODMvdGFibGU6YzFhMTNkYjYyYjliNDUwMWIyM2FiZGE4MmI2MGJhYzkvdGFibGVyYW5nZTpjMWExM2RiNjJiOWI0NTAxYjIzYWJkYTgyYjYwYmFjOV81LTEtMS0xLTgzNDE0_4adcba57-0171-4aa7-b5b5-0572b4ee0863">Q2</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="naut-20220630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3310b8dff9874981ae5250a336f00a88_I20220729"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-07-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i34e4a2a383364c848f4d73f961251253_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i452786b7977748c0a94d775ecb931729_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i324e2cc43a4e4cf587d2f6ab80062f51_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">naut:SeriesSeedRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f90b4ca496645789fa6b735ea5ebed6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdd25765152a4ced9576a609916fc669_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90b7a94b75e741018792ad40fce39e8b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i671a15cf99d44d1784c894a87c80e686_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84e9820405224bd7bd61573fe1ab8754_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if84c94ae09ea4044bd354a2967d293b3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92668a7081b949668c4894010570de77_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e0a243e6ed64e6380f701b2efb5ff8b_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e6daf471bc241889e532847e9ba6e85_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5d7470609454d0e9b5dff503cff7980_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9432f4700dc64531b14d489ac2a5a042_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4472b9eda37d47c1a4d8adc7d6d2cd67_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">naut:SeriesSeedRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8d4f89749114fff9f0cfa6384876a0b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3734d525d0254e38ba1f10086eb40e63_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i389999977661484882273df554199358_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie314d916207a418aa13a6eac1ba0316b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94e283e466604a8d91b96c149bce904f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d2cd67fbecd458cba307172152eed68_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia42f738735254708b40f6633a2122e8e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">naut:SeriesSeedRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie85bed107ca14c97901fe21cb7bb5dd8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1335e9d7772048258994030cd2031c3f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05843a43ee50491196307c78a95fc47c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e040518794245b0863ec2f6444d3794_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5202287c29e942c5b0cdac7690f742a4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bb0ce9e01b540f58814347806008b98_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c6985f8581548c2a524d21940747415_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i331a2564c2fd4ca8a141e5b7414f9560_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4c2e6f425d94a478aa350968a70941c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia19895c7ccdf43c886000a1fe40ad74d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">naut:SeriesSeedRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23ee12f309a94096b523c85c9c89ec41_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb3fddc37cf84806bb3cb2eb9243e764_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64c43e244ef8492fa7383bb02f49cad6_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf5ead0636be44b29ce427b1dd08509d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9e2d89185264884b8085af4b2cd97fc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">naut:SeriesSeedRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic17b9d22c2764dd798b80f5dfc34b5cf_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91ec4082056644ceb4605ae97ee305ff_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5a3a46052d04721ae2a3b35284e5778_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c20cf8954844243a311683aea4cdc51_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93e671a07e70472fbbddd30300e8c88e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5af05f6fd3814dfcbf23c51970fb91b2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibff31d711c89442ab7051c729b67d7e0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cc1b5792cf94105940e3332ea917424_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">naut:SeriesSeedRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36b1b43803b74d6f9880f7465fee5d9b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4e23aef5312440092a0c722a7b14905_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id40db1cc432e4a13bfe6f29d29443dfb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9fc487a3a7a14aa09b1841736e6b5f97_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b2bafa5e4ed4f35b82f303f9778746d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib76ca1b4c23944e7823ec12efb0e4440_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a897b30f9ac4d8a98520fc12b077eb7_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd33588bc4814c39915e2771cc9556d1_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6be3e094f3c24773ad3af2c5ef2aa634_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i149f021a272a4689a24162c8f8e7d768_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1a4309f941040f286a32c33912b765f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">naut:SeriesSeedRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72367460707f479b803532b3fb755692_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d44af6f75f540d7b0ecbde2f40b4975_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifde94ccddd2d45069a65f8843572a9ae_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35476aa1f20349a1b78904608e5b16ab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ea49b1cdab94931bcc33becf8b06845_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i944a24eac2e246da8e69f0c1ac41391d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i616643cbd31d47a686cf71385bb21573_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaec5179caeab4e28a0d89e51f7815911_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ab559ce8be94eab9ca0ec550a426771_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieff8ab03765e4ac7b663c2cbfb8ab6f8_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">naut:SeriesSeedRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43f28fa225984e9bbd35f3d7ff3f55c6_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice89ec8597d741e6a43e56fbdbb1915b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e556ea5dbff49d8b604228bf8cd44a0_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83eab16a45a34043b19482dba0424ebf_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ia44cc7d1aae94a61ab5ee6ba5904ea17_D20210609-20210609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-09</xbrli:startDate><xbrli:endDate>2021-06-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd18e99e03a84549a89394d3537245e4_I20210609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23369e4e61894856b3b29fd3dd2c1609_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>naut:segment</xbrli:measure></xbrli:unit><xbrli:context id="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-09</xbrli:startDate><xbrli:endDate>2021-06-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ff48ca2fc6c45e787116cf1deff00ca_D20210609-20210609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-09</xbrli:startDate><xbrli:endDate>2021-06-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cf39cfd7fd34311bc52d7c3ad8da2ff_I20210609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9aa3fe7e62449e8bd4ba541d238d058_I20210609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">naut:AryaSciencesAcquisitionCorpIIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95b304753b094f299b60dec3c082158f_I20210608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">naut:AryaSciencesAcquisitionCorpIIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i565dd4757c4d4703a0e0f5fd3a984d8a_D20210609-20210609"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">naut:AryaSciencesAcquisitionCorpIIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-09</xbrli:startDate><xbrli:endDate>2021-06-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79037a7aa8bb452a9abe1acf155b0a38_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec519f1b51a74b28a9f702bc1a15de30_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fc5af0cf1f14c46a0f276dc81c59884_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0050fd4d6a3d46e2b3392794b3ad0b86_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1337c836c5934b6bac4f03a65db10d20_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3465ab1d6d8f48b68b3953bf87063529_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaaebac9cbb2145b1baef43c60057d70a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c2daae9584b48c397b73875dc06c78a_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadef21ee44e04221a04d477fe4115655_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a11f62dd1ef4191af3a81425e1797b7_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d8fd5d7b0fa49a481c18d85c47bf96e_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0728a8794dce4087b0492d0e4351e1e6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc43f21c31c5480eb0e220208d1cbaa6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic726402929734cce8dbbe855f46e9393_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7a7db4799084f059a70fe68887a2222_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01ccc819c01f4da4bf182c10a26166db_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6d4c75d853d45118d52af84feb1c9ea_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72d1a4360cb049bcbd0a7a2c5d41cfeb_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43796c765a3b4a81a908d3053773a8d9_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic56b289dcf7e46aa9e1028ca71a10d0b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i642f3161862d43c3b6ae73200ecd113f_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea1db945b9d4412b88ca684b96485097_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd637638870b48e1b476508b5f17a987_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic460f8db52ff40a98fc27d37b206e662_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id56a7a2e33ba4a32a1d5145855a08542_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie358eafdc46d4b668ba594dc1e5b18d6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i406e02c48601468ebc3605dcc7cc3a1d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1239a3c41dbc40e1bbeff834e51c1aee_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65429cbc59dc44efba3731beff6b9dd1_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice7fbda97984484fa4687feefa1e787c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55132e2a8fbb44009e345287f535137b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dc0732a547c47a49a1c5860398b6fa2_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd1d463226d84aad9a1438d158e6eb23_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54b9d11dd5654d79a875c72b42d10b86_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7bad06e2afb4d469055e60478216c8e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ad2ffe0c6c64a0f945e3af8721a487f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i950704d092364ff2b931f1d01449efb0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5acec1f8c5648f6b912abb5a8c70899_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i276d2f47485e4e31b420416f91c282aa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b4de2e6190b45178fbe6a57799d9ce1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0de8e6af07d84138b0e785102ca2f7f6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i325c3c07c7f74c5f98e3c999c65b7441_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idca49185e1c445cfa94d8d799ed53ce3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6a86385f1054cff872febbcd6e2d2eb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9cb68272c8244ea9919716328cc5ef2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70c36a3813d14058806f4eb11606f72e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfd0acaaf2c04dbb8b67de884e3f27b8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b751c1b3c4a4f9d80dd9d109c372f81_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe88c920880047c18b0c9cdf55c6e8df_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id158f09e96ab481f97e32c8613f97003_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82a7bcc7bc4d49e084d69fc0519a1f46_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id14ac15267014aa398c2c76cac075a21_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice46726bd5254e1d955ba67438fa7351_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0677ff7a71e047b1b7f25782cf4ffe83_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id505c63953e54d2184cb7f771dec30b2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3be0b06a9c94f3a9829bec818382447_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1375f50662564d9695c2f9a598ea96ff_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i390387b0a67e446f8057dfcc678f0e57_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e8607b8fc264a58929288d5a7cae83f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ebedf34f1ba432d875df25f515ac771_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic760bbad7d924910b0fc9c0598c7dd1c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c35013b448d4f9a8ea202c0cc904312_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6319ed6f43b45e59b873b4727e4b8df_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4671216a131e4e1a8c9dfea3bb76d2bd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62504dcfdac144e7a5c3c6eb6862529d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">naut:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f485413bc8146e3bbce6629c4dcd539_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">naut:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0083086336d845fdad111086bbba6da7_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e22a0d731ef400b92b19e10336609cc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2148fd953e942c9b5fa08720c4723a6_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">naut:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia89341e52be34f04b93a341be9170381_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">naut:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffc3dca386444731a94b2e7034cbfd79_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc0ee8f762314302abd9fa2688c27560_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69c8e273988d437082cf0d4dd215960d_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e301c5918bb4924a1937829c187cbe6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f3af80321e54f9fb93e4f4f432b503c_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f3067b2fe2743df8d892928fdb699d8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i787199e8a86147f2b16226c6baee76a4_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i646596b1fd7f425b997adba08286e2c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i233799cb44d44a66a5f2ab2cdc7ec56c_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69902fa9a7884b429fd406f65655535f_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie310279ce69747ab9825ced6a3fe78fc_I20220101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89b1c3e45f0b40979b88b450d15bcbfa_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibed4c6e11d5d43c5806dbe2b925b0fea_I20220101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47703b687f7846fcb57b2784db412643_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2017EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e682fab2418499796c2bd51ca5f5d63_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b3c9d4006024ff3b3fc21d16c2ae7ec_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic34352ef98754a5da0e85055bbc95472_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7ff0979e8484728b1b10937c3182077_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf9c413e24a54f04ad65558d7a7137db_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08e2f1e57e9b497f9d8298da3df3d6e6_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdb873a8ec034005806968a7270b26bd_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8caa73d19bf74f9fb01149e58ec6f2b8_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49299c0b86364054a5d2222883ee3b39_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0da319978bcb43ecb4461222b4a14066_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74defcab308e430587503de9ccb5ac4a_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52460f4c2a9740b295d473a2341fa225_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1706d23492b43b7a385b6224b7bb789_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2cf87bc9d4c4ace9ed33c1df39f2e20_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia22d009c3ac44aeb931bf7a56b79db92_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1548f12c35584dfe86dfe82e4fc2766b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95e307280f854c36abc9723392120e2d_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f6592550bdb4e179558e3808e9fa8eb_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a590e5e314f4b95b05e281bd0d44db4_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0333ae88e1f147b9a495311e02ae01c5_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac74a2b58af547489b585fbc6f3a6dc4_I20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22fffe12aeab41308245c99399a1f92b_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i005d3c6634c744229bee47f60e02c564_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">naut:September2021ToSeptember2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43cfc749a9134f95896a73a831e49eb6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">naut:February2021ToOctober2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b12af6151364817bb6215130879f731_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">naut:October2022ToOctober2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5734f6007d394ffdba6338fcd01317d1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">naut:SanCarlosLeaseImprovementsLineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96e9f550a3474120bad073b9f8a36ac5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">naut:SanCarlosLeaseImprovementsLineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b0787d033534be8830b754832d12575_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idae2ad2a8fe44cc2ae26dfcfb3a80cf3_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id173ca79999149b0acf943a294060af6_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1193b3efa76e4883905243879462ee64_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia851771fac4244bc9fcb9380f95e907a_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">naut:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0108800d07f0495691d5110222b35f25_D20220101-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">naut:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51a1bd721e3d4a4e91f03a5a2c31863b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">naut:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4fee951cce3455ca59554a17600d641_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001808805</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">naut:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS05LTEtMS04MzQxNA_6edd4567-16bd-4015-a577-62d71f192da8 id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtNS0xLTEtODQ1MDY_22ceea25-8891-45fb-bfa7-d4ed0c4c76e5 id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi0xNC0xLTEtODQ0NzU_57bc314f-834c-40f1-a242-997899b68f31 id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy01LTEtMS04NDUwNg_b8bc7253-d81f-4b02-959a-8f5afd08a577 id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNC0xNC0xLTEtODQ0OTk_97d76318-92a5-4f80-b04a-d7b50d140d16 id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNy0xNC0xLTEtODQ0OTk_d5a07a5b-d731-47e5-a184-403b6951b5ac id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi05LTEtMS04NDQ2OA_43ffdcfe-0fbb-4d42-9614-cfecfc6ff0c7 id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS0xLTEtMS04MzQxNA_034b4253-3fca-4b18-92d1-236a541cddfd id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtMS0xLTEtODQ1MDY_bffaae5a-9acd-4a32-96ff-e26d68de6ad5 id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtOS0xLTEtODQ1MDY_210860ff-0daf-48e6-97d5-7d4e201f43f6 id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNS0xNC0xLTEtODQ0OTk_80af0f86-b8df-4a3e-bed6-4d2862df830c id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS01LTEtMS04MzQxNA_33093a59-7f1b-49ac-a9c6-08437cf57263 id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi01LTEtMS04NDQ5Mg_480e1859-325f-4374-ae5f-6d4318797597 id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNC0xNC0xLTEtODM0MTQ_60d8abd0-bfc6-4ce0-9a1f-cda9cdbd83ff id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi01LTEtMS04NDQ2OA_9ce79aea-6f5a-4f20-b036-347ba96cdc23 id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy0xNC0xLTEtODQ1MDk_ffa78cf3-5d7a-4ce6-8f0a-89208842a501 id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy01LTEtMS04NDQ5Mg_1d02e536-9978-4a12-9457-c9d32604020b id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi0xLTEtMS04NDQ5Mg_74f4ac74-240d-4f1b-9934-8cac77a2ebaf id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItNS0xLTEtODQ0OTI_46c2bf03-9c4c-49b2-937b-33031864d629 id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS0xNC0xLTEtODM0MTQ_3f69f49b-df8f-49c3-be9b-43be5bd65607 id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy0xLTEtMS04NDQ5Mg_851ca1e7-788c-4451-a018-d1ddcb4366c1 id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi05LTEtMS04NDQ5Mg_7f9b9355-bce7-4582-bdf6-52f2251ca828 id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi0xNC0xLTEtODQ0OTk_52185f78-57f1-41ee-ba4a-19e2df199dea id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItMTQtMS0xLTg0NDk5_ab958293-94be-428e-9d40-eb3216ad4fa3 id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi0xLTEtMS04NDQ2OA_20297a22-d73b-4327-b5ca-3ff135f493d7 id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy05LTEtMS04NDQ5Mg_e6eed32e-e8f9-4997-9df8-2ef2c264d55a id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItMS0xLTEtODQ0OTI_4ca8e9cc-23bf-48c8-bb72-7c3582044e38 id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy05LTEtMS04MzQxNA_daa8f9e7-8532-4003-82f7-c4c3ae86deca id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNS0xNC0xLTEtODQ0NzU_61e3aa2a-5c3e-494b-ae90-37291d77a75f id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy0xNC0xLTEtODQ0OTk_719f2a7b-ec0b-40ac-a508-a821cb3bd035 id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy05LTEtMS04NDUwNg_2d8ba5f5-eee8-4e45-8c28-d31752cafccc id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNy0xNC0xLTEtODQ0NzU_05b2a09e-74fe-48ba-9927-bcbc1cebd63e id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy0xLTEtMS04MzQxNA_d93a5fd4-a81d-4f6a-bcf2-79846171a71b id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtMTQtMS0xLTg0NTA5_26835d7a-7a99-4bda-887f-9ce027293260 id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy01LTEtMS04MzQxNA_3dc86bbc-0b9f-4c1b-a97e-7d41ff3190d9 id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy0xNC0xLTEtODM0MTQ_4d3d6df8-8f33-4873-8fbc-7848e7307f40 id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy0xLTEtMS04NDUwNg_4edba972-c1cb-4ffb-a57b-4e2ca9adfa57 id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItOS0xLTEtODQ0OTI_733722af-14c8-4290-8046-f9cba9551922" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d" order="1"></ix:relationship></ix:resources></ix:header></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_1"></div><div style="min-height:9pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:16.792%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGV4dHJlZ2lvbjplMmY1NTE1ZTZlYjg0ODRjOWE1NDc4NWViMWRkM2MxOV8yMDEz_12acb6e4-1d12-408c-a0fc-5b19f6befdf2">10-Q</ix:nonNumeric> </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Mark One)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.434%"><tr><td style="width:1.0%"></td><td style="width:2.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.252%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6YmM5YjA1ZjY4ZDhhNDdhY2FlMThlMzJhMDJiNGIyMWMvdGFibGVyYW5nZTpiYzliMDVmNjhkOGE0N2FjYWUxOGUzMmEwMmI0YjIxY18wLTAtMS0xLTgzNDE0_bb2ebf3f-0905-405b-9fe9-21f1913c3a41">x</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGV4dHJlZ2lvbjplMmY1NTE1ZTZlYjg0ODRjOWE1NDc4NWViMWRkM2MxOV8xNDg_f1c6261b-4f46-4a82-8342-c867c533710e">June&#160;30, 2022</ix:nonNumeric> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OR</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.434%"><tr><td style="width:1.0%"></td><td style="width:2.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.252%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6MDIzYmExNWIxNDlhNDY5NGEzM2VlNTAyNDE1MGQ3ZGMvdGFibGVyYW5nZTowMjNiYTE1YjE0OWE0Njk0YTMzZWU1MDI0MTUwZDdkY18wLTAtMS0xLTgzNDE0_950333cf-5593-42ac-acbf-8eedd0928da4">o</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from _________ to _________ </span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commission File Number <ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGV4dHJlZ2lvbjplMmY1NTE1ZTZlYjg0ODRjOWE1NDc4NWViMWRkM2MxOV8yMDA5_1467f24a-8ed6-4b02-ab35-2624c3bb54ce">001-39434</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGV4dHJlZ2lvbjplMmY1NTE1ZTZlYjg0ODRjOWE1NDc4NWViMWRkM2MxOV8yMDE0_6cb65bcd-a60c-47e6-9be7-0b05c9d2e39a">NAUTILUS BIOTECHNOLOGY, INC.</ix:nonNumeric></span></div><div style="margin-bottom:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter) </span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.550%"><tr><td style="width:1.0%"></td><td style="width:32.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.051%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.325%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6ZGNlYjM4NzI0OTY1NGRjNzllZDY5OTczNzljMGIwNTYvdGFibGVyYW5nZTpkY2ViMzg3MjQ5NjU0ZGM3OWVkNjk5NzM3OWMwYjA1Nl8wLTAtMS0xLTgzNDE0_35979d8a-c410-44cd-b858-d0c20a361e61">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6ZGNlYjM4NzI0OTY1NGRjNzllZDY5OTczNzljMGIwNTYvdGFibGVyYW5nZTpkY2ViMzg3MjQ5NjU0ZGM3OWVkNjk5NzM3OWMwYjA1Nl8wLTItMS0xLTgzNDE0_d1efcfa3-18e2-4c37-8bd6-54cbc57d276b">98-1541723</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6ZGNlYjM4NzI0OTY1NGRjNzllZDY5OTczNzljMGIwNTYvdGFibGVyYW5nZTpkY2ViMzg3MjQ5NjU0ZGM3OWVkNjk5NzM3OWMwYjA1Nl8zLTAtMS0xLTgzNDE0L3RleHRyZWdpb246NmE2OGYxNTgxMTY3NGFkMjhjMTM3ODdkNDNmZDY5YTZfNQ_ef8ec919-7c5c-4d79-9799-f1d5d052edd1">2701 Eastlake Avenue East</ix:nonNumeric> <ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6ZGNlYjM4NzI0OTY1NGRjNzllZDY5OTczNzljMGIwNTYvdGFibGVyYW5nZTpkY2ViMzg3MjQ5NjU0ZGM3OWVkNjk5NzM3OWMwYjA1Nl8zLTAtMS0xLTgzNDE0L3RleHRyZWdpb246NmE2OGYxNTgxMTY3NGFkMjhjMTM3ODdkNDNmZDY5YTZfOA_45e4cebb-203d-4488-ab83-8fe2c369ee80">Seattle</ix:nonNumeric>, <ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6ZGNlYjM4NzI0OTY1NGRjNzllZDY5OTczNzljMGIwNTYvdGFibGVyYW5nZTpkY2ViMzg3MjQ5NjU0ZGM3OWVkNjk5NzM3OWMwYjA1Nl8zLTAtMS0xLTgzNDE0L3RleHRyZWdpb246NmE2OGYxNTgxMTY3NGFkMjhjMTM3ODdkNDNmZDY5YTZfMTI_78b9e805-073b-4d96-808d-850a63267b4e">Washington</ix:nonNumeric> </span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6ZGNlYjM4NzI0OTY1NGRjNzllZDY5OTczNzljMGIwNTYvdGFibGVyYW5nZTpkY2ViMzg3MjQ5NjU0ZGM3OWVkNjk5NzM3OWMwYjA1Nl8zLTItMS0xLTgzNDE0_47841059-f16a-4815-9293-f461c805a69d">98102</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6ZGNlYjM4NzI0OTY1NGRjNzllZDY5OTczNzljMGIwNTYvdGFibGVyYW5nZTpkY2ViMzg3MjQ5NjU0ZGM3OWVkNjk5NzM3OWMwYjA1Nl81LTEtMS0xLTgzNDE0L3RleHRyZWdpb246Zjg2ZjNmZWJhOTdhNDBhYjliYmRmZTFkNTFiYTVkZmNfNQ_dc72d18b-91cb-4108-b973-2b0d37af8e47">206</ix:nonNumeric>) <ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6ZGNlYjM4NzI0OTY1NGRjNzllZDY5OTczNzljMGIwNTYvdGFibGVyYW5nZTpkY2ViMzg3MjQ5NjU0ZGM3OWVkNjk5NzM3OWMwYjA1Nl81LTEtMS0xLTgzNDE0L3RleHRyZWdpb246Zjg2ZjNmZWJhOTdhNDBhYjliYmRmZTFkNTFiYTVkZmNfOQ_0513ef6c-ea5b-461a-a50f-c651436b3507">333-2001</ix:nonNumeric> </span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Registrant's telephone number, including area code)</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Former name, former address and former fiscal year, if changed since last report)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.606%"><tr><td style="width:1.0%"></td><td style="width:35.035%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.416%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.249%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)&#160;&#160;&#160;&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6MWUzMDVhMzkxMDI0NDg5MmE3YmZmZTE4OGI1MjRkNjIvdGFibGVyYW5nZToxZTMwNWEzOTEwMjQ0ODkyYTdiZmZlMTg4YjUyNGQ2Ml8xLTAtMS0xLTgzNDE0_f7059361-9766-4e45-a61f-55432ede5f8b">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6MWUzMDVhMzkxMDI0NDg5MmE3YmZmZTE4OGI1MjRkNjIvdGFibGVyYW5nZToxZTMwNWEzOTEwMjQ0ODkyYTdiZmZlMTg4YjUyNGQ2Ml8xLTEtMS0xLTgzNDE0_4af80b92-2823-4d54-ae8f-9df31f488191">NAUT</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:107%"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6MWUzMDVhMzkxMDI0NDg5MmE3YmZmZTE4OGI1MjRkNjIvdGFibGVyYW5nZToxZTMwNWEzOTEwMjQ0ODkyYTdiZmZlMTg4YjUyNGQ2Ml8xLTItMS0xLTgzNDE0_79afe71b-a025-4ac3-a13f-73b679b089fc">The Nasdaq Stock Market LLC</ix:nonNumeric></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGV4dHJlZ2lvbjplMmY1NTE1ZTZlYjg0ODRjOWE1NDc4NWViMWRkM2MxOV8yMDE2_f8934ecf-9368-43a9-a1bb-2a21363d99e6">Yes</ix:nonNumeric>  &#9746;    No  &#9744;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). &#160;&#160;&#160;<ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGV4dHJlZ2lvbjplMmY1NTE1ZTZlYjg0ODRjOWE1NDc4NWViMWRkM2MxOV8yMDEy_d3a90565-6315-4a4d-b3b2-b0447b348444">Yes</ix:nonNumeric>  &#9746;    No  &#9744;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:58.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.218%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.952%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Large&#160;accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6OGVlMDNiMDZmMTM1NGQzODlmYTQyY2E2NTg2MjgzNDEvdGFibGVyYW5nZTo4ZWUwM2IwNmYxMzU0ZDM4OWZhNDJjYTY1ODYyODM0MV8xLTAtMS0xLTgzNDE0_706f71f0-c514-4331-8238-f64623f14031">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6OGVlMDNiMDZmMTM1NGQzODlmYTQyY2E2NTg2MjgzNDEvdGFibGVyYW5nZTo4ZWUwM2IwNmYxMzU0ZDM4OWZhNDJjYTY1ODYyODM0MV8xLTMtMS0xLTgzNDE0_95bf2f2c-4ec8-4b96-ab1f-1a44497c5ff1">&#9746;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging&#160;growth&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6OGVlMDNiMDZmMTM1NGQzODlmYTQyY2E2NTg2MjgzNDEvdGFibGVyYW5nZTo4ZWUwM2IwNmYxMzU0ZDM4OWZhNDJjYTY1ODYyODM0MV8yLTMtMS0xLTgzNDE0_0cd2757b-a4c4-4eea-88cb-dca9899f099d">&#9746;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:EntityExTransitionPeriod" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGV4dHJlZ2lvbjplMmY1NTE1ZTZlYjg0ODRjOWE1NDc4NWViMWRkM2MxOV8yMDEw_024cb669-fb04-4d51-a18c-5cb9666ae3a3">o</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). &#160;&#160;&#160;&#160;Yes&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGV4dHJlZ2lvbjplMmY1NTE1ZTZlYjg0ODRjOWE1NDc4NWViMWRkM2MxOV8yMDEx_00da5911-8abc-4930-9bd6-34a28e7a2367">o</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">As of July&#160;29, 2022, the registrant had <ix:nonFraction unitRef="shares" contextRef="i3310b8dff9874981ae5250a336f00a88_I20220729" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGV4dHJlZ2lvbjplMmY1NTE1ZTZlYjg0ODRjOWE1NDc4NWViMWRkM2MxOV8xOTM5_df549588-2945-4958-83e6-074fdbb136af">124,663,186</ix:nonFraction> shares of common stock, $0.0001 par value per share, outstanding.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NAUTILUS BIOTECHNOLOGY, INC.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.878%"><tr><td style="width:1.0%"></td><td style="width:8.138%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.178%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.384%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_13">PART I. FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_13">iii</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_16">Financial Statements</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_16">Condensed Consolidated Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_16">iii</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_22">Condensed Consolidated Balance Sheets as of June 30, 2022 and December 31, 2021 (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_22">1</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_28">Condensed Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2022 and 2021 (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_28">2</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_31">Condensed Consolidated Statements of Comprehensive Loss for the Three and Six Months Ended June 30, 2022 and 2021 (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_31">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_34">Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders&#8217; Equity for the Three and Six Months Ended June 30, 2022 and 2021 (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_34">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_40">Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2022 and 2021 (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_40">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_43">Notes to Condensed Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_43">7</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_82">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_82">21</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_115">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_115">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_118">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_118">32</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_121">PART II - OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_124">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_124">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_127">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_127">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_130">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_130">74</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_133">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_133">74</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_136">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_136">74</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_139">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_139">74</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_142">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_142">75</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_145">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i92b3c97ce8934bb7b7ab6ca5e08b3121_145">76</a></span></div></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_10"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, that are based on our management&#8217;s beliefs and assumptions and on information currently available to our management. The forward-looking statements are contained principally in the section entitled &#8220;Risk Factors&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221; Forward-looking statements include, but are not limited to, statements concerning the following:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our dependence on the success of our proteomics platform (the &#8220;Nautilus platform&#8221;), which remains in the development stage and subject to scientific and technical validation;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the timing and progress of the development of the Nautilus platform;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our estimates of our addressable market, market growth, future revenue, key performance indicators, expenses, capital requirements and needs for additional financing;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the rate and degree of market acceptance of the Nautilus platform;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of the Nautilus platform on the field of proteomics and the size and growth of the addressable proteomics market;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to manage and grow our business and commercialize our Nautilus platform;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully implement our three phase commercial launch plan;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the implementation of our business model and strategic plans for the Nautilus platform;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to establish and maintain intellectual property protection for our products or avoid or defend claims of infringement;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to recognize the anticipated benefits of the Business Combination (as defined in Part I, Item I, Note 1, &#8220;Description of Business and Basis of Presentation,&#8221; in our notes to condensed consolidated financial statements in this Quarterly Report on Form 10-Q), which may be affected by, among other things, competition, our ability to grow and manage future growth effectively, and our ability to retain our key employees;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the use of proceeds from the Business Combination;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the performance of third-party manufacturers and suppliers;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in applicable laws or regulations;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to raise financing in the future;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our success in retaining or recruiting, or changes required in, our officers, key employees or directors or other key personnel;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the volatility of the trading price of our common stock;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to develop and commercialize new products;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations about market trends;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of local, regional, national and international economic conditions and events;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of COVID-19 on the foregoing; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other factors including but not limited to those detailed under the section entitled &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements include statements that are not historical facts and can be identified by terms such as &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;could,&#8221; &#8220;seeks,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;plans,&#8221; &#8220;potential,&#8221; &#8220;predicts,&#8221; &#8220;projects,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; or similar expressions and the negatives of those terms.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. We discuss these risks in greater detail in Part II, Item 1A, &#8220;Risk Factors,&#8221; elsewhere in this Quarterly Report on Form 10-Q. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for us to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the future events and trends discussed in this Quarterly Report on Form 10-Q may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The forward-looking statements made in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made. Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q also contains estimates, projections and other information concerning our industry, our business, and market opportunity, including data regarding the estimated size of the market. Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties and actual events or circumstances may differ materially from events and circumstances reflected in this information. Unless otherwise expressly stated, we obtained this industry, business, market and other data from reports, research surveys, studies and similar data prepared by market research firms and other third parties, industry, medical and general publications, government data and similar sources.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q contains references to trademarks and service marks belonging to other entities. Solely for convenience, trademarks and trade names referred to in this Quarterly Report on Form 10-Q may appear without the &#174; or TM symbols, but such references are not intended to indicate, in any way, that the applicable licensor will not assert, to the fullest extent under applicable law, its rights to these trademarks and trade names. We do not intend our use or display of other companies&#8217; trade names, trademarks or service marks to imply a relationship with, or endorsement or sponsorship of it by, any other companies. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_13"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I. FINANCIAL INFORMATION</span></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_16"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. FINANCIAL STATEMENTS</span></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_19"></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">iii</span></div></div></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_22"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.<br/>Condensed Consolidated Balance Sheets<br/>As of June 30, 2022 and December 31, 2021 (Unaudited)</span></td></tr></table></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except share and per share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMy0xLTEtMS04MzQxNA_f2a34ba3-8ad5-440b-a2b4-b37b168bde33">210,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMy0zLTEtMS04MzQxNA_172ceb15-cb11-4aee-bfff-2237e7bbba83">185,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfNC0xLTEtMS04MzQxNA_8ac6ef9c-53eb-4f7e-9615-130f659eb952">88,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfNC0zLTEtMS04MzQxNA_e4772e06-4eb8-4e53-9e27-2e8f9a25e633">160,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfNS0xLTEtMS04MzQxNA_19f3cede-505b-4b11-bcdc-7c439acecb63">4,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfNS0zLTEtMS04MzQxNA_088e3832-6de0-4138-9f4e-637ba3fab604">3,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfNi0xLTEtMS04MzQxNA_6f361e5c-52e1-4f2d-958b-ac8a503efa54">303,446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfNi0zLTEtMS04MzQxNA_b7e18d9f-a9c1-4d68-a13b-4eebee59e2fa">349,222</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfNy0xLTEtMS04MzQxNA_cbfb0884-0325-423a-9275-36679d07fb21">3,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfNy0zLTEtMS04MzQxNA_5d0ccb3b-78f3-4e00-8241-cb6da98161b6">2,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfOC0xLTEtMS04MzQxNA_83af1df9-3866-42a1-a9ad-d04427fff311">28,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfOC0zLTEtMS04MzQxNA_58a4f38c-bd3f-47ae-bddb-1b4699da0338">29,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfOS0xLTEtMS04MzQxNA_eca101b4-abac-473e-97c9-d2a08ba067cf">35,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:LongTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfOS0zLTEtMS04MzQxNA_13ac0a63-cd10-47b8-9d19-05a912f87738">16,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTAtMS0xLTEtODM0MTQ_6beb1360-f7b9-4b03-a72b-789700206663">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTAtMy0xLTEtODM0MTQ_72f87ed5-1861-4a3b-bc11-bf1e34213704">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTEtMS0xLTEtODM0MTQ_0349a6be-d296-49ea-b3ff-2ee02c33f25a">371,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTEtMy0xLTEtODM0MTQ_05a78b6a-563c-4a26-b3ec-3446dc596398">398,450</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and Stockholders&#8217; Equity</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTQtMS0xLTEtODM0MTQ_cd618fb6-cc18-4640-a021-a64d473456a1">1,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTQtMy0xLTEtODM0MTQ_970f03e3-0212-4cb5-936c-2aed2ea0c49a">1,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTUtMS0xLTEtODM0MTQ_75447f27-d644-476a-a200-0c90e9a0e58b">3,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTUtMy0xLTEtODM0MTQ_0aa57ea6-a9c0-4127-a542-5b8238ba6abc">3,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTYtMS0xLTEtODM0MTQ_eb31bb6b-e7d8-4641-86fd-374b190065b7">1,562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTYtMy0xLTEtODM0MTQ_52cc138c-0428-4ef8-beaa-03b171c5f896">970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTctMS0xLTEtODM0MTQ_6e7502c1-dc03-4205-8186-b921eff117e8">6,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTctMy0xLTEtODM0MTQ_d181b23f-bd72-4fa7-9974-d6c1c796df88">5,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTgtMS0xLTEtODM0MTQ_b188fa6e-b74c-4418-88e8-de7ec36644ae">28,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTgtMy0xLTEtODM0MTQ_876dbba0-0f89-4439-bc20-8b4282ede6e5">29,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTktMS0xLTEtODM0MTQ_523dbc1d-e075-453d-90e7-fe8eaecc2d4e">34,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTktMy0xLTEtODM0MTQ_269a0d90-5cfd-488b-bb4e-d0e047f04e57">34,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 10)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjAtMS0xLTEtODM0MTQ_5ef58b20-dc1d-4263-bf7e-dbfd07f92919"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjAtMy0xLTEtODM0MTQ_70c377dd-5009-4518-abbe-7ace9ffd1e8c"></ix:nonFraction></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjgtMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjo1OWQxYzA2MWQ3YTU0NWYzYjgyYzBhMjMxN2FlMDRhZF8yMQ_9cde1d4f-7d9e-4d97-bffb-515f749eed9e"><ix:nonFraction unitRef="usdPerShare" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjgtMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjo1OWQxYzA2MWQ3YTU0NWYzYjgyYzBhMjMxN2FlMDRhZF8yMQ_a62bbe31-5916-45b8-ac27-63a1b65a3f28">0.0001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjgtMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjo1OWQxYzA2MWQ3YTU0NWYzYjgyYzBhMjMxN2FlMDRhZF8zNQ_a8b2c238-fb24-44c0-ad3a-adb4d1ae68b2"><ix:nonFraction unitRef="shares" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjgtMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjo1OWQxYzA2MWQ3YTU0NWYzYjgyYzBhMjMxN2FlMDRhZF8zNQ_cb6ae7c8-eb1a-452a-bdf7-dbd3e76582f6">200,000,000</ix:nonFraction></ix:nonFraction> authorized as of June 30, 2022 and December 31, 2021; <ix:nonFraction unitRef="shares" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjgtMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjo1OWQxYzA2MWQ3YTU0NWYzYjgyYzBhMjMxN2FlMDRhZF85Mw_5a246a95-262d-4f09-983c-d1ddc236456f"><ix:nonFraction unitRef="shares" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjgtMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjo1OWQxYzA2MWQ3YTU0NWYzYjgyYzBhMjMxN2FlMDRhZF85Mw_5dbb3ead-d3db-42dc-a497-1d25116443d6"><ix:nonFraction unitRef="shares" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjgtMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjo1OWQxYzA2MWQ3YTU0NWYzYjgyYzBhMjMxN2FlMDRhZF85Mw_7940e4c3-5a25-465a-b4ea-1b189c23abd8"><ix:nonFraction unitRef="shares" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjgtMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjo1OWQxYzA2MWQ3YTU0NWYzYjgyYzBhMjMxN2FlMDRhZF85Mw_c5717911-43f1-4a94-a418-7cba61e1b439">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding as of June 30, 2022 and December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjgtMS0xLTEtODM0MTQ_d7de816c-dc05-4672-9a03-42ba1490a130">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjgtMy0xLTEtODM0MTQ_2bab9cde-a501-476f-9486-e4dba93cbeb8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:13.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjktMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjowODljYjg1YmEyNjc0MjZkOGMwMjg2ZDY2OGI0NWNkNl8xOA_87b5993d-f293-40ec-9b68-26716c93841a"><ix:nonFraction unitRef="usdPerShare" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjktMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjowODljYjg1YmEyNjc0MjZkOGMwMjg2ZDY2OGI0NWNkNl8xOA_e36d54de-7207-4a57-9de5-82ab8640741b">0.0001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjktMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjowODljYjg1YmEyNjc0MjZkOGMwMjg2ZDY2OGI0NWNkNl8zMg_973b1940-13ef-482c-b464-3489ca37afa5"><ix:nonFraction unitRef="shares" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjktMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjowODljYjg1YmEyNjc0MjZkOGMwMjg2ZDY2OGI0NWNkNl8zMg_bfd437a5-8e53-47d8-a4ca-9a7651cad426">1,000,000,000</ix:nonFraction></ix:nonFraction> shares authorized as of June 30, 2022 and December 31, 2021; <ix:nonFraction unitRef="shares" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjktMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjowODljYjg1YmEyNjc0MjZkOGMwMjg2ZDY2OGI0NWNkNl81NDk3NTU4MTQxMzg_05d799fa-4752-4729-9390-e8482e49279b"><ix:nonFraction unitRef="shares" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjktMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjowODljYjg1YmEyNjc0MjZkOGMwMjg2ZDY2OGI0NWNkNl81NDk3NTU4MTQxMzg_8f372bb1-36a9-4556-a6cc-ca4e68f3d283">124,562,745</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjktMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjowODljYjg1YmEyNjc0MjZkOGMwMjg2ZDY2OGI0NWNkNl8xMDQ_20973716-f348-458b-ad4a-afeb7799d8ce"><ix:nonFraction unitRef="shares" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjktMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjowODljYjg1YmEyNjc0MjZkOGMwMjg2ZDY2OGI0NWNkNl8xMDQ_6ffc6fa3-7911-4d4f-86db-514ea0620027">124,303,083</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjktMS0xLTEtODM0MTQ_9916d05b-d90f-4399-85b7-fc9e28a190b6">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjktMy0xLTEtODM0MTQ_44771228-fcfb-4fff-924d-ac361562ce11">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMzAtMS0xLTEtODM0MTQ_e6374bb3-b37a-4aa7-8514-4bb949cb7ef8">449,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMzAtMy0xLTEtODM0MTQ_74e74da7-ecf9-47c9-8a52-46d0762e3622">444,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMzEtMS0xLTEtODM0MTQ_11218dcf-a413-4b80-9780-324b63eca68a">768</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMzEtMy0xLTEtODM0MTQ_c1e6c412-41b9-4a11-9498-615d4be46d08">184</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMzItMS0xLTEtODM0MTQ_a9264884-2fbf-4207-bdfb-d10b7d9cd96a">111,092</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMzItMy0xLTEtODM0MTQ_86abe254-cedd-43fb-b8d0-50c83183608a">80,640</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMzMtMS0xLTEtODM0MTQ_983bcdda-72aa-46a3-aa00-de67831197a6">337,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMzMtMy0xLTEtODM0MTQ_c2cff64b-0c5d-4826-a33e-7ea45e1187cc">363,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMzQtMS0xLTEtODM0MTQ_11435570-f0dc-4d47-a477-feabc0f80cf0">371,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMzQtMy0xLTEtODM0MTQ_5445cdb7-114a-400d-87fb-baf60a64dbc8">398,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_28"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Nautilus Biotechnology, Inc.<br/>Condensed Consolidated Statements of Operations<br/>Three and Six Months Ended June 30, 2022 and 2021 (Unaudited)</span></td></tr></table></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:42.037%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.625%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.625%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.625%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.629%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except share and per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfMy0xLTEtMS04MzQxNA_5bf072ee-0f76-4f29-ad8d-a981bdb9957b">8,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfMy0zLTEtMS04MzQxNA_abbb829a-058a-4ef4-9a49-2bab073cf4c8">6,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfMy01LTEtMS04MzQxNA_77aa840c-73b2-4f8e-a5b7-6ac303650b6b">18,514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfMy03LTEtMS04MzQxNA_37546d8d-37e4-42c3-bd08-be95dee76c25">11,215</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNC0xLTEtMS04MzQxNA_8a91502c-8b9e-48b3-b6a3-9df22ebc6949">6,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNC0zLTEtMS04MzQxNA_fec8a2fd-07c4-4408-b2f4-5f54249ca381">4,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNC01LTEtMS04MzQxNA_1b47280a-6469-4ed8-805a-340255f6c94d">12,980</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNC03LTEtMS04MzQxNA_87e34f96-d628-4491-a6d9-6f48bf07d677">7,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNS0xLTEtMS04MzQxNA_792ab35f-3e09-415c-923a-af01972fd6bf">15,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNS0zLTEtMS04MzQxNA_aa64bcec-c4f2-4ad9-9e64-947a66ad242f">10,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNS01LTEtMS04MzQxNA_a6b6e9e9-0a38-42cc-a9c9-eefe27d88065">31,494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNS03LTEtMS04MzQxNA_a12cb879-9fde-4bf0-98d6-f69e66647a9e">19,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNi0xLTEtMS04MzQxNA_165305b1-c05c-4180-9732-09c2224985a6">783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNi0zLTEtMS04MzQxNA_4601102c-3f23-401c-9303-a7e0192a1c79">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNi01LTEtMS04MzQxNA_5484cea3-ca13-4a71-a6ce-660625d0ac77">1,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNi03LTEtMS04MzQxNA_24252394-2af4-404b-80b6-e7ee9a1a1156">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNy0xLTEtMS04MzQxNA_e2a17bf4-2dce-4b7e-b520-65c14085980b">14,689</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNy0zLTEtMS04MzQxNA_e1e5a080-67b7-4bf9-b080-28f45554378c">10,713</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNy01LTEtMS04MzQxNA_41532c2e-7127-450d-8c26-60bd37c0ee73">30,452</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNy03LTEtMS04MzQxNA_85a5d434-c84c-46c2-98e4-23b2b3f9533c">19,122</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share attributable to common stockholders, basic and diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOC0xLTEtMS04MzQxNA_1e0f17c4-2f14-4832-bd55-21c2f0a4d6c6"><ix:nonFraction unitRef="usdPerShare" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOC0xLTEtMS04MzQxNA_2be2c711-690a-4ffd-bb80-8a212b637b72">0.12</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOC0zLTEtMS04MzQxNA_1623d0dc-792b-4eae-8418-3cf486621aaf"><ix:nonFraction unitRef="usdPerShare" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOC0zLTEtMS04MzQxNA_3eb772e5-f061-4cb2-8ee6-833e004fb1fa">0.19</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOC01LTEtMS04MzQxNA_af7a962f-9261-40b0-a744-6385301c6f84"><ix:nonFraction unitRef="usdPerShare" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOC01LTEtMS04MzQxNA_e2e0530f-52c1-42a3-a197-47f5e6e6d305">0.24</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOC03LTEtMS04MzQxNA_7b8120b2-0b82-40df-ae23-bf6603dfabfc"><ix:nonFraction unitRef="usdPerShare" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOC03LTEtMS04MzQxNA_e417f70a-3505-41a2-8b43-4f264d605894">0.43</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOS0xLTEtMS04MzQxNA_2124441b-d8fc-4696-8dcf-a50a033ec28a"><ix:nonFraction unitRef="shares" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOS0xLTEtMS04MzQxNA_54747aa2-1f7c-4079-860e-f8c4cee78248">124,494,036</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOS0zLTEtMS04MzQxNA_452204ca-28cd-4bfa-b6d8-ad156001bb3b"><ix:nonFraction unitRef="shares" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOS0zLTEtMS04MzQxNA_5c220873-1e3c-4a5f-8911-23007abe8f19">55,070,480</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOS01LTEtMS04MzQxNA_816b2f97-5e43-4967-ab89-4d72295bb476"><ix:nonFraction unitRef="shares" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOS01LTEtMS04MzQxNA_b7d149ab-4f2a-4699-8166-7a24531f01e6">124,456,518</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOS03LTEtMS04MzQxNA_20a72585-7f3b-4a14-a8ee-03f73aaf5c70"><ix:nonFraction unitRef="shares" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOS03LTEtMS04MzQxNA_b3a3bf32-878e-4ab6-b43f-d6d6753ea607">44,096,149</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_31"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.<br/>Condensed Consolidated Statements of Comprehensive Loss<br/>Three and Six Months Ended June 30, 2022 and 2021 (Unaudited)</span></td></tr></table></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.557%"><tr><td style="width:1.0%"></td><td style="width:42.314%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.450%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.450%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.450%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.562%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfMi0xLTEtMS04MzQxNA_4dbb0723-e645-454c-b903-c21c550e27b7">14,689</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfMi0zLTEtMS04MzQxNA_2ad794ce-d269-44f7-9b92-38cae5bdd22f">10,713</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfMi01LTEtMS04MzQxNA_f1f011a2-085e-44f1-a2e0-2b5329f0d574">30,452</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfMi03LTEtMS04MzQxNA_5d20a72d-3e60-4219-afc5-7a82580a6618">19,122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss on securities available-for-sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfNC0xLTEtMS04MzQxNA_aaae8e00-7ed1-4ddd-9c84-28e245f984bc">214</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfNC0zLTEtMS04MzQxNA_752c9718-bfab-4ce2-bd33-85b6059775b2">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfNC01LTEtMS04MzQxNA_9dfbcd28-29f7-4d78-b622-18a5287e90c2">584</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfNC03LTEtMS04MzQxNA_77bb59cc-8744-4e1e-af2a-f76dbf536553">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfNS0xLTEtMS04MzQxNA_35bbdff3-cda5-4dce-821b-18feef74ee35">214</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfNS0zLTEtMS04MzQxNA_e67088fc-444f-4334-964f-77c4f1e35614">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfNS01LTEtMS04MzQxNA_7118a275-e010-485b-a7fb-e7c83fb55c26">584</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfNS03LTEtMS04MzQxNA_8c85ca37-2f5a-48ff-ba47-b370972771cc">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfNi0xLTEtMS04MzQxNA_61fc64ab-c124-4253-a9fb-8dae0998800a">14,903</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfNi0zLTEtMS04MzQxNA_c60203a1-332f-4346-8dfb-e77f79ec512e">10,725</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfNi01LTEtMS04MzQxNA_ad85f614-bed4-407d-aba8-db468d9c2c4d">31,036</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfNi03LTEtMS04MzQxNA_2f9540b8-d4ae-417b-a97e-58ba23d9cf34">19,135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_34"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders&#8217; Equity</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Three and Six Months Ended June 30, 2022 and 2021 (Unaudited)</span></div></td></tr></table></div></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.884%"><tr><td style="width:1.0%"></td><td style="width:16.628%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.114%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.114%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.114%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.358%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.968%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.213%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Three Months Ended June 30, 2022</span></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Redeemable Convertible Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total Stockholders&#8217;Equity</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Series Seed</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Series A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Series B</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i324e2cc43a4e4cf587d2f6ab80062f51_I20220331" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMy0xLTEtMS04MzQxNA_4f2de112-61d8-4bb9-93d0-2ca9f47c4787">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i324e2cc43a4e4cf587d2f6ab80062f51_I20220331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMy0zLTEtMS04MzQxNA_83dd1e83-0da1-49f9-b223-60aa8b8cdb4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7f90b4ca496645789fa6b735ea5ebed6_I20220331" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMy01LTEtMS04MzQxNA_d0ab9f6e-6517-497c-a335-58238b38a3c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f90b4ca496645789fa6b735ea5ebed6_I20220331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMy03LTEtMS04MzQxNA_64c4be1e-227f-4bd0-826c-204f058eea24">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icdd25765152a4ced9576a609916fc669_I20220331" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMy05LTEtMS04MzQxNA_185b161f-3e44-4c4d-9e55-a3361a7e6703">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdd25765152a4ced9576a609916fc669_I20220331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMy0xMS0xLTEtODM0MTQ_d314a4f5-fec9-4bcc-ba96-f5f061b26ff6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i90b7a94b75e741018792ad40fce39e8b_I20220331" decimals="0" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMy0xNC0xLTEtODM0MTQ_232b3041-b005-41f9-a8ea-3b8e12db7ce5">124,456,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90b7a94b75e741018792ad40fce39e8b_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMy0xNi0xLTEtODM0MTQ_b466ca58-c24a-421c-a2d1-39dd40ac21d6">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671a15cf99d44d1784c894a87c80e686_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMy0xOC0xLTEtODM0MTQ_fffe595c-757c-43c3-b6cb-da935953461f">446,654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84e9820405224bd7bd61573fe1ab8754_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMy0yMC0xLTEtODM0MTQ_0cb652a3-dd03-4bcb-aa3a-dbfb265a3144">554</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if84c94ae09ea4044bd354a2967d293b3_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMy0yMi0xLTEtODM0MTQ_4f728d23-4764-48ce-baf5-018fb3bd1670">96,403</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i92668a7081b949668c4894010570de77_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMy0yNC0xLTEtODM0MTQ_505e52df-4355-4b54-8e9a-595cb77ec35d">349,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of vested stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8e0a243e6ed64e6380f701b2efb5ff8b_D20220401-20220630" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfNC0xNC0xLTEtODM0MTQ_25ec29a3-b678-491c-9a8a-a204d1aecbb2">57,739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e6daf471bc241889e532847e9ba6e85_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfNC0xOC0xLTEtODM0MTQ_27dcc36a-a9cf-4881-a33e-dffbd5bb9d80">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfNC0yNC0xLTEtODM0MTQ_3e878895-4fe3-47a6-ba0f-7815fbf0b5fd">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8e0a243e6ed64e6380f701b2efb5ff8b_D20220401-20220630" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfOC0xNC0xLTEtODU3Mjk_ca58fa75-9d48-45d5-8c67-46360349960e">48,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e6daf471bc241889e532847e9ba6e85_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfOC0xOC0xLTEtODU3Mjk_c0eb12c5-77f8-4749-9ad0-4829e87b3a86">153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfOC0yNC0xLTEtODU3Mjk_46627f7a-6728-41c7-a64a-bd1f7676c3ff">153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e6daf471bc241889e532847e9ba6e85_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfOC0xOC0xLTEtODM0MTQ_dbdde066-853a-4f3c-93a1-8df024ddf1e1">2,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfOC0yNC0xLTEtODM0MTQ_9c2ff734-6ae8-4367-a9d8-9dc7b3b24cc0">2,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5d7470609454d0e9b5dff503cff7980_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfOS0yMC0xLTEtODM0MTQ_09b84257-f55e-486a-9a40-83ff8b4efc14">214</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfOS0yNC0xLTEtODM0MTQ_709f0dc2-b0fa-4ddf-959f-236933b604ea">214</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9432f4700dc64531b14d489ac2a5a042_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTAtMjItMS0xLTgzNDE0_62d0d793-1e7d-436f-badb-7ce380ab5d09">14,689</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTAtMjQtMS0xLTgzNDE0_31978425-f0b8-46e7-99ae-ea71d19872d3">14,689</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances at June&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4472b9eda37d47c1a4d8adc7d6d2cd67_I20220630" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTEtMS0xLTEtODM0MTQ_88fc44d0-37f9-4ed4-b56e-552752c1af8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4472b9eda37d47c1a4d8adc7d6d2cd67_I20220630" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTEtMy0xLTEtODM0MTQ_567da97a-6747-4651-be5b-96ed646e7d8d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia8d4f89749114fff9f0cfa6384876a0b_I20220630" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTEtNS0xLTEtODM0MTQ_6f535203-24ca-4be3-9a7b-81f33d234284">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8d4f89749114fff9f0cfa6384876a0b_I20220630" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTEtNy0xLTEtODM0MTQ_9813c83e-e45f-49e5-af37-cf4e5f559a5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3734d525d0254e38ba1f10086eb40e63_I20220630" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTEtOS0xLTEtODM0MTQ_10309e3e-07c1-4a4f-b74a-19eda04585c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3734d525d0254e38ba1f10086eb40e63_I20220630" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTEtMTEtMS0xLTgzNDE0_e243dc6a-e409-4fa0-b4a4-2c3fb334e040">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i389999977661484882273df554199358_I20220630" decimals="0" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTEtMTQtMS0xLTgzNDE0_8cfad24e-c405-4f5b-811e-df00e8e7b288">124,562,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i389999977661484882273df554199358_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTEtMTYtMS0xLTgzNDE0_e1dd7a57-a614-481a-9f8a-2090149bf699">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie314d916207a418aa13a6eac1ba0316b_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTEtMTgtMS0xLTgzNDE0_eb6be7ee-7597-489b-a46e-70607ef3d741">449,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e283e466604a8d91b96c149bce904f_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTEtMjAtMS0xLTgzNDE0_c18134a8-82ea-4546-bb02-ba9e5b9b30e4">768</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d2cd67fbecd458cba307172152eed68_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTEtMjItMS0xLTgzNDE0_634cf4a3-4160-4147-8502-c15bf7c989a5">111,092</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTEtMjQtMS0xLTgzNDE0_3a8b2b85-ae57-49f0-9396-c2f281d16587">337,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.884%"><tr><td style="width:1.0%"></td><td style="width:16.628%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.114%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.114%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.114%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.358%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.968%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.213%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Three Months Ended June 30, 2021</span></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Redeemable Convertible Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total Stockholders&#8217; (Deficit) Equity</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Series Seed</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Series A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Series B</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia42f738735254708b40f6633a2122e8e_I20210331" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy0xLTEtMS04MzQxNA_d93a5fd4-a81d-4f6a-bcf2-79846171a71b">13,174,805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia42f738735254708b40f6633a2122e8e_I20210331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy0zLTEtMS04MzQxNA_74f026fb-b1ac-4723-9525-dae8cf62ec7f">5,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie85bed107ca14c97901fe21cb7bb5dd8_I20210331" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy01LTEtMS04MzQxNA_3dc86bbc-0b9f-4c1b-a97e-7d41ff3190d9">16,836,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie85bed107ca14c97901fe21cb7bb5dd8_I20210331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy03LTEtMS04MzQxNA_b61d2c0c-4d5d-4a2c-b791-2eaad1e44964">27,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1335e9d7772048258994030cd2031c3f_I20210331" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy05LTEtMS04MzQxNA_daa8f9e7-8532-4003-82f7-c4c3ae86deca">22,164,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1335e9d7772048258994030cd2031c3f_I20210331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy0xMS0xLTEtODM0MTQ_c8cebed6-c049-4e76-8ade-16e6bc0b38c7">75,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i05843a43ee50491196307c78a95fc47c_I20210331" decimals="0" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy0xNC0xLTEtODM0MTQ_4d3d6df8-8f33-4873-8fbc-7848e7307f40">33,069,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05843a43ee50491196307c78a95fc47c_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy0xNi0xLTEtODM0MTQ_69a009d1-e949-467b-8473-c2f19595d8a1">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e040518794245b0863ec2f6444d3794_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy0xOC0xLTEtODM0MTQ_67fe4961-4b0a-4ba6-9c7c-21725fbd91c9">1,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5202287c29e942c5b0cdac7690f742a4_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy0yMC0xLTEtODM0MTQ_8cd27a55-13ed-4bff-9e12-7128b9535c2a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bb0ce9e01b540f58814347806008b98_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy0yMi0xLTEtODM0MTQ_50b03d28-defb-4def-99df-e20ba1db08c8">38,734</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i3c6985f8581548c2a524d21940747415_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy0yNC0xLTEtODM0MTQ_33d9f17d-bbec-4ecb-9ce3-4f325f3d3871">36,795</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of vested stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i331a2564c2fd4ca8a141e5b7414f9560_D20210401-20210630" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNC0xNC0xLTEtODM0MTQ_60d8abd0-bfc6-4ce0-9a1f-cda9cdbd83ff">65,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4c2e6f425d94a478aa350968a70941c_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNC0xOC0xLTEtODM0MTQ_f3c86b3d-c919-4fc4-ae13-0adf43f9653a">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNC0yNC0xLTEtODM0MTQ_7324e612-566a-42ed-b173-c04e51871f0a">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i331a2564c2fd4ca8a141e5b7414f9560_D20210401-20210630" decimals="0" name="naut:StockIssuedDuringPeriodSharesWarrantsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNS0xNC0xLTEtODQ0NzU_61e3aa2a-5c3e-494b-ae90-37291d77a75f">62,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia19895c7ccdf43c886000a1fe40ad74d_D20210401-20210630" decimals="0" sign="-" name="naut:ReclassificationsOfTemporaryToPermanentEquityShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi0xLTEtMS04NDQ2OA_20297a22-d73b-4327-b5ca-3ff135f493d7">13,174,805</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia19895c7ccdf43c886000a1fe40ad74d_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:ReclassificationsOfTemporaryToPermanentEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi0zLTEtMS04NDQ2OA_102faac5-abf5-4ce5-adc3-3549f86ea6a7">5,494</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i23ee12f309a94096b523c85c9c89ec41_D20210401-20210630" decimals="0" sign="-" name="naut:ReclassificationsOfTemporaryToPermanentEquityShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi01LTEtMS04NDQ2OA_9ce79aea-6f5a-4f20-b036-347ba96cdc23">16,836,436</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23ee12f309a94096b523c85c9c89ec41_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:ReclassificationsOfTemporaryToPermanentEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi03LTEtMS04NDQ2OA_4f3c1bb2-2773-4c67-b7c6-a6922b8769b6">27,067</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ibb3fddc37cf84806bb3cb2eb9243e764_D20210401-20210630" decimals="0" sign="-" name="naut:ReclassificationsOfTemporaryToPermanentEquityShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi05LTEtMS04NDQ2OA_43ffdcfe-0fbb-4d42-9614-cfecfc6ff0c7">22,164,724</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb3fddc37cf84806bb3cb2eb9243e764_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:ReclassificationsOfTemporaryToPermanentEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi0xMS0xLTEtODQ0Njg_856aa965-04c9-4ef7-b35b-e73286357a4d">75,857</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i331a2564c2fd4ca8a141e5b7414f9560_D20210401-20210630" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi0xNC0xLTEtODQ0NzU_57bc314f-834c-40f1-a242-997899b68f31">52,175,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i331a2564c2fd4ca8a141e5b7414f9560_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi0xNi0xLTEtODQ0NzU_6902c066-89ad-44c8-91f1-e34e3a9ac77f">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4c2e6f425d94a478aa350968a70941c_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi0xOC0xLTEtODQ0NzU_0df6904a-298a-48ae-91d8-89e0994e080b">108,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi0yNC0xLTEtODQ0NzU_d41e32d7-7f35-47bc-ba02-39d7feb120d1">108,418</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock upon the reverse recapitalization, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i331a2564c2fd4ca8a141e5b7414f9560_D20210401-20210630" decimals="0" name="naut:StockIssuedDuringPeriodSharesReverseRecapitalization" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNy0xNC0xLTEtODQ0NzU_05b2a09e-74fe-48ba-9927-bcbc1cebd63e">38,721,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i331a2564c2fd4ca8a141e5b7414f9560_D20210401-20210630" decimals="-3" name="naut:StockIssuedDuringPeriodValueReverseRecapitalization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNy0xNi0xLTEtODQ0NzU_749ccf7a-b4ed-41bf-9f19-1143f23fe77c">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4c2e6f425d94a478aa350968a70941c_D20210401-20210630" decimals="-3" name="naut:StockIssuedDuringPeriodValueReverseRecapitalization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNy0xOC0xLTEtODQ0NzU_b88beadd-30cd-49c1-b641-f75fcda5cc86">327,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="-3" name="naut:StockIssuedDuringPeriodValueReverseRecapitalization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNy0yNC0xLTEtODQ0NzU_facf65d2-b995-4a55-b2f4-9d5f83ecbd88">327,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4c2e6f425d94a478aa350968a70941c_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi0xOC0xLTEtODM0MTQ_f4592e0f-7dd2-4fc5-8600-22741c841628">1,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi0yNC0xLTEtODM0MTQ_d1ede71e-ec40-48f0-91f0-75f6f8603a59">1,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64c43e244ef8492fa7383bb02f49cad6_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNy0yMC0xLTEtODM0MTQ_961c877f-50bd-4db6-8783-46b026a99904">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNy0yNC0xLTEtODM0MTQ_ef7d39c7-8394-4d6a-9f7e-10aaebb8d5d3">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf5ead0636be44b29ce427b1dd08509d_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOC0yMi0xLTEtODM0MTQ_588d2ae0-ca5b-4ba5-8f41-c64548e6703e">10,713</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOC0yNC0xLTEtODM0MTQ_dcd87651-b1b3-4552-a625-ea073a3e2145">10,713</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances at June&#160;30, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie9e2d89185264884b8085af4b2cd97fc_I20210630" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS0xLTEtMS04MzQxNA_034b4253-3fca-4b18-92d1-236a541cddfd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9e2d89185264884b8085af4b2cd97fc_I20210630" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS0zLTEtMS04MzQxNA_267b6689-b499-4049-a619-59cd0cc66bb3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic17b9d22c2764dd798b80f5dfc34b5cf_I20210630" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS01LTEtMS04MzQxNA_33093a59-7f1b-49ac-a9c6-08437cf57263">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic17b9d22c2764dd798b80f5dfc34b5cf_I20210630" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS03LTEtMS04MzQxNA_35f2c7c1-5b02-4b2b-b2e5-fab204b3ffb5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i91ec4082056644ceb4605ae97ee305ff_I20210630" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS05LTEtMS04MzQxNA_6edd4567-16bd-4015-a577-62d71f192da8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91ec4082056644ceb4605ae97ee305ff_I20210630" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS0xMS0xLTEtODM0MTQ_8412c177-d857-42d2-bbfd-774dd35e884f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5a3a46052d04721ae2a3b35284e5778_I20210630" decimals="0" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS0xNC0xLTEtODM0MTQ_3f69f49b-df8f-49c3-be9b-43be5bd65607">124,094,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5a3a46052d04721ae2a3b35284e5778_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS0xNi0xLTEtODM0MTQ_a2f0552e-8620-45a6-b8e6-2def11706570">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c20cf8954844243a311683aea4cdc51_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS0xOC0xLTEtODM0MTQ_294dfcf9-fdcc-4789-bed5-b77b6ba5f894">439,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93e671a07e70472fbbddd30300e8c88e_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS0yMC0xLTEtODM0MTQ_f40f8d30-6991-476e-a77f-597396e4c082">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af05f6fd3814dfcbf23c51970fb91b2_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS0yMi0xLTEtODM0MTQ_d605b811-6bc0-4e3e-9ac3-650b83327e24">49,447</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibff31d711c89442ab7051c729b67d7e0_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS0yNC0xLTEtODM0MTQ_cb3df700-d94e-4f41-869b-fd9741fc0429">390,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders&#8217; Equity</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Three and Six Months Ended June 30, 2022 and 2021 (Unaudited)</span></div></td></tr></table></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.418%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.108%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.108%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.108%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.612%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.529%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.802%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.117%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.210%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Six Months Ended June 30, 2022</span></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Redeemable Convertible Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total Stockholders&#8217;Equity</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Series Seed</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Series A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Series B</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7cc1b5792cf94105940e3332ea917424_I20211231" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy0xLTEtMS04NDUwNg_4edba972-c1cb-4ffb-a57b-4e2ca9adfa57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cc1b5792cf94105940e3332ea917424_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy0zLTEtMS04NDUwNg_1c2eb489-595e-40d3-ae48-0e34b7a340b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i36b1b43803b74d6f9880f7465fee5d9b_I20211231" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy01LTEtMS04NDUwNg_b8bc7253-d81f-4b02-959a-8f5afd08a577">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36b1b43803b74d6f9880f7465fee5d9b_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy03LTEtMS04NDUwNg_d7762fa1-23e9-4cc2-96e8-a508cc22a36f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib4e23aef5312440092a0c722a7b14905_I20211231" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy05LTEtMS04NDUwNg_2d8ba5f5-eee8-4e45-8c28-d31752cafccc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4e23aef5312440092a0c722a7b14905_I20211231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy0xMS0xLTEtODQ1MDY_04303050-74ba-4699-a323-c9dc69e9aa7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id40db1cc432e4a13bfe6f29d29443dfb_I20211231" decimals="0" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy0xNC0xLTEtODQ1MDk_ffa78cf3-5d7a-4ce6-8f0a-89208842a501">124,303,083</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id40db1cc432e4a13bfe6f29d29443dfb_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy0xNi0xLTEtODQ1MDk_b7754c9d-40e0-4947-b931-f55d1c31a34c">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fc487a3a7a14aa09b1841736e6b5f97_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy0xOC0xLTEtODQ1MDk_59770708-d6e2-499b-9545-c4aec1ad8b08">444,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b2bafa5e4ed4f35b82f303f9778746d_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy0yMC0xLTEtODQ1MDk_6e64d513-844f-487b-9ca7-1da3e1665f1b">184</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib76ca1b4c23944e7823ec12efb0e4440_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy0yMi0xLTEtODQ1MDk_ce7a83dc-bb01-4847-9b7f-f75e83dd990d">80,640</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy0yNC0xLTEtODQ1MDk_a625d7cd-8675-456f-808f-d3753bfe3099">363,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of vested stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6a897b30f9ac4d8a98520fc12b077eb7_D20220101-20220630" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfNC0xNC0xLTEtODQ1MDk_8f776fee-0955-4314-837d-e64b44ab36d0">211,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd33588bc4814c39915e2771cc9556d1_D20220101-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfNC0xOC0xLTEtODQ1MDk_2f2f6ef8-39a4-4a68-a5e8-cc6ea2dda780">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfNC0yNC0xLTEtODQ1MDk_9b0e5eff-5539-4836-87a3-c86c3bb13d32">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6a897b30f9ac4d8a98520fc12b077eb7_D20220101-20220630" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfOC0xNC0xLTEtODU2OTk_17cc78a9-285a-4683-b922-53ccbca07603">48,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd33588bc4814c39915e2771cc9556d1_D20220101-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfOC0xOC0xLTEtODU2OTk_63722114-c999-4aeb-ac6d-5c56ff437c76">153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfOC0yNC0xLTEtODU2OTk_e0c8abe3-0047-4ad0-9578-2ed6806fe3bf">153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd33588bc4814c39915e2771cc9556d1_D20220101-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfOC0xOC0xLTEtODQ1MDk_8a263ee5-d8d5-4c53-9d24-b9d02b802d39">4,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfOC0yNC0xLTEtODQ1MDk_2505e360-7771-4710-aa47-9dc1535394fe">4,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6be3e094f3c24773ad3af2c5ef2aa634_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfOS0yMC0xLTEtODQ1MDk_fd8ce64c-742e-4851-bdd9-9642f969c064">584</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfOS0yNC0xLTEtODQ1MDk_44a0817d-41bb-4f70-89bc-1f6d3cd32584">584</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i149f021a272a4689a24162c8f8e7d768_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTAtMjItMS0xLTg0NTA5_98696552-f898-49fa-910d-ab81d7d26ff0">30,452</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTAtMjQtMS0xLTg0NTA5_81bdf90c-9fdd-475d-8397-dc84fe223de7">30,452</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances at June 30, 2022 </span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4472b9eda37d47c1a4d8adc7d6d2cd67_I20220630" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtMS0xLTEtODQ1MDY_bffaae5a-9acd-4a32-96ff-e26d68de6ad5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4472b9eda37d47c1a4d8adc7d6d2cd67_I20220630" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtMy0xLTEtODQ1MDY_49fbf8a3-d880-4a89-aba4-d976da0efe07">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia8d4f89749114fff9f0cfa6384876a0b_I20220630" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtNS0xLTEtODQ1MDY_22ceea25-8891-45fb-bfa7-d4ed0c4c76e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8d4f89749114fff9f0cfa6384876a0b_I20220630" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtNy0xLTEtODQ1MDY_391465c4-0a52-4802-89df-589019b17e0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3734d525d0254e38ba1f10086eb40e63_I20220630" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtOS0xLTEtODQ1MDY_210860ff-0daf-48e6-97d5-7d4e201f43f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3734d525d0254e38ba1f10086eb40e63_I20220630" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtMTEtMS0xLTg0NTA2_e6151c55-bf84-49e5-a3fe-d4974dfa5518">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i389999977661484882273df554199358_I20220630" decimals="0" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtMTQtMS0xLTg0NTA5_26835d7a-7a99-4bda-887f-9ce027293260">124,562,745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i389999977661484882273df554199358_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtMTYtMS0xLTg0NTA5_c6d78b3b-69e9-4182-9ead-64d085d1bfc9">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie314d916207a418aa13a6eac1ba0316b_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtMTgtMS0xLTg0NTA5_b84c552c-c8d5-4ee5-83ca-ad5bb4e25bc5">449,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e283e466604a8d91b96c149bce904f_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtMjAtMS0xLTg0NTA5_8e4a9983-9b60-4044-a25e-b64d8cd40a34">768</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d2cd67fbecd458cba307172152eed68_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtMjItMS0xLTg0NTA5_bb452fe9-7b64-4778-a7e6-b3593c7594c7">111,092</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtMjQtMS0xLTg0NTA5_475be139-c8d3-4ac9-b249-8a2581c4081b">337,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.418%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.108%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.108%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.728%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.108%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.612%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.529%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.802%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.117%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.262%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.210%"></td><td style="width:0.1%"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:underline">Six Months Ended June 30, 2021</span></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Redeemable Convertible Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional Paid-in Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total Stockholders&#8217; (Deficit) Equity</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Series Seed</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Series A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Series B</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1a4309f941040f286a32c33912b765f_I20201231" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy0xLTEtMS04NDQ5Mg_851ca1e7-788c-4451-a018-d1ddcb4366c1">13,174,805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1a4309f941040f286a32c33912b765f_I20201231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy0zLTEtMS04NDQ5Mg_9acad75e-925f-49b0-82f7-7e2a822d6467">5,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i72367460707f479b803532b3fb755692_I20201231" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy01LTEtMS04NDQ5Mg_1d02e536-9978-4a12-9457-c9d32604020b">16,836,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72367460707f479b803532b3fb755692_I20201231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy03LTEtMS04NDQ5Mg_2c1cc92d-3225-406a-ae35-43dcc870b071">27,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7d44af6f75f540d7b0ecbde2f40b4975_I20201231" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy05LTEtMS04NDQ5Mg_e6eed32e-e8f9-4997-9df8-2ef2c264d55a">22,164,724</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d44af6f75f540d7b0ecbde2f40b4975_I20201231" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy0xMS0xLTEtODQ0OTI_5473fab1-5d8c-49bb-9181-375cb21b2ba1">75,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifde94ccddd2d45069a65f8843572a9ae_I20201231" decimals="0" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy0xNC0xLTEtODQ0OTk_719f2a7b-ec0b-40ac-a508-a821cb3bd035">33,069,513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifde94ccddd2d45069a65f8843572a9ae_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy0xNi0xLTEtODQ0OTk_fe9faf56-eac0-4e2e-add6-1f6c6f88d799">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35476aa1f20349a1b78904608e5b16ab_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy0xOC0xLTEtODQ0OTk_e522849a-bc2c-4406-bec1-01e03c485c1f">600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ea49b1cdab94931bcc33becf8b06845_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy0yMC0xLTEtODQ0OTk_b1b80ac4-d0c5-4495-bc3a-a48a57547558">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i944a24eac2e246da8e69f0c1ac41391d_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy0yMi0xLTEtODQ0OTk_d1834298-3088-410a-b0d4-a253983066d9">30,325</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i616643cbd31d47a686cf71385bb21573_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy0yNC0xLTEtODQ0OTk_d4c33bb7-53b9-452b-8486-87ad803fc7b7">29,721</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of vested stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaec5179caeab4e28a0d89e51f7815911_D20210101-20210630" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNC0xNC0xLTEtODQ0OTk_97d76318-92a5-4f80-b04a-d7b50d140d16">65,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ab559ce8be94eab9ca0ec550a426771_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNC0xOC0xLTEtODQ0OTk_78084ea5-c04e-44ef-8688-6c93d120997b">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNC0yNC0xLTEtODQ0OTk_f3320890-b48e-4e9f-a1a0-6fd6f90de80e">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaec5179caeab4e28a0d89e51f7815911_D20210101-20210630" decimals="0" name="naut:StockIssuedDuringPeriodSharesWarrantsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNS0xNC0xLTEtODQ0OTk_80af0f86-b8df-4a3e-bed6-4d2862df830c">62,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ieff8ab03765e4ac7b663c2cbfb8ab6f8_D20210101-20210630" decimals="0" sign="-" name="naut:ReclassificationsOfTemporaryToPermanentEquityShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi0xLTEtMS04NDQ5Mg_74f4ac74-240d-4f1b-9934-8cac77a2ebaf">13,174,805</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieff8ab03765e4ac7b663c2cbfb8ab6f8_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:ReclassificationsOfTemporaryToPermanentEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi0zLTEtMS04NDQ5Mg_cf87a956-bfdf-4b1c-acb1-2fcde1ab4192">5,494</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i43f28fa225984e9bbd35f3d7ff3f55c6_D20210101-20210630" decimals="0" sign="-" name="naut:ReclassificationsOfTemporaryToPermanentEquityShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi01LTEtMS04NDQ5Mg_480e1859-325f-4374-ae5f-6d4318797597">16,836,436</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i43f28fa225984e9bbd35f3d7ff3f55c6_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:ReclassificationsOfTemporaryToPermanentEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi03LTEtMS04NDQ5Mg_d6efd2b6-3377-4720-a716-377752b79cea">27,067</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ice89ec8597d741e6a43e56fbdbb1915b_D20210101-20210630" decimals="0" sign="-" name="naut:ReclassificationsOfTemporaryToPermanentEquityShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi05LTEtMS04NDQ5Mg_7f9b9355-bce7-4582-bdf6-52f2251ca828">22,164,724</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice89ec8597d741e6a43e56fbdbb1915b_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:ReclassificationsOfTemporaryToPermanentEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi0xMS0xLTEtODQ0OTI_98fc30b1-3dc4-4681-9def-03b0da8fd9a2">75,857</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaec5179caeab4e28a0d89e51f7815911_D20210101-20210630" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi0xNC0xLTEtODQ0OTk_52185f78-57f1-41ee-ba4a-19e2df199dea">52,175,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5179caeab4e28a0d89e51f7815911_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi0xNi0xLTEtODQ0OTk_bc572a92-eee0-49cc-910b-6bc5334be637">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ab559ce8be94eab9ca0ec550a426771_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi0xOC0xLTEtODQ0OTk_06b1f810-70c2-4749-ad84-dc234272d71a">108,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi0yNC0xLTEtODQ0OTk_05b298ec-4839-4547-b48e-6e95c8f9ce35">108,418</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock upon the reverse recapitalization, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaec5179caeab4e28a0d89e51f7815911_D20210101-20210630" decimals="0" name="naut:StockIssuedDuringPeriodSharesReverseRecapitalization" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNy0xNC0xLTEtODQ0OTk_d5a07a5b-d731-47e5-a184-403b6951b5ac">38,721,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec5179caeab4e28a0d89e51f7815911_D20210101-20210630" decimals="-3" name="naut:StockIssuedDuringPeriodValueReverseRecapitalization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNy0xNi0xLTEtODQ0OTk_60e8fe84-9ac2-4391-afed-79f98c285342">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ab559ce8be94eab9ca0ec550a426771_D20210101-20210630" decimals="-3" name="naut:StockIssuedDuringPeriodValueReverseRecapitalization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNy0xOC0xLTEtODQ0OTk_fb4811cd-0928-4b8a-8f33-917085615e66">327,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="naut:StockIssuedDuringPeriodValueReverseRecapitalization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNy0yNC0xLTEtODQ0OTk_88d0a41b-c3bb-48d9-b8bf-9a66b6b70704">327,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ab559ce8be94eab9ca0ec550a426771_D20210101-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfOS0xOC0xLTEtODQ0OTk_5f9f1317-61a7-4f65-955c-9ce428be3782">3,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfOS0yNC0xLTEtODQ0OTk_743a6a6e-809a-41db-88d0-0ed787a2bcb2">3,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e556ea5dbff49d8b604228bf8cd44a0_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTAtMjAtMS0xLTg0NDk5_cea37258-c576-42b4-8f4a-335eb5686ac9">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTAtMjQtMS0xLTg0NDk5_16167b8e-1d9b-4a0a-91b1-34425899be40">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i83eab16a45a34043b19482dba0424ebf_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTEtMjItMS0xLTg0NDk5_78014abc-8596-40ea-b022-3b697d5a8b19">19,122</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTEtMjQtMS0xLTg0NDk5_c4fd7fd6-8a8d-4b1e-906c-7ac3ccff49b9">19,122</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Balances at June 30, 2021 </span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie9e2d89185264884b8085af4b2cd97fc_I20210630" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItMS0xLTEtODQ0OTI_4ca8e9cc-23bf-48c8-bb72-7c3582044e38">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9e2d89185264884b8085af4b2cd97fc_I20210630" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItMy0xLTEtODQ0OTI_209568eb-7a26-462e-9dc6-cc053a729ac1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic17b9d22c2764dd798b80f5dfc34b5cf_I20210630" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItNS0xLTEtODQ0OTI_46c2bf03-9c4c-49b2-937b-33031864d629">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic17b9d22c2764dd798b80f5dfc34b5cf_I20210630" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItNy0xLTEtODQ0OTI_cae89cae-8002-4d78-9a6a-0d87ceb98a85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i91ec4082056644ceb4605ae97ee305ff_I20210630" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItOS0xLTEtODQ0OTI_733722af-14c8-4290-8046-f9cba9551922">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91ec4082056644ceb4605ae97ee305ff_I20210630" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItMTEtMS0xLTg0NDky_87ce9ccd-25b5-4c40-bd74-6775e1b5c10e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5a3a46052d04721ae2a3b35284e5778_I20210630" decimals="0" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItMTQtMS0xLTg0NDk5_ab958293-94be-428e-9d40-eb3216ad4fa3">124,094,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5a3a46052d04721ae2a3b35284e5778_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItMTYtMS0xLTg0NDk5_586c96f6-e7ba-49d7-b3e9-15cceb0e921b">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c20cf8954844243a311683aea4cdc51_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItMTgtMS0xLTg0NDk5_b7388d6f-7e2f-4570-804c-31caa52e9ab9">439,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93e671a07e70472fbbddd30300e8c88e_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItMjAtMS0xLTg0NDk5_db106d43-dc1f-4b85-9f09-ea1d3175ea0c">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5af05f6fd3814dfcbf23c51970fb91b2_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItMjItMS0xLTg0NDk5_3feee35e-6cb8-47f2-80e8-e9497ed7f9b4">49,447</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibff31d711c89442ab7051c729b67d7e0_I20210630" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItMjQtMS0xLTg0NDk5_8a2db744-4240-42f6-a49c-70ad427381b3">390,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d" footnoteRole="http://www.xbrl.org/2003/role/footnote">(1)&#160;&#160;&#160;&#160;The shares of the Company&#8217;s common and redeemable convertible preferred stock, prior to the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately <ix:nonFraction unitRef="number" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="4" name="naut:RecapitalizationExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMjMw_483b0f35-5b29-4fc6-ad61-ad8b13f4878f">3.6281</ix:nonFraction> established in the Business Combination as described in Note 3.</ix:footnote></span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_40"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Six Months Ended June 30, 2022 and 2021 (Unaudited)</span></div></td></tr></table></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMy0xLTEtMS04MzQxNA_600d069f-d81f-4c91-b70f-5a0aed3a47cf">30,452</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMy0zLTEtMS04MzQxNA_d9c51db2-b462-4c34-a40d-4975ef352a23">19,122</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfNS0xLTEtMS04MzQxNA_8146e581-fbe7-48ec-8b9a-aebcaf534136">562</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="us-gaap:Depreciation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfNS0zLTEtMS04MzQxNA_578eec61-8721-4d0f-91c7-92a230f481fa">479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfNi0xLTEtMS04MzQxNA_6c929818-3ae9-4d9d-82b5-9956a319db85">4,677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfNi0zLTEtMS04MzQxNA_52264e69-6777-4241-aa13-735246dd08ce">3,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of premiums on securities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfNy0xLTEtMS04MzQxNA_d793cb59-81a5-480d-a3ff-f766daabfc1a">147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfNy0zLTEtMS04MzQxNA_fd570e9b-a6dd-471c-a0b7-2057ca57a442">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfOC0xLTEtMS04MzQxNA_e1635090-a3c4-4898-9e39-0aa64881d9fa">1,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfOC0zLTEtMS04MzQxNA_31adceff-eee2-4e07-b533-ff3f11973167">760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTEtMS0xLTEtODM0MTQ_47bd58eb-2a31-4c58-8699-b38fb85f1387">503</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTEtMy0xLTEtODM0MTQ_14a93911-54be-44f1-86b8-85413d779378">331</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTItMS0xLTEtODM0MTQ_e4a3a7ba-f792-4821-b5a0-6e34e1c5d6c7">643</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTItMy0xLTEtODM0MTQ_7aa60067-bf78-4e23-bdfe-754b95ddcc73">725</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTMtMS0xLTEtODM0MTQ_04e5017b-7f8e-4bc9-a3b1-5cc479ca2118">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTMtMy0xLTEtODM0MTQ_35372ec9-ccc9-49dc-91cf-e12640ee1c40">410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTQtMS0xLTEtODM0MTQ_2456ae6b-7ea3-40fe-ac3d-c6e875a5827d">420</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTQtMy0xLTEtODM0MTQ_7c83a54a-1212-4e1e-85bd-3d5296bc1785">835</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTUtMS0xLTEtODM0MTQ_accede5d-804f-45bb-8986-32cee20ac491">25,864</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTUtMy0xLTEtODM0MTQ_bc15a3e3-91a4-4167-9837-20bfb1d4d734">14,545</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from maturities of securities </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTctMS0xLTEtODM0MTQ_76df7be7-a8a7-4339-a1a5-744d2eefc67d">105,575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTctMy0xLTEtODM0MTQ_7650a583-aa61-422f-bfa1-6e6696293c06">40,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of securities </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTgtMS0xLTEtODM0MTQ_cce6a304-0de5-41f4-80c0-40048b0a9acd">54,185</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTgtMy0xLTEtODM0MTQ_19f2a705-75c7-4d20-94d4-1684e7ecbb74">100,035</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTktMS0xLTEtODM0MTQ_3e27fdc8-34c2-4916-9122-9de6faf99baf">1,132</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTktMy0xLTEtODM0MTQ_a244b725-5ee5-4de7-bf84-f4d26afa7fbd">1,013</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjAtMS0xLTEtODM0MTQ_870fea3e-ae44-489d-b8cf-a5ad8d2eefc6">50,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjAtMy0xLTEtODM0MTQ_573aaaed-1a22-4c53-889a-cbe7104f0a33">61,048</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjMtMS0xLTEtODM0MTQ_ee0d63ba-9192-451f-ac8a-71cdb895b282">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjMtMy0xLTEtODM0MTQ_191b0b91-1302-4d95-a7c2-7fcfabbf4491">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:ProceedsFromStockPlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjQtMS0xLTEtODY3MDg_9b41a4cc-6d7b-48d0-beab-78eead647dac">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromStockPlans" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjQtMy0xLTEtODY3MDg_f3193cd9-3b2e-484c-9d5c-a704406b1b18">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net proceeds from reverse recapitalization and PIPE financing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="naut:ProceedsFromReverseRecapitalizationTransaction" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjUtMS0xLTEtODY4NDk_bfdf561c-2153-4b46-b389-8747478eb19e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="naut:ProceedsFromReverseRecapitalizationTransaction" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjUtMy0xLTEtODY4NDk_629ba895-7a18-4d41-85c8-9a731e2330f1">335,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments of offering costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjQtMS0xLTEtODM0MTQ_a0e8fa06-5926-466f-87d3-b5036cad8c0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjQtMy0xLTEtODM0MTQ_620d30a2-4717-4dbf-b437-50d5bccdb3d4">8,082</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjYtMS0xLTEtODM0MTQ_e20df119-6bd9-4d7f-bff2-c00934c6e2c9">341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjYtMy0xLTEtODM0MTQ_9d2daf5b-6758-4346-b70c-64bba17295cd">327,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjctMS0xLTEtODM0MTQ_3be97e67-6466-4ddf-b2c1-b70ccd511385">24,735</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjctMy0xLTEtODM0MTQ_bbc9a1d4-9871-4ea6-bebd-3daf764a63c2">251,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjktMS0xLTEtODM0MTQ_ac931034-f281-4bff-bd2f-4a9aee94353a">186,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i616643cbd31d47a686cf71385bb21573_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjktMy0xLTEtODM0MTQ_4ce92016-0a11-428b-b7d1-1e9c2c756bb6">37,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMzAtMS0xLTEtODM0MTQ_cdd5347b-51d4-4d61-a840-8015b90928d5">211,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibff31d711c89442ab7051c729b67d7e0_I20210630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMzAtMy0xLTEtODM0MTQ_ddfbd8eb-22de-49e3-9bf2-43f4220bd7ec">288,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplementary cash flow information on non-cash activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions of property and equipment included in accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMzMtMS0xLTEtODM0MTQ_f882cbd9-de3e-4220-afab-0140d7e8ec6d">413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMzMtMy0xLTEtODM0MTQ_4a77210b-7943-428f-841f-1210746cd3e3">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred offering costs in accounts payable and accrued expenses and other liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="naut:DeferredStockIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMzQtMS0xLTEtODM0MTQ_5cef3cb5-e149-4aa1-9a25-c0372fcd2ccb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="naut:DeferredStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMzQtMy0xLTEtODM0MTQ_e406c941-93b2-453f-83ed-842a5d61617b">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:ConversionOfStockAmountConverted1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMzUtMS0xLTEtODM0MTQ_153b8946-656b-4199-8a81-306ff81815b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="us-gaap:ConversionOfStockAmountConverted1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMzUtMy0xLTEtODM0MTQ_37913ac9-f786-4706-8ae1-de5cd6c2251d">108,418</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred offering costs reclassified to equity</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="naut:DeferredStockIssuanceCostsReclassifiedToEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMzYtMS0xLTEtODM0MTQ_5a75e9ec-b392-4d2b-82a6-635f4c37b774">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="naut:DeferredStockIssuanceCostsReclassifiedToEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMzYtMy0xLTEtODM0MTQ_856415d1-e8a3-491e-baae-7cfc0caac02b">8,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Modification to reduce right-of-use assets and lease liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="naut:ModificationToReduceRightOfUseAssetsAndLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMzctMS0xLTEtODM0MTQ_0d76a80d-8ca9-4b09-bab2-02b8a58bf242">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="naut:ModificationToReduceRightOfUseAssetsAndLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMzctMy0xLTEtODM0MTQ_dfbce33c-7b77-4428-8205-230a5b018b68">3,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_43"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_46"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80Ni9mcmFnOjljMTE1NDk3M2IzYTQzYzFhNDgzODhlN2M2YTg2NjI5L3RleHRyZWdpb246OWMxMTU0OTczYjNhNDNjMWE0ODM4OGU3YzZhODY2MjlfODY5Mg_41024118-f11e-44ba-a904-f9e359c8300c" continuedAt="i662429bd4c99432a9286f48ea4b6033b" escape="true">Description of Business and Basis of Presentation</ix:nonNumeric></span></div><ix:continuation id="i662429bd4c99432a9286f48ea4b6033b" continuedAt="i887db3fd4a0446e38ddca6859b270a7c"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus Biotechnology, Inc. (the &#8220;Company&#8221;) is a biotechnology company incorporated in 2016 and based in Seattle, Washington with laboratory operations in San Carlos, California. Since the Company&#8217;s incorporation in 2016, the Company has devoted substantially all of its resources to research and development activities, including with respect to its proteomics platform, business planning, establishing and maintaining its intellectual property portfolio, hiring personnel, raising capital and providing general and administrative support for these operations. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 9, 2021 (the &#8220;Closing Date&#8221;), Nautilus Biotechnology, Inc. a Delaware corporation (f/k/a ARYA Sciences Acquisition Corp. III, a Cayman Islands exempted company and the Company&#8217;s predecessor company (&#8220;ARYA&#8221;)), consummated the previously announced business combination (the &#8220;Business Combination&#8221;) pursuant to the terms of that certain Business Combination Agreement, dated as of February 7, 2021 (the &#8220;BCA&#8221;), by and among ARYA, Mako Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of ARYA (&#8220;Mako Merger Sub&#8221;), and Nautilus Subsidiary, Inc., a Delaware corporation (f/k/a Nautilus Biotechnology, Inc.) (&#8220;Legacy Nautilus&#8221;). As a result of the Business Combination, ARYA changed its name to &#8220;Nautilus Biotechnology, Inc.&#8221; and Mako Me</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rger Sub merged with and into Legacy Nautilus with Legacy Nautilus surviving as the surviving company and becoming a wholly-owned subsidiary of ARYA (the &#8220;Merger&#8221; and, collectively with the other transactions described in the BCA, the &#8220;Reverse Recapitalization&#8221;).  </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in conjunction with the completion of the Business Combination, certain investors (&#8220;PIPE Investors&#8221;) subscribed for the purchase of an aggregate of <ix:nonFraction unitRef="shares" contextRef="ia44cc7d1aae94a61ab5ee6ba5904ea17_D20210609-20210609" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80Ni9mcmFnOjljMTE1NDk3M2IzYTQzYzFhNDgzODhlN2M2YTg2NjI5L3RleHRyZWdpb246OWMxMTU0OTczYjNhNDNjMWE0ODM4OGU3YzZhODY2MjlfMTgwNA_c17a509e-f218-470b-a2a1-c68fb8a23525">20,000,000</ix:nonFraction> shares of common stock of the Company (&#8220;New Nautilus Common Stock&#8221;) at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ibd18e99e03a84549a89394d3537245e4_I20210609" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80Ni9mcmFnOjljMTE1NDk3M2IzYTQzYzFhNDgzODhlN2M2YTg2NjI5L3RleHRyZWdpb246OWMxMTU0OTczYjNhNDNjMWE0ODM4OGU3YzZhODY2MjlfMTg4OQ_57c45ed4-f0ef-48f8-b3d8-8464e07aa700">10.00</ix:nonFraction> per share for aggregate gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="ia44cc7d1aae94a61ab5ee6ba5904ea17_D20210609-20210609" decimals="INF" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80Ni9mcmFnOjljMTE1NDk3M2IzYTQzYzFhNDgzODhlN2M2YTg2NjI5L3RleHRyZWdpb246OWMxMTU0OTczYjNhNDNjMWE0ODM4OGU3YzZhODY2MjlfMTkzNA_845709a4-6a15-406a-8bde-4ef5ac713fda">200.0</ix:nonFraction>&#160;million (&#8220;PIPE Financing&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to Note 3 &#8220;Reverse Recapitalization&#8221; for further details of the Business Combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80Ni9mcmFnOjljMTE1NDk3M2IzYTQzYzFhNDgzODhlN2M2YTg2NjI5L3RleHRyZWdpb246OWMxMTU0OTczYjNhNDNjMWE0ODM4OGU3YzZhODY2MjlfODY5Mw_8ca67fec-eef1-4a69-a79c-a1157e84e873" escape="true">The condensed consolidated financial statements and accompanying notes are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) for interim financial reporting. All intercompany transactions and balances have been eliminated upon consolidation. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated financial statements were prepared on the same basis as the audited financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments necessary for a fair statement of the Company&#8217;s financial position as of June&#160;30, 2022, the results of its operations for the three and six months ended June 30, 2022 and 2021 and its cash flows for the six months ended June 30, 2022 and 2021. The results of operations for the three and six months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022. These financial statements and accompanying notes should be read in conjunction with the consolidated financial statements and notes thereto in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 on file with the SEC. The Company&#8217;s reporting currency is the U.S. dollar.</ix:nonNumeric> </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Going Concern</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s condensed consolidated financial statements have been prepared on the basis of continuity of operations, the realization of assets, and the satisfaction of liabilities in the ordinary course of business. Since inception, the Company has been engaged in developing its technology, raising capital, and recruiting personnel. The Company&#8217;s operating plan may change as a result of many factors currently unknown and there can be no assurance that the current operating plan will be achieved in the time frame anticipated by the Company, and it may need to seek additional funds sooner than planned. If adequate funds are not available to the Company on a timely basis, it may be required to delay, limit, reduce, or terminate certain commercial efforts, or pursue merger or acquisition strategies, all of which could adversely affect the holdings or the rights of the Company&#8217;s stockholders. The Company has incurred net operating losses and negative cash flows from operations in every year since </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements&#8212;(Continued)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><ix:continuation id="i887db3fd4a0446e38ddca6859b270a7c" continuedAt="i4ea692ab9902460fa04ad6d395623cee"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">inception and expects this to continue for the foreseeable future. As of June&#160;30, 2022, the Company had an accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80Ni9mcmFnOjljMTE1NDk3M2IzYTQzYzFhNDgzODhlN2M2YTg2NjI5L3RleHRyZWdpb246OWMxMTU0OTczYjNhNDNjMWE0ODM4OGU3YzZhODY2MjlfNTAyOQ_78762282-695c-486f-acd7-42d4727206f0">111.1</ix:nonFraction> million.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has funded its operations primarily with proceeds from the issuance of redeemable convertible preferred stock and common stock. In June 2021, the Company received gross proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="i23369e4e61894856b3b29fd3dd2c1609_D20210601-20210630" decimals="-5" name="naut:ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80Ni9mcmFnOjljMTE1NDk3M2IzYTQzYzFhNDgzODhlN2M2YTg2NjI5L3RleHRyZWdpb246OWMxMTU0OTczYjNhNDNjMWE0ODM4OGU3YzZhODY2MjlfNTMyMw_d5b5f06f-7d64-4046-8e02-3f4b63b806ca">345.5</ix:nonFraction> million from PIPE Investors and the Business Combination offset by approximately $<ix:nonFraction unitRef="usd" contextRef="i23369e4e61894856b3b29fd3dd2c1609_D20210601-20210630" decimals="-5" name="naut:PaymentsOfReverseRecapitalizationTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80Ni9mcmFnOjljMTE1NDk3M2IzYTQzYzFhNDgzODhlN2M2YTg2NjI5L3RleHRyZWdpb246OWMxMTU0OTczYjNhNDNjMWE0ODM4OGU3YzZhODY2MjlfNTM5OQ_bb864042-4766-425a-8ad3-22d331ed58a3">18.2</ix:nonFraction> million of transaction costs and underwriters&#8217; fees relating to the closing of the Business Combination. The Company had cash, cash equivalents, and short-term investments of $<ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-5" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80Ni9mcmFnOjljMTE1NDk3M2IzYTQzYzFhNDgzODhlN2M2YTg2NjI5L3RleHRyZWdpb246OWMxMTU0OTczYjNhNDNjMWE0ODM4OGU3YzZhODY2MjlfMTA5OTUxMTY0MDE0OQ_db5c0c84-874e-4493-b5a0-d940c12ec33e">299.3</ix:nonFraction> million as of June&#160;30, 2022.  As of the date on which these condensed consolidated financial statements were available to be issued, the Company believes that its cash, cash equivalents, and short-term investments will be sufficient to fund its operations for the next twelve months following the issuance of the condensed consolidated financial statements. The Company&#8217;s actual results could vary as a result of, and its near and long-term future capital requirements will depend on many factors, including its growth rate and the timing and extent of spending to support its research and development efforts. The Company has based its estimates on assumptions that may prove to be wrong, and it could use its available capital resources sooner than it currently expects. The Company may be required to seek additional equity or debt financing. Future liquidity and cash requirements will depend on numerous factors. In the event that additional financing is required, the Company may not be able to raise it on acceptable terms or at all. If the Company is unable to raise additional capital when desired, or if it cannot expand its operations or otherwise capitalize on its business opportunities because it lacks sufficient capital, its business, operating results, and financial condition would be adversely affected. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of the COVID-19 Coronavirus</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, COVID-19 was first reported to the World Health Organization (&#8220;WHO&#8221;), and in January 2020, the WHO declared the outbreak to be a public health emergency. In March 2020, the WHO characterized COVID-19 as a pandemic. Since then, the COVID-19 pandemic and efforts to control its spread have significantly curtailed the movement of people, goods, and services worldwide. As a result, the Company has taken certain measures in response to COVID-19. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the duration and extent of the COVID-19 pandemic depends on future developments that cannot be accurately predicted at this time, such as the extent and effectiveness of containment and mitigation actions, it has already had an adverse effect on the global economy, and the ultimate societal and economic impact of the COVID-19 pandemic remains unknown. Additionally, concerns over the economic impact of COVID-19 have caused extreme volatility in financial and other capital markets, which may adversely affect the Company&#8217;s ability to access capital markets in the future. Furthermore, the impact of the COVID-19 pandemic could adversely impact the Company&#8217;s cash flows and operations and delay the Company&#8217;s research and development activities. </span></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4ea692ab9902460fa04ad6d395623cee">While the Company has developed and continues to develop plans to help mitigate the potential negative impact of COVID-19, these efforts may not be effective, and any protracted economic downturn will likely limit the effectiveness of its efforts. Accordingly, it is not possible for the Company to predict the duration and ultimate extent to which this will affect its business, future results of operations, and financial condition at this time.</ix:continuation> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_49"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80OS9mcmFnOmVjYjZiM2VmMmMyNjRjYjBiYmVhMWJjZmE5NDY5ODhmL3RleHRyZWdpb246ZWNiNmIzZWYyYzI2NGNiMGJiZWExYmNmYTk0Njk4OGZfMTQ4MDQ_228d34b5-9b2d-4340-9936-e84c5f565848" continuedAt="ic81faa78c6ea43b2bf6f94232d4e8970" escape="true">Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="ic81faa78c6ea43b2bf6f94232d4e8970" continuedAt="ib6d1172a9639451c835e950f3d0aa0d7"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80OS9mcmFnOmVjYjZiM2VmMmMyNjRjYjBiYmVhMWJjZmE5NDY5ODhmL3RleHRyZWdpb246ZWNiNmIzZWYyYzI2NGNiMGJiZWExYmNmYTk0Njk4OGZfMTQ4MDU_44ea3b40-57a1-4b3a-a5c0-f880e27c892d" continuedAt="i61260e85ee744856a9354e29fde5a9cc" escape="true">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the condensed consolidated financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include determining the estimated lives of property and equipment, stock-based compensation including the estimated fair value per share of common stock prior to the date the Company became public, research and development accruals, and the valuation allowance for deferred tax assets. These estimates and assumptions are based on management&#8217;s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in </ix:nonNumeric></span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements&#8212;(Continued)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><ix:continuation id="ib6d1172a9639451c835e950f3d0aa0d7" continuedAt="id55c8d370872471aad9b2f684a4f29af"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i61260e85ee744856a9354e29fde5a9cc">the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.</ix:continuation> </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk and Other Risks and Uncertainties</span></div><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80OS9mcmFnOmVjYjZiM2VmMmMyNjRjYjBiYmVhMWJjZmE5NDY5ODhmL3RleHRyZWdpb246ZWNiNmIzZWYyYzI2NGNiMGJiZWExYmNmYTk0Njk4OGZfMTQ4MDE_73016830-8dc7-4457-9bf2-3ef6864abc64" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit risk represents the accounting loss that would be recognized as of the reporting date if counterparties failed completely to perform as contracted. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentration of credit risk, consist of cash balances maintained in excess of federal depository insurance limits and investments in U.S. Treasury securities that are not federally insured. The Company has not experienced any losses in such accounts and believes it is not exposed to significant credit risk on cash or investments. The Company relies, and expects to continue to rely, on a number of vendors to provide services, supplies and materials related to its research and development programs. The Company relies on single source suppliers for certain components and materials used in the Nautilus platform. The loss of any of these single source suppliers would require the Company to expend significant time and effort to locate and qualify an alternative source of supply for these components. The Company also relies, and expects to continue to rely, on third-party manufacturers and, in many cases, single third-party manufacturers for the production of certain reagents and antibodies. These programs could be adversely affected by a significant interruption in these services or the availability of materials.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to risks similar to those of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> other&#160;pre-clinical&#160;stage companies in the biopharmaceutical industry, including dependence on key individuals, the need to develop commercially viable products, competition from other companies, many of whom are larger and better capitalized, the impact of the COVID-19 pandemic and the need to obtain adequate additional financing to fund the development of its products. There can be no assurance that the Company&#8217;s research and development will be successfully completed, that adequate protection for the Company&#8217;s intellectual property will be maintained, that any products developed will obtain required regulatory approval or that any approved products will be commercially viable. Even if the Company&#8217;s development efforts are successful, it is uncertain when, if ever, the Company will generate significant revenue from the sale of its products.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Reporting</span></div><div style="margin-bottom:9pt;text-indent:18pt"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80OS9mcmFnOmVjYjZiM2VmMmMyNjRjYjBiYmVhMWJjZmE5NDY5ODhmL3RleHRyZWdpb246ZWNiNmIzZWYyYzI2NGNiMGJiZWExYmNmYTk0Njk4OGZfMTQ4MDk_36c916a6-263f-4c93-b4f0-4accc86b8014" continuedAt="ia0d948eb5df9459086ef27bb0a5e30e5" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision m</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">arket (&#8220;CODM&#8221;) in deciding how to allocate resources and in assessing performance. The Company&#8217;s Chief Executive Officer is its CODM. The Company&#8217;s CODM re</span></ix:nonNumeric><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia0d948eb5df9459086ef27bb0a5e30e5">views financial information presented on a consolidated basis for the purposes of making operating decisions, allocating resources and evaluating financial performance. As such, the Company has determined that it operates in <ix:nonFraction unitRef="segment" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80OS9mcmFnOmVjYjZiM2VmMmMyNjRjYjBiYmVhMWJjZmE5NDY5ODhmL3RleHRyZWdpb246ZWNiNmIzZWYyYzI2NGNiMGJiZWExYmNmYTk0Njk4OGZfNDM4Mw_79587aec-06b7-4512-ab47-131106c91894">one</ix:nonFraction> operating and <ix:nonFraction unitRef="segment" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80OS9mcmFnOmVjYjZiM2VmMmMyNjRjYjBiYmVhMWJjZmE5NDY5ODhmL3RleHRyZWdpb246ZWNiNmIzZWYyYzI2NGNiMGJiZWExYmNmYTk0Njk4OGZfNDQwMA_7de17a9c-9d17-449f-ae00-7ab29e16bc05">one</ix:nonFraction> reportable segment. The Company&#8217;s long-lived assets are entirely based in the United States.</ix:continuation> </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80OS9mcmFnOmVjYjZiM2VmMmMyNjRjYjBiYmVhMWJjZmE5NDY5ODhmL3RleHRyZWdpb246ZWNiNmIzZWYyYzI2NGNiMGJiZWExYmNmYTk0Njk4OGZfMTQ4MDY_a53c4c96-2ada-4af2-a5d6-ca3ab293a288" escape="true">The Company considers all highly-liquid investments with an original maturity of three months or less as of the date of acquisition to be cash equivalents.</ix:nonNumeric> </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80OS9mcmFnOmVjYjZiM2VmMmMyNjRjYjBiYmVhMWJjZmE5NDY5ODhmL3RleHRyZWdpb246ZWNiNmIzZWYyYzI2NGNiMGJiZWExYmNmYTk0Njk4OGZfMTQ4MDc_3378a9b3-18e6-40c9-93fb-66f901481458" continuedAt="ia5cc79ebc791436d8cf682fdbe7513c3" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers investments with an original maturity greater than three months and remaining maturities less than one year to be short-term investments. The Company classifies those investments that are not required for use in current operations and that mature in more than 12 months as long-term investments. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its investments as available for sale and reports them at fair value, with unrealized gains and losses recorded in accumulated other comprehensive income (loss). For investments sold prior to maturity, the cost of investments sold is based on the specific identification method. Realized gains and losses on the sale of investments are recorded in other income (expense), net in the condensed consolidated statement of operations. </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements&#8212;(Continued)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><ix:continuation id="id55c8d370872471aad9b2f684a4f29af" continuedAt="ie79cb973f329431294d436433309a6c9"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="ia5cc79ebc791436d8cf682fdbe7513c3" continuedAt="if1fe3ffc8fa24eb5a73faa9f6c2a8a46">Other-than-temporary Impairment</ix:continuation></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if1fe3ffc8fa24eb5a73faa9f6c2a8a46">The Company evaluates its investments with unrealized losses for other-than-temporary impairment. When assessing investments for other-than-temporary declines in value, the Company considers factors such as, among other things, the extent and length of time the investment&#8217;s fair value has been lower than its cost basis, the financial condition and near-term prospects of the investment, the Company&#8217;s ability and intent to retain the investment for a period of time sufficient to allow for any anticipated recovery in fair value, and the expected cash flows from the security. If any adjustments to fair value reflects a decline in the value of the investment that the Company considers to be &#8220;other than temporary,&#8221; the Company reduces the investment to fair value through a charge to the condensed consolidated statement of operations and condensed consolidated statement of comprehensive loss. No such adjustments were necessary during the periods presented.</ix:continuation> </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80OS9mcmFnOmVjYjZiM2VmMmMyNjRjYjBiYmVhMWJjZmE5NDY5ODhmL3RleHRyZWdpb246ZWNiNmIzZWYyYzI2NGNiMGJiZWExYmNmYTk0Njk4OGZfMTQ4MDI_b0f8ae96-cff4-4399-9abc-be2bcdb56ac3" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of cash and cash equivalents, prepaid expenses and other current assets, accounts payable and accrued expenses and other liabilities approximate their respective fair values due to their short-term nature.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80OS9mcmFnOmVjYjZiM2VmMmMyNjRjYjBiYmVhMWJjZmE5NDY5ODhmL3RleHRyZWdpb246ZWNiNmIzZWYyYzI2NGNiMGJiZWExYmNmYTk0Njk4OGZfMTQ4MTA_a78b5c84-d122-4179-beb7-d152bc1bb88a" continuedAt="i3f118b1475544a50bb2d49c9c2f8d348" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement includes a lease at inception by assessing whether there is an identified asset and whether the contract conveys the right to control the use of the identified asset for a period of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">time in exchange for consideration. Operating leases with a term of more than one year are included in operating lease right-of-use (&#8220;ROU&#8221;) assets and operating lease liabilities on the Company's condensed consolidated balance sheets. ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments. Operating lease ROU assets and liabilities are recognized on the lease commencement date based on the present value of the future minimum lease payments over the lease term. The Company uses the incremental borrowing rate commensurate with the lease term based on the information available at the lease commencement date in determining the present value of the lease payments as the Company's leases generally do not provide an implicit rate. ROU assets initially equal the lease liability, adjusted for any prepaid lease payments and initial direct costs incurred, less any lease incentives received. Certain of the Company's leases include renewal options which allow the Company to, at its election, renew or extend the lease for a fixed or indefinite period of time. These renewal periods are included in the lease terms when the Company is reasonably certain the options will be exercised. Lease expense is recognized on a straight-line basis over the lease term when leases are operating leases. If it is considered a finance lease, expense is recognized over the lease term within </span></ix:nonNumeric></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements&#8212;(Continued)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><ix:continuation id="ie79cb973f329431294d436433309a6c9" continuedAt="i011e20a931d84a749bcf153b661db8c2"><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3f118b1475544a50bb2d49c9c2f8d348">interest expense and amortization in the Company&#8217;s condensed consolidated statements of operations. The Company also has lease arrangements with lease and non-lease components. The Company elected the practical expedient not to separate non-lease components from lease components for the Company's facility leases and to account for the lease and non-lease components as a single lease component. The Company also elected to apply the short-term lease measurement and recognition exemption in which ROU assets and lease liabilities are not recognized for leases with terms of 12 months or less.</ix:continuation></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Loss </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80OS9mcmFnOmVjYjZiM2VmMmMyNjRjYjBiYmVhMWJjZmE5NDY5ODhmL3RleHRyZWdpb246ZWNiNmIzZWYyYzI2NGNiMGJiZWExYmNmYTk0Njk4OGZfMTQ4MDg_18c8116e-e86b-4029-9a72-b4b2c84221d9" escape="true">Comprehensive loss consists of net loss and other gains or losses affecting stockholders&#8217; equity that, under U.S. GAAP are excluded from net loss. For the three and six months ended June 30, 2022 and 2021, unrealized losses on debt securities were included as components of comprehensive loss.</ix:nonNumeric> </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements</span></div><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80OS9mcmFnOmVjYjZiM2VmMmMyNjRjYjBiYmVhMWJjZmE5NDY5ODhmL3RleHRyZWdpb246ZWNiNmIzZWYyYzI2NGNiMGJiZWExYmNmYTk0Njk4OGZfMTQ4MDM_f1aa784c-423c-4128-98b3-166d5b337e51" continuedAt="i7c45a67e735e4cc392eeb1191a6f201a" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is provided the option to adopt new or revised accounting guidance as an &#8220;emerging growth company&#8221; under the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;) either (1) within the same periods as those </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">otherwise applicable to public business entities, or (2) within the same time periods as non-public business entities, including early adoption when permissible. With the exception of standards the Company elected to early adopt, when permissible, the Company has elected to adopt new or revised accounting guidance within the same time period as non-public business entities, as indicated below. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Reference Rate Reform (Topic 848).&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The amendments in ASU 2020-04 provide optional expedients and exceptions for ap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">plying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this ASU are effective for all entities as of March 12, 2020 through December 31, 2022. An entity may elect to apply the amendments for contract modifications by Topic or Industry Subtopic as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or prospectively from the date that the financial statements are available to be issued. Once elected for a Topic or an Industry Subtopic, the amendments must be applied prospectively for all eligible contract modifications for that Topic or Industry Subtopic. The Company adopted this guidance effective January 1, 2022 using the prospective method, which did not have a material impact on the Company&#8217;s condensed consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Financial Instruments- Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, which amends existing guidance on the impairment of financial assets and adds an impairment model that is based on expected losses rather than incurred losses and requires an entity to recognize as an allowance its estimate of expected credit losses for its financial assets. An entity will apply this guidance through a cumulative-effect adjustment to retained earnings upon adoption (a modified-retrospective approach) while a prospective transition approach is required for debt securities for which an other-than-temporary impairment had been recognized before the effective date. This ASU is effective for the Company for its fiscal year ending December 31, 2023. Early adoption is permitted. The Company is in the process of evaluating the impact of the adoption of this ASU on its condensed consolidated financial statements and related disclosures. The Company does not anticipate adoption to have a material impact on its condensed consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December&#160;2019, the FASB issued ASU No. 2019-12, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as the elimination of exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, the recognition of deferred tax liabilities for outside basis differences, ownership changes in investments, and tax basis step-up&#160;in goodwill obtained in a transaction that is not a business combination. This ASU is effective for the Company for its fiscal year ending December&#160;31, 2022. Early adoption is permitted. The Company is in the process of evaluating the impact of the </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements&#8212;(Continued)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i011e20a931d84a749bcf153b661db8c2"><ix:continuation id="i7c45a67e735e4cc392eeb1191a6f201a">adoption of this ASU on its condensed consolidated financial statements and related disclosures. The Company does not anticipate adoption to have a material impact on its condensed consolidated financial statements.</ix:continuation></ix:continuation></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_52"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="naut:ReverseRecapitalizationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMzg5Nw_d318d0c4-95f0-4709-93ed-de887af67974" continuedAt="ic061018756de48978b27431fb3315cd2" escape="true">Reverse Recapitalization</ix:nonNumeric></span></div><ix:continuation id="ic061018756de48978b27431fb3315cd2" continuedAt="i57fe9d346b4e47f29ca957873d2e0777"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 9, 2021, Mako Merger Sub merged with Legacy Nautilus, with Legacy Nautilus surviving as the surviving company and as a wholly-owned subsidiary of ARYA. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Business Combination, Legacy Nautilus equity holders received an aggregate number of shares of New Nautilus Common Stock equal to (i) $<ix:nonFraction unitRef="usd" contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609" decimals="-5" name="naut:StockConvertedValueReverseRecapitalization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMzQ0_bea5d770-5551-428b-95e7-648426e4041e">900.0</ix:nonFraction>&#160;million plus $<ix:nonFraction unitRef="usd" contextRef="i4ff48ca2fc6c45e787116cf1deff00ca_D20210609-20210609" decimals="-5" name="naut:StockConvertedValueReverseRecapitalization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMzUy_18f963f3-2c6d-4718-b73e-b996130c3890">24.3</ix:nonFraction>&#160;million, which reflects the aggregate exercise price of all stock options (whether vested or unvested) of Legacy Nautilus at the consummation of the Business Combination, divided by (ii) $<ix:nonFraction unitRef="usdPerShare" contextRef="i8cf39cfd7fd34311bc52d7c3ad8da2ff_I20210609" decimals="2" name="naut:RecapitalizationExchangeRatioPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfNTM0_6e3b3d2a-341d-4984-a0a9-d91e250c6a2b">10.00</ix:nonFraction> giving effect to the exchange ratio of approximately <ix:nonFraction unitRef="number" contextRef="i8cf39cfd7fd34311bc52d7c3ad8da2ff_I20210609" decimals="4" name="naut:RecapitalizationExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfNTkw_dfd85677-cca0-46db-a073-ed5e08469ca6">3.6281</ix:nonFraction> (&#8220;Exchange Ratio&#8221;) based on the terms of the Business Combination Agreement. For purposes of calculating the aggregate number of New Nautilus Common Stock issuable to each holder of Legacy Nautilus Common Stock pursuant to the Business Combination Agreement, all Legacy Nautilus Common Stock held by such holder was aggregated, and the Exchange Ratio was applied to that aggregate number of shares held by such holder, and not on a share-by-share basis, and the number of New Nautilus Common Stock issued was rounded down to the nearest whole share. At the Closing Date, (i) an aggregate of <ix:nonFraction unitRef="shares" contextRef="ic9aa3fe7e62449e8bd4ba541d238d058_I20210609" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMTE4NA_81faceb7-a92b-4905-a1e0-a1a053d4f504">18,721,137</ix:nonFraction> shares of Class A and Class B ordinary shares of ARYA were exchanged for an equivalent number of Common Stock, (ii) an aggregate of <ix:nonFraction unitRef="shares" contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609" decimals="0" name="naut:StockConvertedReverseRecapitalization" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMTMxOQ_c8f6ff35-7a3d-4afa-8160-764c0511864c">85,324,118</ix:nonFraction> shares of Common Stock were issued in exchange for the shares of Nautilus outstanding as of immediately prior to the Business Combination and (iii) an aggregate of <ix:nonFraction unitRef="shares" contextRef="ia44cc7d1aae94a61ab5ee6ba5904ea17_D20210609-20210609" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMTQ4Ng_739b79e6-6069-4128-9685-e68ad12bb32e">20,000,000</ix:nonFraction> shares of Common stock were issued to the PIPE Investors in the PIPE Financing with total gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="ia44cc7d1aae94a61ab5ee6ba5904ea17_D20210609-20210609" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMTU5Nw_e3b18136-da24-40e4-9152-6104194b1a8c">200.0</ix:nonFraction>&#160;million. Moreover, at the Closing, all options to purchase shares of Nautilus were exchanged for comparable options to purchase shares of Common Stock based on an implied Legacy Nautilus equity value of $<ix:nonFraction unitRef="usd" contextRef="i8cf39cfd7fd34311bc52d7c3ad8da2ff_I20210609" decimals="-5" name="us-gaap:EquityFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMTc5NQ_51dfef58-0790-4070-a6e6-14ad92e523d9">900.0</ix:nonFraction>&#160;million. Immediately after giving effect to the transactions, there were <ix:nonFraction unitRef="shares" contextRef="i8cf39cfd7fd34311bc52d7c3ad8da2ff_I20210609" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMTg2Mw_c12bb021-4736-4a89-9b78-86ca4ddfdee8">124,045,255</ix:nonFraction> shares of Common Stock outstanding and <ix:nonFraction unitRef="shares" contextRef="i8cf39cfd7fd34311bc52d7c3ad8da2ff_I20210609" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMTkwNQ_7491587c-cc9c-4f9d-931f-3a07bc1dff4f">7,106,767</ix:nonFraction> shares of Common Stock subject to outstanding options under the 2017 Plan.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Business Combination is accounted for as a reverse recapitalization under U.S. GAAP. This determination is primarily based on Legacy Nautilus stockholders comprising a relative majority of the voting power of Nautilus and having the ability to nominate the members of the Board, Legacy Nautilus&#8217;s operations prior to the acquisition comprising the only ongoing operations of Nautilus, and Legacy Nautilus&#8217;s senior management comprising a majority of the senior management of Nautilus. Under this method of accounting, ARYA is treated as the &#8220;acquired&#8221; company for financial reporting purposes. Accordingly, for accounting purposes, the financial statements of Nautilus represent a continuation of the financial statements of Legacy Nautilus with the Business Combination being treated as the equivalent of Nautilus issuing stock for the net assets of ARYA, accompanied by a recapitalization. The net assets of ARYA are stated at historical costs, with no goodwill or other intangible assets recorded. Operations prior to the Business Combination are presented as those of Nautilus. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All periods prior to the Business Combination have been retrospectively adjusted using the Exchange Ratio for the equivalent number of shares outstanding immediately after the Business Combination to effect the reverse recapitalization. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Business Combination, the Company raised $<ix:nonFraction unitRef="usd" contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609" decimals="-5" name="naut:ProceedsFromReverseRecapitalizationTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMzM3MQ_b67e30f8-f995-4ac9-897b-bc1a6a7c5ae6">335.4</ix:nonFraction> million of net proceeds. This amount was comprised of $<ix:nonFraction unitRef="usd" contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609" decimals="-5" name="naut:CashAcquiredThroughReverseRecapitalization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMzQyMA_b278a88a-616c-4b3e-8daf-155898339b8b">135.4</ix:nonFraction>&#160;million of cash held in ARYA&#8217;s trust account from its initial public offering, net of ARYA&#8217;s transaction costs and underwriters&#8217; fees of $<ix:nonFraction unitRef="usd" contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609" decimals="-5" name="naut:ReverseRecapitalizationCashPaidToShareholders" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMzU1Mg_eb0f035e-3212-4fa7-9683-e0a771029ed8">10.1</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMzU2MA_0be1a315-9ee1-4868-ac0f-745736c9c3a0">200.0</ix:nonFraction>&#160;million of cash in connection with the PIPE Financing. The Company incurred $<ix:nonFraction unitRef="usd" contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609" decimals="-5" name="naut:PaymentsOfReverseRecapitalizationTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMzYzMQ_6020a436-7a8e-48ee-ad53-8251154e68ba">8.1</ix:nonFraction>&#160;million of transaction costs, consisting of banking, legal, and other professional fees which were recorded as a reduction to additional paid-in capital.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="naut:ScheduleOfReverseRecapitalizationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMzg5OA_684732f2-356d-4ab1-af41-0c280ff91717" continuedAt="i680af186c47d4b28a7cffa80c4bc59ef" escape="true">The number of shares of Common Stock issued immediately following the consummation of the Business Combination was:</ix:nonNumeric></span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements&#8212;(Continued)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><div style="margin-bottom:9pt;text-indent:18pt"><ix:continuation id="i57fe9d346b4e47f29ca957873d2e0777"><ix:continuation id="i680af186c47d4b28a7cffa80c4bc59ef"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.070%"><tr><td style="width:1.0%"></td><td style="width:81.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.936%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock of ARYA outstanding prior to the Business Combination</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i95b304753b094f299b60dec3c082158f_I20210608" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RhYmxlOjg5NzQ4ZmU1NjU5OTRkZDRiNThmNzQ4ZjE2NTI4MWUwL3RhYmxlcmFuZ2U6ODk3NDhmZTU2NTk5NGRkNGI1OGY3NDhmMTY1MjgxZTBfMS0xLTEtMS04MzQxNA_56166a2e-ea5b-4018-8b7f-414c900e995e">19,186,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less redemption of ARYA shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i565dd4757c4d4703a0e0f5fd3a984d8a_D20210609-20210609" decimals="0" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RhYmxlOjg5NzQ4ZmU1NjU5OTRkZDRiNThmNzQ4ZjE2NTI4MWUwL3RhYmxlcmFuZ2U6ODk3NDhmZTU2NTk5NGRkNGI1OGY3NDhmMTY1MjgxZTBfMi0xLTEtMS04MzQxNA_6cec7522-98a0-442b-90d9-5643f3cce2a2">465,363</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock of ARYA</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RhYmxlOjg5NzQ4ZmU1NjU5OTRkZDRiNThmNzQ4ZjE2NTI4MWUwL3RhYmxlcmFuZ2U6ODk3NDhmZTU2NTk5NGRkNGI1OGY3NDhmMTY1MjgxZTBfMy0xLTEtMS04MzQxNA_1cd7f346-8012-4e1f-ab33-b3fde978a2b6">18,721,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued in PIPE Financing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RhYmxlOjg5NzQ4ZmU1NjU5OTRkZDRiNThmNzQ4ZjE2NTI4MWUwL3RhYmxlcmFuZ2U6ODk3NDhmZTU2NTk5NGRkNGI1OGY3NDhmMTY1MjgxZTBfNC0xLTEtMS04MzQxNA_c2e0a06f-dc2c-4c92-add4-606bf6e309a3">20,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business Combination and PIPE Financing shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609" decimals="0" name="naut:StockIssuedDuringPeriodSharesReverseRecapitalization" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RhYmxlOjg5NzQ4ZmU1NjU5OTRkZDRiNThmNzQ4ZjE2NTI4MWUwL3RhYmxlcmFuZ2U6ODk3NDhmZTU2NTk5NGRkNGI1OGY3NDhmMTY1MjgxZTBfNS0xLTEtMS04MzQxNA_77b8ca19-ffd2-4ae8-940d-eabc79fda2e2">38,721,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legacy Nautilus shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609" decimals="0" name="naut:StockConvertedReverseRecapitalization" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RhYmxlOjg5NzQ4ZmU1NjU5OTRkZDRiNThmNzQ4ZjE2NTI4MWUwL3RhYmxlcmFuZ2U6ODk3NDhmZTU2NTk5NGRkNGI1OGY3NDhmMTY1MjgxZTBfNi0xLTEtMS04MzQxNA_cdfb581e-2026-478e-a0f0-f9bda107a54d">85,324,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shares of Common Stock immediately after the Business Combination</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8cf39cfd7fd34311bc52d7c3ad8da2ff_I20210609" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RhYmxlOjg5NzQ4ZmU1NjU5OTRkZDRiNThmNzQ4ZjE2NTI4MWUwL3RhYmxlcmFuZ2U6ODk3NDhmZTU2NTk5NGRkNGI1OGY3NDhmMTY1MjgxZTBfNy0xLTEtMS04MzQxNA_70c596a8-cded-46b5-b446-185ee211c2f5">124,045,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_55"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RleHRyZWdpb246ZGRlYTM1M2E0ZTg0NGY4MmFkZmExMmI3ZGVkMTBlYzZfMzc5_2da7a186-b85d-44a5-a616-65ce16319420" continuedAt="idc451be8596647f995b85c825b56d0b5" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="idc451be8596647f995b85c825b56d0b5" continuedAt="i56fc66e5e07e4ed8b01dc375fd327227"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RleHRyZWdpb246ZGRlYTM1M2E0ZTg0NGY4MmFkZmExMmI3ZGVkMTBlYzZfMzgw_3a6e149c-6924-496a-bca7-58507c2690ea" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table details the assets carried at fair value and measured on a recurring basis within the three levels of fair value as of June&#160;30, 2022 and December&#160;31, 2021:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.282%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term investments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79037a7aa8bb452a9abe1acf155b0a38_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMy0yLTEtMS04MzQxNA_64f2bf90-2fa7-4349-91d3-42140c97fa20">1,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79037a7aa8bb452a9abe1acf155b0a38_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMy00LTEtMS04MzQxNA_8c22c44f-b9bb-4ec3-bb80-015d4d4d6462">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79037a7aa8bb452a9abe1acf155b0a38_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMy02LTEtMS04MzQxNA_035c8baf-9683-4a58-894b-cfda157dfd8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79037a7aa8bb452a9abe1acf155b0a38_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMy04LTEtMS04MzQxNA_eec404c8-2022-4439-9f85-66e7d79d267e">1,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec519f1b51a74b28a9f702bc1a15de30_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMy0xMC0xLTEtODM0MTQ_2f38ab1b-b6ea-42f8-9c75-d8cfa73595bd">1,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fc5af0cf1f14c46a0f276dc81c59884_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMy0xMi0xLTEtODM0MTQ_0e00c5cf-5535-4a48-94ee-a7395f2f3210">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0050fd4d6a3d46e2b3392794b3ad0b86_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMy0xNC0xLTEtODM0MTQ_2acde115-71bd-44b6-8a90-5bc77a711263">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1337c836c5934b6bac4f03a65db10d20_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNC0yLTEtMS04MzQxNA_98e380f1-b892-4a22-a382-eedecb57d9c0">39,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1337c836c5934b6bac4f03a65db10d20_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNC00LTEtMS04MzQxNA_ce222e13-49d9-4be5-b89c-52a7086f8b48">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1337c836c5934b6bac4f03a65db10d20_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNC02LTEtMS04MzQxNA_d524ee02-7f9c-4784-8869-f2808e9072b9">246</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1337c836c5934b6bac4f03a65db10d20_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNC04LTEtMS04MzQxNA_cd07f28c-47f4-4770-9ea2-12f2132bbde8">39,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3465ab1d6d8f48b68b3953bf87063529_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNC0xMC0xLTEtODM0MTQ_b497f25b-92f7-4f85-b7f2-441487508a91">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaebac9cbb2145b1baef43c60057d70a_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNC0xMi0xLTEtODM0MTQ_b8692970-fcab-4b00-a796-c8c0a0fb191c">14,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c2daae9584b48c397b73875dc06c78a_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNC0xNC0xLTEtODM0MTQ_8c50ca3b-264e-4f15-9c78-38585e7c7717">24,201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadef21ee44e04221a04d477fe4115655_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNS0yLTEtMS04MzQxNA_cdb3f6aa-37c8-42c5-9f24-25886a4697d6">41,226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadef21ee44e04221a04d477fe4115655_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNS00LTEtMS04MzQxNA_f8881d48-21de-4e3c-a711-864e1ab528ef">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadef21ee44e04221a04d477fe4115655_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNS02LTEtMS04MzQxNA_9a04a892-8114-4d24-93f7-a2b9224bd31d">246</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadef21ee44e04221a04d477fe4115655_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNS04LTEtMS04MzQxNA_81eeec6e-b3ac-4426-b0e0-2dad32430d3c">40,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a11f62dd1ef4191af3a81425e1797b7_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNS0xMC0xLTEtODM0MTQ_2ca459fa-927f-4391-8d04-d8655e653486">1,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d8fd5d7b0fa49a481c18d85c47bf96e_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNS0xMi0xLTEtODM0MTQ_b88fe632-5fca-4b47-83bc-12c501bb2b72">14,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0728a8794dce4087b0492d0e4351e1e6_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNS0xNC0xLTEtODM0MTQ_9e04abb5-84f7-485e-bf33-16d99cfa1a3f">24,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc43f21c31c5480eb0e220208d1cbaa6_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNy0yLTEtMS04MzQxNA_760074c6-e525-4946-a4a9-4a5f1bb3c84c">266,695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc43f21c31c5480eb0e220208d1cbaa6_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNy00LTEtMS04MzQxNA_a06e43f8-de3b-4bf0-93d8-440f85f635ca">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc43f21c31c5480eb0e220208d1cbaa6_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNy02LTEtMS04MzQxNA_db87c7aa-57a2-4b39-b88f-949a5fe38541">207</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc43f21c31c5480eb0e220208d1cbaa6_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNy04LTEtMS04MzQxNA_c55ddafc-b896-436b-858e-7192a1d8672a">266,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic726402929734cce8dbbe855f46e9393_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNy0xMC0xLTEtODM0MTQ_1b60265e-8ea2-4558-9221-eb6f4732f30f">208,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a7db4799084f059a70fe68887a2222_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNy0xMi0xLTEtODM0MTQ_005ec957-dc65-4116-9edb-3fc01fa98183">57,957</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01ccc819c01f4da4bf182c10a26166db_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNy0xNC0xLTEtODM0MTQ_20121dbd-ee67-4e37-a587-fec0cf48abfe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6d4c75d853d45118d52af84feb1c9ea_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOC0yLTEtMS04MzQxNA_97f9aa7d-7494-49f3-80f1-028078d71012">7,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6d4c75d853d45118d52af84feb1c9ea_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOC00LTEtMS04MzQxNA_11908b62-15e3-4363-9e5c-4ea0a5d15d78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6d4c75d853d45118d52af84feb1c9ea_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOC02LTEtMS04MzQxNA_02b839d3-86f4-4f99-96c2-a23f1a193604">135</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6d4c75d853d45118d52af84feb1c9ea_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOC04LTEtMS04MzQxNA_6ef0d9f4-5f25-4b6a-b29e-bf73a15596e4">7,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72d1a4360cb049bcbd0a7a2c5d41cfeb_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOC0xMC0xLTEtODM0MTQ_84f0f369-6645-4a41-83a2-5025b4a847c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43796c765a3b4a81a908d3053773a8d9_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOC0xMi0xLTEtODM0MTQ_fd0b784a-4253-48e3-9cdc-e1af47fb13b5">7,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic56b289dcf7e46aa9e1028ca71a10d0b_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOC0xNC0xLTEtODM0MTQ_73680037-27b4-4e44-8210-ef6e3294e985">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i642f3161862d43c3b6ae73200ecd113f_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOS0yLTEtMS04MzQxNA_7e0de034-fc17-4bdd-86f2-9ce6fadfddf5">20,378</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i642f3161862d43c3b6ae73200ecd113f_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOS00LTEtMS04MzQxNA_bde2a6c4-d26d-454e-a38c-28172063c046">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i642f3161862d43c3b6ae73200ecd113f_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOS02LTEtMS04MzQxNA_fd9d6c4f-1869-42e9-b047-277919fcceff">219</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i642f3161862d43c3b6ae73200ecd113f_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOS04LTEtMS04MzQxNA_03378622-a93a-43b7-8690-193582ec55a2">20,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea1db945b9d4412b88ca684b96485097_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOS0xMC0xLTEtODM0MTQ_0d9e9614-7340-4008-86dd-19413c199345">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd637638870b48e1b476508b5f17a987_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOS0xMi0xLTEtODM0MTQ_fe8acfd3-37f7-4c83-9ccc-8373038ea823">8,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic460f8db52ff40a98fc27d37b206e662_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOS0xNC0xLTEtODM0MTQ_a6991195-4682-4150-a590-d87cf576a333">11,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id56a7a2e33ba4a32a1d5145855a08542_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTAtMi0xLTEtODM0MTQ_09dd1862-75a9-4bbd-9a57-eb7ebafef668">294,438</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id56a7a2e33ba4a32a1d5145855a08542_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTAtNC0xLTEtODM0MTQ_276b8128-e64b-4e83-bd05-bb22e6a129b9">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id56a7a2e33ba4a32a1d5145855a08542_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTAtNi0xLTEtODM0MTQ_ae03b583-faeb-46c8-9919-02dbfdf128b8">561</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id56a7a2e33ba4a32a1d5145855a08542_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTAtOC0xLTEtODM0MTQ_65f61591-9f8c-4de2-9a99-0724ff11ad97">293,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie358eafdc46d4b668ba594dc1e5b18d6_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTAtMTAtMS0xLTgzNDE0_341f5fcf-acbd-46ce-b278-40b99ea632a8">208,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i406e02c48601468ebc3605dcc7cc3a1d_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTAtMTItMS0xLTgzNDE0_f3fcfaff-0bd3-48d0-894d-7422cb9bd72c">74,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1239a3c41dbc40e1bbeff834e51c1aee_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTAtMTQtMS0xLTgzNDE0_d727ba3e-3101-4b68-8e28-e966815ce8f7">11,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 1 and Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65429cbc59dc44efba3731beff6b9dd1_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTEtMi0xLTEtODM0MTQ_02d883d3-62ee-4e5d-882f-8a0598f09f68">335,664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65429cbc59dc44efba3731beff6b9dd1_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTEtNC0xLTEtODM0MTQ_b53aad2d-93c8-4918-8247-5057c0b522ae">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65429cbc59dc44efba3731beff6b9dd1_I20220630" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTEtNi0xLTEtODM0MTQ_5d995a4e-56db-4ddc-9bf6-7a5f57645f1f">807</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65429cbc59dc44efba3731beff6b9dd1_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTEtOC0xLTEtODM0MTQ_c4858c06-7152-4bea-997a-9512d697b5c4">334,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice7fbda97984484fa4687feefa1e787c_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTEtMTAtMS0xLTgzNDE0_f84b7e62-1501-47b4-90d1-7ee21ee68add">210,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55132e2a8fbb44009e345287f535137b_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTEtMTItMS0xLTgzNDE0_de73cbb6-1c19-4bfb-bfd0-0d2b79857273">88,984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dc0732a547c47a49a1c5860398b6fa2_I20220630" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTEtMTQtMS0xLTgzNDE0_65bf17c9-f6e4-43be-a263-f6b90e6fe8be">35,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:22.495%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.141%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term investments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd1d463226d84aad9a1438d158e6eb23_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMy0yLTEtMS04MzQxNA_d30f4550-5609-4a05-9d60-7697222c4d27">21,925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd1d463226d84aad9a1438d158e6eb23_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMy00LTEtMS04MzQxNA_1b5b550f-977d-406f-bc71-2752dc1dcbbd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd1d463226d84aad9a1438d158e6eb23_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMy02LTEtMS04MzQxNA_a9aaa5e9-a477-47ba-a24f-2dffe0f98046">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd1d463226d84aad9a1438d158e6eb23_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMy04LTEtMS04MzQxNA_cc79cdfd-8144-4973-99f9-81a6e5d34d6a">21,925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54b9d11dd5654d79a875c72b42d10b86_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMy0xMC0xLTEtODM0MTQ_b2b0d6c6-c54f-419a-ad25-116ee25dcb92">21,925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7bad06e2afb4d469055e60478216c8e_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMy0xMi0xLTEtODM0MTQ_858da950-56b8-46b2-b6c9-007c3358859d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ad2ffe0c6c64a0f945e3af8721a487f_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMy0xNC0xLTEtODM0MTQ_999a1d2a-5ed8-48b2-a20d-66df3d60408a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i950704d092364ff2b931f1d01449efb0_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNC0yLTEtMS04MzQxNA_841c3edc-16da-4e22-861a-22d229b84308">15,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i950704d092364ff2b931f1d01449efb0_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNC00LTEtMS04MzQxNA_14a8ad2c-2448-45b4-aa63-a6688d38b804">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i950704d092364ff2b931f1d01449efb0_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNC02LTEtMS04MzQxNA_09384a2a-2f87-4db5-bb39-703f237c0365">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i950704d092364ff2b931f1d01449efb0_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNC04LTEtMS04MzQxNA_4e76a481-0125-4fb6-9735-bc65eb95aa08">15,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5acec1f8c5648f6b912abb5a8c70899_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNC0xMC0xLTEtODM0MTQ_6301a9d6-e614-4267-ba89-e075c7fe9b39">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i276d2f47485e4e31b420416f91c282aa_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNC0xMi0xLTEtODM0MTQ_859e8d2e-bc86-4e6f-a3eb-23e3a92302bc">15,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4de2e6190b45178fbe6a57799d9ce1_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNC0xNC0xLTEtODM0MTQ_729f2beb-9741-4d53-9a0c-95ae2cce9ff6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0de8e6af07d84138b0e785102ca2f7f6_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNS0yLTEtMS04MzQxNA_db3f19f6-792c-4e10-8ee0-ca4a44cd6576">37,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0de8e6af07d84138b0e785102ca2f7f6_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNS00LTEtMS04MzQxNA_42425e22-ab0c-498c-82ed-6676817fa7e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0de8e6af07d84138b0e785102ca2f7f6_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNS02LTEtMS04MzQxNA_d29ce884-0391-405c-9967-01c9cc6b0e9b">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0de8e6af07d84138b0e785102ca2f7f6_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNS04LTEtMS04MzQxNA_e4f087a4-6fb7-40fd-99ce-1df9c3e08aa0">37,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i325c3c07c7f74c5f98e3c999c65b7441_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNS0xMC0xLTEtODM0MTQ_bb282b11-a080-4873-bace-1e0f9e90818a">21,925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca49185e1c445cfa94d8d799ed53ce3_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNS0xMi0xLTEtODM0MTQ_d968b131-ae40-4bc8-a1f3-487be748f00a">15,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6a86385f1054cff872febbcd6e2d2eb_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNS0xNC0xLTEtODM0MTQ_c1d7bf1a-dc38-45dd-87e5-e10cb2145172">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9cb68272c8244ea9919716328cc5ef2_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNy0yLTEtMS04MzQxNA_353bdb69-cbe7-4360-98c2-1d44232fe331">301,906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9cb68272c8244ea9919716328cc5ef2_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNy00LTEtMS04MzQxNA_b075b65c-5e12-465d-acdd-3e09d378954d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9cb68272c8244ea9919716328cc5ef2_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNy02LTEtMS04MzQxNA_bce3430b-465c-443e-9bd3-11ec09a7d8fa">90</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9cb68272c8244ea9919716328cc5ef2_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNy04LTEtMS04MzQxNA_bcf1ee65-e331-4a89-a99c-741f1c03c431">301,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70c36a3813d14058806f4eb11606f72e_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNy0xMC0xLTEtODM0MTQ_90cf93a3-36cd-4069-9a0a-c08420e36007">163,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfd0acaaf2c04dbb8b67de884e3f27b8_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNy0xMi0xLTEtODM0MTQ_b9eb62b4-8c49-45b4-a58e-5257e6ec8919">138,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b751c1b3c4a4f9d80dd9d109c372f81_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNy0xNC0xLTEtODM0MTQ_f08df611-cd65-4cb1-8c8f-deac2e9a100e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe88c920880047c18b0c9cdf55c6e8df_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOC0yLTEtMS04MzQxNA_8aea0a80-2ef6-4e28-85ca-6bab75c646e0">14,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe88c920880047c18b0c9cdf55c6e8df_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOC00LTEtMS04MzQxNA_6a39cc3f-5294-44c7-8332-be3cfda1a944">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe88c920880047c18b0c9cdf55c6e8df_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOC02LTEtMS04MzQxNA_8023e601-0a8e-4477-be81-7e8724d96fee">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe88c920880047c18b0c9cdf55c6e8df_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOC04LTEtMS04MzQxNA_ed41807a-24c1-42cd-a4f1-660bbc1d5987">14,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id158f09e96ab481f97e32c8613f97003_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOC0xMC0xLTEtODM0MTQ_41091993-6856-4170-bc29-ab18bba4cd73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82a7bcc7bc4d49e084d69fc0519a1f46_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOC0xMi0xLTEtODM0MTQ_1a91b658-1f66-40b3-af33-a7ec5ae13520">6,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id14ac15267014aa398c2c76cac075a21_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOC0xNC0xLTEtODM0MTQ_3d58b081-a168-4098-a5a8-ef96e9de5606">7,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice46726bd5254e1d955ba67438fa7351_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOS0yLTEtMS04MzQxNA_a5265d1d-2651-4df4-a33f-e1ddfbe59aca">8,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice46726bd5254e1d955ba67438fa7351_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOS00LTEtMS04MzQxNA_df506322-a4dc-4ed4-933c-acf58ff6f6b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice46726bd5254e1d955ba67438fa7351_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOS02LTEtMS04MzQxNA_d68d3b71-a1fe-4635-a4fd-55c53ebf0c8d">40</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice46726bd5254e1d955ba67438fa7351_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOS04LTEtMS04MzQxNA_f8ff9876-c1ee-4c8f-b851-83ae1c6c136f">8,958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0677ff7a71e047b1b7f25782cf4ffe83_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOS0xMC0xLTEtODM0MTQ_8ac78066-b99b-4c75-bfe4-804b25ae4096">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id505c63953e54d2184cb7f771dec30b2_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOS0xMi0xLTEtODM0MTQ_9c659b90-83b7-4eb3-8fcc-c0c0bd638ce1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3be0b06a9c94f3a9829bec818382447_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOS0xNC0xLTEtODM0MTQ_8283eba3-ecc6-4716-a1f8-ca2259d29df9">8,958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1375f50662564d9695c2f9a598ea96ff_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTAtMi0xLTEtODM0MTQ_70fcbd83-f00f-4ccf-8e47-99463e6fb5d1">325,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1375f50662564d9695c2f9a598ea96ff_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTAtNC0xLTEtODM0MTQ_72beb826-6aad-429b-904a-75c12942f0d3">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1375f50662564d9695c2f9a598ea96ff_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTAtNi0xLTEtODM0MTQ_c065696d-5ef2-4613-8e44-76ba18b1538d">166</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1375f50662564d9695c2f9a598ea96ff_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTAtOC0xLTEtODM0MTQ_1700da23-df80-4da0-965e-b4471060516c">325,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i390387b0a67e446f8057dfcc678f0e57_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTAtMTAtMS0xLTgzNDE0_a96e3c4f-fac9-45a5-bbce-301ff51e78dd">163,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e8607b8fc264a58929288d5a7cae83f_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTAtMTItMS0xLTgzNDE0_1061f845-55b1-4116-ba1c-eb0b3e8838a8">144,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ebedf34f1ba432d875df25f515ac771_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTAtMTQtMS0xLTgzNDE0_f2be1f37-bb64-47b3-b4fd-94117c32c4f4">16,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 1 and Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic760bbad7d924910b0fc9c0598c7dd1c_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTEtMi0xLTEtODM0MTQ_0c90a9a1-4b67-4a96-9979-4db33d83165d">362,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic760bbad7d924910b0fc9c0598c7dd1c_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTEtNC0xLTEtODM0MTQ_98e25287-2414-4bdc-b9ef-2ac67acf6103">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic760bbad7d924910b0fc9c0598c7dd1c_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTEtNi0xLTEtODM0MTQ_ba5c0d03-4e5e-4c9b-8ab9-8c7ea63b6410">186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic760bbad7d924910b0fc9c0598c7dd1c_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTEtOC0xLTEtODM0MTQ_ce4e26d8-fbcd-480a-9481-4bc6a4524120">362,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c35013b448d4f9a8ea202c0cc904312_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTEtMTAtMS0xLTgzNDE0_6ab9fd15-5c7d-4b10-92cb-a42e85c7e639">185,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6319ed6f43b45e59b873b4727e4b8df_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTEtMTItMS0xLTgzNDE0_fd3aac3d-5744-4a28-9c20-40c49d45ebd1">160,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4671216a131e4e1a8c9dfea3bb76d2bd_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTEtMTQtMS0xLTgzNDE0_6e67b1e1-87ba-49a8-ba91-a385e0228dea">16,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual maturities of short-term investments as of June&#160;30, 2022 and December&#160;31, 2021 are due in one year or less. Contractual maturities of long-term investments as of June&#160;30, 2022 and December&#160;31, 2021 are due </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements&#8212;(Continued)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i56fc66e5e07e4ed8b01dc375fd327227">after 1 year through 2 years.  There were no continuous unrealized loss positions in excess of twelve months as of June 30, 2022 and December 31, 2021.</ix:continuation></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_58"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RleHRyZWdpb246Nzk2N2E5YjExYmIzNGMwMWI3ZGQ3NzQ2NzgyMTA4M2VfNjIz_77b7624c-031d-491e-a75d-fbeaa3dd2374" continuedAt="ifbbe4c3b435b4db9865e679434704dc9" escape="true">Composition of Certain Condensed Consolidated Financial Statement Line Items</ix:nonNumeric></span></div><ix:continuation id="ifbbe4c3b435b4db9865e679434704dc9" continuedAt="i28bf1e6abb4049ccb38666aba1cb8f5b"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment, Net </span></div><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RleHRyZWdpb246Nzk2N2E5YjExYmIzNGMwMWI3ZGQ3NzQ2NzgyMTA4M2VfNjI0_4089f8fd-10ca-41ba-9525-79e79a2c326e" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62504dcfdac144e7a5c3c6eb6862529d_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfMS0xLTEtMS04MzQxNA_e9370e7c-d566-4d00-b21a-a6b92ad54e31">4,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f485413bc8146e3bbce6629c4dcd539_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfMS0zLTEtMS04MzQxNA_42092a65-8e8c-410f-9f02-056ab8b67dae">4,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0083086336d845fdad111086bbba6da7_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfMi0xLTEtMS04MzQxNA_4f7156bd-ba9b-416e-b482-bf152953c91d">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e22a0d731ef400b92b19e10336609cc_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfMi0zLTEtMS04MzQxNA_0c8692a6-ba62-40e3-8d5c-6d4f78d4d935">157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and office equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2148fd953e942c9b5fa08720c4723a6_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfMy0xLTEtMS04MzQxNA_10cfbc11-5bdb-415f-99fd-5c59d3dcd019">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia89341e52be34f04b93a341be9170381_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfMy0zLTEtMS04MzQxNA_49e0dda9-251f-488f-ade7-aee5b1239d93">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffc3dca386444731a94b2e7034cbfd79_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfNC0xLTEtMS04MzQxNA_6bccc6f3-c1d6-43d5-8f09-b2e0aaf50f79">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc0ee8f762314302abd9fa2688c27560_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfNC0zLTEtMS04MzQxNA_94866002-1f32-4828-8b04-9a0d50f03f42">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69c8e273988d437082cf0d4dd215960d_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfNS0xLTEtMS04MzQxNA_7fa61c55-f410-4f60-968c-4c3fe94bac39">1,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e301c5918bb4924a1937829c187cbe6_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfNS0zLTEtMS04MzQxNA_fc2e65c2-a7b2-4cf9-9943-4ca3bf85f764">279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfNi0xLTEtMS04MzQxNA_816d0ca3-6806-4414-9dc3-e8afc8254d13">5,958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfNi0zLTEtMS04MzQxNA_997542b6-3bc9-4544-b40d-91a93c9422f2">4,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfNy0xLTEtMS04MzQxNA_492615cb-e487-462b-8570-25a1fe83489d">2,556</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfNy0zLTEtMS04MzQxNA_60b0c5cb-b9d0-447f-9590-8750a275746f">1,994</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfOC0xLTEtMS04MzQxNA_99c74847-1415-45a5-8d0f-015cc95a6564">3,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfOC0zLTEtMS04MzQxNA_d52c8bad-5a87-49c2-8d60-4b768c872fcc">2,483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded depreciation expense of $<ix:nonFraction unitRef="usd" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RleHRyZWdpb246Nzk2N2E5YjExYmIzNGMwMWI3ZGQ3NzQ2NzgyMTA4M2VfMjA5_37db1d66-530f-4112-8c64-27fe8a18f635">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RleHRyZWdpb246Nzk2N2E5YjExYmIzNGMwMWI3ZGQ3NzQ2NzgyMTA4M2VfNTQ5NzU1ODE0NTI2_d583959a-a06c-4747-b39c-cf985b1dc50c">0.6</ix:nonFraction> million for the three and six months ended June 30, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RleHRyZWdpb246Nzk2N2E5YjExYmIzNGMwMWI3ZGQ3NzQ2NzgyMTA4M2VfNTQ5NzU1ODE0NTE4_5d89be1e-41b0-434c-87ee-af0223530190">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RleHRyZWdpb246Nzk2N2E5YjExYmIzNGMwMWI3ZGQ3NzQ2NzgyMTA4M2VfNTQ5NzU1ODE0NTM0_8aa99ab8-e5d3-45e8-b94e-2248984a0099">0.5</ix:nonFraction> million for the three and six months ended June 30, 2021, respectively, which was primarily allocated to research and development expense. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Long Term Assets </span></div><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RleHRyZWdpb246Nzk2N2E5YjExYmIzNGMwMWI3ZGQ3NzQ2NzgyMTA4M2VfNjI1_b7613b1b-6c10-4877-b46f-089f0e24f7ae" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long term assets consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjdiMWE4ZGE5YjAwYzRmZjc4ZTJhNGJmZTVlMzU4YmMxL3RhYmxlcmFuZ2U6N2IxYThkYTliMDBjNGZmNzhlMmE0YmZlNWUzNThiYzFfMS0xLTEtMS04MzQxNA_42e009f3-8be8-4d3e-882e-06007a44e1d6">842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjdiMWE4ZGE5YjAwYzRmZjc4ZTJhNGJmZTVlMzU4YmMxL3RhYmxlcmFuZ2U6N2IxYThkYTliMDBjNGZmNzhlMmE0YmZlNWUzNThiYzFfMS0zLTEtMS04MzQxNA_6f5941a5-e528-492b-af2c-dc28c9e74616">842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Deposits</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:DepositsAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjdiMWE4ZGE5YjAwYzRmZjc4ZTJhNGJmZTVlMzU4YmMxL3RhYmxlcmFuZ2U6N2IxYThkYTliMDBjNGZmNzhlMmE0YmZlNWUzNThiYzFfMi0xLTEtMS04MzQxNA_ac37be93-51f3-4123-aefc-57b7a748ced2">155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:DepositsAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjdiMWE4ZGE5YjAwYzRmZjc4ZTJhNGJmZTVlMzU4YmMxL3RhYmxlcmFuZ2U6N2IxYThkYTliMDBjNGZmNzhlMmE0YmZlNWUzNThiYzFfMi0zLTEtMS04MzQxNA_c5ea6f63-bb19-40ed-831d-14c394e01331">155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjdiMWE4ZGE5YjAwYzRmZjc4ZTJhNGJmZTVlMzU4YmMxL3RhYmxlcmFuZ2U6N2IxYThkYTliMDBjNGZmNzhlMmE0YmZlNWUzNThiYzFfNC0xLTEtMS04MzQxNA_4c5d7799-5787-4df5-be29-e128ac684ad9">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjdiMWE4ZGE5YjAwYzRmZjc4ZTJhNGJmZTVlMzU4YmMxL3RhYmxlcmFuZ2U6N2IxYThkYTliMDBjNGZmNzhlMmE0YmZlNWUzNThiYzFfNC0zLTEtMS04MzQxNA_c2bec689-7182-4ee3-b485-f50d1ed1be14">997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accrued Expenses and Other Liabilities</span></div><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RleHRyZWdpb246Nzk2N2E5YjExYmIzNGMwMWI3ZGQ3NzQ2NzgyMTA4M2VfNjI2_523ea789-8937-4e9c-b426-91859d0a5f00" escape="true"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RleHRyZWdpb246Nzk2N2E5YjExYmIzNGMwMWI3ZGQ3NzQ2NzgyMTA4M2VfNjI2_609e727e-7b5a-42b0-8989-46c40f67f531" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other liabilities consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjcyMjZkYTdjMWYxMDRiMGQ4N2ZhMmFiN2VjYmQ5Y2RmL3RhYmxlcmFuZ2U6NzIyNmRhN2MxZjEwNGIwZDg3ZmEyYWI3ZWNiZDljZGZfMS0xLTEtMS04MzQxNA_6ed37edd-48fb-4a3e-aa94-ccdedf0131f4">1,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjcyMjZkYTdjMWYxMDRiMGQ4N2ZhMmFiN2VjYmQ5Y2RmL3RhYmxlcmFuZ2U6NzIyNmRhN2MxZjEwNGIwZDg3ZmEyYWI3ZWNiZDljZGZfMS0zLTEtMS04MzQxNA_982bdd0c-1d6d-44d9-8a4c-7f350c67ce93">1,465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="naut:AccruedResearchAndDevelopment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjcyMjZkYTdjMWYxMDRiMGQ4N2ZhMmFiN2VjYmQ5Y2RmL3RhYmxlcmFuZ2U6NzIyNmRhN2MxZjEwNGIwZDg3ZmEyYWI3ZWNiZDljZGZfMi0xLTEtMS04MzQxNA_1977d45a-2b4a-417c-9c71-cda76d875624">874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="naut:AccruedResearchAndDevelopment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjcyMjZkYTdjMWYxMDRiMGQ4N2ZhMmFiN2VjYmQ5Y2RmL3RhYmxlcmFuZ2U6NzIyNmRhN2MxZjEwNGIwZDg3ZmEyYWI3ZWNiZDljZGZfMi0zLTEtMS04MzQxNA_d9e9fb44-b20f-42ee-97a2-5ec79efd3db7">518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional and consulting fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjcyMjZkYTdjMWYxMDRiMGQ4N2ZhMmFiN2VjYmQ5Y2RmL3RhYmxlcmFuZ2U6NzIyNmRhN2MxZjEwNGIwZDg3ZmEyYWI3ZWNiZDljZGZfMy0xLTEtMS04MzQxNA_3c623e43-4a47-4ed9-b605-abf7849bf9f7">539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjcyMjZkYTdjMWYxMDRiMGQ4N2ZhMmFiN2VjYmQ5Y2RmL3RhYmxlcmFuZ2U6NzIyNmRhN2MxZjEwNGIwZDg3ZmEyYWI3ZWNiZDljZGZfMy0zLTEtMS04MzQxNA_72a76501-93ef-438b-9ab5-c23692e30318">411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued facilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="naut:AccruedFacilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjcyMjZkYTdjMWYxMDRiMGQ4N2ZhMmFiN2VjYmQ5Y2RmL3RhYmxlcmFuZ2U6NzIyNmRhN2MxZjEwNGIwZDg3ZmEyYWI3ZWNiZDljZGZfNC0xLTEtMS04MzQxNA_5144b59b-faa5-44cc-8587-6adcef64aa48">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="naut:AccruedFacilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjcyMjZkYTdjMWYxMDRiMGQ4N2ZhMmFiN2VjYmQ5Y2RmL3RhYmxlcmFuZ2U6NzIyNmRhN2MxZjEwNGIwZDg3ZmEyYWI3ZWNiZDljZGZfNC0zLTEtMS04MzQxNA_4ae9eca0-d32d-4865-a6fe-a98a040c5da4">337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjcyMjZkYTdjMWYxMDRiMGQ4N2ZhMmFiN2VjYmQ5Y2RmL3RhYmxlcmFuZ2U6NzIyNmRhN2MxZjEwNGIwZDg3ZmEyYWI3ZWNiZDljZGZfNS0xLTEtMS04MzQxNA_9d043ee0-e4d2-4bc6-bfd3-20c9db21333d">396</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:OtherSundryLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjcyMjZkYTdjMWYxMDRiMGQ4N2ZhMmFiN2VjYmQ5Y2RmL3RhYmxlcmFuZ2U6NzIyNmRhN2MxZjEwNGIwZDg3ZmEyYWI3ZWNiZDljZGZfNS0zLTEtMS04MzQxNA_bd5dfe88-27b5-4250-bf2f-336c6a608b9c">388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjcyMjZkYTdjMWYxMDRiMGQ4N2ZhMmFiN2VjYmQ5Y2RmL3RhYmxlcmFuZ2U6NzIyNmRhN2MxZjEwNGIwZDg3ZmEyYWI3ZWNiZDljZGZfNi0xLTEtMS04MzQxNA_954719ab-9896-4c0f-aa09-64d1713ba9a4">3,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjcyMjZkYTdjMWYxMDRiMGQ4N2ZhMmFiN2VjYmQ5Y2RmL3RhYmxlcmFuZ2U6NzIyNmRhN2MxZjEwNGIwZDg3ZmEyYWI3ZWNiZDljZGZfNi0zLTEtMS04MzQxNA_e7fb4f8a-3ec7-4828-869a-8d60f3aa23eb">3,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements&#8212;(Continued)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><ix:continuation id="i28bf1e6abb4049ccb38666aba1cb8f5b"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash</span></div><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RleHRyZWdpb246Nzk2N2E5YjExYmIzNGMwMWI3ZGQ3NzQ2NzgyMTA4M2VfNjI3_0304df85-f859-409b-ae84-1a6094096375" escape="true"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RleHRyZWdpb246Nzk2N2E5YjExYmIzNGMwMWI3ZGQ3NzQ2NzgyMTA4M2VfNjI3_98918a9d-2f23-4ba7-ab3c-fdba2781f588" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOmIzZTkzNDJmZDcxODRhODZiYzIxNGE1ODgxN2ExZjZmL3RhYmxlcmFuZ2U6YjNlOTM0MmZkNzE4NGE4NmJjMjE0YTU4ODE3YTFmNmZfMS0xLTEtMS04MzQxNA_ea5e3e43-3017-4aeb-a89c-38a0a7639dcb">210,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOmIzZTkzNDJmZDcxODRhODZiYzIxNGE1ODgxN2ExZjZmL3RhYmxlcmFuZ2U6YjNlOTM0MmZkNzE4NGE4NmJjMjE0YTU4ODE3YTFmNmZfMS0zLTEtMS04MzQxNA_589dc11f-223d-4a1d-91dd-aea1caa5d9fe">185,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other long term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOmIzZTkzNDJmZDcxODRhODZiYzIxNGE1ODgxN2ExZjZmL3RhYmxlcmFuZ2U6YjNlOTM0MmZkNzE4NGE4NmJjMjE0YTU4ODE3YTFmNmZfMi0xLTEtMS04MzQxNA_c444ebdc-a5f5-4a89-af77-d88d8ccff740">842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOmIzZTkzNDJmZDcxODRhODZiYzIxNGE1ODgxN2ExZjZmL3RhYmxlcmFuZ2U6YjNlOTM0MmZkNzE4NGE4NmJjMjE0YTU4ODE3YTFmNmZfMi0zLTEtMS04MzQxNA_cfdfe8d8-5b08-4126-8132-3a5f8ec7d897">842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOmIzZTkzNDJmZDcxODRhODZiYzIxNGE1ODgxN2ExZjZmL3RhYmxlcmFuZ2U6YjNlOTM0MmZkNzE4NGE4NmJjMjE0YTU4ODE3YTFmNmZfMy0xLTEtMS04MzQxNA_4fa1556d-b26a-4e4c-be0c-752a0d3b5077">211,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOmIzZTkzNDJmZDcxODRhODZiYzIxNGE1ODgxN2ExZjZmL3RhYmxlcmFuZ2U6YjNlOTM0MmZkNzE4NGE4NmJjMjE0YTU4ODE3YTFmNmZfMy0zLTEtMS04MzQxNA_a605691e-691f-4804-8842-bd2e2ff909bb">186,461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_61"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="naut:DisclosureOfRedeemableConvertiblePreferredStockTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82MS9mcmFnOmI4N2M3ODVkMmM2NTQ2ZjViOTI4MGJjNjgyZWQwNzFhL3RleHRyZWdpb246Yjg3Yzc4NWQyYzY1NDZmNWI5MjgwYmM2ODJlZDA3MWFfNTAz_e975e7e6-1161-4067-9438-4ab13f2109e4" continuedAt="icc5908a29f50487e9bb52bec8f481f2e" escape="true">Redeemable Convertible Preferred Stock </ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icc5908a29f50487e9bb52bec8f481f2e">On June 9, 2021, upon the closing of the Business Combination (as defined in Note 1 and further described in Note 3), all of the outstanding redeemable convertible preferred stock was converted to New Nautilus Common Stock pursuant to the Exchange Ratio effective immediately prior to the Business Combination and the remaining amount was reclassified to additional paid-in capital. As of June&#160;30, 2022 the Company had <ix:nonFraction unitRef="shares" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82MS9mcmFnOmI4N2M3ODVkMmM2NTQ2ZjViOTI4MGJjNjgyZWQwNzFhL3RleHRyZWdpb246Yjg3Yzc4NWQyYzY1NDZmNWI5MjgwYmM2ODJlZDA3MWFfNDUz_3e148d9b-1570-4264-a7d5-147add1a342f"><ix:nonFraction unitRef="shares" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82MS9mcmFnOmI4N2M3ODVkMmM2NTQ2ZjViOTI4MGJjNjgyZWQwNzFhL3RleHRyZWdpb246Yjg3Yzc4NWQyYzY1NDZmNWI5MjgwYmM2ODJlZDA3MWFfNDUz_8d32fa7c-f0a8-4af4-afa2-06400f300d63">no</ix:nonFraction></ix:nonFraction> issued and outstanding Preferred Stock shares.</ix:continuation></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_64"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RleHRyZWdpb246NWIxNzFmNjRkMWZlNDhiYjg4ZGVmY2E4Y2Q4NjYxOThfMTAzMw_e9ea60f2-8a90-4ce3-9d18-5bf5a107f6ff" continuedAt="i7939e02035f04db89a86f80ed14490c3" escape="true">Common Stock</ix:nonNumeric></span></div><ix:continuation id="i7939e02035f04db89a86f80ed14490c3"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 9, 2021, the Business Combination (as defined in Note 1 and further described in Note 3) was consummated and the Company issued <ix:nonFraction unitRef="shares" contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609" decimals="0" name="naut:StockIssuedDuringPeriodSharesReverseRecapitalization" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RleHRyZWdpb246NWIxNzFmNjRkMWZlNDhiYjg4ZGVmY2E4Y2Q4NjYxOThfMTU0_1552cfbe-bb26-4360-b267-f00d35f7e07a">38,721,137</ix:nonFraction> shares for an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609" decimals="-5" name="naut:StockIssuedDuringPeriodValueReverseRecapitalization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RleHRyZWdpb246NWIxNzFmNjRkMWZlNDhiYjg4ZGVmY2E4Y2Q4NjYxOThfMTk5_2aec8d9c-e8ac-4002-932b-9302049e2243">327.3</ix:nonFraction>&#160;million, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609" decimals="-5" name="naut:PaymentsOfReverseRecapitalizationTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RleHRyZWdpb246NWIxNzFmNjRkMWZlNDhiYjg4ZGVmY2E4Y2Q4NjYxOThfMjI4_b518a006-25d0-4f72-b6b6-9b62cfd5caef">8.1</ix:nonFraction>&#160;million. Immediately following the Business Combination, there were <ix:nonFraction unitRef="shares" contextRef="i8cf39cfd7fd34311bc52d7c3ad8da2ff_I20210609" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RleHRyZWdpb246NWIxNzFmNjRkMWZlNDhiYjg4ZGVmY2E4Y2Q4NjYxOThfMjkx_bc3e8e73-a723-4d05-b324-5ca2658c750a">124,045,255</ix:nonFraction> shares of Common Stock outstanding. The holder of each share of Common Stock is entitled to one vote.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has retroactively adjusted the shares issued and outstanding prior to June 9, 2021 to give effect to the exchange ratio established in the Business Combination Agreement to determine the number of shares of Common Stock into which they were converted. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, pursuant to the Business Combination, the Company amended its certificate of incorporation to increase the number of authorized common stock shares to <ix:nonFraction unitRef="shares" contextRef="ibff31d711c89442ab7051c729b67d7e0_I20210630" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RleHRyZWdpb246NWIxNzFmNjRkMWZlNDhiYjg4ZGVmY2E4Y2Q4NjYxOThfODI2_e9f43092-8a5b-4c6c-8e7e-36d3d28c3704">1,000,000,000</ix:nonFraction> shares. There were <ix:nonFraction unitRef="shares" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RleHRyZWdpb246NWIxNzFmNjRkMWZlNDhiYjg4ZGVmY2E4Y2Q4NjYxOThfODQ4_48feafc3-d2d0-433a-84fe-35881e96d114"><ix:nonFraction unitRef="shares" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RleHRyZWdpb246NWIxNzFmNjRkMWZlNDhiYjg4ZGVmY2E4Y2Q4NjYxOThfODQ4_5f077156-fec3-42ba-9153-14e7e0ea4e81">124,562,745</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of June&#160;30, 2022.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock Reserved for Future Issuance</span></div><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="naut:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RleHRyZWdpb246NWIxNzFmNjRkMWZlNDhiYjg4ZGVmY2E4Y2Q4NjYxOThfMTAzNA_bec09f08-c4e2-4ff7-9939-63e4c42e5b2d" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of common stock reserved for future issuance on an as-if converted basis, were as follows:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options issued and outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RhYmxlOmQ5NGRlOGU1YjVkNjRiMWJiZjM1MTJiODg3Y2ZhOWI2L3RhYmxlcmFuZ2U6ZDk0ZGU4ZTViNWQ2NGIxYmJmMzUxMmI4ODdjZmE5YjZfMS0xLTEtMS04MzQxNA_10ba635f-79bc-495c-abae-50606a3ee642">11,650,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RhYmxlOmQ5NGRlOGU1YjVkNjRiMWJiZjM1MTJiODg3Y2ZhOWI2L3RhYmxlcmFuZ2U6ZDk0ZGU4ZTViNWQ2NGIxYmJmMzUxMmI4ODdjZmE5YjZfMS0zLTEtMS04MzQxNA_ffd8512f-0d53-4bbf-b907-8b6d4463d947">8,550,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for grant under 2021 Equity Incentive Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4f3af80321e54f9fb93e4f4f432b503c_I20220630" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RhYmxlOmQ5NGRlOGU1YjVkNjRiMWJiZjM1MTJiODg3Y2ZhOWI2L3RhYmxlcmFuZ2U6ZDk0ZGU4ZTViNWQ2NGIxYmJmMzUxMmI4ODdjZmE5YjZfMi0xLTEtMS04MzQxNA_23a633da-e7d3-4afa-8fad-62e25ca554b3">17,384,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f3067b2fe2743df8d892928fdb699d8_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RhYmxlOmQ5NGRlOGU1YjVkNjRiMWJiZjM1MTJiODg3Y2ZhOWI2L3RhYmxlcmFuZ2U6ZDk0ZGU4ZTViNWQ2NGIxYmJmMzUxMmI4ODdjZmE5YjZfMi0zLTEtMS04MzQxNA_c755fe2e-075f-4c8e-8d37-df11f51747be">14,481,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for grant under 2021 Employee Stock Purchase Plan</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i787199e8a86147f2b16226c6baee76a4_I20220630" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RhYmxlOmQ5NGRlOGU1YjVkNjRiMWJiZjM1MTJiODg3Y2ZhOWI2L3RhYmxlcmFuZ2U6ZDk0ZGU4ZTViNWQ2NGIxYmJmMzUxMmI4ODdjZmE5YjZfMy0xLTEtMS04MzQxNA_2e0a0764-48b3-4ce4-b46f-83b8dd3c6654">2,439,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i646596b1fd7f425b997adba08286e2c6_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RhYmxlOmQ5NGRlOGU1YjVkNjRiMWJiZjM1MTJiODg3Y2ZhOWI2L3RhYmxlcmFuZ2U6ZDk0ZGU4ZTViNWQ2NGIxYmJmMzUxMmI4ODdjZmE5YjZfMy0zLTEtMS04MzQxNA_786cd897-6f0b-4de9-acb6-c973e6fc8dc4">1,244,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shares of common stock reserved</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RhYmxlOmQ5NGRlOGU1YjVkNjRiMWJiZjM1MTJiODg3Y2ZhOWI2L3RhYmxlcmFuZ2U6ZDk0ZGU4ZTViNWQ2NGIxYmJmMzUxMmI4ODdjZmE5YjZfNy0xLTEtMS04MzQxNA_fba358bd-e18a-4ffb-a0cd-2075496bede2">31,474,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RhYmxlOmQ5NGRlOGU1YjVkNjRiMWJiZjM1MTJiODg3Y2ZhOWI2L3RhYmxlcmFuZ2U6ZDk0ZGU4ZTViNWQ2NGIxYmJmMzUxMmI4ODdjZmE5YjZfNy0zLTEtMS04MzQxNA_5e086589-65d2-429b-950f-fb68c61b26a1">24,276,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_67"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82Ny9mcmFnOmEyNzk3ZDc3MTM0ODQ5MmU4YmRmNzI4NzJhODhlMjMyL3RleHRyZWdpb246YTI3OTdkNzcxMzQ4NDkyZThiZGY3Mjg3MmE4OGUyMzJfNjMw_df6430b8-f5d3-41d4-92ab-de7bd1e58b72" continuedAt="i36de6358de86440ead012e78cb3ed961" escape="true">Income Taxes </ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i36de6358de86440ead012e78cb3ed961">The Company accounts for income taxes under the asset and liability method. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be realized. For the three and six months ended June 30, 2022 and 2021, <ix:nonFraction unitRef="usd" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82Ny9mcmFnOmEyNzk3ZDc3MTM0ODQ5MmU4YmRmNzI4NzJhODhlMjMyL3RleHRyZWdpb246YTI3OTdkNzcxMzQ4NDkyZThiZGY3Mjg3MmE4OGUyMzJfNDk2_1d96243e-dfd4-4f4d-a7bc-55b2f833e476"><ix:nonFraction unitRef="usd" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82Ny9mcmFnOmEyNzk3ZDc3MTM0ODQ5MmU4YmRmNzI4NzJhODhlMjMyL3RleHRyZWdpb246YTI3OTdkNzcxMzQ4NDkyZThiZGY3Mjg3MmE4OGUyMzJfNDk2_7ad135ed-8cf6-4346-9c66-cad36e41efeb"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82Ny9mcmFnOmEyNzk3ZDc3MTM0ODQ5MmU4YmRmNzI4NzJhODhlMjMyL3RleHRyZWdpb246YTI3OTdkNzcxMzQ4NDkyZThiZGY3Mjg3MmE4OGUyMzJfNDk2_7d88d40f-8a5a-4e75-b41c-e918d366c13f"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82Ny9mcmFnOmEyNzk3ZDc3MTM0ODQ5MmU4YmRmNzI4NzJhODhlMjMyL3RleHRyZWdpb246YTI3OTdkNzcxMzQ4NDkyZThiZGY3Mjg3MmE4OGUyMzJfNDk2_7f1838f1-6cc1-404e-9429-e60fe8431ba3">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> income tax expense or benefit was recognized, primarily due to a full valuation allowance recorded against its deferred tax asset.</ix:continuation></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_70"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements&#8212;(Continued)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:28.5pt"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfNzE4Mg_40457b60-d7f5-458c-8597-d9ac24b8166e" continuedAt="i82b5c6c0f7024b5bbd5d8edced9326ef" escape="true">Stock Option Plan and Stock-based Compensation</ix:nonNumeric></span></div><ix:continuation id="i82b5c6c0f7024b5bbd5d8edced9326ef" continuedAt="i5838f0271372442ea011c5d24087eb8c"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 8, 2021, the stockholders of the Company approved the 2021 Equity Incentive Plan (&#8220;2021 Plan&#8221;) and the 2021 Employee Stock Purchase Plan (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;2021 ESPP&#8221;). As of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2022, <ix:nonFraction unitRef="shares" contextRef="i4f3af80321e54f9fb93e4f4f432b503c_I20220630" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfMjIy_ad5f7c64-c059-4551-9a20-f424bd8a81d0">17,384,590</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i787199e8a86147f2b16226c6baee76a4_I20220630" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfMjI5_fa44e145-10fb-4a1b-9309-99dee00f3ba9">2,439,577</ix:nonFraction> shares were available for grant under the 2021 Plan and 2021 ESPP, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Employee Stock Purchase Plan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2021 ESPP, the Company can grant stock options to employees to purchase shares of Common Stock at a purchase price which equal to <ix:nonFraction unitRef="number" contextRef="i233799cb44d44a66a5f2ab2cdc7ec56c_D20220101-20220630" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfNDg4_46739f27-4466-4d6b-9e27-69b9557b3ffc">85</ix:nonFraction>% of the fair market value of common stock on the enrollment date or on the exercise date, whichever is lower. Participants are permitted to purchase shares of the Company&#8217;s Common Stock at <ix:nonFraction unitRef="number" contextRef="i233799cb44d44a66a5f2ab2cdc7ec56c_D20220101-20220630" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfNjc5_c0dcbdef-77d9-4532-b83a-9108dbaa5fd1">85</ix:nonFraction>% of the lower of the fair market value of the Company&#8217;s Common Stock on the first trading day of an offering period or on the last trading date in each purchase period. Participants may end their participation at any time during an offering and will be paid their accrued contributions that have not yet been used to purchase shares. Participation ends automatically upon termination of employment with the Company. The number of shares of common stock available for issuance under the 2021 ESPP will be increased on the first day of each fiscal year beginning on January 1, 2022, in an amount equal to the least of (i) <ix:nonFraction unitRef="shares" contextRef="i69902fa9a7884b429fd406f65655535f_D20220101-20220630" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfMTMwMQ_b3c3464b-a45f-4657-a524-316c20f2b0f0">3,734,500</ix:nonFraction> shares of common stock, (ii) a number of s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hares of common stock equal to one percent (<ix:nonFraction unitRef="number" contextRef="i69902fa9a7884b429fd406f65655535f_D20220101-20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfMTM5MA_d09c0ac1-1ebc-494b-ac98-27bb0ab74a99">1</ix:nonFraction>%) of the total number of shares of all classes of common stock of the Company on the last day of the immediately preceding fiscal year, or (iii) such number of shares determined by the Administrator no later than the last day of the immediately preceding fiscal year. On January 1, 2022, the number of shares available under the ESPP increased by <ix:nonFraction unitRef="shares" contextRef="ie310279ce69747ab9825ced6a3fe78fc_I20220101" decimals="0" name="naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfMTczOQ_d3002cf0-c6c0-4c5e-9a27-c3cb74c1379c">1,243,030</ix:nonFraction> shares pursuant to this feature.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The first offering period was from October 1, 2021 through June 1, 2022. For subsequent offering periods, the Company will be offering a six month purchase period. As of June&#160;30, 2022, <ix:nonFraction unitRef="shares" contextRef="i69902fa9a7884b429fd406f65655535f_D20220101-20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfNDk0NzgwMjMzMjI0MQ_a0ec90ff-b75c-4028-b134-cb279230ee78">48,353</ix:nonFraction> shares of common stock were purchased under the 2021 ESPP.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Equity Incentive Plan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2021 Plan, the Company can grant incentive stock options, nonstatutory stock options, stock appreciation rig</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hts, restricted stock, restricted stock units and performance awards to employees, directors and consultants. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options generally expire <ix:nonNumeric contextRef="i89b1c3e45f0b40979b88b450d15bcbfa_D20220101-20220630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfMjMwMg_fcf98d66-321b-4962-8643-adad552250ff">ten years</ix:nonNumeric> after the date of grant. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares available for issuance under the 2021 Plan will be increased on the first day of each fiscal year, beginning on January 1, 2022, in an amount equal to the least of (i) <ix:nonFraction unitRef="shares" contextRef="i89b1c3e45f0b40979b88b450d15bcbfa_D20220101-20220630" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfMjUxOQ_d53979ce-4692-4057-b4fe-730a1a3eb8eb">18,672,200</ix:nonFraction> shares, (ii) a number of shares equal to five percent (<ix:nonFraction unitRef="number" contextRef="i89b1c3e45f0b40979b88b450d15bcbfa_D20220101-20220630" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfMjU3Nw_63815c44-9100-49ae-8c1a-ac263673bc60">5</ix:nonFraction>%) of the total number of shares of all classes of common stock of the Company outstanding on the last day of the immediately preceding fiscal year, or (iii) such number of shares determined by the Administrator no later than the last day of the immediately preceding fiscal year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On January 1, 2022, the number of shares available under the 2021 Plan increased by <ix:nonFraction unitRef="shares" contextRef="ibed4c6e11d5d43c5806dbe2b925b0fea_I20220101" decimals="0" name="naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfMjk0Mw_7afdb609-01c3-4765-af01-197b4163fcba">6,215,154</ix:nonFraction> shares pursuant to this feature.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2017 Equity Incentive Plan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time of adoption of the 2021 Plan and the 2021 ESPP, no further awards will be granted under the 2017 Equity Incentive Plan (&#8220;2017 Plan&#8221;) and <ix:nonFraction unitRef="shares" contextRef="i47703b687f7846fcb57b2784db412643_I20220630" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfMzE1NQ_1accdc8e-0fa2-4425-a4ac-1661a1fd135f">7,106,767</ix:nonFraction> shares of common stock were initially reserved for outstanding awards issued under the 2017 Plan.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the compensation cost of the option awards, the fair value for each option award has been estimated using the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Black Scholes model</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. <ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfNzE3OQ_9b8f0718-7b58-4b62-82fb-471f27668dc4" continuedAt="i703b18582b7a4755a4c1c99f7aaf1705" escape="true">The significant assumptions used in these calculations are summarized as follows:</ix:nonNumeric></span></div><div style="margin-bottom:7pt"><ix:continuation id="i703b18582b7a4755a4c1c99f7aaf1705"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"></td><td style="width:27.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.355%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.452%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.355%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.452%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.355%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.452%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.358%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3e682fab2418499796c2bd51ca5f5d63_D20220401-20220630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMi0xLTEtMS04MzQxNC90ZXh0cmVnaW9uOjBkMjkzMjAyMDU0NTRmMDViZDJiOTVkYTI2ZmZmODhkXzQ_2f166912-21c7-4d4e-9807-09c0d090bc6c">5.3</ix:nonNumeric> - <ix:nonNumeric contextRef="i7b3c9d4006024ff3b3fc21d16c2ae7ec_D20220401-20220630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMi0xLTEtMS04MzQxNC90ZXh0cmVnaW9uOjBkMjkzMjAyMDU0NTRmMDViZDJiOTVkYTI2ZmZmODhkXzk_df023184-0350-4e17-ad91-f91d02eb372d">6.1</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic34352ef98754a5da0e85055bbc95472_D20210401-20210630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMi0zLTEtMS04MzQxNC90ZXh0cmVnaW9uOmQxMGQ5MTQ2NmE1ZDRkMzJhNGNhMTVjNmQwZTI1ZjdiXzU_fd0a1e39-bc91-45ed-b0ed-cda3172edcac">5.6</ix:nonNumeric> - <ix:nonNumeric contextRef="id7ff0979e8484728b1b10937c3182077_D20210401-20210630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMi0zLTEtMS04MzQxNC90ZXh0cmVnaW9uOmQxMGQ5MTQ2NmE1ZDRkMzJhNGNhMTVjNmQwZTI1ZjdiXzEw_7ccb565f-16d3-4d20-a469-a822a673d5a4">6.1</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idf9c413e24a54f04ad65558d7a7137db_D20220101-20220630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMi01LTEtMS04MzQxNC90ZXh0cmVnaW9uOmI2NDI2NDQzMWQ5NjQwZDM5NmExNzRmM2RhMjNjNzBiXzQ_77ee4654-1cd7-4530-86de-c761ef703bc6">5.3</ix:nonNumeric> - <ix:nonNumeric contextRef="i08e2f1e57e9b497f9d8298da3df3d6e6_D20220101-20220630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMi01LTEtMS04MzQxNC90ZXh0cmVnaW9uOmI2NDI2NDQzMWQ5NjQwZDM5NmExNzRmM2RhMjNjNzBiXzk_8fdc2717-f92c-44db-b3e1-c6363537a01c">6.1</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifdb873a8ec034005806968a7270b26bd_D20210101-20210630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMi03LTEtMS04MzQxNC90ZXh0cmVnaW9uOjYyYmJmNThkZDVhNzRkZGU4Mzc3OTM2N2ViZmJhNTJjXzQ_faabdcdb-ea27-4a92-b1c8-53af2a952898">5.5</ix:nonNumeric> - <ix:nonNumeric contextRef="i8caa73d19bf74f9fb01149e58ec6f2b8_D20210101-20210630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMi03LTEtMS04MzQxNC90ZXh0cmVnaW9uOjYyYmJmNThkZDVhNzRkZGU4Mzc3OTM2N2ViZmJhNTJjXzk_987fd745-c876-4212-bacf-c30eba0af356">6.6</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i49299c0b86364054a5d2222883ee3b39_D20220401-20220630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMy0xLTEtMS04MzQxNC90ZXh0cmVnaW9uOjYwODIwNGM4ZjkzNTRlYmViM2UyYjE2NzMwYzAzZjAzXzQ_41825abb-bd28-49b7-913f-3ff7ebe3fe55">105.2</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i49299c0b86364054a5d2222883ee3b39_D20220401-20220630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMy0xLTEtMS04MzQxNC90ZXh0cmVnaW9uOjYwODIwNGM4ZjkzNTRlYmViM2UyYjE2NzMwYzAzZjAzXzk_9f74d0f2-edca-4ca0-b51c-20ed7ea39546">109.1</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0da319978bcb43ecb4461222b4a14066_D20210401-20210630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMy0zLTEtMS04MzQxNC90ZXh0cmVnaW9uOmFjZTEwMjM3MDQ5NzQyNjU4YjYzYzdhNGQzZjBhYzRhXzQ_07006857-b27d-40b8-8fde-0441a6a5ba1d">93.0</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i0da319978bcb43ecb4461222b4a14066_D20210401-20210630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMy0zLTEtMS04MzQxNC90ZXh0cmVnaW9uOmFjZTEwMjM3MDQ5NzQyNjU4YjYzYzdhNGQzZjBhYzRhXzk_4fcc0f65-6089-41cc-a894-4ce899c97861">93.7</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i74defcab308e430587503de9ccb5ac4a_D20220101-20220630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMy01LTEtMS04MzQxNC90ZXh0cmVnaW9uOjc0YjNiYjcwNmI2MzRjZjFiZGQ3YTVkMTJlOWYzNWZjXzQ_fb8539b5-0546-436c-b454-6d09f4a20c20">105.2</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i74defcab308e430587503de9ccb5ac4a_D20220101-20220630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMy01LTEtMS04MzQxNC90ZXh0cmVnaW9uOjc0YjNiYjcwNmI2MzRjZjFiZGQ3YTVkMTJlOWYzNWZjXzk_b8f4d21c-eea6-446d-bdad-ebc4923943d0">110.0</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i52460f4c2a9740b295d473a2341fa225_D20210101-20210630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMy03LTEtMS04MzQxNC90ZXh0cmVnaW9uOjM0MzBjNGYwMWEyNDQzZTJiZmIyOWQ1YmMzYmNlY2UzXzQ_78c800a9-8db6-4183-b8d1-60858753c12e">92.0</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i52460f4c2a9740b295d473a2341fa225_D20210101-20210630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMy03LTEtMS04MzQxNC90ZXh0cmVnaW9uOjM0MzBjNGYwMWEyNDQzZTJiZmIyOWQ1YmMzYmNlY2UzXzk_43642f5a-e93d-45fd-863b-b4ed8a404ffc">94.2</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i49299c0b86364054a5d2222883ee3b39_D20220401-20220630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNC0xLTEtMS04MzQxNA_e3f450c5-6709-40f5-bcac-a8e0cedd086c">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0da319978bcb43ecb4461222b4a14066_D20210401-20210630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNC0zLTEtMS04MzQxNA_8a76c114-843c-42df-a081-ecb3146bdcc1">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i74defcab308e430587503de9ccb5ac4a_D20220101-20220630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNC01LTEtMS04MzQxNA_ea28019f-4be9-4a1d-b925-1f26affda324">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i52460f4c2a9740b295d473a2341fa225_D20210101-20210630" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNC03LTEtMS04MzQxNA_6e9aafb8-1201-4306-b81c-44213b55664f">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i49299c0b86364054a5d2222883ee3b39_D20220401-20220630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNS0xLTEtMS04MzQxNC90ZXh0cmVnaW9uOjNmYjRjNDA2ZjAxZDQ5NzU4ZDMxZjkzZTFjMDAxNmRkXzQ_c21d78cf-119f-432c-9cfd-0dff0a4012a4">2.80</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i49299c0b86364054a5d2222883ee3b39_D20220401-20220630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNS0xLTEtMS04MzQxNC90ZXh0cmVnaW9uOjNmYjRjNDA2ZjAxZDQ5NzU4ZDMxZjkzZTFjMDAxNmRkXzk_ee7ef472-1aa6-491f-a2c1-e4de29350b8b">3.36</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0da319978bcb43ecb4461222b4a14066_D20210401-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNS0zLTEtMS04MzQxNC90ZXh0cmVnaW9uOjZmNWJkMjY5ZDI5OTRlYmZhOTg2NTI3NmUzMzJhYzE1XzQ_da704caf-78bd-4ee6-b657-7b9efb1bbc9e">0.91</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i0da319978bcb43ecb4461222b4a14066_D20210401-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNS0zLTEtMS04MzQxNC90ZXh0cmVnaW9uOjZmNWJkMjY5ZDI5OTRlYmZhOTg2NTI3NmUzMzJhYzE1Xzk_f2966fff-4ea5-4036-a136-be0123d049ed">1.02</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i74defcab308e430587503de9ccb5ac4a_D20220101-20220630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNS01LTEtMS04MzQxNC90ZXh0cmVnaW9uOjdkNWM0MDg4MGNmOTQ3ZmE4ZTcxOGY4MWZlYTRhNzY2XzQ_8c099423-7dba-4c2c-bc31-3c8a6dbac82d">1.73</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i74defcab308e430587503de9ccb5ac4a_D20220101-20220630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNS01LTEtMS04MzQxNC90ZXh0cmVnaW9uOjdkNWM0MDg4MGNmOTQ3ZmE4ZTcxOGY4MWZlYTRhNzY2Xzk_a8d31dfb-fc13-4c3a-a530-e6ad51f68e36">3.36</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i52460f4c2a9740b295d473a2341fa225_D20210101-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNS03LTEtMS04MzQxNC90ZXh0cmVnaW9uOjIxNThmZDg5YjkxYjQ5N2M5OGFjMDdkYTcwZjUzMzRmXzQ_e57d778d-f9c8-4bab-9c1a-d9d9aa16274d">0.53</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i52460f4c2a9740b295d473a2341fa225_D20210101-20210630" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNS03LTEtMS04MzQxNC90ZXh0cmVnaW9uOjIxNThmZDg5YjkxYjQ5N2M5OGFjMDdkYTcwZjUzMzRmXzk_771fb697-82e6-46b0-b262-ef26880f79f9">1.02</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i3e682fab2418499796c2bd51ca5f5d63_D20220401-20220630" decimals="2" name="naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNi0xLTEtMS04MzQxNC90ZXh0cmVnaW9uOmExM2IwZmUxNzMxZTQzZDVhYzc1MDEwYTU5NGMzYjViXzQ_beb15b7b-6f02-4b3e-b7b4-8065a2b0aa3c">2.70</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="i7b3c9d4006024ff3b3fc21d16c2ae7ec_D20220401-20220630" decimals="2" name="naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNi0xLTEtMS04MzQxNC90ZXh0cmVnaW9uOmExM2IwZmUxNzMxZTQzZDVhYzc1MDEwYTU5NGMzYjViXzk_4aa36934-83b6-4b13-b608-f2dd95833e52">4.72</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ic34352ef98754a5da0e85055bbc95472_D20210401-20210630" decimals="2" name="naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNi0zLTEtMS04MzQxNC90ZXh0cmVnaW9uOjcwZDQwOTlhNTY0ZTQ4NWJiYWUxZjQ4ZjQ3NjEzNzQ1XzQ_afa2b3b8-3240-45d9-b3ed-f08b61e84c46">10.10</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="id7ff0979e8484728b1b10937c3182077_D20210401-20210630" decimals="2" name="naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNi0zLTEtMS04MzQxNC90ZXh0cmVnaW9uOjcwZDQwOTlhNTY0ZTQ4NWJiYWUxZjQ4ZjQ3NjEzNzQ1Xzk_bde3d411-9c92-4142-9079-5bd7ed5e60fb">11.16</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="idf9c413e24a54f04ad65558d7a7137db_D20220101-20220630" decimals="2" name="naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNi01LTEtMS04MzQxNC90ZXh0cmVnaW9uOjUzZWI0NWE4ZTQ5NjQ4ZWY4Mzg0YjQ5NjdhMzk1YWRlXzQ_8a17842b-3090-4afc-9a99-cbcb5e854df9">2.70</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="i08e2f1e57e9b497f9d8298da3df3d6e6_D20220101-20220630" decimals="2" name="naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNi01LTEtMS04MzQxNC90ZXh0cmVnaW9uOjUzZWI0NWE4ZTQ5NjQ4ZWY4Mzg0YjQ5NjdhMzk1YWRlXzk_db308cc5-e6e9-489a-8450-270d4811723e">4.72</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ifdb873a8ec034005806968a7270b26bd_D20210101-20210630" decimals="2" name="naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNi03LTEtMS04MzQxNC90ZXh0cmVnaW9uOjgxNzZhNzBhMGU0ZDRlNDg5ZTM3OGZiZWZmOWUxODliXzQ_8ca0b053-eb3e-4b09-81d4-fb55df12d43f">7.56</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="i8caa73d19bf74f9fb01149e58ec6f2b8_D20210101-20210630" decimals="2" name="naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNi03LTEtMS04MzQxNC90ZXh0cmVnaW9uOjgxNzZhNzBhMGU0ZDRlNDg5ZTM3OGZiZWZmOWUxODliXzk_dfbe39c9-bf1f-4feb-96a3-cc07a3b01aee">11.16</ix:nonFraction></span></div></td></tr></table></ix:continuation></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements&#8212;(Continued)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><ix:continuation id="i5838f0271372442ea011c5d24087eb8c" continuedAt="i79be61e68bbe4f4b8c39f9f21bd77f8e"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term: The expected term of stock options represents the weighted-average period the stock options are expected to remain outstanding. The Company does not have sufficient historical exercise and post-vesting termination activity to provide accurate data for estimating the expected term of options and has opted to use the &#8220;simplified method,&#8221; whereby the expected term equals the arithmetic average of the vesting term and the original contractual term of the option.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility: Historically, the Company has been a private company and lacked company&#8209;specific historical and implied volatility information for its common stock. Therefore, the expected volatility of the Company&#8217;s common stock was determined by using an average of historical volatilities of selected industry peers deemed to be comparable to the Company&#8217;s business corresponding to the expected term of the awards and the Company expects to continue to do so until such time as the Company has adequate historical data regarding the volatility of its traded common stock price.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected dividend yield: The expected dividend rate is zero as the Company has no history or expectation of declaring dividends on its common stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero-coupon U.S. Treasury notes with maturities corresponding to the expected term of the awards. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value of common stock: Prior to the Business Combination, the fair value of the shares of common stock underlying the stock options has historically been determined by the Company&#8217;s Board of Directors. Because there has been no public market for the common stock, the Board of Directors has determined the fair value of the common stock at the time of grant of the option by contemporaneous valuations performed by an unrelated third-party valuation firm as well as a number of objective and subjective factors including valuation of comparable companies, sales of convertible preferred stock to unrelated third parties, operating and financial performance, the implied equity value of the Company as contemplated by the Business Combination, the lack of liquidity of capital stock and general and industry specific economic outlook, among other factors. The fair value of common stock was determined in accordance with applicable elements of the American Institute of Certified Public Accountants Practice Aid, Valuation of Privately-Held-Company Equity Securities Issued as Compensation. Subsequent to the completion of the Business Combination (as defined in Note 1 and further described in Note 3) the fair value of the Company&#8217;s common stock is determined based on its closing market price.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The awards granted in late January 2021 had an exercise price equal to the grant date fair value of the Company&#8217;s common stock. The Company&#8217;s board of directors made a determination of the fair market value of the Company&#8217;s common stock which contemplated the implied equity value of the Company per the Business Combination Agreement that was executed on February 7, 2021. </span></div><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfNzE4MA_0bf93b1e-d8b7-4461-8cb1-3a3b4ba167c3" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes option award activity during the six months ended June 30, 2022:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Stock Option Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Life (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfMS0xLTEtMS04MzQxNA_e015d945-3cfa-4ee1-8f02-6dbc32b38492">8,550,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfMS0zLTEtMS04MzQxNA_1093445c-e4c5-4f6d-bb89-48a782b0eac8">4.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfMi0xLTEtMS04MzQxNA_82d631b6-137e-4d1f-95fb-3fcc1bd014ca">4,037,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfMi0zLTEtMS04MzQxNA_cf387e9a-be60-41a5-83ff-ace88de7646f">3.81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfMy0xLTEtMS04MzQxNA_93fd8ef4-c252-4fab-a404-3283bd92f8b9">211,309</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfMy0zLTEtMS04MzQxNA_12d323b9-aec7-4f45-99f1-526d4fe652ea">0.89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfNC0xLTEtMS04MzQxNA_ccd7385c-d7b8-4a67-8f32-8bb67d0619a6">725,836</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfNC0zLTEtMS04MzQxNA_50962208-c213-425b-9be5-b97d92296161">8.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of June&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfNS0xLTEtMS04MzQxNA_61e4dbb6-f969-4007-aa70-7e80600bfb71">11,650,794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfNS0zLTEtMS04MzQxNA_fb651e7b-bcc7-437f-b644-d0bd971aec15">4.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfNS01LTEtMS04MzQxNA_6e62310b-4527-4edf-8103-a6ce00ca31d2">8.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfNS03LTEtMS04MzQxNA_402a577d-242b-4610-ae12-67d380aa75d9">7,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest as of June&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfNi0xLTEtMS04MzQxNA_49552d2d-d529-4209-82bc-13832d4ca032">11,650,794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfNi0zLTEtMS04MzQxNA_7d5894ac-6bcb-4335-958a-9baf80225b42">4.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and exercisable at June&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfNy0xLTEtMS04MzQxNA_a026f6c3-9d55-4241-9aae-1a19c7832e11">3,279,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfNy0zLTEtMS04MzQxNA_5a33217e-cd93-4356-b881-ad475d384f59">3.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfNy01LTEtMS04MzQxNA_13f6a648-a93f-474a-86ea-326f2a86d1b8">7.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfNy03LTEtMS04MzQxNA_bb1dfa12-e3ac-497d-b5f5-6880e60d0b35">4,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, there was $<ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfNjY5NQ_fd97c280-4034-4a7f-9b8a-07d69ab739ab">31.0</ix:nonFraction> million of total unrecognized compensation expense expected to be recognized over a weighted average-period of <ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfNjgwMQ_b10dd62c-de6e-4355-9517-563b2584c24d">2.94</ix:nonNumeric> years. Aggregate intrinsic value represents the difference between the fair market value of the common stock and the exercise price of outstanding, in-the-money options. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements&#8212;(Continued)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><ix:continuation id="i79be61e68bbe4f4b8c39f9f21bd77f8e"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based Compensation Expense</span></div><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfNzE4MQ_93147097-6360-412f-aa35-23dc204a36a3" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth the total stock-based compensation expense for the Company&#8217;s stock options included in the Company&#8217;s condensed consolidated statement of operations:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:42.037%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.625%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.625%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.625%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.629%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1706d23492b43b7a385b6224b7bb789_D20220401-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmI5YmI1N2UxNGNhNTQwNzY4MDQ0MGZjMTIyZjMwYmI5L3RhYmxlcmFuZ2U6YjliYjU3ZTE0Y2E1NDA3NjgwNDQwZmMxMjJmMzBiYjlfMi0xLTEtMS04MzQxNA_59c5198f-f0d3-4fb8-980d-ba783deb8560">975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2cf87bc9d4c4ace9ed33c1df39f2e20_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmI5YmI1N2UxNGNhNTQwNzY4MDQ0MGZjMTIyZjMwYmI5L3RhYmxlcmFuZ2U6YjliYjU3ZTE0Y2E1NDA3NjgwNDQwZmMxMjJmMzBiYjlfMi0zLTEtMS04MzQxNA_9d5d6555-002d-4990-a253-2f762d18f4b4">666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia22d009c3ac44aeb931bf7a56b79db92_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmI5YmI1N2UxNGNhNTQwNzY4MDQ0MGZjMTIyZjMwYmI5L3RhYmxlcmFuZ2U6YjliYjU3ZTE0Y2E1NDA3NjgwNDQwZmMxMjJmMzBiYjlfMi01LTEtMS04MzQxNA_9a77678a-72c0-4430-8d47-eea3e8d35541">1,843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1548f12c35584dfe86dfe82e4fc2766b_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmI5YmI1N2UxNGNhNTQwNzY4MDQ0MGZjMTIyZjMwYmI5L3RhYmxlcmFuZ2U6YjliYjU3ZTE0Y2E1NDA3NjgwNDQwZmMxMjJmMzBiYjlfMi03LTEtMS04MzQxNA_ac6cf71c-ee76-4240-a0ec-85477d3d7c56">1,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95e307280f854c36abc9723392120e2d_D20220401-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmI5YmI1N2UxNGNhNTQwNzY4MDQ0MGZjMTIyZjMwYmI5L3RhYmxlcmFuZ2U6YjliYjU3ZTE0Y2E1NDA3NjgwNDQwZmMxMjJmMzBiYjlfMy0xLTEtMS04MzQxNA_a8b30c9a-ba63-4544-af8e-477cb80ddab9">1,592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f6592550bdb4e179558e3808e9fa8eb_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmI5YmI1N2UxNGNhNTQwNzY4MDQ0MGZjMTIyZjMwYmI5L3RhYmxlcmFuZ2U6YjliYjU3ZTE0Y2E1NDA3NjgwNDQwZmMxMjJmMzBiYjlfMy0zLTEtMS04MzQxNA_78411008-b4be-43fb-a444-dc21a3f6de05">1,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a590e5e314f4b95b05e281bd0d44db4_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmI5YmI1N2UxNGNhNTQwNzY4MDQ0MGZjMTIyZjMwYmI5L3RhYmxlcmFuZ2U6YjliYjU3ZTE0Y2E1NDA3NjgwNDQwZmMxMjJmMzBiYjlfMy01LTEtMS04MzQxNA_6c78c7a4-29a8-4e31-a489-db08952d3cba">2,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0333ae88e1f147b9a495311e02ae01c5_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmI5YmI1N2UxNGNhNTQwNzY4MDQ0MGZjMTIyZjMwYmI5L3RhYmxlcmFuZ2U6YjliYjU3ZTE0Y2E1NDA3NjgwNDQwZmMxMjJmMzBiYjlfMy03LTEtMS04MzQxNA_c1ec8abd-eebd-4c80-bd71-031cce836c5e">1,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49299c0b86364054a5d2222883ee3b39_D20220401-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmI5YmI1N2UxNGNhNTQwNzY4MDQ0MGZjMTIyZjMwYmI5L3RhYmxlcmFuZ2U6YjliYjU3ZTE0Y2E1NDA3NjgwNDQwZmMxMjJmMzBiYjlfNC0xLTEtMS04MzQxNA_da7c6123-9fd8-4ca6-abbc-8dfe6d35ff27">2,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0da319978bcb43ecb4461222b4a14066_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmI5YmI1N2UxNGNhNTQwNzY4MDQ0MGZjMTIyZjMwYmI5L3RhYmxlcmFuZ2U6YjliYjU3ZTE0Y2E1NDA3NjgwNDQwZmMxMjJmMzBiYjlfNC0zLTEtMS04MzQxNA_9e794c11-7368-4bfd-a689-6a691139a97c">1,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74defcab308e430587503de9ccb5ac4a_D20220101-20220630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmI5YmI1N2UxNGNhNTQwNzY4MDQ0MGZjMTIyZjMwYmI5L3RhYmxlcmFuZ2U6YjliYjU3ZTE0Y2E1NDA3NjgwNDQwZmMxMjJmMzBiYjlfNC01LTEtMS04MzQxNA_345a4062-26a0-4538-beed-7b594af2665f">4,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52460f4c2a9740b295d473a2341fa225_D20210101-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmI5YmI1N2UxNGNhNTQwNzY4MDQ0MGZjMTIyZjMwYmI5L3RhYmxlcmFuZ2U6YjliYjU3ZTE0Y2E1NDA3NjgwNDQwZmMxMjJmMzBiYjlfNC03LTEtMS04MzQxNA_80b9d418-16cc-4387-9844-472c35848a49">3,156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_73"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfNTU4MQ_4f2a71fa-f169-4c1c-bf47-f397e82a8293" continuedAt="ie30030177a9f4baf884c10519a80d350" escape="true"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfNTU4MQ_5f8628b2-05cc-4a6d-bc4b-284934431bd7" continuedAt="iaca0eeec1e154b358c1e57b1a1014550" escape="true">Commitments and Contingencies </ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="ie30030177a9f4baf884c10519a80d350" continuedAt="i17acc13457b8496dbf390f12fd301a6b"><ix:continuation id="iaca0eeec1e154b358c1e57b1a1014550" continuedAt="ib8fee0eaaac940299a579800ce262159"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Commitments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Open purchase commitments are for the purchase of goods and services related to, but not limited to, research and development, facilities, and professional services under non-cancellable contracts. They were not recorded as liabilities on the condensed consolidated balance sheet as of June&#160;30, 2022 as the Company had not yet received the related goods or services. As of June&#160;30, 2022, the Company had open purchase commitments for goods and services of $<ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-5" name="us-gaap:LongTermPurchaseCommitmentAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfNDkx_d67159d2-af90-4010-9404-400151d10479">2.0</ix:nonFraction> million, which are expected to be received through the next 12 months.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may become involved in litigation relating to claims arising from the ordinary course of business. Management believes that there are currently no claims or actions pending against the Company where the ultimate disposition could have a material adverse effect on the Company&#8217;s results of operations, financial condition or cash flows. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is obligated under certain non-cancellable operating leases for office space and laboratory space. This space includes operating leases in Seattle, Washington, and San Carlos, California.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Seattle Leases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating lease in Seattle, Washington expired in April 2021 and continued to be renewed month to month until August 2021. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company entered into a <ix:nonNumeric contextRef="iac74a2b58af547489b585fbc6f3a6dc4_I20210831" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMTMyNg_4d27a785-ef91-4ff5-b79f-e820d23c6929">7</ix:nonNumeric>-year non-cancellable operating lease, which commenced in August 2021, for an additional office space in Seattle, Washington. Total non-cancellable payments under this lease aggregate $<ix:nonFraction unitRef="usd" contextRef="iac74a2b58af547489b585fbc6f3a6dc4_I20210831" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMTUxMg_de3b5669-11e0-43a5-a9ac-683affd559e6">4.5</ix:nonFraction>&#160;million through June 2028. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">San Carlos Leases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company amended its existing facility lease contract in San Carlos, California which was executed to shorten the remaining term of the lease to expire in December 2021 and reduce monthly lease payments and was accounted for as a modification. The impact of this modification reduced the operating lease right-of-use asset and lease liability balance as a $<ix:nonFraction unitRef="usd" contextRef="i22fffe12aeab41308245c99399a1f92b_D20210201-20210228" decimals="-5" name="naut:OperatingLeaseNoncashAdjustment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMTkzMA_ccfb2e54-3992-4bf3-b403-0546769e023b">3.3</ix:nonFraction>&#160;million non-cash adjustment. In September 2021, the Company further amended the facility lease contract in San Carlos, California to shorten the remaining term of the lease to expire in October 2021 and was also accounted for as a modification.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company entered into a new lease in San Carlos, California for <ix:nonNumeric contextRef="i005d3c6634c744229bee47f60e02c564_I20201231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMjI1NQ_cad77cd3-f4c9-43a5-ab9d-eda4608770af">ten years</ix:nonNumeric> which commenced in October 2021 and expiring in October 2031 with total minimum lease payments of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i005d3c6634c744229bee47f60e02c564_I20201231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMjM1Ng_3bb0f70e-1963-4a6e-8a05-978eec595997">40.7</ix:nonFraction> million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company also entered into a temporary office space lease agreement in San Carlos, California which commenced in February 2021 and expired in October 2021 with total minimum lease payments of </span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements&#8212;(Continued)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><ix:continuation id="i17acc13457b8496dbf390f12fd301a6b" continuedAt="i2ec502edc3354092bf4703a243330aea"><ix:continuation id="ib8fee0eaaac940299a579800ce262159" continuedAt="i82e0dedae0ce4f54bbb3043469d9c551"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i43cfc749a9134f95896a73a831e49eb6_I20201231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMjU3Mw_a7fdb01c-c848-4495-b275-c32a76c43ebe">1.2</ix:nonFraction> million. The temporary office space lease agreement was recognized as a short-term lease due to the election of the short-term lease measurement and recognition exemption.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company entered into another lease in San Carlos, California for <ix:nonNumeric contextRef="i7b12af6151364817bb6215130879f731_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMjgyNw_c857936f-e82d-4758-a404-aab08124650a">nine years</ix:nonNumeric> expected to commence in December 2022 and expiring in October 2031. The Company can terminate this lease after <ix:nonNumeric contextRef="i7b12af6151364817bb6215130879f731_I20211231" name="naut:LesseeOperatingLeaseOptionToTerminateLeaseTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMjk0MA_31a06968-022e-4814-936d-b3aedef94c4e">five years</ix:nonNumeric> from commencement date without bearing any significant termination penalties and therefore the Company concluded that the lease term is <ix:nonNumeric contextRef="i7b12af6151364817bb6215130879f731_I20211231" name="naut:LesseeOperatingLeaseOptionToTerminateLeaseTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMzA3Nw_5cc6e3c6-72f3-4ca6-b26b-cf5e3390a01d">five years</ix:nonNumeric> with total minimum lease payments of $<ix:nonFraction unitRef="usd" contextRef="i7b12af6151364817bb6215130879f731_I20211231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMzExNw_c75f1818-79b8-4ae3-bab8-08efa7adb412">7.2</ix:nonFraction>&#160;million. The Company may borrow funds from the landlord of up to $<ix:nonFraction unitRef="usd" contextRef="i5734f6007d394ffdba6338fcd01317d1_I20211231" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMTY0OTI2NzQ0NzcwOA_ead81cbc-ef38-425a-99bd-1308322005dc">2.0</ix:nonFraction>&#160;million with an interest rate of <ix:nonFraction unitRef="number" contextRef="i5734f6007d394ffdba6338fcd01317d1_I20211231" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMTY0OTI2NzQ0NzcyMg_6c5e703f-bc5b-4ca4-b55e-9b2b4fb5c604">7</ix:nonFraction>% to finance its tenant improvements. <ix:nonFraction unitRef="usd" contextRef="i96e9f550a3474120bad073b9f8a36ac5_I20220630" decimals="-5" name="us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMTY0OTI2NzQ0Nzg2MA_cc041529-ec0b-4937-8a84-80a76fe0ab3a">No</ix:nonFraction> amounts have been borrowed as of June 30, 2022.</span></div><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfNTU3OA_7a640bd7-a7c2-41cf-a017-4bc7daf12b8e" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease costs, which were included in operating expenses in condensed consolidated statements of operations, were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:42.037%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.625%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.625%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.625%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.629%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed operating lease costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfMi0xLTEtMS04MzQxNA_6f98cfe3-a7c9-457e-bdea-3463db5de74d">1,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfMi0zLTEtMS04MzQxNA_09db455e-e9db-497b-b899-6591a5482a6b">362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfMi01LTEtMS04MzQxNA_58d95042-8079-4fec-932e-f9984e5e7c92">2,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfMi03LTEtMS04MzQxNA_3295e211-a37e-4cfd-b8cb-2630ad2d114a">863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable operating lease costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfMy0xLTEtMS04MzQxNA_2a69d058-3328-4cdd-b648-3f9a9b1532b5">380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfMy0zLTEtMS04MzQxNA_1801215f-2ac4-4ae3-8ab4-f59f16bc4cc7">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfMy01LTEtMS04MzQxNA_c7a784a3-45ef-4a3d-98d4-16a609e77ba8">818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfMy03LTEtMS04MzQxNA_86410e4d-9a00-49af-b4ea-705c113705b8">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfNC0xLTEtMS04MzQxNA_4694502e-b902-49cd-81b7-777dc9901a54">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfNC0zLTEtMS04MzQxNA_c9064aa6-5bed-4de3-8b47-4098478cfb6f">440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfNC01LTEtMS04MzQxNA_2676d5d9-2259-490a-b528-3772c0532ce3">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfNC03LTEtMS04MzQxNA_93d3918c-a223-4cec-8240-df4f87097582">619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfNi0xLTEtMS04MzQxNA_81fe4064-c32e-48b2-9c93-5d588ecac67c">1,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="-3" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfNi0zLTEtMS04MzQxNA_fcd93aa9-700c-4440-a307-fce909f1fd12">812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfNi01LTEtMS04MzQxNA_73e0dd76-8ffe-4058-b8c4-19bca31f4531">3,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfNi03LTEtMS04MzQxNA_296de476-9706-429b-9663-ab66054dd604">1,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June 30, 2022 and 2021, cash paid for amounts included in the measurement of operating lease liabilities included in cash flows used in operating activities was $<ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-5" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMzQxNA_0f6d21c9-daf0-407a-a64c-62978c974953">1.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-5" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMzQyMQ_adfcf638-35a8-430b-a21a-2b30caf576f3">0.8</ix:nonFraction> million, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the weighted-average remaining lease term and weighted-average discount rate for operating leases is <ix:nonNumeric contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMzU1MA_e33b5074-db94-4062-939b-7254a687e978">9.0</ix:nonNumeric> years and <ix:nonFraction unitRef="number" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMzU1Nw_0117e48f-3bd3-41f9-9972-bf5939dd9a96">8.9</ix:nonFraction>% respectively.</span></div><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfNTU4MA_4011145c-0ff9-456a-8fe1-5c2ce31d0ac1" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's future principal contractual obligations for operating lease commitments as of June&#160;30, 2022:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease Obligations</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six months ending December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmE3YTk3ZDc3ZmEwOTQ1YTY4MWMxNjdmZjBkYjUyMDJhL3RhYmxlcmFuZ2U6YTdhOTdkNzdmYTA5NDVhNjgxYzE2N2ZmMGRiNTIwMmFfMi0xLTEtMS04MzQxNA_770a1ad7-2d72-4520-81dc-816aac0c8ee9">1,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmE3YTk3ZDc3ZmEwOTQ1YTY4MWMxNjdmZjBkYjUyMDJhL3RhYmxlcmFuZ2U6YTdhOTdkNzdmYTA5NDVhNjgxYzE2N2ZmMGRiNTIwMmFfMy0xLTEtMS04MzQxNA_c8618f06-78be-4614-a8de-1b78c78ee675">4,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmE3YTk3ZDc3ZmEwOTQ1YTY4MWMxNjdmZjBkYjUyMDJhL3RhYmxlcmFuZ2U6YTdhOTdkNzdmYTA5NDVhNjgxYzE2N2ZmMGRiNTIwMmFfNC0xLTEtMS04MzQxNA_fb811a7f-d8fd-4907-8dd0-f2d757d17986">4,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmE3YTk3ZDc3ZmEwOTQ1YTY4MWMxNjdmZjBkYjUyMDJhL3RhYmxlcmFuZ2U6YTdhOTdkNzdmYTA5NDVhNjgxYzE2N2ZmMGRiNTIwMmFfNS0xLTEtMS04MzQxNA_d7595f48-7145-43b9-8dae-77cbc6a73b40">4,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmE3YTk3ZDc3ZmEwOTQ1YTY4MWMxNjdmZjBkYjUyMDJhL3RhYmxlcmFuZ2U6YTdhOTdkNzdmYTA5NDVhNjgxYzE2N2ZmMGRiNTIwMmFfNi0xLTEtMS04MzQxNA_393ddade-97b0-4365-8f6e-2b3968b68cb6">4,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="naut:LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmE3YTk3ZDc3ZmEwOTQ1YTY4MWMxNjdmZjBkYjUyMDJhL3RhYmxlcmFuZ2U6YTdhOTdkNzdmYTA5NDVhNjgxYzE2N2ZmMGRiNTIwMmFfNy0xLTEtMS04MzQxNA_7388492f-7bfe-4f08-bf4c-45456129593d">22,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmE3YTk3ZDc3ZmEwOTQ1YTY4MWMxNjdmZjBkYjUyMDJhL3RhYmxlcmFuZ2U6YTdhOTdkNzdmYTA5NDVhNjgxYzE2N2ZmMGRiNTIwMmFfOC0xLTEtMS04MzQxNA_31928329-c5db-44be-883e-56dfdaab6997">43,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmE3YTk3ZDc3ZmEwOTQ1YTY4MWMxNjdmZjBkYjUyMDJhL3RhYmxlcmFuZ2U6YTdhOTdkNzdmYTA5NDVhNjgxYzE2N2ZmMGRiNTIwMmFfOS0xLTEtMS04MzQxNA_018847fd-53ea-4d25-8fe8-001c1298cd44">13,689</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmE3YTk3ZDc3ZmEwOTQ1YTY4MWMxNjdmZjBkYjUyMDJhL3RhYmxlcmFuZ2U6YTdhOTdkNzdmYTA5NDVhNjgxYzE2N2ZmMGRiNTIwMmFfMTAtMS0xLTEtODM0MTQ_2ce9063c-5066-4817-a22f-e810dbaf4cd7">29,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees and Indemnifications</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, the Company enters into agreements that may include indemnification provisions. Pursuant to such agreements, the Company may indemnify, hold harmless and defend an indemnified party for losses suffered or incurred by the indemnified party. Some of the provisions will limit losses to those arising from third-party actions. In some cases, the indemnifications will continue after the termination of the agreement. The maximum potential amount of future payments the Company could be required to make under these provisions is not determinable. The Company has never incurred material costs to defend lawsuits or settle claims related to these indemnification provisions. </span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Nautilus Biotechnology, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements&#8212;(Continued)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Unaudited)</span></div></td></tr></table></div></div><ix:continuation id="i2ec502edc3354092bf4703a243330aea"><ix:continuation id="i82e0dedae0ce4f54bbb3043469d9c551"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has also agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines and settlement amounts incurred by them in any action or proceeding to which any of them are, or are threatened to be, made a party by reason of their service as a director or officer. The Company maintains director and officer insurance coverage that would generally enable it to recover a portion of any future amounts paid. The Company may be subject to indemnification obligation by law with respect to the actions of its employees under certain circumstances and in certain jurisdictions. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Letter of Credit</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the San Carlos lease agreement entered in December 2020, the Company issued a cash-collateralized letter of credit in lieu of security deposit of $<ix:nonFraction unitRef="usd" contextRef="i616643cbd31d47a686cf71385bb21573_I20201231" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfNTI2Mw_7a63bfdf-11e7-48f1-887b-f72c4ccb8366">0.6</ix:nonFraction> million. In conjunction with the San Carlos lease agreement entered in December 2021, the Company amended the existing cash-collateralized letter of credit and increased the amount to $<ix:nonFraction unitRef="usd" contextRef="i34e4a2a383364c848f4d73f961251253_I20211231" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfNTQ0Mg_a9cc86fe-d3af-4b2b-b9f4-e919b3f22b4c">0.8</ix:nonFraction>&#160;million. The cash amount is recorded as restricted cash under Other long-term assets on the Company&#8217;s condensed consolidated balance sheets.</span></div></ix:continuation></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_76"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.5pt"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RleHRyZWdpb246YTg0ZWQ5OTJjNWVmNDM0OTk4MTk0YWU1ZTg0Yzk4ZjBfOTc2_873dfd3c-e8c2-41bd-913f-00e0e4f4133f" continuedAt="ifc63c88f71194ff8982f5a86abd9b4e0" escape="true">Basic and Diluted Net Loss per Share</ix:nonNumeric></span></div><ix:continuation id="ifc63c88f71194ff8982f5a86abd9b4e0"><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RleHRyZWdpb246YTg0ZWQ5OTJjNWVmNDM0OTk4MTk0YWU1ZTg0Yzk4ZjBfOTc3_df8c3d90-8ceb-4c8d-81fa-bb2c107a4760" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common stockholders for the three and six months ended June 30, 2022 and 2021:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:42.037%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.625%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.625%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.625%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.629%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except share and per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfMy0xLTEtMS04MzQxNA_859f2b30-7529-47d2-bffe-c5e4529170a5"><ix:nonFraction unitRef="usd" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfMy0xLTEtMS04MzQxNA_8f9f1de0-d46e-42f3-bdd1-d33475d8a2ab">14,689</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfMy0zLTEtMS04MzQxNA_0b2bc11c-cd6a-48a4-8b98-cb56140ae56d"><ix:nonFraction unitRef="usd" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfMy0zLTEtMS04MzQxNA_815b4875-96ff-4a54-940d-c546e30fb780">10,713</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfMy01LTEtMS04MzQxNA_50254b1f-55c7-41d3-a4ed-3c6200631a74"><ix:nonFraction unitRef="usd" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfMy01LTEtMS04MzQxNA_9bdaaf13-0028-4292-a334-ec35d9df39b9">30,452</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfMy03LTEtMS04MzQxNA_402525e8-f750-4de9-9cac-d4a559628e3b"><ix:nonFraction unitRef="usd" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfMy03LTEtMS04MzQxNA_5d613926-fc5d-42ef-88c5-fb630470d6a6">19,122</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNS0xLTEtMS04MzQxNA_83cfc29f-2bee-474f-91bf-d43cb622e633">124,494,036</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNS0zLTEtMS04MzQxNA_12daccb3-f5a1-4caf-9734-623896950ace">55,070,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNS01LTEtMS04MzQxNA_0eb02c57-cedb-4d81-bb4e-7d3a95304fd1">124,456,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNS03LTEtMS04MzQxNA_48f29913-4d78-4c8b-8cf2-44a33307ce00">44,130,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Less: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average unvested restricted shares and shares subject to repurchase</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="0" name="naut:WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNi0xLTEtMS04MzQxNA_3c8724e4-0662-41c9-9e0b-dabc883d5359">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="0" name="naut:WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNi0zLTEtMS04MzQxNA_dd5b83a2-9388-40a6-8b14-79407e111e1c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="0" name="naut:WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNi01LTEtMS04MzQxNA_5a3f6333-1a7a-4833-88fa-0d3444294f4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="0" name="naut:WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNi03LTEtMS04MzQxNA_6bea5ed3-e3a0-401d-ba0a-c78fdf95c31d">34,624</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares used in computing net loss per share attributable to common stockholders, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNy0xLTEtMS04MzQxNA_9aeb7400-a419-4195-b421-676ec26997bc"><ix:nonFraction unitRef="shares" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNy0xLTEtMS04MzQxNA_ef0c7e70-f2cb-433f-9355-4a4603462d78">124,494,036</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNy0zLTEtMS04MzQxNA_8f0a1768-1ea5-4ba4-a20b-ce303502cca8"><ix:nonFraction unitRef="shares" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNy0zLTEtMS04MzQxNA_a9ef480e-dba9-4d6d-89f9-1752c34d743a">55,070,480</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNy01LTEtMS04MzQxNA_1d9e5481-06bb-49e7-9a03-eeaa8fb66e31"><ix:nonFraction unitRef="shares" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNy01LTEtMS04MzQxNA_be06489a-40a8-4c3d-8006-0c08bbd277ae">124,456,518</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNy03LTEtMS04MzQxNA_3dc4e53b-4b25-4205-874f-7fed5ad44215"><ix:nonFraction unitRef="shares" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNy03LTEtMS04MzQxNA_77433fdb-bd38-466e-a0e6-6fa52ed87a9f">44,096,149</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share attributable to common stockholders, basic and diluted:</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfOC0xLTEtMS04MzQxNA_2652ef4f-1e94-47d0-a5af-ff948e77cf28"><ix:nonFraction unitRef="usdPerShare" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfOC0xLTEtMS04MzQxNA_a4700d1f-b027-45af-a1fe-ff80aea88f2e">0.12</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfOC0zLTEtMS04MzQxNA_c57145b1-46cb-4c30-a9c4-eee8e2cf27ea"><ix:nonFraction unitRef="usdPerShare" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfOC0zLTEtMS04MzQxNA_ed2d84ab-4341-4008-822b-fd2aca614876">0.19</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfOC01LTEtMS04MzQxNA_98c262b3-0b5b-454c-bacc-3f021da456bb"><ix:nonFraction unitRef="usdPerShare" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfOC01LTEtMS04MzQxNA_c67517d8-7fac-466f-a1ba-d54b49438709">0.24</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfOC03LTEtMS04MzQxNA_d0397406-0b9f-4dd0-a072-49ee7d4f3115"><ix:nonFraction unitRef="usdPerShare" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfOC03LTEtMS04MzQxNA_dcbb6533-65da-4699-9a7c-79bab20716bc">0.43</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Business Combination, the Company has retroactively adjusted the weighted-average number of shares of Common Stock outstanding prior to the Closing Date by multiplying them by the Exchange Ratio of <ix:nonFraction unitRef="number" contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630" decimals="4" name="naut:RecapitalizationExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RleHRyZWdpb246YTg0ZWQ5OTJjNWVmNDM0OTk4MTk0YWU1ZTg0Yzk4ZjBfNDEw_672511a4-2bac-40ed-8c4d-ee5f077408f1">3.6281</ix:nonFraction> used to determine the number of shares of New Nautilus Common Stock into which they converted (as described in Note 3). The Common Stock issued as a result of the redeemable convertible preferred stock conversion on the Closing Date was included in the basic net loss per share calculation on a prospective basis.</span></div><ix:nonNumeric contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RleHRyZWdpb246YTg0ZWQ5OTJjNWVmNDM0OTk4MTk0YWU1ZTg0Yzk4ZjBfOTc4_d3e68acd-8ccf-4e45-8b2b-49f262b956fb" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have had an antidilutive effect were as follows:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.993%"><tr><td style="width:1.0%"></td><td style="width:70.185%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.923%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.925%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three and Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7b0787d033534be8830b754832d12575_D20220401-20220630" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjI1NzRjNzBhMTVmNzRiYmE5OWJmZmIzMTFlMTA4NzVmL3RhYmxlcmFuZ2U6MjU3NGM3MGExNWY3NGJiYTk5YmZmYjMxMWUxMDg3NWZfMi01LTEtMS04MzQxNA_1aa16a70-35ac-4e6f-91de-b1d861e5abc5"><ix:nonFraction unitRef="shares" contextRef="idae2ad2a8fe44cc2ae26dfcfb3a80cf3_D20220101-20220630" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjI1NzRjNzBhMTVmNzRiYmE5OWJmZmIzMTFlMTA4NzVmL3RhYmxlcmFuZ2U6MjU3NGM3MGExNWY3NGJiYTk5YmZmYjMxMWUxMDg3NWZfMi01LTEtMS04MzQxNA_a416729e-918a-4900-b3da-b4f2a7b9e57d">11,650,794</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id173ca79999149b0acf943a294060af6_D20210401-20210630" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjI1NzRjNzBhMTVmNzRiYmE5OWJmZmIzMTFlMTA4NzVmL3RhYmxlcmFuZ2U6MjU3NGM3MGExNWY3NGJiYTk5YmZmYjMxMWUxMDg3NWZfMi03LTEtMS04MzQxNA_89c675cf-58f2-4a3f-86e5-569df6882791"><ix:nonFraction unitRef="shares" contextRef="i1193b3efa76e4883905243879462ee64_D20210101-20210630" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjI1NzRjNzBhMTVmNzRiYmE5OWJmZmIzMTFlMTA4NzVmL3RhYmxlcmFuZ2U6MjU3NGM3MGExNWY3NGJiYTk5YmZmYjMxMWUxMDg3NWZfMi03LTEtMS04MzQxNA_ff8f82e7-ea1f-4af1-ac26-fe9d19d71141">8,014,879</ix:nonFraction></ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia851771fac4244bc9fcb9380f95e907a_D20220401-20220630" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjI1NzRjNzBhMTVmNzRiYmE5OWJmZmIzMTFlMTA4NzVmL3RhYmxlcmFuZ2U6MjU3NGM3MGExNWY3NGJiYTk5YmZmYjMxMWUxMDg3NWZfMy01LTEtMS04MzQxNA_52183eb6-4482-4ac4-b5bc-532867bbf9a3"><ix:nonFraction unitRef="shares" contextRef="i0108800d07f0495691d5110222b35f25_D20220101-20220630" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjI1NzRjNzBhMTVmNzRiYmE5OWJmZmIzMTFlMTA4NzVmL3RhYmxlcmFuZ2U6MjU3NGM3MGExNWY3NGJiYTk5YmZmYjMxMWUxMDg3NWZfMy01LTEtMS04MzQxNA_c0ab2a6b-6fd8-44f7-87ae-3a8701ce875c">61,411</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i51a1bd721e3d4a4e91f03a5a2c31863b_D20210401-20210630" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjI1NzRjNzBhMTVmNzRiYmE5OWJmZmIzMTFlMTA4NzVmL3RhYmxlcmFuZ2U6MjU3NGM3MGExNWY3NGJiYTk5YmZmYjMxMWUxMDg3NWZfMy03LTEtMS04MzQxNA_ee1e187f-f6d1-430d-9d84-3be065a06fa2"><ix:nonFraction unitRef="shares" contextRef="ic4fee951cce3455ca59554a17600d641_D20210101-20210630" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjI1NzRjNzBhMTVmNzRiYmE5OWJmZmIzMTFlMTA4NzVmL3RhYmxlcmFuZ2U6MjU3NGM3MGExNWY3NGJiYTk5YmZmYjMxMWUxMDg3NWZfMy03LTEtMS04MzQxNA_fde881ec-fb34-4861-bcea-5bb6cdd8c21f">&#8212;</ix:nonFraction></ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total potentially dilutive common share equivalents</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjI1NzRjNzBhMTVmNzRiYmE5OWJmZmIzMTFlMTA4NzVmL3RhYmxlcmFuZ2U6MjU3NGM3MGExNWY3NGJiYTk5YmZmYjMxMWUxMDg3NWZfNy01LTEtMS04MzQxNA_22bc5183-9d21-4d8b-9105-78e45a34494a"><ix:nonFraction unitRef="shares" contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjI1NzRjNzBhMTVmNzRiYmE5OWJmZmIzMTFlMTA4NzVmL3RhYmxlcmFuZ2U6MjU3NGM3MGExNWY3NGJiYTk5YmZmYjMxMWUxMDg3NWZfNy01LTEtMS04MzQxNA_2a8247ee-52ed-465a-a126-f52e5831d87f">11,712,205</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjI1NzRjNzBhMTVmNzRiYmE5OWJmZmIzMTFlMTA4NzVmL3RhYmxlcmFuZ2U6MjU3NGM3MGExNWY3NGJiYTk5YmZmYjMxMWUxMDg3NWZfNy03LTEtMS04MzQxNA_467d37da-9ab9-4336-be98-2cc58be46e81"><ix:nonFraction unitRef="shares" contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjI1NzRjNzBhMTVmNzRiYmE5OWJmZmIzMTFlMTA4NzVmL3RhYmxlcmFuZ2U6MjU3NGM3MGExNWY3NGJiYTk5YmZmYjMxMWUxMDg3NWZfNy03LTEtMS04MzQxNA_736fd814-85fe-4ca9-a863-4fc322954e99">8,014,879</ix:nonFraction></ix:nonFraction></span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_82"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis provides information that our management believes is relevant to an assessment and understanding of Nautilus Biotechnology, Inc.&#8217;s (&#8220;Nautilus&#8221; or the &#8220;Company&#8221;) condensed consolidated results of operations and financial condition. The discussion should be read together with the condensed consolidated financial statements and the accompanying notes to those statements that are included elsewhere in this Quarterly Report on Form 10-Q and the audited financial statements for the year ended December 31, 2021 and the related notes included in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on February 24, 2022. This discussion may contain forward-looking statements based upon current expectations that involve risks and uncertainties. Nautilus&#8217; actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth in the section titled &#8220;Risk Factors&#8221; in Part II, Item 1A as set forth in this Quarterly Report on Form 10-Q.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise indicated or the context otherwise requires, references in this &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; section to &#8220;Nautilus,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and other similar terms refer to the business and operations of Legacy Nautilus prior to the Business Combination and to New Nautilus and its consolidated subsidiary following the Business Combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_85"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Our mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. We were founded on the belief that incremental advancements of existing technologies are inadequate, and that a bold scientific leap would be required to radically reinvent proteomics and revolutionize precision medicine. Our vision is to integrate our breakthrough innovations in computer science, engineering, and biochemistry to develop and commercialize a proteomic analysis technology of extreme sensitivity and scale. To accomplish this, we have built a prototype of a proteome analysis system, an instrument to perform massively parallel single protein molecule measurements which will be further developed to deliver the speed, simplicity, accuracy, and versatility that we believe is necessary to establish a new gold standard in the field. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our incorporation in 2016, we have devoted substantially all of our resources to research and development activities, including with respect to our proteomics platform, or Nautilus platform, business planning, establishing and maintaining our intellectual property portfolio, hiring personnel, raising capital and providing general and administrative support for these operations. We do not have any products available for commercial sale, and we have not generated any revenue from our Nautilus platform or other sources since inception. Our ability to generate revenue sufficient to achieve profitability, if ever, will depend on the successful development and eventual commercialization of our Nautilus platform, which we expect, if it ever occurs, will take a number of years. Our Nautilus platform, which includes our end-to-end solution comprised of instruments, consumables, and software analysis, is currently under development and will require significant additional research and development efforts, including extensive testing prior to commercialization. These efforts require significant amounts of additional capital and adequate personnel infrastructure. There can be no assurance that our research and development activities will be successfully completed, or that our Nautilus platform will be commercially viable. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to commercialize our Nautilus platform in volume, we will need to establish internal manufacturing capacity or to contract with one or more manufacturing partners, or both. Our technology is complex, and the manufacturing process for our products will be similarly complex, involving a large number of unique precision parts in addition to the production of various reagents and antibodies. We may encounter unexpected difficulties in manufacturing our Nautilus platform, instruments, and related consumables. Among other factors, we will need to develop reliable supply chains for the various components in the Nautilus platform, instruments, and consumables to support large-scale commercial production. In connection with our Nautilus platform, we intend to utilize over 300 complex reagents and various antibodies in order to generate deep proteomic information at the speed and scale </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which we expect our Nautilus platform to perform. Such reagents and antibodies are expected to be more difficult to manufacture and more expensive to procure. There is no assurance that we will be able to build manufacturing or consumable production capacity internally or find one or more suitable manufacturing or production partners, or both, to meet the volume and quality requirements necessary to be successful in the proteomics market.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given our stage of development, we have not yet established a commercial organization or distribution capabilities. We do intend to build a commercial infrastructure to support sales of our products. We expect to manage sales, marketing and distribution through both internal resources and third-party relationships. We plan to commercialize our proteomics platform using a three-phase plan that has been shown to be effective and optimal for introducing disruptive products in numerous life sciences technology markets. The first phase is expected to involve collaboration with biopharmaceutical companies and key opinion leaders to validate the performance and utility of Nautilus&#8217; product, during which we do not expect to recognize significant revenue, if any. The second phase will include an early access limited release phase in which we expect to recognize limited revenue. Finally, the third phase is anticipated to include a broader commercial launch. We are currently in the collaboration phase during which we have entered into and are seeking to enter into collaborations with a small number of research customers, including with biopharmaceutical companies and key opinion leaders in proteomics whose assessment and validation of our products can significantly influence other researchers in their respective markets and/or fields. During the early access limited release phase, we plan to leverage our publications to drive awareness and customer demand to pre-sell instruments and reagents to select customers performing large-scale proteomics research. We do not anticipate that these activities will result in any material revenue. During the second phase, we expect to work closely with early access customers to demonstrate a unique value proposition for our Nautilus platform. During this phase, we plan to provide early access program partners with broad-scale analysis and profiling of samples analyzed in our facility and shared via a cloud platform. We anticipate meaningful early access engagements and associated revenue to begin at the start of 2024.  We expect this second phase to lead into the third phase of broad commercialization and launch of the proteome analysis platform in mid-2024. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to commercialize our Nautilus platform through a direct sales channel in the United States, and through both direct and distributor sales channels in regions outside the United States. Given our stage of development, we currently have no marketing, sales, commercial product distribution or service and support capabilities. We intend to build the necessary infrastructure for these activities in the United States, European Union, the United Kingdom, and potentially other countries and regions, including Asia-Pacific, as we execute on our three phase commercial launch strategy for our Nautilus platform. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Business Combination, we financed our operations primarily through private placements of convertible preferred stock and had raised aggregate net proceeds of $108.4&#160;million from these private placements. In connection with the consummation of the Business Combination and PIPE Financing, we received additional gross proceeds of approximately $345.5 million from PIPE Investors and the Business Combination, offset by approximately $18.2 million of transaction costs and underwriters&#8217; fees relating to the closing of the Business Combination. As of June&#160;30, 2022, we had cash, cash equivalents and short-term investments of $299.3 million. Based on this, we believe that our existing cash, cash equivalents, and short-term investments will enable us to fund our planned operating expenses and capital expenditures through at least the next 12 months.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred significant losses since the commencement of our operations. Our net loss was $30.5 million during the six months ended June 30, 2022, and we expect to continue to incur significant losses for the foreseeable future as we continue our research and development activities and planned commercialization of our proteomics platform. As of June&#160;30, 2022, we had an accumulated deficit of $111.1 million. These losses have resulted primarily from costs incurred in connection with research and development activities and to a lesser extent from general and administrative costs associated with our operations. We expect to incur significant and increasing expenses and operating losses for the foreseeable future. Our net losses may fluctuate significantly from period to period, depending on the timing of and expenditures on our planned commercialization and research and development activities.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our expenses and capital requirements will increase substantially in connection with our ongoing activities as we:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continue our research and development activities, including with respect to our Nautilus platform;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">undertake activities to establish sales, marketing and distribution capabilities for our Nautilus platform;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">incur setup costs related to production tooling and required testing;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintain, protect and expand our intellectual property portfolio, including patents, trade secrets and know how;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">implement operational, financial and management information systems;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">attract, hire and retain additional management, scientific and administrative personnel; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operate as a public company.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, we will require substantial additional funding to develop our products and support our continuing operations. Until such time that we can generate significant revenue from product sales, if ever, we expect to finance our operations through the sale of equity, debt financings or other capital sources, which could include income from collaborations, strategic partnerships or marketing, distribution or licensing arrangements with third parties or from grants. We may be unable to raise additional funds or to enter into such agreements or arrangements on favorable terms, or at all. Our ability to raise additional funds may be adversely impacted by potential worsening global economic conditions and the recent disruptions to, and volatility in, the credit and financial markets in the United States and worldwide resulting from the ongoing COVID&#8209;19 pandemic, the conflicts in Eastern Europe, and otherwise. Our failure to obtain sufficient funds on acceptable terms when needed could have a material adverse effect on our business, results of operations or financial condition, and could force us to delay, reduce or eliminate our product development or future commercialization efforts. We may also be required to grant rights to develop and market products that we would otherwise prefer to develop and market ourselves. The amount and timing of our future funding requirements will depend on many factors, including the pace and results of our development efforts. We cannot assure you that we will ever be profitable or generate positive cash flow from operating activities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of COVID-19&#160;Pandemic</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global COVID-19 pandemic continues to rapidly evolve. The extent of the impact of the COVID-19 pandemic on our business, operations and development timelines and plans remains uncertain, and will depend on certain developments, including the duration and spread of the outbreak and its impact on our development activities, third-party manufacturers, and other third parties with whom we do business, as well as its impact on regulatory authorities and our key scientific and management personnel. As the COVID-19 pandemic has developed, we have taken numerous steps to help ensure the health and safety of our employees. We are maintaining hygiene and respiratory protocols; controls for social distancing; enhanced cleaning, disinfecting, decontamination, and ventilation protocols; health policies; and usage of personal protective equipment, where appropriate. During March and April of 2020 in which stay at home orders were in place in the state of California and Washington, the volume of ongoing lab work was reduced, and only critical program work in the lab continued with staggered lab employee work shifts to minimize risk of exposure to COVID-19, which disrupted and delayed our ability to conduct development activities. While we were broadly able to resume normal operations in August 2021, if any resurgence or worsening of the COVID-19 pandemic causes us to reinstitute these measures we may experience additional disruption and/or delays in our ability to conduct development activities. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been and continue to actively monitor our supply chain during the COVID-19 pandemic, including third-party materials and suppliers. To date, we have experienced some supply disruptions due to the pandemic, including closures at certain chip manufacturers, which led to extended lead times for certain chips; diversion of certain lab materials needed to support COVID-19 relief efforts; and lower availability of certain reagents. While certain of these disruptions have been resolved since the start of the COVID-19 pandemic, we are continuing to </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">monitor our supply chain and contingency planning is ongoing with our partners to reduce the possibility of an interruption to our development activities or the availability of necessary materials. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ultimate impact of the COVID-19 pandemic or a similar health epidemic is highly uncertain and subject to change. To the extent possible, we are conducting business as usual, with necessary or advisable modifications to employee travel, with masking and vaccination requirements in our offices, and with our employees working remotely fully or intermittently as able from March 2020 until August 2022. We will continue to actively monitor the rapidly evolving situation related to COVID-19 and may take further actions that alter our operations, including those that may be required by federal, state or local authorities, or that we determine are in the best interests of our employees and other third parties with whom we do business. At this point, the extent to which the COVID-19 pandemic may affect our future business, operations and development timelines and plans, including the resulting impact on our expenditures and capital needs, remains uncertain.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reverse Recapitalization Transaction</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 9, 2021 (the &#8220;Closing Date&#8221;), Nautilus Biotechnology, Inc., a Delaware corporation (f/k/a ARYA Sciences Acquisition Corp III, a Cayman Islan</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ds exempted company and our predecessor company (&#8220;ARYA&#8221;)) (the &#8220;Company&#8221;), consummated its previously announced business combination (the &#8220;Business Combination&#8221;) pursuant to the terms of that certain Business Combination Agreement, dated as of February 7, 2021 (the &#8220;Business Combination Agreement&#8221;), by and among ARYA, Mako Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of ARYA (&#8220;Mako Merger Sub&#8221;), and Nautilus Subsidiary, Inc., a Delaware corporation (f/k/a Nautilus Biotechnology, Inc.) (&#8220;Legacy Nautilus&#8221;). </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the Business Combination Agreement, on the Closing Date, (i) ARYA changed its jurisdiction of incorporation by deregistering as a Cayman Islands exempted company and continuing and domesticating as a corporation incorporated under the laws of the State of Delaware (the &#8220;Domestication&#8221;), upon which ARYA changed its name to &#8220;Nautilus Biotechnology, Inc.&#8221; (together with its consolidated subsidiary, &#8220;New Nautilus&#8221; or &#8220;Nautilus&#8221;) and (ii) Mako Merger Sub merged with and into Legacy Nautilus (the &#8220;Merger&#8221;), with Legacy Nautilus as the surviving company in the Merger and, after giving effect to such Merger, Legacy Nautilus becoming a wholly-owned subsidiary of New Nautilus. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the terms and subject to the conditions of the Business Combination Agreement, at the effective time of the Merger (the &#8220;Effective Time&#8221;), (i) each share of Legacy Nautilus outstanding as of immediately prior to the Effective Time was exchanged for shares of common stock of New Nautilus, par value $0.0001 per share (&#8220;Common Stock&#8221;), and (ii) all vested and unvested options to purchase shares of Legacy Nautilus were exchanged for comparable options to purchase shares of Common Stock, in each case, based on an implied Legacy Nautilus equity value of $900,000,000.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the open of trading on June 10, 2021, the Common Stock of the Company, formerly those of ARYA, began trading on the Nasdaq Global Select Market (&#8220;Nasdaq&#8221;) under the symbol &#8220;NAUT.&#8221; </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the consummation of the Business Combination with ARYA, we received gross proceeds of approximately $345.5 million from PIPE Investors and the Business Combination, offset by approximately $18.2 million of transaction costs and underwriters&#8217; fees relating to the closing of the Business Combination.</span></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_88"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Components of Our Results of Operations </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, we have not generated any revenue and we may not generate any revenue from the sale of products or from other sources in the near future.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expense</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses account for a significant portion of our operating expenses and consist primarily of salaries, related benefits and stock-based compensation expense of product development personnel, facilities costs, laboratory supplies and equipment, depreciation and amortization, external costs of vendors engaged to conduct research and development activities, and allocated expenses for technology and facilities. We expense research and development expenses in the periods in which they are incurred.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We plan to continue to invest in our research and development efforts and to increase our investment in research and development efforts related to our product development. As a result, we expect research and development expenses to increase in absolute dollars as we continue to advance our product development, hire additional personnel and retain existing personnel, purchase supplies and materials and allocate expense to our research and development facilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses consist of salaries and benefits, and stock-based compensation expense for personnel in executive, operations, legal, human resources, finance, marketing, commercial, IT personnel and administrative functions, professional fees for legal, patent, consulting, accounting and audit services, and allocated expenses for technology and facilities. We expense general and administrative expenses in the periods in which they are incurred.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that our general and administrative expenses will increase substantially over the next several years as we hire additional personnel to support the continued research and development of our products and commercial activities supporting the growth of our business. We also anticipate that we will incur substantially higher expenses as a result of operating as a public company, i</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ncluding expenses related to accounting, audit, legal, regulatory, insurance, compliance with the rules and regulations of the SEC, Sarbanes-Oxley Act an</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d those of any national securities exchange on which our securities are traded, director and officer insurance, investor and public relations, and other administrative and professional services.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense), Net</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net consists primarily of interest income on our cash, cash equivalents and  investments and other miscellaneous nonrecurring expenses such as loss on disposal of property and equipment. </span></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_91"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Three Months Ended June 30, 2022 to the Three Months Ended June 30, 2021 </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows our condensed consolidated statements of operations for the periods indicated:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:42.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.492%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.492%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.492%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.494%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change<br/>($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change <br/>(%)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,616&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,472&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,697&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,775&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4994)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-0.01pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,689)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,713)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,976)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses were $8.9 million for the three months ended June 30, 2022, compared to $6.4 million for the three months ended June 30, 2021, an increase of $2.5 million, or 39%. The increase was primarily due to a $1.8 million increase in salaries, related benefits, and stock-based compensation, a $0.8 million increase in costs for development services and a $0.5 million increase in facilities costs, partially offset by a $0.5 million reduction in&#160;laboratory supplies and equipment expense.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expense</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">s</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses were $6.6 million for the three months ended June 30, 2022, compared to $4.3 million for the three months ended June 30, 2021, an increase of $2.3 million, or&#160;53%. The increase was primarily due to a $1.1 million increase in salaries, related benefits, and stock-based compensation, a $0.5 million increase in insurance costs and a $0.3 million increase in facilities costs.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income (Expense), Net</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net for the three months ended June 30, 2022 as compared to the three months ended June 30, 2021 changed primarily due to income from accretion and amortization on investments and interest income.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Six Months Ended June 30, 2022 to the Six Months Ended June 30, 2021 </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows our condensed consolidated statements of operations for the periods indicated:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.130%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.364%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change <br/>($)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change <br/>(%)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,215&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,980&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,081&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,494&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,114&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,380&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,042&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13125)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,452)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,122)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,330)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses were $18.5 million for the six months ended June 30, 2022, compared to $11.2 million for the six months ended June 30, 2021, an increase of $7.3 million, or 65%. The increase was primarily due to a $3.9 million increase in salaries, related benefits, and stock-based compensation, a $1.7 million increase in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">costs for development services,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> a $1.2 million increase in facilities costs and a $0.6 million increase in&#160;laboratory supplies and equipment expense.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expenses</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses were $13.0 million for the six months ended June 30, 2022, compared to $7.9 million for the six months ended June 30, 2021, an increase of $5.1 million, or&#160;64%. The increase was primarily due to a $2.4 million increase in salaries, related benefits, and stock-based compensation, a $1.3&#160;million increase in insurance costs and a $0.6 million increase in facilities costs. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense), Net</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net for the six months ended June 30, 2022 as compared to the six months ended June 30, 2021 changed primarily due to income from accretion and amortization on investments and interest income.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_97"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources of Liquidity</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception, we have not generated any revenue from product sales and have incurred significant operating losses and negative cash flows from our operations. Our net loss was $30.5 million for the six months ended June 30, 2022. As of June&#160;30, 2022, we had an accumulated deficit of $111.1 million. Prior to the Business Combination, we funded our operations primarily with proceeds from the sale of convertible preferred stock. Prior to the Business Combination, we had raised net proceeds of $108.4 million from these private placements of our convertible preferred stock. In June 2021, in conjunction with the consummation of the Business Combination with ARYA, we received additional gross proceeds of approximately $345.5 million from PIPE Investors and the Business Combination, offset by approximately $18.2 million of transaction costs and underwriters&#8217; fees relating to the closing of the Business Combination. As of June&#160;30, 2022, we had cash, cash equivalents and short-term investments of $299.3 million.&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary uses of cash to date have been to fund our research and development activities, business planning, establishing and maintaining our intellectual property portfolio, hiring personnel, raising capital, and providing general and administrative support for these operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Funding Requirements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, we have not generated any revenue and we may not generate any revenue from the sale of products or from other sources in the near future. We expect our expenses and capital requirements will increase substantially in connection with our ongoing activities as we:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continue our research and development activities, including with respect to our proteomics platform;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">undertake activities to establish sales, marketing and distribution capabilities for our proteomics platform;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">incur setup costs related to production tooling and required testing;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintain, protect and expand our intellectual property portfolio, including patents, trade secrets and know how;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">implement operational, financial and management information systems;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">attract, hire and retain additional management, scientific and administrative personnel; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operate as a public company.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our planned operations, we expect our current cash, cash equivalents, and short-term investments will be sufficient to fund our operating expenses and capital expenditures for at least the next 12 months. We continue to face challenges and uncertainties and, as a result, our available capital resources may be consumed more rapidly than currently expected due to: delays in execution of our development plans; the scope and timing of our investment in our sales, marketing, and distribution capabilities; changes we may make to the business that affect ongoing operating expenses; the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights; changes we may make in our business or commercialization strategy; changes we may make in our research and development spending plans; our need to implement additional infrastructure and internal systems; the impact of the COVID-19 pandemic; and other items affecting our forecasted level of expenditures and use of cash resources including potential acquisitions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until such time as we can generate significant revenue from commercialization of our products, if ever, we will continue to require substantial additional capital to develop our proteomics platform and fund operations for the foreseeable future. We intend to obtain such capital through public or private equity offerings or debt financings, credit or loan facilities or a combination of one or more of these funding sources. We may also seek additional financing opportunistically. We may be unable to raise additional funds on favorable terms or at all. Our ability to raise additional funds may be adversely impacted by potential worsening global economic conditions and the recent </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">disruptions to, and volatility in, the credit and financial markets in the United States and worldwide resulting from the ongoing COVID&#8209;19 pandemic, the conflicts in Eastern Europe, and otherwise. Our failure to raise additional capital, if needed, would have a negative impact on our financial condition and our ability to execute our business plan.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our expected future capital requirements depend on many factors including expansion of our product portfolio and the timing and extent of spending on sales and marketing and the development of our technology. If we raise additional funds by issuing equity securities, our stockholders will experience dilution. Any future debt financing into which we enter may impose upon us additional covenants that restrict our operations, including limitations on our ability to incur liens or additional debt, pay dividends, repurchase our common stock, make certain investments and engage in certain merger, consolidation or asset sale transactions. Any debt financing or additional equity that we raise may contain terms that are not favorable to us or our stockholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Historical Cash Flows</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">For the Six Months Ended June 30, 2022 and 2021 </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash flows for the six months ended June 30, 2022 and 2021:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,864)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,545)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,258&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61,048)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327,373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase in cash, cash equivalents and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,735&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,780&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Activities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2022, net cash used in operating activities was $25.9 million, primarily resulting from our operating loss of $30.5 million and decrease in net changes in assets and liabilities aggregating $1.6 million, primarily driven by $0.6 million decrease in accounts payable and a $0.5 million increase in prepaid expenses and other assets. Net cash used in operating activities was partially offset by non-cash charges aggregating $6.2 million, which primarily included $4.7 million of stock-based compensation and $1.1 million amortization of operating lease right-of-use assets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2021, net cash used in operating activities was $14.5 million, primarily resulting from our operating loss of $19.1 million, offset by non-cash charges aggregating $4.6 million, which primarily included $3.2 million of stock-based compensation and $0.8 million amortization of operating lease right-of-use assets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing Activities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2022, net cash provided by investing activities was $50.3 million, primarily resulting from&#160;$105.6 million in proceeds from maturities of securities, partially offset by $54.2 million in purchases of securities and $1.1 million in purchases of property and equipment.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2021, net cash used in investing activities was $61.0 million, primarily resulting from $100.0 million in purchases of securities, partially offset by $40.0 million in proceeds from maturities of securities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Activities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2022, net cash provided by financing activities was $0.3 million of proceeds from exercise of stock options and issuance of common stock under the employee stock purchase plan.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2021, net cash provided by financing activities was $327.4 million primarily resulting from $335.4 million in proceeds from the Business Combination and PIPE Financing, offset by $8.1 million in payments of offering costs.</span></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_100"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations and Commitments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of our contractual obligations and commitments, refer to Part I, Item 1, Note 10, &#8220;Commitments and Contingencies,&#8221; in our notes to condensed consolidated financial statements in this Quarterly Report on Form 10-Q.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_106"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our discussion and analysis of our financial condition and results of operations are based upon our condensed consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States. The preparation of these condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, and expenses. We evaluate our estimates and assumptions on an ongoing basis, and base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for the judgments we make about the carrying value of assets and liabilities that are not readily apparent from other sources. Because these estimates can vary depending on the situation, actual results may differ from these estimates. Making estimates and judgments about future events is inherently unpredictable and is subject to significant uncertainties, some of which are beyond our control. Should any of these estimates and assumptions change or prove to have been incorrect, it could have a material impact on our results of operations, financial position and statement of cash flows.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the policies noted in Part I, Item 1, Note 2, &#8220;Significant Accounting Policies,&#8221; in our notes to condensed consolidated financial statements in this Quarterly Report on Form 10-Q, there have been no material changes to our critical accounting policies and estimates as compared to those disclosed in our audited financial statements as of and for the years ended December 31, 2021 and 2020.</span></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_109"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of recent accounting pronouncements, including the expected dates of adoption and estimated effects, if any, on our condensed consolidated financial statements, see Part I, Item 1, Note 2 &#8220;Significant Accounting Policies&#8221; in our notes to condensed consolidated financial statements in this Quarterly Report on Form 10-Q. </span></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_112"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emerging Growth Company Accounting Election</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Jumpstart Our Business Startups Act of 2012, or the JOBS Act, permits an &#8220;emerging growth company&#8221; such as us to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies until those standards would otherwise apply to private companies. We have elected to use this extended transition period under the JOBS Act until the earlier of the date we (i) are no longer an emerging growth company or (ii) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, our financial statements may not be comparable to the financial statements of issuers who are required to comply with the effective dates for new or revised accounting standards that are applicable to public companies, which may make comparison of our financials to those of other public companies more difficult.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will cease to be an emerging growth company on the date that is the earliest of (i) the last day of the fiscal year in which we have total annual gross revenue of $1.07 billion or more, (ii) the last day of our fiscal year following the fifth anniversary of the date of the closing of ARYA&#8217;s initial public offering, (iii) the date on which we have issued more than $1.0 billion in nonconvertible debt during the previous three years or (iv) the date on which we are deemed to be a large accelerated filer under the rules of the Securities and Exchange Commission.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, even after we no longer qualify as an emerging growth company, we may still qualify as a &#8220;smaller reporting company,&#8221; which would allow us to take advantage of many of the same exemptions from disclosure requirements, including reduced disclosure obligations regarding executive compensation in our periodic reports and </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">proxy statements. We cannot predict if investors will find our common shares less attractive because we may rely on these exemptions. If some investors find our common shares less attractive as a result, there may be a less active trading market for our common shares and our share price may be more volatile.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_115"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Qualitative and Quantitative Disclosures About Market Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our market risk exposure is primarily a result of fluctuations in interest rates and inflation. We do not hold or issue financial instruments for trading purposes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had cash, cash equivalents, short-term and long-term investments of $334.9 million as of June&#160;30, 2022. The primary goals of our investment policy are liquidity and capital preservation. We do not enter into investments for trading or speculative purposes. The carrying amount of our cash equivalents reasonably approximates fair value, due to the short maturities of these instruments. Our investments are exposed to market risk due to a fluctuation in interest rates, which may affect the fair market value of our investments in marketable securities. As of June&#160;30, 2022, the effect of a hypothetical 1.00% (100 basis point) change in interest rates would have changed the fair value of our marketable securities by $1.1 million. Such change would only be realized if we sold the marketable securities prior to maturity. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inflation Risk</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inflation generally affects us by increasing our cost of labor and goods and services. We believe that inflation has had some effect on our financial results during the periods presented. If we experience continued or future inflationary pressure, it may impact the costs of our operations as well as the costs to manufacture, sell and distribute our products and provide our services in the future. We may not be able to fully offset those increased costs through reduced spending or price increases to our products and services. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_118"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. CONTROLS AND PROCEDURES</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a&#8209;15(e) and 15d&#8209;15(e) under the Exchange Act, as of the end of the period covered by this Quarterly Report on Form 10-Q. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable and not absolute assurance of achieving the desired control objectives and management necessarily applies its judgment in evaluating the cost benefit relationship of possible controls and procedures. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of June&#160;30, 2022.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been no change in our internal control over financial reporting during the quarter ended June&#160;30, 2022 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inherent Limitations on the Effectiveness of Controls</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Control systems, no matter how well conceived and operated, are designed to provide a reasonable, but not an absolute, level of assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Because of the inherent limitations in any control system, misstatements due to error or fraud may occur and not be detected.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_121"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II: OTHER INFORMATION</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_124"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. LEGAL PROCEEDINGS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may become involved in various claims and legal proceedings. Regardless of outcome, litigation and other legal and administrative proceedings can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors. We are currently not a party to any legal proceedings the outcome of which, if determined adversely to us, would individually or in the aggregate have a material adverse effect on our business, financial condition, and results of operations. </span></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_127"></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A. RISK FACTORS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should consider carefully the following information about the risks described below, together with the other information contained in this Quarterly Report on Form 10-Q and in our other public filings, in evaluating our business. If any of the following risks actually occurs, our business, financial condition, results of operations, and future growth prospects would likely be materially and adversely affected. In these circumstances, the market price of our common stock would likely decline.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary Risk Factors</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is subject to numerous risks and uncertainties that you should consider before investing in our company, as more fully described below. The principal factors and uncertainties that make investing in our company risky include, among others:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are a development stage company that has incurred net losses in every period to date, has not yet commercialized any products, and expects to continue to incur significant losses as we develop our business. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business is entirely dependent on the successful development and commercialization of our proteomics platform (the &#8220;Nautilus platform&#8221;), which remains in the development stage and could be subject to delays, technical challenges and market acceptance challenges. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not compete successfully with our initial or future products in the highly competitive life sciences technology market.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are dependent upon third parties for certain aspects of the development and commercialization of the Nautilus platform.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business depends significantly on research and development spending by pharmaceutical companies as well as by academic institutions and other research institutions and any reduction in spending could limit demand for our products.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be able to launch our Nautilus platform successfully and even if it is successful, we may experience material delays in our commercialization program relative to current expectations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our operating results may fluctuate significantly in the future, which makes our future operating results difficult to predict and could cause our operating results to fall below expectations or our guidance.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may need to raise additional capital to fund our development and commercialization plans.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Intellectual Property</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be unable to obtain and maintain sufficient intellectual property protection for our products and technology, or if the scope of our intellectual property protection obtained is not sufficiently broad, competitors could develop and commercialize products similar or identical to ours.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be able to protect our intellectual property and proprietary rights throughout the world. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Litigation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may become involved in litigation to enforce or defend our intellectual property rights, or to defend ourselves from claims that we infringe the intellectual property rights of others.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may face liability and/or negative publicity for any unknown defects or errors in our products.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Regulatory and Legal Compliance Matters</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our products may, in the future, be subject to regulation by the FDA or other regulatory authorities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are currently subject to, and may in the future become subject to additional, U.S. federal and state laws and regulations, as well as the laws and regulations of other countries, relating to how we collect, store and process personal information.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Future expansion of our development and commercialization activities outside of the United States, may subject us to an increased risk of inadvertently conducting activities in a manner that violates the U.S. Foreign Corrupt Practices Act and similar laws. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Environmental and health safety laws, including any failure to comply with such laws, may result in liabilities, expenses and restrictions on our operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our employees, independent contractors, consultants, commercial partners, distributors and vendors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to our Operations </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may experience a significant disruption in our information technology systems or breaches of data security.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are highly dependent on our key personnel, and if we are unable to recruit and retain key executives and scientists, we may not be able to achieve our goals.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our operations and financial results could be adversely impacted by global and national events, such as the COVID-19 pandemic, conflicts in Eastern Europe, and general economic downturns.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Global supply chain interruptions may negatively impact the development and commercialization of our products.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Common Stock</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The price of and market for our Common Stock may be volatile, which could result in substantial losses for investors and/or an inability to readily trade in our Common Stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Risk Factors</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We will incur significant increased costs and management resources as a result of operating as a public company.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reports published by analysts, including projections in those reports that differ from our actual results, could adversely affect the price and trading volume of our common shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our ability to timely and accurately report our financial results and projections as a public company may be impacted by the effectiveness of our internal controls, and our estimates and judgments relating to critical accounting policies.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are a development stage company that has incurred net losses in every period to date, has not yet commercialized any products, and expects to continue to incur significant losses as we develop our business. We may never achieve profitability.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a development stage company that has incurred net losses in each quarterly and annual period since inception and that has not yet generated any revenue. We expect to incur increasing costs as we continue to devote substantially all of our resources towards the development and anticipated future commercialization of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform, which includes our end-to-end solution comprised of instruments, consumables, and software analysis. We cannot be certain if we will ever generate revenue or if or when we will produce sufficient revenue from operations to support our costs. Even if profitability is achieved, we may not be able to sustain profitability. We incurred net losses of $14.7&#160;million and $10.7&#160;million during the three and six months ended June 30, 2022 and 2021, respectively. As of June&#160;30, 2022, we had an accumulated deficit of $111.1 million. These losses and accumulated deficit were primarily due to the substantial investments we made in the scientific and technological development of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform. We expect to incur substantial losses and negative cash flows for the foreseeable future. In addition, as a public company, we will incur significant legal, accounting, and other expenses that we did not incur as a private company. These increased expenses will make it harder for us to achieve and sustain future profitability. We may incur significant losses in the future for a number of reasons, many of which are beyond our control, including the other risks described in this Quarterly Report on Form 10-Q.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business is entirely dependent on the success of our Nautilus platform, which remains in the development stage and subject to scientific and technical validation. If we are unable to develop and commercialize our Nautilus platform successfully and in a manner that provides currently anticipated functionality and levels of performance, we may never be able to recognize any revenue, and our business, operating results, and financial condition will suffer.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future success is entirely dependent on our ability to successfully develop and commercialize our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform, which is based on innovative yet complex and unproven technologies and which is anticipated to be used in demanding scientific research that requires substantial levels of accuracy and precision. We are investing substantially all of our management efforts and financial resources in the development and commercialization of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform. Additionally, in developing our platform technology, we may rely on co-development partners to assist us in the development of certain component technologies in our platform. We have experienced difficulties with some of these partners successfully delivering these component technologies on time and to our specifications, and these partners may not be successful in delivering these component technologies on time, to our specifications, or at all, in the future, which could have an adverse impact on our ability to meet our development timelines, and/or our products level of currently anticipated functionality and performance. While our goal is to leverage our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus p</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">latform to comprehensively measure the human proteome, the human proteome is dynamic and far more complex and diverse in structure, composition and number of variants than either the genome or transcriptome. If we cannot successfully complete platform development, if we are unable to achieve our goals for mapping the proteome, if our products fail to deliver currently anticipated functionality and levels of performance, if our products are found by a court of law to infringe the intellectual property of another party, or if we are unable to obtain broad scientific and market acceptance of our products and technologies, we may never recognize material revenue and may be unable to continue our operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have not yet commercially launched our Nautilus platform. We may not be able to launch our Nautilus platform successfully and even if it is successful, we may experience material delays in our commercialization program relative to current expectations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate commercializing our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform in three phases involving first collaboration with biopharmaceutical companies and key opinion leaders to validate the performance and utility of our product, during which we do not expect to recognize significant revenue, if any; secondly an early access limited release phase in which we expect to recognize limited revenue; and finally a broader commercial launch phase. We are currently in the collaboration phase during which we have entered into and are seeking to enter into collaborations with a small number of research customers, including with biopharmaceutical companies and key opinion leaders in proteomics </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">whose assessment and validation of our products can significantly influence other researchers in their respective markets and/or fields. We do not anticipate that these activities will result in any material revenue. During the second, early access phase, we expect to work closely with early access customers to demonstrate a unique value proposition for our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform. During this phase, we plan to provide early access program partners with broad-scale analysis and profiling of samples analyzed in our facility and shared via a cloud platform. We anticipate meaningful early access engagements and associated revenue to begin at the start of 2024.  We expect this second phase to lead into the third phase of broad commercialization and launch of the proteome analysis platform in mid-2024. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Achieving the scientific and commercial objectives identified above within currently anticipated timelines will require substantial investments in our technologies and in the underlying science. Scientific and technological development of the nature being undertaken by us is extraordinarily complex, and there can be no assurances that any of these phases of commercial development will be successful or that they will be completed within the timelines currently anticipated. Given the scientific and technical complexity of our products, we could experience material delays in product development and commercial launch. If our research and product development efforts do not result in commercially viable products within the anticipated timelines, our business, operating results, and financial condition will be adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The commercialization of our products will require us to establish relationships and successfully collaborate with leading life science companies and research institutions, initially to test and validate our products and subsequently as we seek to expand the markets for our products. We may be unable to establish sufficient collaborations of this nature, and such collaborations could result in agreements that limit or otherwise impair our flexibility to pursue other strategic opportunities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted above, establishing collaborations and partnerships with large pharmaceutical and biotechnology companies and with major research institutions is a material element of our commercialization strategy. While early collaborations are expected to focus on the assessment and validation of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform with a focus in part on publication of results in peer-reviewed scientific journals, we also intend to pursue additional, potentially revenue-generating collaborations in areas of biological interest. Among other examples, we may pursue collaborations relating to the development and commercialization of therapeutic product candidates targeting proteins identified by our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurance that we will be successful in developing or maintaining collaborations or that, if established, these collaborations will achieve the desired objectives. Establishing collaborations is difficult and time-consuming. Discussions may not lead to collaborations on favorable terms, if at all, and particularly where we are negotiating against major pharmaceutical companies, we may have relatively less leverage in negotiating favorable terms. To the extent we agree to work exclusively with a party in a given field, our opportunities to collaborate with others in that field would be limited. Certain parties may seek to partner with other companies in addition to us in connection with a project. This, in turn, may limit the commercial potential of any products that are the subject of such collaborations. Potential collaborators may elect not to work with us based upon their assessment of our financial, regulatory, commercial or intellectual property position.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we are successful in entering into collaborations, the success of such collaborations will depend heavily on the efforts and activities of our collaborators.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scientific collaborations of the nature we propose to pursue are subject to numerous risks, including that:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators may have significant discretion in determining the efforts and resources that they will apply to a specific project;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators may not pursue development and commercialization of products or may elect not to continue or renew development or commercialization programs based on trial or test results, changes in their strategic focus due to the acquisition of competitive products, availability of funding, or other external factors such as a business combination that diverts resources or creates competing priorities;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators may own intellectual property covering products that result from our collaboration with them, and in such cases, we would not have the right to develop or commercialize such intellectual property;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators may co-own intellectual property covering products that result from our collaboration with them, and in such cases, we would not have the right to exclude others from developing or commercializing such intellectual property;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with product candidates that are being developed under the collaboration with us;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a collaborator with marketing, manufacturing, and distribution rights to one or more products may not commit sufficient resources to or otherwise not perform satisfactorily in carrying out these activities;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we could grant exclusive rights to our collaborators that would prevent us from collaborating with others;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborators may not properly maintain or defend our intellectual property rights or may use our intellectual property or proprietary information in a way that gives rise to actual or threatened litigation that could jeopardize or invalidate our intellectual property or proprietary information or expose us to potential liability;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disputes may arise between us and a collaborator that cause the delay or termination of the research, development, or commercialization of products or that result in costly litigation or arbitration that diverts management attention and resources;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">collaborations may be terminated, and, if terminated, in addition to reducing our revenue, may reduce exposure to research and clinical trials that facilitate the collection and incorporation of new information into our platform; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a collaborator&#8217;s sales and marketing activities or other operations may not be in compliance with applicable laws resulting in civil or criminal proceedings.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, before obtaining marketing approval from regulatory authorities for the sale of product candidates subject to future collaborations, our collaborators must conduct extensive clinical trials to demonstrate the safety and efficacy of the product candidates. If clinical trials of product candidates resulting from collaborations are prolonged or delayed, collaborators may be unable to obtain required regulatory approvals and therefore be unable to commercialize product candidates on a timely basis or at all, which may have a material impact on the revenue recognized from such collaborations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if we are able to complete development of our Nautilus platform, we may not achieve or maintain significant commercial market acceptance.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we are able to complete development of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform, the platform will be subject to market forces and adoption curves common to new technologies. The market for novel proteomics technologies and products like those being developed by us is in the early stages of development. While these technologies present the potential to displace legacy products, changing long-standing scientific workflows with new instruments requiring substantial capital expenditures will require us to invest substantial financial and management resources to educate potential customers on the benefits of our</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Nautilus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform relative to existing technologies and to validate our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform&#8217;s ability to meet customer requirements. In that regard, we anticipate that our initial market focus will be pharmaceutical development and associated research, which are characterized by demanding and exacting requirements for product performance and accuracy. If widespread adoption of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform takes longer than anticipated or does not occur, our business will be materially and adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">More specifically, the successful introduction of new technologies in life science markets requires substantial engagement with the scientific community in order to encourage community acceptance of the utility, performance, and cost of the technology relative to its benefits in the applicable field or fields of research. The life sciences scientific community is often led by a small number of early adopters and key opinion leaders who significantly influence the larger community through publications in peer-reviewed journals. In these journal publications, the researchers describe not only their discoveries but also the methods and typically the products used to fuel these </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">discoveries. We expect that references to the use of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus p</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">latform in peer-reviewed journal publications will be critical to our ability to obtain widespread acceptance within the scientific community. In addition, continuing collaborative relationships with key opinion leaders will be vital to maintaining any market acceptance we achieve. If too few researchers describe the use of our products, too many researchers shift to a competing product and publish research outlining their use of that product, or too many researchers negatively describe the use of our products in publications, customers may be less willing to engage with us concerning our products, which could materially delay our commercialization plan and/or substantially extend our sales cycles. Moreover, these customers may ultimately be less willing to purchase our products, which would adversely affect our business and future revenue.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specific, material factors that will influence our ability to achieve market acceptance include the following:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of our marketing and engagement initiatives to increase awareness of the capabilities of our Nautilus platform;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of our Nautilus platform to demonstrate reliable performance in intended use applications, in particular, when the platform is used by customers in their own research;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to demonstrate that the functionality and performance of our Nautilus platform relative to alternative products and technologies justifies the substantial anticipated cost of the platform;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the willingness of prospective customers to adopt new products and workflows;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ease of use of our Nautilus platform and whether it reliably provides significant advantages over alternative products and technologies;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the rate of adoption of our Nautilus platform by biopharmaceutical companies, laboratories, academic institutions and others;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to develop new products, workflows, and solutions that meet customer requirements;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the introduction or development and commercialization by competitors of new products or enhancements to existing products with functionality and/or performance similar to our Nautilus platform; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of our investments in product innovation and commercial growth.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot assure you that we will be successful in addressing any of these criteria or any additional criteria that might affect the market acceptance of our products. If we are unsuccessful in achieving and maintaining market acceptance of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus p</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">latform, our business, financial condition and results of operations would be adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have no experience in manufacturing our products at commercial scale. If we are unable to establish manufacturing capacity by ourselves or with partners in a timely manner after completing development, commercialization of our Nautilus platform would be delayed, which would result in lost revenue and harm our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order for us to commercialize our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus p</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">latform in volume, we will need to establish internal manufacturing capacity or to contract with one or more manufacturing partners, or both. Our technology is complex, and the manufacturing process for our products will be similarly complex, involving a large number of unique precision parts in addition to the production of various reagents and antibodies. We may encounter unexpected difficulties in manufacturing our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus p</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">latform, including our proteome analysis system and related consumables. Among other factors, we will need to develop reliable supply chains for the various components in our platform and consumables to support large-scale commercial production. In connection with our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus p</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">latform, we intend to utilize over 300 complex reagents and various antibodies in order to generate deep proteomic information at the speed and scale which we expect our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus p</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">latform to perform. Such reagents and antibodies are expected to be more difficult to manufacture and more expensive to procure. There are no assurances that we will be able to build manufacturing or consumable production capacity internally or find one or more suitable </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">manufacturing or production partners, or both, to meet the volume and quality requirements necessary to be successful in the proteomics market. In addition, in connection with establishing third party relationships or sourcing component supplies, including with respect to reagents and antibodies, we may incur costs that are higher than currently expected and that may adversely affect our gross margins and operating results following commercialization. Assuming we complete development of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus p</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">latform, we may experience manufacturing and product quality issues as we increase the scale of our production. Any delay or inability in establishing or expanding our manufacturing capacity could diminish our ability to develop or sell our products, result in increased or unanticipated costs, result in lost revenue, and seriously harm our business, results of operations and financial condition.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to establish an effective commercial organization, including effective distribution channels and sales and marketing functions, we may not be successful in commercializing our Nautilus platform.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are only beginning to establish an internal organization focused specifically on the commercialization of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform. Our initial hiring has focused on senior commercial leadership, and although this leadership has considerable industry experience, in order to achieve substantial revenue growth and profitability, we will be required to develop sales, marketing, distribution, customer service, and customer support capabilities. Staffing of these functions will frequently require individuals with the requisite technical and scientific expertise to establish and support sales of a sophisticated and complex platform for life sciences experimentation. We will be required to expend substantial financial resources to hire personnel and develop our commercial operations prior to commercial launch of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform. Accordingly, these initiatives will adversely affect our operating expenses prior to us having material off-setting revenue, if any.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To develop these functions successfully, we will face a number of additional risks, including:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to attract, retain, and manage the sales, marketing, customer service, and customer support force necessary to commercialize and gain market acceptance for our technology, with the additional challenge that many of these new hires will require specific scientific and technological expertise that may be more difficult to find; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the time and cost of establishing a specialized sales, marketing and customer service and support force.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our internal organization, we may seek to enlist one or more third parties to assist with sales, distribution, and customer service and support globally or in certain regions of the world. In certain markets, we could seek to establish partnerships with larger market participants to provide access to their distribution channels and which could also involve scientific or technological collaboration. There is no guarantee, if we do seek to enter into any of these arrangements, that we will be successful in attracting desirable partners or that we will be able to enter into such arrangements on commercially favorable terms. If our commercialization efforts, or those of any third-party partners, are not successful, our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus p</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">latform may not gain market acceptance, which could materially impact our business and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The size of the markets for our Nautilus platform may be smaller than estimated, and new market opportunities may not develop as quickly as we expect, or at all, limiting our ability to successfully sell our products.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market for proteomics technologies and products is evolving, making it difficult to predict with any accuracy the size of the markets for our current and future products, including our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our estimates of the total addressable market for our current and future products, including with respect to the proteomics market, the diagnostic market, and the mass spectrometry market, are based on a number of internal and third-party estimates and assumptions. In particular, our estimates are based on our expectations that researchers in the market for certain life sciences research tools and technologies will view our products as competitive alternatives to, or better options than, existing tools and technologies. We also expect researchers will recognize the ability of our products to complement, enhance and enable new applications of their current tools and technologies. We expect them to recognize the value proposition offered by our products enough to purchase our products in addition to the tools and technologies they already own. Underlying each of these expectations are a number of estimates and assumptions that may be incorrect, including the assumptions that government or other sources of funding will continue to be available to life sciences researchers at times and in amounts necessary to allow them to purchase our </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products and that researchers have sufficient samples and an unmet need for performing proteomics studies at scale across thousands of samples. In addition, sales of new products into new market opportunities may take years to develop and mature and we cannot be certain that these market opportunities will develop as we expect. New life sciences technology may not be adopted until the consistency and accuracy of such technology, method or device has been proven. As a result, the sizes of the annual total addressable market for new markets and new products are even more difficult to predict. Our product is an innovative new product, and while we draw comparisons between the evolution and growth of the genomics market, the proteomics market may develop more slowly or differently. In addition, our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> may not impact the field of proteomics in the same manner or degree, or within the same time frame, that NGS technologies have impacted the field of genomics, or at all. While we believe our assumptions and the data underlying our estimates of the total addressable market for our products are reasonable, these assumptions and estimates may not be correct and the conditions supporting our assumptions or estimates, or those underlying the third-party data we have used, may change at any time, thereby reducing the accuracy of our estimates. As a result, our estimates of the total addressable market for our products may be incorrect.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The future growth of the market for our current and future products depends on many factors beyond our control, including recognition and acceptance of our products by the scientific community and the growth, prevalence and costs of competing products and solutions. Such recognition and acceptance may not occur in the near term, or at all. If the markets for our current and future products are smaller than estimated or do not develop as we expect, our growth may be limited and our business, financial condition and operational results of operations could be adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are dependent on single source suppliers for some of the components and materials used in our</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nautilus platform, and the loss of any of these suppliers could harm our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on single source suppliers for certain components and materials used in our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, including our click-reagent </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">modified oligos, glass or silicon that is nano-fabricated into our biochips and high-speed stage used in the instrument. The loss of any of these single source suppliers would require us to expend significant time and effort to locate and qualify an alternative source of supply for these components. Though we do not c</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">urrently have contracts for third parties to provide manufacturing capabilities for our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, if we are successful in reaching the point of manufacturing our products for commercialization, we may rely on a single company for such manufacturing. Any contractual disputes between us and such manufacturer or loss of manufacturing ability by such manufacturer could similarly require significant time, effort and expense to locate and qualify an alternative source of manufacturing, which could materially harm our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also rely, and expect to continue to rely, on third-party manufacturers and, in many cases, single third-party manufacturers for the production of certain reagents and antibodies needed to generate the deep proteomic information at the speed and scale which we expect our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to perform. With respect to any antibodies or reagents that are single sourced, the loss of any suppliers would require significant time and effort to locate and qualify an alternative source of supply. Such reagents and antibodies may also become scarce, more expensive to procure, or not meet quality standards, and we may not be able to obtain favorable terms in agreements with suppliers. Given their complexity, our suppliers may not be able to provide these reagents and antibodies in a cost-effective manner or in a time frame that is consistent with our expected future needs. If our suppliers cease or interrupt production or if suppliers fail to supply materials, products or services to us for any reason, such interruption could delay development, or interrupt the commercial supply, with the potential for additional costs and lost revenue. If this were to occur, we might also need to seek alternative means to fulfill our manufacturing needs. Any such transition would require significant efforts in testing and validation and could result in delays or other issues, which could materially harm our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The life sciences technology market is highly competitive. If we fail to compete effectively, our business and results of operation will suffer.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face significant competition in the life sciences technology market. We currently compete with technology and diagnostic companies tha</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t supply components, products, and services to customers engaged in proteomics analysis. These companies include Agilent Technologies; Becton, Dickinson and Company; Bruker Corporation; </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Danaher; Luminex; Olink Proteomics; Quanterix; SomaLogic; Quantum-Si; and Thermo Fisher Scientific. We also compete with a number of emerging companies that are developing proteomic products and solut</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our current competitors are large publicly-traded companies, or are divisions of large publicly-traded companies, and enjoy a number of competitive advantages over us, including:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">greater name and brand recognition;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">greater financial and human resources;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">broader product lines;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">larger sales forces and more established distributor networks;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">substantial intellectual property portfolios;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">larger and more established customer bases and relationships; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">better established, larger scale and lower cost manufacturing capabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot assure investors that our products will compete favorably or that we will be successful in the face of increasing competition from products and technologies introduced by our existing or future competitors or by companies entering our markets or that are developed by our customers internally. In addition, we cannot assure investors that our competitors do not have or will not develop products or technologies that currently or in the future will enable them to produce competitive products with superior functionality or performance or at lower costs than ours or that are able to run comparable experiments at a lower total experiment cost. Any failure to compete effectively could materially and adversely affect our business, financial condition and operating results.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if our Nautilus platform is commercialized and achieves broad scientific and market acceptance, if we fail to improve it or introduce compelling new products, our revenue and our prospects could be harmed.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The life sciences industry is characterized by rapid and significant technological changes, frequent new product introductions and enhancements and evolving industry standards. Even if we are able to commercialize our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and achieve broad scientific and market acceptance, our ability to attract new customers and increase revenue from existing customers will depend in large part on our ability to enhance and improve our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and to introduce compelling new products. The success of any enhancement to our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or introduction of new products depends on several factors, including timely completion and delivery, competitive pricing, adequate quality testing, integration with existing technologies, freedom from intellectual property encumbrance, appropriately timed and staged introduction and overall market acceptance. Any new product or enhancement to our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that we develop may not be introduced in a timely or cost-effective manner, may contain defects, errors, vulnerabilities or bugs, or may not achieve the market acceptance necessary to generate significant revenue.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The typical development cycle of new life sciences products can be lengthy and complicated, and may require new scientific discoveries or advancements, considerable resources and complex technology and engineering. Such developments may involve external suppliers and service providers, making the management of development projects complex and subject to risks and uncertainties regarding timing, timely delivery of required components or services and satisfactory technical performance of such components or assembled products. If we do not achieve the required technical specifications or successfully manage new product development processes, or if development work is not performed according to schedule, then such new technologies or products may be adversely impacted. If we are unable to successfully develop new products, enhance our proteomics product platform to meet customer requirements, compete with alternative products, or otherwise gain and maintain market acceptance, our business, results of operations and financial condition could be harmed.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on third parties for development of certain aspects of the Nautilus platform, and any failure of these third parties to perform their respective obligations in a timely manner or to our specifications could negatively impact our timelines, costs or product performance.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are engaged with a number of third party collaborators who assist us in co-development of certain aspects of the Nautilus platform, including, for example, certain affinity reagents and array chip substrates.  Our agreements with these third party collaborators include obligations for these third parties to deliver certain aspects of technology to be used in the Nautilus platform in accordance with certain defined timelines, in accordance with defined specifications, and in accordance with certain cost limitations.  We have also sought to include redundancy and contingency planning with respect to the efforts of our third party collaborators where practicable.  Despite our contractual assurances and contingency planning, it is possible that one or more of our third party collaborators may fail to deliver their respective technologies to us on time or in accordance with our specifications, and such failure could negatively impact the timing of the commercialization of the Nautilus platform, its performance, or its cost.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business will depend significantly on research and development spending by pharmaceutical companies as well as by academic institutions and other research institutions. Any reduction in spending could limit demand for our products and adversely affect our business, results of operations, financial condition and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that our revenue in the foreseeable future will be derived primarily from sales of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to biotechnology companies and life science laboratories worldwide, and to a lesser extent, academic institutions and non-profit organizations. Our success will depend upon demand for and use of our products. Accordingly, the spending policies of these customers could have a significant effect on the demand for our technology. These policies may be based on a wide variety of factors, including the resources available to make purchases, the spending priorities among various types of equipment, policies regarding spending during recessionary periods and changes in the political climate. In addition, academic, governmental and other research institutions that fund research and development activities may be subject to stringent budgetary constraints that could result in spending reductions, reduced allocations or budget cutbacks, which could jeopardize the ability of these customers to purchase our products. Our operating results may fluctuate substantially due to reductions and delays in research and development expenditures by these customers. For example, reductions in capital expenditures by these customers may result in lower than expected system sales and, similarly, reductions in operating expenditures by these customers could result in lower than expected sales of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These reductions and delays may result from factors that are not within our control, such as:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in economic conditions;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in government programs that provide funding to research institutions and companies;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the regulatory environment affecting life science and Ag-Bio companies engaged in research and commercial activities;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">differences in budget cycles across various geographies and industries;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market-driven pressures on companies to consolidate operations and reduce costs;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">mergers and acquisitions in the life science and Ag-Bio industries; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other factors affecting research and development spending.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any decrease in our customers&#8217; budgets or expenditures or in the size, scope or frequency of capital or operating expenditures as a result of the foregoing or other factors could materially and adversely affect our business, results of operations, financial condition, and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operating results may fluctuate significantly in the future, which makes our future operating results difficult to predict and could cause our operating results to fall below expectations or any guidance we may provide.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our quarterly and annual operating results may fluctuate significantly, which makes it difficult for us to predict our future operating results. In the near term, as we devote substantially all of our resources towards the development and anticipated future commercialization of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform, specific factors that may result in fluctuations include, without limitation:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and cost of, and level of investment in, research and development and commercialization activities relating to, our Nautilus platform;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully establish and successfully maintain appropriate collaborations and derive revenue from those collaborations; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully develop and commercialize our Nautilus platform on our anticipated timeline.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we transition from a company with a focus on research and development to a company capable of supporting manufacturing, these fluctuations may also occur due to a variety of other factors, many of which are outside of our control, including, but not limited to:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the level of demand for any products we are able to commercialize, particularly our Nautilus platform, which may vary significantly from period to period;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to drive adoption of our Nautilus platform in our target markets and our ability to expand into any future target markets;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact that economic inflation may have on our costs for manufacturing our products;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the prices at which we will be able to sell our Nautilus platform;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the volume and mix of our sales between consumables, instruments and software, or changes in the manufacturing or sales costs related to our products;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and amount of expenditures that we may incur to develop, commercialize or acquire additional products and technologies or for other purposes, such as the expansion of our facilities;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in governmental funding of life sciences research and development or changes that impact budgets and budget cycles;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seasonal spending patterns of our customers;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of when we recognize any revenue;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">future accounting pronouncements or changes in our accounting policies;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the outcome of any future litigation or governmental investigations involving us, our industry or both;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">higher than anticipated service, replacement and warranty costs;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of the COVID-19 pandemic, the conflicts in Eastern Europe, and other national and global events on the economy, investment in life sciences and research industries, our business operations, and resources and operations of our customers, suppliers, and distributors; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general industry, economic and market conditions and other factors, including factors unrelated to our operating performance or the operating performance of our competitors.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cumulative effects of the factors discussed above could result in large fluctuations and unpredictability in our quarterly and annual operating results. As a result, comparing our operating results on a period-to-period basis may not be meaningful. Investors should not rely on our past results as an indication of our future performance.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This variability and unpredictability could also result in us failing to meet the expectations of industry or financial analysts or investors for any period. If we are unable to commercialize products or generate revenue, or if our operating results fall below the expectations of analysts or investors or below any guidance we may provide, or if the guidance we provide is below the expectations of analysts or investors, it could cause the market price of our Common Stock to decline.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have a limited operating history, which may make it difficult to evaluate our current business and the prospects for our future viability, and to predict our future performance.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a life sciences technology company with a limited operating history. We have not completed development of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform or any other products and have not generated any revenue to date. Our operations to date have been limited to developing our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> platform. Our prospects must be considered in light of the uncertainties, risks, expenses, and difficulties frequently encountered by companies in their early stages of operations. Consequently, predictions about our future success or viability are highly uncertain and may not be as accurate as they could be if we had a longer operating history or a company history of successfully developing and commercializing products.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as a business with a limited operating history, we may encounter unforeseen expenses, difficulties, complications, delays and other known and unknown obstacles. We will eventually need to transition from a company with a focus on research and development to a company capable of supporting manufacturing and commercial activities as well, and we may not be successful in such a transition. We have encountered in the past, and will encounter in the future, risks and uncertainties frequently experienced by growing companies with limited operating histories in emerging and rapidly changing industries. If our assumptions regarding these risks and uncertainties, which we use to plan and operate our business, are incorrect or change, or if we do not address these risks successfully, our results of operations could differ materially from our expectations, and our business, financial condition and results of operations could be adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may need to raise additional capital to fund our development and commercialization plans.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our current plans, we believe that our available resources and existing cash, cash equivalents and short-term investments, will be sufficient to meet our anticipated cash requirements for at least 12 months from the date of this Quarterly Report on Form 10-Q. If our available resources and existing cash and cash equivalents and short-term investments are insufficient to satisfy our liquidity requirements, including because of the realization of other risks described in this Quarterly Report on Form 10-Q, we may be required to raise additional capital prior to such time through issuances of equity or convertible debt securities, enter into a credit facility or another form of third-party funding or seek other debt financing.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may consider raising additional capital in the future to expand our business, to pursue strategic investments, to take advantage of financing or acquisition opportunities or for other reasons, including:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">funding development and marketing efforts of our Nautilus platform or any other future products;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increasing our sales and marketing and other commercialization efforts to drive market adoption of our Nautilus platform, once commercialized;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expanding our technologies into additional markets;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">preparing, filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acquiring, licensing or defending against third party intellectual property rights;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acquiring or investing in complementary technologies, businesses or assets; and</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">financing capital expenditures and general and administrative expenses.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our present and future funding requirements will depend on many factors, including:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in execution of our development plans;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope and timing of our investment in our sales, marketing, and distribution capabilities;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes we may make to our business that affect ongoing operating expenses;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes we may make in our business or commercialization strategy;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes we may make in our research and development spending plans;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our need to implement additional infrastructure and internal systems;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of the COVID-19 pandemic; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other items affecting our forecasted level of expenditures and use of cash resources including potential acquisitions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The various ways we could raise additional capital carry potential risks. If we raise funds by issuing equity securities, dilution to our stockholders could result. If we raise funds by issuing debt securities, those debt securities could have rights, preferences and privileges senior to those of holders of our Common Stock. The terms of debt securities issued or borrowings pursuant to a credit agreement could impose significant restrictions on our operations. If we raise funds through collaborations or licensing arrangements, we might be required to relinquish significant rights to our technologies or products or grant licenses on terms that are not favorable to us.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be unable to raise additional funds or to enter into such agreements or arrangements on favorable terms, or at all. Our ability to raise additional funds may be adversely impacted by potential worsening global economic conditions and the recent disruptions to, and volatility in, the credit and financial markets in the United States and worldwide resulting from the ongoing COVID&#8209;19 pandemic, the conflicts in Eastern Europe, and otherwise. If we are unable to obtain adequate financing or financing on terms satisfactory to us, if we require it, our ability to continue to pursue our business objectives and to respond to business opportunities, challenges, or unforeseen circumstances could be significantly limited, and could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Intellectual Property</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to obtain and maintain sufficient intellectual property protection for our products and technology, or if the scope of our intellectual property protection obtained is not sufficiently broad, competitors could develop and commercialize products similar or identical to ours, and our ability to successfully commercialize our products may be impaired.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial success depends in part on our ability to protect our intellectual property and proprietary technologies. We rely on patent protection, where appropriate and available, as well as a combination of copyright, trade secret and trademark laws, and nondisclosure, confidentiality and other contractual restrictions to protect our proprietary technology. However, these legal means afford only limited protection and may not adequately protect our rights or permit us to gain or keep any competitive advantage. If we fail to obtain, maintain and protect our intellectual property, third parties may be able to compete more effectively against us. In addition, we may incur substantial costs related to litigation or other patent proceedings in our attempts to recover or restrict use of our intellectual property.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent our intellectual property offers inadequate protection, or is found to be invalid or unenforceable, we would be exposed to a greater risk of direct competition. If our intellectual property does not provide adequate </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">coverage of our competitors&#8217; products, our competitive position could be adversely affected, as could our business, financial condition, results of operations and prospects. Both the patent application process and the process of managing patent and other intellectual property disputes are generally unpredictable, time-consuming and expensive.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends in large part on our and any future licensor&#8217;s ability to obtain and maintain protection of the intellectual property we may own or license, whether solely or jointly, particularly patents, in the United States and other countries with respect to our products and technologies. We apply for patents to protect our products, technologies and commercial activities, as we deem appropriate. However, obtaining and enforcing patents is costly, time-consuming and complex, and we may fail to apply for patents on important products and technologies in a timely fashion or at all, or we may fail to apply for patents in potentially relevant jurisdictions. We may not be able to file and prosecute all necessary or desirable patent applications, or maintain, enforce and license any patents that may issue from such patent applications, at a reasonable cost or in a timely manner or in all jurisdictions. It is also possible that we will fail to identify patentable aspects of our research and development output before it is too late to obtain patent protection. Moreover, we may not develop additional proprietary products, methods and technologies that are patentable. We may not have the right to control the preparation, filing and prosecution of patent applications, or to maintain the rights to patents which may be licensed from or to third parties. In connection with any future licensing arrangements with third parties, these patents and applications may not be prosecuted and enforced by such third parties in a manner consistent with the best interests of our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the patent position of life sciences technology companies generally is highly uncertain, involves complex legal and factual questions, and has been the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">subject of much litigation in recent years. Changes in either the patent laws or in interpretations of patent laws in the United States or other jurisdictions may diminish the value of our intellectual property. As a result, the issuance, scope, validity, enforceability, and commercial value of our patent rights are highly uncertain. It is possible that none of our pending patent applications will result in issued patents in a timely fashion or at all, and even if issued, the patents may not provide a basis for intellectual property protection of commercially viable products or services, may not provide us with any competitive advantages, or may be challenged, narrowed or invalidated by third parties. We cannot predict the breadth of claims that may be allowed or enforced in our patents or in third-party patents. It is possible that third parties will design around our current or future patents such that we cannot prevent such third parties from using similar technologies and commercializing similar products to compete with us. Some of our owned or any future licensed patents or patent applications may be challenged at a future point in time and we may not be successful in defending any such challenges made against our patents or patent applications. Any successful third-party challenge to our patents could result in diminished or lost rights, for example, due to narrowing, unenforceability or invalidity of such patents and increased competition to our business. The outcome of patent litigation or other proceedings is generally uncertain, and any attempt by us to enforce our patent rights against others or to challenge the patent rights of others may not be successful, or, regardless of success, may take substantial time and result in substantial cost, and may divert our efforts and attention from other aspects of our business. Any of the foregoing events could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The U.S. law relating to the patentability of certain inventions in the life sciences technology industry is uncertain and rapidly changing, which may adversely impact our existing patents or our ability to obtain patents in the future.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in either the patent laws or interpretation of the patent laws in the United States or in other jurisdictions could increase the uncertainties and costs surrounding the prosecution of patent applications and the enforcement or defense of issued patents. In the last decade, the US Congress made sweeping changes to patent law in passing the America Invents Act (AIA). These changes include, among others, allowing third-party submission of prior art to the United States Patent and Trademark Office (USPTO) during patent prosecution and additional procedures to challenge the validity of a patent by USPTO administered post-grant proceedings, including post-grant review, inter partes review and derivation proceedings. The changes brought about by the AIA have not been extensively tested, and therefore increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various courts, including the U.S. Supreme Court, have recently rendered decisions that impact the scope of patentability of certain inventions or discoveries relating to our technology and commercial goals. Specifically, these </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">decisions have substantially increased the probability that patent claims will be ruled patent ineligible for reciting a natural phenomenon, law of nature or abstract idea. Furthermore, in view of these decisions, since December 2014, the USPTO has published and continues to publish revised guidelines for patent examiners to apply when examining claims for patent eligibility. Patent claims relating to software algorithms, biologically-derived reagents, methods for analyzing biological systems and other subject matters that underlies our technology and commercial goals are impacted by these changes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actions taken by the U.S. Congress, federal courts and USPTO have from time to time narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. Similar changes have been made by authorities in other jurisdictions. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, such changes create uncertainty with respect to the value of patents, once obtained. Depending on decisions by authorities in various jurisdictions, the laws and regulations governing patents could change in unpredictable ways that may have a material adverse effect on our ability to obtain new patents and to defend and enforce our existing patents and patents that we might obtain in the future.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot assure you that our patent portfolio will not be negatively impacted by the current uncertain state of the law, new court rulings or changes in guidance or procedures issued by governments or patent offices around the world. From ti</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">me to time, the U.S. Supreme Court, other federal courts, the U.S. Congress or the USPTO may change the standards of patentability, scope and validity of patents within the life sciences technology and any such changes, or any similar adverse changes in the patent laws of other jurisdictions, could have a negative impact on our business, financial condition, prospects and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to protect our intellectual property rights throughout the world.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filing, prosecuting and defending patents on our Nautilus platform in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the United States can be less extensive than those in the United States.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws of some foreign countries do not protect intellectual property rights to the same extent as the laws of the United States, and we and any future licensor may encounter difficulties in protecting and defending such rights in foreign jurisdictions. Consequently, we and any future licensor may not be able to prevent third parties from practicing our inventions in some or all countries outside the United States, or from selling or importing products made using our or any future licensor&#8217;s inventions in and into the United States or other jurisdictions. Competitors and other third parties may be able to use our technologies in jurisdictions where we have not obtained patent protection to develop our own products and technologies and may also export infringing products to territories where we have patent protection, but enforcement is not as strong as that in the United States. These products may compete with our products. We and any future licensor&#8217;s patents or other intellectual property rights may not be effective or sufficient to prevent them from competing. In addition, certain countries have compulsory licensing laws under which a patent owner may be compelled to grant licenses to other parties. Furthermore, many countries limit the enforceability of patents against other parties, including government agencies or government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value of any patents.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many companies have enc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of many other countries do not favor the enforcement of patents and other intellectual property protection, which could make it difficult for us to stop the misappropriation or other violations of our intellectual property rights including infringement of our patents in such countries. The legal systems in certain countries may also favor state-sponsored companies or companies headquartered in particular jurisdictions over our patents and other intellectual property protection. The absence of harmonized intellectual property protection laws and effective enforcement makes it difficult to ensure consistent respect for patent, trade secret, and other intellectual property rights on a worldwide basis. As a result, it is possible that we will not be able to enforce our rights against third parties that misappropriate our proprietary technology in those countries.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proceedings to enforce our or any future licensor&#8217;s patent rights in foreign jurisdictions could result in substantial cost and divert our efforts and attention from other aspects of our business, could put our and any future licensor&#8217;s patents at risk of being invalidated or interpreted narrowly and our and any future licensor&#8217;s patent applications at risk of not issuing, and could provoke third parties to assert claims against us. We and any future licensor may not prevail in any lawsuits that we and any future licensor initiates, or that are initiated against us or any future licensor, and the damages or other remedies awarded, if any, may not be commercially meaningful. In addition, changes in the law and legal decisions by courts in the United States and foreign countries may affect our ability to obtain adequate protection for our products, services and other technologies and the enforcement of intellectual property. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license. Any of the foregoing events could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may become involved in lawsuits to defend against third-party claims of infringement, misappropriation or other violations of intellectual property or to protect or enforce our intellectual property, any of which could be expensive, time consuming and unsuccessful, and may prevent or delay our development and commercialization efforts.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation may be necessary for us to enforce our patent and proprietary rights and/or to determine the scope, coverage and validity of others&#8217; proprietary rights. Litigation on these matters has been prevalent in our industry and we expect that this will continue. To determine the priority of inventions, we may have to initiate and participate in interference proceedings declared by the USPTO that could result in substantial legal fees and could substantially affect the scope of our patent protection. Also, our intellectual property may be subject to significant administrative and litigation proceedings such as invalidity, unenforceability, re-examination and opposition proceedings against our patents. The outcome of any litigation or other proceeding is inherently uncertain and might not be favorable to us, and we might not be able to obtain licenses to technology that we require or a competitor may have already obtained an exclusive license to such technology in all fields. Even if such licenses are obtainable, they may not be available at a reasonable cost. We could therefore incur substantial costs related to royalty payments for licenses obtained from third parties, which could negatively affect our gross margins. In some cases, the outcome of litigation may be to enjoin us from commercializing a patent protected technology. We could encounter delays in product introductions, or interruptions in product sales, as we develop alternative methods or products.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if we resort to legal proceedings to enforce our intellectual property rights or to determine the validity, scope and coverage of the intellectual property or other proprietary rights of others, the proceedings could be burdensome and expensive, even if we were to prevail.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial success may depend in part on our non-infringement of the patents or proprietary rights of third parties. Numerous significant intellectual property issues have been litigated, and will likely continue to be litigated, between existing and new participants in the life sciences market and competitors may assert that our products infringe their intellectual property rights as part of a business strategy to impede our successful entry into those markets. Third parties may assert that we are employing our proprietary technology without authorization. We are aware that there are issued third party patents that are in the general proteomics field. Specifically, we are aware of various U.S. patents and U.S. non-provisional applications assigned to Washington University and the National Institute of Health, with claims directed to characterizing and identifying a polypeptide strand.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our competitors and others may have patents or may in the future obtain patents and may claim that use of our products infringes these patents. As we move into new markets and applications for our products, incumbent participants in such markets may assert their patents and other proprietary rights against us as a means of slowing or preventing our entry into such markets, or as a means to extract substantial license and royalty payments from us.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issued patents covering our products could be found invalid or unenforceable if challenged.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our owned and any future licensed patents and</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patent applications may be subject to validity, enforceability and priority disputes. The issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our patents or patent applications may be challenged at a future point in time in opposition, derivation, reexamination, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review, post-grant review or interference or other similar proceedings. Any successful third-party challenge to our patents in this or any other proceeding could result in the unenforceability or invalidity of such patents, which may lead to increase</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d competition to our business, which could have a material adverse effect on our business, financial condition, results of operations and prospects. In addition, if we or any future licensor initiates legal proceedings against a third party to enforce a patent covering our products, the defendant could counterclaim that such patent covering our products, as applicable, is invalid and/or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity or unenforceability are commonplace. There are numerous grounds upon which a third party can assert invalidity or unenforceability of a patent. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including, but not limited to, lack of novelty, obviousness or non-enablement. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the relevant patent office, or made a m</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">isleading statement, during prosecution. Third parties may also raise similar claims before administrative bodies in the United States or abroad, even outside the context of litigation. Such mechanisms include ex parte re-examination, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review, post-grant review, derivation and equivalent proceedings in non-U.S. jurisdictions, such as opposition proceedings. Such proceedings could result in revocation of or amendment to our patents in such a way that they no longer cover and protect our products. With respect to the validity of our patents, for example, we cannot be certain that there is no invalidating prior art of which us, any future licensor, our patent counsel and the patent examiner were unaware during prosecution. The outcome following legal assertions of invalidity and unenforceability during patent litigation is unpredictable. If a defendant or other third party were to prevail on a legal assertion of invalidity or unenforceability, we would lose at least part, and perhaps all, of the patent protection for our products and technologies, which could have a material adverse effect on our business, financial condition, results of operations and prospects. In addition, if the breadth or strength of protection provided by our patents and patent applications is threatened, regardless of the outcome, it could dissuade companies from collaborating with us to license intellectual property or develop or commercialize current or future products.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be aware of all third-party intel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lectual property rights potentially relating to our products. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until approximately 18 months after filing or, in some cases, not until such patent applications issue as patents. We might not have been the first to make the inventions covered by each of our pending patent applications and we might not have been the first to file patent applications for these inventions. To determine the priority of these inventions, we may have to participate in interference proceedings, derivation proceedings or other post-grant proceedings declared by the USPTO, or other similar proceedings in non-U.S. jurisdictions, that could result in substantial cost to us and the loss of valuable patent protection. The outcome of such proceedings is uncertain. No assurance can be given that other patent applications will not have priority over our patent applications. In addition, changes to the patent laws of the United States in the last decade allow for various post-grant opposition proceedings that have not been extensively tested, and their outcome is therefore uncertain. Furthermore, if third parties bring these proceedings against our patents, regardless of the merit of such proceedings and regardless of whether we are successful, we could experience significant costs and our management may be distracted. Any of the foregoing events could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to protect the confidentiality of our trade secrets, the value of our technology could be materially adversely affected, and our business could be harmed.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely heavily on trade secrets and confidentiality agreements to protect our unpatented know-how, technology and other proprietary information, including parts of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and to maintain our competitive position. However, trade secrets and know-how can be difficult to protect. In particular, we anticipate that with respect to our technologies, these trade secrets and know how will over time be disseminated within the industry through independent development, the publication of journal articles describing the methodology, and the movement of personnel between academic and industry scientific positions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to pursuing patents on our technology, we take steps to protect our intellectual property and proprietary technology by entering into agreements, including confidentiality agreements, non-disclosure agreements and intellectual property assignment agreements, with our employees, consultants, academic institutions, </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">corporate partners and, when needed, our advisers. However, we cannot be certain that such agreements have been entered into with all relevant parties, and we cannot be certain that our trade secrets and other confidential proprietary information will not be disclosed or that competitors or other third parties will not otherwise gain access to our trade secrets or independently develop substantially equivalent information and techniques. For example, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches. Such agreements may not be enforceable or may not provide meaningful protection for our trade secrets or other proprietary information in the event of unauthorized use or disclosure or other breaches of the agreements, and we may not be able to prevent such unauthorized disclosure, which could adversely impact our ability to establish or maintain a competitive advantage in the market, business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Monitoring unauthorized disclosure is difficult, and we do not know whether the steps we have taken to prevent such disclosure are, or will be, adequate. If we were to enforce a claim that a third party had wrongfully obtained and was using our trade secrets, it would be expensive and time-consuming, it could distract our personnel, and the outcome would be unpredictable. In addition, courts outside the United States may be less willing to protect trade secrets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also seek to preserve the integrity and confidentiality of our confidential proprietary information by maintaining physical security of our premises and physical and electronic security of our information technology systems, but it is possible that these security measures could be breached. If any of our confidential proprietary information were to be lawfully obtained or independently developed by a competitor or other third party, absent patent protection, we would have no right to prevent such competitor from using that technology or information to compete with us, which could harm our competitive position. Competitors or third parties could purchase our products and attempt to replicate some or all of the competitive advantages we derive from our development efforts, design around our protected technology</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, develop their own competitive technologies that fall outside the scope of our intellectual property rights or independently develop our technologies without reference to our trade secrets. If any of our trade secrets were to be disclosed to or independently discovered by a competitor or other third party, it could materially and adversely affect our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to claims challenging the inventorship of our patents and other intellectual property.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We or any future licensor may be subject to claims that former employees, collaborators or other third parties have an interest in our patents, trade secrets or other intellectual property. For example, us or any future licensor may have inventorship disputes arise from conflicting obligations of employees, consultants or others who are involved in developing our products. In addition, counterparties to our consulting, software development, and other agreements may assert that they have an ownership interest in intellectual property developed under such arrangements. Litigation may be necessary to defend against claims challenging ownership or inventorship of our or any future licensor&#8217;s ownership of our patents, trade secrets or other intellectual property. If we or any future licensor fails in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, intellectual property that is im</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">portant to our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, including our software, workflows, consumables and reagent kits. In such an event, we may be required to obtain licenses from third parties and such licenses may not be available on commercially reasonable terms or at all or may be non-exclusive. If we are unable to obtain and maintain such licenses, we may need to cease the development, manufacture or commercialization of our products and technologies. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees, and certain customers or partners may defer engaging with us until the particular dispute is resolved. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to protect and enforce our trademarks and trade names or build name recognition in our markets of interest thereby harming our competitive position.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registered or unregistered trademarks or trade names that we own may be challenged, infringed, circumvented, declared generic, lapsed or determined to be infringing on or dilutive of other marks. We may not be able to protect our rights in these trademarks and trade names, which we need in order to build name recognition. In </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">addition, third parties have filed, and may in the future file, for registration of trademarks similar or identical to our trademarks, thereby impeding our ability to build brand identity and possibly leading to market confusion. In addition, there could be potential trade name or trademark infringement claims brought by owners of other registered trademarks or trademarks that incorporate variations of our registered or unregistered trademarks or trade names. Further, we have and may in the future enter into agreements with owners of such third-party trade names or trademarks to avoid potential trademark litigation which may limit our ability to use our trade names or trademarks in certain fields of business. Over the long term, if we are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively, and our business, financial condition, results of operations and prospects may be adversely affected. Our efforts to enforce or protect our proprietary rights related to trademarks, domain names, copyrights or other intellectual property may be ineffective and could result in substantial costs and diversion of resources. Any of the foregoing events could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Patent terms may be inadequate to protect our competitive position on our Nautilus platform for an adequate amount of time.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patents have a limited lifespan. In the United States, if all maintenance fees are timely paid, the natural expiration of a patent is generally 20 years from its earliest U.S. non-provisional filing date. While extensions may be available, the life of a patent, and the protection it affords, is limited. In the United States, a patent&#8217;s term may, in certain cases, be lengthened by patent term adjustment, which comp</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ensates a patentee for administrative delays by the USPTO in examining and granting a patent, or may be shortened</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> if a patent is terminally disclaimed over a commonly owned patent or a patent naming a common inventor and having an earlier expiration date. Even if patents covering our products are obtained, once the patent life has expired, we may be open to competition from competitive products. If one of our products requires extended development, testing and/or regulatory review, patents protecting such products might expire before or shortly after such products are commercialized. As a result, our owned and licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Obtaining and maintaining our patent protection depends on compliance with various required procedures, document submissions, fee payments and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodic maintenance fees, renewal fees, annuity fees and various other governmental fees on patents and/or applications will be due to be paid to the USPTO and various governmental patent agencies outside of the United States at several stages over the lifetime of the patents and/or applications. The USPTO and various non-U.S. governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. In certain circumstances, we may rely on any future licensor to pay these fees due to the U.S. and non-U.S. patent agencies and to take the necessary action to comply with these requirements with respect to any future licensed intellectual property. In many cases, an inadvertent lapse can be cured by payment of a late fee or by other means in accordance with the applicable rules. However, there are situations in which non-compliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such an event, our competitors may be able to enter the market without infringing our patents and this circumstance would have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to claims that our employees, consultants or independent contractors have wrongfully used or disclosed confidential information of third parties or that our employees have wrongfully used or disclosed trade secrets of our former employers.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have employed and expect to employ individuals who were previously employed at universities or other companies, including, for example, our competitors or potential competitors. Although we try to ensure that our employees, consultants, advisors and independent contractors do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that our employees, advisors, consultants or independent contractors have inadvertently or otherwise used or disclosed intellectual property, including trade secrets or other </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">proprietary information of their former employers or other third parties, or to claims that we have improperly used or obtained such trade secrets. Litigation may be necessary to defend against these claims. If we fail in defending such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights and face increased competition to our business. Any such litigation or the threat thereof may adversely affect our ability to hire employees or contract with advisors, contractors and consultants. A loss of key research personnel work product could hamper or prevent our ability to commercialize potential products, which could harm our business. Even if we are successful in defending against these claims, litigation could result in substantial costs and be a distraction to management. This type of litigation or proceeding could substantially increase our operating losses and reduce our resources available for development activities. Some of our competitors may be able to sustain the costs of this type of litigation or proceedings more effectively than we can because of their substantially greater financial resources.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, while it is our policy to require our employees and contractors who may be involved in the conception or development of intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party who, in fact, conceives or develops intellectual property that we regard as our own. The assignment of intellectual property rights may not be self-executing, or the assignment agreements may be breached, and we may be forced to bring claims against third parties, or defend claims that they may bring against us, to determine the ownership of what we regard as our intellectual property. Furthermore, individuals executing agreements with us may have pre-existing or competing obligations to a third party, such as an academic institution, and thus an agreement with us may be ineffective in perfecting ownership of inventions developed by that individual, which could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, we or any future licensor may in the futur</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e be subject to claims by former or current employees, consultants or other third parties asserting an ownership right or inventorship in our owned, or any future licensed, patents or patent applications. For example, our Founder and Chief Scientist is employed by Stanford University and a member of the Stanford Cancer Institute. Stanford University and the Stanford Cancer Institute may assert an ownership right in any of our owned patents or patent applications. We may have </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other consultants that are or have been employed by third parties, which may assert an ownership right in any of our owned patents or patent applications. In addition, we are aware that we might not be able to obtain ownership of or seek a license to any intellectual property developed during a research collaboration with a third party. An adverse determination in any such proceeding may result in loss of exclusivity or freedom to operate or in patent claims being narrowed, invalidated or held unenforceable, in whole or in part, which could limit our ability to stop others from using or commercializing similar technology, without payment to us, or could limit the duration of the patent protection covering our technology and products. Such challenges may also result in our inability to develop, manufacture or commercialize our products without infringing third-party patent rights. Any of the foregoing could harm our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we cannot license rights to use technologies on reasonable terms, we may not be able to commercialize new products in the future.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may identify third-party technology that we may need to license or acquire in order to develop or commercialize our products or technologies, including our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. However, we may be unable to secure such licenses or acquisitions. The licensing or acquisition of third-party intellectual property rights is a competitive area, and several more established companies may pursue strategies to license or acquire third-party intellectual property rights that we may consider attractive or necessary. These established companies may have a competitive advantage over us due to their size, capital resources, or greater development and commercialization capabilities. In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also may be unable to license or acquire third-party intellectual property rights on terms that would allow us to make an appropriate return on our investment or at all. In return for the use of a third party&#8217;s technology, we may agree to pay the licensor royalties based on sales of our products or services. Royalties are a component of cost of products or technologies and affect the margins on our products. We may also need to negotiate licenses to patents or patent applications before or after introducing a commercial product. We may not be able to obtain necessary licenses to patents or patent applications, and our business may suffer if we are unable to enter into the necessary licenses on acceptable terms or at all, if any necessary licenses are subsequently terminated, if the licensor fails to </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">abide by the terms of the license or fails to prevent infringement by third parties, or if the licensed intellectual property rights are found to be invalid or unenforceable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our use of open source software and failure to comply with the terms of the underlying open source software licenses could impose limitations on our ability to commercialize our products and provide third parties to our proprietary software.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products utilize open source software that contain modules licensed for use from third-party authors under open source licenses. In particular, some of the software may be provided under license arrangements that allow use of the software for research or other noncommercial purposes. Use and distribution of open source software may entail greater risks than use of third-party commercial software, as open source software licensors generally do not provide warranties or other contractual protections regarding infringement claims or the quality of the code. Some open source software licenses contain requirements that the licensee make its source code publicly available if the licensee creates modifications or derivative works using the open source software, depending on the type of open source software the licensee uses and how the licensee uses it. If we combine our proprietary software with open source software in a certain manner, we could, under certain open source software licenses, be required to release the source code of our proprietary software to the public for free. This would allow our competitors and other third parties to create similar products with less development effort and time and ultimately could result in a loss of our product sales and revenue, which could have a material adverse effect on our business, financial condition, results of operations and prospects. In addition, some companies that use third-party open source software have faced claims challenging their use of such open source software and their compliance with the terms of the applicable open source license. We may be subject to suits by third parties claiming ownership of what we believe to be open source software or claiming non-compliance with the applicable open source licensing terms. Use of open source software may also present additional security risks because the public availability of such software may make it easier for hackers and other third parties to compromise or attempt to compromise our technology platform and systems.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we review and monitors our use of open source software to avoid subjecting our proprietary software to conditions we do not intend, the terms of many open source software licenses have not been interpreted by United States courts, and there is a risk that these licenses could be construed in a way that could impose unanticipated conditions or restrictions on our ability to commercialize our products and proprietary software. Moreover, we cannot assure investors that our processes for monitoring and controlling our use of open source software in our products will be effective. If we are held to have breached the terms of an open source software license, we could be subject to damages, required to seek licenses from third parties to continue offering our products on terms that are not economically feasible, to re-engineer our products, to discontinue the sale of our products if re-engineering could not be accomplished on a timely basis, or to make generally available, in source code form, our proprietary code, any of which could adversely affect our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intellectual property rights do not necessarily address all potential threats.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations and may not adequately protect our business or permit us to maintain our competitive advantage. For example:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">others may be able to make products that are similar to products and technologies we may develop or may be able to utilize similar technologies that are not covered by the claims of the patents that we own or licenses now or in the future;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we, or any future licensor(s), might not have been the first to make the inventions covered by the issued patent or pending patent application that we license or may own in the future;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we, or any future licensor(s), might not have been the first to file patent applications covering certain of our or their inventions;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing, misappropriating or otherwise violating our owned or future licensed intellectual property rights;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">it is possible that our pending patent applications or those that we may license or own in the future will not lead to issued patents;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">issued patents that we hold rights to may be held invalid or unenforceable, including as a result of legal challenges by our competitors;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our competitors might conduct research and development activities in countries where we do not have patent rights and then use the information learned from such activities to develop competitive products for sale in our major commercial markets;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may not develop additional proprietary technologies that are patentable;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the patents of others may harm our business; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may choose not to file a patent for certain trade secrets or know-how, and a third party may independently derive, use, commercialize, publish or patent such intellectual property.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Should any of these events occur, they could materially adversely affect our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Litigation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may become involved in litigation to enforce or defend our intellectual property rights, or defend ourselves from claims that we infringe the intellectual property rights of others, which litigation could consume significant resources and management time, and in which an adverse result could result in loss of our intellectual property rights, a requirement that we pay significant damages, and could prevent us from selling our products.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The life sciences industry is highly competitive, and companies in this industry routinely engage in litigation and governmental proceedings to enforce and defend the intellectual property rights that they believe they possess. We may become involved in litigation or governmental and/or administrative proceedings to enforce or defend our intellectual property rights.  Additionally, we may become involved in litigation and/or governmental or administrative proceedings to defend ourselves from claims that our products or services infringe the intellectual property rights of others, or to challenge the claimed intellectual property rights of others where we believe they may not be entitled to such rights.  Such litigation and governmental proceedings are inherently unpredictable and costly, and can require significant time and attention of management.  In addition to the costs and distraction of litigation, if we are unsuccessful in enforcing our intellectual property rights, or in defending our intellectual property rights from challenges of others, wit could result in our loss of our ability to exclude others from practicing aspects of our technology which could lead to greater competition for our products and services.  Additionally, if we are unable to successfully defend ourselves from claims that we infringe the intellectual property rights of others and are unable to develop non-infringing alternative approaches for our products and services, we may be required to pay significant damages and ongoing royalties, or we may be prohibited from selling our products and services.  Our success depends upon our ability to successfully enforce and defend our own intellectual property rights, and to defend ourselves from claims that we infringe the intellectual property rights of others.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our products could have unknown defects or errors, which may give rise to claims against us and adversely affect market adoption of our Nautilus platform.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> utilizes novel and complex technology applied on a microscopic scale, using key components that are not amenable to full characterization or quality assessment using conventional techniques or instrumentation, and such systems may develop or contain undetected defects or errors. We cannot assure you that material performance problems, defects or errors will not arise, and as we increase the density and integration of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, these risks may increase. We expect to provide warranties that our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> will meet performance expectations or be free from defects. The costs incurred in correcting any defects or errors may be substantial and could adversely affect our operating margins.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In manufacturing our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we depend upon third parties for the supply of various components. Many of these components require a significant degree of technical expertise to produce. If our suppliers fail to </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">produce components to specification, or if the suppliers, or we, use defective materials or workmanship in the manufacturing process, the reliability and performance of our products will be compromised.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our products contain defects, we may experience:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a failure to achieve market acceptance or expansion of our product sales;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss of customer orders and delay in order fulfillment;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">damage to our brand reputation;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased cost of our warranty program due to product repair or replacement;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">product recalls or replacements;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inability to attract new customers;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">diversion of resources from our manufacturing and research and development departments into our service department; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">legal claims against us, including product liability claims, which could be costly and time consuming to defend and result in substantial damages. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The occurrence of any one or more of the foregoing could negatively affect our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are sued for product liability, we could face substantial liabilities that exceed our resources.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The marketing, sale and use of our products could lead to the filing of product liability claims were someone to allege that our products identified inaccurate or incomplete information regarding the proteins analyzed or otherwise failed to perform as designed. We may also be subject to liability for errors in, a misunderstanding of or inappropriate reliance upon, the information we provide in the ordinary course of our business activities. A product liability claim could result in substantial damages and be costly and time-consuming for us to defend. We maintain product liability insurance, but this insurance may not fully protect us from the financial impact of defending against product liability claims. Any product liability claim brought against us, with or without merit, could increase our insurance rates or prevent us from securing insurance coverage in the future. Additionally, any product liability lawsuit could damage our reputation, or cause current customers to terminate existing agreements and potential partners to seek other partners, any of which could adversely impact our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Regulatory and Legal Compliance Matters</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Although our products currently are not labeled or intended for any use which would subject us to regulation by the FDA or other regulatory authorities, if we elect to label and promote any of our products as clinical or medical device products, we would be subject to regulation in the future and would be required to obtain prior approval or clearance by the FDA or other regulatory authorities, which could take significant time and expense and could fail to result in FDA clearance or approval for the intended uses we believe are commercially attractive.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are currently labeled and promoted, and are, and in the n</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ear-future will be, sold primarily to research companies and academic and research institutions as research use only (&#8220;RUO&#8221;) products, and are not currently intended to be used, for clinical diagnostic tests or as medical devices. If we elect to label and market our products for use as, or in the performance of, clinical diagnostics in the United States, thereby subjecting them to FDA regulation as medical devices, we would be required to obtain premarket 510(k) clearance or premarket approval from the FDA, unless an exception applies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may in the future register with the FDA as a medical device manufacturer and list some of our products with the FDA pursuant to an FDA Class I listing for general purpose laboratory equipment. While this regulatory </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">classification is exempt from certain FDA requirements, such as the need to submit a premarket notification commonly known as a 510(k) application, and some of the requirements of the FDA&#8217;s Quality System Regulations (the &#8220;QSRs&#8221;), we would be subject to ongoing FDA &#8220;general controls,&#8221; which include compliance with FDA regulations for labeling, inspections by the FDA, complaint evaluation, corrections and removals reporting, promotional restrictions, reporting adverse events or malfunctions for our products, and general prohibitions against misbranding and adulteration.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may in the future submit 510(k) premarket notification applications to the FDA to obtain FDA clearance of certain of our products on a selective basis. It is possible, in the event we elect to submit 510(k) applications for certain of our products, that the FDA would take the position that a more burdensome premarket application, such as a premarket approval application (&#8220;PMA&#8221;) or a de novo application is required for some of our products. If such applications were required, greater time and investment would </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be required to obtain FDA approval. Even if the FDA agreed that a 510(k) was appropriate, FDA clearance can be expensive and time consuming. It can take a significant amount of time to prepare and submit a 510(k) application, including conducting appropriate testing on our products, and several months to years for the FDA to review a submission. Notwithstanding the effort and expense, FDA clearance or approval could be denied for some or all of our products for which we choose to market as a medical device or a clinical diagnostic device. Even if we were to seek and obtain regulatory approval or clearance, it may not be for the intended uses we request or that we believe are important or commercially attractive. There can be no assurance that future products for which we may seek premarket clearance or approval will be cleared or approved by the FDA or a comparable foreign regulatory authority on a timely basis, if at all, nor can there be assurance that labeling claims will be consistent with our anticipated claims or adequate to support continued adoption of such products. Compliance with FDA or comparable foreign regulatory authority regulations will require substantial costs, and subject us to heightened scrutiny by regulators and substantial penalties for failure to comply with such requirements or the inability to market our products. The lengthy and unpredictable premarket clearance or approval process, as well as the unpredictability of the results of any required clinical studies, may result in our failing to obtain regulatory clearance or approval to market such products, which would significantly harm our business, results of operations, reputation, and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e sought and received regulatory clearance or approval for certain of our products, we would be subject to ongoing FDA obligations and continued regulatory oversight and review, including the general controls listed above and the FDA&#8217;s QSRs for our development and manufacturing operations. In addition, we may be required to obtain a new 510(k) clearance before we could introduce subsequent modifications or improvements to such products. We could also be subject to additional FDA post-marketing obligations for such products, any or all of which would increase our costs and divert resources away from other projects. If we sought and received regulatory clearance or approval and are not able to maintain regulatory compliance with applicable laws, we could be prohibited from marketing our products for use as, or in the performance of, clinical diagnostics and/or could be subject to enforcement actions, including warning letters and adverse publicity, fines, injunctions, and civil penalties; recall or seizure of products; operating restrictions; and criminal prosecution.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we could decide to seek regulatory clearance or approval for certain of our products in countries outside of the United States. Sales of such products outside the United States will likely be subject to foreign regulatory requirements, which can vary greatly from country to country. As a result, the time required to obtain clearances or approvals outside the United States may differ from that required to obtain FDA clearance or approval and we may not be able to obtain foreign regulatory approvals on a timely basis or at all. Once the Brexit transition period ends, for medical device products we intend to market in the U.K., we will be subject to regulatory requirements of the Medicines and Healthcare products Regulatory Agency (the &#8220;MHRA&#8221;). These foreign regulations and any future requirements that may be implemented by regulatory authorities will increase the difficulty of obtaining and maintaining regulatory approvals and compliance in Europe in the future. In addition, the FDA regulates exports of medical devices. Failure to comply with these regulatory requireme</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nts or obtain and maintain required approvals, clearances or certifications could impair our ability to commercialize our products for diagnostic use outside of the United States.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our products could become subject to government regulation as medical devices by the FDA and other regulatory agencies even if we do not elect to seek regulatory clearance or approval to market our products for diagnostic purposes, which would adversely impact our ability to market and sell our products and harm our business. If our products become subject to FDA regulation, the regulatory clearance or approval and the maintenance of continued and post-market regulatory compliance for such products will be expensive, time-consuming, and uncertain both in timing and in outcome.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not currentl</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">y expect our Nautilus platform to be subject to the clearance or approval of the FDA, as it is not intended to be used for the diagnosis, treatment or prevention of disease. However, as we expand our product line and the applications and uses of our current or products into new fields, certain of our future products could become subject to regulation by the FDA, or comparable international agencies, including requirements for regulatory clearance or approval of such products before they can be marketed. Also, even if our products are labeled, promoted, and intended as RUO, the FDA or comparable agencies of other countries could disagree with our conclusion that our products are intended for research use only or deem our sales, marketing and promotional efforts as being inconsistent with RUO products. For example, our customers may independently elect to use our RUO labeled products in their own laboratory developed tests (&#8220;LDTs&#8221;) for clinical diagnostic use. While the FDA has traditionally exercised enforcement discretion with LDTs, the FDA could take the view that our sale of our RUO labeled products were made with the knowledge that the products will be used as medical devices, and could therefore subject our products to government regulation, and the regulatory clearance or approval and maintenance process for such products may be uncertain, expensive, and time-consuming. Regulatory requirements related to marketing, selling, and distribution of RUO products could change or be uncertain, even if clinical uses of our RUO products by our customers were done without our consent. If the FDA or other regulatory authorities assert that any of our RUO products are subject to regulatory clearance or approval, our business, financial condition, or results of operations could be adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has historically exercised enforcement discretion in not enforcing the medical device regulations against laboratories offering LDTs. In August 2020, as part of the Trump Administration&#8217;s efforts to combat COVID-19 and consistent with the President&#8217;s direction in Executive Orders 13771 and 13924, the Department of Health and Human Services (the &#8220;HHS&#8221;) announced rescission of guidance and other informal issuances of the FDA regarding premarket review of LDT absent notice-and-comment rulemaking, stating that, absent notice-and-comment rulemaking, those seeking approval or clearance of, or an emergency use authorization, for an LDT may nonetheless voluntarily submit a premarket approval application, premarket notification or an Emergency Use Authorization request, respectively, but are not required to do so. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, HHS under the Biden administration issued a statement that withdrew the August 2020 policy announcement stating that HHS does not have a policy on LDTs that is separate from FDA&#8217;s longstanding approach. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislative and administrative proposals to amend the FDA&#8217;s oversight of LDTs have been introduced in recent years, including the Verifying Accurate Leading-edge IVCT Development Act of 2021 (VALID Act). It is unclear how such action as well as future legislation by federal and state governments and changes in FDA regulation will impact the industry, including our business and that of our customers. Any restrictions on LDTs by the FDA, HHS, Congress, or state regulatory authorities may decrease the demand for our products. The adoption of new restrictions on RUO products, whether by the FDA or Congress, could adversely affect demand for our specialized reagents and instruments. Further, we could be required to obtain premarket clearance or approval before we can sell our products to certain customers.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, sales of devices for diagnostic purposes may subject us to additional healthcare regulation and enforcement by the applicable government agencies. Such laws include, without limitation, state and federal anti-kickback or anti-referral laws, healthcare fraud and abuse laws, false claims laws, privacy and security laws, the Physician Payments Sunshine Act and related transparency and manufactu</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rer reporting laws, and other laws and regulations applicable to medical device manufacturers. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our operations are found to be in violation of any applicable FDA or healthcare laws and regulations, we may be subject to penalties, monetary damages, disgorgement, imprisonment, the curtailment or restructuring of our operations, loss of eligibility to obtain clearance or approvals from the FDA, fees from regulators, fines, significant settlements or judgments, or exclusion from participation in government contracting, healthcare reimbursement or other government programs, including Medicare and Medicaid, or other restrictions on our operations, any of which could adversely impact our financial results. Any action against us for an alleged or suspected violation by a private party or governmental agency could </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cause us to incur significant legal expenses, adversely impact our reputation, and could divert our management&#8217;s attention from the operation of our business, even if our defense is successful. In addition, achieving and sustaining compliance with applicable laws and regulations may be costly to us in terms of money, time and resources.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, on November 25, 2013, the FDA issued Final Guidance &#8220;Distribution of In Vitro Diagnostic Products Labeled for Research Use Only.&#8221; This guidance emphasizes that the FDA will review the totality of the circumstances when it comes to evaluating whether equipment and testing components are properly labeled as RUO. This guidance states that merely including a labeling statement that the product is for research purposes only will not necessarily render the device exempt from the FDA&#8217;s clearance, approval, and other regulatory requirements if the circumstances surrounding the distribution, marketing and promotional practices indicate that the m</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">anufacturer knows its products are, or intends for its products to be, used for clinical diagnostic purposes. These circumstances may include written or verbal sales and marketing claims or links to articles regarding a product&#8217;s performance in clinical applications and a manufacturer&#8217;s provision of technical support for clinical applications.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if the FDA does not modify its policy of enforcement discretion, whether due to changes in FDA policy or legislative action, the FDA may disagree with the marketing of our current products in the United States. We may also be required to conduct clinical studies to support our currently marketed products or planned product launches. If we are required to conduct such clinical trials or to obtain regulatory authorization, delays in the commencement of our product launches or our changes to our current marketing strategy could significantly increase our costs and delay our commercialization plans, which could harm our financial prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are currently subject to, and may in the future become subject to additional, U.S. federal and state laws and regulations imposing obligations on how we collect, store and processes personal information. Our actual or perceived failure to comply with such obligations could harm our business. Ensuring compliance with such laws could also impair our efforts to maintain and expand our future customer base, and thereby decrease our revenue.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we currently, and, in the future, will, collect, store, transfer, use or process sensitive data, including personally identifiable information of employees, and intellectual property and proprietary business information owned or controlled by us and other parties. The secure processing, storage, maintenance, and transmission of this critical information are vital to our operations and business strategy. We are, and may increasingly become, subject to various laws and regulations, as well as contractual obligations, relating to data privacy and security in the jurisdictions in which we operate. The regulatory environment related to data privacy and security is increasingly rigorous, with new and constantly changing requirements applicable to our business, and enforcement practices are likely to remain uncertain for the foreseeable future. These laws and regulations may be interpreted and applied differently over time and from jurisdiction to jurisdiction, and it is possible that they will be interpreted and applied in ways that may have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, various federal and state regulators, including governmental agencies like the Consumer Financial Protection Bureau and the Federal Trade Commission, have adopted, or are considering adopting, laws and regulations concerning personal information and data security. Certain state laws may be more stringent or broader in scope, or offer greater individual rights, with respect to personal information than federal, international or other state laws, and such laws may differ from each other, all of which may complicate compliance efforts. For example, the California Consumer Privacy Act (the &#8220;CCPA&#8221;), which increases privacy rights for California residents and imposes obligations on companies that process their personal information, came into effect on January 1, 2020. Among other things, the CCPA requires covered companies to provide new disclosures to California consumers and provide such co</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nsumers new data protection and privacy rights, including the ability to opt-out of certain sales of personal information. The CCPA provides for civil penalties for violations, as well as a private right of action for certain data breaches that result in the loss of personal information. This private right of action may increase the likelihood of, and risks associated with, data breach litigation. In November 2020, California passed the California Privacy Rights Act (the &#8220;CPRA&#8221;), which amends and expands the CCPA. While most of the substantive provisions in CPRA will not take effect until 2023 and although the CCPA includes exemptions for certain clinical trial data, the law may increase our compliance costs and potential liability with respect to other personal information we collect about California customers. It is possible that these consumer, health-related and data protection laws may be </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interpreted and applied in a manner that is inconsistent with our practices. If so, this could result in government-imposed fines or orders requiring that we change our practices, which could adversely affect our business. In addition to the CCPA, numerous other states&#8217; legislatures are considering or have enacted similar data privacy laws that will require ongoing compliance efforts and investment, including Virginia and Colorado. In addition, laws in all 50 U.S. states require businesses to provide notice to consumers whose personal information has been disclosed as a result of a data breach. State laws are changing rapidly and there is discussion in the U.S. Congress of a new comprehensive federal data privacy law to which we would become subject if it is enacted.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, regulations promulgated pursuant to the Health Insurance Portability and Accountability Act of 1996 (the &#8220;HIPAA&#8221;), establish privacy and security standards that limit the use and disclosure of individually identifiable health information (known as &#8220;protected health information&#8221;) and require the implementation of administrative, physical and technological safeguards to protect the privacy of protected health information and ensure the confidentiality, integrity and availability of electronic protected health information. Determining whether protected health information has been handled in compliance with applicable privacy standards and our contractual obligations can require complex factual and statistical analyses and may be subject to changing interpretation. Although we take measures to protect sensitive data from unauthorized access, use or disclosure, our information technology and infrastructure may be vulnerable to attacks by hackers or viruses or breached due to employee error, malfeasance or other malicious or inadvertent disruptions. Any such breach or interruption could compromise our networks and the information stored there could be accessed by unauthorized parties, manipulated, publicly disclosed, lost or stolen. Any such access, breach or other loss of information could result in legal claims or proceedings, and liability under federal or state laws that protect the privacy of personal information, such as the HIPAA, the Health Information Technology for Economic and Clinical Health Act (the &#8220;HITECH&#8221;), and regulatory penalties. Notice of breaches must be made to affected individuals, the Secretary of the Department of Health and Human Services, and for extensive breaches, notice may need to be made to the media or State Attorneys General. Such a notice could harm our reputation and our ability to compete.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are in the process of evaluating compliance needs but do not currently have in place formal policies and procedures related to the storage, collection and processing of information, and has not conducted any internal or external data privacy audits, to ensure our compliance with all applicable data protection laws and regulations. Additionally, we do not currently have policies and procedures in place for assessing our third-party vendors&#8217; compliance with applicable data protection laws and regulations. All of these evolving compliance and operatio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nal requirements impose significant costs, such as costs related to organizational changes, implementing additional protection technologies, training employees and engaging consultants, which are likely to increase over time. In addition, such requirements may require us to modify our data processing practices and policies, distract management or divert resources from other initiatives and projects, all of which could have a material adverse effect on our business, financial condition, results of operations and prospects. Any failure or perceived failure by us or our third-party vendors, collaborators, contractors and consultants to comply with any applicable federal, state or similar foreign laws and regulations relating to data privacy and security, or could result in damage to our reputation, as well as proceedings or litigation by governmental agencies or other third parties, including class action privacy litigation in certain jurisdictions, which would subject us to significant fines, sanctions, awards, penalties or judgments, all of which could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we commercialize our Nautilus platform outside of the United States, our international business could expose us to business, regulatory, political, operational, financial, and economic risks associated with doing business outside of the United States.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we commercialize our</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> outside of the United States, our international business may be adversely affected by changing economic, political and regulatory conditions in foreign countries. Engaging in international business inherently involves a number of difficulties and risks, including:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">required compliance with existing and changing foreign regulatory requirements and laws;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">required compliance with U.S. laws such as the Foreign Corrupt Practices Act, and other U.S. federal laws and regulations established by the office of Foreign Asset Control;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">export or import restrictions;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laws and business practices favoring local companies;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">foreign currency exchange, longer payment cycles and difficulties in enforcing agreements and collecting receivables through certain foreign legal systems;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">political and economic instability;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in social, economic, and political conditions or in laws, regulations and policies governing foreign trade, intellectual property, manufacturing, research and development, and investment both domestically as well as in the other countries and jurisdictions in which we operate and into which we may sell our products including as a result of the separation of the United Kingdom from the European Union (Brexit);</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potentially adverse tax consequences, tariffs, customs charges, bureaucratic requirements and other trade barriers;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties and costs of staffing and managing foreign operations; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties protecting, maintaining, enforcing or procuring intellectual property rights.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If one or more of these risks occurs, it could require us to dedicate significant resources to remedy such occurrence, and if we are unsuccessful in finding a solution, our financial results will suffer.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if we commercialize our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> outside of the United States, we may rely on distributors for sales of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and related products. To do so we must attract distributors and maintain distributors to maximize the commercial opportunity for our platform. There is no guarantee that we will be successful in attracting or retaining desirable sales and distribution partners or that we will be able to enter into such arrangements on favorable terms. Distributors may not commit the necessary resources to market and sell our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and related products to the level of our expectations or may choose to favor marketing the products of our competitors. If current or future distributors do not perform adequately, or we are unable to enter into effective arrangements with distributors in particular geographic areas, we may not realize long-term international revenue growth and our financial results will suffer.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we expand our development and commercialization activities outside of the United States, we will be subject to an increased risk of inadvertently conducting activities in a manner that violates the U.S. Foreign Corrupt Practices Act and similar laws. If that occurs, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">we may be subject to civil or criminal penalties which could have a material adverse effect on our business, financial condition, results of operations and growth prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the U.S. Foreign Corrupt Practices Act, or the FCPA, which prohibits corporations and individuals from paying, offering to pay, or authorizing the payment of anything of value to any foreign government official, government staff member, political party, or political candidate in an attempt to obtain or retain business or to otherwise influence a person working in an official capacity. We are also subject to the UK Anti-Bribery Act, which prohibits both domestic and international bribery, as well as bribery across both public and private sectors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we choose to establish and expand our commercial operations outside of the United States we will need to comply with non-U.S. regulatory requirements, will need to establish and expand business relationships with various third parties, and we will interact more frequently with foreign officials, including regulatory authorities. Expanded programs to maintain compliance with such laws will be costly and may not be effective. Any interactions with any such parties or individuals where compensation is provided that are found to be in violation of such laws could result in substantial fines and penalties and could materially harm our business. Furthermore, any finding of a violation under one country&#8217;s laws may increase the likelihood that we will be prosecuted and be found to have violated another country&#8217;s laws. If our business practices outside the United States are found to be in violation of the FCPA, UK Anti-Bribery Act or other similar laws, we may be subject to significant civil and criminal penalties which co</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">uld have a material adverse effect on our financial condition and results of operations.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Environmental and health safety laws may result in liabilities, expenses and restrictions on our operations. Failure to comply with environmental laws and regulations could subject us to significant liability.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal, state, local and foreign laws regarding environmental protection, hazardous substances and human health and safety may adversely affect our business. Our research and development operations involve the use of hazardous substances and are subject to a variety of federal, state, local and foreign environmental laws and regulations relating to the storage, use, discharge, disposal, remediation of, and human exposure to, hazardous substances and the sale, labeling, collection, recycling, treatment and disposal of products containing hazardous substances. These operations are permitted by regulatory authorities, and the resultant waste materials are disposed of in material compliance with environmental laws and regulations. Using hazardous substances in our operations exposes us to the risk of accidental injury, contamination or other liability from the use, storage, importation, handling or disposal of hazardous materials. If we or our suppliers&#8217; operations result in the contamination of the environment or expose individuals to hazardous substances, we could be liable for damages and fines, and any liability could significantly exceed our insurance coverage and have a material adverse effect on our business, financial condition and results of operations. Liability under environmental laws and regulations can be joint and several and without regard to fault or negligence. Compliance with environmental laws and regulations may be expensive and noncompliance could result in substantial liabilities, fines and penalties, personal injury and third-party property damage claims and substantial investigation and remediation costs. Environmental laws and regulations could become more stringent over time, imposing greater compliance costs and increasing risks and penalties associated with violations. We cannot assure you that violations of these laws and regulations will not occur in the future or have not occurred in the past as a result of human error, accidents, equipment failure or other causes. The expense associated with environmental regulation and remediation could harm our financial condition and operating results.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our employees, independent contractors, consultants, commercial partners, distributors and vendors may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to the risk that our employees, independent contractors, consultants, commercial collaborators, distributors, suppliers and vendors may engage in misconduct or other improper activities. Misconduct by these parties could include failures to comply with applicable FDA regulations, provide accurate information to the FDA, comply with federal and state health care fraud and abuse laws and regulations, accurately report financial information or data or disclose unauthorized activities to us. In particular, sales, marketing and business arrangements in the health care industry are subject to extensive laws and regulations intended to prevent fraud, misconduct, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Misconduct by these parties could also involve the improper use of information obtained in the course of clinical trials, which could result in regulatory sanctions and serious harm to our reputation. It is not always possible to identify and deter misconduct by these parties, and the precautions we take to detect and prevent such misconduct may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations. If any such actions are instituted against us, and we are not successful in defending our self or asserting our rights, those actions could have a significant impact on our business, including the imposition of significant penalties, including civil, criminal and administrative penalties, damages, fines, disgorgement, individual imprisonment, exclusion from participation in government funded healthcare programs, such as Medicare and Medicaid, integrity oversight and reporting obligations, contractual damages, reputational harm, diminished profits and future earnings and the curtailment or restructuring of our operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Demand for our technology could be reduced by legal, social and ethical concerns surrounding the use of genetic information and biological materials.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products may be used to provide genetic information or analyze biological materials from humans and other living organisms. The information obtained from our products could be used in a variety of applications, which may have underlying legal, social and ethical concerns, including the genetic engineering or modification of agricultural products, testing for genetic predisposition for certain medical conditions and stem cell research. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Governmental authorities could, for safety, social or other purposes, call for limits on or impose regulations on the use of genetic testing or the use of certain biological materials. Such concerns or governmental restrictions could limit the use of our products, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to our Operations </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we experience a significant disruption in our information technology systems or breaches of data security, our business could be adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely, or will rely, on information technology systems to keep financial records, facilitate our research and development initiatives, manage our manufacturing operations, maintain quality control, fulfill customer orders, maintain corporate records, communicate with staff and external parties and operate other critical functions. Our information technology systems and those of our vendors and partners are potentially vulnerable to disruption due to breakdown, malicious intrusion and computer viruses or other disruptive events, including, but not limited to, natural disasters and catastrophes. Cyberattacks and other malicious internet-based activity continue to increase and cloud-based platform providers of services have been and are expected to continue to be targeted. Furthermore, there may be a heightened risk of potential cyberattacks by state actors or others since the escalation of the conflicts in Eastern Europe. Methods of attacks on information technology systems and data security breaches change frequently, are increasingly complex and sophisticated, including social engineering and phishing scams, and can originate from a wide variety of sources. In addition to traditional computer &#8220;hackers,&#8221; malicious code, such as viruses and worms, employee theft or misuse, denial-of-service attacks and sophisticated nation-state and nation-state supported actors now engage in attacks, including advanced persistent threat intrusions. Despite our efforts to create security barriers to such threats, it is virtually impossible for us to entirely mitigate these risks. In addition, we have not finalized our information technology and data security procedures and therefore, our information technology systems may be more susceptible to cybersecurity attacks than if such security procedures were finalized. Despite any of our current or future efforts to protect against cybersecurity attacks and data security breaches, there is no guarantee that our efforts are adequate to safeguard against all such attacks and breaches. Moreover, it is possible that we may not be able to anticipate, detect, appropriately react and respond to, or implement effective preventative measures against, all cybersecurity incidents.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our security measures, or those of our vendors and partners, are compromised due to any cybersecurity attacks or data security breaches, including as a result of third-party action, employee or customer error, malfeasance, stolen or fraudulently obtained log-in credentials or otherwise, our reputation could be damaged, our business and reputation may be harmed, we could become subject to litigation and we could incur significant liability. If we were to experience a prolonged system disruption in our information technology systems or those of certain of our vendors and partners, it could negatively impact our ability to serve our customers, which could adversely impact our business, financial condition, results of operations and prospects. If operations at our facilities were disrupted, it may cause a material disruption in our business if we are not capable of restoring functionality on an acceptable timeframe. In addition, our information technology systems, and those of our vendors and partners, are potentially vulnerable to data security breaches, whether by internal bad actors, such as employees or other third parties with legitimate access to our or our third-party providers&#8217; systems, or external bad actors, which could lead to the exposure of personal data, sensitive data and confidential information to unauthorized persons. Any such data security breaches could lead to the loss of trade secrets or other intellectual property, or could lead to the exposure of personal information, including sensitive personal information, of our employees, customers and others, any of which could have a material adverse effect on our business, reputation, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, any such access, disclosure or other loss or unauthorized use of information or data could result in legal claims or proceedings, regulatory investigations or actions, and other types of liability under laws that protect the privacy and security of personal information, including federal, state and foreign data protection and privacy regulations, violations of which could result in significant penalties and fines. Additionally, a new privacy law, the California Privacy Rights Act (CPRA), was approved by California voters in the election on November 3, 2020. The CPRA will modify the California Consumer Privacy Act significantly, potentially resulting in further uncertainty and requiring us to incur additional costs and expenses in an effort to comply. In addition, U.S. and international laws and regulations that have been applied to protect user privacy (including laws regarding unfair and deceptive </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">practices in the U.S. and GDPR in the E.U.) may be subject to evolving interpretations or applications. Furthermore, defending a suit, regardless of its merit, could be costly, divert management&#8217;s attention and harm our reputation. In addition, although we seek to detect and investigate data security incidents, security breaches and other incidents of unauthorized access to our information technology systems and data can be difficult to detect and any delay in identifying such breaches or incidents may lead to increased harm and legal exposure of the type described above. Moreover, there could be public announcements regarding any cybersecurity incidents and any steps we take to respond to or remediate such incidents, and if securities analysts or investors perceive these announcements to be negative, it could, among other things, have a material adverse effect on the price of our Common Stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost of protecting against, investigating, mitigating and responding to potential breaches of our information technology systems and data security breaches and complying with applicable breach notification obligations to individuals, regulators, partners and others can be significant. As cybersecurity incidents continue to evolve, we may be required to expend significant additional resources to continue to modify or enhance our protective measures or to investigate and remediate any information security vulnerabilities. The inability to implement, maintain and upgrade adequate safeguards could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to manage our anticipated growth effectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our anticipated growth will place significant strains on our management, operational and manufacturing systems and processes, sales and marketing team, financial systems and internal controls and other aspects of our business. We must upgrade our internal business processes and capabilities to create the scalability that a growing business demands. As of June&#160;30, 2022, we had 124 employees. To execute our anticipated growth successfully, we must continue to attract and retain qualified personnel and manage and train them effectively. Developing and commercializing our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> will require us to hire and retain scientific, sales and marketing, software, manufacturing, customer service, distribution and quality assurance personnel. In addition, we expect that we will need to hire additional accounting, finance and other personnel as a public company. As a public company, our management and other personnel will need to devote a substantial amount of time towards maintaining compliance with these requirements and effectively manage these growth activities. We may face challenges integrating, developing and motivating our rapidly growing employee base.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, our anticipated growth will place additional strain on our suppliers and manufacturing facilities, resulting in an increased need for us to carefully monitor quality assurance. Any failure by us to manage our growth effectively could have an adverse effect on our ability to achieve our development and commercialization goals.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to successfully manage our expected growth is uncertain given the fact that we have been in operation only since 2016. As we continue to grow, we will be required to implement more complex organizational management structures and may find it increasingly difficult to maintain the benefits of our corporate culture, including our ability to quickly develop and launch new and innovative products. If we do not successfully manage our anticipated growth, our business, results of operations, financial condition and prospects will be harmed.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to recruit and retain key executives and scientists, we may be unable to achieve our goals.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our performance is substan</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tially dependent on the performance of our senior management and key scientific and technical personnel, particularly Sujal Patel, one of our founders and our Chief Executive Officer, and Parag Mallick, one of our founders and our Chief Scientist.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss of the services of any member of our senior management or our scientific or technical staff might significantly delay or prevent the development of our products or achievement of other business objectives by diverting management&#8217;s attention to transition matters and identification of suitable replacements, if any, and could have a material adverse effect on our business. We do not maintain fixed term employment contracts with any of our employees and do not maintain key man life insurance on any of our employees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our research and product development efforts could be delayed or curtailed if we are unable to attract, train and retain highly skilled employees, particularly, senior scientists and engineers. To expand our research and product development efforts, we need additional people skilled in areas such as molecular and cellular </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">biology, biochemistry, surface chemistry, software, bioinformatics, assay development, mechanical engineering, electrical engineering, optics, fluidics and manufacturing. Competition for these people is intense. Because of the complex and technical nature of our system and the dynamic market in which we compete, any failure to attract and retain a sufficient number of qualified employees could materially harm our ability to develop and commercialize our technology.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This competition has become exacerbated by the increase in employee resignations in 2021 reported by employers nationwide and continued high rates of employee turnover continuing into 2022. As part of our retention and incentive efforts, in addition to salary and cash incentives, we have issued stock options that vest over time. The value to employees of stock options that vest over time may be significantly affected by decreases in our stock price (whether or not related to or proportional to our operating performance) and may at any time be insufficient to counteract more lucrative offers from other companies. We may face challenges in retaining and recruiting such individuals due to sustained declines in our stock price that could reduce the retention value of equity awards.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may acquire other companies or technologies, which could divert our management&#8217;s attention, result in additional dilution to our stockholders and otherwise disrupt our operations and harm our operating results.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may in the future seek to acquire or invest in businesses, applications or technologies that we believe could complement or expand our Nautilus platform or future products, enhance our technical capabilities or otherwise offer growth opportunities. The pursuit of potential acquisitions may divert the attention of our management and cause us to incur various costs and expenses in identifying, investigating and pursuing suitable acquisitions, whether or not they are consummated. We may not be able to identify desirable acquisition targets or be successful in entering into an agreement with any particular target or obtain the expected benefits of any acquisition or investment.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have limited experience in acquiring other businesses or technologies. We may not be able to successfully integrate acquired personnel, operations and technologies, or effectively manage the combined business following an acquisition. Acquisitions could also result in dilutive issuances of equity securities, the use of our available cash, or the incurrence of debt, which could harm our operating results. In addition, if an acquired business fails to meet our expectations, our operating results, business and financial condition may suffer.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The COVID-19 pandemic and efforts to reduce its spread have adversely impacted and are expected to continue to materially and adversely impact, our business and operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has had, and is expected to continue to have, an adverse impact on our operations, particularly as a result of preventive and precautionary measures that we, other businesses, and governments are taking. Governmental mandates related to COVID-19 or other infectious diseases, or public health crises, have impacted, and we expect them to continue to impact, our personnel and personnel at our suppliers in the United States and other countries, and the availability or cost of materials, which would disrupt or delay our receipt of instruments, components and supplies from the third parties we rely on. For instance, &#8220;stay-at-home&#8221; orders were imposed in California, where our primary research and development facility is located, and in Washington state, where our primary corporate facility is located, that required reductions in capacity or shutdowns of businesses as well as the implementation of social distancing protocols and other plans and measures. During March and April of 2020, the volume of ongoing lab work was reduced, and only critical program work in the lab continued with staggered lab employee work shifts to minimize risk of exposure to COVID-19, which has and may continue to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">disrupt or delay our ability to conduct development activities. Additionally, our suppliers have also been impacted by the COVID-19 pandemic. For example, we have experienced some supply disruptions due to the pandemic, including closures at certain chip manufacturers, which led to extended lead times for certain chips; diversion of certain lab materials needed to support COVID-19 relief efforts; and lower availability of certain reagents.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that any governmental authority imposes additional regulatory requirements or changes existing laws, regulations, and policies that apply to our business and operations, such as workplace safety measures, our product development may be delayed, and we may incur further costs in bringing our business and operations into compliance with changing or new laws, regulations, and policies.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we are currently in the development stage, we expect that substantially all of our revenue will be derived from sales of our</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, including our instruments and consumables, to biopharmaceutical companies and academic and research institutions. As we leave the development stage and enter the next stage of our commercialization plan, the research and development budgets of these customers, the ability of such customers to receive funding for research, and the ability of such customers to receive instrument installations and visitors to their facilities and to travel to our facilities, other laboratories and industry events, will become increasingly important to the adoption of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All of these considerations are impacted by factors beyond our control, such as:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disruptions in the supply chains of entities providing important services and products to our Nautilus platform;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reductions in capacity or shutdowns of laboratories and other institutions as well as other impacts stemming from the COVID-19 pandemic, such as reduced or delayed spending on instruments or consumables as a result of such shutdowns and delays before re-opened laboratories and institutions resume previous levels of research activities that require new purchases of our instruments or consumables;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decreases in government funding of research and development; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes to programs that provide funding to research laboratories and institutions, including changes in the amount of funds allocated to different areas of research, changes that have the effect of increasing the length of the funding process or the impact of the COVID-19 pandemic on our customers and potential customers and their funding sources.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ultimate impact of the COVID-19 pandemic is highly uncertain and subject to sudden change. This impact could have a material, adverse impact on our liquidity, capital resources, operations and business and those of the third parties on which we rely and could worsen over time. The extent to which the COVID-19 pandemic impacts our results will depend on future developments, which are highly uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and the actions to contain COVID-19 or treat its impact, the emergence or further spread of additional variants, and the risk of waning immunity among persons already vaccinated among others. While we do not yet know the full extent of potential impacts on our business, any of these occurrences could significantly harm our business, results of operations and financial condition.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unfavorable U.S. or global economic conditions as a result of multiple global events, including the COVID-19 pandemic, the conflict in Eastern Europe, increasing interest rates and general economic downturns, could adversely affect our ability to raise capital and our business, results of operations and financial condition.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the potential economic impact brought by multiple adverse global circumstances, such as the COVID-19 pandemic conflicts in Eastern Europe, increasing interest rates and general economic downturns are difficult to assess or predict, both as to magnitude and duration, these events have resulted in, and may continue to result in, extreme volatility and disruptions in the capital and credit markets, reducing our ability to raise additional capital through equity, equity-linked or debt financings, which could negatively impact our short-term and long-term liquidity and our ability to operate in accordance with our operating plan, or at all. Additionally, our results of operations could be adversely affected by general conditions in the global economy and financial markets. A severe or prolonged economic downturn could result in a variety of risks to our business, including weakened demand for our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and our ability to raise additional capital when needed on favorable terms, if at all. A weak or declining economy could strain our customers&#8217; budgets or cause delays in their payments to us. As a result of such events, we or our contractors, partners and/or suppliers could experience shortages, business disruptions or delays for materials sourced or manufactured in countries affected by such events, and their ability to supply us with services or components may be adversely affected. In addition, our contractors and suppliers have raised and may continue to raise prices for goods and services we employ in our research and development efforts and for components or materials used in our Nautilus platform. Any of the foregoing could harm our business, financial condition and results of operations, and we cannot anticipate all of the ways in which the current economic climate and financial market conditions could adversely impact our ability to raise capital, business, results of operations and financial condition.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Global supply chain interruptions could adversely affect our ability to develop and commercialize our products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be subject to supply chain interruptions. Current or future supply chain interruptions that could be exacerbated by global political tensions, such as the situation in Ukraine, could negatively impact our ability to further develop our products or to manufacture and deliver our products or services, which could negatively impact our timelines and business results. For example, as discussed in the risk factor above entitled &#8220;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The COVID-19 pandemic and efforts to reduce its spread have adversely impacted and are expected to continue to materially and adversely impact, our business and operations</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we have experienced some supply disruptions due to the COVID-19 pandemic, including closures at certain chip manufacturers, which led to extended lead times for certain chips; diversion of certain lab materials needed to support COVID-19 relief efforts; and lower availability of certain reagents, and similar delays could impact us if they recur or are exacerbated due to the situation in Ukraine. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our facilities become unavailable or inoperable, our research and development program and commercialization launch plan could be adversely impacted and manufacturing of our instruments and consumables could be interrupted.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Seattle, Washington, facility houses our corporate executive team and our software development operations, while our San Carlos, California facility houses our research and development team.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our facilities in Seattle and San Carlos are vulnerable to natural disasters, public health crises, including the impact of the COVID-19 pandemic, and catastrophic events. For example, our San Carlos facilities are located near earthquake fault zones and are vulnerable to damage from earthquakes as well as other types of disasters, including fires, floods, power loss, communications failures and similar events. If any disaster, public health crisis or catastrophic event were to occur, our ability to operate our business would be seriously, or potentially completely, impaired. If our facilities become unavailable for any reason, we cannot provide assurances that we will be able to secure alternative facilities with the necessary capabilities and equipment on acceptable terms, if at all. We may encounter particular difficulties in replacing our San Carlos facilities given the specialized equipment housed within it. The inability to manufacture our instruments or consumables, combined with our limited inventory of manufactured instruments and consumables, may result in the loss of future customers or harm our reputation, and we may be unable to re-establish relationships with those customers in the future.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our research and development program or planned commercialization program were disrupted by a disaster or catastrophe, the launch of new products, including our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and the timing of improvements to our products could be significantly delayed and could adversely impact our ability to compete with other available products and solutions. If our capabilities are impaired, we may not be able to manufacture and ship our products in a timely manner, which would adversely impact our business. Although we possess insurance for damage to our property and the disruption of our business, this insurance may not be sufficient to cover all of our potential losses and may not continue to be available to us on acceptable terms, or at all.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We use hazardous chemicals and biological materials in our business. Any claims relating to improper handling, storage or disposal of these materials could be time consuming and costly.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development processes involve the controlled use of hazardous materials, including select chemicals that may be flammables, toxic or corrosives, as well as potential biohazard materials. We cannot eliminate the risk of accidental contamination or discharge and any resultant injury from these materials. In addition, our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus platform</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> involves the use of a high-powered laser system, which could result in injury. We may be sued for any injury or contamination that results from our use or the use by third parties of these materials. We do not currently maintain separate environmental liability coverage and any such contamination or discharge could result in significant cost to us in penalties, damages and suspension of our operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Common Stock</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">An active trading market for our Common Stock may never develop or be sustained.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Business Combination, there was no public trading market for Legacy Nautilus&#8217; Common Stock. Although our Common Stock is listed on the Nasdaq Global Select Market, the market for our shares has demonstrated varying levels of trading activity. If an active trading market does not develop, or develops but is not maintained, you may have difficulty selling any of our Common Stock due to the limited public float. We cannot predict the prices at which our Common Stock will trade. It is possible that in one or more future periods our results of operations and progression of our product pipeline may not meet the expectations of public market analysts and investors, and, as a result of these and other factors, the price of our Common Stock may fall. Accordingly, we cannot assure you of your ability to sell your shares of our Common Stock when desired or at prices at or above the price you paid for your shares or at all.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The market price of our Common Stock may be volatile, which could result in substantial losses for investors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading price of our Common Stock has been and may continue to be highly volatile and could be subject to wide fluctuations in response to various factors, some of which are beyond our control. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market price of our Common Stock may fluctuate due to a variety of factors, including:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of the launch and commercialization of our products and degree to which such launch and commercialization meets the expectations of securities analysts and investors;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated fluctuations in our operating results, including fluctuations in our quarterly and annual results;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operating expenses being more than anticipated;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the failure or discontinuation of any of our product development and research programs;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the structure or funding of research at academic and research laboratories and institutions, including changes that would affect their ability to purchase our instruments or consumables;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the success of existing or new competitive businesses or technologies;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements about new research programs or products of our competitors;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments or disputes concerning patent applications, issued patents or other proprietary rights;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the recruitment or departure of key personnel;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">litigation and governmental investigations involving us, our industry or both;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory or legal developments in the United States and other countries;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">volatility and variations in market conditions in the life sciences technology sector generally, or the proteomics or genomics sectors specifically;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">investor perceptions of us or our industry;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the level of expenses related to any of our research and development programs or products;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated changes in our estimates as to our financial results or development timelines, variations in our financial results or those of companies that are perceived to be similar to us or changes in estimates or recommendations by securities analysts, if any, that cover our Common Stock or companies that are perceived to be similar to us;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether our financial results meet the expectations of securities analysts or investors;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the announcement or expectation of additional financing efforts;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sales of our Common Stock by us or by our insiders or other stockholders;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the expiration of market standoff or lock-up agreements;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic, industry and market conditions; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the COVID-19 pandemic, natural disasters or major catastrophic events.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recently, stock markets in general, and the market for life sciences technology companies in particular, have experienced significant price and volume fluctuations that have often been unrelated or disproportionate to changes in the operating performance of the companies whose stock is experiencing those price and volume fluctuations, particularly in light of the current COVID-19 pandemic. Broad market and industry factors may seriously affect the market price of our Common Stock, regardless of our actual operating performance. These fluctuations may be even more pronounced in the trading market for our Common Stock. Following periods of such volatility in the market price of a company&#8217;s securities, securities class action litigation has often been brought against that company. Because of the potential volatility of our Common Stock price, we may become the target of securities litigation in the future. Securities litigation could result in substantial costs and divert management&#8217;s attention and resources from our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There can be no assurance that we will be able to comply with the continued listing standards of Nasdaq.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Nasdaq delists our shares of Common Stock from trading on its exchange for failure to meet Nasdaq&#8217;s listing standards, we and our stockholders could face significant material adverse consequences including: </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a limited availability of market quotations for our securities; </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reduced liquidity for our securities; </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a determination that our Common Stock is a &#8220;penny stock&#8221; which will require brokers trading in our Common Stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities; </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a limited amount of new and analyst coverage; and </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a decreased ability to issue additional securities or obtain additional financing in the future. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our principal stockholders and management own a significant percentage of our Common Stock and will be able to exercise significant influence over matters subject to stockholder approval.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, our directors, executive officers, holders of more than 5% of our outstanding shares of Common Stock and their respective affiliates beneficially owned, collectively, approximately 68.3% of the outstanding shares of Common Stock. As a result, these stockholders, if they act together, may significantly influence all matters requiring stockholder approval, including the election of directors and approval of significant corporate transactions. This concentration of ownership may have the effect of delaying or preventing a change in control of our company that our other stockholders may believe is in their best interests. This in turn could have a material adverse effect on our stock price and may prevent attempts by our stockholders to replace or remove the board of directors or management.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The sale or the perception of future sales of a substantial number of shares of our Common Stock could cause the market price of our Common Stock to drop significantly, even if our business is doing well.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of a substantial number of shares of our Common Stock in the public market could occur at any time. These sales, or the perception in the market that the holders of a large number of shares intend to sell shares, could reduce the market price of our Common Stock.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Amended and Restated Registration Rights and Lock-Up Agreement (the &#8220;Registration Rights and Lock-Up Agreement&#8221;) and the Subscription Agreements entered into in connection with the PIPE Financing, we have filed resale registration statements to provide for the resale of the shares issued in the PIPE Financing and the shares of our Common Stock held by the parties to the Registration Rights and Lock-Up Agreement. The market price of our Common Stock could decline if the holders whose shares are registered under such registration statements sell their shares or are perceived by the market as intending to sell their shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not expect to pay any dividends for the foreseeable future. Investors may never obtain a return on their investment.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should not rely on an investment in our Common Stock to provide dividend income. We do not anticipate that we will pay any dividends to holders of our Common Stock in the foreseeable future. Instead, we plan to retain any earnings to maintain and expand our existing operations, fund our research and development programs and continue to invest in our commercial infrastructure. In addition, any future credit facility or financing we obtain may contain terms prohibiting or limiting the amount of dividends that may be declared or paid on our Common Stock. Accordingly, investors must rely on sales of our Common Stock after price appreciation, which may never occur, as the only way to realize any return on their investment. As a result, investors seeking cash dividends should not purchase our Common Stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our bylaws designate a state or federal court located within the State of Delaware as the exclusive forum for substantially all disputes between us and our stockholders, and also provide that the federal district courts will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act of 1933, as amended, each of which could limit our stockholders&#8217; ability to choose the judicial forum for disputes with us or our directors, officers, stockholders, or employees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Bylaws provide that, unless we consent in writing to the selection of an alternative forum (an &#8220;Alternative Forum Consent&#8221;), the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, another state court in Delaware or the federal district court for the District of Delaware) will, to the fullest extent permitted by law, be the sole and exclusive forum for (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers, stockholders or other employees to us or our stockholders, (iii) any action arising pursuant to any provision of the Delaware General Corporation Law or our Certificate of Incorporation or bylaws (each, as may be amended from time to time), or (iv) any action asserting a claim governed by the internal affairs doctrine of the State of Delaware, except for any claim as to which the court does not have jurisdiction over an indispensable party to that claim. The foregoing shall not apply to any claims under the Exchange Act or the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). In addition, unless we give an Alternative Forum Consent, the federal district courts of the United States shall be the sole and exclusive forum for resolving any action asserting a claim arising under the Securities Act.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all such Securities Act actions. Accordingly, both state and federal courts have jurisdiction to entertain such claims. To prevent having to litigate claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, our bylaws also provide that, unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States of America will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any person or entity purchasing or otherwise acquiring or holding or owning (or continuing to hold or own) any interest in any of our securities shall be deemed to have notice of and consented to the foregoing bylaw provisions. Although we believe these exclusive forum provisions benefit us by providing increased consistency in the application of Delaware law and federal securities laws in the types of lawsuits to which each applies, the exclusive forum provisions may limit a stockholder&#8217;s ability to bring a claim in a judicial forum of its choosing for disputes with us or any of our directors, officers, stockholders, or other employees, which may discourage lawsuits with respect to such claims against us and our current and former directors, officers, stockholders, or other employees. In addition, a stockholder that is unable to bring a claim in the judicial forum of its choosing may be required to incur additional costs in the pursuit of actions which are subject to the exclusive forum provisions described above. Our </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stockholders will not be deemed to have waived our compliance with the federal securities laws and the rules and regulations thereunder as a result of our exclusive forum provisions. Further, in the event a court finds either exclusive forum provision contained in our bylaws to be unenforceable or inapplicable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Delaware law and provisions in our certificate of incorporation and bylaws might discourage, delay or prevent a change in control of our company or changes in our management and, therefore, depress the trading price of our Common Stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our status as a Delaware corporation and the anti-takeover provisions of the Delaware General Corporation Law may discourage, delay or prevent a change in control by prohibiting us from engaging in a business combination with an interested stockholder for a period of three years after the person becomes an interested stockholder without the approval of holders of 66 2/3% of the voting power of our stockholders other than the interested stockholder, even if a change of control would be beneficial to our existing stockholders. In addition, our certificate of incorporation and bylaws contain provisions that may make the acquisition of our company more difficult, including the following:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our board of directors is classified into three classes of directors with staggered three-year terms and directors are only able to be removed from office for cause by the affirmative vote of holders of at least two-thirds of the voting power of our then outstanding capital stock;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">certain amendments to our certificate of incorporation require the approval of stockholders holding two-thirds of the voting power of our then outstanding capital stock;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any stockholder-proposed amendment to certain provisions of our bylaws require the approval of stockholders holding two-thirds of the voting power of our then outstanding capital stock;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our stockholders are only able to take action at a meeting of stockholders and are not able to take action by written consent for any matter;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">vacancies on our board of directors are able to be filled only by our board of directors and not by stockholders;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">only the chair of our board of directors, our chief executive officer, our president or a majority of our board of directors are authorized to call a special meeting of stockholders;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">certain litigation against us can only be brought in Delaware;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our certificate of incorporation authorizes undesignated preferred stock, the terms of which may be established by our Board and shares of which may be issued, without the approval of the holders of our capital stock; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">advance notice procedures apply for stockholders to nominate candidates for election as directors or to bring matters before an annual meeting of stockholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These anti-takeover defenses could discourage, delay, or prevent a transaction involving our change in control. These provisions could also discourage proxy contests and make it more difficult for stockholders to elect directors of their choosing and to cause us to take other corporate actions they desire, any of which, under certain circumstances, could limit the opportunity for our stockholders to receive a premium for their shares of our capital stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Risk Factors</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will incur significant increased costs and management resources as a result of operating as a public company.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public company, we will incur significant legal, accounting, compliance and other expenses that we did not incur as a private company and these expenses may increase even more after we are no longer an &#8220;emerging growth company.&#8221; Our management and other personnel will need to devote a substantial amount of time and incur significant expense in connection with compliance initiatives. As a public company, we will bear all of the internal and external costs of preparing and distributing periodic public reports in compliance with our obligations under the securities laws.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, regulations and standards relating to corporate governance and public disclosure, including the SOX, and the related rules and regulations implemented by the SEC and The Nasdaq Stock Market LLC, have increased legal and financial compliance costs and will make some compliance activities more time-consuming. We intend to invest resources to comply with evolving laws, regulations and standards, and this investment will result in increased general and administrative expenses and may divert management&#8217;s time and attention from our other business activities. If our efforts to comply with new laws, regulations and standards differ from the activities intended by regulatory or governing bodies due to ambiguities related to practice, regulatory authorities may initiate legal proceedings against us, and our business may be harmed. In the future, it may be more expensive or more difficult for us to obtain director and officer liability insurance, and we may be required to accept reduced coverage or incur substantially higher costs to obtain coverage. These factors could also make it more difficult for us to attract and retain qualified members for our board of directors, particularly to serve on our audit committee and compensation committee, and qualified executive officers.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have broad discretion in the use of the net proceeds from the Business Combination and the PIPE Financing and may not use them effectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot specify with certainty the particular uses of the net proceeds we received from the Business Combination and the PIPE Financing. Our management will have broad discretion in the application of the net proceeds. Our management may spend a portion or all of the net proceeds in ways that our stockholders may not desire or that may not yield a favorable return. The failure by our management to apply these funds effectively could harm our business, financial condition, results of operations and prospects. Pending their use, we may invest the net proceeds from the Business Combination and the PIPE Financing in a manner that does not produce income or that loses value.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to use net operating losses to offset future taxable income may be subject to certain limitations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we had U.S</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. federal and state net operating loss carryforw</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ards, or NOLs, of $0.5 million for federal and $9.1 million for state, which if not utilized will expire in 2037. Federal net operating loss carryforwards of $31.6 million that arose after the 2017 tax year will carryforward indefinitely. We ma</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">y use these NOLs to offset against taxable income for U.S. federal and state income tax purposes. However, Section 382 of the Internal Revenue Code of 1986, as amended, may limit the NOLs we may use in any year for U.S. federal income tax purposes in the event of certain changes in our ownership. A Section 382 &#8220;ownership change&#8221; generally occurs if one or more stockholders or groups of stockholders who own at least 5% of a company&#8217;s stock increase their ownership by more than 50 percentage points over their lowest ownership percentage within a rolling three-year period. Similar rules may apply under state tax laws. We have not conducted a 382 study to determine whether the use of our NOLs is impaired. We may have previously undergone an &#8220;ownership change.&#8221; In addition, the future issuances or sales of our stock, including certain transactions involving our stock that are outside of our control, could result in future &#8220;ownership changes.&#8221; &#8220;Ownership changes&#8221; that have occurred in the past or that may occur in the future could result in the imposition of an annual limit on the amount of pre-ownership change NOLs and other tax attributes we can use to reduce our taxable income, potentially increasing and accelerating our liability for income taxes, and also potentially causing those tax attributes to expire unused. States may impose other limitations on the use of our NOLs. Any limitation on using NOLs could, depending on the extent of such limitation and the NOLs previously used, result in our retaining less cash after payment of U.S. federal and state income taxes during </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any year in which we have taxable income, rather than losses, than we would be entitled to retain if such NOLs were available as an offset against such income for U.S. federal and state income tax reporting purposes, which coul</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d adversely impact our operating results.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results in a timely manner or prevent fraud, which would harm our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective internal controls over financial reporting are necessary for us to provide reliable financial reports and, together with adequate disclosure controls and procedures, are designed to prevent fraud. Any failure to implement required new or improved controls, or difficulties encountered in their implementation, could cause us to fail to meet our reporting ob</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ligations in a timely manner, or at all. In addition, any testing by us conducted in connection with Section 404(a) of the Sarbanes-Oxley Act of 2002 (&#8220;SOX&#8221;) or any subsequent testing by our independent registered public accounting firm in connection with Sectio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n 404(b) of SOX, may reveal deficiencies in our internal controls over financial reporting that are deemed to be significant deficiencies or material weaknesses or that may require prospective or retroactive changes to our financial statements or identify other areas for further attention or improvement. Ineffective internal controls could also cause investors to lose confidence in our reported financial information, which could have a negative effect on the trading price of our Common Stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will be required to disclose material changes made in our internal controls over financing reporting and procedures on a quarterly basis and our management will be required to assess the effectiveness of these controls annually. We will be required to make a formal assessment of the effectiveness of our internal control over financial reporting, and once we cease to be an &#8220;emerging growth company&#8221; under the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;), we will be required to include an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. However, for as long as we are an &#8220;emerging growth company,&#8221; our independent registered public accounting firm will not be required to attest to the effectiveness of our internal controls over financial reporting pursuant to Section 404(b) of SOX.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To achieve compliance with Section 404(a) of SOX within the prescribed period, we have engaged in a process to document and evaluate our internal control over financial reporting, which is both costly and challenging. In this regard, we will need to continue to dedicate internal resources, potentially engage outside consultants and adopt a plan to assess and document the adequacy of our internal control over financial reporting, continue steps to improve control processes as appropriate, validate through testing that controls are designed and operating effectively and implement a continuous reporting and improvement process for internal control over financial reporting.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An independent assessment of the effectiveness of our internal controls could detect problems that our management&#8217;s assessment might not identify. Undetected material weaknesses in our internal controls could lead to financial statement restatements and require us to incur the expense of remediation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our estimates or judgments relating to our critical accounting policies are based on assumptions that change or prove to be incorrect, our results of operation could fall below our publicly announced guidance or the expectations of securities analysts and investors, resulting in a decline in the market price of our Common Stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in our financial statements and accompanying notes. We base our estimates on historical experience and estimates and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets, liabilities, equity, and expenses that are not readily apparent from other sources. For example, in connection with the implementation of the new revenue accounting standard if and when we have product sales, management makes judgments and assumptions based on our interpretation of the new standard. The new revenue standard is principle-based, and interpretation of those principles may vary from company to company based on their unique circumstances. It is possible that interpretation, industry practice and guidance may evolve as we apply the new standard. If our assumptions underlying our estimates and judgements relating to our critical accounting policies change or if actual circumstances differ from our assumptions, estimates or judgements, our operating results may be adversely affected and could fall below our publicly announced guidance or the expectations of securities analysts and investors, resulting in a decline in the market price of our Common Stock.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are an &#8220;emerging growth company&#8221; and a &#8220;smaller reporting company&#8221; and the reduced disclosure requirements applicable to emerging growth companies and smaller reporting companies may make our Common Stock less attractive to investors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an &#8220;emerging growth company,&#8221; as defined in the JOBS Act. For so long as we remain an emerging growth company, we are permitted by SEC rules and plan to rely on exemptions from certain disclosure requirements that are applicable to other SEC registered public companies that are not emerging growth companies. These exemptions include not being required to comply with the auditor attestation requirements of Section 404 of SOX, not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor&#8217;s report providing additional information about the audit and the financial statements, reduced disclosure obligations regarding executive compensation and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. As a result, the information we provide stockholders will be different than the information that is available with respect to other public companies that are not emerging growth companies. To the extent that we continue to qualify as a &#8220;smaller reporting company,&#8221; as such term is defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), after we cease to qualify as an emerging growth company, we will continue to be permitted to make certain reduced disclosures in our periodic reports and other documents that we file with the SEC. We cannot predict whether investors will find our Common Stock less attractive if we rely on these exemptions. If some investors find our Common Stock less attractive as a result, there may be a less active trading market for our Common Stock and our stock price may be more volatile.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. This allows an emerging growth company to delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to avail ourselves of this exemption from new or revised accounting standards and, therefore, we will not be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reports published by analysts, including projections in those reports that differ from our actual results, could adversely affect the price and trading volume of our common shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities research analysts may establish and publish their own periodic projections for us. These projections may vary widely and may not accurately predict the results we actually achieve. The share price of our Common Stock may decline if our actual results do not match the projections of these securities research analysts. Similarly, if one or more of the analysts who write reports on us downgrades our stock or publishes inaccurate or unfavorable research about our business, the share price of our Common Stock could decline. If one or more of these analysts ceases coverage of us or fails to publish reports on us regularly, the share price or trading volume of our Common Stock could decline. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_130"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_133"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. DEFAULTS UPON SENIOR SECURITIES</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_136"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. MINE SAFETY DISCLOSURES</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_139"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5. OTHER INFORMATION</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_142"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6. EXHIBITS</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.324%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1*+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit101-offerletter_god.htm">Offer Letter between Nautilus Biotechnology, Inc. and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit101-offerletter_god.htm">Mary Godwin</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit101-offerletter_god.htm"> dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit101-offerletter_god.htm">July </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit101-offerletter_god.htm">26</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit101-offerletter_god.htm">, 2022</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2*+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit102-changeincontrol.htm">Change in Control and Severance Agreement between Nautilus Biotechnology, Inc. and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit102-changeincontrol.htm">Mary Godwin</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit102-changeincontrol.htm"> dated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit102-changeincontrol.htm">June</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit102-changeincontrol.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit102-changeincontrol.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit102-changeincontrol.htm">7</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit102-changeincontrol.htm">, 2022</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311-2022q210xq.htm">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312-2022q210xq.htm">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.1*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321-2022q210xq.htm">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.2*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322-2022q210xq.htm">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document &#8211; the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.SCH</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.CAL</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.DEF</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover page Interactive Data File (embedded with the Inline XBRL document)</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">* Filed herewith.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">+ Indicates management contract or compensatory plan.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8224; The certifications attached as Exhibit 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are deemed furnished and not filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of Nautilus Biotechnology, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><div id="i92b3c97ce8934bb7b7ab6ca5e08b3121_145"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NAUTILUS BIOTECHNOLOGY, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: August&#160;2, 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Sujal Patel </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sujal Patel</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Chief Executive Officer (Principal Executive Officer)</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: August&#160;2, 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Anna Mowry</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anna Mowry</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Chief Financial Officer (Principal Financial and Accounting Officer)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exhibit101-offerletter_god.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ic54cb26375f44d2ca94822b53b8f9db2_51"></div><div style="min-height:49.68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Exhibit 10.1</font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">July 26, 2022</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">Mary Godwin</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">Via email </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">Re&#58; Offer of Employment </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">Dear Mary&#58; </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">This confirmatory employment letter agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">&#8221;) is entered into between Mary Godwin (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">you</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">&#8221;) and Nautilus Biotechnology, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">we</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">&#8221;), effective as of July 1, 2022 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">&#8221;), to confirm the terms and conditions of your employment with the Company in connection with your promotion to Senior Vice President of Operations as of the Effective Date.  </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%;padding-left:27.38pt">Title&#59; Position&#59; Location</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">.  You will serve as the Company&#8217;s Senior Vice President of Operations.  You will continue to report to the Company&#8217;s Chief Executive Officer and will perform the duties and responsibilities customary for such position and such other related duties as are reasonably assigned by the Chief Executive Officer.  You will perform your duties from the Company&#8217;s corporate offices located in San Carlos, California (with the exception of the period during which any shelter-in-place order, quarantine order, or similar work-from-home requirement affecting your ability to work at the Company&#8217;s corporate offices remains in effect), subject to customary travel as reasonably required by the Company and necessary to perform your job duties.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%;padding-left:27.38pt">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">.  Your annual base salary as of the Effective Date will be $320,000, which will be payable, less any applicable withholdings, in accordance with the Company&#8217;s normal payroll practices.  Your base salary will be subject to review and adjustment from time to time by our Board of Directors (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">&#8221;) or its Compensation Committee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">&#8221;)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">as applicable, in its sole discretion.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%;padding-left:27.38pt">Annual Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">.  For the Company&#8217;s 2022 fiscal year, you will be eligible for a target annual cash bonus opportunity equal to forty percent (40%) of your annual base salary.  Any annual bonus will be subject to performance and other criteria established by the Board or the Committee, as applicable, in its sole discretion, and subject to your continued employment through the date that the bonus is paid to you.  Your annual bonus opportunity and the applicable terms and conditions may be adjusted from time to time by our Board or the Committee, as applicable, in its sole discretion, and no amount of any annual bonus is guaranteed.  In addition, the Board or the Committee, as applicable and in its sole discretion, may approve that the Company grant additional discretionary bonus amounts to you.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%;padding-left:27.38pt">Equity Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">.  You will be eligible to receive awards of stock options or other equity awards pursuant to any plans or arrangements the Company may have in effect from time to time.  The Board or Committee, as applicable, will determine in its sole discretion whether you will be granted any such equity awards and the terms of any such award in accordance with the terms of any applicable plan or arrangement that may be in effect from time to time.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%;padding-left:27.38pt">Employee Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">.  You will be eligible to participate in the benefit plans and programs established by the Company for its employees from time to time, subject to their applicable terms and conditions, including without limitation any eligibility requirements.  The Company will reimburse you for reasonable travel or other expenses incurred by you in the furtherance of or in connection with the performance of your duties under this Agreement, pursuant to the terms of the Company&#8217;s expense reimbursement policy as may be in effect from time to time.  The Company reserves the right to modify, amend, suspend or terminate the benefit plans, programs, and arrangements it offers to its employees at any time. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%;padding-left:27.38pt">Confidentiality Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">.  As an employee of the Company, you will continue to have access to certain confidential information of the Company and, during the course of your employment, you may develop certain information or inventions that will be the property of the Company.  To protect the interests of the Company, your acceptance of this Agreement confirms that the terms of the At-Will Employment, Confidential Information, Invention Assignment, and Arbitration Agreement between you and the Company dated January 14, 2020, as may be amended or amended and restated from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">Confidentiality Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">&#8221;) still apply.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%;padding-left:27.38pt">At-Will Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">.  This Agreement does not imply any right to your continued employment for any period with the Company or any parent, subsidiary, or other affiliate of the Company.  Your employment with the Company is for no specified period and will continue to constitute at-will employment.  As a result, you are free to resign at any time, for any reason or for no reason.  Similarly, the Company is free to conclude its employment relationship with you at any time, with or without cause, and with or without notice.  We request that, in the event of resignation, you give the Company at least two weeks&#8217; notice.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%;padding-left:27.38pt">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">.  The Company (or its affiliate, as applicable) will have the right and authority to deduct from any payments or benefits under this Agreement all applicable federal, state, and local taxes or other required withholdings and payroll deductions (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">Withholdings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">&#8221;).  Prior to the payment of any amounts or provision of any benefits under this Agreement, the Company (and its affiliate, as applicable) is permitted to deduct or withhold, or require you to remit to the Company, an amount sufficient to satisfy any applicable Withholdings with respect to such payments and benefits.  The payments and benefits under this Agreement are intended to be exempt from, or otherwise to comply with, Section&#160;409A of the Internal Revenue Code of 1986, as amended, and any regulations and other formal guidance promulgated thereunder (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">Section&#160;409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">&#8221;) so that none of the payments and benefits under this Agreement will be subject to the additional tax imposed under Section&#160;409A, and any ambiguities and ambiguous terms herein will be interpreted to be exempt or to so comply.  Any taxable reimbursements payable to you under this Agreement will be paid, less applicable withholdings, only with respect to expenses incurred while you are employed with the Company, no later than the last day of your taxable year immediately following your taxable year in which the expense was incurred by you.  No such amounts reimbursable to you in one taxable year of yours will affect the amounts reimbursable to you in another taxable year of yours.  Notwithstanding any contrary Agreement provision, the Company reserves the right to amend the Agreement as it deems necessary or advisable, in its sole discretion and without your consent or the consent of any other person or entity, to comply with Section&#160;409A or to avoid income recognition under Section&#160;409A or to otherwise avoid the imposition of additional tax under Section&#160;409A prior to the actual payment or provision of any payments or benefits under this Agreement.  In no event will you have any discretion to choose your taxable year in which any payments or benefits are provided under this Agreement.  In no event will the Company, or any parent, subsidiary or other affiliate of the Company have any responsibility, liability or obligation to reimburse or indemnify you or hold you harmless for any taxes imposed, or other costs incurred, as a result of Section&#160;409A.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%;padding-left:27.38pt">Additional Employment Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">.  During the term of your employment with the Company, you agree to perform your duties faithfully and to the best of your abilities and will devote your full business efforts and time to rendering services to the Company hereunder.  Moreover, you agree that, during the term of your employment with the Company, you will not engage in any other employment, occupation, consulting or other business activity directly related to the business in which the Company is now involved or becomes involved during the term of your employment, nor will you engage in any other activities that conflict with your obligations to the Company.  Nothing in this Agreement shall prohibit you from (a) making and managing passive investments, or (b) participating in professional and charitable organizations in an unpaid capacity, in a manner, and to an extent, that will not interfere with your duties or obligations to the Company, including under the Confidentiality Agreement.  You agree not to bring any third party confidential information to the Company, including that of your former employer, and that in performing your duties for the Company you will not in any way utilize any such information.  As a Company employee, you will be expected to abide by the Company&#8217;s rules and standards.  You agree that in the rendering of all services to the Company and in all aspects of employment with the Company, you will comply in all </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font><br></font></div><div style="padding-right:18pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">material respects with all lawful directives, policies, standards and regulations from time to time established by the Company.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%;padding-left:21.63pt">Protected Activity Not Prohibited</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">.  Notwithstanding any contrary provision of the Agreement or the Confidentiality Agreement, nothing in this Agreement, or the Confidentiality Agreement will prohibit or impede you from engaging in any Protected Activity.  For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">Protected Activity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">&#8221; will mean (i) communicating, cooperating or filing a complaint with any U.S. federal, state or local governmental or law enforcement branch, agency or entity, including, but not limited to, the Securities and Exchange Commission, the Equal Employment Opportunity Commission, the Occupational Safety and Health Administration, and the National Labor Relations Board (collectively, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%">Governmental Entity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">&#8221;) with respect to possible violations of any U.S. federal, state or local law or regulation, or otherwise making disclosures to any Governmental Entity and (ii) discussing or disclosing information about unlawful acts in the workplace, such as harassment or discrimination or any other conduct that you have reason to believe is unlawful.  Notwithstanding the foregoing, you agree to take all reasonable precautions to prevent any unauthorized use or disclosure of any Company trade secrets, proprietary information, or confidential information that does not involve unlawful acts in the workplace or the activity otherwise protected herein. You further understand that Protected Activity does not include disclosure of any Company attorney-client privileged communications or attorney work product.  Any language in the Confidentiality Agreement or any other confidential information agreement between you and the Company or any parent, subsidiary, or other affiliate of the Company that conflicts with, or is contrary to, this paragraph is superseded by this Agreement.  You understand and acknowledge that pursuant to the Defend Trade Secrets Act of 2016 (a) an individual will not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that is made (i) in confidence to a Federal, state, or local government official or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, or (ii) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal and (b) an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal, and does not disclose the trade secret, except pursuant to court order.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%;padding-left:21.63pt">Representation by Counsel</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">. You acknowledge that Wilson Sonsini Goodrich &#38; Rosati, Professional Corporation, is representing only the Company in the negotiation of this Agreement. You acknowledge that you have had the opportunity to review this Agreement and the transactions contemplated by this Agreement with your own legal counsel, tax advisors and other advisors. You are relying solely on your own counsel and advisors and not on any statements or representations of the Company or its agents for legal or other advice with respect to the transactions contemplated by this Agreement. If an ambiguity exists with respect to any provision of this Agreement, such provision shall not be construed against any party because such party or such party&#8217;s representatives drafted such provision.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:700;line-height:100%;padding-left:21.63pt">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">. This Agreement, together with the Confidentiality Agreement, the Change in Control and Severance Agreement between you and the Company dated June 27, 2022, and the equity awards granted to you by the Company under its equity plans and the applicable award agreements thereunder, constitute the entire agreement between you and the Company regarding the material terms and conditions of your employment, and they supersede and replace all prior negotiations, representations or agreements between you and the Company.  This Agreement will be governed by the laws of the State of California but without regard to the conflicts of law provision.  This Agreement may be modified only by a written agreement signed by a duly authorized officer of the Company (other than yourself) and you.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font><br></font></div><div style="padding-right:18pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">To confirm the terms and conditions of your employment with the Company, please sign and date in the spaces indicated and return this Agreement to me. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">Sincerely,</font></div><div style="margin-top:12pt;text-align:justify;text-indent:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">NAUTILUS BIOTECHNOLOGY, INC.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:252pt"><font><br></font></div><div style="margin-top:12pt;text-align:justify;text-indent:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Sujal Patel&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:270pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">Sujal Patel</font></div><div style="text-align:justify;text-indent:270pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">Chief Executive Officer</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">Agreed to and accepted&#58;</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Mary Godwin&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">Mary Godwin</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">Dated&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%;text-decoration:underline">7&#47;26&#47;2022&#160;&#160;&#160;&#160;</font></div><div style="margin-top:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">Enclosures&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">At-Will Employment, Confidential Information, Invention Assignment and Arbitration Agreement</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11.5pt;font-weight:400;line-height:100%">Change in Control and Severance Agreement</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-left:9pt;padding-right:9pt;text-align:center"><font><br></font></div><div style="padding-right:18pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>exhibit102-changeincontrol.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i07a2835b29654975b212daf1be721e3a_52"></div><div style="min-height:97.92pt;width:100%"><div style="margin-top:12pt;text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Exhibit 10.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NAUTILUS BIOTECHNOLOGY, INC.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CHANGE IN CONTROL AND SEVERANCE AGREEMENT</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Change in Control and Severance Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) is made by and between Nautilus Biotechnology Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and Mary Godwin (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), effective as of the date this Agreement is executed by both the Company and Executive (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Agreement provides certain protections to Executive in connection with an involuntary termination of Executive&#8217;s employment with the Company under the circumstances described in this Agreement, including in connection with a change in control of the Company.  Certain capitalized terms used in this Agreement are defined in Section&#160;7 below.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company and Executive agree as follows&#58; </font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Term of Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement will have an initial term of three (3) years commencing on the Effective Date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Initial Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  On the three (3) year anniversary of the Effective Date, this Agreement will renew automatically for additional, one (1) year terms (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Additional Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) unless either party provides the other party with written notice of nonrenewal at least ninety (90) days prior to the date of automatic renewal.  Notwithstanding the foregoing, if a Change in Control occurs (a)&#160;when there are fewer than twelve (12) months remaining during the Initial Term or (b)&#160;during an Additional Term, then the term of this Agreement will extend automatically through the date that is twelve&#160;(12) months following the date of the Change in Control.  If Executive becomes entitled to the benefits under Section&#160;3 of this Agreement, then the Agreement will not terminate until all of the obligations of the parties hereto with respect to this Agreement have been satisfied.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">At-Will Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company and Executive acknowledge that Executive&#8217;s employment is and will continue to be at-will, as defined under applicable law.  No payments, benefits, or provisions under this Agreement will confer upon Executive any right to continue Executive&#8217;s employment with the Company, nor will they interfere with or limit in any way the right of the Company or Executive to terminate such relationship at any time, with or without cause, to the extent permitted by applicable laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Severance Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:18.68pt">Qualifying Termination Outside of the Change in Control Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event of a Qualifying Termination that occurs other than during the Change in Control Period, Executive will receive the following payments and benefits from the Company, subject to the requirements of this Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:83.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.1.i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Salary Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  A single, lump sum, cash payment equal to fifty percent (50%) of Executive&#8217;s Salary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:80.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.1.ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COBRA Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to Executive timely electing continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COBRA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and further subject to Section&#160;5.3, the Company will pay the employer portion of the premiums required for continued coverage pursuant to COBRA under the Company&#8217;s group health, dental and vision care plans for Executive and any of Executive&#8217;s eligible dependents, as applicable, following the Qualifying Termination until the earliest of&#58;  (a) six (6) months following the date of the Qualifying Termination, (b) the date on which Executive and Executive&#8217;s eligible dependents (as applicable) become covered </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:97.92pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">under similar plans, or (c) the expiration of Executive&#8217;s (and any of Executive&#8217;s eligible dependents&#8217;, as applicable) eligibility for continuation coverage under COBRA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:18pt"> Qualifying Termination During the Change in Control Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event of a Qualifying Termination that occurs during the Change in Control Period, Executive will receive the following payments and benefits from the Company, subject to the requirements of this Agreement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:83.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.2.i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Salary Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  A single, lump sum, cash payment equal to one hundred percent (100%) of Executive&#8217;s Salary.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:80.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.2.ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Target Bonus Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  A single, lump sum, cash payment equal to one hundred percent (100%) of Executive&#8217;s Target Bonus. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:77.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.2.iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COBRA Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Subject to Executive timely electing continuation coverage under COBRA and further subject to Section&#160;5.3, the Company will pay the premiums required for continued coverage pursuant to COBRA under the Company&#8217;s group health, dental and vision care plans for Executive and any of Executive&#8217;s eligible dependents, as applicable, following the Qualifying Termination until the earliest of&#58;  (a) twelve (12) months following the date of the Qualifying Termination, (b) the date on which Executive and Executive&#8217;s eligible dependents (as applicable) become covered under similar plans, or (c) the expiration of Executive&#8217;s (and any of Executive&#8217;s eligible dependents, as applicable) eligibility for continuation coverage under COBRA.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:77.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.2.iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Vesting Acceleration of Time-Based Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Vesting acceleration of one hundred percent (100%) of any Time-Based Awards that are outstanding and unvested as of the date of the Qualifying Termination.  For the avoidance of doubt, in the event of Executive&#8217;s Qualifying Termination that occurs prior to a Change in Control, any then outstanding and unvested portion of Executive&#8217;s Awards will remain outstanding (and unvested) until the earlier of (x)&#160;three (3) months following the Qualifying Termination, or (y) a Change in Control that occurs within three (3) months following the Qualifying Termination, solely so that any benefits due on a Qualifying Termination can be provided if the Qualifying Termination occurs during the Change in Control Period (provided that in no event will Executive&#8217;s stock option Awards or similar Awards remain outstanding beyond the Award&#8217;s maximum term to expiration).  If no Change in Control occurs within three (3) months following a Qualifying Termination, any unvested portion of Executive&#8217;s Awards automatically and permanently will be forfeited on the date three (3) months following the date of the Qualifying Termination without having vested.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:18.68pt">Termination Other Than a Qualifying Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the termination of Executive&#8217;s employment does not constitute a Qualifying Termination, then Executive will not be entitled to receive any severance or other benefits in connection with such termination except for those, if any, as may then be established under the Company&#8217;s then existing severance and benefits plans or programs.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:18pt">Non-duplication of Payment or Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  For purposes of clarity, in the event of a Qualifying Termination that occurs during the period within three (3) months prior to a Change in Control, any severance payments and benefits to be provided to Executive under Section 3.2 will be reduced by any amounts that already were provided to Executive under Section&#160;3.1.  Notwithstanding any provision of this Agreement to the contrary, if Executive is entitled to any cash severance, continued health coverage benefits, vesting acceleration of any Awards, or other severance or separation benefits similar to those provided under this Agreement, by operation of applicable law or under a plan, policy, contract, or arrangement sponsored by the Company or to which the Company is a party other than this </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-2-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:97.92pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Agreement (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Other Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), then the corresponding severance payments and benefits under this Agreement will be reduced by the amount of Other Benefits paid or provided to Executive.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:18.68pt">Death of Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In the event of Executive&#8217;s death before all payments or benefits Executive is entitled to receive under this Agreement have been provided, the unpaid amounts will be provided to Executive&#8217;s designated beneficiary, if living, or otherwise to Executive&#8217;s personal representative in accordance with the terms of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Accrued Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  On any termination of Executive&#8217;s employment with the Company, Executive will be entitled to receive all accrued but unpaid vacation, expense reimbursements, wages, and other benefits due to Executive under any Company-provided plans, policies, and arrangements.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Conditions to Receipt of Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:18.68pt">Separation Agreement and Release of Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Executive&#8217;s receipt of any severance payments or benefits upon a Qualifying Termination under Section 3 is subject to Executive signing and not revoking the Company&#8217;s then standard separation agreement and release of claims with the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), which must become effective and irrevocable no later than the sixtieth&#160;(60th) day following the date of the Qualifying Termination (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Release Deadline Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  If the Release does not become effective and irrevocable by the Release Deadline Date, Executive will forfeit any right to the severance payments or benefits under Section 3.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:18pt">Payment Timing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any lump sum cash severance payments under Section 3 relating to salary severance and any bonus severance will be provided to Executive on the first regularly scheduled payroll date of the Company following the date the Release becomes effective and irrevocable (or with respect to such payments under Section&#160;3.2, if later, on the date of the Change in Control), subject to any delay required by Section&#160;5.4 below.  Any Time-Based Awards that are restricted stock units, performance shares, performance units, and&#47;or similar full value awards (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Full Value Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) that accelerate vesting under Section&#160;3.2.4 will be settled, subject to any delay required by Section&#160;5.4 below (or the terms of the Full Value Award agreement or other Company plan, policy, or arrangement governing the settlement timing of the Full Value Award to the extent such terms specifically require any such delay in order to comply with the requirements of Section 409A, as applicable), (a) on a date within ten (10) days following the date the Release becomes effective and irrevocable, or (b) if later, in the event of a Qualifying Termination that occurs prior to a Change in Control, on a date on or before the date of completion of the Change in Control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:18.68pt">COBRA Severance Limitations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Company determines in its sole discretion that it cannot provide the COBRA-related benefits set forth in Section&#160;3.1.2 or 3.2.3, as applicable (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COBRA Severance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) without potentially violating, or being subject to an excise tax under, applicable law (including, without limitation, Section 2716 of the Public Health Service Act), then in lieu of such COBRA Severance, subject to any delay required by Section&#160;5.4 below, the Company will provide to Executive a taxable monthly payment payable on the last day of a given month (except as provided by the last sentence in this Section&#160;5.3), in an amount equal to (x)&#160;in the case of COBRA Severance under Section&#160;3.1.2, the employer portion of the monthly COBRA premium necessary to continue coverage under the Company&#8217;s group health, dental and vision care plans for Executive and any of Executive&#8217;s eligible dependents, as applicable, as in effect on the date of the Qualifying Termination, or (y) in the case of COBRA Severance under Section&#160;3.2.3, the monthly COBRA premium that would be required to continue coverage under the Company&#8217;s group health, dental and vision care plans for Executive and Executive&#8217;s eligible dependents, as applicable, as in effect on the date of the Qualifying Termination, in each case, which amount will be based on the premium </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-3-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:97.92pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">rates applicable for the first month of COBRA Severance for Executive and any eligible dependents of Executive (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COBRA Replacement Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and which COBRA Replacement Payments will be made regardless of whether Executive elects COBRA continuation coverage and will end on the earlier of (a) the date upon which Executive obtains other employment, or (b) the date the Company has paid an amount totaling the number of COBRA Replacement Payments equal to the number of months in the applicable COBRA Severance period set forth in clause (a) of Section&#160;3.1.2 or Section&#160;3.2.3, as applicable.  For the avoidance of doubt, the COBRA Replacement Payments may be used for any purpose, including, but not limited to continuation coverage under COBRA, and will be subject to any applicable withholdings.  Notwithstanding anything to the contrary under this Agreement, if the Company determines in its sole discretion at any time that it cannot provide the COBRA Replacement Payments without violating applicable law (including, without limitation, Section 2716 of the Public Health Service Act), Executive will not receive the COBRA Replacement Payments or any further COBRA Severance.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:18pt">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company intends that all payments and benefits provided under this Agreement or otherwise are exempt from, or comply with, the requirements of Section 409A so that none of the payments or benefits will be subject to the additional tax imposed under Section 409A, and any ambiguities and ambiguous terms in this Agreement will be interpreted in accordance with this intent.  No payments or benefits to be provided to Executive, if any, under this Agreement or otherwise, when considered together with any other severance payments or separation benefits that are considered deferred compensation under Section 409A (together, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Deferred Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) will be paid or otherwise provided until Executive has a &#8220;separation from service&#8221; within the meaning of Section 409A.  To the extent required to be exempt from or comply with Section 409A, references to the termination of Executive&#8217;s employment or similar phrases used in this Agreement will mean Executive&#8217;s &#8220;separation from service&#8221; within the meaning of Section 409A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:83.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.4.i.Any payments or benefits paid or provided under this Agreement that satisfy the requirements of the &#8220;short-term deferral&#8221; rule under Treasury Regulations Section&#160;1.409A-1(b)(4), or that qualify as payments made as a result of an involuntary separation from service under Treasury Regulations Section 1.409A-1(b)(9)(iii) that is within the limit set forth thereunder, will not constitute Deferred Payments for purposes of this Section&#160;5.4.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:80.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.4.ii.Notwithstanding any provisions to the contrary in this Agreement, if Executive is a &#8220;specified employee&#8221; within the meaning of Section 409A at the time of Executive&#8217;s separation from service (other than due to death), then any payments or benefits under this Agreement that constitute Deferred Payments payable within the first six (6) months after Executive&#8217;s separation from service instead will be payable on the date six (6) months and one (1) day after Executive&#8217;s separation from service&#59; provided that in the event of Executive&#8217;s death within such six (6) month period, any payments delayed by this Section&#160;5.4.2 will be paid to Executive in a lump sum as soon as administratively practicable after the date of Executive&#8217;s death.  To the extent that Executive is not a specified employee but Executive&#8217;s Qualifying Termination occurs at a time during the year whereby the Release Deadline Date will occur in the year immediately following the year in which the Qualifying Termination occurs, then any payments or benefits under this Agreement that constitute Deferred Payments that otherwise would be payable prior to the Release Deadline Date instead will be paid on the Release Deadline Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:77.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.4.iii.The Company reserves the right to amend this Agreement as it considers necessary or advisable, in its sole discretion and without the consent of Executive or any other individual, to comply with any provision required to avoid the imposition of the additional tax imposed under Section&#160;409A or to otherwise avoid income recognition under Section 409A prior to the actual payment of any benefits or imposition of any additional tax.  Each payment, installment, and benefit payable under this Agreement is intended to constitute a separate payment for purposes of Treasury </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-4-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:97.92pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Regulations Section&#160;1.409A-2(b)(2).  In no event will Executive have any discretion to choose Executive&#8217;s taxable year in which any payments or benefits are provided under this Agreement.  In no event will the Company or any parent, subsidiary or other affiliate of the Company have any responsibility, liability or obligation to reimburse, indemnify or hold harmless Executive for any taxes, penalties or interest that may be imposed, or other costs that may be incurred, as a result of Section&#160;409A.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Limitation on Payments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:18.68pt">Reduction of Severance Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If any payment or benefit that Executive would receive from the Company or any other party whether in connection with the provisions in this Agreement or otherwise (the &#8220;Payments&#8221;) would (a) constitute a &#8220;parachute payment&#8221; within the meaning of Section&#160;280G of the Code and (b) but for this sentence, be subject to the excise tax imposed by Section&#160;4999 of the Code (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Excise Tax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), then the Payments will be either delivered in full, or delivered as to such lesser extent that would result in no portion of the Payments being subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the Excise Tax, results in Executive&#8217;s receipt, on an after-tax basis, of the greatest amount of Payments, notwithstanding that all or some of the Payments may be subject to the Excise Tax.  If a reduction in Payments is made in accordance with the immediately preceding sentence, the reduction will occur, with respect to the Payments considered parachute payments within the meaning of Code Section 280G, in the following order&#58;  (i) reduction of cash payments in reverse chronological order (that is, the cash payment owed on the latest date following the occurrence of the event triggering the Excise Tax will be the first cash payment to be reduced)&#59; (ii) cancellation of equity awards that were granted &#8220;contingent on a change in ownership or control&#8221; within the meaning of Section 280G of the Code in the reverse order of date of grant of the equity awards (that is, the most recently granted equity awards will be cancelled first)&#59; (iii) reduction of the accelerated vesting of equity awards in the reverse order of date of grant of the equity awards (that is, the vesting of the most recently granted equity awards will be cancelled first)&#59; and (iv) reduction of employee benefits in reverse chronological order (that is, the benefit owed on the latest date following the occurrence of the event triggering the Excise Tax will be the first benefit to be reduced).  In no event will Executive have any discretion with respect to the ordering of Payment reductions.  Executive will be solely responsible for the payment of all personal tax liability that is incurred as a result of the payments and benefits received under this Agreement, and neither the Company nor any parent, subsidiary or other affiliate of the Company have any responsibility, liability or obligation to reimburse, indemnify or hold harmless Executive for any of those payments of personal tax liability.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:18pt">Determination of Excise Tax Liability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Unless the Company and Executive otherwise agree in writing, any determinations required under this Section 6 will be made in writing by a nationally recognized accounting or valuation firm (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Firm</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) selected by the Company, whose determinations will be conclusive and binding upon Executive and the Company for all purposes.  For purposes of making the calculations required by this Section&#160;6, the Firm may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code.  The Company and Executive will furnish to the Firm such information and documents as the Firm reasonably may request in order to make determinations under this Section&#160;6.  The Company will bear the costs and make all payments required to be made to the Firm for the Firm&#8217;s services that are rendered in connection with any calculations contemplated by this Section&#160;6.  The Company will have no liability to Executive for the determinations of the Firm.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-5-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:97.92pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.68pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means stock options and other equity awards covering shares of Company common stock granted to Executive.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Company&#8217;s Board of Directors.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.68pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means&#58;  (a)&#160;Executive&#8217;s failure to substantially perform Executive&#8217;s material duties and obligations as an employee (for reasons other than Executive&#8217;s death or Disability), which failure is not cured to the sole and reasonable satisfaction of the Company&#59; (b)&#160;Executive&#8217;s failure or refusal to comply with the policies, standards and regulations established by the Company from time to time, which failure is not cured to the sole and reasonable satisfaction of the Company&#59; (c)&#160;any act of personal dishonesty, moral turpitude, fraud, embezzlement, misrepresentation, or other unlawful act committed by Executive that results in harm to the Company or its affiliates, including financial or reputational, which harm will be determined in the Company&#8217;s sole and reasonable discretion&#59; (d)&#160;Executive&#8217;s violation of a federal or state law or regulation applicable to the business of the Company or its affiliates&#59; (e)&#160;Executive being convicted of, or entering a plea of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">nolo contendere</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or guilty to, a felony under the laws of the United States or its equivalent in the jurisdiction in which the act that constituted the felony occurred&#59; (f)&#160;Executive&#8217;s material breach of the terms of this Agreement or any other agreement between Executive and the Company (or any affiliate of the Company)&#59; or (g)&#160;the Company&#8217;s economic duress or necessity, as determined by the Company, in its sole and reasonable discretion.  With respect to clauses&#160;(a) and&#160;(b) above only, Executive will have ten&#160;(10) days to cure following written notice of Executive&#8217;s failure or refusal to perform or comply, provided that whether the failure is curable will be within the Company&#8217;s sole and reasonable discretion.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the first occurrence of any of the following events on or after the Effective Date&#58;  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:83.67pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.4.i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Change in Ownership of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  A change in the ownership of the Company which occurs on the date that any one person, or more than one person acting as a group (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), acquires ownership of the stock of the Company that, together with the stock held by such Person, constitutes more than fifty percent (50%) of the total voting power of the stock of the Company&#59; provided, however, that for purposes of this subsection, the acquisition of additional stock by any one Person, who is considered to own more than fifty percent (50%) of the total voting power of the stock of the Company will not be considered a Change in Control&#59; provided, further, that any change in the ownership of the stock of the Company as a result of a private financing of the Company that is approved by the Board also will not be considered a Change in Control.  Further, if the stockholders of the Company immediately before such change in ownership continue to retain immediately after the change in ownership, in substantially the same proportions as their ownership of shares of the Company&#8217;s voting stock immediately prior to the change in ownership, direct or indirect beneficial ownership of fifty percent (50%) or more of the total voting power of the stock of the Company or of the ultimate parent entity of the Company, such event shall not be considered a Change in Control under this Section&#160;7.4.1.  For this purpose, indirect beneficial ownership shall include, without limitation, an interest resulting from ownership of the voting securities of one or more corporations or other business entities which own the Company, as the case may be, either directly or through one or more subsidiary corporations or other business entities&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:80.34pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.4.ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Change in Effective Control of the Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Company has a class of securities registered pursuant to Section 12 of the U.S. Securities Exchange Act of 1934, as amended, a change in the effective control of the Company which occurs on the date that a majority of members of the Board is replaced during any twelve (12) month period by Directors whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election.  For purposes of this Section&#160;7.4.2, if any Person is considered to be in effective control of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-6-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:97.92pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Company, the acquisition of additional control of the Company by the same Person will not be considered a Change in Control&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:77.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.4.iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Change in Ownership of a Substantial Portion of the Company&#8217;s Assets</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  A change in the ownership of a substantial portion of the Company&#8217;s assets which occurs on the date that any Person acquires (or has acquired during the twelve (12) month period ending on the date of the most recent acquisition by such Person or Persons) assets from the Company that have a total gross fair market value equal to or more than fifty percent (50%) of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions&#59; provided, however, that for purposes of this Section&#160;7.4.3, the following will not constitute a change in the ownership of a substantial portion of the Company&#8217;s assets&#58; (a) a transfer to an entity that is controlled by the Company&#8217;s stockholders immediately after the transfer, or (b) a transfer of assets by the Company to&#58; (i) a stockholder of the Company (immediately before the asset transfer) in exchange for or with respect to the Company&#8217;s stock, (ii) an entity, fifty percent (50%) or more of the total value or voting power of which is owned, directly or indirectly, by the Company, (iii) a Person, that owns, directly or indirectly, fifty percent (50%) or more of the total value or voting power of all the outstanding stock of the Company, or (iv) an entity, at least fifty percent (50%) of the total value or voting power of which is owned, directly or indirectly, by a Person described in this Section&#160;7.4.3(b)(iii).  For purposes of this Section&#160;7.4.3, gross fair market value means the value of the assets of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For purposes of this Change in Control definition under Section&#160;7.4, persons will be considered to be acting as a group if they are owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, a transaction will not be deemed a Change in Control unless the transaction qualifies as a change in control event within the meaning of Section 409A.  Further and for the avoidance of doubt, a transaction will not constitute a Change in Control if&#58; (x) its sole purpose is to change the jurisdiction of the Company&#8217;s incorporation, or (y) its sole purpose is to create a holding company that will be owned in substantially the same proportions by the persons who held the Company&#8217;s securities immediately before such transaction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.68pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Change in Control Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the period beginning on the date three (3) months prior to a Change in Control and ending on (and inclusive of) the date that is the one (1) year anniversary of a Change in Control.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.01pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Internal Revenue Code of 1986, as amended.  Reference to a specific section of the Code or regulation thereunder will include such section or regulation, any valid regulation promulgated under such section, and any comparable provision of any future legislation or regulation amending, supplementing or superseding such section or regulation.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Confidentiality Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Executive&#8217;s At-Will Employment, Confidential Information, Invention Assignment and Arbitration Agreement entered into with the Company dated January 14, 2020.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Director</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a member of the Board. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.67pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means total and permanent disability as defined in Code Section&#160;22(e)(3).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-7-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:97.92pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.j.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.67pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Executive&#8217;s termination of Executive&#8217;s employment with the Company within ninety (90) days following the expiration of the Company&#8217;s Cure Period (as defined below) following the occurrence of any of the following without Executive&#8217;s written consent&#58;  (a)&#160;a material reduction in Executive&#8217;s responsibilities, provided that neither a mere change in title nor reassignment following a Change in Control to a position that is substantially similar to the position held prior to the Change in Control will constitute a material reduction in job responsibilities&#59; (b)&#160;relocation by the Company (or subsidiary, parent, affiliate or successor thereto, as applicable) of Executive&#8217;s principal work location to a principal work location more than forty (40) miles from Executive&#8217;s principal work location immediately before such relocation&#59; or (c)&#160;a reduction in Executive then current base salary by at least ten percent (10%), provided that an across-the-board reduction in the salary level of all other similarly situated employees by the same percentage amount as part of a general salary level reduction will not constitute such a reduction under this clause&#160;(c).  In order for an event to qualify as Good Reason, Executive must not terminate employment with the Company without first providing the Company with written notice of the acts or omissions constituting the grounds for &#8220;Good Reason&#8221; within ninety&#160;(90) days following the initial existence of the grounds for &#8220;Good Reason&#8221; and a cure period of thirty (30) days following the date of such notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Cure Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  To the extent Executive&#8217;s principal work location is not the Company&#8217;s corporate offices or facilities due to a shelter-in-place order, quarantine order, or similar work-from-home requirement that applies to Executive, Executive&#8217;s principal work location, from which a change in location under the foregoing clause (b) will be measured, will be considered the Company&#8217;s office or facility location where Executive&#8217;s employment with the Company primarily was based immediately prior to the commencement of such shelter-in-place order, quarantine order, or similar work-from-home requirement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.k.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Qualifying Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means a termination of Executive&#8217;s employment with the Company either (a) by the Company without Cause and other than due to Executive&#8217;s death or Disability, or (b) by Executive for Good Reason.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.l.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:20.67pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Executive&#8217;s annual base salary in effect immediately prior to Executive&#8217;s Qualifying Termination (or, if the termination is due to a resignation for Good Reason based on a material reduction in Executive&#8217;s base salary, then Executive&#8217;s annual base salary in effect immediately prior to the reduction) or, if Executive&#8217;s Qualifying Termination occurs during the Change in Control Period and the amount is greater, Executive&#8217;s annual base salary in effect immediately prior to the Change in Control. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.m.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.67pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Code Section 409A and the Treasury Regulations and guidance thereunder, and any applicable state law equivalent, as each may be promulgated, amended or modified from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.n.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Target Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Executive&#8217;s annual (or annualized, as applicable) target bonus in effect immediately prior to Executive&#8217;s Qualifying Termination or, if Executive&#8217;s Qualifying Termination occurs during the Change in Control Period and the amount is greater, Executive&#8217;s annual (or annualized, if applicable) target bonus in effect immediately prior to the Change in Control. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.o.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18pt">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Time-Based Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Awards that, as of the date of the Qualifying Termination, or in the case of a Qualifying Termination during the Change in Control Period, the later of the date of the Qualifying Termination or immediately prior to the Change in Control, are held by Executive and subject to continued service-based vesting criteria, but not subject to the achievement of any performance-based or other similar vesting criteria.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement will be binding upon and inure to the benefit of (a) the heirs, executors, and legal representatives of Executive upon Executive&#8217;s death, and (b) any successor of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-8-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:97.92pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Company.  Any such successor of the Company will be deemed substituted for the Company under the terms of this Agreement for all purposes.  For this purpose, &#8220;successor&#8221; means any person, firm, corporation, or other business entity which at any time, whether by purchase, merger, or otherwise, directly or indirectly acquires all or substantially all of the assets or business of the Company.  None of the rights of Executive to receive any form of compensation payable pursuant to this Agreement may be assigned or transferred except by will or the laws of descent and distribution.  Any other attempted assignment, transfer, conveyance, or other disposition of Executive&#8217;s right to compensation or other benefits will be null and void.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt">Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:18.68pt">General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  All notices and other communications required or permitted under this Agreement will be in writing and will be effectively given (a) upon actual delivery to the party to be notified, (b) upon transmission by email, (c) twenty-four (24) hours after confirmed facsimile transmission, (d) one (1) business day after deposit with a recognized overnight courier, or (e) three (3) business days after deposit with the U.S. Postal Service by first class certified or registered mail, return receipt requested, postage prepaid, addressed&#58; (i) if to Executive, at the address Executive will have most recently furnished to the Company in writing, (ii) if to the Company, at the following address&#58;</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Nautilus Biotechnology, Inc.</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2701 Eastlake Ave East</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Seattle, WA 98102</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Attention&#58;  Chief Executive Officer</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:18pt">Notice of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Any termination of Executive&#8217;s employment by the Company for Cause will be communicated by a notice of termination of Executive&#8217;s employment to Executive, and any termination by Executive for Good Reason will be communicated by a notice of termination to the Company, in each case given in accordance with Section&#160;9.1.  The notice will indicate the specific termination provision in this Agreement relied upon, will set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination under the provision so indicated, and will specify the termination date (which will be not more than thirty (30) days after the later of (i) the giving of the notice or (ii) the end of any applicable cure period, except as set forth in Section&#160;7.10).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt">Resignation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The termination of Executive&#8217;s employment for any reason also will constitute, without any further required action by Executive, Executive&#8217;s voluntary resignation from all officer and&#47;or director positions held at the Company or any of its subsidiaries or affiliates, and at the Board&#8217;s request, Executive will execute any documents reasonably necessary to reflect the resignations.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt">Miscellaneous Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:12.68pt">No Duty to Mitigate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Executive will not be required to mitigate the amount of any payment contemplated by this Agreement, nor will any payment be reduced by any earnings that Executive may receive from any other source except as specified in Sections 3.4, 5.3, 5.4.3, and 6.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:12pt">Waiver&#59; Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  No provision of this Agreement will be modified, waived or discharged unless the modification, waiver or discharge is agreed to in writing and signed by an authorized officer of the Company (other than Executive) and by Executive.  No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the other party will be considered a waiver of any other condition or provision or of the same condition or provision at another time.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-9-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:97.92pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:12.68pt">Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Headings are provided herein for convenience only, and will not serve as a basis for interpretation or construction of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:12pt">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement, together with the Confidentiality Agreement, Executive&#8217;s confirmatory offer letter dated April 7, 2021, and the Company&#8217;s 2021&#160;Equity Incentive Plan and award agreements thereunder governing Executive&#8217;s Awards, constitutes the entire agreement of the parties and supersedes in their entirety all prior representations, understandings, undertakings or agreements (whether oral or written and whether expressed or implied) of the parties with respect to the subject matter of this Agreement, including without limitation, Executive&#8217;s offer letter entered into with the Company and dated January 7, 2020, the Change in Control and Severance Agreement entered into with the Company and dated April 7, 2021, and the Change in Control and Severance Agreement entered into with the Company and dated May 2, 2022.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:12.68pt">Governing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement will be governed by the laws of the State of Washington but without regard to the conflict of law provision.  To the extent that any lawsuit is permitted with respect to any provisions under this Agreement, Executive hereby expressly consents to the personal and exclusive jurisdiction and venue of the state and federal courts located in the State of Washington for any lawsuit filed against Executive by the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:14.01pt">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If any provision of this Agreement is or becomes or is deemed to be invalid, illegal, or unenforceable for any reason, such invalidity, illegality, or unenforceability will not affect the remaining parts of this Agreement, and this Agreement will be construed and enforced as if the invalid, illegal, or unenforceable provision had not been included.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:12pt">Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company (and any parent, subsidiary or other affiliate of the Company, as applicable) will have the right and authority to deduct from any payments or benefits all applicable federal, state, local, and&#47;or non U.S. taxes or other required withholdings and payroll deductions (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Withholdings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;).  Prior to the payment of any amounts or provision of any benefits under this Agreement, the Company (and any parent, subsidiary or other affiliate of the Company, as applicable) is permitted to deduct or withhold, or require Executive to remit to the Company, an amount sufficient to satisfy any applicable Withholdings with respect to such payments and benefits.  Neither the Company nor any parent, subsidiary or other affiliate of the Company will have any responsibility, liability or obligation to pay Executive&#8217;s taxes arising from or relating to any payments or benefits under this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:12pt">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  This Agreement may be executed in counterparts, each of which will be deemed an original, but all of which together will constitute one and the same instrument.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-10-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:97.92pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By its signature below, each of the parties signifies its acceptance of the terms of this Agreement, in the case of the Company by its duly authorized officer. </font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COMPANY&#160;&#160;&#160;&#160;NAUTILUS BIOTECHNOLOGY, INC.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;By&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Sujal Patel&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Sujal Patel</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Title&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Chief Executive Officer&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Date&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">6&#47;27&#47;2022&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXECUTIVE&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Mary Godwin&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Mary Godwin</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Date&#58;  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">6&#47;27&#47;2022&#160;&#160;&#160;&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">-11-</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>exhibit311-2022q210xq.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ic56b03d2a9af4f28b99ce9e799c4afa7_1"></div><div style="min-height:57.6pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Exhibit 31.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">I, Sujal Patel, certify that&#58;</font></div><div><font><br></font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q of Nautilus Biotechnology, Inc.&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:11.07pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:6pt;padding-left:27pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.844%"><tr><td style="width:1.0%"></td><td style="width:42.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.168%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Date&#58; August&#160;2, 2022</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Sujal Patel </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sujal Patel</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">President and Chief Executive Officer</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Principal Executive Officer)</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>exhibit312-2022q210xq.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="id6b028190b274a65a975ebd5c485c7bd_1"></div><div style="min-height:57.6pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Exhibit 31.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">I, Anna Mowry, certify that&#58;</font></div><div><font><br></font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q of Nautilus Biotechnology, Inc.&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:11.07pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:63pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-top:6pt;padding-left:27pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.844%"><tr><td style="width:1.0%"></td><td style="width:42.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.168%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Date&#58; August&#160;2, 2022</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Anna Mowry</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Anna Mowry</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Principal Financial and Accounting Officer)</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>exhibit321-2022q210xq.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i3d1311bb7f58496bb6d23cb2074b93c2_1"></div><div style="min-height:57.6pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Exhibit 32.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In connection with the Quarterly Report of Nautilus Biotechnology, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ended June&#160;30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Sujal Patel, hereby certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt;padding-left:27pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.844%"><tr><td style="width:1.0%"></td><td style="width:42.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.168%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Date&#58; August&#160;2, 2022</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Sujal Patel </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sujal Patel</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">President and Chief Executive Officer</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Principal Executive Officer)</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>exhibit322-2022q210xq.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ie52ccf65e5b544e2a7900d0f2c3850e8_1"></div><div style="min-height:57.6pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Exhibit 32.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In connection with the Quarterly Report of Nautilus Biotechnology, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the period ended June&#160;30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Anna Mowry, hereby certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div><font><br></font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:6pt"><font><br></font></div><div style="margin-top:6pt;padding-left:27pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.844%"><tr><td style="width:1.0%"></td><td style="width:42.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.168%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.795%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Date&#58; August&#160;2, 2022</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Anna Mowry</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Anna Mowry</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Principal Financial and Accounting Officer)</font></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>naut-20220630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9cc3a1fd-7e26-418c-9538-c00b184efabf,g:ab9b2c40-7a18-466f-af91-0013c7c3cb4b-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:naut="http://www.nautilus.bio/20220630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.nautilus.bio/20220630">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="naut-20220630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="naut-20220630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="naut-20220630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="naut-20220630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.nautilus.bio/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1402401 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperations" roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations">
        <link:definition>1003003 - Statement - Condensed Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveLoss" roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss">
        <link:definition>1004004 - Statement - Condensed Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit" roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit">
        <link:definition>1005005 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficitParenthetical" roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficitParenthetical">
        <link:definition>1406402 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>1007006 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofBusinessandBasisofPresentation" roleURI="http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentation">
        <link:definition>2101101 - Disclosure - Description of Business and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionofBusinessandBasisofPresentationDetails" roleURI="http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails">
        <link:definition>2402403 - Disclosure - Description of Business and Basis of Presentation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://www.nautilus.bio/role/SignificantAccountingPolicies">
        <link:definition>2103102 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies">
        <link:definition>2204201 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesDetails" roleURI="http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails">
        <link:definition>2405404 - Disclosure - Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReverseRecapitalization" roleURI="http://www.nautilus.bio/role/ReverseRecapitalization">
        <link:definition>2106103 - Disclosure - Reverse Recapitalization</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReverseRecapitalizationTables" roleURI="http://www.nautilus.bio/role/ReverseRecapitalizationTables">
        <link:definition>2307301 - Disclosure - Reverse Recapitalization (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReverseRecapitalizationNarrativeDetails" roleURI="http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails">
        <link:definition>2408405 - Disclosure - Reverse Recapitalization - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ReverseRecapitalizationSharesReconciliationDetails" roleURI="http://www.nautilus.bio/role/ReverseRecapitalizationSharesReconciliationDetails">
        <link:definition>2409406 - Disclosure - Reverse Recapitalization - Shares Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.nautilus.bio/role/FairValueMeasurements">
        <link:definition>2110104 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.nautilus.bio/role/FairValueMeasurementsTables">
        <link:definition>2311302 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails" roleURI="http://www.nautilus.bio/role/FairValueMeasurementsDetails">
        <link:definition>2412407 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompositionofCertainCondensedConsolidatedFinancialStatementLineItems" roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItems">
        <link:definition>2113105 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsTables" roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsTables">
        <link:definition>2314303 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails" roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails">
        <link:definition>2415408 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items - Property, Plant and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsOtherLongtermAssetsDetails" roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsOtherLongtermAssetsDetails">
        <link:definition>2416409 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items - Other Long-term Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsAccruedExpensesandOtherLiabilitiesDetails" roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsAccruedExpensesandOtherLiabilitiesDetails">
        <link:definition>2417410 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items - Accrued Expenses and Other Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsCashCashEquivalentsandRestrictedCashDetails" roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsCashCashEquivalentsandRestrictedCashDetails">
        <link:definition>2418411 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items - Cash, Cash Equivalents and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableConvertiblePreferredStock" roleURI="http://www.nautilus.bio/role/RedeemableConvertiblePreferredStock">
        <link:definition>2119106 - Disclosure - Redeemable Convertible Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableConvertiblePreferredStockNarrativeDetails" roleURI="http://www.nautilus.bio/role/RedeemableConvertiblePreferredStockNarrativeDetails">
        <link:definition>2420412 - Disclosure - Redeemable Convertible Preferred Stock - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStock" roleURI="http://www.nautilus.bio/role/CommonStock">
        <link:definition>2121107 - Disclosure - Common Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockTables" roleURI="http://www.nautilus.bio/role/CommonStockTables">
        <link:definition>2322304 - Disclosure - Common Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockNarrativeDetails" roleURI="http://www.nautilus.bio/role/CommonStockNarrativeDetails">
        <link:definition>2423413 - Disclosure - Common Stock - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockCommonStockReservedforFutureIssuanceDetails" roleURI="http://www.nautilus.bio/role/CommonStockCommonStockReservedforFutureIssuanceDetails">
        <link:definition>2424414 - Disclosure - Common Stock - Common Stock Reserved for Future Issuance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.nautilus.bio/role/IncomeTaxes">
        <link:definition>2125108 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.nautilus.bio/role/IncomeTaxesNarrativeDetails">
        <link:definition>2426415 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockOptionPlanandStockbasedCompensation" roleURI="http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensation">
        <link:definition>2127109 - Disclosure - Stock Option Plan and Stock-based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockOptionPlanandStockbasedCompensationTables" roleURI="http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationTables">
        <link:definition>2328305 - Disclosure - Stock Option Plan and Stock-based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockOptionPlanandStockbasedCompensationNarrativeDetails" roleURI="http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails">
        <link:definition>2429416 - Disclosure - Stock Option Plan and Stock-based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails" roleURI="http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails">
        <link:definition>2430417 - Disclosure - Stock Option Plan and Stock-based Compensation - Significant Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockOptionPlanandStockbasedCompensationStockOptionActivityDetails" roleURI="http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockOptionActivityDetails">
        <link:definition>2431418 - Disclosure - Stock Option Plan and Stock-based Compensation - Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockOptionPlanandStockbasedCompensationStockBasedCompensationExpenseDetails" roleURI="http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockBasedCompensationExpenseDetails">
        <link:definition>2432419 - Disclosure - Stock Option Plan and Stock-based Compensation - Stock Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingencies" roleURI="http://www.nautilus.bio/role/CommitmentandContingencies">
        <link:definition>2133110 - Disclosure - Commitment and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesTables" roleURI="http://www.nautilus.bio/role/CommitmentandContingenciesTables">
        <link:definition>2334306 - Disclosure - Commitment and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesNarrativeDetails" roleURI="http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails">
        <link:definition>2435420 - Disclosure - Commitment and Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesComponentsofLeaseCostDetails" roleURI="http://www.nautilus.bio/role/CommitmentandContingenciesComponentsofLeaseCostDetails">
        <link:definition>2436421 - Disclosure - Commitment and Contingencies - Components of Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesLeaseMaturityDetails" roleURI="http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails">
        <link:definition>2437422 - Disclosure - Commitment and Contingencies - Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesLeaseMaturityDetails_1" roleURI="http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails_1">
        <link:definition>2437422 - Disclosure - Commitment and Contingencies - Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasicandDilutedNetLossperShare" roleURI="http://www.nautilus.bio/role/BasicandDilutedNetLossperShare">
        <link:definition>2138111 - Disclosure - Basic and Diluted Net Loss per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasicandDilutedNetLossperShareTables" roleURI="http://www.nautilus.bio/role/BasicandDilutedNetLossperShareTables">
        <link:definition>2339307 - Disclosure - Basic and Diluted Net Loss per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasicandDilutedNetLossperShareBasicandDilutedNotLossperShareDetails" roleURI="http://www.nautilus.bio/role/BasicandDilutedNetLossperShareBasicandDilutedNotLossperShareDetails">
        <link:definition>2440423 - Disclosure - Basic and Diluted Net Loss per Share - Basic and Diluted Not Loss per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasicandDilutedNetLossperShareAntidilutiveSecuritiesDetails" roleURI="http://www.nautilus.bio/role/BasicandDilutedNetLossperShareAntidilutiveSecuritiesDetails">
        <link:definition>2441424 - Disclosure - Basic and Diluted Net Loss per Share - Antidilutive Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="naut_DeferredStockIssuanceCostsReclassifiedToEquity" abstract="false" name="DeferredStockIssuanceCostsReclassifiedToEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="naut_PaymentsOfReverseRecapitalizationTransactionCosts" abstract="false" name="PaymentsOfReverseRecapitalizationTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="naut_A2017EquityIncentivePlanMember" abstract="true" name="A2017EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="naut_StockIssuedDuringPeriodSharesReverseRecapitalization" abstract="false" name="StockIssuedDuringPeriodSharesReverseRecapitalization" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="naut_ReverseRecapitalizationDisclosureTextBlock" abstract="false" name="ReverseRecapitalizationDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction" abstract="false" name="ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="naut_LaboratoryEquipmentMember" abstract="true" name="LaboratoryEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="naut_CashAcquiredThroughReverseRecapitalization" abstract="false" name="CashAcquiredThroughReverseRecapitalization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" abstract="false" name="ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="naut_StockIssuedDuringPeriodSharesWarrantsExercised" abstract="false" name="StockIssuedDuringPeriodSharesWarrantsExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="naut_DeferredStockIssuanceCosts" abstract="false" name="DeferredStockIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="naut_AccruedFacilities" abstract="false" name="AccruedFacilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="naut_ScheduleOfReverseRecapitalizationTable" abstract="true" name="ScheduleOfReverseRecapitalizationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="naut_AccruedResearchAndDevelopment" abstract="false" name="AccruedResearchAndDevelopment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="naut_RecapitalizationExchangeRatio" abstract="false" name="RecapitalizationExchangeRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="naut_DisclosureOfRedeemableConvertiblePreferredStockTextBlock" abstract="false" name="DisclosureOfRedeemableConvertiblePreferredStockTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent" abstract="false" name="AccruedLiabilitiesAndOtherLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="naut_ProceedsFromReverseRecapitalizationTransaction" abstract="false" name="ProceedsFromReverseRecapitalizationTransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="naut_StockConvertedReverseRecapitalization" abstract="false" name="StockConvertedReverseRecapitalization" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="naut_ReverseRecapitalizationAbstract" abstract="true" name="ReverseRecapitalizationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="naut_SanCarlosLeaseImprovementsLineOfCreditMember" abstract="true" name="SanCarlosLeaseImprovementsLineOfCreditMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="naut_September2021ToSeptember2031Member" abstract="true" name="September2021ToSeptember2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="naut_AryaSciencesAcquisitionCorpIIIMember" abstract="true" name="AryaSciencesAcquisitionCorpIIIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="naut_A2021EquityIncentivePlanMember" abstract="true" name="A2021EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="naut_LesseeOperatingLeaseOptionToTerminateLeaseTerm" abstract="false" name="LesseeOperatingLeaseOptionToTerminateLeaseTerm" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="naut_ReverseRecapitalizationCashPaidToShareholders" abstract="false" name="ReverseRecapitalizationCashPaidToShareholders" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="naut_StockIssuedDuringPeriodValueReverseRecapitalization" abstract="false" name="StockIssuedDuringPeriodValueReverseRecapitalization" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="naut_LongTermInvestmentsMember" abstract="true" name="LongTermInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="naut_RecapitalizationExchangeRatioPerShare" abstract="false" name="RecapitalizationExchangeRatioPerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="naut_OperatingLeaseNoncashAdjustment" abstract="false" name="OperatingLeaseNoncashAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="naut_ScheduleOfReverseRecapitalizationTableTextBlock" abstract="false" name="ScheduleOfReverseRecapitalizationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="naut_ReclassificationsOfTemporaryToPermanentEquityShares" abstract="false" name="ReclassificationsOfTemporaryToPermanentEquityShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="naut_February2021ToOctober2021Member" abstract="true" name="February2021ToOctober2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="naut_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="naut_A2021EmployeeStockPurchasePlanMember" abstract="true" name="A2021EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="naut_StockConvertedValueReverseRecapitalization" abstract="false" name="StockConvertedValueReverseRecapitalization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="naut_ModificationToReduceRightOfUseAssetsAndLeaseLiability" abstract="false" name="ModificationToReduceRightOfUseAssetsAndLeaseLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="naut_WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase" abstract="false" name="WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="naut_October2022ToOctober2031Member" abstract="true" name="October2022ToOctober2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="naut_FurnitureFixturesAndOfficeEquipmentMember" abstract="true" name="FurnitureFixturesAndOfficeEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="naut_SeriesSeedRedeemableConvertiblePreferredStockMember" abstract="true" name="SeriesSeedRedeemableConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="naut_ScheduleOfReverseRecapitalizationLineItems" abstract="true" name="ScheduleOfReverseRecapitalizationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>naut-20220630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9cc3a1fd-7e26-418c-9538-c00b184efabf,g:ab9b2c40-7a18-466f-af91-0013c7c3cb4b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="naut-20220630.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_fde0cce7-fdb4-49ae-aaa3-3ad497aafd78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0defd6cd-ccb5-4354-9309-26cb11409c35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_fde0cce7-fdb4-49ae-aaa3-3ad497aafd78" xlink:to="loc_us-gaap_LiabilitiesCurrent_0defd6cd-ccb5-4354-9309-26cb11409c35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_38de42b6-bdbd-4216-9176-86b1320266ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_fde0cce7-fdb4-49ae-aaa3-3ad497aafd78" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_38de42b6-bdbd-4216-9176-86b1320266ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7f7bdb0e-b5f9-49b3-9761-88c55335c77e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_22102a8d-9488-4dd4-92ba-94ab02a638db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7f7bdb0e-b5f9-49b3-9761-88c55335c77e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_22102a8d-9488-4dd4-92ba-94ab02a638db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_f8adb697-dd9a-4ca0-9695-9b0ac4c98d98" xlink:href="naut-20220630.xsd#naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7f7bdb0e-b5f9-49b3-9761-88c55335c77e" xlink:to="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_f8adb697-dd9a-4ca0-9695-9b0ac4c98d98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_3b9a76f0-89fc-40f1-9e02-0e15c1ecda25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7f7bdb0e-b5f9-49b3-9761-88c55335c77e" xlink:to="loc_us-gaap_AccountsPayableCurrent_3b9a76f0-89fc-40f1-9e02-0e15c1ecda25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_26a66ccc-91e8-42c5-953c-28547a9a876e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c322575f-8230-4728-9fd5-f90d8adc31f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_26a66ccc-91e8-42c5-953c-28547a9a876e" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c322575f-8230-4728-9fd5-f90d8adc31f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_9e8b9a6d-34bd-4c32-ad66-38ff1303cdec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_26a66ccc-91e8-42c5-953c-28547a9a876e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_9e8b9a6d-34bd-4c32-ad66-38ff1303cdec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_96c0d8af-f3ec-4711-b1b7-da65fa49cb71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_26a66ccc-91e8-42c5-953c-28547a9a876e" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_96c0d8af-f3ec-4711-b1b7-da65fa49cb71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_9f92f748-c952-4675-b94e-3fa9bf9031b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6cfc2760-96d3-4f31-a3f3-cdf914cb008c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9f92f748-c952-4675-b94e-3fa9bf9031b2" xlink:to="loc_us-gaap_StockholdersEquity_6cfc2760-96d3-4f31-a3f3-cdf914cb008c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_bd533cf3-98f5-46e4-aa0a-591bd56d3e05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9f92f748-c952-4675-b94e-3fa9bf9031b2" xlink:to="loc_us-gaap_Liabilities_bd533cf3-98f5-46e4-aa0a-591bd56d3e05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_534209be-d99d-46da-b2bc-cd2b0faabd8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9f92f748-c952-4675-b94e-3fa9bf9031b2" xlink:to="loc_us-gaap_CommitmentsAndContingencies_534209be-d99d-46da-b2bc-cd2b0faabd8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d4e10b5a-93ae-4334-8a6a-e12d4fc9e0ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a6bef367-35c3-4dc7-967f-e80af28c6767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d4e10b5a-93ae-4334-8a6a-e12d4fc9e0ae" xlink:to="loc_us-gaap_AssetsCurrent_a6bef367-35c3-4dc7-967f-e80af28c6767" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ba40b082-4986-48e8-af25-a4c8308c4486" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d4e10b5a-93ae-4334-8a6a-e12d4fc9e0ae" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ba40b082-4986-48e8-af25-a4c8308c4486" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0b8868f9-491d-46e1-ad39-2c9e7c6550b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d4e10b5a-93ae-4334-8a6a-e12d4fc9e0ae" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0b8868f9-491d-46e1-ad39-2c9e7c6550b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ce899284-7436-48fa-9d44-ef2408d6f9b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d4e10b5a-93ae-4334-8a6a-e12d4fc9e0ae" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_ce899284-7436-48fa-9d44-ef2408d6f9b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_71e1faf1-572b-4f90-a36b-ab2ca0c6cf7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_d4e10b5a-93ae-4334-8a6a-e12d4fc9e0ae" xlink:to="loc_us-gaap_LongTermInvestments_71e1faf1-572b-4f90-a36b-ab2ca0c6cf7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3dcf9c6e-58f6-4006-922c-fd60f0e307d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_4aeeb9da-fba4-4d58-980d-70c47dd55e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3dcf9c6e-58f6-4006-922c-fd60f0e307d9" xlink:to="loc_us-gaap_PreferredStockValue_4aeeb9da-fba4-4d58-980d-70c47dd55e4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_4d4c2943-ecb5-4910-b6e6-9094690634ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3dcf9c6e-58f6-4006-922c-fd60f0e307d9" xlink:to="loc_us-gaap_CommonStockValue_4d4c2943-ecb5-4910-b6e6-9094690634ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_c485f36c-b157-4aef-a694-cdfb49a9eac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3dcf9c6e-58f6-4006-922c-fd60f0e307d9" xlink:to="loc_us-gaap_AdditionalPaidInCapital_c485f36c-b157-4aef-a694-cdfb49a9eac5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5a45f699-1901-478e-a05d-6068e2d12766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3dcf9c6e-58f6-4006-922c-fd60f0e307d9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5a45f699-1901-478e-a05d-6068e2d12766" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8afc69e2-2497-45c0-a699-3d0854a4d3e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_3dcf9c6e-58f6-4006-922c-fd60f0e307d9" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8afc69e2-2497-45c0-a699-3d0854a4d3e9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="naut-20220630.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_8e629683-1271-437f-8df4-d67b957a0372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_743ac682-be82-4c0d-b773-24e08f7c73e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8e629683-1271-437f-8df4-d67b957a0372" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_743ac682-be82-4c0d-b773-24e08f7c73e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_25d655d1-0a6e-4a15-b75f-1e38848740d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8e629683-1271-437f-8df4-d67b957a0372" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_25d655d1-0a6e-4a15-b75f-1e38848740d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f4f38028-5fe2-4af7-a283-8e2782957a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_f01e8d32-bc40-43e0-a015-f4b09b8df6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f4f38028-5fe2-4af7-a283-8e2782957a4e" xlink:to="loc_us-gaap_OperatingExpenses_f01e8d32-bc40-43e0-a015-f4b09b8df6e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_9860cac5-56f5-4da6-b611-2eb12ce246e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_f4f38028-5fe2-4af7-a283-8e2782957a4e" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_9860cac5-56f5-4da6-b611-2eb12ce246e9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="naut-20220630.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_72dd5072-92b4-46d4-b1cb-6c457909e4d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4b4c02d8-8bce-46c7-8725-b628b7aaf5db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_72dd5072-92b4-46d4-b1cb-6c457909e4d3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_4b4c02d8-8bce-46c7-8725-b628b7aaf5db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_64e85cf7-a2bd-43d4-b882-d1ed6fa114a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_72dd5072-92b4-46d4-b1cb-6c457909e4d3" xlink:to="loc_us-gaap_NetIncomeLoss_64e85cf7-a2bd-43d4-b882-d1ed6fa114a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_b32292b3-429d-44d6-bd36-536e7b9db5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_82c8f2ab-2aa4-41d3-8a9f-1ac8445624e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_b32292b3-429d-44d6-bd36-536e7b9db5bb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_82c8f2ab-2aa4-41d3-8a9f-1ac8445624e8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="naut-20220630.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_40ff451a-65ef-4d4a-95a9-c3ca64f970b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8dd4906c-fbdb-40a2-b8d0-469594ddd01b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_40ff451a-65ef-4d4a-95a9-c3ca64f970b5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8dd4906c-fbdb-40a2-b8d0-469594ddd01b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_564b28ec-33a5-4e8f-a2ad-59e92d1ed32e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_40ff451a-65ef-4d4a-95a9-c3ca64f970b5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_564b28ec-33a5-4e8f-a2ad-59e92d1ed32e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a3d5d039-8da2-45d3-813b-856aea4cb1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_40ff451a-65ef-4d4a-95a9-c3ca64f970b5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a3d5d039-8da2-45d3-813b-856aea4cb1eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_57be528b-8b7e-4cc6-ab87-4249ef1be479" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ProceedsFromReverseRecapitalizationTransaction_afb9fcff-1a24-4f39-b420-6888270dcb37" xlink:href="naut-20220630.xsd#naut_ProceedsFromReverseRecapitalizationTransaction"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_57be528b-8b7e-4cc6-ab87-4249ef1be479" xlink:to="loc_naut_ProceedsFromReverseRecapitalizationTransaction_afb9fcff-1a24-4f39-b420-6888270dcb37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_b0f4bf1f-dad3-4282-bc8a-28c01a96efde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_57be528b-8b7e-4cc6-ab87-4249ef1be479" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_b0f4bf1f-dad3-4282-bc8a-28c01a96efde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_0e2bdf2b-39cc-4a96-87af-849c6b6861c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_57be528b-8b7e-4cc6-ab87-4249ef1be479" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_0e2bdf2b-39cc-4a96-87af-849c6b6861c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_182c8578-b000-42e6-aee0-f17223b7dd13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_57be528b-8b7e-4cc6-ab87-4249ef1be479" xlink:to="loc_us-gaap_ProceedsFromStockPlans_182c8578-b000-42e6-aee0-f17223b7dd13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b4960238-cfa8-4ab6-8699-403ca058efdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_b319e6ac-b157-4119-86b4-35f98bf12b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b4960238-cfa8-4ab6-8699-403ca058efdf" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_b319e6ac-b157-4119-86b4-35f98bf12b2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d7758b22-fb4b-42c8-a308-684efa139d65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b4960238-cfa8-4ab6-8699-403ca058efdf" xlink:to="loc_us-gaap_NetIncomeLoss_d7758b22-fb4b-42c8-a308-684efa139d65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_db794316-aee1-479f-8b0f-92f85225508e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b4960238-cfa8-4ab6-8699-403ca058efdf" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_db794316-aee1-479f-8b0f-92f85225508e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_2cae3682-d9c0-404a-b1d5-6fe451c8806d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b4960238-cfa8-4ab6-8699-403ca058efdf" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_2cae3682-d9c0-404a-b1d5-6fe451c8806d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_6fc7cf7c-9d24-4a99-9a0c-ee2d6ca6aecb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b4960238-cfa8-4ab6-8699-403ca058efdf" xlink:to="loc_us-gaap_ShareBasedCompensation_6fc7cf7c-9d24-4a99-9a0c-ee2d6ca6aecb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_4d780e26-94b0-471a-8c6b-1a754f21586f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b4960238-cfa8-4ab6-8699-403ca058efdf" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_4d780e26-94b0-471a-8c6b-1a754f21586f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_f8a8192a-7c15-4dbc-8953-df567681f3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b4960238-cfa8-4ab6-8699-403ca058efdf" xlink:to="loc_us-gaap_Depreciation_f8a8192a-7c15-4dbc-8953-df567681f3e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_84bc5ba5-cd68-4c7c-8422-c1528910082c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b4960238-cfa8-4ab6-8699-403ca058efdf" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_84bc5ba5-cd68-4c7c-8422-c1528910082c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_8269b0fc-bd67-4d65-bc8b-3d2be76bc3f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_b4960238-cfa8-4ab6-8699-403ca058efdf" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_8269b0fc-bd67-4d65-bc8b-3d2be76bc3f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6c52aa08-5efb-44b6-8258-c6ae93e2110c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_ba32a83b-de8d-4881-b781-02d65acf4f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6c52aa08-5efb-44b6-8258-c6ae93e2110c" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_ba32a83b-de8d-4881-b781-02d65acf4f6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5494f024-4b3f-4c85-9fd3-9653628eaf2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6c52aa08-5efb-44b6-8258-c6ae93e2110c" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5494f024-4b3f-4c85-9fd3-9653628eaf2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_9069d2fc-01eb-442f-8bc0-2090f0044db4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6c52aa08-5efb-44b6-8258-c6ae93e2110c" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_9069d2fc-01eb-442f-8bc0-2090f0044db4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#FairValueMeasurementsDetails"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_6eb9cc23-3d4a-49aa-a523-72adfa9dc860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_462ddf5e-95a7-401e-a336-0277f6cf805f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_6eb9cc23-3d4a-49aa-a523-72adfa9dc860" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_462ddf5e-95a7-401e-a336-0277f6cf805f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d2ac0f96-a4a4-42dd-8b89-b588bdaa6a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_6eb9cc23-3d4a-49aa-a523-72adfa9dc860" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d2ac0f96-a4a4-42dd-8b89-b588bdaa6a8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8914c4f1-36ca-4e48-af79-5084f61dc6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_6eb9cc23-3d4a-49aa-a523-72adfa9dc860" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_8914c4f1-36ca-4e48-af79-5084f61dc6d2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_eab4ebbc-8447-413d-80fe-d71509d1fe22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c091272f-83d8-4d22-9272-305af035fe77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_eab4ebbc-8447-413d-80fe-d71509d1fe22" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c091272f-83d8-4d22-9272-305af035fe77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_67a1d58a-a7c2-4116-8adb-882d8bf66e69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_eab4ebbc-8447-413d-80fe-d71509d1fe22" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_67a1d58a-a7c2-4116-8adb-882d8bf66e69" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsOtherLongtermAssetsDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsOtherLongtermAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsOtherLongtermAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_2bc6e812-5beb-4932-baa2-79fd05522b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent_2d285635-dd0f-4f57-95b7-f6dc7542e1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_2bc6e812-5beb-4932-baa2-79fd05522b3b" xlink:to="loc_us-gaap_DepositsAssetsNoncurrent_2d285635-dd0f-4f57-95b7-f6dc7542e1cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_c8bea6b3-ed6d-4f4a-ac6f-6ed10d486d37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_2bc6e812-5beb-4932-baa2-79fd05522b3b" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_c8bea6b3-ed6d-4f4a-ac6f-6ed10d486d37" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsAccruedExpensesandOtherLiabilitiesDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsAccruedExpensesandOtherLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsAccruedExpensesandOtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_f619cf48-bd2d-4716-995c-3254aa86804c" xlink:href="naut-20220630.xsd#naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_AccruedResearchAndDevelopment_3f9a34f7-c774-416f-8fe7-b8d7168772c0" xlink:href="naut-20220630.xsd#naut_AccruedResearchAndDevelopment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_f619cf48-bd2d-4716-995c-3254aa86804c" xlink:to="loc_naut_AccruedResearchAndDevelopment_3f9a34f7-c774-416f-8fe7-b8d7168772c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_03b710dd-8feb-4f80-baaf-eb96e0786d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_f619cf48-bd2d-4716-995c-3254aa86804c" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_03b710dd-8feb-4f80-baaf-eb96e0786d1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_1e1f7580-9509-47c0-a7f3-ddbe6bfa567b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_f619cf48-bd2d-4716-995c-3254aa86804c" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_1e1f7580-9509-47c0-a7f3-ddbe6bfa567b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_AccruedFacilities_fbb56d3e-4a6f-40ce-9845-f104c1518e98" xlink:href="naut-20220630.xsd#naut_AccruedFacilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_f619cf48-bd2d-4716-995c-3254aa86804c" xlink:to="loc_naut_AccruedFacilities_fbb56d3e-4a6f-40ce-9845-f104c1518e98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_dcdee17d-19d5-4457-b1af-6da863f39ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_f619cf48-bd2d-4716-995c-3254aa86804c" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_dcdee17d-19d5-4457-b1af-6da863f39ad9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsCashCashEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_70a5bf95-3f33-40b3-b6fb-15f366decf19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_b29528ea-6042-46d1-886c-156584278896" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_70a5bf95-3f33-40b3-b6fb-15f366decf19" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_b29528ea-6042-46d1-886c-156584278896" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_51506f44-8cf2-423d-b642-3b64d2ff4d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_70a5bf95-3f33-40b3-b6fb-15f366decf19" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_51506f44-8cf2-423d-b642-3b64d2ff4d05" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommonStockCommonStockReservedforFutureIssuanceDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#CommonStockCommonStockReservedforFutureIssuanceDetails"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/CommonStockCommonStockReservedforFutureIssuanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_6a865d2e-98eb-497a-91f6-81d0fd643f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_63ad8988-f8a5-401d-b1f9-7679da655b1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_6a865d2e-98eb-497a-91f6-81d0fd643f6c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_63ad8988-f8a5-401d-b1f9-7679da655b1b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3385d540-6deb-450a-bf7d-d00c17e998b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_6a865d2e-98eb-497a-91f6-81d0fd643f6c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3385d540-6deb-450a-bf7d-d00c17e998b3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommitmentandContingenciesComponentsofLeaseCostDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#CommitmentandContingenciesComponentsofLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/CommitmentandContingenciesComponentsofLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_0c08caec-c834-46e7-bc9c-057eeccb4403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_48fa6d0a-f5ca-4a23-a55a-c9ff4b64bd60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_0c08caec-c834-46e7-bc9c-057eeccb4403" xlink:to="loc_us-gaap_OperatingLeaseCost_48fa6d0a-f5ca-4a23-a55a-c9ff4b64bd60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_639cbf5c-b389-4ec6-94a7-47de03ed4019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_0c08caec-c834-46e7-bc9c-057eeccb4403" xlink:to="loc_us-gaap_VariableLeaseCost_639cbf5c-b389-4ec6-94a7-47de03ed4019" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_4d50c30d-d2a2-409b-9263-f8fbf1aa62d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_0c08caec-c834-46e7-bc9c-057eeccb4403" xlink:to="loc_us-gaap_ShortTermLeaseCost_4d50c30d-d2a2-409b-9263-f8fbf1aa62d4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#CommitmentandContingenciesLeaseMaturityDetails"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_74406237-9105-4565-93e8-16f2a6932d13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_20d355d8-49f1-4a4a-96d2-45e5229c3e32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_74406237-9105-4565-93e8-16f2a6932d13" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_20d355d8-49f1-4a4a-96d2-45e5229c3e32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_cf021420-f8a2-4d02-b28b-b8c2c0f5a565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_74406237-9105-4565-93e8-16f2a6932d13" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_cf021420-f8a2-4d02-b28b-b8c2c0f5a565" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_e8943dd4-8878-4cba-9127-79f4bf1af190" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_74406237-9105-4565-93e8-16f2a6932d13" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_e8943dd4-8878-4cba-9127-79f4bf1af190" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_43991d28-ce6c-4f8d-ac7c-2dfd61df7d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_74406237-9105-4565-93e8-16f2a6932d13" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_43991d28-ce6c-4f8d-ac7c-2dfd61df7d3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour_a7a3fc48-e4e4-484e-8080-2b1503241ce1" xlink:href="naut-20220630.xsd#naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_74406237-9105-4565-93e8-16f2a6932d13" xlink:to="loc_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour_a7a3fc48-e4e4-484e-8080-2b1503241ce1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f4fe823d-4120-407a-8631-0fd9e97eedf6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_74406237-9105-4565-93e8-16f2a6932d13" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f4fe823d-4120-407a-8631-0fd9e97eedf6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails_1" xlink:type="simple" xlink:href="naut-20220630.xsd#CommitmentandContingenciesLeaseMaturityDetails_1"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f2c83dfc-6b83-438c-8e80-b123ad3207c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_30f74f88-55a1-4269-bddd-6d26b2e74fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f2c83dfc-6b83-438c-8e80-b123ad3207c6" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_30f74f88-55a1-4269-bddd-6d26b2e74fbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_3d673129-e066-4c94-a9e6-90861c83178e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f2c83dfc-6b83-438c-8e80-b123ad3207c6" xlink:to="loc_us-gaap_OperatingLeaseLiability_3d673129-e066-4c94-a9e6-90861c83178e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/BasicandDilutedNetLossperShareBasicandDilutedNotLossperShareDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#BasicandDilutedNetLossperShareBasicandDilutedNotLossperShareDetails"/>
  <link:calculationLink xlink:role="http://www.nautilus.bio/role/BasicandDilutedNetLossperShareBasicandDilutedNotLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_91bf0444-8ca4-47b3-ac6c-64e928dffce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_3897e1db-2fc1-4bd0-9cc6-e6b508d2a0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_91bf0444-8ca4-47b3-ac6c-64e928dffce2" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_3897e1db-2fc1-4bd0-9cc6-e6b508d2a0c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase_3f7720ae-1ad1-4899-97b2-32371303d499" xlink:href="naut-20220630.xsd#naut_WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_91bf0444-8ca4-47b3-ac6c-64e928dffce2" xlink:to="loc_naut_WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase_3f7720ae-1ad1-4899-97b2-32371303d499" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ab5098e3-638f-48bc-9bb6-22af0d28cac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_cd2e57ab-b788-4cbf-91ca-e49cde8e801a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ab5098e3-638f-48bc-9bb6-22af0d28cac9" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_cd2e57ab-b788-4cbf-91ca-e49cde8e801a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase_bdc2e4f6-ae1f-441c-940e-852ee3c9c66c" xlink:href="naut-20220630.xsd#naut_WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ab5098e3-638f-48bc-9bb6-22af0d28cac9" xlink:to="loc_naut_WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase_bdc2e4f6-ae1f-441c-940e-852ee3c9c66c" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>naut-20220630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9cc3a1fd-7e26-418c-9538-c00b184efabf,g:ab9b2c40-7a18-466f-af91-0013c7c3cb4b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit" xlink:type="simple" xlink:href="naut-20220630.xsd#CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit" xlink:type="extended" id="i9f11a6341f2a4606b60c334d8778c6bf_CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6b0043ff-dfe6-481f-ac84-0257d46f00ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_29dcafbd-87c5-4ac0-9f34-3830c61576b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6b0043ff-dfe6-481f-ac84-0257d46f00ba" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_29dcafbd-87c5-4ac0-9f34-3830c61576b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_6640b375-22a0-45ac-bba6-5f264d5ed0cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_29dcafbd-87c5-4ac0-9f34-3830c61576b0" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_6640b375-22a0-45ac-bba6-5f264d5ed0cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_ade20f23-0b98-4f11-8ad7-f06c0997d6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_29dcafbd-87c5-4ac0-9f34-3830c61576b0" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_ade20f23-0b98-4f11-8ad7-f06c0997d6b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ReclassificationsOfTemporaryToPermanentEquityShares_2cf63644-7eb1-4a23-a8ab-d4ec8d8749a6" xlink:href="naut-20220630.xsd#naut_ReclassificationsOfTemporaryToPermanentEquityShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_29dcafbd-87c5-4ac0-9f34-3830c61576b0" xlink:to="loc_naut_ReclassificationsOfTemporaryToPermanentEquityShares_2cf63644-7eb1-4a23-a8ab-d4ec8d8749a6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_3b8675ed-5533-43b7-971f-ae0588b81cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_29dcafbd-87c5-4ac0-9f34-3830c61576b0" xlink:to="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_3b8675ed-5533-43b7-971f-ae0588b81cf0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_43290bad-4d95-45db-b236-432fe67d594a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_a4f61ccd-6f52-43b8-9ce2-86b228eb0dec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6b0043ff-dfe6-481f-ac84-0257d46f00ba" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_cacffb95-204b-4945-b920-65388682ad03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_us-gaap_SharesOutstanding_cacffb95-204b-4945-b920-65388682ad03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_beabcda8-c420-49cd-ac19-73ddf172c5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_us-gaap_StockholdersEquity_beabcda8-c420-49cd-ac19-73ddf172c5c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b8942767-fad7-4517-8853-ae15e3c60efa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b8942767-fad7-4517-8853-ae15e3c60efa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0908767b-3ece-4838-8c89-3959884cd9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0908767b-3ece-4838-8c89-3959884cd9b5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_017c4a2a-1764-4e24-9583-37d653328554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_017c4a2a-1764-4e24-9583-37d653328554" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_fca2d591-744b-42c8-8869-d0353262a735" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_fca2d591-744b-42c8-8869-d0353262a735" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_StockIssuedDuringPeriodSharesWarrantsExercised_1e92ede3-c367-4c09-b559-982a544c5977" xlink:href="naut-20220630.xsd#naut_StockIssuedDuringPeriodSharesWarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_naut_StockIssuedDuringPeriodSharesWarrantsExercised_1e92ede3-c367-4c09-b559-982a544c5977" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_26fa7ddc-b53e-4c4d-89f1-d51d95f52e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_26fa7ddc-b53e-4c4d-89f1-d51d95f52e7f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c8be5d2e-68b8-466d-9d3c-99fb971702a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c8be5d2e-68b8-466d-9d3c-99fb971702a2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_StockIssuedDuringPeriodSharesReverseRecapitalization_5b48f1aa-1be0-4d97-823f-b45bcb2fad7f" xlink:href="naut-20220630.xsd#naut_StockIssuedDuringPeriodSharesReverseRecapitalization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_naut_StockIssuedDuringPeriodSharesReverseRecapitalization_5b48f1aa-1be0-4d97-823f-b45bcb2fad7f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_StockIssuedDuringPeriodValueReverseRecapitalization_4040b14d-2107-43ea-925c-b35ed32b9f28" xlink:href="naut-20220630.xsd#naut_StockIssuedDuringPeriodValueReverseRecapitalization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_naut_StockIssuedDuringPeriodValueReverseRecapitalization_4040b14d-2107-43ea-925c-b35ed32b9f28" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f54897b3-1324-4d50-8d7f-b85e6bcccf61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f54897b3-1324-4d50-8d7f-b85e6bcccf61" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_216bc12c-25ce-43ca-9d35-4e1c6548cfa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_216bc12c-25ce-43ca-9d35-4e1c6548cfa3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b0214f2b-490c-4b4b-ad2e-bdbe245582a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_us-gaap_NetIncomeLoss_b0214f2b-490c-4b4b-ad2e-bdbe245582a6" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_02f969f7-6958-4ad2-b3f2-a00a4fe365d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_390141aa-0592-4f68-80d9-9aa1a159f776" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2755d0e4-4db0-4967-8b66-6f6e6128ecea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_6b0043ff-dfe6-481f-ac84-0257d46f00ba" xlink:to="loc_us-gaap_StatementTable_2755d0e4-4db0-4967-8b66-6f6e6128ecea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5bd69cc0-f4f2-4e78-afa0-b61bfe436369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2755d0e4-4db0-4967-8b66-6f6e6128ecea" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5bd69cc0-f4f2-4e78-afa0-b61bfe436369" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5bd69cc0-f4f2-4e78-afa0-b61bfe436369_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5bd69cc0-f4f2-4e78-afa0-b61bfe436369" xlink:to="loc_us-gaap_EquityComponentDomain_5bd69cc0-f4f2-4e78-afa0-b61bfe436369_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bc395324-2507-444e-9596-b9ce07634a58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5bd69cc0-f4f2-4e78-afa0-b61bfe436369" xlink:to="loc_us-gaap_EquityComponentDomain_bc395324-2507-444e-9596-b9ce07634a58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e6f73242-730e-401d-bb5e-003ffb8e11af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bc395324-2507-444e-9596-b9ce07634a58" xlink:to="loc_us-gaap_CommonStockMember_e6f73242-730e-401d-bb5e-003ffb8e11af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_0c425600-0432-47c9-aeb4-0601c7a2ee3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bc395324-2507-444e-9596-b9ce07634a58" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_0c425600-0432-47c9-aeb4-0601c7a2ee3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9dcbc1a8-a56e-487b-9ae4-87c4f45c6796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bc395324-2507-444e-9596-b9ce07634a58" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9dcbc1a8-a56e-487b-9ae4-87c4f45c6796" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_7f2defa8-d0cb-4148-b1b8-7499cc80585d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_bc395324-2507-444e-9596-b9ce07634a58" xlink:to="loc_us-gaap_RetainedEarningsMember_7f2defa8-d0cb-4148-b1b8-7499cc80585d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_498c4f37-5d90-4d27-a0dc-bd6c6153dfa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2755d0e4-4db0-4967-8b66-6f6e6128ecea" xlink:to="loc_us-gaap_StatementClassOfStockAxis_498c4f37-5d90-4d27-a0dc-bd6c6153dfa2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_498c4f37-5d90-4d27-a0dc-bd6c6153dfa2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_498c4f37-5d90-4d27-a0dc-bd6c6153dfa2" xlink:to="loc_us-gaap_ClassOfStockDomain_498c4f37-5d90-4d27-a0dc-bd6c6153dfa2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_169058c6-6aa8-4409-91a8-96ad0f36869a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_498c4f37-5d90-4d27-a0dc-bd6c6153dfa2" xlink:to="loc_us-gaap_ClassOfStockDomain_169058c6-6aa8-4409-91a8-96ad0f36869a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_SeriesSeedRedeemableConvertiblePreferredStockMember_f39b3076-10f4-469c-8b68-b163d08d2132" xlink:href="naut-20220630.xsd#naut_SeriesSeedRedeemableConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_169058c6-6aa8-4409-91a8-96ad0f36869a" xlink:to="loc_naut_SeriesSeedRedeemableConvertiblePreferredStockMember_f39b3076-10f4-469c-8b68-b163d08d2132" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_50aaf074-0109-4ce5-b236-c088a82f1ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_169058c6-6aa8-4409-91a8-96ad0f36869a" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_50aaf074-0109-4ce5-b236-c088a82f1ad9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_3b0a4d18-c054-41a3-a2c1-82a18e01546f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_169058c6-6aa8-4409-91a8-96ad0f36869a" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_3b0a4d18-c054-41a3-a2c1-82a18e01546f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#DescriptionofBusinessandBasisofPresentationDetails"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails" xlink:type="extended" id="i06b9cb5ba2784696a5b24ddca15a8ad7_DescriptionofBusinessandBasisofPresentationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_b1ddef85-8664-4013-bd9d-524dccb6ab9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_b9d457ff-1ff8-4fdd-bdc2-0da5d16bdaee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b1ddef85-8664-4013-bd9d-524dccb6ab9a" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_b9d457ff-1ff8-4fdd-bdc2-0da5d16bdaee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_da66bf44-d2e9-4720-92e2-1a66189a19cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b1ddef85-8664-4013-bd9d-524dccb6ab9a" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_da66bf44-d2e9-4720-92e2-1a66189a19cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_caa836ae-b3d3-4b78-bd27-ffc31b025023" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b1ddef85-8664-4013-bd9d-524dccb6ab9a" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_caa836ae-b3d3-4b78-bd27-ffc31b025023" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b68ac3e5-2228-48e4-ac20-acc559b192d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b1ddef85-8664-4013-bd9d-524dccb6ab9a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b68ac3e5-2228-48e4-ac20-acc559b192d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction_3cc77dd3-3b8d-4c43-af81-ff9309ab98b3" xlink:href="naut-20220630.xsd#naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b1ddef85-8664-4013-bd9d-524dccb6ab9a" xlink:to="loc_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction_3cc77dd3-3b8d-4c43-af81-ff9309ab98b3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_PaymentsOfReverseRecapitalizationTransactionCosts_eadb6e1e-4b14-42cf-8687-66dbf20aa13c" xlink:href="naut-20220630.xsd#naut_PaymentsOfReverseRecapitalizationTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b1ddef85-8664-4013-bd9d-524dccb6ab9a" xlink:to="loc_naut_PaymentsOfReverseRecapitalizationTransactionCosts_eadb6e1e-4b14-42cf-8687-66dbf20aa13c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_ea1007fb-8644-43b8-b66a-cfd88689fb24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b1ddef85-8664-4013-bd9d-524dccb6ab9a" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_ea1007fb-8644-43b8-b66a-cfd88689fb24" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_0b314b4e-da4e-496b-8615-d408798f0678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b1ddef85-8664-4013-bd9d-524dccb6ab9a" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_0b314b4e-da4e-496b-8615-d408798f0678" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_560c40d8-2b70-4981-a95c-081a45885c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_0b314b4e-da4e-496b-8615-d408798f0678" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_560c40d8-2b70-4981-a95c-081a45885c4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_560c40d8-2b70-4981-a95c-081a45885c4f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_560c40d8-2b70-4981-a95c-081a45885c4f" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_560c40d8-2b70-4981-a95c-081a45885c4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c3e73b7d-c475-4c3b-b1f0-ea5ea36459fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_560c40d8-2b70-4981-a95c-081a45885c4f" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c3e73b7d-c475-4c3b-b1f0-ea5ea36459fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_41e39a40-68ce-4572-bed5-0918084bb27b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c3e73b7d-c475-4c3b-b1f0-ea5ea36459fb" xlink:to="loc_us-gaap_PrivatePlacementMember_41e39a40-68ce-4572-bed5-0918084bb27b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#ReverseRecapitalizationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails" xlink:type="extended" id="ie41c4206a9fd41afa52eadbb30df722a_ReverseRecapitalizationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:href="naut-20220630.xsd#naut_ScheduleOfReverseRecapitalizationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_StockConvertedValueReverseRecapitalization_fe1b3c09-f803-42ea-91d8-aa6fcbd9ec6e" xlink:href="naut-20220630.xsd#naut_StockConvertedValueReverseRecapitalization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_naut_StockConvertedValueReverseRecapitalization_fe1b3c09-f803-42ea-91d8-aa6fcbd9ec6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_RecapitalizationExchangeRatioPerShare_98be0af5-03ac-4b5e-a2bb-f47ba082e169" xlink:href="naut-20220630.xsd#naut_RecapitalizationExchangeRatioPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_naut_RecapitalizationExchangeRatioPerShare_98be0af5-03ac-4b5e-a2bb-f47ba082e169" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_RecapitalizationExchangeRatio_de74e869-771d-4813-a730-95cdde16a808" xlink:href="naut-20220630.xsd#naut_RecapitalizationExchangeRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_naut_RecapitalizationExchangeRatio_de74e869-771d-4813-a730-95cdde16a808" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_c73fe11a-b582-4031-8dd1-6b4c081612fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_c73fe11a-b582-4031-8dd1-6b4c081612fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_StockConvertedReverseRecapitalization_f876ca84-6eb8-4932-a5bf-76240e7aa267" xlink:href="naut-20220630.xsd#naut_StockConvertedReverseRecapitalization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_naut_StockConvertedReverseRecapitalization_f876ca84-6eb8-4932-a5bf-76240e7aa267" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e7621bda-1428-4676-8a93-3c204d1ff83a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e7621bda-1428-4676-8a93-3c204d1ff83a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_1a63ca61-47bb-4c32-b376-cd08e3a5d2ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_1a63ca61-47bb-4c32-b376-cd08e3a5d2ab" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFairValueDisclosure_74eceee4-201a-4015-93e8-2b1a1396b259" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_us-gaap_EquityFairValueDisclosure_74eceee4-201a-4015-93e8-2b1a1396b259" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4cbc3889-6ba0-4c46-87b2-2f9a2cc82e23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4cbc3889-6ba0-4c46-87b2-2f9a2cc82e23" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ProceedsFromReverseRecapitalizationTransaction_9911b8a9-191b-400a-b0f7-a5a11105b340" xlink:href="naut-20220630.xsd#naut_ProceedsFromReverseRecapitalizationTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_naut_ProceedsFromReverseRecapitalizationTransaction_9911b8a9-191b-400a-b0f7-a5a11105b340" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_CashAcquiredThroughReverseRecapitalization_5d95e85d-6167-4eba-8438-cde3c950bd6a" xlink:href="naut-20220630.xsd#naut_CashAcquiredThroughReverseRecapitalization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_naut_CashAcquiredThroughReverseRecapitalization_5d95e85d-6167-4eba-8438-cde3c950bd6a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ReverseRecapitalizationCashPaidToShareholders_6b1db886-b66f-42f5-af57-6b6424b9d0a5" xlink:href="naut-20220630.xsd#naut_ReverseRecapitalizationCashPaidToShareholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_naut_ReverseRecapitalizationCashPaidToShareholders_6b1db886-b66f-42f5-af57-6b6424b9d0a5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_de4839e3-b6e4-49a5-b0a4-bd6c06141ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_de4839e3-b6e4-49a5-b0a4-bd6c06141ed8" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_PaymentsOfReverseRecapitalizationTransactionCosts_6f094583-f4ac-4778-bedc-b6e97c25c080" xlink:href="naut-20220630.xsd#naut_PaymentsOfReverseRecapitalizationTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_naut_PaymentsOfReverseRecapitalizationTransactionCosts_6f094583-f4ac-4778-bedc-b6e97c25c080" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ScheduleOfReverseRecapitalizationTable_b1636068-091f-4185-879e-2155d5594c1c" xlink:href="naut-20220630.xsd#naut_ScheduleOfReverseRecapitalizationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_naut_ScheduleOfReverseRecapitalizationTable_b1636068-091f-4185-879e-2155d5594c1c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_486fca12-5322-4769-ac45-3589cd442225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationTable_b1636068-091f-4185-879e-2155d5594c1c" xlink:to="loc_us-gaap_AwardTypeAxis_486fca12-5322-4769-ac45-3589cd442225" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_486fca12-5322-4769-ac45-3589cd442225_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_486fca12-5322-4769-ac45-3589cd442225" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_486fca12-5322-4769-ac45-3589cd442225_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d24e507d-09a4-4712-ae14-d2beab6e51f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_486fca12-5322-4769-ac45-3589cd442225" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d24e507d-09a4-4712-ae14-d2beab6e51f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9db68f5d-57b5-443d-a842-717fd2a34e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d24e507d-09a4-4712-ae14-d2beab6e51f4" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9db68f5d-57b5-443d-a842-717fd2a34e08" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_9aacad2c-9ba4-430a-9970-d24ba8b9496c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationTable_b1636068-091f-4185-879e-2155d5594c1c" xlink:to="loc_dei_LegalEntityAxis_9aacad2c-9ba4-430a-9970-d24ba8b9496c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9aacad2c-9ba4-430a-9970-d24ba8b9496c_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_9aacad2c-9ba4-430a-9970-d24ba8b9496c" xlink:to="loc_dei_EntityDomain_9aacad2c-9ba4-430a-9970-d24ba8b9496c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_203e459a-d134-41af-a728-85e05b246352" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_9aacad2c-9ba4-430a-9970-d24ba8b9496c" xlink:to="loc_dei_EntityDomain_203e459a-d134-41af-a728-85e05b246352" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_AryaSciencesAcquisitionCorpIIIMember_f2cc320f-7498-48f7-b807-121005f04512" xlink:href="naut-20220630.xsd#naut_AryaSciencesAcquisitionCorpIIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_203e459a-d134-41af-a728-85e05b246352" xlink:to="loc_naut_AryaSciencesAcquisitionCorpIIIMember_f2cc320f-7498-48f7-b807-121005f04512" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_fb070d15-db5c-419c-8714-b2d80d415400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationTable_b1636068-091f-4185-879e-2155d5594c1c" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_fb070d15-db5c-419c-8714-b2d80d415400" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fb070d15-db5c-419c-8714-b2d80d415400_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_fb070d15-db5c-419c-8714-b2d80d415400" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_fb070d15-db5c-419c-8714-b2d80d415400_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_78ac5808-a53a-4ecd-b378-a254b9b48e56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_fb070d15-db5c-419c-8714-b2d80d415400" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_78ac5808-a53a-4ecd-b378-a254b9b48e56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_c4b805e2-d25d-402f-a302-e95b02338dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_78ac5808-a53a-4ecd-b378-a254b9b48e56" xlink:to="loc_us-gaap_PrivatePlacementMember_c4b805e2-d25d-402f-a302-e95b02338dd0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/ReverseRecapitalizationSharesReconciliationDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#ReverseRecapitalizationSharesReconciliationDetails"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/ReverseRecapitalizationSharesReconciliationDetails" xlink:type="extended" id="i4708e2ec7f7b426ca4c2330df8f30306_ReverseRecapitalizationSharesReconciliationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_naut_ScheduleOfReverseRecapitalizationLineItems_8a9ece0c-cc7e-48b7-adb1-baf064dd5534" xlink:href="naut-20220630.xsd#naut_ScheduleOfReverseRecapitalizationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_c514de95-7fa4-48cb-b829-67855037a5c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_8a9ece0c-cc7e-48b7-adb1-baf064dd5534" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_c514de95-7fa4-48cb-b829-67855037a5c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_84e1bf21-a043-43b6-95ee-737c01ad80cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_8a9ece0c-cc7e-48b7-adb1-baf064dd5534" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_84e1bf21-a043-43b6-95ee-737c01ad80cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_7a6409e2-2d5a-4d2a-98c6-59403482c6e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_8a9ece0c-cc7e-48b7-adb1-baf064dd5534" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_7a6409e2-2d5a-4d2a-98c6-59403482c6e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e6277326-b0ec-46d7-a295-cae14ee7393d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_8a9ece0c-cc7e-48b7-adb1-baf064dd5534" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e6277326-b0ec-46d7-a295-cae14ee7393d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_StockIssuedDuringPeriodSharesReverseRecapitalization_e43cfaf9-3208-4974-998d-6d7253481530" xlink:href="naut-20220630.xsd#naut_StockIssuedDuringPeriodSharesReverseRecapitalization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_8a9ece0c-cc7e-48b7-adb1-baf064dd5534" xlink:to="loc_naut_StockIssuedDuringPeriodSharesReverseRecapitalization_e43cfaf9-3208-4974-998d-6d7253481530" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_StockConvertedReverseRecapitalization_c7e17504-ca7c-43ae-a0d6-f760644f534c" xlink:href="naut-20220630.xsd#naut_StockConvertedReverseRecapitalization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_8a9ece0c-cc7e-48b7-adb1-baf064dd5534" xlink:to="loc_naut_StockConvertedReverseRecapitalization_c7e17504-ca7c-43ae-a0d6-f760644f534c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ScheduleOfReverseRecapitalizationTable_9418a8a2-9713-4a89-b9e8-81554ed8f086" xlink:href="naut-20220630.xsd#naut_ScheduleOfReverseRecapitalizationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_8a9ece0c-cc7e-48b7-adb1-baf064dd5534" xlink:to="loc_naut_ScheduleOfReverseRecapitalizationTable_9418a8a2-9713-4a89-b9e8-81554ed8f086" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c22977b7-6c83-4c33-848d-de02f315b3a9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationTable_9418a8a2-9713-4a89-b9e8-81554ed8f086" xlink:to="loc_dei_LegalEntityAxis_c22977b7-6c83-4c33-848d-de02f315b3a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c22977b7-6c83-4c33-848d-de02f315b3a9_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_c22977b7-6c83-4c33-848d-de02f315b3a9" xlink:to="loc_dei_EntityDomain_c22977b7-6c83-4c33-848d-de02f315b3a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_51e4a2d7-dd99-4060-b7a1-12b901ec132e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_c22977b7-6c83-4c33-848d-de02f315b3a9" xlink:to="loc_dei_EntityDomain_51e4a2d7-dd99-4060-b7a1-12b901ec132e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_AryaSciencesAcquisitionCorpIIIMember_5ad429aa-909e-496f-ac2e-2df0963dafe3" xlink:href="naut-20220630.xsd#naut_AryaSciencesAcquisitionCorpIIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_51e4a2d7-dd99-4060-b7a1-12b901ec132e" xlink:to="loc_naut_AryaSciencesAcquisitionCorpIIIMember_5ad429aa-909e-496f-ac2e-2df0963dafe3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#FairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/FairValueMeasurementsDetails" xlink:type="extended" id="i978655e5420e438880e372895943597f_FairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a5e0bdd8-2b38-4b6c-9689-c502784d1ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ec2ebb38-faa1-4595-a28e-4de16b090f21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a5e0bdd8-2b38-4b6c-9689-c502784d1ca9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ec2ebb38-faa1-4595-a28e-4de16b090f21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_710c5657-325d-4082-9d73-edc1cd9dde08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a5e0bdd8-2b38-4b6c-9689-c502784d1ca9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_710c5657-325d-4082-9d73-edc1cd9dde08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c61a5336-f1c1-4a94-8cfa-b936cba6dbb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a5e0bdd8-2b38-4b6c-9689-c502784d1ca9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c61a5336-f1c1-4a94-8cfa-b936cba6dbb0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c7f3a5d5-293b-492d-9505-6fe33fe136de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a5e0bdd8-2b38-4b6c-9689-c502784d1ca9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c7f3a5d5-293b-492d-9505-6fe33fe136de" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4b234283-92e9-4970-99a2-f7814ee88cba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a5e0bdd8-2b38-4b6c-9689-c502784d1ca9" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4b234283-92e9-4970-99a2-f7814ee88cba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_264c5f84-d203-4b95-846a-920e5b290edb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4b234283-92e9-4970-99a2-f7814ee88cba" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_264c5f84-d203-4b95-846a-920e5b290edb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_264c5f84-d203-4b95-846a-920e5b290edb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_264c5f84-d203-4b95-846a-920e5b290edb" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_264c5f84-d203-4b95-846a-920e5b290edb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_4630b254-dc87-4d53-be8a-90a48da2c4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_264c5f84-d203-4b95-846a-920e5b290edb" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_4630b254-dc87-4d53-be8a-90a48da2c4f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_964bcb91-1b1e-4809-8c9f-d240ec763821" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_4630b254-dc87-4d53-be8a-90a48da2c4f9" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_964bcb91-1b1e-4809-8c9f-d240ec763821" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1b362c77-aacd-499d-ac7d-05d3af8e743b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4b234283-92e9-4970-99a2-f7814ee88cba" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1b362c77-aacd-499d-ac7d-05d3af8e743b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1b362c77-aacd-499d-ac7d-05d3af8e743b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1b362c77-aacd-499d-ac7d-05d3af8e743b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_1b362c77-aacd-499d-ac7d-05d3af8e743b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8a8a20f8-134a-4995-a0b2-3df133b1cf8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1b362c77-aacd-499d-ac7d-05d3af8e743b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8a8a20f8-134a-4995-a0b2-3df133b1cf8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_12e4448e-78b8-45f7-8d40-684e2acbb12e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8a8a20f8-134a-4995-a0b2-3df133b1cf8f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_12e4448e-78b8-45f7-8d40-684e2acbb12e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_33b2a1f7-fdaa-4758-9378-6972af6c602e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8a8a20f8-134a-4995-a0b2-3df133b1cf8f" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_33b2a1f7-fdaa-4758-9378-6972af6c602e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2e792305-818f-48de-ab02-5ac099550827" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4b234283-92e9-4970-99a2-f7814ee88cba" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2e792305-818f-48de-ab02-5ac099550827" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2e792305-818f-48de-ab02-5ac099550827_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2e792305-818f-48de-ab02-5ac099550827" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2e792305-818f-48de-ab02-5ac099550827_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_95037847-99a2-4b20-8eed-3e18ee7ee6df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2e792305-818f-48de-ab02-5ac099550827" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_95037847-99a2-4b20-8eed-3e18ee7ee6df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_31bdff55-1da4-4ea9-b368-6a16ac578cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MutualFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_95037847-99a2-4b20-8eed-3e18ee7ee6df" xlink:to="loc_us-gaap_MutualFundMember_31bdff55-1da4-4ea9-b368-6a16ac578cbb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_f1a9fc2f-0fcb-4080-af8d-b44034c211c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_95037847-99a2-4b20-8eed-3e18ee7ee6df" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_f1a9fc2f-0fcb-4080-af8d-b44034c211c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_e7a85dd3-7e5e-4ef2-9a9d-ace8236ac4dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_95037847-99a2-4b20-8eed-3e18ee7ee6df" xlink:to="loc_us-gaap_CommercialPaperMember_e7a85dd3-7e5e-4ef2-9a9d-ace8236ac4dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_eda12d01-bf08-41d8-9248-79eb9173c22e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_95037847-99a2-4b20-8eed-3e18ee7ee6df" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_eda12d01-bf08-41d8-9248-79eb9173c22e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_ea5a6e45-edbc-4743-b583-6a068a49fc27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_95037847-99a2-4b20-8eed-3e18ee7ee6df" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_ea5a6e45-edbc-4743-b583-6a068a49fc27" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_b3e8b362-d093-489e-8a7e-0f2b3c6b12d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4b234283-92e9-4970-99a2-f7814ee88cba" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_b3e8b362-d093-489e-8a7e-0f2b3c6b12d3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b3e8b362-d093-489e-8a7e-0f2b3c6b12d3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b3e8b362-d093-489e-8a7e-0f2b3c6b12d3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b3e8b362-d093-489e-8a7e-0f2b3c6b12d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_77a9cbaa-38ea-452b-b357-7b849c26012b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b3e8b362-d093-489e-8a7e-0f2b3c6b12d3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_77a9cbaa-38ea-452b-b357-7b849c26012b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_7536801f-30fc-441f-81ff-f1e69fa319b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_77a9cbaa-38ea-452b-b357-7b849c26012b" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_7536801f-30fc-441f-81ff-f1e69fa319b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_842adee7-386d-4586-aecd-2b0cb5acda53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_77a9cbaa-38ea-452b-b357-7b849c26012b" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_842adee7-386d-4586-aecd-2b0cb5acda53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_LongTermInvestmentsMember_55d5d7e0-0f73-4a01-9573-c7b0c42e93e8" xlink:href="naut-20220630.xsd#naut_LongTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_77a9cbaa-38ea-452b-b357-7b849c26012b" xlink:to="loc_naut_LongTermInvestmentsMember_55d5d7e0-0f73-4a01-9573-c7b0c42e93e8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails" xlink:type="extended" id="i0400675b3efc44479e9ef4488428ae5a_CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4ef677db-26d6-4f3f-9d25-9cff616040f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_ed537b1b-aa77-4d26-a973-3529ef3db7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4ef677db-26d6-4f3f-9d25-9cff616040f4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_ed537b1b-aa77-4d26-a973-3529ef3db7ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3cc5e978-83a5-405b-b22b-d25e9b4fc2e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4ef677db-26d6-4f3f-9d25-9cff616040f4" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3cc5e978-83a5-405b-b22b-d25e9b4fc2e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a3972be0-18b7-4f48-a1d5-0042c410c1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4ef677db-26d6-4f3f-9d25-9cff616040f4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a3972be0-18b7-4f48-a1d5-0042c410c1c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_5cff76f7-6a28-4081-bf10-2f171d43cf27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4ef677db-26d6-4f3f-9d25-9cff616040f4" xlink:to="loc_us-gaap_Depreciation_5cff76f7-6a28-4081-bf10-2f171d43cf27" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_edfa0f60-2179-43f9-8567-5d5adcf86f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4ef677db-26d6-4f3f-9d25-9cff616040f4" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_edfa0f60-2179-43f9-8567-5d5adcf86f3b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_43ba5acf-9562-4760-91d8-3b6dc0cd82c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_edfa0f60-2179-43f9-8567-5d5adcf86f3b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_43ba5acf-9562-4760-91d8-3b6dc0cd82c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_43ba5acf-9562-4760-91d8-3b6dc0cd82c6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_43ba5acf-9562-4760-91d8-3b6dc0cd82c6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_43ba5acf-9562-4760-91d8-3b6dc0cd82c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_294cb8cd-fdb7-4591-bb34-362913922623" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_43ba5acf-9562-4760-91d8-3b6dc0cd82c6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_294cb8cd-fdb7-4591-bb34-362913922623" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_LaboratoryEquipmentMember_e9ec1963-05ed-4134-8adc-a0f080407568" xlink:href="naut-20220630.xsd#naut_LaboratoryEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_294cb8cd-fdb7-4591-bb34-362913922623" xlink:to="loc_naut_LaboratoryEquipmentMember_e9ec1963-05ed-4134-8adc-a0f080407568" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_7e31f4fd-1c19-44ba-8559-7236e599d44e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_294cb8cd-fdb7-4591-bb34-362913922623" xlink:to="loc_us-gaap_ComputerEquipmentMember_7e31f4fd-1c19-44ba-8559-7236e599d44e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_FurnitureFixturesAndOfficeEquipmentMember_3cc3f61e-f5a0-4aad-abb7-5569a784c429" xlink:href="naut-20220630.xsd#naut_FurnitureFixturesAndOfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_294cb8cd-fdb7-4591-bb34-362913922623" xlink:to="loc_naut_FurnitureFixturesAndOfficeEquipmentMember_3cc3f61e-f5a0-4aad-abb7-5569a784c429" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_6b8b0d8d-b651-46f0-ab23-8d5a47459bab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_294cb8cd-fdb7-4591-bb34-362913922623" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_6b8b0d8d-b651-46f0-ab23-8d5a47459bab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_f7b92ec0-6a54-474a-a80a-150335a19aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_294cb8cd-fdb7-4591-bb34-362913922623" xlink:to="loc_us-gaap_ConstructionInProgressMember_f7b92ec0-6a54-474a-a80a-150335a19aa9" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommonStockCommonStockReservedforFutureIssuanceDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#CommonStockCommonStockReservedforFutureIssuanceDetails"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/CommonStockCommonStockReservedforFutureIssuanceDetails" xlink:type="extended" id="i6e0e781c0bb4418489f94a8522b8b1fd_CommonStockCommonStockReservedforFutureIssuanceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_00c6ddcc-ac9b-48d8-8303-9764fd5ed4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_176646ad-f8ca-47f6-97bb-b6b6f8491dde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_00c6ddcc-ac9b-48d8-8303-9764fd5ed4d1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_176646ad-f8ca-47f6-97bb-b6b6f8491dde" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5db245ca-4870-441b-98b9-79455ad4101d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_00c6ddcc-ac9b-48d8-8303-9764fd5ed4d1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5db245ca-4870-441b-98b9-79455ad4101d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_24bed647-87f5-4142-966b-e127c3bebec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_00c6ddcc-ac9b-48d8-8303-9764fd5ed4d1" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_24bed647-87f5-4142-966b-e127c3bebec5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_7bc1b2b4-7865-4d62-b817-dea230a47dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_00c6ddcc-ac9b-48d8-8303-9764fd5ed4d1" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_7bc1b2b4-7865-4d62-b817-dea230a47dea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_b0510c64-5ac6-4ba9-88d8-4010ec8c4133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_7bc1b2b4-7865-4d62-b817-dea230a47dea" xlink:to="loc_us-gaap_PlanNameAxis_b0510c64-5ac6-4ba9-88d8-4010ec8c4133" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_b0510c64-5ac6-4ba9-88d8-4010ec8c4133_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_b0510c64-5ac6-4ba9-88d8-4010ec8c4133" xlink:to="loc_us-gaap_PlanNameDomain_b0510c64-5ac6-4ba9-88d8-4010ec8c4133_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3e076d43-d218-4606-80f0-b482002650d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_b0510c64-5ac6-4ba9-88d8-4010ec8c4133" xlink:to="loc_us-gaap_PlanNameDomain_3e076d43-d218-4606-80f0-b482002650d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_A2021EquityIncentivePlanMember_7b16b628-3eb6-49c4-9745-ada6d345b78e" xlink:href="naut-20220630.xsd#naut_A2021EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3e076d43-d218-4606-80f0-b482002650d6" xlink:to="loc_naut_A2021EquityIncentivePlanMember_7b16b628-3eb6-49c4-9745-ada6d345b78e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_A2021EmployeeStockPurchasePlanMember_c09231c8-0e20-4cb3-bfb6-3fdc117bd11d" xlink:href="naut-20220630.xsd#naut_A2021EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3e076d43-d218-4606-80f0-b482002650d6" xlink:to="loc_naut_A2021EmployeeStockPurchasePlanMember_c09231c8-0e20-4cb3-bfb6-3fdc117bd11d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#StockOptionPlanandStockbasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails" xlink:type="extended" id="i80f0837b4fde457dbf75d5d23fba35b1_StockOptionPlanandStockbasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7533b5b6-a7b0-459f-8fb7-6691b4733e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0fd1ae41-c501-4c31-8d6a-f22e44bccd7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7533b5b6-a7b0-459f-8fb7-6691b4733e33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0fd1ae41-c501-4c31-8d6a-f22e44bccd7c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_fc08ef53-087c-4b30-9bc3-2cfdbb2c38e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7533b5b6-a7b0-459f-8fb7-6691b4733e33" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_fc08ef53-087c-4b30-9bc3-2cfdbb2c38e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c812f2f9-95a3-4771-a61d-fce3cc8496e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7533b5b6-a7b0-459f-8fb7-6691b4733e33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c812f2f9-95a3-4771-a61d-fce3cc8496e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_103c0452-e140-438f-9b98-e15327c64608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7533b5b6-a7b0-459f-8fb7-6691b4733e33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_103c0452-e140-438f-9b98-e15327c64608" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant_ccc86adc-09f8-42a7-8deb-d142a1e5e0ae" xlink:href="naut-20220630.xsd#naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7533b5b6-a7b0-459f-8fb7-6691b4733e33" xlink:to="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant_ccc86adc-09f8-42a7-8deb-d142a1e5e0ae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_5994f3d7-c78e-4363-9a9b-d99525740e80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7533b5b6-a7b0-459f-8fb7-6691b4733e33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_5994f3d7-c78e-4363-9a9b-d99525740e80" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_8a2156ec-ee79-4c5b-8065-38be20fcd657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7533b5b6-a7b0-459f-8fb7-6691b4733e33" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_8a2156ec-ee79-4c5b-8065-38be20fcd657" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_3029feec-1f85-4e61-9549-b477ae931d59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7533b5b6-a7b0-459f-8fb7-6691b4733e33" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_3029feec-1f85-4e61-9549-b477ae931d59" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d641d7ef-057d-4f77-9b14-b644eb56cd37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7533b5b6-a7b0-459f-8fb7-6691b4733e33" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d641d7ef-057d-4f77-9b14-b644eb56cd37" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_122ed3ca-52e0-4cea-8014-f71aad042fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7533b5b6-a7b0-459f-8fb7-6691b4733e33" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_122ed3ca-52e0-4cea-8014-f71aad042fc9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e93c568-2296-46f5-9dce-33eff18bb0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7533b5b6-a7b0-459f-8fb7-6691b4733e33" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e93c568-2296-46f5-9dce-33eff18bb0b8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c27242f7-8258-4d0a-91c9-af6c3072e88c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e93c568-2296-46f5-9dce-33eff18bb0b8" xlink:to="loc_us-gaap_AwardTypeAxis_c27242f7-8258-4d0a-91c9-af6c3072e88c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c27242f7-8258-4d0a-91c9-af6c3072e88c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c27242f7-8258-4d0a-91c9-af6c3072e88c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c27242f7-8258-4d0a-91c9-af6c3072e88c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a2677a33-167e-47d4-8584-1182aca83de1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c27242f7-8258-4d0a-91c9-af6c3072e88c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a2677a33-167e-47d4-8584-1182aca83de1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_7dbe8d7d-dfee-4074-9f4f-b8f1a63a45f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a2677a33-167e-47d4-8584-1182aca83de1" xlink:to="loc_us-gaap_EmployeeStockMember_7dbe8d7d-dfee-4074-9f4f-b8f1a63a45f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ad4073f2-23c0-4ab9-9e6f-a3a1640a2eec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e93c568-2296-46f5-9dce-33eff18bb0b8" xlink:to="loc_us-gaap_PlanNameAxis_ad4073f2-23c0-4ab9-9e6f-a3a1640a2eec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ad4073f2-23c0-4ab9-9e6f-a3a1640a2eec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_ad4073f2-23c0-4ab9-9e6f-a3a1640a2eec" xlink:to="loc_us-gaap_PlanNameDomain_ad4073f2-23c0-4ab9-9e6f-a3a1640a2eec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_fb647ec4-57be-4ff7-b2a7-a640b8babe12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_ad4073f2-23c0-4ab9-9e6f-a3a1640a2eec" xlink:to="loc_us-gaap_PlanNameDomain_fb647ec4-57be-4ff7-b2a7-a640b8babe12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_A2021EquityIncentivePlanMember_477de8d4-46c9-44e6-b65d-e94dc0f7e7f8" xlink:href="naut-20220630.xsd#naut_A2021EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_fb647ec4-57be-4ff7-b2a7-a640b8babe12" xlink:to="loc_naut_A2021EquityIncentivePlanMember_477de8d4-46c9-44e6-b65d-e94dc0f7e7f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_A2021EmployeeStockPurchasePlanMember_c4c43a19-6ce8-4ab9-a93a-82000d35b665" xlink:href="naut-20220630.xsd#naut_A2021EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_fb647ec4-57be-4ff7-b2a7-a640b8babe12" xlink:to="loc_naut_A2021EmployeeStockPurchasePlanMember_c4c43a19-6ce8-4ab9-a93a-82000d35b665" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_A2017EquityIncentivePlanMember_c25c5514-81f1-4501-9bbf-6f4d81e2a14c" xlink:href="naut-20220630.xsd#naut_A2017EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_fb647ec4-57be-4ff7-b2a7-a640b8babe12" xlink:to="loc_naut_A2017EquityIncentivePlanMember_c25c5514-81f1-4501-9bbf-6f4d81e2a14c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails" xlink:type="extended" id="iae3b016f9d2c4ea08fee3f6ae5baddea_StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94344577-e59c-40f8-a80c-5602593e8d61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6649142e-d5c3-444e-88b7-5482a05eb984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94344577-e59c-40f8-a80c-5602593e8d61" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6649142e-d5c3-444e-88b7-5482a05eb984" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2909d4d4-14f0-4576-a7a3-1e54c2cd48df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94344577-e59c-40f8-a80c-5602593e8d61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2909d4d4-14f0-4576-a7a3-1e54c2cd48df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_6a30de98-b9b5-4d63-b823-62ce5d43bea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94344577-e59c-40f8-a80c-5602593e8d61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_6a30de98-b9b5-4d63-b823-62ce5d43bea1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_952e0ae9-b134-4a73-8261-f8286c5b2739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94344577-e59c-40f8-a80c-5602593e8d61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_952e0ae9-b134-4a73-8261-f8286c5b2739" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_96a8315b-388f-44a1-83af-f7675cc09412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94344577-e59c-40f8-a80c-5602593e8d61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_96a8315b-388f-44a1-83af-f7675cc09412" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_00c0bd13-a626-4380-b25e-ace357aee5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94344577-e59c-40f8-a80c-5602593e8d61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_00c0bd13-a626-4380-b25e-ace357aee5b5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice_97bf62cc-a63d-4d05-97c0-daa43a814083" xlink:href="naut-20220630.xsd#naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94344577-e59c-40f8-a80c-5602593e8d61" xlink:to="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice_97bf62cc-a63d-4d05-97c0-daa43a814083" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b6bbb710-07a1-4a0d-b210-67b4e14e76b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94344577-e59c-40f8-a80c-5602593e8d61" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b6bbb710-07a1-4a0d-b210-67b4e14e76b5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_eef114db-fd61-4883-a7b1-7521debea82a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b6bbb710-07a1-4a0d-b210-67b4e14e76b5" xlink:to="loc_us-gaap_AwardTypeAxis_eef114db-fd61-4883-a7b1-7521debea82a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_eef114db-fd61-4883-a7b1-7521debea82a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_eef114db-fd61-4883-a7b1-7521debea82a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_eef114db-fd61-4883-a7b1-7521debea82a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbc69cbf-b367-41b4-ab7a-cc9ac0410183" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_eef114db-fd61-4883-a7b1-7521debea82a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbc69cbf-b367-41b4-ab7a-cc9ac0410183" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_bb2db165-e886-415c-94b1-ebc86d027e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbc69cbf-b367-41b4-ab7a-cc9ac0410183" xlink:to="loc_us-gaap_EmployeeStockOptionMember_bb2db165-e886-415c-94b1-ebc86d027e1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a87ae30f-f139-4c2a-978a-b97cf744b1bd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b6bbb710-07a1-4a0d-b210-67b4e14e76b5" xlink:to="loc_srt_RangeAxis_a87ae30f-f139-4c2a-978a-b97cf744b1bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a87ae30f-f139-4c2a-978a-b97cf744b1bd_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a87ae30f-f139-4c2a-978a-b97cf744b1bd" xlink:to="loc_srt_RangeMember_a87ae30f-f139-4c2a-978a-b97cf744b1bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_16d27d3f-c649-4f64-8c32-c73e3aa2c605" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a87ae30f-f139-4c2a-978a-b97cf744b1bd" xlink:to="loc_srt_RangeMember_16d27d3f-c649-4f64-8c32-c73e3aa2c605" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1684ac24-e42c-404a-a5e4-d98dfdb0606a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_16d27d3f-c649-4f64-8c32-c73e3aa2c605" xlink:to="loc_srt_MinimumMember_1684ac24-e42c-404a-a5e4-d98dfdb0606a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_05dbfd3b-1245-4da9-8249-08035652fe09" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_16d27d3f-c649-4f64-8c32-c73e3aa2c605" xlink:to="loc_srt_MaximumMember_05dbfd3b-1245-4da9-8249-08035652fe09" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#StockOptionPlanandStockbasedCompensationStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockBasedCompensationExpenseDetails" xlink:type="extended" id="idc226f62bc8740e69c8fa512d1bc7fe6_StockOptionPlanandStockbasedCompensationStockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_558420bd-8453-4984-9428-44ed0f1a80c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_ee788dde-b11c-45a8-9403-3d6cea8efffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_558420bd-8453-4984-9428-44ed0f1a80c2" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_ee788dde-b11c-45a8-9403-3d6cea8efffb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66c3ea1d-7133-48c9-9ba7-0e7b85c6c166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_558420bd-8453-4984-9428-44ed0f1a80c2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66c3ea1d-7133-48c9-9ba7-0e7b85c6c166" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_56e45fc1-6fef-4bcd-8758-d5e2ec04fd80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66c3ea1d-7133-48c9-9ba7-0e7b85c6c166" xlink:to="loc_us-gaap_AwardTypeAxis_56e45fc1-6fef-4bcd-8758-d5e2ec04fd80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56e45fc1-6fef-4bcd-8758-d5e2ec04fd80_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_56e45fc1-6fef-4bcd-8758-d5e2ec04fd80" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_56e45fc1-6fef-4bcd-8758-d5e2ec04fd80_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1bb24af-7708-4b1f-8043-78de99d3f5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_56e45fc1-6fef-4bcd-8758-d5e2ec04fd80" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1bb24af-7708-4b1f-8043-78de99d3f5c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_c2f91623-be20-4457-ac15-55b00bcfff18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1bb24af-7708-4b1f-8043-78de99d3f5c5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_c2f91623-be20-4457-ac15-55b00bcfff18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_786fc0d3-0485-4eff-bfa7-05cb3ca94af5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66c3ea1d-7133-48c9-9ba7-0e7b85c6c166" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_786fc0d3-0485-4eff-bfa7-05cb3ca94af5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_786fc0d3-0485-4eff-bfa7-05cb3ca94af5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_786fc0d3-0485-4eff-bfa7-05cb3ca94af5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_786fc0d3-0485-4eff-bfa7-05cb3ca94af5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_38986db0-d210-4c26-a6dd-c2b858af897e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_786fc0d3-0485-4eff-bfa7-05cb3ca94af5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_38986db0-d210-4c26-a6dd-c2b858af897e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1f7415f0-6db0-4884-8eb1-813e1fad0114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_38986db0-d210-4c26-a6dd-c2b858af897e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1f7415f0-6db0-4884-8eb1-813e1fad0114" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_19d05577-4c03-41f5-bd09-07ed3ee47155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_38986db0-d210-4c26-a6dd-c2b858af897e" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_19d05577-4c03-41f5-bd09-07ed3ee47155" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#CommitmentandContingenciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails" xlink:type="extended" id="i815b1af32faa41e089c2af76669831f3_CommitmentandContingenciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount_fe514a8d-1fa4-4576-9dcf-09e8521deded" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentAmount_fe514a8d-1fa4-4576-9dcf-09e8521deded" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_93c9aff8-fc55-41a1-bcb9-097781c31bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_93c9aff8-fc55-41a1-bcb9-097781c31bf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_be0d437c-8d6f-41f2-964d-6756df475381" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_be0d437c-8d6f-41f2-964d-6756df475381" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_OperatingLeaseNoncashAdjustment_83efb75e-0f18-46c8-98c8-32d2698bf312" xlink:href="naut-20220630.xsd#naut_OperatingLeaseNoncashAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:to="loc_naut_OperatingLeaseNoncashAdjustment_83efb75e-0f18-46c8-98c8-32d2698bf312" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_LesseeOperatingLeaseOptionToTerminateLeaseTerm_60f7adc4-4885-474e-a199-e1d687eb277d" xlink:href="naut-20220630.xsd#naut_LesseeOperatingLeaseOptionToTerminateLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:to="loc_naut_LesseeOperatingLeaseOptionToTerminateLeaseTerm_60f7adc4-4885-474e-a199-e1d687eb277d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_825a8ce9-65fd-45cb-aa23-0746e047f85d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_825a8ce9-65fd-45cb-aa23-0746e047f85d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5f3f85c4-cb57-41b6-a8d2-e1ee2be42d85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5f3f85c4-cb57-41b6-a8d2-e1ee2be42d85" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_3eefc404-a0c5-4171-bbca-58316a4e469a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_3eefc404-a0c5-4171-bbca-58316a4e469a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_f45c466c-47cf-4932-bb81-7d88a765ea32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:to="loc_us-gaap_OperatingLeasePayments_f45c466c-47cf-4932-bb81-7d88a765ea32" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0745a815-2f22-44db-8bdd-73d27a14c12f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0745a815-2f22-44db-8bdd-73d27a14c12f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_96309969-47d2-4290-be7c-e067bf863d27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_96309969-47d2-4290-be7c-e067bf863d27" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_60ec5bdd-d60f-443d-9195-a1cf05caa841" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_60ec5bdd-d60f-443d-9195-a1cf05caa841" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_0d676166-bdc6-45ec-aff9-b9afd3330627" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_0d676166-bdc6-45ec-aff9-b9afd3330627" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_3c65148f-5ede-4c39-a35c-2e0be1413d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_0d676166-bdc6-45ec-aff9-b9afd3330627" xlink:to="loc_us-gaap_LeaseContractualTermAxis_3c65148f-5ede-4c39-a35c-2e0be1413d05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_3c65148f-5ede-4c39-a35c-2e0be1413d05_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LeaseContractualTermAxis_3c65148f-5ede-4c39-a35c-2e0be1413d05" xlink:to="loc_us-gaap_LeaseContractualTermDomain_3c65148f-5ede-4c39-a35c-2e0be1413d05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_3b2c055b-9a15-4e57-9cd5-13ad67118f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LeaseContractualTermAxis_3c65148f-5ede-4c39-a35c-2e0be1413d05" xlink:to="loc_us-gaap_LeaseContractualTermDomain_3b2c055b-9a15-4e57-9cd5-13ad67118f6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_September2021ToSeptember2031Member_da6c84d0-7d2e-4770-a8b9-c285cf66e0d5" xlink:href="naut-20220630.xsd#naut_September2021ToSeptember2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseContractualTermDomain_3b2c055b-9a15-4e57-9cd5-13ad67118f6c" xlink:to="loc_naut_September2021ToSeptember2031Member_da6c84d0-7d2e-4770-a8b9-c285cf66e0d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_February2021ToOctober2021Member_1150d8a3-06a1-4d18-903d-205e3a25c155" xlink:href="naut-20220630.xsd#naut_February2021ToOctober2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseContractualTermDomain_3b2c055b-9a15-4e57-9cd5-13ad67118f6c" xlink:to="loc_naut_February2021ToOctober2021Member_1150d8a3-06a1-4d18-903d-205e3a25c155" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_October2022ToOctober2031Member_d3144556-de1b-4a7a-b25a-89210012c33c" xlink:href="naut-20220630.xsd#naut_October2022ToOctober2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseContractualTermDomain_3b2c055b-9a15-4e57-9cd5-13ad67118f6c" xlink:to="loc_naut_October2022ToOctober2031Member_d3144556-de1b-4a7a-b25a-89210012c33c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_8c2919bd-fad5-4371-a069-fe1909c82caf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_0d676166-bdc6-45ec-aff9-b9afd3330627" xlink:to="loc_us-gaap_CreditFacilityAxis_8c2919bd-fad5-4371-a069-fe1909c82caf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_8c2919bd-fad5-4371-a069-fe1909c82caf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_8c2919bd-fad5-4371-a069-fe1909c82caf" xlink:to="loc_us-gaap_CreditFacilityDomain_8c2919bd-fad5-4371-a069-fe1909c82caf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2732b61a-5e5e-487d-87c6-8590e3948e01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_8c2919bd-fad5-4371-a069-fe1909c82caf" xlink:to="loc_us-gaap_CreditFacilityDomain_2732b61a-5e5e-487d-87c6-8590e3948e01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_SanCarlosLeaseImprovementsLineOfCreditMember_034c875d-0a5d-476c-b418-ce37a8eefecf" xlink:href="naut-20220630.xsd#naut_SanCarlosLeaseImprovementsLineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_2732b61a-5e5e-487d-87c6-8590e3948e01" xlink:to="loc_naut_SanCarlosLeaseImprovementsLineOfCreditMember_034c875d-0a5d-476c-b418-ce37a8eefecf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/BasicandDilutedNetLossperShareAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#BasicandDilutedNetLossperShareAntidilutiveSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.nautilus.bio/role/BasicandDilutedNetLossperShareAntidilutiveSecuritiesDetails" xlink:type="extended" id="i74badf3d54264c5fa1f0ceb3d45caf7a_BasicandDilutedNetLossperShareAntidilutiveSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5d56ac0a-bdb5-4787-a867-dadeb2b52d23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0672c84a-548f-4914-aff1-ebb7dd7c912f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5d56ac0a-bdb5-4787-a867-dadeb2b52d23" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0672c84a-548f-4914-aff1-ebb7dd7c912f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1e133ee2-420b-4bd4-aa1d-a8dbc88ff24a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5d56ac0a-bdb5-4787-a867-dadeb2b52d23" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1e133ee2-420b-4bd4-aa1d-a8dbc88ff24a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_614edc4c-2d06-4f87-b717-11a3fb3fe506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1e133ee2-420b-4bd4-aa1d-a8dbc88ff24a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_614edc4c-2d06-4f87-b717-11a3fb3fe506" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_614edc4c-2d06-4f87-b717-11a3fb3fe506_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_614edc4c-2d06-4f87-b717-11a3fb3fe506" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_614edc4c-2d06-4f87-b717-11a3fb3fe506_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d1e07824-975a-4aa9-a46d-314244c5cf96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_614edc4c-2d06-4f87-b717-11a3fb3fe506" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d1e07824-975a-4aa9-a46d-314244c5cf96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_91f62199-0db0-4060-863c-e4480a0d114c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d1e07824-975a-4aa9-a46d-314244c5cf96" xlink:to="loc_us-gaap_EmployeeStockOptionMember_91f62199-0db0-4060-863c-e4480a0d114c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_EmployeeStockPurchasePlanMember_84ea8771-1dce-4cb7-a300-a4a0fc2a947a" xlink:href="naut-20220630.xsd#naut_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d1e07824-975a-4aa9-a46d-314244c5cf96" xlink:to="loc_naut_EmployeeStockPurchasePlanMember_84ea8771-1dce-4cb7-a300-a4a0fc2a947a" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>naut-20220630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9cc3a1fd-7e26-418c-9538-c00b184efabf,g:ab9b2c40-7a18-466f-af91-0013c7c3cb4b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_79679c65-3a40-494c-9fad-adb9946bc1d1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_93fd2002-e1fe-46c8-85b8-3a80a6a1a101_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less redemption of Arya shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_SeriesSeedRedeemableConvertiblePreferredStockMember_25c08fe5-5fa7-4a4b-9b18-6a3d4c7134f6_terseLabel_en-US" xlink:label="lab_naut_SeriesSeedRedeemableConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series Seed</link:label>
    <link:label id="lab_naut_SeriesSeedRedeemableConvertiblePreferredStockMember_label_en-US" xlink:label="lab_naut_SeriesSeedRedeemableConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series Seed Redeemable Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_naut_SeriesSeedRedeemableConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_naut_SeriesSeedRedeemableConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series Seed Redeemable Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_SeriesSeedRedeemableConvertiblePreferredStockMember" xlink:href="naut-20220630.xsd#naut_SeriesSeedRedeemableConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_SeriesSeedRedeemableConvertiblePreferredStockMember" xlink:to="lab_naut_SeriesSeedRedeemableConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c6826cf0-eacc-44b2-80c2-0659819a5cda_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c0d69982-d3e5-43fd-a979-5d2188ad1452_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6422e262-8af2-4fef-bd7a-81ccf5b73862_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_47116575-488a-495e-8a16-74e62f7694dd_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_A2017EquityIncentivePlanMember_63268fe2-1fdc-4aef-9d3c-80975c298136_terseLabel_en-US" xlink:label="lab_naut_A2017EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Equity Incentive Plan</link:label>
    <link:label id="lab_naut_A2017EquityIncentivePlanMember_label_en-US" xlink:label="lab_naut_A2017EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_naut_A2017EquityIncentivePlanMember_documentation_en-US" xlink:label="lab_naut_A2017EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2017 Equity Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_A2017EquityIncentivePlanMember" xlink:href="naut-20220630.xsd#naut_A2017EquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_A2017EquityIncentivePlanMember" xlink:to="lab_naut_A2017EquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_ff0fbb75-f484-411c-83a5-abd200fcb74e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_6a2bd0fa-2f09-4e8b-960f-a1211f08e195_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_9326b62c-21a0-4ce3-b8f2-6f8ecfbbd15a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_1b1c046c-4349-424b-8fe3-0e2944c972ef_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B</link:label>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesBPreferredStockMember" xlink:to="lab_us-gaap_SeriesBPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_901e0c61-1668-4086-ae7e-c18b5d21e4e4_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_114bed32-3513-43ce-b72a-5d87b4ab79bf_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_7ea193c1-ffc8-4d59-86f3-de4b16802772_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_6cc24f49-c4e2-4299-9e46-0eadf5f26a6c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice_268cdb41-b272-4159-a497-5c5102389765_terseLabel_en-US" xlink:label="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock price (in dollars per share)</link:label>
    <link:label id="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice_label_en-US" xlink:label="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Share Price</link:label>
    <link:label id="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice_documentation_en-US" xlink:label="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" xlink:href="naut-20220630.xsd#naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" xlink:to="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_ea3641d1-f9d4-4fcf-95eb-f6d7a60e5529_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_bbad3f83-a104-4f62-8214-71893ceebde4_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_c10bf59b-dcc9-4ac2-8068-44cd02e4f702_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_a8220228-cf35-45ef-8379-f7e0dec26a5d_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_cff666c5-a8f4-441a-89c3-fde79a7f76a6_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_0532cf49-2226-40d7-9126-e3683879ed4b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss on securities available-for-sale</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_18c54a12-949e-404d-969e-531d307faa39_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_048b7663-08f0-4dce-b27b-b148e4ed75d3_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_84711258-7f39-4bc1-b376-a557b3829eb6_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_541a3517-e277-434c-934d-ffba9bcb3d44_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_cf7ea485-f3ac-424d-ae93-eff92c7ad5e7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_5de7478b-066c-4d72-8b23-8e2ad9a1a0a1_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_c06c7805-4333-4157-b267-2b3ebad15307_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0d666b6e-d4f6-40ac-a89b-51dc19fd2243_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity to finance tenant improvements</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_505c7aa6-5ed4-421d-a469-2eff9e5f6e61_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour_463a0eea-7646-4436-8599-4a5607848c74_terseLabel_en-US" xlink:label="lab_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027 and thereafter</link:label>
    <link:label id="lab_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour_label_en-US" xlink:label="lab_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Due after Year Four</link:label>
    <link:label id="lab_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour_documentation_en-US" xlink:label="lab_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Due after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" xlink:href="naut-20220630.xsd#naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" xlink:to="lab_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_150f4485-516d-4e49-9e53-b3195c82615b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_a3e5fa21-3742-4639-93d9-a53ae3ed011e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">#REF!</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_8e08f183-520b-440f-8156-befc7fd81e2c_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_37f79ac3-726f-4dc6-aca2-1a0d41276d48_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction_6b47eeaf-474a-4ace-8d7d-e6e251db2ca6_terseLabel_en-US" xlink:label="lab_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of stock and reverse recapitalization transaction</link:label>
    <link:label id="lab_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction_label_en-US" xlink:label="lab_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Stock And Reverse Recapitalization Transaction</link:label>
    <link:label id="lab_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction_documentation_en-US" xlink:label="lab_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Stock And Reverse Recapitalization Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction" xlink:href="naut-20220630.xsd#naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction" xlink:to="lab_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_42a8ec58-bcba-4182-939d-fa0c0276cddc_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_4299ce2c-3192-4f37-b29b-bc12506a5beb_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_aee76343-67d3-4f47-ad92-e65bd32552d8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Potential Shares of Common Stock Excluded from the Computation of Diluted Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_A2021EquityIncentivePlanMember_39b080b3-d2ec-4020-9461-c35b009667c5_terseLabel_en-US" xlink:label="lab_naut_A2021EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Equity Incentive Plan</link:label>
    <link:label id="lab_naut_A2021EquityIncentivePlanMember_label_en-US" xlink:label="lab_naut_A2021EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_naut_A2021EquityIncentivePlanMember_documentation_en-US" xlink:label="lab_naut_A2021EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Equity Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_A2021EquityIncentivePlanMember" xlink:href="naut-20220630.xsd#naut_A2021EquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_A2021EquityIncentivePlanMember" xlink:to="lab_naut_A2021EquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_48d96c8b-f597-4c8a-ac59-1ff3e4ea622e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of vested stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d22ffc71-8748-4dbb-ad08-079168c4b7dd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_f6961fae-b8ad-4f62-8607-a5f318211a31_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_94ff3f4b-c71f-4935-9bf9-e633b022300f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate on borrowings to finance tenant improvements</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_FurnitureFixturesAndOfficeEquipmentMember_efc1b4c8-38ea-47ff-96d8-e49b12f7307e_terseLabel_en-US" xlink:label="lab_naut_FurnitureFixturesAndOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture, fixtures and office equipment</link:label>
    <link:label id="lab_naut_FurnitureFixturesAndOfficeEquipmentMember_label_en-US" xlink:label="lab_naut_FurnitureFixturesAndOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture, Fixtures And Office Equipment [Member]</link:label>
    <link:label id="lab_naut_FurnitureFixturesAndOfficeEquipmentMember_documentation_en-US" xlink:label="lab_naut_FurnitureFixturesAndOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture, Fixtures And Office Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_FurnitureFixturesAndOfficeEquipmentMember" xlink:href="naut-20220630.xsd#naut_FurnitureFixturesAndOfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_FurnitureFixturesAndOfficeEquipmentMember" xlink:to="lab_naut_FurnitureFixturesAndOfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_e7b704bc-bd24-438d-a847-fe248e6cf53f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_40213ba9-51e4-4070-9dbc-b69baff37e30_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term lease costs</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrivatePlacementMember_02b2a075-0ce7-400e-8407-56f80b26cd4b_terseLabel_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Placement</link:label>
    <link:label id="lab_us-gaap_PrivatePlacementMember_label_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Placement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivatePlacementMember" xlink:to="lab_us-gaap_PrivatePlacementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_7bf63cc4-8280-4aa0-9c99-3500193ae751_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c464c04d-dc74-4a0e-9109-89adf728fd06_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cd0556be-5148-4120-87c7-1f0f9bff2769_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ece938b8-fb51-4823-b019-5018b2d7a4c5_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_11bb7b9c-5e42-48ba-a68a-13b723e583db_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_DeferredStockIssuanceCostsReclassifiedToEquity_190d2b2c-4644-4b27-960e-9f17c8c9fcfd_terseLabel_en-US" xlink:label="lab_naut_DeferredStockIssuanceCostsReclassifiedToEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred offering costs reclassified to equity</link:label>
    <link:label id="lab_naut_DeferredStockIssuanceCostsReclassifiedToEquity_label_en-US" xlink:label="lab_naut_DeferredStockIssuanceCostsReclassifiedToEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Stock Issuance Costs Reclassified To Equity</link:label>
    <link:label id="lab_naut_DeferredStockIssuanceCostsReclassifiedToEquity_documentation_en-US" xlink:label="lab_naut_DeferredStockIssuanceCostsReclassifiedToEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Stock Issuance Costs Reclassified To Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_DeferredStockIssuanceCostsReclassifiedToEquity" xlink:href="naut-20220630.xsd#naut_DeferredStockIssuanceCostsReclassifiedToEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_DeferredStockIssuanceCostsReclassifiedToEquity" xlink:to="lab_naut_DeferredStockIssuanceCostsReclassifiedToEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_e51a3b9d-bbab-4475-8037-66208ae9d3bd_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock of Arya (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_88d742fa-07c8-4148-89a4-a278025db231_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_3924914b-e26b-4a4e-b0ec-4180a8901545_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_a597a099-fef6-4148-a394-a8347207de9b_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to common stockholders, basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_88bd6482-99c3-4639-85dc-0d0d39c8d327_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_273baebd-a178-4328-9b10-e504ba8f3410_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_968add77-8685-430b-abf2-dd0df45668b9_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_2a9f3b24-7d32-4cec-9588-7b902c556aba_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_ed2ec0d9-1aff-4251-aae5-e91533d4ab9e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_445bb450-1827-42cd-a86c-e8042ba6e7f4_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_0d14589e-c7e3-44be-ad1c-3044d00ac22d_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_ac87e3e0-d9fe-4af7-9746-a3fa708872ea_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_0a2a9a12-1eaa-46e6-8b3b-47dfd0407f4d_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_06871c87-69e7-444b-82fc-a4f8829a9a3d_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total potentially dilutive common share equivalents</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositsAssetsNoncurrent_2b1cce57-e029-4f03-8463-2963a6a52de6_terseLabel_en-US" xlink:label="lab_us-gaap_DepositsAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits</link:label>
    <link:label id="lab_us-gaap_DepositsAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DepositsAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssetsNoncurrent" xlink:to="lab_us-gaap_DepositsAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_feba431a-b1a5-45ff-96f2-1bdcad7ad729_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d7a03944-3ace-4a2a-8141-c2d46692060d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_September2021ToSeptember2031Member_53881564-c8c7-4f70-aee9-307c77b431c7_terseLabel_en-US" xlink:label="lab_naut_September2021ToSeptember2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 2021 to September 2031</link:label>
    <link:label id="lab_naut_September2021ToSeptember2031Member_label_en-US" xlink:label="lab_naut_September2021ToSeptember2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 2021 To September 2031 [Member]</link:label>
    <link:label id="lab_naut_September2021ToSeptember2031Member_documentation_en-US" xlink:label="lab_naut_September2021ToSeptember2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 2021 To September 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_September2021ToSeptember2031Member" xlink:href="naut-20220630.xsd#naut_September2021ToSeptember2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_September2021ToSeptember2031Member" xlink:to="lab_naut_September2021ToSeptember2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_22d9be10-1a20-4a70-9893-0c371d53a211_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_91084746-1c30-467c-9dea-dc2eca720172_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_LongTermInvestmentsMember_b6142a0b-70c8-4299-9173-9d1617795eae_terseLabel_en-US" xlink:label="lab_naut_LongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_naut_LongTermInvestmentsMember_label_en-US" xlink:label="lab_naut_LongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Investments [Member]</link:label>
    <link:label id="lab_naut_LongTermInvestmentsMember_documentation_en-US" xlink:label="lab_naut_LongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_LongTermInvestmentsMember" xlink:href="naut-20220630.xsd#naut_LongTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_LongTermInvestmentsMember" xlink:to="lab_naut_LongTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_b9934453-0b8e-49a2-a761-77ca711a9b93_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_1b38e1af-5982-474e-850d-be9c450b25e2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed operating lease costs</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_6a51e42f-b209-4990-9c50-6e459989d9a1_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_8cd9e28b-71a0-4e77-a381-e0a7c56aaeb6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_4e3e38c0-c2a5-402f-aeb4-932a20f7bed7_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_669ef194-79c2-412b-9e22-e9a087f2139a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_7f38d1fe-9de5-4763-91ee-6e3a7dc93bf2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_e7420f03-f336-4002-ae39-204d4ec92258_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_8562b2f6-7acb-4110-b3ca-e30e1c2f0906_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_dff4100f-130f-4aa6-81fb-5c8a733a4053_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_9291e937-7120-4349-b4ca-329b6af81fcc_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_a0a871b8-68a9-4758-869a-2708df9cadb6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_d0821df4-780c-4082-bc67-53eb6643dcc8_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6ab66504-ef3d-4c07-87c1-071105e6e702_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_a29f739d-01fe-416a-8bc7-7e4882481f60_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplementary cash flow information on non-cash activities</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_StockConvertedValueReverseRecapitalization_530daf5c-f1db-4dab-85bf-afd2773eccec_terseLabel_en-US" xlink:label="lab_naut_StockConvertedValueReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock converted, value, reverse recapitalization</link:label>
    <link:label id="lab_naut_StockConvertedValueReverseRecapitalization_label_en-US" xlink:label="lab_naut_StockConvertedValueReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Converted, Value, Reverse Recapitalization</link:label>
    <link:label id="lab_naut_StockConvertedValueReverseRecapitalization_documentation_en-US" xlink:label="lab_naut_StockConvertedValueReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Converted, Value, Reverse Recapitalization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_StockConvertedValueReverseRecapitalization" xlink:href="naut-20220630.xsd#naut_StockConvertedValueReverseRecapitalization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_StockConvertedValueReverseRecapitalization" xlink:to="lab_naut_StockConvertedValueReverseRecapitalization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_971f7f72-2f59-437d-b6b1-a80e9c0a20be_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_932c47da-a32d-4868-9b1c-60346be55e4c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price of common stock, percent</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_a59ed9e8-07b9-410c-9ade-828592ff1ada_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseContractualTermDomain_0274ea63-099e-4c00-8284-7f6733becff2_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Domain]</link:label>
    <link:label id="lab_us-gaap_LeaseContractualTermDomain_label_en-US" xlink:label="lab_us-gaap_LeaseContractualTermDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseContractualTermDomain" xlink:to="lab_us-gaap_LeaseContractualTermDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_be8cca74-9200-4138-a00b-6cfba42b2cb3_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_c2557177-5cd2-42b1-85c0-a0a889b1ecb6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Six months ending December 31, 2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_ffc4df88-826d-422c-8a84-05b2c08e0d82_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_93421839-2f14-472c-9ce6-a9f81567e042_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_3cafdf9b-0752-4e9c-b4e6-2335e35e869a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_3e02efe0-9a4e-4eee-800c-000770b25ee0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_1a46efda-135f-4fe7-870d-63f23a06444c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_a380285d-88e4-482c-977c-6a09f2127d11_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_43e982de-18a2-48b0-a700-0cd1e5028046_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_05b74c12-7cc7-4ace-9f7e-8eda93ade205_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_d6c83a4e-afa5-44dd-bd12-f0f70074a699_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, weighted average remaining contractual life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_16659bb5-8ebc-4730-a548-51d740aa0cf6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options issued and outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_797fefa6-60e8-4cf6-8821-543ee5a9d8db_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d6b811f4-3c68-49bd-9c88-7633d72a01a1_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_AccruedFacilities_3820a5aa-cc9d-4639-8b27-00e69c50dcb6_terseLabel_en-US" xlink:label="lab_naut_AccruedFacilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued facilities</link:label>
    <link:label id="lab_naut_AccruedFacilities_label_en-US" xlink:label="lab_naut_AccruedFacilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Facilities</link:label>
    <link:label id="lab_naut_AccruedFacilities_documentation_en-US" xlink:label="lab_naut_AccruedFacilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Facilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_AccruedFacilities" xlink:href="naut-20220630.xsd#naut_AccruedFacilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_AccruedFacilities" xlink:to="lab_naut_AccruedFacilities" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_RecapitalizationExchangeRatioPerShare_59c6cb99-63a9-45a1-9435-5c200fe1bffc_terseLabel_en-US" xlink:label="lab_naut_RecapitalizationExchangeRatioPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recapitalization exchange ratio, per share (in dollars per share)</link:label>
    <link:label id="lab_naut_RecapitalizationExchangeRatioPerShare_label_en-US" xlink:label="lab_naut_RecapitalizationExchangeRatioPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recapitalization Exchange Ratio, Per Share</link:label>
    <link:label id="lab_naut_RecapitalizationExchangeRatioPerShare_documentation_en-US" xlink:label="lab_naut_RecapitalizationExchangeRatioPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recapitalization Exchange Ratio, Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_RecapitalizationExchangeRatioPerShare" xlink:href="naut-20220630.xsd#naut_RecapitalizationExchangeRatioPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_RecapitalizationExchangeRatioPerShare" xlink:to="lab_naut_RecapitalizationExchangeRatioPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_96bc97cb-977e-4f56-94ba-11026717787a_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_d20fc9ab-ac85-4946-82bd-c6d940047b28_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_51a7320c-69bd-4bb4-8fa3-02a087c3e52e_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_46deb523-9677-4f33-9725-f8a0f4fe1016_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_f53ddd8b-124e-4614-85bd-7e3cf3f80267_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_400720e2-f941-4530-814d-bdcd69143902_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_e4c7f5f4-424b-4a4e-89bc-90f348383693_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_fdc22e78-bb01-48eb-9658-61b7f24978a3_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_19825c1c-9e0f-40ff-9b4e-5242202fb678_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for lease liabilities included in operating activities</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_caae053b-1e01-4fd3-8e9b-e61dd74de477_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization</link:label>
    <link:label id="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_label_en-US" xlink:label="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications of Temporary to Permanent Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:to="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_6e498bc4-a954-469f-bba8-0565e642a0a7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_cc265883-67c4-4e3f-9080-6b4a0767f20e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_9e3d762e-0693-466d-80b9-9134d1669fb6_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options to purchase common stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_EmployeeStockPurchasePlanMember_3ee104b9-2d08-498b-a5bd-1a23679b778c_terseLabel_en-US" xlink:label="lab_naut_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_naut_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_naut_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_naut_EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_naut_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_EmployeeStockPurchasePlanMember" xlink:href="naut-20220630.xsd#naut_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_EmployeeStockPurchasePlanMember" xlink:to="lab_naut_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_ed373efe-cb71-49a4-b251-1d7805011bb0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_5dc36895-59f3-4122-a283-e17ff27bf781_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of vested stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_d6ebfcef-0cbc-4f5b-be4c-cf6e55b962b4_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_dd9189e6-6da2-4e4c-ad56-1c267dd42884_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_OperatingLeaseNoncashAdjustment_d787222d-e35a-4ec8-8b1a-9ac3543a96b5_terseLabel_en-US" xlink:label="lab_naut_OperatingLeaseNoncashAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, noncash adjustment</link:label>
    <link:label id="lab_naut_OperatingLeaseNoncashAdjustment_label_en-US" xlink:label="lab_naut_OperatingLeaseNoncashAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Noncash Adjustment</link:label>
    <link:label id="lab_naut_OperatingLeaseNoncashAdjustment_documentation_en-US" xlink:label="lab_naut_OperatingLeaseNoncashAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Noncash Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_OperatingLeaseNoncashAdjustment" xlink:href="naut-20220630.xsd#naut_OperatingLeaseNoncashAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_OperatingLeaseNoncashAdjustment" xlink:to="lab_naut_OperatingLeaseNoncashAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_DisclosureOfRedeemableConvertiblePreferredStockTextBlock_6d57c01c-0d4d-49de-8e8a-59ee3571610b_terseLabel_en-US" xlink:label="lab_naut_DisclosureOfRedeemableConvertiblePreferredStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock</link:label>
    <link:label id="lab_naut_DisclosureOfRedeemableConvertiblePreferredStockTextBlock_label_en-US" xlink:label="lab_naut_DisclosureOfRedeemableConvertiblePreferredStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Redeemable Convertible Preferred Stock [Text Block]</link:label>
    <link:label id="lab_naut_DisclosureOfRedeemableConvertiblePreferredStockTextBlock_documentation_en-US" xlink:label="lab_naut_DisclosureOfRedeemableConvertiblePreferredStockTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Redeemable Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_DisclosureOfRedeemableConvertiblePreferredStockTextBlock" xlink:href="naut-20220630.xsd#naut_DisclosureOfRedeemableConvertiblePreferredStockTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_DisclosureOfRedeemableConvertiblePreferredStockTextBlock" xlink:to="lab_naut_DisclosureOfRedeemableConvertiblePreferredStockTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_98576eff-02c6-4ece-9240-8a565660fa68_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_b45b3a91-7511-4437-9329-58746ec227e4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_ea5dbf51-a70b-4020-8b6f-9fdcb9d0aa0f_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_a809dd9c-624e-4a7a-8fc2-e7373135b448_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAbstract_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAbstract" xlink:to="lab_us-gaap_TemporaryEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f33419af-53fb-40a3-b01d-a23549eabd00_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_9549a955-6c99-4d44-867e-ab2800194af0_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_63889e9b-865f-40cd-9274-8a812087abcd_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bb942c27-327b-407c-9bf6-9559212ad90d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_ae8c821a-c285-4143-a78a-cb46a6c2750d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Issued, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_42849578-39f9-43be-a9b5-d56f0fe9116b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_006c7695-95b4-405d-9353-010c5b4bc399_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding borrowings</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Fair Value of Amount Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:to="lab_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_66427a75-195c-4102-9167-b93130e4ef3f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_e2528fff-5b58-4a1f-8529-b7897293ce57_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_68fff0e8-377e-41e4-91f6-44197b73d9fd_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_AccruedResearchAndDevelopment_c40d490f-64de-4f71-abf3-daa98885ff02_terseLabel_en-US" xlink:label="lab_naut_AccruedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued research and development</link:label>
    <link:label id="lab_naut_AccruedResearchAndDevelopment_label_en-US" xlink:label="lab_naut_AccruedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Research and Development</link:label>
    <link:label id="lab_naut_AccruedResearchAndDevelopment_documentation_en-US" xlink:label="lab_naut_AccruedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_AccruedResearchAndDevelopment" xlink:href="naut-20220630.xsd#naut_AccruedResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_AccruedResearchAndDevelopment" xlink:to="lab_naut_AccruedResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e92c7776-e4ce-44d3-95b7-adc0537f2829_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_6f5f31f4-bf28-44ee-b95e-50d358680cce_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_4a87bea7-5fac-4ce9-ac30-0325e93c4911_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_53256197-d3c6-4b67-9fc7-db87f4d62846_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_64bea0eb-7cb6-4144-aefb-f93fa1f5abf8_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_ac7827c1-2ae7-4a8a-ae75-bcb7202edec5_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_ee4dda69-9d52-46b1-95f0-b81599253bb0_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_588c76d6-fc5f-4d93-af64-05174b4419b7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_48b123c6-6297-48ff-ae1b-082fe5a38170_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_658cc059-1498-4f0b-9483-dcb36e79f043_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_5ca0bd2d-3bba-4916-9389-b65d5802c554_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_4a1413f5-b933-4a39-b09b-c2fdf1c8c201_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_25923033-a357-46e9-9778-2d30ae250f7a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_1c40ca07-10ac-4c51-bce4-6ce2e9f17a4c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_4b948cc2-81b8-4120-8b71-4573d3e909c6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of common stock issued in period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_d213ed5a-9b34-4781-84f3-e3f5661c3b16_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets Carried at Fair Value and Measured on a Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_bbf739c4-12f7-4f7a-a0b0-79c9491c4165_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_4b2f4a13-6f45-4917-89e3-8680ae1b411c_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_PaymentsOfReverseRecapitalizationTransactionCosts_48333b1a-4663-4300-8cef-6b2cdf6aa3b8_terseLabel_en-US" xlink:label="lab_naut_PaymentsOfReverseRecapitalizationTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of transaction costs</link:label>
    <link:label id="lab_naut_PaymentsOfReverseRecapitalizationTransactionCosts_label_en-US" xlink:label="lab_naut_PaymentsOfReverseRecapitalizationTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Reverse Recapitalization Transaction Costs</link:label>
    <link:label id="lab_naut_PaymentsOfReverseRecapitalizationTransactionCosts_documentation_en-US" xlink:label="lab_naut_PaymentsOfReverseRecapitalizationTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Reverse Recapitalization Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_PaymentsOfReverseRecapitalizationTransactionCosts" xlink:href="naut-20220630.xsd#naut_PaymentsOfReverseRecapitalizationTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_PaymentsOfReverseRecapitalizationTransactionCosts" xlink:to="lab_naut_PaymentsOfReverseRecapitalizationTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c78c79f0-ffa4-488b-819f-48ff7b50546c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_4dc4b818-ac39-4f79-b436-b6cc211a0488_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_38808a50-dec2-41ca-b101-3d190b5699db_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Stock Option Awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f631fec4-1203-4600-94e2-363f4d981c96_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_5127e1f5-d56b-46c2-9160-87814996af4e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_5b81cdff-1dab-4669-9b8b-a1493f293404_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_325750b8-d278-4447-9322-da5b1cda1238_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_90904bba-3644-4639-8936-8eb02bc2f0f7_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_RecapitalizationExchangeRatio_fca0c504-4697-466f-8ed6-63073259dba8_terseLabel_en-US" xlink:label="lab_naut_RecapitalizationExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recapitalization exchange ratio</link:label>
    <link:label id="lab_naut_RecapitalizationExchangeRatio_label_en-US" xlink:label="lab_naut_RecapitalizationExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recapitalization Exchange Ratio</link:label>
    <link:label id="lab_naut_RecapitalizationExchangeRatio_documentation_en-US" xlink:label="lab_naut_RecapitalizationExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recapitalization Exchange Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_RecapitalizationExchangeRatio" xlink:href="naut-20220630.xsd#naut_RecapitalizationExchangeRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_RecapitalizationExchangeRatio" xlink:to="lab_naut_RecapitalizationExchangeRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_ScheduleOfReverseRecapitalizationLineItems_0c48be96-83b2-43f7-bfa5-86cc1ddb98d7_terseLabel_en-US" xlink:label="lab_naut_ScheduleOfReverseRecapitalizationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Reverse Recapitalization [Line Items]</link:label>
    <link:label id="lab_naut_ScheduleOfReverseRecapitalizationLineItems_label_en-US" xlink:label="lab_naut_ScheduleOfReverseRecapitalizationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Reverse Recapitalization [Line Items]</link:label>
    <link:label id="lab_naut_ScheduleOfReverseRecapitalizationLineItems_documentation_en-US" xlink:label="lab_naut_ScheduleOfReverseRecapitalizationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Reverse Recapitalization [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ScheduleOfReverseRecapitalizationLineItems" xlink:href="naut-20220630.xsd#naut_ScheduleOfReverseRecapitalizationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems" xlink:to="lab_naut_ScheduleOfReverseRecapitalizationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_e127227e-a1c1-4325-9b3e-aa6c7f353cd5_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockAmountConverted1_5acc208c-8e9a-48e5-aa0c-183517615681_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockAmountConverted1_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Amount Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockAmountConverted1" xlink:to="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_920bbcd5-168c-475c-bb20-d03d107b8833_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_2ee8d433-de64-4759-b7ef-adf441527ee8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_9904077b-1ccf-4a24-af53-b622d9bd6a25_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agency bonds</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_4b4539fd-8b7a-445a-96d6-210cfa8aca16_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_9d9c0804-2e28-4d3e-bffe-deabfac6a4e1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of premiums on securities, net</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_8e36b93f-b9f9-4c60-9f9e-3a348c7152dd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_5c6e42b5-b524-4801-b2d1-dbccf2e642cd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_760fbd43-5498-4b59-a322-d82c291d0939_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_79ace384-528c-4c1e-aeb3-f21db27a1c52_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_2ab55d42-b609-4679-badc-f117a56c2e8e_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. treasury securities</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_cf596ce2-7283-4dbd-aa98-2e37dc49aca6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_29d4c2bb-040f-4b75-8b16-7f07eb7c0c7a_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_409772a0-2192-4254-9559-c7588bd616bd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_ReclassificationsOfTemporaryToPermanentEquityShares_b9077dc9-37c8-4f88-b446-0b528aa3a635_terseLabel_en-US" xlink:label="lab_naut_ReclassificationsOfTemporaryToPermanentEquityShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization (in shares)</link:label>
    <link:label id="lab_naut_ReclassificationsOfTemporaryToPermanentEquityShares_label_en-US" xlink:label="lab_naut_ReclassificationsOfTemporaryToPermanentEquityShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications of Temporary to Permanent Equity, Shares</link:label>
    <link:label id="lab_naut_ReclassificationsOfTemporaryToPermanentEquityShares_documentation_en-US" xlink:label="lab_naut_ReclassificationsOfTemporaryToPermanentEquityShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares subject to possible redemption reclassified from temporary equity to permanent equity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ReclassificationsOfTemporaryToPermanentEquityShares" xlink:href="naut-20220630.xsd#naut_ReclassificationsOfTemporaryToPermanentEquityShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_ReclassificationsOfTemporaryToPermanentEquityShares" xlink:to="lab_naut_ReclassificationsOfTemporaryToPermanentEquityShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_e69eb857-c766-46cf-bf5f-a45e903a067e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_8b14a06b-2170-4f66-8bfe-5d02ec4c0477_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_4304dacb-327b-4db0-8c55-0a99c6db061f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_8f66d82a-76db-45aa-ab21-1ce1018211e6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_SanCarlosLeaseImprovementsLineOfCreditMember_f9808d18-dd94-46c7-bafd-945a1cf20235_terseLabel_en-US" xlink:label="lab_naut_SanCarlosLeaseImprovementsLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">San Carlos Lease Improvements Line of Credit</link:label>
    <link:label id="lab_naut_SanCarlosLeaseImprovementsLineOfCreditMember_label_en-US" xlink:label="lab_naut_SanCarlosLeaseImprovementsLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">San Carlos Lease Improvements Line of Credit [Member]</link:label>
    <link:label id="lab_naut_SanCarlosLeaseImprovementsLineOfCreditMember_documentation_en-US" xlink:label="lab_naut_SanCarlosLeaseImprovementsLineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">San Carlos Lease Improvements Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_SanCarlosLeaseImprovementsLineOfCreditMember" xlink:href="naut-20220630.xsd#naut_SanCarlosLeaseImprovementsLineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_SanCarlosLeaseImprovementsLineOfCreditMember" xlink:to="lab_naut_SanCarlosLeaseImprovementsLineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_079f3c93-759c-483c-ad9d-e7e869ca8fe2_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration received on transaction</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_3df364ab-930b-4f82-b390-04444cb0b23b_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_4304c058-d5cf-4667-894f-3fcc05067329_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable operating lease costs</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_6b54d4b8-c292-4209-83c4-1e2984ea67ce_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_d2ecf18b-a94e-41ac-a32e-9c6146a172ce_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_429d3a21-dc8a-40a1-828a-5e1749a93b62_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_5f8edc74-62a1-4c55-a094-c1ea1fe78f2b_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b6070877-831b-48e6-a37e-2fbdca09eeca_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_711413a0-c2d2-415d-a622-494f3ba1f441_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic and Diluted Net Loss per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_f7ddb112-c7bb-4273-8008-f7cc2fab9520_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Significant Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_52fcee3b-f2d4-4d8a-b622-6297f49c4107_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Composition of Certain Condensed Consolidated Financial Statement Line Items</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_77c56f50-2906-443a-81c2-b9601a129590_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_06408ac8-e650-4535-83f8-61b178e0b21f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_ed7fc1df-0b2e-433e-b114-a61c75c7b1b2_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_b15f9855-98db-4353-a2c5-b11503d2aa4b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsMember" xlink:to="lab_us-gaap_ShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8e10d275-d579-4bb9-9b1f-812f149a6059_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9e88dd68-e4fc-4f37-9df9-8e559eb6d0c9_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares used in computing net loss per share attributable to common stockholders, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6f984806-02c6-4ade-83e8-f46301497f31_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_3011c244-0826-40ac-a410-a682200f94bc_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense, period for recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_ReverseRecapitalizationAbstract_label_en-US" xlink:label="lab_naut_ReverseRecapitalizationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization [Abstract]</link:label>
    <link:label id="lab_naut_ReverseRecapitalizationAbstract_documentation_en-US" xlink:label="lab_naut_ReverseRecapitalizationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ReverseRecapitalizationAbstract" xlink:href="naut-20220630.xsd#naut_ReverseRecapitalizationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_ReverseRecapitalizationAbstract" xlink:to="lab_naut_ReverseRecapitalizationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_e9e33cc4-0581-4c03-bcfb-344035b1a334_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_a5ac43a0-e89b-4ee5-a44e-99dec4be9861_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_774e7b1c-cbfd-4590-b5fd-331b10fbc950_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer hardware</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_daa6cc6e-adec-4516-8d56-ff7bbaa4dd78_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_7b87385e-262b-4737-aaf9-bf03238bbc36_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_2664c015-cdba-4f58-abeb-69eebe6ef1b5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Long Term Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets, Noncurrent [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_58707fba-22de-47eb-a018-3b2878ba5cd0_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_6df7fe37-f4ff-47fd-bf27-c2cbb50694f6_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b6d46a25-9c0a-4b1d-b373-1df305158ae0_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1bac63a5-6e69-4415-85b0-6ddd0c03d620_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_2f006b69-9b18-4257-aafe-53a44d2a808a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued in PIPE Financing (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_4e1def17-d07e-455b-8b9f-9b15060140a6_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.0001 par value, 200,000,000 authorized as of June 30, 2022 and December 31, 2021; 0 shares issued and outstanding as of June 30, 2022 and December 31, 2021</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_65cf0022-9d7d-422b-97e1-3b628ff24a04_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1550a0fa-006b-4c83-b278-a5526fe6e169_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_ac59c8d6-2479-473e-b180-6f7037ce717a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_872be15d-b249-4568-9ff3-85489d0b0be6_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c7db3a60-51eb-420d-9816-4cddc09cc24c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_0805f068-f09d-4ac9-af34-a34b05aae4bf_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_StockConvertedReverseRecapitalization_fc06bb7b-133d-48ee-a76f-ae50b27b9b03_terseLabel_en-US" xlink:label="lab_naut_StockConvertedReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock converted, reverse recapitalization (in shares)</link:label>
    <link:label id="lab_naut_StockConvertedReverseRecapitalization_6c60cb9a-1165-4802-a89c-852e520ffa55_verboseLabel_en-US" xlink:label="lab_naut_StockConvertedReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legacy Nautilus shares (in shares)</link:label>
    <link:label id="lab_naut_StockConvertedReverseRecapitalization_label_en-US" xlink:label="lab_naut_StockConvertedReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Converted, Reverse Recapitalization</link:label>
    <link:label id="lab_naut_StockConvertedReverseRecapitalization_documentation_en-US" xlink:label="lab_naut_StockConvertedReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Converted, Reverse Recapitalization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_StockConvertedReverseRecapitalization" xlink:href="naut-20220630.xsd#naut_StockConvertedReverseRecapitalization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_StockConvertedReverseRecapitalization" xlink:to="lab_naut_StockConvertedReverseRecapitalization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_40ee0a98-a7e7-45ee-a138-892be0f4b1ab_totalLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shares of common stock reserved (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_7056fc3f-81cf-42c5-ad8d-d6ff69eeca9f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of common stock reserved (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_def1ff18-e6b1-42a5-8408-99499f6f5fcb_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_5659db57-4f97-45d8-a506-4cf8b4555a63_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_aa51910b-0d63-4d8e-b236-7241f6d412d9_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MutualFundMember_2c2d21f7-5343-48a5-bb9d-6866f706edec_terseLabel_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual funds</link:label>
    <link:label id="lab_us-gaap_MutualFundMember_label_en-US" xlink:label="lab_us-gaap_MutualFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mutual Fund [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MutualFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MutualFundMember" xlink:to="lab_us-gaap_MutualFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_8d24b490-d632-4e84-8f43-8f7f0846656c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_a89cb498-7ea7-4bd1-9766-67b2f07799a4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of outstanding stock maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_b1ce5e85-3f1d-4ec1-aa08-cb4bea1231e9_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Plan and Stock-based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_25a9fc2a-86e3-4dec-b07b-9b477dd8ed94_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_2551d86f-6c64-48db-af48-2cf399011939_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_ac66212e-0565-4560-8934-3c84faaa84eb_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_c0c66681-b60a-4d83-a155-674b2e3babe2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_d790e3f4-212b-4fff-95fe-d1fbe41014b0_terseLabel_en-US" xlink:label="lab_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_b82fd530-3be1-4850-bf9a-9ad0b61e05ca_totalLabel_en-US" xlink:label="lab_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_label_en-US" xlink:label="lab_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities and Other Liabilities, Current</link:label>
    <link:label id="lab_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_documentation_en-US" xlink:label="lab_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities and Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent" xlink:href="naut-20220630.xsd#naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent" xlink:to="lab_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_898ad0fd-028f-4ad0-a78e-7f430b66b2a7_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_3cd476f6-ccb9-4005-9d8b-907cd3a94b19_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_70f4ec4d-30cf-4b54-9b9e-033fcabe1285_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_6815850a-d50b-41e5-9cc2-45e556ceaf8d_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_ea45b5f8-9e3a-43bb-857a-9c9d9c4abe87_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_d914a13a-2061-410d-a864-8a9b26700794_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_February2021ToOctober2021Member_ec714dab-1b27-432d-9d9b-90e468a00ffa_terseLabel_en-US" xlink:label="lab_naut_February2021ToOctober2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2021 to October 2021</link:label>
    <link:label id="lab_naut_February2021ToOctober2021Member_label_en-US" xlink:label="lab_naut_February2021ToOctober2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2021 To October 2021 [Member]</link:label>
    <link:label id="lab_naut_February2021ToOctober2021Member_documentation_en-US" xlink:label="lab_naut_February2021ToOctober2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2021 To October 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_February2021ToOctober2021Member" xlink:href="naut-20220630.xsd#naut_February2021ToOctober2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_February2021ToOctober2021Member" xlink:to="lab_naut_February2021ToOctober2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_718db1df-d503-4d46-b7b8-8036e28d2803_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_c5de3bd4-8166-4182-afb8-43314b8909f4_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable, weighted average remaining contractual life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_DeferredStockIssuanceCosts_de084f71-6c99-4832-b1b3-5047dc1d0c1d_terseLabel_en-US" xlink:label="lab_naut_DeferredStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred offering costs in accounts payable and accrued expenses and other liabilities</link:label>
    <link:label id="lab_naut_DeferredStockIssuanceCosts_label_en-US" xlink:label="lab_naut_DeferredStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Stock Issuance Costs</link:label>
    <link:label id="lab_naut_DeferredStockIssuanceCosts_documentation_en-US" xlink:label="lab_naut_DeferredStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_DeferredStockIssuanceCosts" xlink:href="naut-20220630.xsd#naut_DeferredStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_DeferredStockIssuanceCosts" xlink:to="lab_naut_DeferredStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_ProceedsFromReverseRecapitalizationTransaction_4f57e81b-fcd3-4856-8513-8e9c71a97710_terseLabel_en-US" xlink:label="lab_naut_ProceedsFromReverseRecapitalizationTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from reverse recapitalization and PIPE financing</link:label>
    <link:label id="lab_naut_ProceedsFromReverseRecapitalizationTransaction_label_en-US" xlink:label="lab_naut_ProceedsFromReverseRecapitalizationTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Reverse Recapitalization Transaction</link:label>
    <link:label id="lab_naut_ProceedsFromReverseRecapitalizationTransaction_documentation_en-US" xlink:label="lab_naut_ProceedsFromReverseRecapitalizationTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Reverse Recapitalization Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ProceedsFromReverseRecapitalizationTransaction" xlink:href="naut-20220630.xsd#naut_ProceedsFromReverseRecapitalizationTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_ProceedsFromReverseRecapitalizationTransaction" xlink:to="lab_naut_ProceedsFromReverseRecapitalizationTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_b61e103b-ff5c-41d1-b13f-9ad9dcc69b1f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_68585b94-49d4-4f8a-9b3e-77c794e813ea_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash included in other long term assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_33298906-1dd6-4ec1-a040-358b668e356d_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_3459096e-8793-4e62-b9af-81914f4eecfe_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_91d15ce8-e660-4dba-9f8c-8ce451bd925f_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to common stockholders, diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_99f618d3-e11d-4aa6-ab38-2ba63ea9b954_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share attributable to common stockholders, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_cce99202-19d7-487c-8952-389513bd152c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested and expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_e2f3283b-a400-40a3-8489-0a353edc4f93_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_61230edd-f5f0-4c3f-8b32-6b74922b96c4_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_b6d56943-7014-469a-8a4f-ecfb42b4ff92_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of offering costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_2b22c594-90b4-4d34-ac41-12a718df79ba_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_75a01a78-d8eb-4c2c-8574-41c4940190ee_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_11b51bea-6501-41e5-9ea9-feeecd5a3a7d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_b2085ba3-38a8-4bb5-939e-e5b1e40092db_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_3dbed95a-53b0-4345-b1be-38b0b5cea4c9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk free interest rate, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_d1e1355c-13ff-41e8-ad53-79157bc3fb5e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_f8da445a-8e63-451d-a4b0-b6a0efdade0d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_f122eb48-8e6e-4a70-b39a-6dd3c22d5acd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_ad1c87a0-3e2f-4be1-8619-ceac0fd954b6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_ModificationToReduceRightOfUseAssetsAndLeaseLiability_926d0069-17d5-4bf0-be39-317dcef76e4d_terseLabel_en-US" xlink:label="lab_naut_ModificationToReduceRightOfUseAssetsAndLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Modification to reduce right-of-use assets and lease liability</link:label>
    <link:label id="lab_naut_ModificationToReduceRightOfUseAssetsAndLeaseLiability_label_en-US" xlink:label="lab_naut_ModificationToReduceRightOfUseAssetsAndLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Modification To Reduce Right-Of-Use Assets And Lease Liability</link:label>
    <link:label id="lab_naut_ModificationToReduceRightOfUseAssetsAndLeaseLiability_documentation_en-US" xlink:label="lab_naut_ModificationToReduceRightOfUseAssetsAndLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Modification To Reduce Right-Of-Use Assets And Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ModificationToReduceRightOfUseAssetsAndLeaseLiability" xlink:href="naut-20220630.xsd#naut_ModificationToReduceRightOfUseAssetsAndLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_ModificationToReduceRightOfUseAssetsAndLeaseLiability" xlink:to="lab_naut_ModificationToReduceRightOfUseAssetsAndLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_October2022ToOctober2031Member_9ce1d315-d138-4623-adbe-8e51ac5c7571_terseLabel_en-US" xlink:label="lab_naut_October2022ToOctober2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2022 to October 2031</link:label>
    <link:label id="lab_naut_October2022ToOctober2031Member_label_en-US" xlink:label="lab_naut_October2022ToOctober2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2022 to October 2031 [Member]</link:label>
    <link:label id="lab_naut_October2022ToOctober2031Member_documentation_en-US" xlink:label="lab_naut_October2022ToOctober2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2022 to October 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_October2022ToOctober2031Member" xlink:href="naut-20220630.xsd#naut_October2022ToOctober2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_October2022ToOctober2031Member" xlink:to="lab_naut_October2022ToOctober2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_b839583d-9905-4efa-8fc3-b3bd625a997f_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_41227087-c318-463a-a54d-bbc37511737c_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_41a30976-0b89-4944-978c-6192afb75b78_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share attributable to common stockholders, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_a7ff55de-b132-4ac7-89e1-66366e1a9aef_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share attributable to common stockholders, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_StockIssuedDuringPeriodValueReverseRecapitalization_ee6e76ea-4451-4c72-a58b-369afbcaaf3e_terseLabel_en-US" xlink:label="lab_naut_StockIssuedDuringPeriodValueReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon the reverse recapitalization, net of issuance costs</link:label>
    <link:label id="lab_naut_StockIssuedDuringPeriodValueReverseRecapitalization_label_en-US" xlink:label="lab_naut_StockIssuedDuringPeriodValueReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Reverse Recapitalization</link:label>
    <link:label id="lab_naut_StockIssuedDuringPeriodValueReverseRecapitalization_documentation_en-US" xlink:label="lab_naut_StockIssuedDuringPeriodValueReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Reverse Recapitalization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_StockIssuedDuringPeriodValueReverseRecapitalization" xlink:href="naut-20220630.xsd#naut_StockIssuedDuringPeriodValueReverseRecapitalization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_StockIssuedDuringPeriodValueReverseRecapitalization" xlink:to="lab_naut_StockIssuedDuringPeriodValueReverseRecapitalization" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_A2021EmployeeStockPurchasePlanMember_16b14f3d-1c1a-4437-b7c3-b9bae0c0fc2b_terseLabel_en-US" xlink:label="lab_naut_A2021EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Employee Stock Purchase Plan</link:label>
    <link:label id="lab_naut_A2021EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_naut_A2021EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_naut_A2021EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_naut_A2021EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_A2021EmployeeStockPurchasePlanMember" xlink:href="naut-20220630.xsd#naut_A2021EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_A2021EmployeeStockPurchasePlanMember" xlink:to="lab_naut_A2021EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_8731ea63-0e3a-4d86-ae90-cfd3d84e9e91_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_29cb8477-e9a4-4b14-9fa0-12bee622201c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_42a540e4-92bf-4153-a853-50ca8fbcc4ab_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_a0917d53-ee32-4d35-ab97-f6988d4f30ad_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_2f87d5a6-8979-4dfc-9111-6b63400a14fb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk free interest rate, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_ScheduleOfReverseRecapitalizationTable_0777ffa8-8ab3-4bf4-9400-addf20c06ca1_terseLabel_en-US" xlink:label="lab_naut_ScheduleOfReverseRecapitalizationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Reverse Recapitalization [Table]</link:label>
    <link:label id="lab_naut_ScheduleOfReverseRecapitalizationTable_label_en-US" xlink:label="lab_naut_ScheduleOfReverseRecapitalizationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Reverse Recapitalization [Table]</link:label>
    <link:label id="lab_naut_ScheduleOfReverseRecapitalizationTable_documentation_en-US" xlink:label="lab_naut_ScheduleOfReverseRecapitalizationTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Reverse Recapitalization [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ScheduleOfReverseRecapitalizationTable" xlink:href="naut-20220630.xsd#naut_ScheduleOfReverseRecapitalizationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationTable" xlink:to="lab_naut_ScheduleOfReverseRecapitalizationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f0902ee9-18a9-4ff1-8397-56b39f74a158_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Future Principal Contractual Obligations for Operating Lease Commitments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_0e754e3d-da6f-445c-aaf8-16d67d9dc9e7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_3c71f596-8a0c-42e7-a3c9-45460eca6c59_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Cash</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_d4e92e5b-836b-4474-8b5f-d7470fdd33bc_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_f990b4b9-d850-46c9-8b02-575f3064e84a_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_282a946c-2203-475b-a048-7e3e51c6bca3_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseContractualTermAxis_16343098-d80d-4418-83f0-3e1b4ac04ab0_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Axis]</link:label>
    <link:label id="lab_us-gaap_LeaseContractualTermAxis_label_en-US" xlink:label="lab_us-gaap_LeaseContractualTermAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Contractual Term [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseContractualTermAxis" xlink:to="lab_us-gaap_LeaseContractualTermAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_b9ede2b0-3e80-474b-83fc-c1070b38cf5e_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_5e422352-ed8f-42dd-8a46-755a9a2eb389_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_8941c36c-aee2-45e2-92c3-9d3f8c331e65_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Options Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_8a1a584f-d366-472b-a019-a4904a3fbce0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_575d3647-6e12-4bb0-b86a-7e4e02f02eb0_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_b8343b32-c9d9-438d-a558-0186d57fdb86_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued in transaction (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_6895e592-0ab1-406d-a29b-f55360a1dd68_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1b8cb911-f111-42bd-849c-d5425c59eef0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_6305343c-2226-41f3-9565-38f9a85f77b5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from maturities of securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_99cf51d9-93c2-4c2e-bea0-6b176a113408_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_bd00ddc5-f2b5-4532-b9cf-be3acffab3ea_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_ReverseRecapitalizationDisclosureTextBlock_8fc6bf01-ca2c-45aa-ba7e-1e0b1b556daa_terseLabel_en-US" xlink:label="lab_naut_ReverseRecapitalizationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization</link:label>
    <link:label id="lab_naut_ReverseRecapitalizationDisclosureTextBlock_label_en-US" xlink:label="lab_naut_ReverseRecapitalizationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization Disclosure [Text Block]</link:label>
    <link:label id="lab_naut_ReverseRecapitalizationDisclosureTextBlock_documentation_en-US" xlink:label="lab_naut_ReverseRecapitalizationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ReverseRecapitalizationDisclosureTextBlock" xlink:href="naut-20220630.xsd#naut_ReverseRecapitalizationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_ReverseRecapitalizationDisclosureTextBlock" xlink:to="lab_naut_ReverseRecapitalizationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_3c07c992-7caf-4813-b37d-7911d5e5f8a0_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_2592f3a2-e6f6-43ee-a937-afaf75fb8a50_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_AryaSciencesAcquisitionCorpIIIMember_ed491e81-0920-4441-bd96-4e55e9e99b08_terseLabel_en-US" xlink:label="lab_naut_AryaSciencesAcquisitionCorpIIIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arya Sciences Acquisition Corp III</link:label>
    <link:label id="lab_naut_AryaSciencesAcquisitionCorpIIIMember_label_en-US" xlink:label="lab_naut_AryaSciencesAcquisitionCorpIIIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arya Sciences Acquisition Corp III [Member]</link:label>
    <link:label id="lab_naut_AryaSciencesAcquisitionCorpIIIMember_documentation_en-US" xlink:label="lab_naut_AryaSciencesAcquisitionCorpIIIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arya Sciences Acquisition Corp III</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_AryaSciencesAcquisitionCorpIIIMember" xlink:href="naut-20220630.xsd#naut_AryaSciencesAcquisitionCorpIIIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_AryaSciencesAcquisitionCorpIIIMember" xlink:to="lab_naut_AryaSciencesAcquisitionCorpIIIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_f768be46-f3c6-4df5-b953-f7e143242aca_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_b08196ba-457f-429d-81d7-2ac6335af85e_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease costs</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_c11747ec-440c-4c9e-9698-28777a672186_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_eaee58f2-698a-40d3-9a3f-54007d07afba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6287198f-a52b-4171-985e-6e46258a2502_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_fda1c28a-5fd4-49cb-9947-cbcb1671dd94_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_214d8543-92ab-45cb-8fda-f21632a39050_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Lease Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_6ddecaf8-bb0d-449c-b7bb-a9f14687d878_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_12f1239f-4c6d-4ab8-a838-7f1a844712ab_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for grant under equity plan (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_5be03602-b5af-4dac-9b14-8ea469231662_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_3a84acc9-b898-45a0-a38e-773c81e04434_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_38f5c5ab-d817-4c29-a226-013608c22d29_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and short-term investments</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_LaboratoryEquipmentMember_01bd28aa-02d2-486d-9e57-9ca0ae51f33c_terseLabel_en-US" xlink:label="lab_naut_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory equipment</link:label>
    <link:label id="lab_naut_LaboratoryEquipmentMember_label_en-US" xlink:label="lab_naut_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Equipment [Member]</link:label>
    <link:label id="lab_naut_LaboratoryEquipmentMember_documentation_en-US" xlink:label="lab_naut_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_LaboratoryEquipmentMember" xlink:href="naut-20220630.xsd#naut_LaboratoryEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_LaboratoryEquipmentMember" xlink:to="lab_naut_LaboratoryEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_39c693fd-8640-48ea-9c26-a56407b54dca_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_1cbdb713-7201-4d05-bb25-2f8af851eea1_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesIssued" xlink:to="lab_us-gaap_TemporaryEquitySharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_a59c6da8-d9dc-44e5-b630-11646e41bac7_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_86eed99f-6568-4d44-8d6e-0cca826e6a4a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability, net of current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_ReverseRecapitalizationCashPaidToShareholders_36265a6d-fc31-4619-a6f8-dfa82871c911_terseLabel_en-US" xlink:label="lab_naut_ReverseRecapitalizationCashPaidToShareholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse recapitalization, cash paid to shareholders</link:label>
    <link:label id="lab_naut_ReverseRecapitalizationCashPaidToShareholders_label_en-US" xlink:label="lab_naut_ReverseRecapitalizationCashPaidToShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization, Cash Paid To Shareholders</link:label>
    <link:label id="lab_naut_ReverseRecapitalizationCashPaidToShareholders_documentation_en-US" xlink:label="lab_naut_ReverseRecapitalizationCashPaidToShareholders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization, Cash Paid To Shareholders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ReverseRecapitalizationCashPaidToShareholders" xlink:href="naut-20220630.xsd#naut_ReverseRecapitalizationCashPaidToShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_ReverseRecapitalizationCashPaidToShareholders" xlink:to="lab_naut_ReverseRecapitalizationCashPaidToShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_58556bd2-50e7-44db-970f-64662d594583_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_25872079-59a1-4663-82c1-6504fdf3bd29_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_6cc3f4e3-814d-4481-8947-c14edae5cf7f_terseLabel_en-US" xlink:label="lab_naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Common Stock Reserved for Future Issuance</link:label>
    <link:label id="lab_naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_label_en-US" xlink:label="lab_naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Common Stock Reserved For Future Issuance [Table Text Block]</link:label>
    <link:label id="lab_naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_documentation_en-US" xlink:label="lab_naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Common Stock Reserved For Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:href="naut-20220630.xsd#naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:to="lab_naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_fa1daf25-cacd-4897-9b62-13bf1d454abd_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_8b1dc183-71d4-47b4-9d68-e0fdb58fc717_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_e899f1d9-f809-43ec-b70e-5b9c5b87f1d3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_ea7b507e-fb9e-4bbc-9c46-addea65cc8af_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_bea460e0-9751-4d2f-aae9-1376aa3156e8_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_5637c33d-ca04-422e-82db-b7b44a107567_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_394c9b1b-0bd8-42af-ba27-185e49ac759a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_ed06c9c7-3bce-43c7-ab32-6d9945347ec1_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions of property and equipment included in accounts payable</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Fixed Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_1cea2bc4-c59b-42c3-b92f-1a4836cde050_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_StockIssuedDuringPeriodSharesReverseRecapitalization_102694c2-eb83-4a68-9dda-de66488451b7_terseLabel_en-US" xlink:label="lab_naut_StockIssuedDuringPeriodSharesReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon the reverse recapitalization, net of issuance costs (in shares)</link:label>
    <link:label id="lab_naut_StockIssuedDuringPeriodSharesReverseRecapitalization_547fc2f9-f8f2-42cf-b0e2-2eacabde8950_verboseLabel_en-US" xlink:label="lab_naut_StockIssuedDuringPeriodSharesReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and PIPE Financing shares (in shares)</link:label>
    <link:label id="lab_naut_StockIssuedDuringPeriodSharesReverseRecapitalization_label_en-US" xlink:label="lab_naut_StockIssuedDuringPeriodSharesReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Reverse Recapitalization</link:label>
    <link:label id="lab_naut_StockIssuedDuringPeriodSharesReverseRecapitalization_documentation_en-US" xlink:label="lab_naut_StockIssuedDuringPeriodSharesReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Reverse Recapitalization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_StockIssuedDuringPeriodSharesReverseRecapitalization" xlink:href="naut-20220630.xsd#naut_StockIssuedDuringPeriodSharesReverseRecapitalization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_StockIssuedDuringPeriodSharesReverseRecapitalization" xlink:to="lab_naut_StockIssuedDuringPeriodSharesReverseRecapitalization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_e63521bc-e667-4504-9c39-586ab72d97ef_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_a0b54365-f970-4b03-b8eb-1fbe03fc107a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross proceeds from private placement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Private Placement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f64e9524-e83c-4f2b-8ee3-1a17fd81ca41_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_LesseeOperatingLeaseOptionToTerminateLeaseTerm_b530e7ae-3a0c-4e73-9868-9a573ac6a0b5_terseLabel_en-US" xlink:label="lab_naut_LesseeOperatingLeaseOptionToTerminateLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease term with option to terminate</link:label>
    <link:label id="lab_naut_LesseeOperatingLeaseOptionToTerminateLeaseTerm_label_en-US" xlink:label="lab_naut_LesseeOperatingLeaseOptionToTerminateLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Option to Terminate, Lease Term</link:label>
    <link:label id="lab_naut_LesseeOperatingLeaseOptionToTerminateLeaseTerm_documentation_en-US" xlink:label="lab_naut_LesseeOperatingLeaseOptionToTerminateLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Option to Terminate, Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_LesseeOperatingLeaseOptionToTerminateLeaseTerm" xlink:href="naut-20220630.xsd#naut_LesseeOperatingLeaseOptionToTerminateLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_LesseeOperatingLeaseOptionToTerminateLeaseTerm" xlink:to="lab_naut_LesseeOperatingLeaseOptionToTerminateLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_2fa53a2a-543d-4586-a19e-bbb73d00f886_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_04118ce1-39d8-41f2-8a1f-249100e7372c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_68b7f110-e992-4caf-9e3f-b43e81cabbc5_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of Credit Risk and Other Risks and Uncertainties</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_15f593b0-4237-4493-991e-8fe0185ab7d9_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_0b08980a-4619-44a6-9c72-d12cf33ae189_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_873531b1-396a-4397-bbba-11841be6cceb_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_b6a9a003-1e84-4ded-8e78-01518c88b90d_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_c732330b-a3d9-43b9-b039-ce90005c8ccf_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued professional and consulting fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_822cffa8-1732-4db7-a0c6-257eccabc501_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_e940d893-1829-414e-94e8-ebd04ec0c483_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_75ae6dde-9c6e-4fc3-b697-34bd1d42c1c4_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_StockIssuedDuringPeriodSharesWarrantsExercised_b3cb69e7-7afc-4d4d-91b5-14101525130f_terseLabel_en-US" xlink:label="lab_naut_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of warrants (in shares)</link:label>
    <link:label id="lab_naut_StockIssuedDuringPeriodSharesWarrantsExercised_label_en-US" xlink:label="lab_naut_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Warrants Exercised</link:label>
    <link:label id="lab_naut_StockIssuedDuringPeriodSharesWarrantsExercised_documentation_en-US" xlink:label="lab_naut_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Warrants Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:href="naut-20220630.xsd#naut_StockIssuedDuringPeriodSharesWarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:to="lab_naut_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_94dbb87f-280f-44fe-b597-86635fe8f3f6_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityFairValueDisclosure_2a8ded83-8934-4a76-a249-0772cac07306_terseLabel_en-US" xlink:label="lab_us-gaap_EquityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity value</link:label>
    <link:label id="lab_us-gaap_EquityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_EquityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityFairValueDisclosure" xlink:to="lab_us-gaap_EquityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_8e4d9a3f-22ef-49b0-970b-c95dfed3adbb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_5ec89c54-ae9b-40d7-87f5-8c5a312a8c57_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_253af0b2-282a-4aef-a6e6-fb2efbd74d7f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4835d33f-e0ff-491b-90fa-7bc1ce36a536_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_95b4cefc-773b-415b-9895-fe3b189d205e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_2ce7b7df-7370-48a5-88a0-c57983df1290_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b7060296-d1db-434d-9b58-38963d93e1e4_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_1cd6207c-21bf-40ea-9dce-cb2d046e446f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_ab5a4484-d404-4e2e-b720-da16dd8e4d14_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A</link:label>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesAPreferredStockMember" xlink:to="lab_us-gaap_SeriesAPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_b3c7e6d8-7075-4077-9964-d415ac9c2f1b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested and expected to vest (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_f63d9da4-bde9-4209-9e65-645a554be8ea_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_b7755064-0d69-436e-9d41-4ca19002d762_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c1dc14f6-bead-4772-a37b-3cfea35994d0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_c8018fc1-7af3-45cf-9829-7329213cf22e_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentAmount_c451328c-5628-4e38-8e59-207882681006_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Open purchase commitment</link:label>
    <link:label id="lab_us-gaap_LongTermPurchaseCommitmentAmount_label_en-US" xlink:label="lab_us-gaap_LongTermPurchaseCommitmentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Purchase Commitment, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermPurchaseCommitmentAmount" xlink:to="lab_us-gaap_LongTermPurchaseCommitmentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase_ee97e2ad-331f-4752-b15e-f46cdf81007e_negatedTerseLabel_en-US" xlink:label="lab_naut_WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Weighted-average unvested restricted shares and shares subject to repurchase (in shares)</link:label>
    <link:label id="lab_naut_WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase_label_en-US" xlink:label="lab_naut_WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Of Shares, Unvested Restricted Stock And Shares Subject To Repurchase</link:label>
    <link:label id="lab_naut_WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase_documentation_en-US" xlink:label="lab_naut_WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Of Shares, Unvested Restricted Stock And Shares Subject To Repurchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase" xlink:href="naut-20220630.xsd#naut_WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase" xlink:to="lab_naut_WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f22fcff0-71d0-441b-bdb2-8031092ba570_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_CashAcquiredThroughReverseRecapitalization_c3f067fb-e180-4a2f-881d-73a17bae4fae_terseLabel_en-US" xlink:label="lab_naut_CashAcquiredThroughReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash acquired through reverse recapitalization</link:label>
    <link:label id="lab_naut_CashAcquiredThroughReverseRecapitalization_label_en-US" xlink:label="lab_naut_CashAcquiredThroughReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired Through Reverse Recapitalization</link:label>
    <link:label id="lab_naut_CashAcquiredThroughReverseRecapitalization_documentation_en-US" xlink:label="lab_naut_CashAcquiredThroughReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired Through Reverse Recapitalization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_CashAcquiredThroughReverseRecapitalization" xlink:href="naut-20220630.xsd#naut_CashAcquiredThroughReverseRecapitalization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_CashAcquiredThroughReverseRecapitalization" xlink:to="lab_naut_CashAcquiredThroughReverseRecapitalization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_8b6b0220-fc93-4784-b672-775c7de07efa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_ScheduleOfReverseRecapitalizationTableTextBlock_500ec952-ce61-4614-bdd8-14ecf9eebb1f_terseLabel_en-US" xlink:label="lab_naut_ScheduleOfReverseRecapitalizationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reverse Recapitalization</link:label>
    <link:label id="lab_naut_ScheduleOfReverseRecapitalizationTableTextBlock_label_en-US" xlink:label="lab_naut_ScheduleOfReverseRecapitalizationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Reverse Recapitalization [Table Text Block]</link:label>
    <link:label id="lab_naut_ScheduleOfReverseRecapitalizationTableTextBlock_documentation_en-US" xlink:label="lab_naut_ScheduleOfReverseRecapitalizationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Reverse Recapitalization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ScheduleOfReverseRecapitalizationTableTextBlock" xlink:href="naut-20220630.xsd#naut_ScheduleOfReverseRecapitalizationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationTableTextBlock" xlink:to="lab_naut_ScheduleOfReverseRecapitalizationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a51a98fd-f8cf-40db-88ed-5ebf22b63ac9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_9dd5e581-4278-4c82-b40f-67299cacd097_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_0eac8876-008d-4c3a-92b9-509605c58d6d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business and Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant_50e5e92d-ee90-42ee-b094-c2fe72b710f9_terseLabel_en-US" xlink:label="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in shares available for grant under equity plan (in shares)</link:label>
    <link:label id="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Increase in Number of Shares Available for Grant</link:label>
    <link:label id="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant_documentation_en-US" xlink:label="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Increase in Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant" xlink:href="naut-20220630.xsd#naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant" xlink:to="lab_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>naut-20220630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9cc3a1fd-7e26-418c-9538-c00b184efabf,g:ab9b2c40-7a18-466f-af91-0013c7c3cb4b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.nautilus.bio/role/Cover" xlink:type="simple" xlink:href="naut-20220630.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_13538b2c-f2ba-4e78-825a-1db2ad3d8eae" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_DocumentType_13538b2c-f2ba-4e78-825a-1db2ad3d8eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_10e1748f-69bb-4557-89b7-08f838ba5c5a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_DocumentQuarterlyReport_10e1748f-69bb-4557-89b7-08f838ba5c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_f4c40cb6-67fc-43a8-8d83-32897ffe042f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_DocumentPeriodEndDate_f4c40cb6-67fc-43a8-8d83-32897ffe042f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_2d68f3c7-f56d-4b31-8802-16963cb1a3d1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_DocumentTransitionReport_2d68f3c7-f56d-4b31-8802-16963cb1a3d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_1a4e8883-3708-473f-bbc9-e189b655fc72" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_EntityFileNumber_1a4e8883-3708-473f-bbc9-e189b655fc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_654de34a-1a98-49d7-96b1-461a7710fe33" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_EntityRegistrantName_654de34a-1a98-49d7-96b1-461a7710fe33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_faa23665-ef23-4d01-925e-d6aacd36dd57" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_EntityIncorporationStateCountryCode_faa23665-ef23-4d01-925e-d6aacd36dd57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_1cfb586c-de73-4b61-9953-ecb62893c425" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_EntityTaxIdentificationNumber_1cfb586c-de73-4b61-9953-ecb62893c425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_6ca8fa4b-96b8-4dd4-ada8-d554dc3db492" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_EntityAddressAddressLine1_6ca8fa4b-96b8-4dd4-ada8-d554dc3db492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_d56d7899-b3cd-482e-94b0-e0e4188b9d6e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_EntityAddressCityOrTown_d56d7899-b3cd-482e-94b0-e0e4188b9d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_7ee78c73-0fdc-4047-9255-6101b6fe4dda" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_EntityAddressStateOrProvince_7ee78c73-0fdc-4047-9255-6101b6fe4dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_ce3415be-70d3-47cb-9c15-689048dc3f98" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_EntityAddressPostalZipCode_ce3415be-70d3-47cb-9c15-689048dc3f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_5b55b9a1-e349-4278-971c-a75f71db3fb2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_CityAreaCode_5b55b9a1-e349-4278-971c-a75f71db3fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_d2964abf-6f9c-4c53-9dcf-669aaeb023d0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_LocalPhoneNumber_d2964abf-6f9c-4c53-9dcf-669aaeb023d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_18cb3019-27ab-424d-b4d4-32529dc3a4cd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_Security12bTitle_18cb3019-27ab-424d-b4d4-32529dc3a4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_745acb87-42b9-458d-870e-f871fe5843dd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_TradingSymbol_745acb87-42b9-458d-870e-f871fe5843dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_842a05f8-6191-4d4f-ba0f-239d48bde177" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_SecurityExchangeName_842a05f8-6191-4d4f-ba0f-239d48bde177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_5b0126fa-cbac-4ed6-b2da-12b6e2494550" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_EntityCurrentReportingStatus_5b0126fa-cbac-4ed6-b2da-12b6e2494550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_c412ad17-01f5-4910-8d90-fccbaac58c5f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_EntityInteractiveDataCurrent_c412ad17-01f5-4910-8d90-fccbaac58c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_a00628ff-84dc-45c6-b70e-aa42502bb840" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_EntityFilerCategory_a00628ff-84dc-45c6-b70e-aa42502bb840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_dde897df-f5f0-43b3-9edf-6eb2c4ae334c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_EntitySmallBusiness_dde897df-f5f0-43b3-9edf-6eb2c4ae334c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d6900085-426a-4fa4-9351-5ecdd2b9fb9c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_EntityEmergingGrowthCompany_d6900085-426a-4fa4-9351-5ecdd2b9fb9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_2d201c79-b661-4681-bb17-5c0b38313e2a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_EntityExTransitionPeriod_2d201c79-b661-4681-bb17-5c0b38313e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_ca14b2ac-f6d9-4649-95fe-87907431ac24" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_EntityShellCompany_ca14b2ac-f6d9-4649-95fe-87907431ac24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_9488ab4e-de4d-40d0-a0a8-62e246023d5c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_9488ab4e-de4d-40d0-a0a8-62e246023d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_ac8ba83b-8b88-445e-908a-dd39686fb75f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_EntityCentralIndexKey_ac8ba83b-8b88-445e-908a-dd39686fb75f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_8138a765-9718-47fc-a46e-1d7e98897a0c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_AmendmentFlag_8138a765-9718-47fc-a46e-1d7e98897a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_0ca38e9d-2cf2-449d-b0aa-cd55e58c8761" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_CurrentFiscalYearEndDate_0ca38e9d-2cf2-449d-b0aa-cd55e58c8761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_2fcbeeeb-8532-4eb5-8e55-1b97b152dd80" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_DocumentFiscalYearFocus_2fcbeeeb-8532-4eb5-8e55-1b97b152dd80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_69cc51c4-cc5f-44a1-af6e-b2b08b858c31" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_236543d5-cd81-4caf-8c78-d38b6560b169" xlink:to="loc_dei_DocumentFiscalPeriodFocus_69cc51c4-cc5f-44a1-af6e-b2b08b858c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="naut-20220630.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_4af4fac8-a78e-43a9-9e76-ac65b9408019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_28246034-6286-48df-90a4-8db68d3dc950" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4af4fac8-a78e-43a9-9e76-ac65b9408019" xlink:to="loc_us-gaap_AssetsAbstract_28246034-6286-48df-90a4-8db68d3dc950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_422dc23c-1d42-45cc-9c61-cc8271ab2a23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_28246034-6286-48df-90a4-8db68d3dc950" xlink:to="loc_us-gaap_AssetsCurrentAbstract_422dc23c-1d42-45cc-9c61-cc8271ab2a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8ff1aade-239d-45db-bd6d-868dd87ab7c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_422dc23c-1d42-45cc-9c61-cc8271ab2a23" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8ff1aade-239d-45db-bd6d-868dd87ab7c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_a765fbce-7881-4847-af7e-d13903059456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_422dc23c-1d42-45cc-9c61-cc8271ab2a23" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_a765fbce-7881-4847-af7e-d13903059456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_14852d10-0a31-47fa-b30e-58fe08caa458" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_422dc23c-1d42-45cc-9c61-cc8271ab2a23" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_14852d10-0a31-47fa-b30e-58fe08caa458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8516abc8-354b-4088-802e-bc561f9a5205" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_422dc23c-1d42-45cc-9c61-cc8271ab2a23" xlink:to="loc_us-gaap_AssetsCurrent_8516abc8-354b-4088-802e-bc561f9a5205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_afadefc0-c969-41a5-b4a9-917540a2b855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_28246034-6286-48df-90a4-8db68d3dc950" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_afadefc0-c969-41a5-b4a9-917540a2b855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0a33e4f8-ee02-4f4b-aa28-488124ec6fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_28246034-6286-48df-90a4-8db68d3dc950" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0a33e4f8-ee02-4f4b-aa28-488124ec6fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_1aefdf06-c1b4-4baa-bc4f-36ef09feec1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_28246034-6286-48df-90a4-8db68d3dc950" xlink:to="loc_us-gaap_LongTermInvestments_1aefdf06-c1b4-4baa-bc4f-36ef09feec1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_0c4087ea-a1de-4d2e-bd79-ea20ba7f2d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_28246034-6286-48df-90a4-8db68d3dc950" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_0c4087ea-a1de-4d2e-bd79-ea20ba7f2d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a7c48f94-8508-4cc9-8109-91c948c1f8a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_28246034-6286-48df-90a4-8db68d3dc950" xlink:to="loc_us-gaap_Assets_a7c48f94-8508-4cc9-8109-91c948c1f8a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ab061c04-4b01-4722-a509-221064cb0eca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4af4fac8-a78e-43a9-9e76-ac65b9408019" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ab061c04-4b01-4722-a509-221064cb0eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_b8afc786-fcf4-4fe8-ae43-3a312c75e758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ab061c04-4b01-4722-a509-221064cb0eca" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_b8afc786-fcf4-4fe8-ae43-3a312c75e758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_b39f2492-0fc3-411b-a46d-666bcad56eea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b8afc786-fcf4-4fe8-ae43-3a312c75e758" xlink:to="loc_us-gaap_AccountsPayableCurrent_b39f2492-0fc3-411b-a46d-666bcad56eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_7269b6c8-3894-445a-97f6-e96907beb379" xlink:href="naut-20220630.xsd#naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b8afc786-fcf4-4fe8-ae43-3a312c75e758" xlink:to="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_7269b6c8-3894-445a-97f6-e96907beb379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_a4619466-8402-4e88-b9c7-ca47ed258176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b8afc786-fcf4-4fe8-ae43-3a312c75e758" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_a4619466-8402-4e88-b9c7-ca47ed258176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_021c0b77-815e-4c32-be11-d28bdab2d5f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b8afc786-fcf4-4fe8-ae43-3a312c75e758" xlink:to="loc_us-gaap_LiabilitiesCurrent_021c0b77-815e-4c32-be11-d28bdab2d5f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1498dd15-b03f-49f7-8138-b8ef1451f9d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ab061c04-4b01-4722-a509-221064cb0eca" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1498dd15-b03f-49f7-8138-b8ef1451f9d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_360dcefd-4cc4-45a9-99e2-e42991dd91b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ab061c04-4b01-4722-a509-221064cb0eca" xlink:to="loc_us-gaap_Liabilities_360dcefd-4cc4-45a9-99e2-e42991dd91b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_fcaf8865-6833-4813-acb0-d7f1600aef19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ab061c04-4b01-4722-a509-221064cb0eca" xlink:to="loc_us-gaap_CommitmentsAndContingencies_fcaf8865-6833-4813-acb0-d7f1600aef19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_1f192772-f484-4413-90e8-cd88fe0e206c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ab061c04-4b01-4722-a509-221064cb0eca" xlink:to="loc_us-gaap_StockholdersEquityAbstract_1f192772-f484-4413-90e8-cd88fe0e206c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_ff187d60-0cc3-49a3-aa9f-ac3a8e33249d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1f192772-f484-4413-90e8-cd88fe0e206c" xlink:to="loc_us-gaap_PreferredStockValue_ff187d60-0cc3-49a3-aa9f-ac3a8e33249d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_4983001a-aa1a-412f-9039-014d8954b7d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1f192772-f484-4413-90e8-cd88fe0e206c" xlink:to="loc_us-gaap_CommonStockValue_4983001a-aa1a-412f-9039-014d8954b7d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_072d3b54-a52b-463f-ba89-d049046be500" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1f192772-f484-4413-90e8-cd88fe0e206c" xlink:to="loc_us-gaap_AdditionalPaidInCapital_072d3b54-a52b-463f-ba89-d049046be500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_250347e5-4bb5-47d0-b757-5508e0becafb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1f192772-f484-4413-90e8-cd88fe0e206c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_250347e5-4bb5-47d0-b757-5508e0becafb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2027059d-f0c5-460b-9eb4-8f807f832bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1f192772-f484-4413-90e8-cd88fe0e206c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2027059d-f0c5-460b-9eb4-8f807f832bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_90f86e44-f0c1-46cc-bcfc-7cf71369a72d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_1f192772-f484-4413-90e8-cd88fe0e206c" xlink:to="loc_us-gaap_StockholdersEquity_90f86e44-f0c1-46cc-bcfc-7cf71369a72d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_be7a5f53-e4a2-4ef1-865f-4e367804bcb5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_ab061c04-4b01-4722-a509-221064cb0eca" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_be7a5f53-e4a2-4ef1-865f-4e367804bcb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="naut-20220630.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_478dd40c-3534-4d70-a105-deb81f39b0bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_aba86a34-9af3-4135-a91f-b5bfb1fd106b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_478dd40c-3534-4d70-a105-deb81f39b0bd" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_aba86a34-9af3-4135-a91f-b5bfb1fd106b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_fa7f1312-6b02-4e1a-9ae3-0a9bc188d99f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_478dd40c-3534-4d70-a105-deb81f39b0bd" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_fa7f1312-6b02-4e1a-9ae3-0a9bc188d99f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_c8751f90-f1dd-4ffd-a64f-f79a0a3c3e05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_478dd40c-3534-4d70-a105-deb81f39b0bd" xlink:to="loc_us-gaap_PreferredStockSharesIssued_c8751f90-f1dd-4ffd-a64f-f79a0a3c3e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_3fa4d6ad-c79b-4c89-847e-bb716a7fd02d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_478dd40c-3534-4d70-a105-deb81f39b0bd" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_3fa4d6ad-c79b-4c89-847e-bb716a7fd02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_f6844f40-db93-4636-a509-f201708d52f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_478dd40c-3534-4d70-a105-deb81f39b0bd" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_f6844f40-db93-4636-a509-f201708d52f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_7bd6a541-dd45-400b-accb-0ea1241c656a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_478dd40c-3534-4d70-a105-deb81f39b0bd" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_7bd6a541-dd45-400b-accb-0ea1241c656a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_1361421f-0b2b-4410-b86d-2d700c17d963" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_478dd40c-3534-4d70-a105-deb81f39b0bd" xlink:to="loc_us-gaap_CommonStockSharesIssued_1361421f-0b2b-4410-b86d-2d700c17d963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_338bc39f-4378-4ac3-b14e-a79c843b719a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_478dd40c-3534-4d70-a105-deb81f39b0bd" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_338bc39f-4378-4ac3-b14e-a79c843b719a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="naut-20220630.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_48e45304-39d6-46bd-b49e-7227d7c1a0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_136881e0-5f38-4c74-80c9-ecacd8088837" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_48e45304-39d6-46bd-b49e-7227d7c1a0e0" xlink:to="loc_us-gaap_OperatingExpensesAbstract_136881e0-5f38-4c74-80c9-ecacd8088837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_7695799e-c316-4059-bba2-2aed8752b987" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_136881e0-5f38-4c74-80c9-ecacd8088837" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_7695799e-c316-4059-bba2-2aed8752b987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_2e1e32ee-6efc-4ad9-964c-0c4e49f90eee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_136881e0-5f38-4c74-80c9-ecacd8088837" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_2e1e32ee-6efc-4ad9-964c-0c4e49f90eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_992af954-536b-4aaa-ba59-ce9254d361d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_136881e0-5f38-4c74-80c9-ecacd8088837" xlink:to="loc_us-gaap_OperatingExpenses_992af954-536b-4aaa-ba59-ce9254d361d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_bef6e67b-b0ea-4540-b4e5-70f70173b080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_48e45304-39d6-46bd-b49e-7227d7c1a0e0" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_bef6e67b-b0ea-4540-b4e5-70f70173b080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d1a5c50c-05a1-4f76-bde8-ab8039af4966" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_48e45304-39d6-46bd-b49e-7227d7c1a0e0" xlink:to="loc_us-gaap_NetIncomeLoss_d1a5c50c-05a1-4f76-bde8-ab8039af4966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_4aaa154d-4b7d-4878-a7ae-255c09044634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_48e45304-39d6-46bd-b49e-7227d7c1a0e0" xlink:to="loc_us-gaap_EarningsPerShareBasic_4aaa154d-4b7d-4878-a7ae-255c09044634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a2e6dcb3-6483-44bc-b4f0-d80609729469" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_48e45304-39d6-46bd-b49e-7227d7c1a0e0" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a2e6dcb3-6483-44bc-b4f0-d80609729469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b889cf93-00e3-4870-86d2-55ef7e90bc4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_48e45304-39d6-46bd-b49e-7227d7c1a0e0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b889cf93-00e3-4870-86d2-55ef7e90bc4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_06a0c671-db82-4b54-920b-860d513000c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_48e45304-39d6-46bd-b49e-7227d7c1a0e0" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_06a0c671-db82-4b54-920b-860d513000c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="naut-20220630.xsd#CondensedConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4391180d-10c4-4475-bfde-ec10d8c9256d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5a50f4a5-88fc-4f85-b5bb-23eac15bf770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4391180d-10c4-4475-bfde-ec10d8c9256d" xlink:to="loc_us-gaap_NetIncomeLoss_5a50f4a5-88fc-4f85-b5bb-23eac15bf770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_40e6f2a5-cc09-4b9f-b7e2-f074972e9e0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4391180d-10c4-4475-bfde-ec10d8c9256d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_40e6f2a5-cc09-4b9f-b7e2-f074972e9e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_053b66f2-fba1-49c0-a377-fc4447d8532d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_40e6f2a5-cc09-4b9f-b7e2-f074972e9e0e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_053b66f2-fba1-49c0-a377-fc4447d8532d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_00cf4645-4ceb-48e2-9577-66332176ddce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_40e6f2a5-cc09-4b9f-b7e2-f074972e9e0e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_00cf4645-4ceb-48e2-9577-66332176ddce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_04c0ceec-c11a-4283-8232-252dffa1b26b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4391180d-10c4-4475-bfde-ec10d8c9256d" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_04c0ceec-c11a-4283-8232-252dffa1b26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit" xlink:type="simple" xlink:href="naut-20220630.xsd#CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_d83111f2-ffaf-440d-9493-7d52b7dbeb44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2755d0e4-4db0-4967-8b66-6f6e6128ecea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_d83111f2-ffaf-440d-9493-7d52b7dbeb44" xlink:to="loc_us-gaap_StatementTable_2755d0e4-4db0-4967-8b66-6f6e6128ecea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5bd69cc0-f4f2-4e78-afa0-b61bfe436369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2755d0e4-4db0-4967-8b66-6f6e6128ecea" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5bd69cc0-f4f2-4e78-afa0-b61bfe436369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bc395324-2507-444e-9596-b9ce07634a58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5bd69cc0-f4f2-4e78-afa0-b61bfe436369" xlink:to="loc_us-gaap_EquityComponentDomain_bc395324-2507-444e-9596-b9ce07634a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e6f73242-730e-401d-bb5e-003ffb8e11af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bc395324-2507-444e-9596-b9ce07634a58" xlink:to="loc_us-gaap_CommonStockMember_e6f73242-730e-401d-bb5e-003ffb8e11af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_0c425600-0432-47c9-aeb4-0601c7a2ee3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bc395324-2507-444e-9596-b9ce07634a58" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_0c425600-0432-47c9-aeb4-0601c7a2ee3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9dcbc1a8-a56e-487b-9ae4-87c4f45c6796" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bc395324-2507-444e-9596-b9ce07634a58" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9dcbc1a8-a56e-487b-9ae4-87c4f45c6796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_7f2defa8-d0cb-4148-b1b8-7499cc80585d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_bc395324-2507-444e-9596-b9ce07634a58" xlink:to="loc_us-gaap_RetainedEarningsMember_7f2defa8-d0cb-4148-b1b8-7499cc80585d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_498c4f37-5d90-4d27-a0dc-bd6c6153dfa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2755d0e4-4db0-4967-8b66-6f6e6128ecea" xlink:to="loc_us-gaap_StatementClassOfStockAxis_498c4f37-5d90-4d27-a0dc-bd6c6153dfa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_169058c6-6aa8-4409-91a8-96ad0f36869a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_498c4f37-5d90-4d27-a0dc-bd6c6153dfa2" xlink:to="loc_us-gaap_ClassOfStockDomain_169058c6-6aa8-4409-91a8-96ad0f36869a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_SeriesSeedRedeemableConvertiblePreferredStockMember_f39b3076-10f4-469c-8b68-b163d08d2132" xlink:href="naut-20220630.xsd#naut_SeriesSeedRedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_169058c6-6aa8-4409-91a8-96ad0f36869a" xlink:to="loc_naut_SeriesSeedRedeemableConvertiblePreferredStockMember_f39b3076-10f4-469c-8b68-b163d08d2132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_50aaf074-0109-4ce5-b236-c088a82f1ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_169058c6-6aa8-4409-91a8-96ad0f36869a" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_50aaf074-0109-4ce5-b236-c088a82f1ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_3b0a4d18-c054-41a3-a2c1-82a18e01546f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_169058c6-6aa8-4409-91a8-96ad0f36869a" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_3b0a4d18-c054-41a3-a2c1-82a18e01546f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6b0043ff-dfe6-481f-ac84-0257d46f00ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2755d0e4-4db0-4967-8b66-6f6e6128ecea" xlink:to="loc_us-gaap_StatementLineItems_6b0043ff-dfe6-481f-ac84-0257d46f00ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_29dcafbd-87c5-4ac0-9f34-3830c61576b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6b0043ff-dfe6-481f-ac84-0257d46f00ba" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_29dcafbd-87c5-4ac0-9f34-3830c61576b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_6640b375-22a0-45ac-bba6-5f264d5ed0cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_29dcafbd-87c5-4ac0-9f34-3830c61576b0" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_6640b375-22a0-45ac-bba6-5f264d5ed0cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_ade20f23-0b98-4f11-8ad7-f06c0997d6b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_29dcafbd-87c5-4ac0-9f34-3830c61576b0" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_ade20f23-0b98-4f11-8ad7-f06c0997d6b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ReclassificationsOfTemporaryToPermanentEquityShares_2cf63644-7eb1-4a23-a8ab-d4ec8d8749a6" xlink:href="naut-20220630.xsd#naut_ReclassificationsOfTemporaryToPermanentEquityShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_29dcafbd-87c5-4ac0-9f34-3830c61576b0" xlink:to="loc_naut_ReclassificationsOfTemporaryToPermanentEquityShares_2cf63644-7eb1-4a23-a8ab-d4ec8d8749a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_3b8675ed-5533-43b7-971f-ae0588b81cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_29dcafbd-87c5-4ac0-9f34-3830c61576b0" xlink:to="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_3b8675ed-5533-43b7-971f-ae0588b81cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_43290bad-4d95-45db-b236-432fe67d594a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_29dcafbd-87c5-4ac0-9f34-3830c61576b0" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_43290bad-4d95-45db-b236-432fe67d594a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_a4f61ccd-6f52-43b8-9ce2-86b228eb0dec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_29dcafbd-87c5-4ac0-9f34-3830c61576b0" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_a4f61ccd-6f52-43b8-9ce2-86b228eb0dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6b0043ff-dfe6-481f-ac84-0257d46f00ba" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_cacffb95-204b-4945-b920-65388682ad03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_us-gaap_SharesOutstanding_cacffb95-204b-4945-b920-65388682ad03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_beabcda8-c420-49cd-ac19-73ddf172c5c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_us-gaap_StockholdersEquity_beabcda8-c420-49cd-ac19-73ddf172c5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b8942767-fad7-4517-8853-ae15e3c60efa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b8942767-fad7-4517-8853-ae15e3c60efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0908767b-3ece-4838-8c89-3959884cd9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_0908767b-3ece-4838-8c89-3959884cd9b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_017c4a2a-1764-4e24-9583-37d653328554" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_017c4a2a-1764-4e24-9583-37d653328554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_fca2d591-744b-42c8-8869-d0353262a735" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_fca2d591-744b-42c8-8869-d0353262a735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_StockIssuedDuringPeriodSharesWarrantsExercised_1e92ede3-c367-4c09-b559-982a544c5977" xlink:href="naut-20220630.xsd#naut_StockIssuedDuringPeriodSharesWarrantsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_naut_StockIssuedDuringPeriodSharesWarrantsExercised_1e92ede3-c367-4c09-b559-982a544c5977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_26fa7ddc-b53e-4c4d-89f1-d51d95f52e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_26fa7ddc-b53e-4c4d-89f1-d51d95f52e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c8be5d2e-68b8-466d-9d3c-99fb971702a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c8be5d2e-68b8-466d-9d3c-99fb971702a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_StockIssuedDuringPeriodSharesReverseRecapitalization_5b48f1aa-1be0-4d97-823f-b45bcb2fad7f" xlink:href="naut-20220630.xsd#naut_StockIssuedDuringPeriodSharesReverseRecapitalization"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_naut_StockIssuedDuringPeriodSharesReverseRecapitalization_5b48f1aa-1be0-4d97-823f-b45bcb2fad7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_StockIssuedDuringPeriodValueReverseRecapitalization_4040b14d-2107-43ea-925c-b35ed32b9f28" xlink:href="naut-20220630.xsd#naut_StockIssuedDuringPeriodValueReverseRecapitalization"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_naut_StockIssuedDuringPeriodValueReverseRecapitalization_4040b14d-2107-43ea-925c-b35ed32b9f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f54897b3-1324-4d50-8d7f-b85e6bcccf61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f54897b3-1324-4d50-8d7f-b85e6bcccf61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_216bc12c-25ce-43ca-9d35-4e1c6548cfa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_216bc12c-25ce-43ca-9d35-4e1c6548cfa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b0214f2b-490c-4b4b-ad2e-bdbe245582a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_us-gaap_NetIncomeLoss_b0214f2b-490c-4b4b-ad2e-bdbe245582a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_02f969f7-6958-4ad2-b3f2-a00a4fe365d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_us-gaap_SharesOutstanding_02f969f7-6958-4ad2-b3f2-a00a4fe365d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_390141aa-0592-4f68-80d9-9aa1a159f776" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_06a207a1-9f6c-472b-bd5c-4024249f3392" xlink:to="loc_us-gaap_StockholdersEquity_390141aa-0592-4f68-80d9-9aa1a159f776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficitParenthetical" xlink:type="simple" xlink:href="naut-20220630.xsd#CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficitParenthetical"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficitParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_a1774ad3-a4c4-48db-92aa-3056d10e1eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_RecapitalizationExchangeRatio_ccf003c4-ffbe-4359-8f11-05ba2ef68160" xlink:href="naut-20220630.xsd#naut_RecapitalizationExchangeRatio"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_a1774ad3-a4c4-48db-92aa-3056d10e1eb8" xlink:to="loc_naut_RecapitalizationExchangeRatio_ccf003c4-ffbe-4359-8f11-05ba2ef68160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="naut-20220630.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_deb8eed4-9d89-45db-a68b-c51c53051a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b0162ec4-8eef-4b93-b880-a619de77f2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_deb8eed4-9d89-45db-a68b-c51c53051a2e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b0162ec4-8eef-4b93-b880-a619de77f2cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5873d926-81b4-4d53-9097-3b3859b86404" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b0162ec4-8eef-4b93-b880-a619de77f2cc" xlink:to="loc_us-gaap_NetIncomeLoss_5873d926-81b4-4d53-9097-3b3859b86404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_26717339-d63a-4d80-8b17-ab5c233810a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b0162ec4-8eef-4b93-b880-a619de77f2cc" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_26717339-d63a-4d80-8b17-ab5c233810a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_fde0e95f-e45f-4c16-b369-e6316db20f98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_26717339-d63a-4d80-8b17-ab5c233810a5" xlink:to="loc_us-gaap_Depreciation_fde0e95f-e45f-4c16-b369-e6316db20f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_c23667cc-17ac-4078-a6fc-77abc67b13a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_26717339-d63a-4d80-8b17-ab5c233810a5" xlink:to="loc_us-gaap_ShareBasedCompensation_c23667cc-17ac-4078-a6fc-77abc67b13a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_b38f21bc-ac5c-41dd-9371-dc491d8a8b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_26717339-d63a-4d80-8b17-ab5c233810a5" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_b38f21bc-ac5c-41dd-9371-dc491d8a8b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_afabdb69-6c6a-471b-8f5b-7ca6bfb8036f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_26717339-d63a-4d80-8b17-ab5c233810a5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_afabdb69-6c6a-471b-8f5b-7ca6bfb8036f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ef86b6e0-fee6-4ef9-8680-88650cb930df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_26717339-d63a-4d80-8b17-ab5c233810a5" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ef86b6e0-fee6-4ef9-8680-88650cb930df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ffdca97f-22bf-4060-b99e-d3459f2e5391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ef86b6e0-fee6-4ef9-8680-88650cb930df" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ffdca97f-22bf-4060-b99e-d3459f2e5391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_72cb61a9-12e2-4f57-b3e4-bc9bb87e6377" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ef86b6e0-fee6-4ef9-8680-88650cb930df" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_72cb61a9-12e2-4f57-b3e4-bc9bb87e6377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_004a07e3-7e6f-4055-87fa-fdf3ec939d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ef86b6e0-fee6-4ef9-8680-88650cb930df" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_004a07e3-7e6f-4055-87fa-fdf3ec939d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_feb2884b-11ef-43f9-af24-0aba6e4d3a83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ef86b6e0-fee6-4ef9-8680-88650cb930df" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_feb2884b-11ef-43f9-af24-0aba6e4d3a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_56e81397-7758-4890-b09c-4d5d28c92320" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b0162ec4-8eef-4b93-b880-a619de77f2cc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_56e81397-7758-4890-b09c-4d5d28c92320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ea521c13-dc3d-498c-9f8b-cf552b0fd4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_deb8eed4-9d89-45db-a68b-c51c53051a2e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ea521c13-dc3d-498c-9f8b-cf552b0fd4b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_6a9577e1-7e91-4259-aaf6-04d690df3395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ea521c13-dc3d-498c-9f8b-cf552b0fd4b7" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_6a9577e1-7e91-4259-aaf6-04d690df3395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_de033979-a83d-4794-92f7-a7086dbb4ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ea521c13-dc3d-498c-9f8b-cf552b0fd4b7" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_de033979-a83d-4794-92f7-a7086dbb4ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_21aa5381-8089-4971-baf7-2c0537787d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ea521c13-dc3d-498c-9f8b-cf552b0fd4b7" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_21aa5381-8089-4971-baf7-2c0537787d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5cf43134-6202-40df-a2a8-b7b5df919581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ea521c13-dc3d-498c-9f8b-cf552b0fd4b7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5cf43134-6202-40df-a2a8-b7b5df919581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f0d7164a-3b14-448b-ad1b-727560d46778" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_deb8eed4-9d89-45db-a68b-c51c53051a2e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f0d7164a-3b14-448b-ad1b-727560d46778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_6a6b8662-5288-41b8-8d85-a5880a197557" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f0d7164a-3b14-448b-ad1b-727560d46778" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_6a6b8662-5288-41b8-8d85-a5880a197557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_f30ef024-a631-40fd-99d6-982877651770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f0d7164a-3b14-448b-ad1b-727560d46778" xlink:to="loc_us-gaap_ProceedsFromStockPlans_f30ef024-a631-40fd-99d6-982877651770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ProceedsFromReverseRecapitalizationTransaction_0cf501d0-b3b6-4769-a083-6e981f7e1b54" xlink:href="naut-20220630.xsd#naut_ProceedsFromReverseRecapitalizationTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f0d7164a-3b14-448b-ad1b-727560d46778" xlink:to="loc_naut_ProceedsFromReverseRecapitalizationTransaction_0cf501d0-b3b6-4769-a083-6e981f7e1b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_b6d2764b-c6ba-482d-b336-6847bec6d8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f0d7164a-3b14-448b-ad1b-727560d46778" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_b6d2764b-c6ba-482d-b336-6847bec6d8ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_44326495-2e02-4fbe-b709-3e5d05f82f17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f0d7164a-3b14-448b-ad1b-727560d46778" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_44326495-2e02-4fbe-b709-3e5d05f82f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_44255100-5102-410a-a2ea-4ff16005bbc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_deb8eed4-9d89-45db-a68b-c51c53051a2e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_44255100-5102-410a-a2ea-4ff16005bbc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f510779a-aac9-436f-8ead-6f94e8ad876a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_deb8eed4-9d89-45db-a68b-c51c53051a2e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f510779a-aac9-436f-8ead-6f94e8ad876a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3e81c46d-69a2-4e73-912d-1360cc659255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_deb8eed4-9d89-45db-a68b-c51c53051a2e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3e81c46d-69a2-4e73-912d-1360cc659255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_0a2a36ef-de0f-4723-92f0-4eaf4aa4711e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_deb8eed4-9d89-45db-a68b-c51c53051a2e" xlink:to="loc_us-gaap_SupplementalCashFlowElementsAbstract_0a2a36ef-de0f-4723-92f0-4eaf4aa4711e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_4af4e665-0be6-4bcb-b358-d529db0073ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_0a2a36ef-de0f-4723-92f0-4eaf4aa4711e" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_4af4e665-0be6-4bcb-b358-d529db0073ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_DeferredStockIssuanceCosts_a38be47e-de7c-49b2-b4e0-b8c77d19d6e9" xlink:href="naut-20220630.xsd#naut_DeferredStockIssuanceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_0a2a36ef-de0f-4723-92f0-4eaf4aa4711e" xlink:to="loc_naut_DeferredStockIssuanceCosts_a38be47e-de7c-49b2-b4e0-b8c77d19d6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1_340e75d5-8c35-4017-b376-e11f863515f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_0a2a36ef-de0f-4723-92f0-4eaf4aa4711e" xlink:to="loc_us-gaap_ConversionOfStockAmountConverted1_340e75d5-8c35-4017-b376-e11f863515f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_DeferredStockIssuanceCostsReclassifiedToEquity_44d406f4-0a6c-43f8-80df-d2ab47b5bb6b" xlink:href="naut-20220630.xsd#naut_DeferredStockIssuanceCostsReclassifiedToEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_0a2a36ef-de0f-4723-92f0-4eaf4aa4711e" xlink:to="loc_naut_DeferredStockIssuanceCostsReclassifiedToEquity_44d406f4-0a6c-43f8-80df-d2ab47b5bb6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ModificationToReduceRightOfUseAssetsAndLeaseLiability_2a2a6629-e196-4b10-b9fe-c2b552dac478" xlink:href="naut-20220630.xsd#naut_ModificationToReduceRightOfUseAssetsAndLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_0a2a36ef-de0f-4723-92f0-4eaf4aa4711e" xlink:to="loc_naut_ModificationToReduceRightOfUseAssetsAndLeaseLiability_2a2a6629-e196-4b10-b9fe-c2b552dac478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentation" xlink:type="simple" xlink:href="naut-20220630.xsd#DescriptionofBusinessandBasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a7752d33-c023-41b1-a5c9-1604870c19fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_52bfa717-4e15-4f32-af3e-9d966fea13f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a7752d33-c023-41b1-a5c9-1604870c19fa" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_52bfa717-4e15-4f32-af3e-9d966fea13f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#DescriptionofBusinessandBasisofPresentationDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8ebae380-545f-4a72-8482-a6db1f7f5d98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_0b314b4e-da4e-496b-8615-d408798f0678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8ebae380-545f-4a72-8482-a6db1f7f5d98" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_0b314b4e-da4e-496b-8615-d408798f0678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_560c40d8-2b70-4981-a95c-081a45885c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_0b314b4e-da4e-496b-8615-d408798f0678" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_560c40d8-2b70-4981-a95c-081a45885c4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c3e73b7d-c475-4c3b-b1f0-ea5ea36459fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_560c40d8-2b70-4981-a95c-081a45885c4f" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c3e73b7d-c475-4c3b-b1f0-ea5ea36459fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_41e39a40-68ce-4572-bed5-0918084bb27b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c3e73b7d-c475-4c3b-b1f0-ea5ea36459fb" xlink:to="loc_us-gaap_PrivatePlacementMember_41e39a40-68ce-4572-bed5-0918084bb27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_b1ddef85-8664-4013-bd9d-524dccb6ab9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_0b314b4e-da4e-496b-8615-d408798f0678" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_b1ddef85-8664-4013-bd9d-524dccb6ab9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_b9d457ff-1ff8-4fdd-bdc2-0da5d16bdaee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b1ddef85-8664-4013-bd9d-524dccb6ab9a" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_b9d457ff-1ff8-4fdd-bdc2-0da5d16bdaee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_da66bf44-d2e9-4720-92e2-1a66189a19cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b1ddef85-8664-4013-bd9d-524dccb6ab9a" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_da66bf44-d2e9-4720-92e2-1a66189a19cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_caa836ae-b3d3-4b78-bd27-ffc31b025023" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b1ddef85-8664-4013-bd9d-524dccb6ab9a" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_caa836ae-b3d3-4b78-bd27-ffc31b025023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b68ac3e5-2228-48e4-ac20-acc559b192d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b1ddef85-8664-4013-bd9d-524dccb6ab9a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_b68ac3e5-2228-48e4-ac20-acc559b192d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction_3cc77dd3-3b8d-4c43-af81-ff9309ab98b3" xlink:href="naut-20220630.xsd#naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b1ddef85-8664-4013-bd9d-524dccb6ab9a" xlink:to="loc_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction_3cc77dd3-3b8d-4c43-af81-ff9309ab98b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_PaymentsOfReverseRecapitalizationTransactionCosts_eadb6e1e-4b14-42cf-8687-66dbf20aa13c" xlink:href="naut-20220630.xsd#naut_PaymentsOfReverseRecapitalizationTransactionCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b1ddef85-8664-4013-bd9d-524dccb6ab9a" xlink:to="loc_naut_PaymentsOfReverseRecapitalizationTransactionCosts_eadb6e1e-4b14-42cf-8687-66dbf20aa13c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_ea1007fb-8644-43b8-b66a-cfd88689fb24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_b1ddef85-8664-4013-bd9d-524dccb6ab9a" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_ea1007fb-8644-43b8-b66a-cfd88689fb24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="naut-20220630.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ea46e668-76f0-4b37-afd7-aab6785aaf3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_67da2b2d-dc30-4c00-aceb-81dc353a40b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ea46e668-76f0-4b37-afd7-aab6785aaf3f" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_67da2b2d-dc30-4c00-aceb-81dc353a40b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="naut-20220630.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ffdc8006-4b19-4bfd-972d-cbbffaa573d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_60bf3490-4e03-4fda-b4ce-2f452c3f46bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ffdc8006-4b19-4bfd-972d-cbbffaa573d0" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_60bf3490-4e03-4fda-b4ce-2f452c3f46bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_04900ec9-d08c-4342-889e-2edeb794e6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ffdc8006-4b19-4bfd-972d-cbbffaa573d0" xlink:to="loc_us-gaap_UseOfEstimates_04900ec9-d08c-4342-889e-2edeb794e6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_747cb11d-1f24-499f-8415-083847862bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ffdc8006-4b19-4bfd-972d-cbbffaa573d0" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_747cb11d-1f24-499f-8415-083847862bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_b3fc586f-2a27-4e33-a2f3-ae0b36700308" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ffdc8006-4b19-4bfd-972d-cbbffaa573d0" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_b3fc586f-2a27-4e33-a2f3-ae0b36700308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_5e838584-b791-4181-bf6c-d1bccbc42b74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ffdc8006-4b19-4bfd-972d-cbbffaa573d0" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_5e838584-b791-4181-bf6c-d1bccbc42b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_be8e4ea1-fadc-4cf9-a1aa-e36bfd1bc7a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ffdc8006-4b19-4bfd-972d-cbbffaa573d0" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_be8e4ea1-fadc-4cf9-a1aa-e36bfd1bc7a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_b190cbcb-67bb-44cc-b3e0-6aac9cb5234d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ffdc8006-4b19-4bfd-972d-cbbffaa573d0" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_b190cbcb-67bb-44cc-b3e0-6aac9cb5234d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_4ac4f987-47d0-4b5d-afb0-d77f57912c41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ffdc8006-4b19-4bfd-972d-cbbffaa573d0" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_4ac4f987-47d0-4b5d-afb0-d77f57912c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_047c1e93-687a-4cde-a3b3-3fc1e2369331" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ffdc8006-4b19-4bfd-972d-cbbffaa573d0" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_047c1e93-687a-4cde-a3b3-3fc1e2369331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_4a32b6ca-0a5f-4dd8-a0da-ae2bf91ccdbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ffdc8006-4b19-4bfd-972d-cbbffaa573d0" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_4a32b6ca-0a5f-4dd8-a0da-ae2bf91ccdbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#SignificantAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1de3d780-9ffa-40af-b678-1f8dd024059a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_90782bed-24ba-4d61-a542-7a9ca1a4cef6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1de3d780-9ffa-40af-b678-1f8dd024059a" xlink:to="loc_us-gaap_NumberOfOperatingSegments_90782bed-24ba-4d61-a542-7a9ca1a4cef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_4304a125-26ea-40d5-bb20-06c72a74e6fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1de3d780-9ffa-40af-b678-1f8dd024059a" xlink:to="loc_us-gaap_NumberOfReportableSegments_4304a125-26ea-40d5-bb20-06c72a74e6fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/ReverseRecapitalization" xlink:type="simple" xlink:href="naut-20220630.xsd#ReverseRecapitalization"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/ReverseRecapitalization" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_naut_ReverseRecapitalizationAbstract_93c3aaef-0521-439e-b7c5-b0019ce4f5a7" xlink:href="naut-20220630.xsd#naut_ReverseRecapitalizationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ReverseRecapitalizationDisclosureTextBlock_5f579313-41eb-42d1-8517-3ea106129a09" xlink:href="naut-20220630.xsd#naut_ReverseRecapitalizationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ReverseRecapitalizationAbstract_93c3aaef-0521-439e-b7c5-b0019ce4f5a7" xlink:to="loc_naut_ReverseRecapitalizationDisclosureTextBlock_5f579313-41eb-42d1-8517-3ea106129a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/ReverseRecapitalizationTables" xlink:type="simple" xlink:href="naut-20220630.xsd#ReverseRecapitalizationTables"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/ReverseRecapitalizationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_naut_ReverseRecapitalizationAbstract_e9a49c02-e87d-4f82-85ac-4106256f3ca4" xlink:href="naut-20220630.xsd#naut_ReverseRecapitalizationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ScheduleOfReverseRecapitalizationTableTextBlock_dcde6c30-16f6-4982-bb0b-dbcf4ebfe9c9" xlink:href="naut-20220630.xsd#naut_ScheduleOfReverseRecapitalizationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ReverseRecapitalizationAbstract_e9a49c02-e87d-4f82-85ac-4106256f3ca4" xlink:to="loc_naut_ScheduleOfReverseRecapitalizationTableTextBlock_dcde6c30-16f6-4982-bb0b-dbcf4ebfe9c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#ReverseRecapitalizationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_naut_ReverseRecapitalizationAbstract_f9db8f3b-89c5-48bb-8f63-daf2b032c8c0" xlink:href="naut-20220630.xsd#naut_ReverseRecapitalizationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ScheduleOfReverseRecapitalizationTable_b1636068-091f-4185-879e-2155d5594c1c" xlink:href="naut-20220630.xsd#naut_ScheduleOfReverseRecapitalizationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ReverseRecapitalizationAbstract_f9db8f3b-89c5-48bb-8f63-daf2b032c8c0" xlink:to="loc_naut_ScheduleOfReverseRecapitalizationTable_b1636068-091f-4185-879e-2155d5594c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_486fca12-5322-4769-ac45-3589cd442225" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationTable_b1636068-091f-4185-879e-2155d5594c1c" xlink:to="loc_us-gaap_AwardTypeAxis_486fca12-5322-4769-ac45-3589cd442225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d24e507d-09a4-4712-ae14-d2beab6e51f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_486fca12-5322-4769-ac45-3589cd442225" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d24e507d-09a4-4712-ae14-d2beab6e51f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_9db68f5d-57b5-443d-a842-717fd2a34e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d24e507d-09a4-4712-ae14-d2beab6e51f4" xlink:to="loc_us-gaap_EmployeeStockOptionMember_9db68f5d-57b5-443d-a842-717fd2a34e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_9aacad2c-9ba4-430a-9970-d24ba8b9496c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationTable_b1636068-091f-4185-879e-2155d5594c1c" xlink:to="loc_dei_LegalEntityAxis_9aacad2c-9ba4-430a-9970-d24ba8b9496c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_203e459a-d134-41af-a728-85e05b246352" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_9aacad2c-9ba4-430a-9970-d24ba8b9496c" xlink:to="loc_dei_EntityDomain_203e459a-d134-41af-a728-85e05b246352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_AryaSciencesAcquisitionCorpIIIMember_f2cc320f-7498-48f7-b807-121005f04512" xlink:href="naut-20220630.xsd#naut_AryaSciencesAcquisitionCorpIIIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_203e459a-d134-41af-a728-85e05b246352" xlink:to="loc_naut_AryaSciencesAcquisitionCorpIIIMember_f2cc320f-7498-48f7-b807-121005f04512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_fb070d15-db5c-419c-8714-b2d80d415400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationTable_b1636068-091f-4185-879e-2155d5594c1c" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_fb070d15-db5c-419c-8714-b2d80d415400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_78ac5808-a53a-4ecd-b378-a254b9b48e56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_fb070d15-db5c-419c-8714-b2d80d415400" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_78ac5808-a53a-4ecd-b378-a254b9b48e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_c4b805e2-d25d-402f-a302-e95b02338dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_78ac5808-a53a-4ecd-b378-a254b9b48e56" xlink:to="loc_us-gaap_PrivatePlacementMember_c4b805e2-d25d-402f-a302-e95b02338dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:href="naut-20220630.xsd#naut_ScheduleOfReverseRecapitalizationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationTable_b1636068-091f-4185-879e-2155d5594c1c" xlink:to="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_StockConvertedValueReverseRecapitalization_fe1b3c09-f803-42ea-91d8-aa6fcbd9ec6e" xlink:href="naut-20220630.xsd#naut_StockConvertedValueReverseRecapitalization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_naut_StockConvertedValueReverseRecapitalization_fe1b3c09-f803-42ea-91d8-aa6fcbd9ec6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_RecapitalizationExchangeRatioPerShare_98be0af5-03ac-4b5e-a2bb-f47ba082e169" xlink:href="naut-20220630.xsd#naut_RecapitalizationExchangeRatioPerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_naut_RecapitalizationExchangeRatioPerShare_98be0af5-03ac-4b5e-a2bb-f47ba082e169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_RecapitalizationExchangeRatio_de74e869-771d-4813-a730-95cdde16a808" xlink:href="naut-20220630.xsd#naut_RecapitalizationExchangeRatio"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_naut_RecapitalizationExchangeRatio_de74e869-771d-4813-a730-95cdde16a808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_c73fe11a-b582-4031-8dd1-6b4c081612fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_c73fe11a-b582-4031-8dd1-6b4c081612fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_StockConvertedReverseRecapitalization_f876ca84-6eb8-4932-a5bf-76240e7aa267" xlink:href="naut-20220630.xsd#naut_StockConvertedReverseRecapitalization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_naut_StockConvertedReverseRecapitalization_f876ca84-6eb8-4932-a5bf-76240e7aa267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e7621bda-1428-4676-8a93-3c204d1ff83a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e7621bda-1428-4676-8a93-3c204d1ff83a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_1a63ca61-47bb-4c32-b376-cd08e3a5d2ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_1a63ca61-47bb-4c32-b376-cd08e3a5d2ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFairValueDisclosure_74eceee4-201a-4015-93e8-2b1a1396b259" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityFairValueDisclosure"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_us-gaap_EquityFairValueDisclosure_74eceee4-201a-4015-93e8-2b1a1396b259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4cbc3889-6ba0-4c46-87b2-2f9a2cc82e23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4cbc3889-6ba0-4c46-87b2-2f9a2cc82e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ProceedsFromReverseRecapitalizationTransaction_9911b8a9-191b-400a-b0f7-a5a11105b340" xlink:href="naut-20220630.xsd#naut_ProceedsFromReverseRecapitalizationTransaction"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_naut_ProceedsFromReverseRecapitalizationTransaction_9911b8a9-191b-400a-b0f7-a5a11105b340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_CashAcquiredThroughReverseRecapitalization_5d95e85d-6167-4eba-8438-cde3c950bd6a" xlink:href="naut-20220630.xsd#naut_CashAcquiredThroughReverseRecapitalization"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_naut_CashAcquiredThroughReverseRecapitalization_5d95e85d-6167-4eba-8438-cde3c950bd6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ReverseRecapitalizationCashPaidToShareholders_6b1db886-b66f-42f5-af57-6b6424b9d0a5" xlink:href="naut-20220630.xsd#naut_ReverseRecapitalizationCashPaidToShareholders"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_naut_ReverseRecapitalizationCashPaidToShareholders_6b1db886-b66f-42f5-af57-6b6424b9d0a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_de4839e3-b6e4-49a5-b0a4-bd6c06141ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_de4839e3-b6e4-49a5-b0a4-bd6c06141ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_PaymentsOfReverseRecapitalizationTransactionCosts_6f094583-f4ac-4778-bedc-b6e97c25c080" xlink:href="naut-20220630.xsd#naut_PaymentsOfReverseRecapitalizationTransactionCosts"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_de21c235-5c08-4e14-9e35-2b8bf6ba5c1f" xlink:to="loc_naut_PaymentsOfReverseRecapitalizationTransactionCosts_6f094583-f4ac-4778-bedc-b6e97c25c080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/ReverseRecapitalizationSharesReconciliationDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#ReverseRecapitalizationSharesReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/ReverseRecapitalizationSharesReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_naut_ReverseRecapitalizationAbstract_fb8a49f9-ff3f-4b4e-a744-7086c85263b6" xlink:href="naut-20220630.xsd#naut_ReverseRecapitalizationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ScheduleOfReverseRecapitalizationTable_9418a8a2-9713-4a89-b9e8-81554ed8f086" xlink:href="naut-20220630.xsd#naut_ScheduleOfReverseRecapitalizationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ReverseRecapitalizationAbstract_fb8a49f9-ff3f-4b4e-a744-7086c85263b6" xlink:to="loc_naut_ScheduleOfReverseRecapitalizationTable_9418a8a2-9713-4a89-b9e8-81554ed8f086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c22977b7-6c83-4c33-848d-de02f315b3a9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationTable_9418a8a2-9713-4a89-b9e8-81554ed8f086" xlink:to="loc_dei_LegalEntityAxis_c22977b7-6c83-4c33-848d-de02f315b3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_51e4a2d7-dd99-4060-b7a1-12b901ec132e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_c22977b7-6c83-4c33-848d-de02f315b3a9" xlink:to="loc_dei_EntityDomain_51e4a2d7-dd99-4060-b7a1-12b901ec132e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_AryaSciencesAcquisitionCorpIIIMember_5ad429aa-909e-496f-ac2e-2df0963dafe3" xlink:href="naut-20220630.xsd#naut_AryaSciencesAcquisitionCorpIIIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_51e4a2d7-dd99-4060-b7a1-12b901ec132e" xlink:to="loc_naut_AryaSciencesAcquisitionCorpIIIMember_5ad429aa-909e-496f-ac2e-2df0963dafe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ScheduleOfReverseRecapitalizationLineItems_8a9ece0c-cc7e-48b7-adb1-baf064dd5534" xlink:href="naut-20220630.xsd#naut_ScheduleOfReverseRecapitalizationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationTable_9418a8a2-9713-4a89-b9e8-81554ed8f086" xlink:to="loc_naut_ScheduleOfReverseRecapitalizationLineItems_8a9ece0c-cc7e-48b7-adb1-baf064dd5534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_c514de95-7fa4-48cb-b829-67855037a5c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_8a9ece0c-cc7e-48b7-adb1-baf064dd5534" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_c514de95-7fa4-48cb-b829-67855037a5c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_84e1bf21-a043-43b6-95ee-737c01ad80cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_8a9ece0c-cc7e-48b7-adb1-baf064dd5534" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_84e1bf21-a043-43b6-95ee-737c01ad80cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_7a6409e2-2d5a-4d2a-98c6-59403482c6e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_8a9ece0c-cc7e-48b7-adb1-baf064dd5534" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_7a6409e2-2d5a-4d2a-98c6-59403482c6e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e6277326-b0ec-46d7-a295-cae14ee7393d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_8a9ece0c-cc7e-48b7-adb1-baf064dd5534" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_e6277326-b0ec-46d7-a295-cae14ee7393d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_StockIssuedDuringPeriodSharesReverseRecapitalization_e43cfaf9-3208-4974-998d-6d7253481530" xlink:href="naut-20220630.xsd#naut_StockIssuedDuringPeriodSharesReverseRecapitalization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_8a9ece0c-cc7e-48b7-adb1-baf064dd5534" xlink:to="loc_naut_StockIssuedDuringPeriodSharesReverseRecapitalization_e43cfaf9-3208-4974-998d-6d7253481530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_StockConvertedReverseRecapitalization_c7e17504-ca7c-43ae-a0d6-f760644f534c" xlink:href="naut-20220630.xsd#naut_StockConvertedReverseRecapitalization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_naut_ScheduleOfReverseRecapitalizationLineItems_8a9ece0c-cc7e-48b7-adb1-baf064dd5534" xlink:to="loc_naut_StockConvertedReverseRecapitalization_c7e17504-ca7c-43ae-a0d6-f760644f534c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/FairValueMeasurements" xlink:type="simple" xlink:href="naut-20220630.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d6204bf4-18bf-4a84-a926-a999776131e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_28c13a4a-e515-4436-ba94-aff7433d3660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d6204bf4-18bf-4a84-a926-a999776131e4" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_28c13a4a-e515-4436-ba94-aff7433d3660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="naut-20220630.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9b4d0ddb-53db-4222-ae9a-2edb68769447" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_3925f2ef-f52c-41c6-8af3-ee1887d105fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9b4d0ddb-53db-4222-ae9a-2edb68769447" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_3925f2ef-f52c-41c6-8af3-ee1887d105fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#FairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7b8938e1-a828-49fb-987b-1f64b31ed0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4b234283-92e9-4970-99a2-f7814ee88cba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7b8938e1-a828-49fb-987b-1f64b31ed0eb" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4b234283-92e9-4970-99a2-f7814ee88cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_264c5f84-d203-4b95-846a-920e5b290edb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4b234283-92e9-4970-99a2-f7814ee88cba" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_264c5f84-d203-4b95-846a-920e5b290edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_4630b254-dc87-4d53-be8a-90a48da2c4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_264c5f84-d203-4b95-846a-920e5b290edb" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_4630b254-dc87-4d53-be8a-90a48da2c4f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_964bcb91-1b1e-4809-8c9f-d240ec763821" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_4630b254-dc87-4d53-be8a-90a48da2c4f9" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_964bcb91-1b1e-4809-8c9f-d240ec763821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1b362c77-aacd-499d-ac7d-05d3af8e743b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4b234283-92e9-4970-99a2-f7814ee88cba" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1b362c77-aacd-499d-ac7d-05d3af8e743b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8a8a20f8-134a-4995-a0b2-3df133b1cf8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_1b362c77-aacd-499d-ac7d-05d3af8e743b" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8a8a20f8-134a-4995-a0b2-3df133b1cf8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_12e4448e-78b8-45f7-8d40-684e2acbb12e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8a8a20f8-134a-4995-a0b2-3df133b1cf8f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_12e4448e-78b8-45f7-8d40-684e2acbb12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_33b2a1f7-fdaa-4758-9378-6972af6c602e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8a8a20f8-134a-4995-a0b2-3df133b1cf8f" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_33b2a1f7-fdaa-4758-9378-6972af6c602e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_2e792305-818f-48de-ab02-5ac099550827" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4b234283-92e9-4970-99a2-f7814ee88cba" xlink:to="loc_us-gaap_FinancialInstrumentAxis_2e792305-818f-48de-ab02-5ac099550827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_95037847-99a2-4b20-8eed-3e18ee7ee6df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_2e792305-818f-48de-ab02-5ac099550827" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_95037847-99a2-4b20-8eed-3e18ee7ee6df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MutualFundMember_31bdff55-1da4-4ea9-b368-6a16ac578cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MutualFundMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_95037847-99a2-4b20-8eed-3e18ee7ee6df" xlink:to="loc_us-gaap_MutualFundMember_31bdff55-1da4-4ea9-b368-6a16ac578cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_f1a9fc2f-0fcb-4080-af8d-b44034c211c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_95037847-99a2-4b20-8eed-3e18ee7ee6df" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_f1a9fc2f-0fcb-4080-af8d-b44034c211c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_e7a85dd3-7e5e-4ef2-9a9d-ace8236ac4dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_95037847-99a2-4b20-8eed-3e18ee7ee6df" xlink:to="loc_us-gaap_CommercialPaperMember_e7a85dd3-7e5e-4ef2-9a9d-ace8236ac4dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_eda12d01-bf08-41d8-9248-79eb9173c22e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_95037847-99a2-4b20-8eed-3e18ee7ee6df" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_eda12d01-bf08-41d8-9248-79eb9173c22e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_ea5a6e45-edbc-4743-b583-6a068a49fc27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_95037847-99a2-4b20-8eed-3e18ee7ee6df" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_ea5a6e45-edbc-4743-b583-6a068a49fc27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_b3e8b362-d093-489e-8a7e-0f2b3c6b12d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4b234283-92e9-4970-99a2-f7814ee88cba" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_b3e8b362-d093-489e-8a7e-0f2b3c6b12d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_77a9cbaa-38ea-452b-b357-7b849c26012b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b3e8b362-d093-489e-8a7e-0f2b3c6b12d3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_77a9cbaa-38ea-452b-b357-7b849c26012b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_7536801f-30fc-441f-81ff-f1e69fa319b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_77a9cbaa-38ea-452b-b357-7b849c26012b" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_7536801f-30fc-441f-81ff-f1e69fa319b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_842adee7-386d-4586-aecd-2b0cb5acda53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_77a9cbaa-38ea-452b-b357-7b849c26012b" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_842adee7-386d-4586-aecd-2b0cb5acda53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_LongTermInvestmentsMember_55d5d7e0-0f73-4a01-9573-c7b0c42e93e8" xlink:href="naut-20220630.xsd#naut_LongTermInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_77a9cbaa-38ea-452b-b357-7b849c26012b" xlink:to="loc_naut_LongTermInvestmentsMember_55d5d7e0-0f73-4a01-9573-c7b0c42e93e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a5e0bdd8-2b38-4b6c-9689-c502784d1ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_4b234283-92e9-4970-99a2-f7814ee88cba" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a5e0bdd8-2b38-4b6c-9689-c502784d1ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ec2ebb38-faa1-4595-a28e-4de16b090f21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a5e0bdd8-2b38-4b6c-9689-c502784d1ca9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ec2ebb38-faa1-4595-a28e-4de16b090f21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_710c5657-325d-4082-9d73-edc1cd9dde08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a5e0bdd8-2b38-4b6c-9689-c502784d1ca9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_710c5657-325d-4082-9d73-edc1cd9dde08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c61a5336-f1c1-4a94-8cfa-b936cba6dbb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a5e0bdd8-2b38-4b6c-9689-c502784d1ca9" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c61a5336-f1c1-4a94-8cfa-b936cba6dbb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c7f3a5d5-293b-492d-9505-6fe33fe136de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a5e0bdd8-2b38-4b6c-9689-c502784d1ca9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c7f3a5d5-293b-492d-9505-6fe33fe136de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItems" xlink:type="simple" xlink:href="naut-20220630.xsd#CompositionofCertainCondensedConsolidatedFinancialStatementLineItems"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItems" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_428f3f05-0a6a-4700-84da-95d78dca6447" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_9d9c050b-b225-4118-9e97-39379525d0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_428f3f05-0a6a-4700-84da-95d78dca6447" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_9d9c050b-b225-4118-9e97-39379525d0c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsTables" xlink:type="simple" xlink:href="naut-20220630.xsd#CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsTables"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bf868570-1851-431f-a37a-d52da5b5f43e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_17d4b68a-04c2-4c0c-abee-3ff4f61c7c91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bf868570-1851-431f-a37a-d52da5b5f43e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_17d4b68a-04c2-4c0c-abee-3ff4f61c7c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_2849e7e7-bba1-4604-8df4-f7ed44a3b044" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bf868570-1851-431f-a37a-d52da5b5f43e" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_2849e7e7-bba1-4604-8df4-f7ed44a3b044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_49eea696-88d6-4996-8014-b74ee6088af1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bf868570-1851-431f-a37a-d52da5b5f43e" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_49eea696-88d6-4996-8014-b74ee6088af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_25896de1-34f7-4d95-ab85-3224cfbec10e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bf868570-1851-431f-a37a-d52da5b5f43e" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_25896de1-34f7-4d95-ab85-3224cfbec10e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_c9caa6d8-e717-4b89-b2d8-4ccaeeb04ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bf868570-1851-431f-a37a-d52da5b5f43e" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_c9caa6d8-e717-4b89-b2d8-4ccaeeb04ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_2f315f51-5b06-4b71-a223-bbdeb58ade7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_bf868570-1851-431f-a37a-d52da5b5f43e" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_2f315f51-5b06-4b71-a223-bbdeb58ade7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc37816b-87f2-4a08-805f-1a01afd38aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_edfa0f60-2179-43f9-8567-5d5adcf86f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc37816b-87f2-4a08-805f-1a01afd38aa8" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_edfa0f60-2179-43f9-8567-5d5adcf86f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_43ba5acf-9562-4760-91d8-3b6dc0cd82c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_edfa0f60-2179-43f9-8567-5d5adcf86f3b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_43ba5acf-9562-4760-91d8-3b6dc0cd82c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_294cb8cd-fdb7-4591-bb34-362913922623" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_43ba5acf-9562-4760-91d8-3b6dc0cd82c6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_294cb8cd-fdb7-4591-bb34-362913922623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_LaboratoryEquipmentMember_e9ec1963-05ed-4134-8adc-a0f080407568" xlink:href="naut-20220630.xsd#naut_LaboratoryEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_294cb8cd-fdb7-4591-bb34-362913922623" xlink:to="loc_naut_LaboratoryEquipmentMember_e9ec1963-05ed-4134-8adc-a0f080407568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_7e31f4fd-1c19-44ba-8559-7236e599d44e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_294cb8cd-fdb7-4591-bb34-362913922623" xlink:to="loc_us-gaap_ComputerEquipmentMember_7e31f4fd-1c19-44ba-8559-7236e599d44e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_FurnitureFixturesAndOfficeEquipmentMember_3cc3f61e-f5a0-4aad-abb7-5569a784c429" xlink:href="naut-20220630.xsd#naut_FurnitureFixturesAndOfficeEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_294cb8cd-fdb7-4591-bb34-362913922623" xlink:to="loc_naut_FurnitureFixturesAndOfficeEquipmentMember_3cc3f61e-f5a0-4aad-abb7-5569a784c429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_6b8b0d8d-b651-46f0-ab23-8d5a47459bab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_294cb8cd-fdb7-4591-bb34-362913922623" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_6b8b0d8d-b651-46f0-ab23-8d5a47459bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_f7b92ec0-6a54-474a-a80a-150335a19aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_294cb8cd-fdb7-4591-bb34-362913922623" xlink:to="loc_us-gaap_ConstructionInProgressMember_f7b92ec0-6a54-474a-a80a-150335a19aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4ef677db-26d6-4f3f-9d25-9cff616040f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_edfa0f60-2179-43f9-8567-5d5adcf86f3b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4ef677db-26d6-4f3f-9d25-9cff616040f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_ed537b1b-aa77-4d26-a973-3529ef3db7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4ef677db-26d6-4f3f-9d25-9cff616040f4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_ed537b1b-aa77-4d26-a973-3529ef3db7ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3cc5e978-83a5-405b-b22b-d25e9b4fc2e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4ef677db-26d6-4f3f-9d25-9cff616040f4" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3cc5e978-83a5-405b-b22b-d25e9b4fc2e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a3972be0-18b7-4f48-a1d5-0042c410c1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4ef677db-26d6-4f3f-9d25-9cff616040f4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a3972be0-18b7-4f48-a1d5-0042c410c1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_5cff76f7-6a28-4081-bf10-2f171d43cf27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_4ef677db-26d6-4f3f-9d25-9cff616040f4" xlink:to="loc_us-gaap_Depreciation_5cff76f7-6a28-4081-bf10-2f171d43cf27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsOtherLongtermAssetsDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsOtherLongtermAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsOtherLongtermAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_976c9b04-9226-44fb-b22f-4e2320c80b75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_ff6652e8-6b3c-43b3-a168-78a88543b5ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_976c9b04-9226-44fb-b22f-4e2320c80b75" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_ff6652e8-6b3c-43b3-a168-78a88543b5ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsNoncurrent_a7acf0f8-fa0d-4214-8bda-12cf2cd77b93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepositsAssetsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_976c9b04-9226-44fb-b22f-4e2320c80b75" xlink:to="loc_us-gaap_DepositsAssetsNoncurrent_a7acf0f8-fa0d-4214-8bda-12cf2cd77b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_56eb9a08-13c7-460d-8fc0-7d492a52866e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_976c9b04-9226-44fb-b22f-4e2320c80b75" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_56eb9a08-13c7-460d-8fc0-7d492a52866e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsAccruedExpensesandOtherLiabilitiesDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsAccruedExpensesandOtherLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsAccruedExpensesandOtherLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_540953f1-41c8-4ab4-af60-76cc380c1ac8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_6703946e-832c-48e2-a167-55f612c44e90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_540953f1-41c8-4ab4-af60-76cc380c1ac8" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_6703946e-832c-48e2-a167-55f612c44e90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_AccruedResearchAndDevelopment_822adbf5-3681-48cc-8293-8b7dda3cb211" xlink:href="naut-20220630.xsd#naut_AccruedResearchAndDevelopment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_540953f1-41c8-4ab4-af60-76cc380c1ac8" xlink:to="loc_naut_AccruedResearchAndDevelopment_822adbf5-3681-48cc-8293-8b7dda3cb211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_123668d5-cc1c-4c52-8e96-da96af9c8013" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_540953f1-41c8-4ab4-af60-76cc380c1ac8" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_123668d5-cc1c-4c52-8e96-da96af9c8013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_AccruedFacilities_9e6672eb-64a9-4fd2-b237-dd5cf3e35fa6" xlink:href="naut-20220630.xsd#naut_AccruedFacilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_540953f1-41c8-4ab4-af60-76cc380c1ac8" xlink:to="loc_naut_AccruedFacilities_9e6672eb-64a9-4fd2-b237-dd5cf3e35fa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_cfbf31c1-c5ab-406a-a5a5-1fe9ca58ef8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_540953f1-41c8-4ab4-af60-76cc380c1ac8" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_cfbf31c1-c5ab-406a-a5a5-1fe9ca58ef8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_70e2910f-7a48-44dc-b54c-80d4e2390181" xlink:href="naut-20220630.xsd#naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_540953f1-41c8-4ab4-af60-76cc380c1ac8" xlink:to="loc_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent_70e2910f-7a48-44dc-b54c-80d4e2390181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsCashCashEquivalentsandRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3735db79-be6f-4c68-8e3d-55c685dfd694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fe54328c-7686-443e-a3a7-2141cb07e8fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3735db79-be6f-4c68-8e3d-55c685dfd694" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fe54328c-7686-443e-a3a7-2141cb07e8fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_449bc7ee-c599-4767-9bec-c088526a1467" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3735db79-be6f-4c68-8e3d-55c685dfd694" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_449bc7ee-c599-4767-9bec-c088526a1467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_df28b019-1cf3-4e9d-9a90-b44e111b36ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3735db79-be6f-4c68-8e3d-55c685dfd694" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_df28b019-1cf3-4e9d-9a90-b44e111b36ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/RedeemableConvertiblePreferredStock" xlink:type="simple" xlink:href="naut-20220630.xsd#RedeemableConvertiblePreferredStock"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/RedeemableConvertiblePreferredStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract_c052097b-bab4-4a87-ae79-1c5aab64ccff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_DisclosureOfRedeemableConvertiblePreferredStockTextBlock_67e185e9-c610-4e75-896b-1ee8f36e365a" xlink:href="naut-20220630.xsd#naut_DisclosureOfRedeemableConvertiblePreferredStockTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityAbstract_c052097b-bab4-4a87-ae79-1c5aab64ccff" xlink:to="loc_naut_DisclosureOfRedeemableConvertiblePreferredStockTextBlock_67e185e9-c610-4e75-896b-1ee8f36e365a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/RedeemableConvertiblePreferredStockNarrativeDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#RedeemableConvertiblePreferredStockNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/RedeemableConvertiblePreferredStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract_c9ca1401-5603-4a37-b1b7-bb35f0525fbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_7e8444be-759f-4efb-be74-02caa476a67a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityAbstract_c9ca1401-5603-4a37-b1b7-bb35f0525fbd" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_7e8444be-759f-4efb-be74-02caa476a67a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_e3ea39b8-d99b-4793-8889-9a644ecadc3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityAbstract_c9ca1401-5603-4a37-b1b7-bb35f0525fbd" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_e3ea39b8-d99b-4793-8889-9a644ecadc3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommonStock" xlink:type="simple" xlink:href="naut-20220630.xsd#CommonStock"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CommonStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4c6441b7-e5f4-4b7d-adef-a25b934eb16e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_4079a990-a298-4cad-b68d-a53be48a5d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4c6441b7-e5f4-4b7d-adef-a25b934eb16e" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_4079a990-a298-4cad-b68d-a53be48a5d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommonStockTables" xlink:type="simple" xlink:href="naut-20220630.xsd#CommonStockTables"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CommonStockTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b69a51c3-c981-4125-a5f3-62c39209a993" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_6f474d3b-4e7f-4a7b-8e42-7fba1f0e8e87" xlink:href="naut-20220630.xsd#naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b69a51c3-c981-4125-a5f3-62c39209a993" xlink:to="loc_naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock_6f474d3b-4e7f-4a7b-8e42-7fba1f0e8e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommonStockNarrativeDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#CommonStockNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CommonStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_86db15ed-57be-44a7-87e6-f6b0bfc867d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_StockIssuedDuringPeriodSharesReverseRecapitalization_a5317f7c-be81-4c0a-b195-f5b403ec0110" xlink:href="naut-20220630.xsd#naut_StockIssuedDuringPeriodSharesReverseRecapitalization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_86db15ed-57be-44a7-87e6-f6b0bfc867d6" xlink:to="loc_naut_StockIssuedDuringPeriodSharesReverseRecapitalization_a5317f7c-be81-4c0a-b195-f5b403ec0110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_StockIssuedDuringPeriodValueReverseRecapitalization_02ff9429-850e-40d0-9b8a-d00d41786299" xlink:href="naut-20220630.xsd#naut_StockIssuedDuringPeriodValueReverseRecapitalization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_86db15ed-57be-44a7-87e6-f6b0bfc867d6" xlink:to="loc_naut_StockIssuedDuringPeriodValueReverseRecapitalization_02ff9429-850e-40d0-9b8a-d00d41786299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_PaymentsOfReverseRecapitalizationTransactionCosts_ab04c32f-1d41-46b9-9aac-b3bf144459e4" xlink:href="naut-20220630.xsd#naut_PaymentsOfReverseRecapitalizationTransactionCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_86db15ed-57be-44a7-87e6-f6b0bfc867d6" xlink:to="loc_naut_PaymentsOfReverseRecapitalizationTransactionCosts_ab04c32f-1d41-46b9-9aac-b3bf144459e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_14d00efd-06dd-44c9-9202-2dc30e93d238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_86db15ed-57be-44a7-87e6-f6b0bfc867d6" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_14d00efd-06dd-44c9-9202-2dc30e93d238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_72d1258f-41fb-4c83-a833-2ab199f3c828" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_86db15ed-57be-44a7-87e6-f6b0bfc867d6" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_72d1258f-41fb-4c83-a833-2ab199f3c828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_a230d2b0-dbfe-4e03-bc87-830025b36b53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_86db15ed-57be-44a7-87e6-f6b0bfc867d6" xlink:to="loc_us-gaap_CommonStockSharesIssued_a230d2b0-dbfe-4e03-bc87-830025b36b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommonStockCommonStockReservedforFutureIssuanceDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#CommonStockCommonStockReservedforFutureIssuanceDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CommonStockCommonStockReservedforFutureIssuanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_3c2c06bf-8c69-4e60-b377-2b76c0d3711d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_7bc1b2b4-7865-4d62-b817-dea230a47dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3c2c06bf-8c69-4e60-b377-2b76c0d3711d" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_7bc1b2b4-7865-4d62-b817-dea230a47dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_b0510c64-5ac6-4ba9-88d8-4010ec8c4133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_7bc1b2b4-7865-4d62-b817-dea230a47dea" xlink:to="loc_us-gaap_PlanNameAxis_b0510c64-5ac6-4ba9-88d8-4010ec8c4133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3e076d43-d218-4606-80f0-b482002650d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_b0510c64-5ac6-4ba9-88d8-4010ec8c4133" xlink:to="loc_us-gaap_PlanNameDomain_3e076d43-d218-4606-80f0-b482002650d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_A2021EquityIncentivePlanMember_7b16b628-3eb6-49c4-9745-ada6d345b78e" xlink:href="naut-20220630.xsd#naut_A2021EquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3e076d43-d218-4606-80f0-b482002650d6" xlink:to="loc_naut_A2021EquityIncentivePlanMember_7b16b628-3eb6-49c4-9745-ada6d345b78e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_A2021EmployeeStockPurchasePlanMember_c09231c8-0e20-4cb3-bfb6-3fdc117bd11d" xlink:href="naut-20220630.xsd#naut_A2021EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3e076d43-d218-4606-80f0-b482002650d6" xlink:to="loc_naut_A2021EmployeeStockPurchasePlanMember_c09231c8-0e20-4cb3-bfb6-3fdc117bd11d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_00c6ddcc-ac9b-48d8-8303-9764fd5ed4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_7bc1b2b4-7865-4d62-b817-dea230a47dea" xlink:to="loc_us-gaap_ClassOfStockLineItems_00c6ddcc-ac9b-48d8-8303-9764fd5ed4d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_176646ad-f8ca-47f6-97bb-b6b6f8491dde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_00c6ddcc-ac9b-48d8-8303-9764fd5ed4d1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_176646ad-f8ca-47f6-97bb-b6b6f8491dde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5db245ca-4870-441b-98b9-79455ad4101d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_00c6ddcc-ac9b-48d8-8303-9764fd5ed4d1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_5db245ca-4870-441b-98b9-79455ad4101d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_24bed647-87f5-4142-966b-e127c3bebec5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_00c6ddcc-ac9b-48d8-8303-9764fd5ed4d1" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_24bed647-87f5-4142-966b-e127c3bebec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/IncomeTaxes" xlink:type="simple" xlink:href="naut-20220630.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c66f8f6d-4b52-4953-b8b2-be38eaadaa14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_d1e381f6-ea1d-448e-9a80-8bb3aa5df00f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c66f8f6d-4b52-4953-b8b2-be38eaadaa14" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_d1e381f6-ea1d-448e-9a80-8bb3aa5df00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1db1a01b-07f2-4466-a0cd-5f45aa2bbdab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_b701623a-9dc8-4269-a6e5-e380999ccb56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1db1a01b-07f2-4466-a0cd-5f45aa2bbdab" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_b701623a-9dc8-4269-a6e5-e380999ccb56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensation" xlink:type="simple" xlink:href="naut-20220630.xsd#StockOptionPlanandStockbasedCompensation"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9053e1d0-53cb-41e3-8374-e7ea12f1c9e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_31e74db1-2137-4eac-9468-d46aa73f8a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9053e1d0-53cb-41e3-8374-e7ea12f1c9e9" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_31e74db1-2137-4eac-9468-d46aa73f8a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationTables" xlink:type="simple" xlink:href="naut-20220630.xsd#StockOptionPlanandStockbasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_799661dd-dfbf-42ee-8e8b-09c500fb5f95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_9c62b0f4-3a86-468a-b28c-8db70bc68b13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_799661dd-dfbf-42ee-8e8b-09c500fb5f95" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_9c62b0f4-3a86-468a-b28c-8db70bc68b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_70d8177d-aba3-431b-8327-3ca9ab603148" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_799661dd-dfbf-42ee-8e8b-09c500fb5f95" xlink:to="loc_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_70d8177d-aba3-431b-8327-3ca9ab603148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_9e0dfba7-d256-4721-abd1-76f656f47f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_799661dd-dfbf-42ee-8e8b-09c500fb5f95" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_9e0dfba7-d256-4721-abd1-76f656f47f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#StockOptionPlanandStockbasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1af59993-e088-46b8-a868-abbc3e47768e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e93c568-2296-46f5-9dce-33eff18bb0b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1af59993-e088-46b8-a868-abbc3e47768e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e93c568-2296-46f5-9dce-33eff18bb0b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c27242f7-8258-4d0a-91c9-af6c3072e88c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e93c568-2296-46f5-9dce-33eff18bb0b8" xlink:to="loc_us-gaap_AwardTypeAxis_c27242f7-8258-4d0a-91c9-af6c3072e88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a2677a33-167e-47d4-8584-1182aca83de1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c27242f7-8258-4d0a-91c9-af6c3072e88c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a2677a33-167e-47d4-8584-1182aca83de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_7dbe8d7d-dfee-4074-9f4f-b8f1a63a45f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a2677a33-167e-47d4-8584-1182aca83de1" xlink:to="loc_us-gaap_EmployeeStockMember_7dbe8d7d-dfee-4074-9f4f-b8f1a63a45f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ad4073f2-23c0-4ab9-9e6f-a3a1640a2eec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e93c568-2296-46f5-9dce-33eff18bb0b8" xlink:to="loc_us-gaap_PlanNameAxis_ad4073f2-23c0-4ab9-9e6f-a3a1640a2eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_fb647ec4-57be-4ff7-b2a7-a640b8babe12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_ad4073f2-23c0-4ab9-9e6f-a3a1640a2eec" xlink:to="loc_us-gaap_PlanNameDomain_fb647ec4-57be-4ff7-b2a7-a640b8babe12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_A2021EquityIncentivePlanMember_477de8d4-46c9-44e6-b65d-e94dc0f7e7f8" xlink:href="naut-20220630.xsd#naut_A2021EquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_fb647ec4-57be-4ff7-b2a7-a640b8babe12" xlink:to="loc_naut_A2021EquityIncentivePlanMember_477de8d4-46c9-44e6-b65d-e94dc0f7e7f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_A2021EmployeeStockPurchasePlanMember_c4c43a19-6ce8-4ab9-a93a-82000d35b665" xlink:href="naut-20220630.xsd#naut_A2021EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_fb647ec4-57be-4ff7-b2a7-a640b8babe12" xlink:to="loc_naut_A2021EmployeeStockPurchasePlanMember_c4c43a19-6ce8-4ab9-a93a-82000d35b665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_A2017EquityIncentivePlanMember_c25c5514-81f1-4501-9bbf-6f4d81e2a14c" xlink:href="naut-20220630.xsd#naut_A2017EquityIncentivePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_fb647ec4-57be-4ff7-b2a7-a640b8babe12" xlink:to="loc_naut_A2017EquityIncentivePlanMember_c25c5514-81f1-4501-9bbf-6f4d81e2a14c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7533b5b6-a7b0-459f-8fb7-6691b4733e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e93c568-2296-46f5-9dce-33eff18bb0b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7533b5b6-a7b0-459f-8fb7-6691b4733e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0fd1ae41-c501-4c31-8d6a-f22e44bccd7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7533b5b6-a7b0-459f-8fb7-6691b4733e33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0fd1ae41-c501-4c31-8d6a-f22e44bccd7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_fc08ef53-087c-4b30-9bc3-2cfdbb2c38e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7533b5b6-a7b0-459f-8fb7-6691b4733e33" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_fc08ef53-087c-4b30-9bc3-2cfdbb2c38e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c812f2f9-95a3-4771-a61d-fce3cc8496e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7533b5b6-a7b0-459f-8fb7-6691b4733e33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_c812f2f9-95a3-4771-a61d-fce3cc8496e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_103c0452-e140-438f-9b98-e15327c64608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7533b5b6-a7b0-459f-8fb7-6691b4733e33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_103c0452-e140-438f-9b98-e15327c64608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant_ccc86adc-09f8-42a7-8deb-d142a1e5e0ae" xlink:href="naut-20220630.xsd#naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7533b5b6-a7b0-459f-8fb7-6691b4733e33" xlink:to="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant_ccc86adc-09f8-42a7-8deb-d142a1e5e0ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_5994f3d7-c78e-4363-9a9b-d99525740e80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7533b5b6-a7b0-459f-8fb7-6691b4733e33" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_5994f3d7-c78e-4363-9a9b-d99525740e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_8a2156ec-ee79-4c5b-8065-38be20fcd657" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7533b5b6-a7b0-459f-8fb7-6691b4733e33" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_8a2156ec-ee79-4c5b-8065-38be20fcd657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_3029feec-1f85-4e61-9549-b477ae931d59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7533b5b6-a7b0-459f-8fb7-6691b4733e33" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_3029feec-1f85-4e61-9549-b477ae931d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d641d7ef-057d-4f77-9b14-b644eb56cd37" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7533b5b6-a7b0-459f-8fb7-6691b4733e33" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d641d7ef-057d-4f77-9b14-b644eb56cd37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_122ed3ca-52e0-4cea-8014-f71aad042fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7533b5b6-a7b0-459f-8fb7-6691b4733e33" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_122ed3ca-52e0-4cea-8014-f71aad042fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_13d5429e-fb98-4ee7-8a15-6d8d71adb385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b6bbb710-07a1-4a0d-b210-67b4e14e76b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_13d5429e-fb98-4ee7-8a15-6d8d71adb385" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b6bbb710-07a1-4a0d-b210-67b4e14e76b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_eef114db-fd61-4883-a7b1-7521debea82a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b6bbb710-07a1-4a0d-b210-67b4e14e76b5" xlink:to="loc_us-gaap_AwardTypeAxis_eef114db-fd61-4883-a7b1-7521debea82a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbc69cbf-b367-41b4-ab7a-cc9ac0410183" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_eef114db-fd61-4883-a7b1-7521debea82a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbc69cbf-b367-41b4-ab7a-cc9ac0410183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_bb2db165-e886-415c-94b1-ebc86d027e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bbc69cbf-b367-41b4-ab7a-cc9ac0410183" xlink:to="loc_us-gaap_EmployeeStockOptionMember_bb2db165-e886-415c-94b1-ebc86d027e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a87ae30f-f139-4c2a-978a-b97cf744b1bd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b6bbb710-07a1-4a0d-b210-67b4e14e76b5" xlink:to="loc_srt_RangeAxis_a87ae30f-f139-4c2a-978a-b97cf744b1bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_16d27d3f-c649-4f64-8c32-c73e3aa2c605" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a87ae30f-f139-4c2a-978a-b97cf744b1bd" xlink:to="loc_srt_RangeMember_16d27d3f-c649-4f64-8c32-c73e3aa2c605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1684ac24-e42c-404a-a5e4-d98dfdb0606a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_16d27d3f-c649-4f64-8c32-c73e3aa2c605" xlink:to="loc_srt_MinimumMember_1684ac24-e42c-404a-a5e4-d98dfdb0606a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_05dbfd3b-1245-4da9-8249-08035652fe09" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_16d27d3f-c649-4f64-8c32-c73e3aa2c605" xlink:to="loc_srt_MaximumMember_05dbfd3b-1245-4da9-8249-08035652fe09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94344577-e59c-40f8-a80c-5602593e8d61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b6bbb710-07a1-4a0d-b210-67b4e14e76b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94344577-e59c-40f8-a80c-5602593e8d61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6649142e-d5c3-444e-88b7-5482a05eb984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94344577-e59c-40f8-a80c-5602593e8d61" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6649142e-d5c3-444e-88b7-5482a05eb984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2909d4d4-14f0-4576-a7a3-1e54c2cd48df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94344577-e59c-40f8-a80c-5602593e8d61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2909d4d4-14f0-4576-a7a3-1e54c2cd48df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_6a30de98-b9b5-4d63-b823-62ce5d43bea1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94344577-e59c-40f8-a80c-5602593e8d61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_6a30de98-b9b5-4d63-b823-62ce5d43bea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_952e0ae9-b134-4a73-8261-f8286c5b2739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94344577-e59c-40f8-a80c-5602593e8d61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_952e0ae9-b134-4a73-8261-f8286c5b2739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_96a8315b-388f-44a1-83af-f7675cc09412" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94344577-e59c-40f8-a80c-5602593e8d61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_96a8315b-388f-44a1-83af-f7675cc09412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_00c0bd13-a626-4380-b25e-ace357aee5b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94344577-e59c-40f8-a80c-5602593e8d61" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_00c0bd13-a626-4380-b25e-ace357aee5b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice_97bf62cc-a63d-4d05-97c0-daa43a814083" xlink:href="naut-20220630.xsd#naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_94344577-e59c-40f8-a80c-5602593e8d61" xlink:to="loc_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice_97bf62cc-a63d-4d05-97c0-daa43a814083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockOptionActivityDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#StockOptionPlanandStockbasedCompensationStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c411b032-0111-47e6-82f7-ebc1108dc81f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8c13f58f-1be5-46e6-a43d-22313d4d1782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c411b032-0111-47e6-82f7-ebc1108dc81f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8c13f58f-1be5-46e6-a43d-22313d4d1782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_17f66607-f0ad-4352-bf7d-933cc9bfa596" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8c13f58f-1be5-46e6-a43d-22313d4d1782" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_17f66607-f0ad-4352-bf7d-933cc9bfa596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1604bc83-2db8-4e0f-839e-e631a185fe90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8c13f58f-1be5-46e6-a43d-22313d4d1782" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1604bc83-2db8-4e0f-839e-e631a185fe90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7a192deb-2f99-4c1d-88d7-5c570306b7ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8c13f58f-1be5-46e6-a43d-22313d4d1782" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7a192deb-2f99-4c1d-88d7-5c570306b7ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_6d3ead52-6229-48be-b589-4d860beadbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8c13f58f-1be5-46e6-a43d-22313d4d1782" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_6d3ead52-6229-48be-b589-4d860beadbf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_986b3b66-b6a9-4b98-b9cd-a5067acd0623" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8c13f58f-1be5-46e6-a43d-22313d4d1782" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_986b3b66-b6a9-4b98-b9cd-a5067acd0623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_b99a4d37-f4fa-4907-8f49-ef7248e5f929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c411b032-0111-47e6-82f7-ebc1108dc81f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_b99a4d37-f4fa-4907-8f49-ef7248e5f929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0d34108a-07aa-435c-b810-d7002e24f702" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c411b032-0111-47e6-82f7-ebc1108dc81f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0d34108a-07aa-435c-b810-d7002e24f702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4a43a45f-5c47-4db5-901f-94bd1a9d05df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c411b032-0111-47e6-82f7-ebc1108dc81f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4a43a45f-5c47-4db5-901f-94bd1a9d05df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1d5ed394-1358-4ed4-b92d-b79532d2e1ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4a43a45f-5c47-4db5-901f-94bd1a9d05df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1d5ed394-1358-4ed4-b92d-b79532d2e1ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_afa71b2d-a115-4359-9e95-c3ccc1326ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4a43a45f-5c47-4db5-901f-94bd1a9d05df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_afa71b2d-a115-4359-9e95-c3ccc1326ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_28265b88-5463-4b6f-8d6b-c15feba560ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4a43a45f-5c47-4db5-901f-94bd1a9d05df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_28265b88-5463-4b6f-8d6b-c15feba560ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_6c7af846-2210-4c22-93b3-2b2565ad6fae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4a43a45f-5c47-4db5-901f-94bd1a9d05df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_6c7af846-2210-4c22-93b3-2b2565ad6fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_54726519-2f7b-4b2c-8713-8aebf2ea58d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4a43a45f-5c47-4db5-901f-94bd1a9d05df" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_54726519-2f7b-4b2c-8713-8aebf2ea58d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_e69942b7-cbb2-48de-ae0e-5cc4623afc69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c411b032-0111-47e6-82f7-ebc1108dc81f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_e69942b7-cbb2-48de-ae0e-5cc4623afc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_57798ae7-41d3-410c-b577-5f0676478f81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c411b032-0111-47e6-82f7-ebc1108dc81f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_57798ae7-41d3-410c-b577-5f0676478f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_11217f15-ee5b-4467-9b6c-61da9ddc8e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c411b032-0111-47e6-82f7-ebc1108dc81f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_11217f15-ee5b-4467-9b6c-61da9ddc8e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_93b775a6-43c0-49e9-8559-e1ffd069d5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c411b032-0111-47e6-82f7-ebc1108dc81f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_93b775a6-43c0-49e9-8559-e1ffd069d5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_fc03dda3-d540-4353-93c3-76a43de11c65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c411b032-0111-47e6-82f7-ebc1108dc81f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_fc03dda3-d540-4353-93c3-76a43de11c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_48bca7ea-bedf-4fe5-84ea-efd986d1f0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c411b032-0111-47e6-82f7-ebc1108dc81f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_48bca7ea-bedf-4fe5-84ea-efd986d1f0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#StockOptionPlanandStockbasedCompensationStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9065fe0d-bea7-4012-aa6d-e9dbe9a94cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66c3ea1d-7133-48c9-9ba7-0e7b85c6c166" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9065fe0d-bea7-4012-aa6d-e9dbe9a94cbc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66c3ea1d-7133-48c9-9ba7-0e7b85c6c166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_56e45fc1-6fef-4bcd-8758-d5e2ec04fd80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66c3ea1d-7133-48c9-9ba7-0e7b85c6c166" xlink:to="loc_us-gaap_AwardTypeAxis_56e45fc1-6fef-4bcd-8758-d5e2ec04fd80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1bb24af-7708-4b1f-8043-78de99d3f5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_56e45fc1-6fef-4bcd-8758-d5e2ec04fd80" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1bb24af-7708-4b1f-8043-78de99d3f5c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_c2f91623-be20-4457-ac15-55b00bcfff18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1bb24af-7708-4b1f-8043-78de99d3f5c5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_c2f91623-be20-4457-ac15-55b00bcfff18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_786fc0d3-0485-4eff-bfa7-05cb3ca94af5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66c3ea1d-7133-48c9-9ba7-0e7b85c6c166" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_786fc0d3-0485-4eff-bfa7-05cb3ca94af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_38986db0-d210-4c26-a6dd-c2b858af897e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_786fc0d3-0485-4eff-bfa7-05cb3ca94af5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_38986db0-d210-4c26-a6dd-c2b858af897e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1f7415f0-6db0-4884-8eb1-813e1fad0114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_38986db0-d210-4c26-a6dd-c2b858af897e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1f7415f0-6db0-4884-8eb1-813e1fad0114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_19d05577-4c03-41f5-bd09-07ed3ee47155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_38986db0-d210-4c26-a6dd-c2b858af897e" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_19d05577-4c03-41f5-bd09-07ed3ee47155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_558420bd-8453-4984-9428-44ed0f1a80c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_66c3ea1d-7133-48c9-9ba7-0e7b85c6c166" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_558420bd-8453-4984-9428-44ed0f1a80c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_ee788dde-b11c-45a8-9403-3d6cea8efffb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_558420bd-8453-4984-9428-44ed0f1a80c2" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_ee788dde-b11c-45a8-9403-3d6cea8efffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommitmentandContingencies" xlink:type="simple" xlink:href="naut-20220630.xsd#CommitmentandContingencies"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CommitmentandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1591393e-a4d9-4d2c-9ff0-4f5e7a165243" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_f4d89429-d316-4e52-ad7e-28cba6f0f4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1591393e-a4d9-4d2c-9ff0-4f5e7a165243" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_f4d89429-d316-4e52-ad7e-28cba6f0f4ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_627c09e0-fb92-4778-bf74-c6aaabc615d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1591393e-a4d9-4d2c-9ff0-4f5e7a165243" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_627c09e0-fb92-4778-bf74-c6aaabc615d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommitmentandContingenciesTables" xlink:type="simple" xlink:href="naut-20220630.xsd#CommitmentandContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CommitmentandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_464a2429-e797-4d04-b35d-cf3eb05f02d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_576d7c17-8edc-48e3-87b6-db7018191572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_464a2429-e797-4d04-b35d-cf3eb05f02d8" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_576d7c17-8edc-48e3-87b6-db7018191572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_b0bc1124-4840-4571-a307-84ef3cddb05d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_464a2429-e797-4d04-b35d-cf3eb05f02d8" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_b0bc1124-4840-4571-a307-84ef3cddb05d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#CommitmentandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e2644cc3-eee4-4b3d-96f1-691e3733a1ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_0d676166-bdc6-45ec-aff9-b9afd3330627" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e2644cc3-eee4-4b3d-96f1-691e3733a1ad" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_0d676166-bdc6-45ec-aff9-b9afd3330627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermAxis_3c65148f-5ede-4c39-a35c-2e0be1413d05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_0d676166-bdc6-45ec-aff9-b9afd3330627" xlink:to="loc_us-gaap_LeaseContractualTermAxis_3c65148f-5ede-4c39-a35c-2e0be1413d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseContractualTermDomain_3b2c055b-9a15-4e57-9cd5-13ad67118f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseContractualTermDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermAxis_3c65148f-5ede-4c39-a35c-2e0be1413d05" xlink:to="loc_us-gaap_LeaseContractualTermDomain_3b2c055b-9a15-4e57-9cd5-13ad67118f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_September2021ToSeptember2031Member_da6c84d0-7d2e-4770-a8b9-c285cf66e0d5" xlink:href="naut-20220630.xsd#naut_September2021ToSeptember2031Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_3b2c055b-9a15-4e57-9cd5-13ad67118f6c" xlink:to="loc_naut_September2021ToSeptember2031Member_da6c84d0-7d2e-4770-a8b9-c285cf66e0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_February2021ToOctober2021Member_1150d8a3-06a1-4d18-903d-205e3a25c155" xlink:href="naut-20220630.xsd#naut_February2021ToOctober2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_3b2c055b-9a15-4e57-9cd5-13ad67118f6c" xlink:to="loc_naut_February2021ToOctober2021Member_1150d8a3-06a1-4d18-903d-205e3a25c155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_October2022ToOctober2031Member_d3144556-de1b-4a7a-b25a-89210012c33c" xlink:href="naut-20220630.xsd#naut_October2022ToOctober2031Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseContractualTermDomain_3b2c055b-9a15-4e57-9cd5-13ad67118f6c" xlink:to="loc_naut_October2022ToOctober2031Member_d3144556-de1b-4a7a-b25a-89210012c33c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_8c2919bd-fad5-4371-a069-fe1909c82caf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_0d676166-bdc6-45ec-aff9-b9afd3330627" xlink:to="loc_us-gaap_CreditFacilityAxis_8c2919bd-fad5-4371-a069-fe1909c82caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2732b61a-5e5e-487d-87c6-8590e3948e01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_8c2919bd-fad5-4371-a069-fe1909c82caf" xlink:to="loc_us-gaap_CreditFacilityDomain_2732b61a-5e5e-487d-87c6-8590e3948e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_SanCarlosLeaseImprovementsLineOfCreditMember_034c875d-0a5d-476c-b418-ce37a8eefecf" xlink:href="naut-20220630.xsd#naut_SanCarlosLeaseImprovementsLineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_2732b61a-5e5e-487d-87c6-8590e3948e01" xlink:to="loc_naut_SanCarlosLeaseImprovementsLineOfCreditMember_034c875d-0a5d-476c-b418-ce37a8eefecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_0d676166-bdc6-45ec-aff9-b9afd3330627" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermPurchaseCommitmentAmount_fe514a8d-1fa4-4576-9dcf-09e8521deded" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermPurchaseCommitmentAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:to="loc_us-gaap_LongTermPurchaseCommitmentAmount_fe514a8d-1fa4-4576-9dcf-09e8521deded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_93c9aff8-fc55-41a1-bcb9-097781c31bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_93c9aff8-fc55-41a1-bcb9-097781c31bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_be0d437c-8d6f-41f2-964d-6756df475381" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_be0d437c-8d6f-41f2-964d-6756df475381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_OperatingLeaseNoncashAdjustment_83efb75e-0f18-46c8-98c8-32d2698bf312" xlink:href="naut-20220630.xsd#naut_OperatingLeaseNoncashAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:to="loc_naut_OperatingLeaseNoncashAdjustment_83efb75e-0f18-46c8-98c8-32d2698bf312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_LesseeOperatingLeaseOptionToTerminateLeaseTerm_60f7adc4-4885-474e-a199-e1d687eb277d" xlink:href="naut-20220630.xsd#naut_LesseeOperatingLeaseOptionToTerminateLeaseTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:to="loc_naut_LesseeOperatingLeaseOptionToTerminateLeaseTerm_60f7adc4-4885-474e-a199-e1d687eb277d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_825a8ce9-65fd-45cb-aa23-0746e047f85d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_825a8ce9-65fd-45cb-aa23-0746e047f85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5f3f85c4-cb57-41b6-a8d2-e1ee2be42d85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5f3f85c4-cb57-41b6-a8d2-e1ee2be42d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_3eefc404-a0c5-4171-bbca-58316a4e469a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:to="loc_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding_3eefc404-a0c5-4171-bbca-58316a4e469a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_f45c466c-47cf-4932-bb81-7d88a765ea32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:to="loc_us-gaap_OperatingLeasePayments_f45c466c-47cf-4932-bb81-7d88a765ea32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0745a815-2f22-44db-8bdd-73d27a14c12f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_0745a815-2f22-44db-8bdd-73d27a14c12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_96309969-47d2-4290-be7c-e067bf863d27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_96309969-47d2-4290-be7c-e067bf863d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_60ec5bdd-d60f-443d-9195-a1cf05caa841" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_dc4a548c-43b5-4b3d-af62-bed489b6f11d" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_60ec5bdd-d60f-443d-9195-a1cf05caa841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommitmentandContingenciesComponentsofLeaseCostDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#CommitmentandContingenciesComponentsofLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CommitmentandContingenciesComponentsofLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2c607bb8-db9c-42d5-b0fa-0df297562a09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_dda55c6b-8216-421f-a204-7feaad5394ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2c607bb8-db9c-42d5-b0fa-0df297562a09" xlink:to="loc_us-gaap_OperatingLeaseCost_dda55c6b-8216-421f-a204-7feaad5394ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_526fbb8d-6dc1-4e6f-9ef1-621a64448a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2c607bb8-db9c-42d5-b0fa-0df297562a09" xlink:to="loc_us-gaap_VariableLeaseCost_526fbb8d-6dc1-4e6f-9ef1-621a64448a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_55cf63d4-fa63-4781-8d1c-dacf0498fac6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2c607bb8-db9c-42d5-b0fa-0df297562a09" xlink:to="loc_us-gaap_ShortTermLeaseCost_55cf63d4-fa63-4781-8d1c-dacf0498fac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_c2bf4536-3d0d-4de9-88aa-c782b3b9b42f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2c607bb8-db9c-42d5-b0fa-0df297562a09" xlink:to="loc_us-gaap_LeaseCost_c2bf4536-3d0d-4de9-88aa-c782b3b9b42f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#CommitmentandContingenciesLeaseMaturityDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a734b60c-ca84-4300-bdf5-08e998f9ff98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_44f2a3cf-f3c6-44f4-8e1e-25072ddaef86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a734b60c-ca84-4300-bdf5-08e998f9ff98" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_44f2a3cf-f3c6-44f4-8e1e-25072ddaef86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_94a4988e-d909-4aea-9045-3fd55e8e930c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a734b60c-ca84-4300-bdf5-08e998f9ff98" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_94a4988e-d909-4aea-9045-3fd55e8e930c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3f51ca32-e373-44b0-9b2e-78c4abd36527" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a734b60c-ca84-4300-bdf5-08e998f9ff98" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3f51ca32-e373-44b0-9b2e-78c4abd36527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_8b97814d-413a-41b2-94ad-f1b0323e8277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a734b60c-ca84-4300-bdf5-08e998f9ff98" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_8b97814d-413a-41b2-94ad-f1b0323e8277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_9331ce59-af50-411c-bb17-88b86665e4d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a734b60c-ca84-4300-bdf5-08e998f9ff98" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_9331ce59-af50-411c-bb17-88b86665e4d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour_22833e6d-0549-42e6-b3de-4e62ff9f7376" xlink:href="naut-20220630.xsd#naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a734b60c-ca84-4300-bdf5-08e998f9ff98" xlink:to="loc_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour_22833e6d-0549-42e6-b3de-4e62ff9f7376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_aa7b9f1a-f1f4-4e8f-bbe3-36c7c2bc0e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a734b60c-ca84-4300-bdf5-08e998f9ff98" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_aa7b9f1a-f1f4-4e8f-bbe3-36c7c2bc0e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_28cb178d-6ebb-4377-a3b8-ddb4b8465704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a734b60c-ca84-4300-bdf5-08e998f9ff98" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_28cb178d-6ebb-4377-a3b8-ddb4b8465704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_6451ae37-af36-4169-b8d1-54a3ac3f6bba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a734b60c-ca84-4300-bdf5-08e998f9ff98" xlink:to="loc_us-gaap_OperatingLeaseLiability_6451ae37-af36-4169-b8d1-54a3ac3f6bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails_1" xlink:type="simple" xlink:href="naut-20220630.xsd#CommitmentandContingenciesLeaseMaturityDetails_1"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.nautilus.bio/role/BasicandDilutedNetLossperShare" xlink:type="simple" xlink:href="naut-20220630.xsd#BasicandDilutedNetLossperShare"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/BasicandDilutedNetLossperShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_4cc2b472-b16a-49df-aa1a-9aaec9d21a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_90f49bcc-cb13-4c0b-bb47-c01286641396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4cc2b472-b16a-49df-aa1a-9aaec9d21a4f" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_90f49bcc-cb13-4c0b-bb47-c01286641396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/BasicandDilutedNetLossperShareTables" xlink:type="simple" xlink:href="naut-20220630.xsd#BasicandDilutedNetLossperShareTables"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/BasicandDilutedNetLossperShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_77f3ddae-168f-4e1e-9251-399503544dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_6ef8d55b-d01b-4893-92e5-9e9386d9b9a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_77f3ddae-168f-4e1e-9251-399503544dd2" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_6ef8d55b-d01b-4893-92e5-9e9386d9b9a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_3df7de2d-2385-4a4b-a8c1-b2daf797e567" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_77f3ddae-168f-4e1e-9251-399503544dd2" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_3df7de2d-2385-4a4b-a8c1-b2daf797e567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/BasicandDilutedNetLossperShareBasicandDilutedNotLossperShareDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#BasicandDilutedNetLossperShareBasicandDilutedNotLossperShareDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/BasicandDilutedNetLossperShareBasicandDilutedNotLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_86482b39-9539-43a1-b9b4-2c1b8f25c457" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_bf8319f6-4fa1-4c73-8bd2-47a9b88f07bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_86482b39-9539-43a1-b9b4-2c1b8f25c457" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_bf8319f6-4fa1-4c73-8bd2-47a9b88f07bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_3a487829-9eef-4368-ab1e-639ebfe05cfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_86482b39-9539-43a1-b9b4-2c1b8f25c457" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_3a487829-9eef-4368-ab1e-639ebfe05cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_248df848-499d-4b4b-b67e-c7b8f3b0d541" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_86482b39-9539-43a1-b9b4-2c1b8f25c457" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_248df848-499d-4b4b-b67e-c7b8f3b0d541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase_52e9e3f0-c465-4c98-9aee-e1afdc1d8a02" xlink:href="naut-20220630.xsd#naut_WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_86482b39-9539-43a1-b9b4-2c1b8f25c457" xlink:to="loc_naut_WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase_52e9e3f0-c465-4c98-9aee-e1afdc1d8a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_58979981-e334-49d1-b6f2-b93f61797ce4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_86482b39-9539-43a1-b9b4-2c1b8f25c457" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_58979981-e334-49d1-b6f2-b93f61797ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9035b193-4d6b-4518-ae87-1aea5437b7e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_86482b39-9539-43a1-b9b4-2c1b8f25c457" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9035b193-4d6b-4518-ae87-1aea5437b7e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_fb9e0027-60a0-4341-8269-2631358160e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_86482b39-9539-43a1-b9b4-2c1b8f25c457" xlink:to="loc_us-gaap_EarningsPerShareBasic_fb9e0027-60a0-4341-8269-2631358160e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_07a4141f-d9fd-4342-846a-135d62739de0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_86482b39-9539-43a1-b9b4-2c1b8f25c457" xlink:to="loc_us-gaap_EarningsPerShareDiluted_07a4141f-d9fd-4342-846a-135d62739de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_RecapitalizationExchangeRatio_4650c83e-a7d0-4d56-a5ab-8db2b75b1301" xlink:href="naut-20220630.xsd#naut_RecapitalizationExchangeRatio"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_86482b39-9539-43a1-b9b4-2c1b8f25c457" xlink:to="loc_naut_RecapitalizationExchangeRatio_4650c83e-a7d0-4d56-a5ab-8db2b75b1301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.nautilus.bio/role/BasicandDilutedNetLossperShareAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="naut-20220630.xsd#BasicandDilutedNetLossperShareAntidilutiveSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.nautilus.bio/role/BasicandDilutedNetLossperShareAntidilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_46f32097-cf07-4d6f-9048-583b02938133" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1e133ee2-420b-4bd4-aa1d-a8dbc88ff24a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_46f32097-cf07-4d6f-9048-583b02938133" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1e133ee2-420b-4bd4-aa1d-a8dbc88ff24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_614edc4c-2d06-4f87-b717-11a3fb3fe506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1e133ee2-420b-4bd4-aa1d-a8dbc88ff24a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_614edc4c-2d06-4f87-b717-11a3fb3fe506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d1e07824-975a-4aa9-a46d-314244c5cf96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_614edc4c-2d06-4f87-b717-11a3fb3fe506" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d1e07824-975a-4aa9-a46d-314244c5cf96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_91f62199-0db0-4060-863c-e4480a0d114c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d1e07824-975a-4aa9-a46d-314244c5cf96" xlink:to="loc_us-gaap_EmployeeStockOptionMember_91f62199-0db0-4060-863c-e4480a0d114c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naut_EmployeeStockPurchasePlanMember_84ea8771-1dce-4cb7-a300-a4a0fc2a947a" xlink:href="naut-20220630.xsd#naut_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d1e07824-975a-4aa9-a46d-314244c5cf96" xlink:to="loc_naut_EmployeeStockPurchasePlanMember_84ea8771-1dce-4cb7-a300-a4a0fc2a947a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5d56ac0a-bdb5-4787-a867-dadeb2b52d23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1e133ee2-420b-4bd4-aa1d-a8dbc88ff24a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5d56ac0a-bdb5-4787-a867-dadeb2b52d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0672c84a-548f-4914-aff1-ebb7dd7c912f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_5d56ac0a-bdb5-4787-a867-dadeb2b52d23" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0672c84a-548f-4914-aff1-ebb7dd7c912f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627215736208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jul. 29, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NAUTILUS BIOTECHNOLOGY, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1541723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2701 Eastlake Avenue East<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Seattle<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">WA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">98102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">333-2001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NAUT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,663,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001808805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627215831824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 210,354<span></span>
</td>
<td class="nump">$ 185,619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investments</a></td>
<td class="nump">88,984<span></span>
</td>
<td class="nump">160,110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">4,108<span></span>
</td>
<td class="nump">3,493<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">303,446<span></span>
</td>
<td class="nump">349,222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">3,402<span></span>
</td>
<td class="nump">2,483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">28,304<span></span>
</td>
<td class="nump">29,377<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Long-term investments</a></td>
<td class="nump">35,558<span></span>
</td>
<td class="nump">16,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long term assets</a></td>
<td class="nump">997<span></span>
</td>
<td class="nump">997<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">371,707<span></span>
</td>
<td class="nump">398,450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,429<span></span>
</td>
<td class="nump">1,723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">3,108<span></span>
</td>
<td class="nump">3,119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liability</a></td>
<td class="nump">1,562<span></span>
</td>
<td class="nump">970<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">6,099<span></span>
</td>
<td class="nump">5,812<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, net of current portion</a></td>
<td class="nump">28,050<span></span>
</td>
<td class="nump">29,062<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">34,149<span></span>
</td>
<td class="nump">34,874<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value, 200,000,000 authorized as of June 30, 2022 and December 31, 2021; 0 shares issued and outstanding as of June 30, 2022 and December 31, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">#REF!</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">449,406<span></span>
</td>
<td class="nump">444,388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(768)<span></span>
</td>
<td class="num">(184)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(111,092)<span></span>
</td>
<td class="num">(80,640)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">337,558<span></span>
</td>
<td class="nump">363,576<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 371,707<span></span>
</td>
<td class="nump">$ 398,450<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Liabilities and Other Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627215062896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 8,856<span></span>
</td>
<td class="nump">$ 6,380<span></span>
</td>
<td class="nump">$ 18,514<span></span>
</td>
<td class="nump">$ 11,215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">6,616<span></span>
</td>
<td class="nump">4,317<span></span>
</td>
<td class="nump">12,980<span></span>
</td>
<td class="nump">7,899<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">15,472<span></span>
</td>
<td class="nump">10,697<span></span>
</td>
<td class="nump">31,494<span></span>
</td>
<td class="nump">19,114<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">783<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="nump">1,042<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (14,689)<span></span>
</td>
<td class="num">$ (10,713)<span></span>
</td>
<td class="num">$ (30,452)<span></span>
</td>
<td class="num">$ (19,122)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share attributable to common stockholders, basic (in dollars per share)</a></td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.19)<span></span>
</td>
<td class="num">$ (0.24)<span></span>
</td>
<td class="num">$ (0.43)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share attributable to common stockholders, diluted (in dollars per share)</a></td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.19)<span></span>
</td>
<td class="num">$ (0.24)<span></span>
</td>
<td class="num">$ (0.43)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)</a></td>
<td class="nump">124,494,036<span></span>
</td>
<td class="nump">55,070,480<span></span>
</td>
<td class="nump">124,456,518<span></span>
</td>
<td class="nump">44,096,149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)</a></td>
<td class="nump">124,494,036<span></span>
</td>
<td class="nump">55,070,480<span></span>
</td>
<td class="nump">124,456,518<span></span>
</td>
<td class="nump">44,096,149<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627216654256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (14,689)<span></span>
</td>
<td class="num">$ (10,713)<span></span>
</td>
<td class="num">$ (30,452)<span></span>
</td>
<td class="num">$ (19,122)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Unrealized loss on securities available-for-sale</a></td>
<td class="num">(214)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(584)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive loss</a></td>
<td class="num">(214)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(584)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (14,903)<span></span>
</td>
<td class="num">$ (10,725)<span></span>
</td>
<td class="num">$ (31,036)<span></span>
</td>
<td class="num">$ (19,135)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627210887840">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th" colspan="2"><div>Series Seed</div></th>
<th class="th" colspan="2"><div>Series A</div></th>
<th class="th" colspan="2"><div>Series B</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,174,805<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">16,836,436<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">22,164,724<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,494<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 27,067<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 75,857<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_ReclassificationsOfTemporaryToPermanentEquityShares', window );">Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,174,805)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(16,836,436)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(22,164,724)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity', window );">Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,494)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (27,067)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (75,857)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">33,069,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (29,721)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="num">$ (30,325)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of vested stock options (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">65,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of vested stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Issuance of common stock upon exercise of warrants (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">62,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">52,175,965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">108,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">108,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_StockIssuedDuringPeriodSharesReverseRecapitalization', window );">Issuance of common stock upon the reverse recapitalization, net of issuance costs (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">38,721,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_StockIssuedDuringPeriodValueReverseRecapitalization', window );">Issuance of common stock upon the reverse recapitalization, net of issuance costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">327,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">327,276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(19,122)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,122)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">124,094,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">390,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">439,489<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(49,447)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,174,805<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">16,836,436<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">22,164,724<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance at Mar. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,494<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 27,067<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 75,857<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_ReclassificationsOfTemporaryToPermanentEquityShares', window );">Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,174,805)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(16,836,436)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(22,164,724)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity', window );">Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5,494)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (27,067)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (75,857)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">33,069,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(36,795)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,936<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(38,734)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of vested stock options (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">65,003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of vested stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Issuance of common stock upon exercise of warrants (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">62,772<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">52,175,965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">108,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">108,411<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_StockIssuedDuringPeriodSharesReverseRecapitalization', window );">Issuance of common stock upon the reverse recapitalization, net of issuance costs (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">38,721,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_StockIssuedDuringPeriodValueReverseRecapitalization', window );">Issuance of common stock upon the reverse recapitalization, net of issuance costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">327,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">327,276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(10,713)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,713)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">124,094,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 390,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">439,489<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="num">(49,447)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Jun. 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">124,303,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 363,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">444,388<span></span>
</td>
<td class="num">(184)<span></span>
</td>
<td class="num">(80,640)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of vested stock options (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">211,309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">211,309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of vested stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under employee stock purchase plan (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">48,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under employee stock purchase plan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(584)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(584)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(30,452)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,452)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">124,562,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 337,558<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">449,406<span></span>
</td>
<td class="num">(768)<span></span>
</td>
<td class="num">(111,092)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance at Mar. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Jun. 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">124,456,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 349,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">446,654<span></span>
</td>
<td class="num">(554)<span></span>
</td>
<td class="num">(96,403)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of vested stock options (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">57,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of vested stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under employee stock purchase plan (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">48,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under employee stock purchase plan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(214)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(214)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(14,689)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,689)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">124,562,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 337,558<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">$ 449,406<span></span>
</td>
<td class="num">$ (768)<span></span>
</td>
<td class="num">$ (111,092)<span></span>
</td>
</tr>
<tr><td colspan="12"></td></tr>
<tr><td colspan="12"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">(1)&#160;&#160;&#160;&#160;The shares of the Company&#8217;s common and redeemable convertible preferred stock, prior to the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 3.6281 established in the Business Combination as described in Note 3.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_ReclassificationsOfTemporaryToPermanentEquityShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares subject to possible redemption reclassified from temporary equity to permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_ReclassificationsOfTemporaryToPermanentEquityShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_StockIssuedDuringPeriodSharesReverseRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Reverse Recapitalization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_StockIssuedDuringPeriodSharesReverseRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_StockIssuedDuringPeriodSharesWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_StockIssuedDuringPeriodSharesWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_StockIssuedDuringPeriodValueReverseRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Reverse Recapitalization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_StockIssuedDuringPeriodValueReverseRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90193-114008<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationsOfTemporaryToPermanentEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627210758864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (30,452)<span></span>
</td>
<td class="num">$ (19,122)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">562<span></span>
</td>
<td class="nump">479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">4,677<span></span>
</td>
<td class="nump">3,156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of premiums on securities, net</a></td>
<td class="num">(147)<span></span>
</td>
<td class="nump">213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of operating lease right-of-use assets</a></td>
<td class="nump">1,073<span></span>
</td>
<td class="nump">760<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(503)<span></span>
</td>
<td class="num">(331)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(643)<span></span>
</td>
<td class="nump">725<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="num">(11)<span></span>
</td>
<td class="nump">410<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="num">(420)<span></span>
</td>
<td class="num">(835)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(25,864)<span></span>
</td>
<td class="num">(14,545)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Proceeds from maturities of securities</a></td>
<td class="nump">105,575<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of securities</a></td>
<td class="num">(54,185)<span></span>
</td>
<td class="num">(100,035)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(1,132)<span></span>
</td>
<td class="num">(1,013)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">50,258<span></span>
</td>
<td class="num">(61,048)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">188<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from issuance of common stock under employee stock purchase plan</a></td>
<td class="nump">153<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_ProceedsFromReverseRecapitalizationTransaction', window );">Net proceeds from reverse recapitalization and PIPE financing</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">335,409<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of offering costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,082)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">341<span></span>
</td>
<td class="nump">327,373<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash, cash equivalents and restricted cash</a></td>
<td class="nump">24,735<span></span>
</td>
<td class="nump">251,780<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">186,461<span></span>
</td>
<td class="nump">37,219<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at end of period</a></td>
<td class="nump">211,196<span></span>
</td>
<td class="nump">288,999<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplementary cash flow information on non-cash activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1', window );">Acquisitions of property and equipment included in accounts payable</a></td>
<td class="nump">413<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_DeferredStockIssuanceCosts', window );">Deferred offering costs in accounts payable and accrued expenses and other liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">108,418<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_DeferredStockIssuanceCostsReclassifiedToEquity', window );">Deferred offering costs reclassified to equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_ModificationToReduceRightOfUseAssetsAndLeaseLiability', window );">Modification to reduce right-of-use assets and lease liability</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,254<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_DeferredStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Stock Issuance Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_DeferredStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_DeferredStockIssuanceCostsReclassifiedToEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Stock Issuance Costs Reclassified To Equity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_DeferredStockIssuanceCostsReclassifiedToEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_ModificationToReduceRightOfUseAssetsAndLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Modification To Reduce Right-Of-Use Assets And Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_ModificationToReduceRightOfUseAssetsAndLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_ProceedsFromReverseRecapitalizationTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Reverse Recapitalization Transaction</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_ProceedsFromReverseRecapitalizationTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627216661312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">124,562,745<span></span>
</td>
<td class="nump">124,303,083<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">124,562,745<span></span>
</td>
<td class="nump">124,303,083<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627220507024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders&#8217; Equity (Deficit) (Parenthetical)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 09, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_RecapitalizationExchangeRatio', window );">Recapitalization exchange ratio</a></td>
<td class="nump">3.6281<span></span>
</td>
<td class="nump">3.6281<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_RecapitalizationExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recapitalization Exchange Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_RecapitalizationExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627308138544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">Description of Business and Basis of Presentation</a></td>
<td class="text">Description of Business and Basis of Presentation<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus Biotechnology, Inc. (the &#8220;Company&#8221;) is a biotechnology company incorporated in 2016 and based in Seattle, Washington with laboratory operations in San Carlos, California. Since the Company&#8217;s incorporation in 2016, the Company has devoted substantially all of its resources to research and development activities, including with respect to its proteomics platform, business planning, establishing and maintaining its intellectual property portfolio, hiring personnel, raising capital and providing general and administrative support for these operations. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 9, 2021 (the &#8220;Closing Date&#8221;), Nautilus Biotechnology, Inc. a Delaware corporation (f/k/a ARYA Sciences Acquisition Corp. III, a Cayman Islands exempted company and the Company&#8217;s predecessor company (&#8220;ARYA&#8221;)), consummated the previously announced business combination (the &#8220;Business Combination&#8221;) pursuant to the terms of that certain Business Combination Agreement, dated as of February 7, 2021 (the &#8220;BCA&#8221;), by and among ARYA, Mako Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of ARYA (&#8220;Mako Merger Sub&#8221;), and Nautilus Subsidiary, Inc., a Delaware corporation (f/k/a Nautilus Biotechnology, Inc.) (&#8220;Legacy Nautilus&#8221;). As a result of the Business Combination, ARYA changed its name to &#8220;Nautilus Biotechnology, Inc.&#8221; and Mako Me</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rger Sub merged with and into Legacy Nautilus with Legacy Nautilus surviving as the surviving company and becoming a wholly-owned subsidiary of ARYA (the &#8220;Merger&#8221; and, collectively with the other transactions described in the BCA, the &#8220;Reverse Recapitalization&#8221;).  </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in conjunction with the completion of the Business Combination, certain investors (&#8220;PIPE Investors&#8221;) subscribed for the purchase of an aggregate of 20,000,000 shares of common stock of the Company (&#8220;New Nautilus Common Stock&#8221;) at a price of $10.00 per share for aggregate gross proceeds of $200.0&#160;million (&#8220;PIPE Financing&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to Note 3 &#8220;Reverse Recapitalization&#8221; for further details of the Business Combination.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements and accompanying notes are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) for interim financial reporting. All intercompany transactions and balances have been eliminated upon consolidation. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated financial statements were prepared on the same basis as the audited financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments necessary for a fair statement of the Company&#8217;s financial position as of June&#160;30, 2022, the results of its operations for the three and six months ended June 30, 2022 and 2021 and its cash flows for the six months ended June 30, 2022 and 2021. The results of operations for the three and six months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022. These financial statements and accompanying notes should be read in conjunction with the consolidated financial statements and notes thereto in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 on file with the SEC. The Company&#8217;s reporting currency is the U.S. dollar. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Going Concern</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s condensed consolidated financial statements have been prepared on the basis of continuity of operations, the realization of assets, and the satisfaction of liabilities in the ordinary course of business. Since inception, the Company has been engaged in developing its technology, raising capital, and recruiting personnel. The Company&#8217;s operating plan may change as a result of many factors currently unknown and there can be no assurance that the current operating plan will be achieved in the time frame anticipated by the Company, and it may need to seek additional funds sooner than planned. If adequate funds are not available to the Company on a timely basis, it may be required to delay, limit, reduce, or terminate certain commercial efforts, or pursue merger or acquisition strategies, all of which could adversely affect the holdings or the rights of the Company&#8217;s stockholders. The Company has incurred net operating losses and negative cash flows from operations in every year since </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">inception and expects this to continue for the foreseeable future. As of June&#160;30, 2022, the Company had an accumulated deficit of $111.1 million.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has funded its operations primarily with proceeds from the issuance of redeemable convertible preferred stock and common stock. In June 2021, the Company received gross proceeds of approximately $345.5 million from PIPE Investors and the Business Combination offset by approximately $18.2 million of transaction costs and underwriters&#8217; fees relating to the closing of the Business Combination. The Company had cash, cash equivalents, and short-term investments of $299.3 million as of June&#160;30, 2022.  As of the date on which these condensed consolidated financial statements were available to be issued, the Company believes that its cash, cash equivalents, and short-term investments will be sufficient to fund its operations for the next twelve months following the issuance of the condensed consolidated financial statements. The Company&#8217;s actual results could vary as a result of, and its near and long-term future capital requirements will depend on many factors, including its growth rate and the timing and extent of spending to support its research and development efforts. The Company has based its estimates on assumptions that may prove to be wrong, and it could use its available capital resources sooner than it currently expects. The Company may be required to seek additional equity or debt financing. Future liquidity and cash requirements will depend on numerous factors. In the event that additional financing is required, the Company may not be able to raise it on acceptable terms or at all. If the Company is unable to raise additional capital when desired, or if it cannot expand its operations or otherwise capitalize on its business opportunities because it lacks sufficient capital, its business, operating results, and financial condition would be adversely affected. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of the COVID-19 Coronavirus</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, COVID-19 was first reported to the World Health Organization (&#8220;WHO&#8221;), and in January 2020, the WHO declared the outbreak to be a public health emergency. In March 2020, the WHO characterized COVID-19 as a pandemic. Since then, the COVID-19 pandemic and efforts to control its spread have significantly curtailed the movement of people, goods, and services worldwide. As a result, the Company has taken certain measures in response to COVID-19. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the duration and extent of the COVID-19 pandemic depends on future developments that cannot be accurately predicted at this time, such as the extent and effectiveness of containment and mitigation actions, it has already had an adverse effect on the global economy, and the ultimate societal and economic impact of the COVID-19 pandemic remains unknown. Additionally, concerns over the economic impact of COVID-19 have caused extreme volatility in financial and other capital markets, which may adversely affect the Company&#8217;s ability to access capital markets in the future. Furthermore, the impact of the COVID-19 pandemic could adversely impact the Company&#8217;s cash flows and operations and delay the Company&#8217;s research and development activities. </span></div>While the Company has developed and continues to develop plans to help mitigate the potential negative impact of COVID-19, these efforts may not be effective, and any protracted economic downturn will likely limit the effectiveness of its efforts. Accordingly, it is not possible for the Company to predict the duration and ultimate extent to which this will affect its business, future results of operations, and financial condition at this time.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627297613504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">Significant Accounting Policies<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the condensed consolidated financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include determining the estimated lives of property and equipment, stock-based compensation including the estimated fair value per share of common stock prior to the date the Company became public, research and development accruals, and the valuation allowance for deferred tax assets. These estimates and assumptions are based on management&#8217;s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit risk represents the accounting loss that would be recognized as of the reporting date if counterparties failed completely to perform as contracted. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentration of credit risk, consist of cash balances maintained in excess of federal depository insurance limits and investments in U.S. Treasury securities that are not federally insured. The Company has not experienced any losses in such accounts and believes it is not exposed to significant credit risk on cash or investments. The Company relies, and expects to continue to rely, on a number of vendors to provide services, supplies and materials related to its research and development programs. The Company relies on single source suppliers for certain components and materials used in the Nautilus platform. The loss of any of these single source suppliers would require the Company to expend significant time and effort to locate and qualify an alternative source of supply for these components. The Company also relies, and expects to continue to rely, on third-party manufacturers and, in many cases, single third-party manufacturers for the production of certain reagents and antibodies. These programs could be adversely affected by a significant interruption in these services or the availability of materials.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to risks similar to those of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> other&#160;pre-clinical&#160;stage companies in the biopharmaceutical industry, including dependence on key individuals, the need to develop commercially viable products, competition from other companies, many of whom are larger and better capitalized, the impact of the COVID-19 pandemic and the need to obtain adequate additional financing to fund the development of its products. There can be no assurance that the Company&#8217;s research and development will be successfully completed, that adequate protection for the Company&#8217;s intellectual property will be maintained, that any products developed will obtain required regulatory approval or that any approved products will be commercially viable. Even if the Company&#8217;s development efforts are successful, it is uncertain when, if ever, the Company will generate significant revenue from the sale of its products.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Reporting</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision m</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">arket (&#8220;CODM&#8221;) in deciding how to allocate resources and in assessing performance. The Company&#8217;s Chief Executive Officer is its CODM. The Company&#8217;s CODM re</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">views financial information presented on a consolidated basis for the purposes of making operating decisions, allocating resources and evaluating financial performance. As such, the Company has determined that it operates in one operating and one reportable segment. The Company&#8217;s long-lived assets are entirely based in the United States. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly-liquid investments with an original maturity of three months or less as of the date of acquisition to be cash equivalents. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers investments with an original maturity greater than three months and remaining maturities less than one year to be short-term investments. The Company classifies those investments that are not required for use in current operations and that mature in more than 12 months as long-term investments. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its investments as available for sale and reports them at fair value, with unrealized gains and losses recorded in accumulated other comprehensive income (loss). For investments sold prior to maturity, the cost of investments sold is based on the specific identification method. Realized gains and losses on the sale of investments are recorded in other income (expense), net in the condensed consolidated statement of operations. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other-than-temporary Impairment</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its investments with unrealized losses for other-than-temporary impairment. When assessing investments for other-than-temporary declines in value, the Company considers factors such as, among other things, the extent and length of time the investment&#8217;s fair value has been lower than its cost basis, the financial condition and near-term prospects of the investment, the Company&#8217;s ability and intent to retain the investment for a period of time sufficient to allow for any anticipated recovery in fair value, and the expected cash flows from the security. If any adjustments to fair value reflects a decline in the value of the investment that the Company considers to be &#8220;other than temporary,&#8221; the Company reduces the investment to fair value through a charge to the condensed consolidated statement of operations and condensed consolidated statement of comprehensive loss. No such adjustments were necessary during the periods presented. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of cash and cash equivalents, prepaid expenses and other current assets, accounts payable and accrued expenses and other liabilities approximate their respective fair values due to their short-term nature.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement includes a lease at inception by assessing whether there is an identified asset and whether the contract conveys the right to control the use of the identified asset for a period of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">time in exchange for consideration. Operating leases with a term of more than one year are included in operating lease right-of-use (&#8220;ROU&#8221;) assets and operating lease liabilities on the Company's condensed consolidated balance sheets. ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments. Operating lease ROU assets and liabilities are recognized on the lease commencement date based on the present value of the future minimum lease payments over the lease term. The Company uses the incremental borrowing rate commensurate with the lease term based on the information available at the lease commencement date in determining the present value of the lease payments as the Company's leases generally do not provide an implicit rate. ROU assets initially equal the lease liability, adjusted for any prepaid lease payments and initial direct costs incurred, less any lease incentives received. Certain of the Company's leases include renewal options which allow the Company to, at its election, renew or extend the lease for a fixed or indefinite period of time. These renewal periods are included in the lease terms when the Company is reasonably certain the options will be exercised. Lease expense is recognized on a straight-line basis over the lease term when leases are operating leases. If it is considered a finance lease, expense is recognized over the lease term within </span></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">interest expense and amortization in the Company&#8217;s condensed consolidated statements of operations. The Company also has lease arrangements with lease and non-lease components. The Company elected the practical expedient not to separate non-lease components from lease components for the Company's facility leases and to account for the lease and non-lease components as a single lease component. The Company also elected to apply the short-term lease measurement and recognition exemption in which ROU assets and lease liabilities are not recognized for leases with terms of 12 months or less.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Loss </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive loss consists of net loss and other gains or losses affecting stockholders&#8217; equity that, under U.S. GAAP are excluded from net loss. For the three and six months ended June 30, 2022 and 2021, unrealized losses on debt securities were included as components of comprehensive loss. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is provided the option to adopt new or revised accounting guidance as an &#8220;emerging growth company&#8221; under the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;) either (1) within the same periods as those </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">otherwise applicable to public business entities, or (2) within the same time periods as non-public business entities, including early adoption when permissible. With the exception of standards the Company elected to early adopt, when permissible, the Company has elected to adopt new or revised accounting guidance within the same time period as non-public business entities, as indicated below. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Reference Rate Reform (Topic 848).&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The amendments in ASU 2020-04 provide optional expedients and exceptions for ap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">plying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this ASU are effective for all entities as of March 12, 2020 through December 31, 2022. An entity may elect to apply the amendments for contract modifications by Topic or Industry Subtopic as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or prospectively from the date that the financial statements are available to be issued. Once elected for a Topic or an Industry Subtopic, the amendments must be applied prospectively for all eligible contract modifications for that Topic or Industry Subtopic. The Company adopted this guidance effective January 1, 2022 using the prospective method, which did not have a material impact on the Company&#8217;s condensed consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Financial Instruments- Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, which amends existing guidance on the impairment of financial assets and adds an impairment model that is based on expected losses rather than incurred losses and requires an entity to recognize as an allowance its estimate of expected credit losses for its financial assets. An entity will apply this guidance through a cumulative-effect adjustment to retained earnings upon adoption (a modified-retrospective approach) while a prospective transition approach is required for debt securities for which an other-than-temporary impairment had been recognized before the effective date. This ASU is effective for the Company for its fiscal year ending December 31, 2023. Early adoption is permitted. The Company is in the process of evaluating the impact of the adoption of this ASU on its condensed consolidated financial statements and related disclosures. The Company does not anticipate adoption to have a material impact on its condensed consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December&#160;2019, the FASB issued ASU No. 2019-12, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as the elimination of exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, the recognition of deferred tax liabilities for outside basis differences, ownership changes in investments, and tax basis step-up&#160;in goodwill obtained in a transaction that is not a business combination. This ASU is effective for the Company for its fiscal year ending December&#160;31, 2022. Early adoption is permitted. The Company is in the process of evaluating the impact of the </span></div>adoption of this ASU on its condensed consolidated financial statements and related disclosures. The Company does not anticipate adoption to have a material impact on its condensed consolidated financial statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627218097632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reverse Recapitalization<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_ReverseRecapitalizationAbstract', window );"><strong>Reverse Recapitalization [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_ReverseRecapitalizationDisclosureTextBlock', window );">Reverse Recapitalization</a></td>
<td class="text">Reverse Recapitalization<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 9, 2021, Mako Merger Sub merged with Legacy Nautilus, with Legacy Nautilus surviving as the surviving company and as a wholly-owned subsidiary of ARYA. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Business Combination, Legacy Nautilus equity holders received an aggregate number of shares of New Nautilus Common Stock equal to (i) $900.0&#160;million plus $24.3&#160;million, which reflects the aggregate exercise price of all stock options (whether vested or unvested) of Legacy Nautilus at the consummation of the Business Combination, divided by (ii) $10.00 giving effect to the exchange ratio of approximately 3.6281 (&#8220;Exchange Ratio&#8221;) based on the terms of the Business Combination Agreement. For purposes of calculating the aggregate number of New Nautilus Common Stock issuable to each holder of Legacy Nautilus Common Stock pursuant to the Business Combination Agreement, all Legacy Nautilus Common Stock held by such holder was aggregated, and the Exchange Ratio was applied to that aggregate number of shares held by such holder, and not on a share-by-share basis, and the number of New Nautilus Common Stock issued was rounded down to the nearest whole share. At the Closing Date, (i) an aggregate of 18,721,137 shares of Class A and Class B ordinary shares of ARYA were exchanged for an equivalent number of Common Stock, (ii) an aggregate of 85,324,118 shares of Common Stock were issued in exchange for the shares of Nautilus outstanding as of immediately prior to the Business Combination and (iii) an aggregate of 20,000,000 shares of Common stock were issued to the PIPE Investors in the PIPE Financing with total gross proceeds of $200.0&#160;million. Moreover, at the Closing, all options to purchase shares of Nautilus were exchanged for comparable options to purchase shares of Common Stock based on an implied Legacy Nautilus equity value of $900.0&#160;million. Immediately after giving effect to the transactions, there were 124,045,255 shares of Common Stock outstanding and 7,106,767 shares of Common Stock subject to outstanding options under the 2017 Plan.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Business Combination is accounted for as a reverse recapitalization under U.S. GAAP. This determination is primarily based on Legacy Nautilus stockholders comprising a relative majority of the voting power of Nautilus and having the ability to nominate the members of the Board, Legacy Nautilus&#8217;s operations prior to the acquisition comprising the only ongoing operations of Nautilus, and Legacy Nautilus&#8217;s senior management comprising a majority of the senior management of Nautilus. Under this method of accounting, ARYA is treated as the &#8220;acquired&#8221; company for financial reporting purposes. Accordingly, for accounting purposes, the financial statements of Nautilus represent a continuation of the financial statements of Legacy Nautilus with the Business Combination being treated as the equivalent of Nautilus issuing stock for the net assets of ARYA, accompanied by a recapitalization. The net assets of ARYA are stated at historical costs, with no goodwill or other intangible assets recorded. Operations prior to the Business Combination are presented as those of Nautilus. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All periods prior to the Business Combination have been retrospectively adjusted using the Exchange Ratio for the equivalent number of shares outstanding immediately after the Business Combination to effect the reverse recapitalization. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Business Combination, the Company raised $335.4 million of net proceeds. This amount was comprised of $135.4&#160;million of cash held in ARYA&#8217;s trust account from its initial public offering, net of ARYA&#8217;s transaction costs and underwriters&#8217; fees of $10.1&#160;million, and $200.0&#160;million of cash in connection with the PIPE Financing. The Company incurred $8.1&#160;million of transaction costs, consisting of banking, legal, and other professional fees which were recorded as a reduction to additional paid-in capital.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares of Common Stock issued immediately following the consummation of the Business Combination was:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.070%"><tr><td style="width:1.0%"/><td style="width:81.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock of ARYA outstanding prior to the Business Combination</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,186,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less redemption of ARYA shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(465,363)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock of ARYA</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,721,137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued in PIPE Financing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business Combination and PIPE Financing shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,721,137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legacy Nautilus shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,324,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shares of Common Stock immediately after the Business Combination</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,045,255&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_ReverseRecapitalizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_ReverseRecapitalizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_ReverseRecapitalizationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization Disclosure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_ReverseRecapitalizationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627297532096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table details the assets carried at fair value and measured on a recurring basis within the three levels of fair value as of June&#160;30, 2022 and December&#160;31, 2021:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.797%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.797%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.797%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.797%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.282%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term investments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,226&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,998&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,821&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,976&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,201&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,957&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(219)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294,438&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(561)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,898&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,533&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,008&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 1 and Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335,664&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(807)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334,896&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,354&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,984&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,558&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:22.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.814%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.407%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.407%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.814%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.814%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.814%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.141%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term investments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,081&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,061&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,925&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,136&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301,906&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,039&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,694&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,974&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,371&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 1 and Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362,284&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362,100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185,619&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,110&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,371&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual maturities of short-term investments as of June&#160;30, 2022 and December&#160;31, 2021 are due in one year or less. Contractual maturities of long-term investments as of June&#160;30, 2022 and December&#160;31, 2021 are due </span></div>after 1 year through 2 years.  There were no continuous unrealized loss positions in excess of twelve months as of June 30, 2022 and December 31, 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627297553792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Composition of Certain Condensed Consolidated Financial Statement Line Items<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Composition of Certain Condensed Consolidated Financial Statement Line Items</a></td>
<td class="text">Composition of Certain Condensed Consolidated Financial Statement Line Items<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Property and Equipment, Net </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,460&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,032&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and office equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,958&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,477&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,556)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,994)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,402&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,483&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded depreciation expense of $0.3 million and $0.6 million for the three and six months ended June 30, 2022 and $0.3 million and $0.5 million for the three and six months ended June 30, 2021, respectively, which was primarily allocated to research and development expense. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Long Term Assets </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long term assets consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Deposits</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accrued Expenses and Other Liabilities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other liabilities consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional and consulting fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued facilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,108&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,119&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash, Cash Equivalents and Restricted Cash</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,354&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185,619&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other long term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,196&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,461&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI https://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627218127824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_DisclosureOfRedeemableConvertiblePreferredStockTextBlock', window );">Redeemable Convertible Preferred Stock</a></td>
<td class="text">Redeemable Convertible Preferred Stock On June 9, 2021, upon the closing of the Business Combination (as defined in Note 1 and further described in Note 3), all of the outstanding redeemable convertible preferred stock was converted to New Nautilus Common Stock pursuant to the Exchange Ratio effective immediately prior to the Business Combination and the remaining amount was reclassified to additional paid-in capital. As of June&#160;30, 2022 the Company had no issued and outstanding Preferred Stock shares.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_DisclosureOfRedeemableConvertiblePreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of Redeemable Convertible Preferred Stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_DisclosureOfRedeemableConvertiblePreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627217868576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Common Stock</a></td>
<td class="text">Common Stock<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 9, 2021, the Business Combination (as defined in Note 1 and further described in Note 3) was consummated and the Company issued 38,721,137 shares for an aggregate purchase price of $327.3&#160;million, net of issuance costs of $8.1&#160;million. Immediately following the Business Combination, there were 124,045,255 shares of Common Stock outstanding. The holder of each share of Common Stock is entitled to one vote.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has retroactively adjusted the shares issued and outstanding prior to June 9, 2021 to give effect to the exchange ratio established in the Business Combination Agreement to determine the number of shares of Common Stock into which they were converted. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, pursuant to the Business Combination, the Company amended its certificate of incorporation to increase the number of authorized common stock shares to 1,000,000,000 shares. There were 124,562,745 shares issued and outstanding as of June&#160;30, 2022.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock Reserved for Future Issuance</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of common stock reserved for future issuance on an as-if converted basis, were as follows:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options issued and outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,650,794&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,550,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for grant under 2021 Equity Incentive Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,384,590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,481,463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for grant under 2021 Employee Stock Purchase Plan</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,439,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,244,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shares of common stock reserved</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,474,961&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,276,439&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627218043808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes The Company accounts for income taxes under the asset and liability method. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be realized. For the three and six months ended June 30, 2022 and 2021, no income tax expense or benefit was recognized, primarily due to a full valuation allowance recorded against its deferred tax asset.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627217963504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plan and Stock-based Compensation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock Option Plan and Stock-based Compensation</a></td>
<td class="text">Stock Option Plan and Stock-based Compensation<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 8, 2021, the stockholders of the Company approved the 2021 Equity Incentive Plan (&#8220;2021 Plan&#8221;) and the 2021 Employee Stock Purchase Plan (</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;2021 ESPP&#8221;). As of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June&#160;30, 2022, 17,384,590 and 2,439,577 shares were available for grant under the 2021 Plan and 2021 ESPP, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Employee Stock Purchase Plan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2021 ESPP, the Company can grant stock options to employees to purchase shares of Common Stock at a purchase price which equal to 85% of the fair market value of common stock on the enrollment date or on the exercise date, whichever is lower. Participants are permitted to purchase shares of the Company&#8217;s Common Stock at 85% of the lower of the fair market value of the Company&#8217;s Common Stock on the first trading day of an offering period or on the last trading date in each purchase period. Participants may end their participation at any time during an offering and will be paid their accrued contributions that have not yet been used to purchase shares. Participation ends automatically upon termination of employment with the Company. The number of shares of common stock available for issuance under the 2021 ESPP will be increased on the first day of each fiscal year beginning on January 1, 2022, in an amount equal to the least of (i) 3,734,500 shares of common stock, (ii) a number of s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hares of common stock equal to one percent (1%) of the total number of shares of all classes of common stock of the Company on the last day of the immediately preceding fiscal year, or (iii) such number of shares determined by the Administrator no later than the last day of the immediately preceding fiscal year. On January 1, 2022, the number of shares available under the ESPP increased by 1,243,030 shares pursuant to this feature.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The first offering period was from October 1, 2021 through June 1, 2022. For subsequent offering periods, the Company will be offering a six month purchase period. As of June&#160;30, 2022, 48,353 shares of common stock were purchased under the 2021 ESPP.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Equity Incentive Plan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2021 Plan, the Company can grant incentive stock options, nonstatutory stock options, stock appreciation rig</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hts, restricted stock, restricted stock units and performance awards to employees, directors and consultants. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options generally expire ten years after the date of grant. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares available for issuance under the 2021 Plan will be increased on the first day of each fiscal year, beginning on January 1, 2022, in an amount equal to the least of (i) 18,672,200 shares, (ii) a number of shares equal to five percent (5%) of the total number of shares of all classes of common stock of the Company outstanding on the last day of the immediately preceding fiscal year, or (iii) such number of shares determined by the Administrator no later than the last day of the immediately preceding fiscal year</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On January 1, 2022, the number of shares available under the 2021 Plan increased by 6,215,154 shares pursuant to this feature.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2017 Equity Incentive Plan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the time of adoption of the 2021 Plan and the 2021 ESPP, no further awards will be granted under the 2017 Equity Incentive Plan (&#8220;2017 Plan&#8221;) and 7,106,767 shares of common stock were initially reserved for outstanding awards issued under the 2017 Plan.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the compensation cost of the option awards, the fair value for each option award has been estimated using the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Black Scholes model</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The significant assumptions used in these calculations are summarized as follows:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"/><td style="width:27.121%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.355%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.452%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.355%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.452%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.355%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.452%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.358%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 - 6.1</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 - 6.1</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 - 6.1</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 - 6.6</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.2% - 109.1%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.0% - 93.7%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.2% - 110.0%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.0% - 94.2%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80% - 3.36%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.91% - 1.02%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.73% - 3.36%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.53% - 1.02%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.70 - $4.72</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.10 - $11.16</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.70 - $4.72</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7.56 - $11.16</span></div></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected term: The expected term of stock options represents the weighted-average period the stock options are expected to remain outstanding. The Company does not have sufficient historical exercise and post-vesting termination activity to provide accurate data for estimating the expected term of options and has opted to use the &#8220;simplified method,&#8221; whereby the expected term equals the arithmetic average of the vesting term and the original contractual term of the option.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility: Historically, the Company has been a private company and lacked company&#8209;specific historical and implied volatility information for its common stock. Therefore, the expected volatility of the Company&#8217;s common stock was determined by using an average of historical volatilities of selected industry peers deemed to be comparable to the Company&#8217;s business corresponding to the expected term of the awards and the Company expects to continue to do so until such time as the Company has adequate historical data regarding the volatility of its traded common stock price.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected dividend yield: The expected dividend rate is zero as the Company has no history or expectation of declaring dividends on its common stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero-coupon U.S. Treasury notes with maturities corresponding to the expected term of the awards. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value of common stock: Prior to the Business Combination, the fair value of the shares of common stock underlying the stock options has historically been determined by the Company&#8217;s Board of Directors. Because there has been no public market for the common stock, the Board of Directors has determined the fair value of the common stock at the time of grant of the option by contemporaneous valuations performed by an unrelated third-party valuation firm as well as a number of objective and subjective factors including valuation of comparable companies, sales of convertible preferred stock to unrelated third parties, operating and financial performance, the implied equity value of the Company as contemplated by the Business Combination, the lack of liquidity of capital stock and general and industry specific economic outlook, among other factors. The fair value of common stock was determined in accordance with applicable elements of the American Institute of Certified Public Accountants Practice Aid, Valuation of Privately-Held-Company Equity Securities Issued as Compensation. Subsequent to the completion of the Business Combination (as defined in Note 1 and further described in Note 3) the fair value of the Company&#8217;s common stock is determined based on its closing market price.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The awards granted in late January 2021 had an exercise price equal to the grant date fair value of the Company&#8217;s common stock. The Company&#8217;s board of directors made a determination of the fair market value of the Company&#8217;s common stock which contemplated the implied equity value of the Company per the Business Combination Agreement that was executed on February 7, 2021. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes option award activity during the six months ended June 30, 2022:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Stock Option Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Life (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,550,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,037,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211,309)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(725,836)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of June&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,650,794&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest as of June&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,650,794&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and exercisable at June&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,279,223&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,474&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, there was $31.0 million of total unrecognized compensation expense expected to be recognized over a weighted average-period of 2.94 years. Aggregate intrinsic value represents the difference between the fair market value of the common stock and the exercise price of outstanding, in-the-money options. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based Compensation Expense</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth the total stock-based compensation expense for the Company&#8217;s stock options included in the Company&#8217;s condensed consolidated statement of operations:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"/><td style="width:42.037%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.629%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,567&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,677&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,156&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627217988880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies <div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Commitments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Open purchase commitments are for the purchase of goods and services related to, but not limited to, research and development, facilities, and professional services under non-cancellable contracts. They were not recorded as liabilities on the condensed consolidated balance sheet as of June&#160;30, 2022 as the Company had not yet received the related goods or services. As of June&#160;30, 2022, the Company had open purchase commitments for goods and services of $2.0 million, which are expected to be received through the next 12 months.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may become involved in litigation relating to claims arising from the ordinary course of business. Management believes that there are currently no claims or actions pending against the Company where the ultimate disposition could have a material adverse effect on the Company&#8217;s results of operations, financial condition or cash flows. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is obligated under certain non-cancellable operating leases for office space and laboratory space. This space includes operating leases in Seattle, Washington, and San Carlos, California.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Seattle Leases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating lease in Seattle, Washington expired in April 2021 and continued to be renewed month to month until August 2021. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company entered into a 7-year non-cancellable operating lease, which commenced in August 2021, for an additional office space in Seattle, Washington. Total non-cancellable payments under this lease aggregate $4.5&#160;million through June 2028. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">San Carlos Leases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company amended its existing facility lease contract in San Carlos, California which was executed to shorten the remaining term of the lease to expire in December 2021 and reduce monthly lease payments and was accounted for as a modification. The impact of this modification reduced the operating lease right-of-use asset and lease liability balance as a $3.3&#160;million non-cash adjustment. In September 2021, the Company further amended the facility lease contract in San Carlos, California to shorten the remaining term of the lease to expire in October 2021 and was also accounted for as a modification.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company entered into a new lease in San Carlos, California for ten years which commenced in October 2021 and expiring in October 2031 with total minimum lease payments of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$40.7 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company also entered into a temporary office space lease agreement in San Carlos, California which commenced in February 2021 and expired in October 2021 with total minimum lease payments of </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.2 million. The temporary office space lease agreement was recognized as a short-term lease due to the election of the short-term lease measurement and recognition exemption.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company entered into another lease in San Carlos, California for nine years expected to commence in December 2022 and expiring in October 2031. The Company can terminate this lease after five years from commencement date without bearing any significant termination penalties and therefore the Company concluded that the lease term is five years with total minimum lease payments of $7.2&#160;million. The Company may borrow funds from the landlord of up to $2.0&#160;million with an interest rate of 7% to finance its tenant improvements. No amounts have been borrowed as of June 30, 2022.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease costs, which were included in operating expenses in condensed consolidated statements of operations, were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"/><td style="width:42.037%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.629%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed operating lease costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable operating lease costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,568&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,194&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,502&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June 30, 2022 and 2021, cash paid for amounts included in the measurement of operating lease liabilities included in cash flows used in operating activities was $1.7 million and $0.8 million, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the weighted-average remaining lease term and weighted-average discount rate for operating leases is 9.0 years and 8.9% respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's future principal contractual obligations for operating lease commitments as of June&#160;30, 2022:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease Obligations</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six months ending December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,812&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,689)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,612&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees and Indemnifications</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, the Company enters into agreements that may include indemnification provisions. Pursuant to such agreements, the Company may indemnify, hold harmless and defend an indemnified party for losses suffered or incurred by the indemnified party. Some of the provisions will limit losses to those arising from third-party actions. In some cases, the indemnifications will continue after the termination of the agreement. The maximum potential amount of future payments the Company could be required to make under these provisions is not determinable. The Company has never incurred material costs to defend lawsuits or settle claims related to these indemnification provisions. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has also agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines and settlement amounts incurred by them in any action or proceeding to which any of them are, or are threatened to be, made a party by reason of their service as a director or officer. The Company maintains director and officer insurance coverage that would generally enable it to recover a portion of any future amounts paid. The Company may be subject to indemnification obligation by law with respect to the actions of its employees under certain circumstances and in certain jurisdictions. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Letter of Credit</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the San Carlos lease agreement entered in December 2020, the Company issued a cash-collateralized letter of credit in lieu of security deposit of $0.6 million. In conjunction with the San Carlos lease agreement entered in December 2021, the Company amended the existing cash-collateralized letter of credit and increased the amount to $0.8&#160;million. The cash amount is recorded as restricted cash under Other long-term assets on the Company&#8217;s condensed consolidated balance sheets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies <div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Commitments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Open purchase commitments are for the purchase of goods and services related to, but not limited to, research and development, facilities, and professional services under non-cancellable contracts. They were not recorded as liabilities on the condensed consolidated balance sheet as of June&#160;30, 2022 as the Company had not yet received the related goods or services. As of June&#160;30, 2022, the Company had open purchase commitments for goods and services of $2.0 million, which are expected to be received through the next 12 months.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company may become involved in litigation relating to claims arising from the ordinary course of business. Management believes that there are currently no claims or actions pending against the Company where the ultimate disposition could have a material adverse effect on the Company&#8217;s results of operations, financial condition or cash flows. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is obligated under certain non-cancellable operating leases for office space and laboratory space. This space includes operating leases in Seattle, Washington, and San Carlos, California.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Seattle Leases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operating lease in Seattle, Washington expired in April 2021 and continued to be renewed month to month until August 2021. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company entered into a 7-year non-cancellable operating lease, which commenced in August 2021, for an additional office space in Seattle, Washington. Total non-cancellable payments under this lease aggregate $4.5&#160;million through June 2028. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">San Carlos Leases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, the Company amended its existing facility lease contract in San Carlos, California which was executed to shorten the remaining term of the lease to expire in December 2021 and reduce monthly lease payments and was accounted for as a modification. The impact of this modification reduced the operating lease right-of-use asset and lease liability balance as a $3.3&#160;million non-cash adjustment. In September 2021, the Company further amended the facility lease contract in San Carlos, California to shorten the remaining term of the lease to expire in October 2021 and was also accounted for as a modification.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company entered into a new lease in San Carlos, California for ten years which commenced in October 2021 and expiring in October 2031 with total minimum lease payments of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$40.7 million</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company also entered into a temporary office space lease agreement in San Carlos, California which commenced in February 2021 and expired in October 2021 with total minimum lease payments of </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.2 million. The temporary office space lease agreement was recognized as a short-term lease due to the election of the short-term lease measurement and recognition exemption.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company entered into another lease in San Carlos, California for nine years expected to commence in December 2022 and expiring in October 2031. The Company can terminate this lease after five years from commencement date without bearing any significant termination penalties and therefore the Company concluded that the lease term is five years with total minimum lease payments of $7.2&#160;million. The Company may borrow funds from the landlord of up to $2.0&#160;million with an interest rate of 7% to finance its tenant improvements. No amounts have been borrowed as of June 30, 2022.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease costs, which were included in operating expenses in condensed consolidated statements of operations, were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"/><td style="width:42.037%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.629%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed operating lease costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable operating lease costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,568&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,194&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,502&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June 30, 2022 and 2021, cash paid for amounts included in the measurement of operating lease liabilities included in cash flows used in operating activities was $1.7 million and $0.8 million, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2022, the weighted-average remaining lease term and weighted-average discount rate for operating leases is 9.0 years and 8.9% respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's future principal contractual obligations for operating lease commitments as of June&#160;30, 2022:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease Obligations</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six months ending December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,812&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,689)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,612&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees and Indemnifications</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, the Company enters into agreements that may include indemnification provisions. Pursuant to such agreements, the Company may indemnify, hold harmless and defend an indemnified party for losses suffered or incurred by the indemnified party. Some of the provisions will limit losses to those arising from third-party actions. In some cases, the indemnifications will continue after the termination of the agreement. The maximum potential amount of future payments the Company could be required to make under these provisions is not determinable. The Company has never incurred material costs to defend lawsuits or settle claims related to these indemnification provisions. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has also agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines and settlement amounts incurred by them in any action or proceeding to which any of them are, or are threatened to be, made a party by reason of their service as a director or officer. The Company maintains director and officer insurance coverage that would generally enable it to recover a portion of any future amounts paid. The Company may be subject to indemnification obligation by law with respect to the actions of its employees under certain circumstances and in certain jurisdictions. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Letter of Credit</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the San Carlos lease agreement entered in December 2020, the Company issued a cash-collateralized letter of credit in lieu of security deposit of $0.6 million. In conjunction with the San Carlos lease agreement entered in December 2021, the Company amended the existing cash-collateralized letter of credit and increased the amount to $0.8&#160;million. The cash amount is recorded as restricted cash under Other long-term assets on the Company&#8217;s condensed consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627217978896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basic and Diluted Net Loss per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Basic and Diluted Net Loss per Share</a></td>
<td class="text">Basic and Diluted Net Loss per Share<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common stockholders for the three and six months ended June 30, 2022 and 2021:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"/><td style="width:42.037%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.629%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except share and per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,689)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,713)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,452)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,494,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,070,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,456,518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,130,773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Less: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average unvested restricted shares and shares subject to repurchase</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,624)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares used in computing net loss per share attributable to common stockholders, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,494,036&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,070,480&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,456,518&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,096,149&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share attributable to common stockholders, basic and diluted:</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.12)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.19)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.24)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.43)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the Business Combination, the Company has retroactively adjusted the weighted-average number of shares of Common Stock outstanding prior to the Closing Date by multiplying them by the Exchange Ratio of 3.6281 used to determine the number of shares of New Nautilus Common Stock into which they converted (as described in Note 3). The Common Stock issued as a result of the redeemable convertible preferred stock conversion on the Closing Date was included in the basic net loss per share calculation on a prospective basis.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have had an antidilutive effect were as follows:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.993%"><tr><td style="width:1.0%"/><td style="width:70.185%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.923%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.925%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three and Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,650,794</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,014,879</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,411</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total potentially dilutive common share equivalents</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,712,205</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,014,879</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627215467952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">The condensed consolidated financial statements and accompanying notes are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and regulations of the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) for interim financial reporting. All intercompany transactions and balances have been eliminated upon consolidation. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated financial statements were prepared on the same basis as the audited financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments necessary for a fair statement of the Company&#8217;s financial position as of June&#160;30, 2022, the results of its operations for the three and six months ended June 30, 2022 and 2021 and its cash flows for the six months ended June 30, 2022 and 2021. The results of operations for the three and six months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022. These financial statements and accompanying notes should be read in conjunction with the consolidated financial statements and notes thereto in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 on file with the SEC. The Company&#8217;s reporting currency is the U.S. dollar.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the condensed consolidated financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include determining the estimated lives of property and equipment, stock-based compensation including the estimated fair value per share of common stock prior to the date the Company became public, research and development accruals, and the valuation allowance for deferred tax assets. These estimates and assumptions are based on management&#8217;s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk and Other Risks and Uncertainties</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit risk represents the accounting loss that would be recognized as of the reporting date if counterparties failed completely to perform as contracted. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentration of credit risk, consist of cash balances maintained in excess of federal depository insurance limits and investments in U.S. Treasury securities that are not federally insured. The Company has not experienced any losses in such accounts and believes it is not exposed to significant credit risk on cash or investments. The Company relies, and expects to continue to rely, on a number of vendors to provide services, supplies and materials related to its research and development programs. The Company relies on single source suppliers for certain components and materials used in the Nautilus platform. The loss of any of these single source suppliers would require the Company to expend significant time and effort to locate and qualify an alternative source of supply for these components. The Company also relies, and expects to continue to rely, on third-party manufacturers and, in many cases, single third-party manufacturers for the production of certain reagents and antibodies. These programs could be adversely affected by a significant interruption in these services or the availability of materials.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to risks similar to those of</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> other&#160;pre-clinical&#160;stage companies in the biopharmaceutical industry, including dependence on key individuals, the need to develop commercially viable products, competition from other companies, many of whom are larger and better capitalized, the impact of the COVID-19 pandemic and the need to obtain adequate additional financing to fund the development of its products. There can be no assurance that the Company&#8217;s research and development will be successfully completed, that adequate protection for the Company&#8217;s intellectual property will be maintained, that any products developed will obtain required regulatory approval or that any approved products will be commercially viable. Even if the Company&#8217;s development efforts are successful, it is uncertain when, if ever, the Company will generate significant revenue from the sale of its products.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision m</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">arket (&#8220;CODM&#8221;) in deciding how to allocate resources and in assessing performance. The Company&#8217;s Chief Executive Officer is its CODM. The Company&#8217;s CODM re</span>views financial information presented on a consolidated basis for the purposes of making operating decisions, allocating resources and evaluating financial performance. As such, the Company has determined that it operates in one operating and one reportable segment. The Company&#8217;s long-lived assets are entirely based in the United States.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">The Company considers all highly-liquid investments with an original maturity of three months or less as of the date of acquisition to be cash equivalents.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers investments with an original maturity greater than three months and remaining maturities less than one year to be short-term investments. The Company classifies those investments that are not required for use in current operations and that mature in more than 12 months as long-term investments. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its investments as available for sale and reports them at fair value, with unrealized gains and losses recorded in accumulated other comprehensive income (loss). For investments sold prior to maturity, the cost of investments sold is based on the specific identification method. Realized gains and losses on the sale of investments are recorded in other income (expense), net in the condensed consolidated statement of operations. </span></div>Other-than-temporary ImpairmentThe Company evaluates its investments with unrealized losses for other-than-temporary impairment. When assessing investments for other-than-temporary declines in value, the Company considers factors such as, among other things, the extent and length of time the investment&#8217;s fair value has been lower than its cost basis, the financial condition and near-term prospects of the investment, the Company&#8217;s ability and intent to retain the investment for a period of time sufficient to allow for any anticipated recovery in fair value, and the expected cash flows from the security. If any adjustments to fair value reflects a decline in the value of the investment that the Company considers to be &#8220;other than temporary,&#8221; the Company reduces the investment to fair value through a charge to the condensed consolidated statement of operations and condensed consolidated statement of comprehensive loss. No such adjustments were necessary during the periods presented.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of cash and cash equivalents, prepaid expenses and other current assets, accounts payable and accrued expenses and other liabilities approximate their respective fair values due to their short-term nature.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement includes a lease at inception by assessing whether there is an identified asset and whether the contract conveys the right to control the use of the identified asset for a period of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">time in exchange for consideration. Operating leases with a term of more than one year are included in operating lease right-of-use (&#8220;ROU&#8221;) assets and operating lease liabilities on the Company's condensed consolidated balance sheets. ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments. Operating lease ROU assets and liabilities are recognized on the lease commencement date based on the present value of the future minimum lease payments over the lease term. The Company uses the incremental borrowing rate commensurate with the lease term based on the information available at the lease commencement date in determining the present value of the lease payments as the Company's leases generally do not provide an implicit rate. ROU assets initially equal the lease liability, adjusted for any prepaid lease payments and initial direct costs incurred, less any lease incentives received. Certain of the Company's leases include renewal options which allow the Company to, at its election, renew or extend the lease for a fixed or indefinite period of time. These renewal periods are included in the lease terms when the Company is reasonably certain the options will be exercised. Lease expense is recognized on a straight-line basis over the lease term when leases are operating leases. If it is considered a finance lease, expense is recognized over the lease term within </span>interest expense and amortization in the Company&#8217;s condensed consolidated statements of operations. The Company also has lease arrangements with lease and non-lease components. The Company elected the practical expedient not to separate non-lease components from lease components for the Company's facility leases and to account for the lease and non-lease components as a single lease component. The Company also elected to apply the short-term lease measurement and recognition exemption in which ROU assets and lease liabilities are not recognized for leases with terms of 12 months or less.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Loss</a></td>
<td class="text">Comprehensive loss consists of net loss and other gains or losses affecting stockholders&#8217; equity that, under U.S. GAAP are excluded from net loss. For the three and six months ended June 30, 2022 and 2021, unrealized losses on debt securities were included as components of comprehensive loss.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is provided the option to adopt new or revised accounting guidance as an &#8220;emerging growth company&#8221; under the Jumpstart Our Business Startups Act of 2012 (the &#8220;JOBS Act&#8221;) either (1) within the same periods as those </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">otherwise applicable to public business entities, or (2) within the same time periods as non-public business entities, including early adoption when permissible. With the exception of standards the Company elected to early adopt, when permissible, the Company has elected to adopt new or revised accounting guidance within the same time period as non-public business entities, as indicated below. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Reference Rate Reform (Topic 848).&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The amendments in ASU 2020-04 provide optional expedients and exceptions for ap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">plying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this ASU are effective for all entities as of March 12, 2020 through December 31, 2022. An entity may elect to apply the amendments for contract modifications by Topic or Industry Subtopic as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or prospectively from the date that the financial statements are available to be issued. Once elected for a Topic or an Industry Subtopic, the amendments must be applied prospectively for all eligible contract modifications for that Topic or Industry Subtopic. The Company adopted this guidance effective January 1, 2022 using the prospective method, which did not have a material impact on the Company&#8217;s condensed consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Financial Instruments- Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, which amends existing guidance on the impairment of financial assets and adds an impairment model that is based on expected losses rather than incurred losses and requires an entity to recognize as an allowance its estimate of expected credit losses for its financial assets. An entity will apply this guidance through a cumulative-effect adjustment to retained earnings upon adoption (a modified-retrospective approach) while a prospective transition approach is required for debt securities for which an other-than-temporary impairment had been recognized before the effective date. This ASU is effective for the Company for its fiscal year ending December 31, 2023. Early adoption is permitted. The Company is in the process of evaluating the impact of the adoption of this ASU on its condensed consolidated financial statements and related disclosures. The Company does not anticipate adoption to have a material impact on its condensed consolidated financial statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December&#160;2019, the FASB issued ASU No. 2019-12, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&#8221;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as the elimination of exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, the recognition of deferred tax liabilities for outside basis differences, ownership changes in investments, and tax basis step-up&#160;in goodwill obtained in a transaction that is not a business combination. This ASU is effective for the Company for its fiscal year ending December&#160;31, 2022. Early adoption is permitted. The Company is in the process of evaluating the impact of the </span></div>adoption of this ASU on its condensed consolidated financial statements and related disclosures. The Company does not anticipate adoption to have a material impact on its condensed consolidated financial statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627217914512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reverse Recapitalization (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_ReverseRecapitalizationAbstract', window );"><strong>Reverse Recapitalization [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_ScheduleOfReverseRecapitalizationTableTextBlock', window );">Schedule of Reverse Recapitalization</a></td>
<td class="text">The number of shares of Common Stock issued immediately following the consummation of the Business Combination was:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.070%"><tr><td style="width:1.0%"/><td style="width:81.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock of ARYA outstanding prior to the Business Combination</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,186,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less redemption of ARYA shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(465,363)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock of ARYA</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,721,137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued in PIPE Financing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business Combination and PIPE Financing shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,721,137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Legacy Nautilus shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,324,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shares of Common Stock immediately after the Business Combination</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,045,255&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_ReverseRecapitalizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_ReverseRecapitalizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_ScheduleOfReverseRecapitalizationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Reverse Recapitalization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_ScheduleOfReverseRecapitalizationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627220429424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of Assets Carried at Fair Value and Measured on a Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table details the assets carried at fair value and measured on a recurring basis within the three levels of fair value as of June&#160;30, 2022 and December&#160;31, 2021:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.797%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.797%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.797%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.797%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.282%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term investments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,405&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,177&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,226&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,998&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,821&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,976&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,201&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(207)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,957&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(219)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294,438&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(561)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293,898&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,533&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,008&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 1 and Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335,664&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(807)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334,896&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,354&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,984&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,558&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:22.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.814%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.407%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.407%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.814%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.814%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.814%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.141%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reported as:</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Short-term investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Long-term investments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mutual funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,081&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,061&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,925&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,136&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301,906&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,299&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agency bonds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325,039&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,694&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,974&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,371&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Level 1 and Level 2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362,284&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(186)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362,100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185,619&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,110&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,371&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627210864624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Composition of Certain Condensed Consolidated Financial Statement Line Items (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment consisted of the following:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,460&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,032&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and office equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,958&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,477&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,556)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,994)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,402&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,483&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock', window );">Schedule of Other Long Term Assets</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long term assets consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Deposits</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">997&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other liabilities consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional and consulting fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued facilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,108&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,119&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Schedule of Other Liabilities</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other liabilities consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,465&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional and consulting fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued facilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,108&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,119&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,354&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185,619&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other long term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,196&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,461&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">Schedule of Restricted Cash</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210,354&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185,619&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other long term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,196&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186,461&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627219519904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock', window );">Schedule of Common Stock Reserved for Future Issuance</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of common stock reserved for future issuance on an as-if converted basis, were as follows:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options issued and outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,650,794&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,550,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for grant under 2021 Equity Incentive Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,384,590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,481,463&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for grant under 2021 Employee Stock Purchase Plan</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,439,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,244,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shares of common stock reserved</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,474,961&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,276,439&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Common Stock Reserved For Future Issuance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627220477344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plan and Stock-based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Significant Assumptions</a></td>
<td class="text">The significant assumptions used in these calculations are summarized as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"><tr><td style="width:1.0%"/><td style="width:27.121%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.355%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.452%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.355%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.452%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.355%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.452%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.358%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 - 6.1</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6 - 6.1</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3 - 6.1</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5 - 6.6</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.2% - 109.1%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.0% - 93.7%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.2% - 110.0%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.0% - 94.2%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.80% - 3.36%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.91% - 1.02%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.73% - 3.36%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.53% - 1.02%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock price</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.70 - $4.72</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.10 - $11.16</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.70 - $4.72</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$7.56 - $11.16</span></div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes option award activity during the six months ended June 30, 2022:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Stock Option Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Life (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,550,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,037,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211,309)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(725,836)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of June&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,650,794&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and expected to vest as of June&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,650,794&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and exercisable at June&#160;30, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,279,223&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,474&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock Based Compensation Expense</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth the total stock-based compensation expense for the Company&#8217;s stock options included in the Company&#8217;s condensed consolidated statement of operations:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"/><td style="width:42.037%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.629%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,567&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,677&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,156&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627221401200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of Lease Cost</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease costs, which were included in operating expenses in condensed consolidated statements of operations, were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"/><td style="width:42.037%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.629%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed operating lease costs</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,182&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">362&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable operating lease costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease costs</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,568&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">812&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,194&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,502&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Summary of Future Principal Contractual Obligations for Operating Lease Commitments</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the Company's future principal contractual obligations for operating lease commitments as of June&#160;30, 2022:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lease Obligations</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Six months ending December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,812&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,569&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027 and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,689)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,612&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627212795952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basic and Diluted Net Loss per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth the computation of the Company&#8217;s basic and diluted net loss per share attributable to common stockholders for the three and six months ended June 30, 2022 and 2021:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"/><td style="width:42.037%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.453%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.629%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except share and per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,689)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,713)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,452)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,122)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,494,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,070,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,456,518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,130,773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Less: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average unvested restricted shares and shares subject to repurchase</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,624)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares used in computing net loss per share attributable to common stockholders, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,494,036&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,070,480&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,456,518&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,096,149&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share attributable to common stockholders, basic and diluted:</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.12)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.19)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.24)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.43)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Potential Shares of Common Stock Excluded from the Computation of Diluted Net Loss Per Share</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have had an antidilutive effect were as follows:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.993%"><tr><td style="width:1.0%"/><td style="width:70.185%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.923%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.925%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three and Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common stock</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,650,794</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,014,879</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,411</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total potentially dilutive common share equivalents</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,712,205</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,014,879</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627215051936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Business and Basis of Presentation (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 09, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111,092,000<span></span>
</td>
<td class="nump">$ 80,640,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction', window );">Proceeds from sale of stock and reverse recapitalization transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 345,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_PaymentsOfReverseRecapitalizationTransactionCosts', window );">Payments of transaction costs</a></td>
<td class="nump">$ 8,100,000<span></span>
</td>
<td class="nump">$ 18,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Cash, cash equivalents, and short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 299,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued in transaction (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (in dollars per share)</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Consideration received on transaction</a></td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_PaymentsOfReverseRecapitalizationTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments of Reverse Recapitalization Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_PaymentsOfReverseRecapitalizationTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Sale Of Stock And Reverse Recapitalization Transaction</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627217977584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2022 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627216562240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Reverse Recapitalization - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 09, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 08, 2021 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_ScheduleOfReverseRecapitalizationLineItems', window );"><strong>Schedule Of Reverse Recapitalization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_StockConvertedValueReverseRecapitalization', window );">Stock converted, value, reverse recapitalization</a></td>
<td class="nump">$ 900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_RecapitalizationExchangeRatioPerShare', window );">Recapitalization exchange ratio, per share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_RecapitalizationExchangeRatio', window );">Recapitalization exchange ratio</a></td>
<td class="nump">3.6281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.6281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares) | shares</a></td>
<td class="nump">124,045,255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,562,745<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,303,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_StockConvertedReverseRecapitalization', window );">Stock converted, reverse recapitalization (in shares) | shares</a></td>
<td class="nump">85,324,118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityFairValueDisclosure', window );">Equity value</a></td>
<td class="nump">$ 900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options issued and outstanding (in shares) | shares</a></td>
<td class="nump">7,106,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,650,794<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,550,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_ProceedsFromReverseRecapitalizationTransaction', window );">Net proceeds from reverse recapitalization and PIPE financing</a></td>
<td class="nump">$ 335,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 335,409,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_CashAcquiredThroughReverseRecapitalization', window );">Cash acquired through reverse recapitalization</a></td>
<td class="nump">135,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_ReverseRecapitalizationCashPaidToShareholders', window );">Reverse recapitalization, cash paid to shareholders</a></td>
<td class="nump">10,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Gross proceeds from private placement</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_PaymentsOfReverseRecapitalizationTransactionCosts', window );">Payments of transaction costs</a></td>
<td class="nump">$ 8,100,000<span></span>
</td>
<td class="nump">$ 18,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_ScheduleOfReverseRecapitalizationLineItems', window );"><strong>Schedule Of Reverse Recapitalization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued in transaction (in shares) | shares</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Consideration received on transaction</a></td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=naut_AryaSciencesAcquisitionCorpIIIMember', window );">Arya Sciences Acquisition Corp III</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_ScheduleOfReverseRecapitalizationLineItems', window );"><strong>Schedule Of Reverse Recapitalization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares) | shares</a></td>
<td class="nump">18,721,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,186,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_ScheduleOfReverseRecapitalizationLineItems', window );"><strong>Schedule Of Reverse Recapitalization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_StockConvertedValueReverseRecapitalization', window );">Stock converted, value, reverse recapitalization</a></td>
<td class="nump">$ 24,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_CashAcquiredThroughReverseRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Acquired Through Reverse Recapitalization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_CashAcquiredThroughReverseRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_PaymentsOfReverseRecapitalizationTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments of Reverse Recapitalization Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_PaymentsOfReverseRecapitalizationTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_ProceedsFromReverseRecapitalizationTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Reverse Recapitalization Transaction</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_ProceedsFromReverseRecapitalizationTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_RecapitalizationExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recapitalization Exchange Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_RecapitalizationExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_RecapitalizationExchangeRatioPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recapitalization Exchange Ratio, Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_RecapitalizationExchangeRatioPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_ReverseRecapitalizationCashPaidToShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization, Cash Paid To Shareholders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_ReverseRecapitalizationCashPaidToShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_ScheduleOfReverseRecapitalizationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Reverse Recapitalization [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_ScheduleOfReverseRecapitalizationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_StockConvertedReverseRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Converted, Reverse Recapitalization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_StockConvertedReverseRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_StockConvertedValueReverseRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Converted, Value, Reverse Recapitalization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_StockConvertedValueReverseRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the entity's equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=naut_AryaSciencesAcquisitionCorpIIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=naut_AryaSciencesAcquisitionCorpIIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627215347136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Reverse Recapitalization - Shares Reconciliation (Details) - shares<br></strong></div></th>
<th class="th"><div>Jun. 09, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 08, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_ScheduleOfReverseRecapitalizationLineItems', window );"><strong>Schedule Of Reverse Recapitalization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">124,045,255<span></span>
</td>
<td class="nump">124,562,745<span></span>
</td>
<td class="nump">124,303,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Common Stock of Arya (in shares)</a></td>
<td class="nump">18,721,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued in PIPE Financing (in shares)</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_StockIssuedDuringPeriodSharesReverseRecapitalization', window );">Business Combination and PIPE Financing shares (in shares)</a></td>
<td class="nump">38,721,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_StockConvertedReverseRecapitalization', window );">Legacy Nautilus shares (in shares)</a></td>
<td class="nump">85,324,118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=naut_AryaSciencesAcquisitionCorpIIIMember', window );">Arya Sciences Acquisition Corp III</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_ScheduleOfReverseRecapitalizationLineItems', window );"><strong>Schedule Of Reverse Recapitalization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">18,721,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,186,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Less redemption of Arya shares (in shares)</a></td>
<td class="num">(465,363)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_ScheduleOfReverseRecapitalizationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Reverse Recapitalization [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_ScheduleOfReverseRecapitalizationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_StockConvertedReverseRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Converted, Reverse Recapitalization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_StockConvertedReverseRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_StockIssuedDuringPeriodSharesReverseRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Reverse Recapitalization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_StockIssuedDuringPeriodSharesReverseRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=naut_AryaSciencesAcquisitionCorpIIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=naut_AryaSciencesAcquisitionCorpIIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627211931056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - Fair Value, Recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 335,664<span></span>
</td>
<td class="nump">$ 362,284<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gains</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Losses</a></td>
<td class="num">(807)<span></span>
</td>
<td class="num">(186)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">334,896<span></span>
</td>
<td class="nump">362,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">210,354<span></span>
</td>
<td class="nump">185,619<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">88,984<span></span>
</td>
<td class="nump">160,110<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Long-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">35,558<span></span>
</td>
<td class="nump">16,371<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">41,226<span></span>
</td>
<td class="nump">37,081<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gains</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Losses</a></td>
<td class="num">(246)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">40,998<span></span>
</td>
<td class="nump">37,061<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">1,821<span></span>
</td>
<td class="nump">21,925<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">14,976<span></span>
</td>
<td class="nump">15,136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | Long-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">24,201<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | Mutual funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">1,821<span></span>
</td>
<td class="nump">21,925<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">1,821<span></span>
</td>
<td class="nump">21,925<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | Mutual funds | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">1,821<span></span>
</td>
<td class="nump">21,925<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | Mutual funds | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | Mutual funds | Long-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | U.S. treasury securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">39,405<span></span>
</td>
<td class="nump">15,156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gains</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Losses</a></td>
<td class="num">(246)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">39,177<span></span>
</td>
<td class="nump">15,136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | U.S. treasury securities | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | U.S. treasury securities | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">14,976<span></span>
</td>
<td class="nump">15,136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | U.S. treasury securities | Long-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">24,201<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">294,438<span></span>
</td>
<td class="nump">325,203<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gains</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Losses</a></td>
<td class="num">(561)<span></span>
</td>
<td class="num">(166)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">293,898<span></span>
</td>
<td class="nump">325,039<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">208,533<span></span>
</td>
<td class="nump">163,694<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">74,008<span></span>
</td>
<td class="nump">144,974<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Long-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">11,357<span></span>
</td>
<td class="nump">16,371<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">266,695<span></span>
</td>
<td class="nump">301,906<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Losses</a></td>
<td class="num">(207)<span></span>
</td>
<td class="num">(90)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">266,490<span></span>
</td>
<td class="nump">301,818<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Commercial paper | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">208,533<span></span>
</td>
<td class="nump">163,694<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Commercial paper | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">57,957<span></span>
</td>
<td class="nump">138,124<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Commercial paper | Long-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">7,365<span></span>
</td>
<td class="nump">14,299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Losses</a></td>
<td class="num">(135)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">7,230<span></span>
</td>
<td class="nump">14,263<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Corporate debt securities | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Corporate debt securities | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">7,230<span></span>
</td>
<td class="nump">6,850<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Corporate debt securities | Long-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,413<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Agency bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">20,378<span></span>
</td>
<td class="nump">8,998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gains</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Losses</a></td>
<td class="num">(219)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">20,178<span></span>
</td>
<td class="nump">8,958<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Agency bonds | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Agency bonds | Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">8,821<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Agency bonds | Long-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 11,357<span></span>
</td>
<td class="nump">$ 8,958<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=naut_LongTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=naut_LongTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MutualFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627215509344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Composition of Certain Condensed Consolidated Financial Statement Line Items - Property, Plant and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 5,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,477<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation</a></td>
<td class="num">(2,556)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,556)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,994)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total</a></td>
<td class="nump">3,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">562<span></span>
</td>
<td class="nump">$ 479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=naut_LaboratoryEquipmentMember', window );">Laboratory equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">4,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,032<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer hardware</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">157<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=naut_FurnitureFixturesAndOfficeEquipmentMember', window );">Furniture, fixtures and office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 1,307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 279<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=naut_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=naut_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=naut_FurnitureFixturesAndOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=naut_FurnitureFixturesAndOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627220350080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Composition of Certain Condensed Consolidated Financial Statement Line Items - Other Long-term Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">$ 842<span></span>
</td>
<td class="nump">$ 842<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Deposits</a></td>
<td class="nump">155<span></span>
</td>
<td class="nump">155<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Total</a></td>
<td class="nump">$ 997<span></span>
</td>
<td class="nump">$ 997<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627216185632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Composition of Certain Condensed Consolidated Financial Statement Line Items - Accrued Expenses and Other Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee compensation</a></td>
<td class="nump">$ 1,299<span></span>
</td>
<td class="nump">$ 1,465<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_AccruedResearchAndDevelopment', window );">Accrued research and development</a></td>
<td class="nump">874<span></span>
</td>
<td class="nump">518<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional and consulting fees</a></td>
<td class="nump">539<span></span>
</td>
<td class="nump">411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_AccruedFacilities', window );">Accrued facilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">337<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">396<span></span>
</td>
<td class="nump">388<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 3,108<span></span>
</td>
<td class="nump">$ 3,119<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_AccruedFacilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Facilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_AccruedFacilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Liabilities and Other Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_AccruedResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Research and Development</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_AccruedResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1243-112600<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627216551744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Composition of Certain Condensed Consolidated Financial Statement Line Items - Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 210,354<span></span>
</td>
<td class="nump">$ 185,619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash included in other long term assets</a></td>
<td class="nump">842<span></span>
</td>
<td class="nump">842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total</a></td>
<td class="nump">$ 211,196<span></span>
</td>
<td class="nump">$ 186,461<span></span>
</td>
<td class="nump">$ 288,999<span></span>
</td>
<td class="nump">$ 37,219<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627215010336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock - Narrative (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Temporary Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Redeemable convertible preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Redeemable convertible preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627215686304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 09, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_StockIssuedDuringPeriodSharesReverseRecapitalization', window );">Issuance of common stock upon the reverse recapitalization, net of issuance costs (in shares)</a></td>
<td class="nump">38,721,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_StockIssuedDuringPeriodValueReverseRecapitalization', window );">Issuance of common stock upon the reverse recapitalization, net of issuance costs</a></td>
<td class="nump">$ 327,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 327,280<span></span>
</td>
<td class="nump">$ 327,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_PaymentsOfReverseRecapitalizationTransactionCosts', window );">Payments of transaction costs</a></td>
<td class="nump">$ 8,100<span></span>
</td>
<td class="nump">$ 18,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">124,045,255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,562,745<span></span>
</td>
<td class="nump">124,303,083<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,562,745<span></span>
</td>
<td class="nump">124,303,083<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_PaymentsOfReverseRecapitalizationTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments of Reverse Recapitalization Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_PaymentsOfReverseRecapitalizationTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_StockIssuedDuringPeriodSharesReverseRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Reverse Recapitalization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_StockIssuedDuringPeriodSharesReverseRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_StockIssuedDuringPeriodValueReverseRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Reverse Recapitalization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_StockIssuedDuringPeriodValueReverseRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627379142048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Common Stock - Common Stock Reserved for Future Issuance (Details) - shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 09, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Stock options issued and outstanding (in shares)</a></td>
<td class="nump">11,650,794<span></span>
</td>
<td class="nump">8,550,076<span></span>
</td>
<td class="nump">7,106,767<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total shares of common stock reserved (in shares)</a></td>
<td class="nump">31,474,961<span></span>
</td>
<td class="nump">24,276,439<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=naut_A2021EquityIncentivePlanMember', window );">2021 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant under equity plan (in shares)</a></td>
<td class="nump">17,384,590<span></span>
</td>
<td class="nump">14,481,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=naut_A2021EmployeeStockPurchasePlanMember', window );">2021 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant under equity plan (in shares)</a></td>
<td class="nump">2,439,577<span></span>
</td>
<td class="nump">1,244,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=naut_A2021EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=naut_A2021EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=naut_A2021EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=naut_A2021EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627220315728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627216587392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plan and Stock-based Compensation - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jan. 01, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares of common stock reserved (in shares)</a></td>
<td class="nump">31,474,961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,276,439<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 31.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation expense, period for recognition</a></td>
<td class="text">2 years 11 months 8 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=naut_A2021EquityIncentivePlanMember', window );">2021 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant under equity plan (in shares)</a></td>
<td class="nump">17,384,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,481,463<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Number of additional shares authorized (in shares)</a></td>
<td class="nump">18,672,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Percentage of outstanding stock maximum</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant', window );">Increase in shares available for grant under equity plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,215,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Award expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=naut_A2021EmployeeStockPurchasePlanMember', window );">2021 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant under equity plan (in shares)</a></td>
<td class="nump">2,439,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,244,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Number of additional shares authorized (in shares)</a></td>
<td class="nump">3,734,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Percentage of outstanding stock maximum</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant', window );">Increase in shares available for grant under equity plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,243,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Shares of common stock issued in period (in shares)</a></td>
<td class="nump">48,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=naut_A2017EquityIncentivePlanMember', window );">2017 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares of common stock reserved (in shares)</a></td>
<td class="nump">7,106,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock | 2021 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of common stock, percent</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Increase in Number of Shares Available for Grant</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=naut_A2021EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=naut_A2021EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=naut_A2021EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=naut_A2021EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=naut_A2017EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=naut_A2017EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627216486816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plan and Stock-based Compensation - Significant Assumptions (Details) - Options - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">105.20%<span></span>
</td>
<td class="nump">93.00%<span></span>
</td>
<td class="nump">105.20%<span></span>
</td>
<td class="nump">92.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">109.10%<span></span>
</td>
<td class="nump">93.70%<span></span>
</td>
<td class="nump">110.00%<span></span>
</td>
<td class="nump">94.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk free interest rate, minimum</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">0.91%<span></span>
</td>
<td class="nump">1.73%<span></span>
</td>
<td class="nump">0.53%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk free interest rate, maximum</a></td>
<td class="nump">3.36%<span></span>
</td>
<td class="nump">1.02%<span></span>
</td>
<td class="nump">3.36%<span></span>
</td>
<td class="nump">1.02%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
<td class="text">5 years 7 months 6 days<span></span>
</td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice', window );">Stock price (in dollars per share)</a></td>
<td class="nump">$ 2.70<span></span>
</td>
<td class="nump">$ 10.10<span></span>
</td>
<td class="nump">$ 2.70<span></span>
</td>
<td class="nump">$ 7.56<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">6 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice', window );">Stock price (in dollars per share)</a></td>
<td class="nump">$ 4.72<span></span>
</td>
<td class="nump">$ 11.16<span></span>
</td>
<td class="nump">$ 4.72<span></span>
</td>
<td class="nump">$ 11.16<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Share Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627215501264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plan and Stock-based Compensation - Stock Option Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Stock Option Awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding beginning balance (in shares)</a></td>
<td class="nump">8,550,076<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">4,037,863<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(211,309)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(725,836)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding ending balance (in shares)</a></td>
<td class="nump">11,650,794<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options vested and expected to vest (in shares)</a></td>
<td class="nump">11,650,794<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Vested and exercisable (in shares)</a></td>
<td class="nump">3,279,223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding beginning balance (in dollars per share)</a></td>
<td class="nump">$ 4.66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">3.81<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">0.89<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">8.11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding ending balance (in dollars per share)</a></td>
<td class="nump">4.21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Options vested and expected to vest (in dollars per share)</a></td>
<td class="nump">4.21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Vested and exercisable (in dollars per share)</a></td>
<td class="nump">$ 3.59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Options outstanding, weighted average remaining contractual life</a></td>
<td class="text">8 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Vested and exercisable, weighted average remaining contractual life</a></td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options outstanding, aggregate intrinsic value</a></td>
<td class="nump">$ 7,964<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Vested and exercisable, aggregate intrinsic value</a></td>
<td class="nump">$ 4,474<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627215047440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Option Plan and Stock-based Compensation - Stock Based Compensation Expense (Details) - Options - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 2,567<span></span>
</td>
<td class="nump">$ 1,820<span></span>
</td>
<td class="nump">$ 4,677<span></span>
</td>
<td class="nump">$ 3,156<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">975<span></span>
</td>
<td class="nump">666<span></span>
</td>
<td class="nump">1,843<span></span>
</td>
<td class="nump">1,163<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 1,592<span></span>
</td>
<td class="nump">$ 1,154<span></span>
</td>
<td class="nump">$ 2,834<span></span>
</td>
<td class="nump">$ 1,993<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627216415584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentAmount', window );">Open purchase commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Term of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_OperatingLeaseNoncashAdjustment', window );">Operating lease, noncash adjustment</a></td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for lease liabilities included in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=naut_SanCarlosLeaseImprovementsLineOfCreditMember', window );">San Carlos Lease Improvements Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity to finance tenant improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on borrowings to finance tenant improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding', window );">Outstanding borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=naut_September2021ToSeptember2031Member', window );">September 2021 to September 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Term of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=naut_February2021ToOctober2021Member', window );">February 2021 to October 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=naut_October2022ToOctober2031Member', window );">October 2022 to October 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Term of contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_LesseeOperatingLeaseOptionToTerminateLeaseTerm', window );">Lease term with option to terminate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_LesseeOperatingLeaseOptionToTerminateLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Option to Terminate, Lease Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_LesseeOperatingLeaseOptionToTerminateLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_OperatingLeaseNoncashAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Noncash Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_OperatingLeaseNoncashAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the amount outstanding under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum amount the entity agreed to spend under the long-term purchase commitment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=naut_SanCarlosLeaseImprovementsLineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=naut_SanCarlosLeaseImprovementsLineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=naut_September2021ToSeptember2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=naut_September2021ToSeptember2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=naut_February2021ToOctober2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=naut_February2021ToOctober2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=naut_October2022ToOctober2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=naut_October2022ToOctober2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627220308816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies - Components of Lease Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Fixed operating lease costs</a></td>
<td class="nump">$ 1,182<span></span>
</td>
<td class="nump">$ 362<span></span>
</td>
<td class="nump">$ 2,365<span></span>
</td>
<td class="nump">$ 863<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable operating lease costs</a></td>
<td class="nump">380<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">818<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease costs</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">440<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">619<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease costs</a></td>
<td class="nump">$ 1,568<span></span>
</td>
<td class="nump">$ 812<span></span>
</td>
<td class="nump">$ 3,194<span></span>
</td>
<td class="nump">$ 1,502<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627210717632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitment and Contingencies - Lease Maturity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Aug. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Six months ending December 31, 2022</a></td>
<td class="nump">$ 1,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">4,440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">4,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">4,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">4,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour', window );">2027 and thereafter</a></td>
<td class="nump">22,942<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">43,301<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="num">(13,689)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 29,612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, to be Paid, Due after Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627211634416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basic and Diluted Net Loss per Share - Basic and Diluted Not Loss per Share (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Jun. 09, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders, basic | $</a></td>
<td class="num">$ (14,689)<span></span>
</td>
<td class="num">$ (10,713)<span></span>
</td>
<td class="num">$ (30,452)<span></span>
</td>
<td class="num">$ (19,122)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net loss attributable to common stockholders, diluted | $</a></td>
<td class="num">$ (14,689)<span></span>
</td>
<td class="num">$ (10,713)<span></span>
</td>
<td class="num">$ (30,452)<span></span>
</td>
<td class="num">$ (19,122)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic', window );">Weighted average common shares outstanding (in shares)</a></td>
<td class="nump">124,494,036<span></span>
</td>
<td class="nump">55,070,480<span></span>
</td>
<td class="nump">124,456,518<span></span>
</td>
<td class="nump">44,130,773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase', window );">Less: Weighted-average unvested restricted shares and shares subject to repurchase (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(34,624)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares used in computing net loss per share attributable to common stockholders, basic (in shares)</a></td>
<td class="nump">124,494,036<span></span>
</td>
<td class="nump">55,070,480<span></span>
</td>
<td class="nump">124,456,518<span></span>
</td>
<td class="nump">44,096,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)</a></td>
<td class="nump">124,494,036<span></span>
</td>
<td class="nump">55,070,480<span></span>
</td>
<td class="nump">124,456,518<span></span>
</td>
<td class="nump">44,096,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share attributable to common stockholders, basic (in dollars per share) | $ / shares</a></td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.19)<span></span>
</td>
<td class="num">$ (0.24)<span></span>
</td>
<td class="num">$ (0.43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share attributable to common stockholders, diluted (in dollars per share) | $ / shares</a></td>
<td class="num">$ (0.12)<span></span>
</td>
<td class="num">$ (0.19)<span></span>
</td>
<td class="num">$ (0.24)<span></span>
</td>
<td class="num">$ (0.43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_naut_RecapitalizationExchangeRatio', window );">Recapitalization exchange ratio</a></td>
<td class="nump">3.6281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.6281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.6281<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_RecapitalizationExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recapitalization Exchange Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_RecapitalizationExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_naut_WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Number Of Shares, Unvested Restricted Stock And Shares Subject To Repurchase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">naut_WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>naut_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesIssuedBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2</span><table class="report" border="0" cellspacing="2" id="idm139627212781248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basic and Diluted Net Loss per Share - Antidilutive Securities (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potentially dilutive common share equivalents</a></td>
<td class="nump">11,712,205<span></span>
</td>
<td class="nump">8,014,879<span></span>
</td>
<td class="nump">11,712,205<span></span>
</td>
<td class="nump">8,014,879<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potentially dilutive common share equivalents</a></td>
<td class="nump">11,650,794<span></span>
</td>
<td class="nump">8,014,879<span></span>
</td>
<td class="nump">11,650,794<span></span>
</td>
<td class="nump">8,014,879<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=naut_EmployeeStockPurchasePlanMember', window );">Employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total potentially dilutive common share equivalents</a></td>
<td class="nump">61,411<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">61,411<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=naut_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=naut_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>naut-20220630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:naut="http://www.nautilus.bio/20220630"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="naut-20220630.xsd" xlink:type="simple"/>
    <context id="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i3310b8dff9874981ae5250a336f00a88_I20220729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <instant>2022-07-29</instant>
        </period>
    </context>
    <context id="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i34e4a2a383364c848f4d73f961251253_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i452786b7977748c0a94d775ecb931729_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i324e2cc43a4e4cf587d2f6ab80062f51_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">naut:SeriesSeedRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7f90b4ca496645789fa6b735ea5ebed6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="icdd25765152a4ced9576a609916fc669_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i90b7a94b75e741018792ad40fce39e8b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i671a15cf99d44d1784c894a87c80e686_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i84e9820405224bd7bd61573fe1ab8754_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if84c94ae09ea4044bd354a2967d293b3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i92668a7081b949668c4894010570de77_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8e0a243e6ed64e6380f701b2efb5ff8b_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7e6daf471bc241889e532847e9ba6e85_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="if5d7470609454d0e9b5dff503cff7980_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9432f4700dc64531b14d489ac2a5a042_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i4472b9eda37d47c1a4d8adc7d6d2cd67_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">naut:SeriesSeedRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia8d4f89749114fff9f0cfa6384876a0b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3734d525d0254e38ba1f10086eb40e63_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i389999977661484882273df554199358_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie314d916207a418aa13a6eac1ba0316b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i94e283e466604a8d91b96c149bce904f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0d2cd67fbecd458cba307172152eed68_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia42f738735254708b40f6633a2122e8e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">naut:SeriesSeedRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie85bed107ca14c97901fe21cb7bb5dd8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1335e9d7772048258994030cd2031c3f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i05843a43ee50491196307c78a95fc47c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8e040518794245b0863ec2f6444d3794_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5202287c29e942c5b0cdac7690f742a4_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5bb0ce9e01b540f58814347806008b98_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3c6985f8581548c2a524d21940747415_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i331a2564c2fd4ca8a141e5b7414f9560_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic4c2e6f425d94a478aa350968a70941c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia19895c7ccdf43c886000a1fe40ad74d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">naut:SeriesSeedRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i23ee12f309a94096b523c85c9c89ec41_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibb3fddc37cf84806bb3cb2eb9243e764_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i64c43e244ef8492fa7383bb02f49cad6_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iaf5ead0636be44b29ce427b1dd08509d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie9e2d89185264884b8085af4b2cd97fc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">naut:SeriesSeedRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic17b9d22c2764dd798b80f5dfc34b5cf_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i91ec4082056644ceb4605ae97ee305ff_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib5a3a46052d04721ae2a3b35284e5778_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1c20cf8954844243a311683aea4cdc51_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i93e671a07e70472fbbddd30300e8c88e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5af05f6fd3814dfcbf23c51970fb91b2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibff31d711c89442ab7051c729b67d7e0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7cc1b5792cf94105940e3332ea917424_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">naut:SeriesSeedRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i36b1b43803b74d6f9880f7465fee5d9b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib4e23aef5312440092a0c722a7b14905_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id40db1cc432e4a13bfe6f29d29443dfb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9fc487a3a7a14aa09b1841736e6b5f97_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3b2bafa5e4ed4f35b82f303f9778746d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib76ca1b4c23944e7823ec12efb0e4440_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6a897b30f9ac4d8a98520fc12b077eb7_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ifd33588bc4814c39915e2771cc9556d1_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i6be3e094f3c24773ad3af2c5ef2aa634_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i149f021a272a4689a24162c8f8e7d768_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ib1a4309f941040f286a32c33912b765f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">naut:SeriesSeedRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i72367460707f479b803532b3fb755692_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7d44af6f75f540d7b0ecbde2f40b4975_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifde94ccddd2d45069a65f8843572a9ae_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i35476aa1f20349a1b78904608e5b16ab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4ea49b1cdab94931bcc33becf8b06845_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i944a24eac2e246da8e69f0c1ac41391d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i616643cbd31d47a686cf71385bb21573_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaec5179caeab4e28a0d89e51f7815911_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4ab559ce8be94eab9ca0ec550a426771_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ieff8ab03765e4ac7b663c2cbfb8ab6f8_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">naut:SeriesSeedRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i43f28fa225984e9bbd35f3d7ff3f55c6_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ice89ec8597d741e6a43e56fbdbb1915b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5e556ea5dbff49d8b604228bf8cd44a0_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i83eab16a45a34043b19482dba0424ebf_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia44cc7d1aae94a61ab5ee6ba5904ea17_D20210609-20210609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-09</startDate>
            <endDate>2021-06-09</endDate>
        </period>
    </context>
    <context id="ibd18e99e03a84549a89394d3537245e4_I20210609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-09</instant>
        </period>
    </context>
    <context id="i23369e4e61894856b3b29fd3dd2c1609_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <startDate>2021-06-09</startDate>
            <endDate>2021-06-09</endDate>
        </period>
    </context>
    <context id="i4ff48ca2fc6c45e787116cf1deff00ca_D20210609-20210609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-09</startDate>
            <endDate>2021-06-09</endDate>
        </period>
    </context>
    <context id="i8cf39cfd7fd34311bc52d7c3ad8da2ff_I20210609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <instant>2021-06-09</instant>
        </period>
    </context>
    <context id="ic9aa3fe7e62449e8bd4ba541d238d058_I20210609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">naut:AryaSciencesAcquisitionCorpIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-09</instant>
        </period>
    </context>
    <context id="i95b304753b094f299b60dec3c082158f_I20210608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">naut:AryaSciencesAcquisitionCorpIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-08</instant>
        </period>
    </context>
    <context id="i565dd4757c4d4703a0e0f5fd3a984d8a_D20210609-20210609">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">naut:AryaSciencesAcquisitionCorpIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-09</startDate>
            <endDate>2021-06-09</endDate>
        </period>
    </context>
    <context id="i79037a7aa8bb452a9abe1acf155b0a38_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iec519f1b51a74b28a9f702bc1a15de30_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2fc5af0cf1f14c46a0f276dc81c59884_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0050fd4d6a3d46e2b3392794b3ad0b86_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1337c836c5934b6bac4f03a65db10d20_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3465ab1d6d8f48b68b3953bf87063529_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iaaebac9cbb2145b1baef43c60057d70a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2c2daae9584b48c397b73875dc06c78a_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iadef21ee44e04221a04d477fe4115655_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4a11f62dd1ef4191af3a81425e1797b7_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4d8fd5d7b0fa49a481c18d85c47bf96e_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0728a8794dce4087b0492d0e4351e1e6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="idc43f21c31c5480eb0e220208d1cbaa6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic726402929734cce8dbbe855f46e9393_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id7a7db4799084f059a70fe68887a2222_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i01ccc819c01f4da4bf182c10a26166db_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ib6d4c75d853d45118d52af84feb1c9ea_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i72d1a4360cb049bcbd0a7a2c5d41cfeb_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i43796c765a3b4a81a908d3053773a8d9_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic56b289dcf7e46aa9e1028ca71a10d0b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i642f3161862d43c3b6ae73200ecd113f_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="iea1db945b9d4412b88ca684b96485097_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibd637638870b48e1b476508b5f17a987_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ic460f8db52ff40a98fc27d37b206e662_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="id56a7a2e33ba4a32a1d5145855a08542_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ie358eafdc46d4b668ba594dc1e5b18d6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i406e02c48601468ebc3605dcc7cc3a1d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i1239a3c41dbc40e1bbeff834e51c1aee_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i65429cbc59dc44efba3731beff6b9dd1_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ice7fbda97984484fa4687feefa1e787c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i55132e2a8fbb44009e345287f535137b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7dc0732a547c47a49a1c5860398b6fa2_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ibd1d463226d84aad9a1438d158e6eb23_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i54b9d11dd5654d79a875c72b42d10b86_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id7bad06e2afb4d469055e60478216c8e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1ad2ffe0c6c64a0f945e3af8721a487f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MutualFundMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i950704d092364ff2b931f1d01449efb0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib5acec1f8c5648f6b912abb5a8c70899_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i276d2f47485e4e31b420416f91c282aa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2b4de2e6190b45178fbe6a57799d9ce1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0de8e6af07d84138b0e785102ca2f7f6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i325c3c07c7f74c5f98e3c999c65b7441_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idca49185e1c445cfa94d8d799ed53ce3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic6a86385f1054cff872febbcd6e2d2eb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if9cb68272c8244ea9919716328cc5ef2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i70c36a3813d14058806f4eb11606f72e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icfd0acaaf2c04dbb8b67de884e3f27b8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3b751c1b3c4a4f9d80dd9d109c372f81_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibe88c920880047c18b0c9cdf55c6e8df_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id158f09e96ab481f97e32c8613f97003_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i82a7bcc7bc4d49e084d69fc0519a1f46_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id14ac15267014aa398c2c76cac075a21_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ice46726bd5254e1d955ba67438fa7351_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0677ff7a71e047b1b7f25782cf4ffe83_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id505c63953e54d2184cb7f771dec30b2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id3be0b06a9c94f3a9829bec818382447_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1375f50662564d9695c2f9a598ea96ff_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i390387b0a67e446f8057dfcc678f0e57_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5e8607b8fc264a58929288d5a7cae83f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1ebedf34f1ba432d875df25f515ac771_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic760bbad7d924910b0fc9c0598c7dd1c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0c35013b448d4f9a8ea202c0cc904312_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if6319ed6f43b45e59b873b4727e4b8df_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4671216a131e4e1a8c9dfea3bb76d2bd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">naut:LongTermInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i62504dcfdac144e7a5c3c6eb6862529d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">naut:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i5f485413bc8146e3bbce6629c4dcd539_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">naut:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0083086336d845fdad111086bbba6da7_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9e22a0d731ef400b92b19e10336609cc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic2148fd953e942c9b5fa08720c4723a6_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">naut:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ia89341e52be34f04b93a341be9170381_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">naut:FurnitureFixturesAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iffc3dca386444731a94b2e7034cbfd79_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="idc0ee8f762314302abd9fa2688c27560_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i69c8e273988d437082cf0d4dd215960d_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3e301c5918bb4924a1937829c187cbe6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4f3af80321e54f9fb93e4f4f432b503c_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i2f3067b2fe2743df8d892928fdb699d8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i787199e8a86147f2b16226c6baee76a4_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i646596b1fd7f425b997adba08286e2c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i233799cb44d44a66a5f2ab2cdc7ec56c_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i69902fa9a7884b429fd406f65655535f_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie310279ce69747ab9825ced6a3fe78fc_I20220101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="i89b1c3e45f0b40979b88b450d15bcbfa_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ibed4c6e11d5d43c5806dbe2b925b0fea_I20220101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2021EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="i47703b687f7846fcb57b2784db412643_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">naut:A2017EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i3e682fab2418499796c2bd51ca5f5d63_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i7b3c9d4006024ff3b3fc21d16c2ae7ec_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic34352ef98754a5da0e85055bbc95472_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id7ff0979e8484728b1b10937c3182077_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idf9c413e24a54f04ad65558d7a7137db_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i08e2f1e57e9b497f9d8298da3df3d6e6_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ifdb873a8ec034005806968a7270b26bd_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8caa73d19bf74f9fb01149e58ec6f2b8_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i49299c0b86364054a5d2222883ee3b39_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0da319978bcb43ecb4461222b4a14066_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i74defcab308e430587503de9ccb5ac4a_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i52460f4c2a9740b295d473a2341fa225_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib1706d23492b43b7a385b6224b7bb789_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ie2cf87bc9d4c4ace9ed33c1df39f2e20_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia22d009c3ac44aeb931bf7a56b79db92_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i1548f12c35584dfe86dfe82e4fc2766b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i95e307280f854c36abc9723392120e2d_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i9f6592550bdb4e179558e3808e9fa8eb_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6a590e5e314f4b95b05e281bd0d44db4_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0333ae88e1f147b9a495311e02ae01c5_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iac74a2b58af547489b585fbc6f3a6dc4_I20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="i22fffe12aeab41308245c99399a1f92b_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="i005d3c6634c744229bee47f60e02c564_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">naut:September2021ToSeptember2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i43cfc749a9134f95896a73a831e49eb6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">naut:February2021ToOctober2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7b12af6151364817bb6215130879f731_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">naut:October2022ToOctober2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5734f6007d394ffdba6338fcd01317d1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">naut:SanCarlosLeaseImprovementsLineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i96e9f550a3474120bad073b9f8a36ac5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">naut:SanCarlosLeaseImprovementsLineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i7b0787d033534be8830b754832d12575_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="idae2ad2a8fe44cc2ae26dfcfb3a80cf3_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="id173ca79999149b0acf943a294060af6_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1193b3efa76e4883905243879462ee64_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia851771fac4244bc9fcb9380f95e907a_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">naut:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i0108800d07f0495691d5110222b35f25_D20220101-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">naut:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i51a1bd721e3d4a4e91f03a5a2c31863b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">naut:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic4fee951cce3455ca59554a17600d641_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001808805</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">naut:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="segment">
        <measure>naut:segment</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80L2ZyYWc6YzE3ODBmYWUzNWIwNDQ0NzhhYmE5ZGMzODNlOTRlODMvdGFibGU6YzFhMTNkYjYyYjliNDUwMWIyM2FiZGE4MmI2MGJhYzkvdGFibGVyYW5nZTpjMWExM2RiNjJiOWI0NTAxYjIzYWJkYTgyYjYwYmFjOV8xLTEtMS0xLTgzNDE0_2bccc42c-c518-44f0-8a2a-79280920bfca">0001808805</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80L2ZyYWc6YzE3ODBmYWUzNWIwNDQ0NzhhYmE5ZGMzODNlOTRlODMvdGFibGU6YzFhMTNkYjYyYjliNDUwMWIyM2FiZGE4MmI2MGJhYzkvdGFibGVyYW5nZTpjMWExM2RiNjJiOWI0NTAxYjIzYWJkYTgyYjYwYmFjOV8yLTEtMS0xLTgzNDE0_e77186ee-0055-46f8-96c6-541d4d763a7a">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80L2ZyYWc6YzE3ODBmYWUzNWIwNDQ0NzhhYmE5ZGMzODNlOTRlODMvdGFibGU6YzFhMTNkYjYyYjliNDUwMWIyM2FiZGE4MmI2MGJhYzkvdGFibGVyYW5nZTpjMWExM2RiNjJiOWI0NTAxYjIzYWJkYTgyYjYwYmFjOV8zLTEtMS0xLTgzNDE0_08f37a3b-36df-4cf6-9373-dc838717cc94">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80L2ZyYWc6YzE3ODBmYWUzNWIwNDQ0NzhhYmE5ZGMzODNlOTRlODMvdGFibGU6YzFhMTNkYjYyYjliNDUwMWIyM2FiZGE4MmI2MGJhYzkvdGFibGVyYW5nZTpjMWExM2RiNjJiOWI0NTAxYjIzYWJkYTgyYjYwYmFjOV80LTEtMS0xLTgzNDE0_8ca3a271-621c-46b9-a8a2-6b82341cc29c">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80L2ZyYWc6YzE3ODBmYWUzNWIwNDQ0NzhhYmE5ZGMzODNlOTRlODMvdGFibGU6YzFhMTNkYjYyYjliNDUwMWIyM2FiZGE4MmI2MGJhYzkvdGFibGVyYW5nZTpjMWExM2RiNjJiOWI0NTAxYjIzYWJkYTgyYjYwYmFjOV81LTEtMS0xLTgzNDE0_4adcba57-0171-4aa7-b5b5-0572b4ee0863">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentType
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGV4dHJlZ2lvbjplMmY1NTE1ZTZlYjg0ODRjOWE1NDc4NWViMWRkM2MxOV8yMDEz_12acb6e4-1d12-408c-a0fc-5b19f6befdf2">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6YmM5YjA1ZjY4ZDhhNDdhY2FlMThlMzJhMDJiNGIyMWMvdGFibGVyYW5nZTpiYzliMDVmNjhkOGE0N2FjYWUxOGUzMmEwMmI0YjIxY18wLTAtMS0xLTgzNDE0_bb2ebf3f-0905-405b-9fe9-21f1913c3a41">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGV4dHJlZ2lvbjplMmY1NTE1ZTZlYjg0ODRjOWE1NDc4NWViMWRkM2MxOV8xNDg_f1c6261b-4f46-4a82-8342-c867c533710e">2022-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6MDIzYmExNWIxNDlhNDY5NGEzM2VlNTAyNDE1MGQ3ZGMvdGFibGVyYW5nZTowMjNiYTE1YjE0OWE0Njk0YTMzZWU1MDI0MTUwZDdkY18wLTAtMS0xLTgzNDE0_950333cf-5593-42ac-acbf-8eedd0928da4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGV4dHJlZ2lvbjplMmY1NTE1ZTZlYjg0ODRjOWE1NDc4NWViMWRkM2MxOV8yMDA5_1467f24a-8ed6-4b02-ab35-2624c3bb54ce">001-39434</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGV4dHJlZ2lvbjplMmY1NTE1ZTZlYjg0ODRjOWE1NDc4NWViMWRkM2MxOV8yMDE0_6cb65bcd-a60c-47e6-9be7-0b05c9d2e39a">NAUTILUS BIOTECHNOLOGY, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6ZGNlYjM4NzI0OTY1NGRjNzllZDY5OTczNzljMGIwNTYvdGFibGVyYW5nZTpkY2ViMzg3MjQ5NjU0ZGM3OWVkNjk5NzM3OWMwYjA1Nl8wLTAtMS0xLTgzNDE0_35979d8a-c410-44cd-b858-d0c20a361e61">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6ZGNlYjM4NzI0OTY1NGRjNzllZDY5OTczNzljMGIwNTYvdGFibGVyYW5nZTpkY2ViMzg3MjQ5NjU0ZGM3OWVkNjk5NzM3OWMwYjA1Nl8wLTItMS0xLTgzNDE0_d1efcfa3-18e2-4c37-8bd6-54cbc57d276b">98-1541723</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6ZGNlYjM4NzI0OTY1NGRjNzllZDY5OTczNzljMGIwNTYvdGFibGVyYW5nZTpkY2ViMzg3MjQ5NjU0ZGM3OWVkNjk5NzM3OWMwYjA1Nl8zLTAtMS0xLTgzNDE0L3RleHRyZWdpb246NmE2OGYxNTgxMTY3NGFkMjhjMTM3ODdkNDNmZDY5YTZfNQ_ef8ec919-7c5c-4d79-9799-f1d5d052edd1">2701 Eastlake Avenue East</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6ZGNlYjM4NzI0OTY1NGRjNzllZDY5OTczNzljMGIwNTYvdGFibGVyYW5nZTpkY2ViMzg3MjQ5NjU0ZGM3OWVkNjk5NzM3OWMwYjA1Nl8zLTAtMS0xLTgzNDE0L3RleHRyZWdpb246NmE2OGYxNTgxMTY3NGFkMjhjMTM3ODdkNDNmZDY5YTZfOA_45e4cebb-203d-4488-ab83-8fe2c369ee80">Seattle</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6ZGNlYjM4NzI0OTY1NGRjNzllZDY5OTczNzljMGIwNTYvdGFibGVyYW5nZTpkY2ViMzg3MjQ5NjU0ZGM3OWVkNjk5NzM3OWMwYjA1Nl8zLTAtMS0xLTgzNDE0L3RleHRyZWdpb246NmE2OGYxNTgxMTY3NGFkMjhjMTM3ODdkNDNmZDY5YTZfMTI_78b9e805-073b-4d96-808d-850a63267b4e">WA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6ZGNlYjM4NzI0OTY1NGRjNzllZDY5OTczNzljMGIwNTYvdGFibGVyYW5nZTpkY2ViMzg3MjQ5NjU0ZGM3OWVkNjk5NzM3OWMwYjA1Nl8zLTItMS0xLTgzNDE0_47841059-f16a-4815-9293-f461c805a69d">98102</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6ZGNlYjM4NzI0OTY1NGRjNzllZDY5OTczNzljMGIwNTYvdGFibGVyYW5nZTpkY2ViMzg3MjQ5NjU0ZGM3OWVkNjk5NzM3OWMwYjA1Nl81LTEtMS0xLTgzNDE0L3RleHRyZWdpb246Zjg2ZjNmZWJhOTdhNDBhYjliYmRmZTFkNTFiYTVkZmNfNQ_dc72d18b-91cb-4108-b973-2b0d37af8e47">206</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6ZGNlYjM4NzI0OTY1NGRjNzllZDY5OTczNzljMGIwNTYvdGFibGVyYW5nZTpkY2ViMzg3MjQ5NjU0ZGM3OWVkNjk5NzM3OWMwYjA1Nl81LTEtMS0xLTgzNDE0L3RleHRyZWdpb246Zjg2ZjNmZWJhOTdhNDBhYjliYmRmZTFkNTFiYTVkZmNfOQ_0513ef6c-ea5b-461a-a50f-c651436b3507">333-2001</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6MWUzMDVhMzkxMDI0NDg5MmE3YmZmZTE4OGI1MjRkNjIvdGFibGVyYW5nZToxZTMwNWEzOTEwMjQ0ODkyYTdiZmZlMTg4YjUyNGQ2Ml8xLTAtMS0xLTgzNDE0_f7059361-9766-4e45-a61f-55432ede5f8b">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6MWUzMDVhMzkxMDI0NDg5MmE3YmZmZTE4OGI1MjRkNjIvdGFibGVyYW5nZToxZTMwNWEzOTEwMjQ0ODkyYTdiZmZlMTg4YjUyNGQ2Ml8xLTEtMS0xLTgzNDE0_4af80b92-2823-4d54-ae8f-9df31f488191">NAUT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6MWUzMDVhMzkxMDI0NDg5MmE3YmZmZTE4OGI1MjRkNjIvdGFibGVyYW5nZToxZTMwNWEzOTEwMjQ0ODkyYTdiZmZlMTg4YjUyNGQ2Ml8xLTItMS0xLTgzNDE0_79afe71b-a025-4ac3-a13f-73b679b089fc">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGV4dHJlZ2lvbjplMmY1NTE1ZTZlYjg0ODRjOWE1NDc4NWViMWRkM2MxOV8yMDE2_f8934ecf-9368-43a9-a1bb-2a21363d99e6">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGV4dHJlZ2lvbjplMmY1NTE1ZTZlYjg0ODRjOWE1NDc4NWViMWRkM2MxOV8yMDEy_d3a90565-6315-4a4d-b3b2-b0447b348444">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6OGVlMDNiMDZmMTM1NGQzODlmYTQyY2E2NTg2MjgzNDEvdGFibGVyYW5nZTo4ZWUwM2IwNmYxMzU0ZDM4OWZhNDJjYTY1ODYyODM0MV8xLTAtMS0xLTgzNDE0_706f71f0-c514-4331-8238-f64623f14031">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6OGVlMDNiMDZmMTM1NGQzODlmYTQyY2E2NTg2MjgzNDEvdGFibGVyYW5nZTo4ZWUwM2IwNmYxMzU0ZDM4OWZhNDJjYTY1ODYyODM0MV8xLTMtMS0xLTgzNDE0_95bf2f2c-4ec8-4b96-ab1f-1a44497c5ff1">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGFibGU6OGVlMDNiMDZmMTM1NGQzODlmYTQyY2E2NTg2MjgzNDEvdGFibGVyYW5nZTo4ZWUwM2IwNmYxMzU0ZDM4OWZhNDJjYTY1ODYyODM0MV8yLTMtMS0xLTgzNDE0_0cd2757b-a4c4-4eea-88cb-dca9899f099d">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGV4dHJlZ2lvbjplMmY1NTE1ZTZlYjg0ODRjOWE1NDc4NWViMWRkM2MxOV8yMDEw_024cb669-fb04-4d51-a18c-5cb9666ae3a3">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGV4dHJlZ2lvbjplMmY1NTE1ZTZlYjg0ODRjOWE1NDc4NWViMWRkM2MxOV8yMDEx_00da5911-8abc-4930-9bd6-34a28e7a2367">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i3310b8dff9874981ae5250a336f00a88_I20220729"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8xL2ZyYWc6ZTJmNTUxNWU2ZWI4NDg0YzlhNTQ3ODVlYjFkZDNjMTkvdGV4dHJlZ2lvbjplMmY1NTE1ZTZlYjg0ODRjOWE1NDc4NWViMWRkM2MxOV8xOTM5_df549588-2945-4958-83e6-074fdbb136af"
      unitRef="shares">124663186</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMy0xLTEtMS04MzQxNA_f2a34ba3-8ad5-440b-a2b4-b37b168bde33"
      unitRef="usd">210354000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMy0zLTEtMS04MzQxNA_172ceb15-cb11-4aee-bfff-2237e7bbba83"
      unitRef="usd">185619000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfNC0xLTEtMS04MzQxNA_8ac6ef9c-53eb-4f7e-9615-130f659eb952"
      unitRef="usd">88984000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfNC0zLTEtMS04MzQxNA_e4772e06-4eb8-4e53-9e27-2e8f9a25e633"
      unitRef="usd">160110000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfNS0xLTEtMS04MzQxNA_19f3cede-505b-4b11-bcdc-7c439acecb63"
      unitRef="usd">4108000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfNS0zLTEtMS04MzQxNA_088e3832-6de0-4138-9f4e-637ba3fab604"
      unitRef="usd">3493000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfNi0xLTEtMS04MzQxNA_6f361e5c-52e1-4f2d-958b-ac8a503efa54"
      unitRef="usd">303446000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfNi0zLTEtMS04MzQxNA_b7e18d9f-a9c1-4d68-a13b-4eebee59e2fa"
      unitRef="usd">349222000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfNy0xLTEtMS04MzQxNA_cbfb0884-0325-423a-9275-36679d07fb21"
      unitRef="usd">3402000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfNy0zLTEtMS04MzQxNA_5d0ccb3b-78f3-4e00-8241-cb6da98161b6"
      unitRef="usd">2483000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfOC0xLTEtMS04MzQxNA_83af1df9-3866-42a1-a9ad-d04427fff311"
      unitRef="usd">28304000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfOC0zLTEtMS04MzQxNA_58a4f38c-bd3f-47ae-bddb-1b4699da0338"
      unitRef="usd">29377000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:LongTermInvestments
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfOS0xLTEtMS04MzQxNA_eca101b4-abac-473e-97c9-d2a08ba067cf"
      unitRef="usd">35558000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfOS0zLTEtMS04MzQxNA_13ac0a63-cd10-47b8-9d19-05a912f87738"
      unitRef="usd">16371000</us-gaap:LongTermInvestments>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTAtMS0xLTEtODM0MTQ_6beb1360-f7b9-4b03-a72b-789700206663"
      unitRef="usd">997000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTAtMy0xLTEtODM0MTQ_72f87ed5-1861-4a3b-bc11-bf1e34213704"
      unitRef="usd">997000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTEtMS0xLTEtODM0MTQ_0349a6be-d296-49ea-b3ff-2ee02c33f25a"
      unitRef="usd">371707000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTEtMy0xLTEtODM0MTQ_05a78b6a-563c-4a26-b3ec-3446dc596398"
      unitRef="usd">398450000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTQtMS0xLTEtODM0MTQ_cd618fb6-cc18-4640-a021-a64d473456a1"
      unitRef="usd">1429000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTQtMy0xLTEtODM0MTQ_970f03e3-0212-4cb5-936c-2aed2ea0c49a"
      unitRef="usd">1723000</us-gaap:AccountsPayableCurrent>
    <naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTUtMS0xLTEtODM0MTQ_75447f27-d644-476a-a200-0c90e9a0e58b"
      unitRef="usd">3108000</naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent>
    <naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTUtMy0xLTEtODM0MTQ_0aa57ea6-a9c0-4127-a542-5b8238ba6abc"
      unitRef="usd">3119000</naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTYtMS0xLTEtODM0MTQ_eb31bb6b-e7d8-4641-86fd-374b190065b7"
      unitRef="usd">1562000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTYtMy0xLTEtODM0MTQ_52cc138c-0428-4ef8-beaa-03b171c5f896"
      unitRef="usd">970000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTctMS0xLTEtODM0MTQ_6e7502c1-dc03-4205-8186-b921eff117e8"
      unitRef="usd">6099000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTctMy0xLTEtODM0MTQ_d181b23f-bd72-4fa7-9974-d6c1c796df88"
      unitRef="usd">5812000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTgtMS0xLTEtODM0MTQ_b188fa6e-b74c-4418-88e8-de7ec36644ae"
      unitRef="usd">28050000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTgtMy0xLTEtODM0MTQ_876dbba0-0f89-4439-bc20-8b4282ede6e5"
      unitRef="usd">29062000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTktMS0xLTEtODM0MTQ_523dbc1d-e075-453d-90e7-fe8eaecc2d4e"
      unitRef="usd">34149000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMTktMy0xLTEtODM0MTQ_269a0d90-5cfd-488b-bb4e-d0e047f04e57"
      unitRef="usd">34874000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjAtMS0xLTEtODM0MTQ_5ef58b20-dc1d-4263-bf7e-dbfd07f92919"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjAtMy0xLTEtODM0MTQ_70c377dd-5009-4518-abbe-7ace9ffd1e8c"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjgtMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjo1OWQxYzA2MWQ3YTU0NWYzYjgyYzBhMjMxN2FlMDRhZF8yMQ_9cde1d4f-7d9e-4d97-bffb-515f749eed9e"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjgtMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjo1OWQxYzA2MWQ3YTU0NWYzYjgyYzBhMjMxN2FlMDRhZF8yMQ_a62bbe31-5916-45b8-ac27-63a1b65a3f28"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjgtMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjo1OWQxYzA2MWQ3YTU0NWYzYjgyYzBhMjMxN2FlMDRhZF8zNQ_a8b2c238-fb24-44c0-ad3a-adb4d1ae68b2"
      unitRef="shares">200000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjgtMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjo1OWQxYzA2MWQ3YTU0NWYzYjgyYzBhMjMxN2FlMDRhZF8zNQ_cb6ae7c8-eb1a-452a-bdf7-dbd3e76582f6"
      unitRef="shares">200000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjgtMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjo1OWQxYzA2MWQ3YTU0NWYzYjgyYzBhMjMxN2FlMDRhZF85Mw_5a246a95-262d-4f09-983c-d1ddc236456f"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjgtMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjo1OWQxYzA2MWQ3YTU0NWYzYjgyYzBhMjMxN2FlMDRhZF85Mw_5dbb3ead-d3db-42dc-a497-1d25116443d6"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjgtMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjo1OWQxYzA2MWQ3YTU0NWYzYjgyYzBhMjMxN2FlMDRhZF85Mw_7940e4c3-5a25-465a-b4ea-1b189c23abd8"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjgtMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjo1OWQxYzA2MWQ3YTU0NWYzYjgyYzBhMjMxN2FlMDRhZF85Mw_c5717911-43f1-4a94-a418-7cba61e1b439"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjgtMS0xLTEtODM0MTQ_d7de816c-dc05-4672-9a03-42ba1490a130"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjgtMy0xLTEtODM0MTQ_2bab9cde-a501-476f-9486-e4dba93cbeb8"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjktMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjowODljYjg1YmEyNjc0MjZkOGMwMjg2ZDY2OGI0NWNkNl8xOA_87b5993d-f293-40ec-9b68-26716c93841a"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjktMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjowODljYjg1YmEyNjc0MjZkOGMwMjg2ZDY2OGI0NWNkNl8xOA_e36d54de-7207-4a57-9de5-82ab8640741b"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjktMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjowODljYjg1YmEyNjc0MjZkOGMwMjg2ZDY2OGI0NWNkNl8zMg_973b1940-13ef-482c-b464-3489ca37afa5"
      unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjktMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjowODljYjg1YmEyNjc0MjZkOGMwMjg2ZDY2OGI0NWNkNl8zMg_bfd437a5-8e53-47d8-a4ca-9a7651cad426"
      unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjktMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjowODljYjg1YmEyNjc0MjZkOGMwMjg2ZDY2OGI0NWNkNl81NDk3NTU4MTQxMzg_05d799fa-4752-4729-9390-e8482e49279b"
      unitRef="shares">124562745</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjktMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjowODljYjg1YmEyNjc0MjZkOGMwMjg2ZDY2OGI0NWNkNl81NDk3NTU4MTQxMzg_8f372bb1-36a9-4556-a6cc-ca4e68f3d283"
      unitRef="shares">124562745</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjktMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjowODljYjg1YmEyNjc0MjZkOGMwMjg2ZDY2OGI0NWNkNl8xMDQ_20973716-f348-458b-ad4a-afeb7799d8ce"
      unitRef="shares">124303083</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjktMC0xLTEtODM0MTQvdGV4dHJlZ2lvbjowODljYjg1YmEyNjc0MjZkOGMwMjg2ZDY2OGI0NWNkNl8xMDQ_6ffc6fa3-7911-4d4f-86db-514ea0620027"
      unitRef="shares">124303083</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjktMS0xLTEtODM0MTQ_9916d05b-d90f-4399-85b7-fc9e28a190b6"
      unitRef="usd">12000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMjktMy0xLTEtODM0MTQ_44771228-fcfb-4fff-924d-ac361562ce11"
      unitRef="usd">12000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMzAtMS0xLTEtODM0MTQ_e6374bb3-b37a-4aa7-8514-4bb949cb7ef8"
      unitRef="usd">449406000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMzAtMy0xLTEtODM0MTQ_74e74da7-ecf9-47c9-8a52-46d0762e3622"
      unitRef="usd">444388000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMzEtMS0xLTEtODM0MTQ_11218dcf-a413-4b80-9780-324b63eca68a"
      unitRef="usd">-768000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMzEtMy0xLTEtODM0MTQ_c1e6c412-41b9-4a11-9498-615d4be46d08"
      unitRef="usd">-184000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMzItMS0xLTEtODM0MTQ_a9264884-2fbf-4207-bdfb-d10b7d9cd96a"
      unitRef="usd">-111092000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMzItMy0xLTEtODM0MTQ_86abe254-cedd-43fb-b8d0-50c83183608a"
      unitRef="usd">-80640000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMzMtMS0xLTEtODM0MTQ_983bcdda-72aa-46a3-aa00-de67831197a6"
      unitRef="usd">337558000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMzMtMy0xLTEtODM0MTQ_c2cff64b-0c5d-4826-a33e-7ea45e1187cc"
      unitRef="usd">363576000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMzQtMS0xLTEtODM0MTQ_11435570-f0dc-4d47-a477-feabc0f80cf0"
      unitRef="usd">371707000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yMi9mcmFnOjEzNDA1ZDJhNjcxMTQ3ZWY5MmUyNTY3YmJkNWQwZjJmL3RhYmxlOjYyOTI3OTZjYTVjYTQxZTM5YTQ2NzExZWYxOWVkZmRlL3RhYmxlcmFuZ2U6NjI5Mjc5NmNhNWNhNDFlMzlhNDY3MTFlZjE5ZWRmZGVfMzQtMy0xLTEtODM0MTQ_5445cdb7-114a-400d-87fb-baf60a64dbc8"
      unitRef="usd">398450000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfMy0xLTEtMS04MzQxNA_5bf072ee-0f76-4f29-ad8d-a981bdb9957b"
      unitRef="usd">8856000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfMy0zLTEtMS04MzQxNA_abbb829a-058a-4ef4-9a49-2bab073cf4c8"
      unitRef="usd">6380000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfMy01LTEtMS04MzQxNA_77aa840c-73b2-4f8e-a5b7-6ac303650b6b"
      unitRef="usd">18514000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfMy03LTEtMS04MzQxNA_37546d8d-37e4-42c3-bd08-be95dee76c25"
      unitRef="usd">11215000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNC0xLTEtMS04MzQxNA_8a91502c-8b9e-48b3-b6a3-9df22ebc6949"
      unitRef="usd">6616000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNC0zLTEtMS04MzQxNA_fec8a2fd-07c4-4408-b2f4-5f54249ca381"
      unitRef="usd">4317000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNC01LTEtMS04MzQxNA_1b47280a-6469-4ed8-805a-340255f6c94d"
      unitRef="usd">12980000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNC03LTEtMS04MzQxNA_87e34f96-d628-4491-a6d9-6f48bf07d677"
      unitRef="usd">7899000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNS0xLTEtMS04MzQxNA_792ab35f-3e09-415c-923a-af01972fd6bf"
      unitRef="usd">15472000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNS0zLTEtMS04MzQxNA_aa64bcec-c4f2-4ad9-9e64-947a66ad242f"
      unitRef="usd">10697000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNS01LTEtMS04MzQxNA_a6b6e9e9-0a38-42cc-a9c9-eefe27d88065"
      unitRef="usd">31494000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNS03LTEtMS04MzQxNA_a12cb879-9fde-4bf0-98d6-f69e66647a9e"
      unitRef="usd">19114000</us-gaap:OperatingExpenses>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNi0xLTEtMS04MzQxNA_165305b1-c05c-4180-9732-09c2224985a6"
      unitRef="usd">783000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNi0zLTEtMS04MzQxNA_4601102c-3f23-401c-9303-a7e0192a1c79"
      unitRef="usd">-16000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNi01LTEtMS04MzQxNA_5484cea3-ca13-4a71-a6ce-660625d0ac77"
      unitRef="usd">1042000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNi03LTEtMS04MzQxNA_24252394-2af4-404b-80b6-e7ee9a1a1156"
      unitRef="usd">-8000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNy0xLTEtMS04MzQxNA_e2a17bf4-2dce-4b7e-b520-65c14085980b"
      unitRef="usd">-14689000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNy0zLTEtMS04MzQxNA_e1e5a080-67b7-4bf9-b080-28f45554378c"
      unitRef="usd">-10713000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNy01LTEtMS04MzQxNA_41532c2e-7127-450d-8c26-60bd37c0ee73"
      unitRef="usd">-30452000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfNy03LTEtMS04MzQxNA_85a5d434-c84c-46c2-98e4-23b2b3f9533c"
      unitRef="usd">-19122000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOC0xLTEtMS04MzQxNA_1e0f17c4-2f14-4832-bd55-21c2f0a4d6c6"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOC0xLTEtMS04MzQxNA_2be2c711-690a-4ffd-bb80-8a212b637b72"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOC0zLTEtMS04MzQxNA_1623d0dc-792b-4eae-8418-3cf486621aaf"
      unitRef="usdPerShare">-0.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOC0zLTEtMS04MzQxNA_3eb772e5-f061-4cb2-8ee6-833e004fb1fa"
      unitRef="usdPerShare">-0.19</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOC01LTEtMS04MzQxNA_af7a962f-9261-40b0-a744-6385301c6f84"
      unitRef="usdPerShare">-0.24</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOC01LTEtMS04MzQxNA_e2e0530f-52c1-42a3-a197-47f5e6e6d305"
      unitRef="usdPerShare">-0.24</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOC03LTEtMS04MzQxNA_7b8120b2-0b82-40df-ae23-bf6603dfabfc"
      unitRef="usdPerShare">-0.43</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOC03LTEtMS04MzQxNA_e417f70a-3505-41a2-8b43-4f264d605894"
      unitRef="usdPerShare">-0.43</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOS0xLTEtMS04MzQxNA_2124441b-d8fc-4696-8dcf-a50a033ec28a"
      unitRef="shares">124494036</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOS0xLTEtMS04MzQxNA_54747aa2-1f7c-4079-860e-f8c4cee78248"
      unitRef="shares">124494036</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOS0zLTEtMS04MzQxNA_452204ca-28cd-4bfa-b6d8-ad156001bb3b"
      unitRef="shares">55070480</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOS0zLTEtMS04MzQxNA_5c220873-1e3c-4a5f-8911-23007abe8f19"
      unitRef="shares">55070480</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOS01LTEtMS04MzQxNA_816b2f97-5e43-4967-ab89-4d72295bb476"
      unitRef="shares">124456518</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOS01LTEtMS04MzQxNA_b7d149ab-4f2a-4699-8166-7a24531f01e6"
      unitRef="shares">124456518</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOS03LTEtMS04MzQxNA_20a72585-7f3b-4a14-a8ee-03f73aaf5c70"
      unitRef="shares">44096149</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8yOC9mcmFnOjE5ZmZlYmI4MDUyMTQzZDM4MjI5ZjAzNzcwZjFhMDEwL3RhYmxlOmUyOGFkMzNmNzc3MDQ0OGJiZjcxZDg5OGRlYTQ3Zjc2L3RhYmxlcmFuZ2U6ZTI4YWQzM2Y3NzcwNDQ4YmJmNzFkODk4ZGVhNDdmNzZfOS03LTEtMS04MzQxNA_b3a3bf32-878e-4ab6-b43f-d6d6753ea607"
      unitRef="shares">44096149</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfMi0xLTEtMS04MzQxNA_4dbb0723-e645-454c-b903-c21c550e27b7"
      unitRef="usd">-14689000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfMi0zLTEtMS04MzQxNA_2ad794ce-d269-44f7-9b92-38cae5bdd22f"
      unitRef="usd">-10713000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfMi01LTEtMS04MzQxNA_f1f011a2-085e-44f1-a2e0-2b5329f0d574"
      unitRef="usd">-30452000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfMi03LTEtMS04MzQxNA_5d20a72d-3e60-4219-afc5-7a82580a6618"
      unitRef="usd">-19122000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfNC0xLTEtMS04MzQxNA_aaae8e00-7ed1-4ddd-9c84-28e245f984bc"
      unitRef="usd">-214000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfNC0zLTEtMS04MzQxNA_752c9718-bfab-4ce2-bd33-85b6059775b2"
      unitRef="usd">-12000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfNC01LTEtMS04MzQxNA_9dfbcd28-29f7-4d78-b622-18a5287e90c2"
      unitRef="usd">-584000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfNC03LTEtMS04MzQxNA_77bb59cc-8744-4e1e-af2a-f76dbf536553"
      unitRef="usd">-13000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfNS0xLTEtMS04MzQxNA_35bbdff3-cda5-4dce-821b-18feef74ee35"
      unitRef="usd">-214000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfNS0zLTEtMS04MzQxNA_e67088fc-444f-4334-964f-77c4f1e35614"
      unitRef="usd">-12000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfNS01LTEtMS04MzQxNA_7118a275-e010-485b-a7fb-e7c83fb55c26"
      unitRef="usd">-584000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfNS03LTEtMS04MzQxNA_8c85ca37-2f5a-48ff-ba47-b370972771cc"
      unitRef="usd">-13000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfNi0xLTEtMS04MzQxNA_61fc64ab-c124-4253-a9fb-8dae0998800a"
      unitRef="usd">-14903000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfNi0zLTEtMS04MzQxNA_c60203a1-332f-4346-8dfb-e77f79ec512e"
      unitRef="usd">-10725000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfNi01LTEtMS04MzQxNA_ad85f614-bed4-407d-aba8-db468d9c2c4d"
      unitRef="usd">-31036000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zMS9mcmFnOjRhZjdmY2I0MDY5NTQzODZiZjEyMzVlMzlhMmFiM2NmL3RhYmxlOjU4NDc1OWE5NjgyOTQ1MTA4NzYxMjIyYWMyNjRlMmYzL3RhYmxlcmFuZ2U6NTg0NzU5YTk2ODI5NDUxMDg3NjEyMjJhYzI2NGUyZjNfNi03LTEtMS04MzQxNA_2f9540b8-d4ae-417b-a97e-58ba23d9cf34"
      unitRef="usd">-19135000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i324e2cc43a4e4cf587d2f6ab80062f51_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMy0xLTEtMS04MzQxNA_4f2de112-61d8-4bb9-93d0-2ca9f47c4787"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i324e2cc43a4e4cf587d2f6ab80062f51_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMy0zLTEtMS04MzQxNA_83dd1e83-0da1-49f9-b223-60aa8b8cdb4b"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i7f90b4ca496645789fa6b735ea5ebed6_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMy01LTEtMS04MzQxNA_d0ab9f6e-6517-497c-a335-58238b38a3c0"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i7f90b4ca496645789fa6b735ea5ebed6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMy03LTEtMS04MzQxNA_64c4be1e-227f-4bd0-826c-204f058eea24"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="icdd25765152a4ced9576a609916fc669_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMy05LTEtMS04MzQxNA_185b161f-3e44-4c4d-9e55-a3361a7e6703"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="icdd25765152a4ced9576a609916fc669_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMy0xMS0xLTEtODM0MTQ_d314a4f5-fec9-4bcc-ba96-f5f061b26ff6"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i90b7a94b75e741018792ad40fce39e8b_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMy0xNC0xLTEtODM0MTQ_232b3041-b005-41f9-a8ea-3b8e12db7ce5"
      unitRef="shares">124456653</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i90b7a94b75e741018792ad40fce39e8b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMy0xNi0xLTEtODM0MTQ_b466ca58-c24a-421c-a2d1-39dd40ac21d6"
      unitRef="usd">12000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i671a15cf99d44d1784c894a87c80e686_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMy0xOC0xLTEtODM0MTQ_fffe595c-757c-43c3-b6cb-da935953461f"
      unitRef="usd">446654000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i84e9820405224bd7bd61573fe1ab8754_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMy0yMC0xLTEtODM0MTQ_0cb652a3-dd03-4bcb-aa3a-dbfb265a3144"
      unitRef="usd">-554000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if84c94ae09ea4044bd354a2967d293b3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMy0yMi0xLTEtODM0MTQ_4f728d23-4764-48ce-baf5-018fb3bd1670"
      unitRef="usd">-96403000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i92668a7081b949668c4894010570de77_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMy0yNC0xLTEtODM0MTQ_505e52df-4355-4b54-8e9a-595cb77ec35d"
      unitRef="usd">349709000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i8e0a243e6ed64e6380f701b2efb5ff8b_D20220401-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfNC0xNC0xLTEtODM0MTQ_25ec29a3-b678-491c-9a8a-a204d1aecbb2"
      unitRef="shares">57739</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7e6daf471bc241889e532847e9ba6e85_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfNC0xOC0xLTEtODM0MTQ_27dcc36a-a9cf-4881-a33e-dffbd5bb9d80"
      unitRef="usd">32000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfNC0yNC0xLTEtODM0MTQ_3e878895-4fe3-47a6-ba0f-7815fbf0b5fd"
      unitRef="usd">32000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i8e0a243e6ed64e6380f701b2efb5ff8b_D20220401-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfOC0xNC0xLTEtODU3Mjk_ca58fa75-9d48-45d5-8c67-46360349960e"
      unitRef="shares">48353</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i7e6daf471bc241889e532847e9ba6e85_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfOC0xOC0xLTEtODU3Mjk_c0eb12c5-77f8-4749-9ad0-4829e87b3a86"
      unitRef="usd">153000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfOC0yNC0xLTEtODU3Mjk_46627f7a-6728-41c7-a64a-bd1f7676c3ff"
      unitRef="usd">153000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7e6daf471bc241889e532847e9ba6e85_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfOC0xOC0xLTEtODM0MTQ_dbdde066-853a-4f3c-93a1-8df024ddf1e1"
      unitRef="usd">2567000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfOC0yNC0xLTEtODM0MTQ_9c2ff734-6ae8-4367-a9d8-9dc7b3b24cc0"
      unitRef="usd">2567000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if5d7470609454d0e9b5dff503cff7980_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfOS0yMC0xLTEtODM0MTQ_09b84257-f55e-486a-9a40-83ff8b4efc14"
      unitRef="usd">-214000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfOS0yNC0xLTEtODM0MTQ_709f0dc2-b0fa-4ddf-959f-236933b604ea"
      unitRef="usd">-214000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i9432f4700dc64531b14d489ac2a5a042_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTAtMjItMS0xLTgzNDE0_62d0d793-1e7d-436f-badb-7ce380ab5d09"
      unitRef="usd">-14689000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTAtMjQtMS0xLTgzNDE0_31978425-f0b8-46e7-99ae-ea71d19872d3"
      unitRef="usd">-14689000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i4472b9eda37d47c1a4d8adc7d6d2cd67_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTEtMS0xLTEtODM0MTQ_88fc44d0-37f9-4ed4-b56e-552752c1af8f"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i4472b9eda37d47c1a4d8adc7d6d2cd67_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTEtMy0xLTEtODM0MTQ_567da97a-6747-4651-be5b-96ed646e7d8d"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ia8d4f89749114fff9f0cfa6384876a0b_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTEtNS0xLTEtODM0MTQ_6f535203-24ca-4be3-9a7b-81f33d234284"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ia8d4f89749114fff9f0cfa6384876a0b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTEtNy0xLTEtODM0MTQ_9813c83e-e45f-49e5-af37-cf4e5f559a5e"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i3734d525d0254e38ba1f10086eb40e63_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTEtOS0xLTEtODM0MTQ_10309e3e-07c1-4a4f-b74a-19eda04585c0"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i3734d525d0254e38ba1f10086eb40e63_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTEtMTEtMS0xLTgzNDE0_e243dc6a-e409-4fa0-b4a4-2c3fb334e040"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i389999977661484882273df554199358_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTEtMTQtMS0xLTgzNDE0_8cfad24e-c405-4f5b-811e-df00e8e7b288"
      unitRef="shares">124562745</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i389999977661484882273df554199358_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTEtMTYtMS0xLTgzNDE0_e1dd7a57-a614-481a-9f8a-2090149bf699"
      unitRef="usd">12000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie314d916207a418aa13a6eac1ba0316b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTEtMTgtMS0xLTgzNDE0_eb6be7ee-7597-489b-a46e-70607ef3d741"
      unitRef="usd">449406000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i94e283e466604a8d91b96c149bce904f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTEtMjAtMS0xLTgzNDE0_c18134a8-82ea-4546-bb02-ba9e5b9b30e4"
      unitRef="usd">-768000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0d2cd67fbecd458cba307172152eed68_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTEtMjItMS0xLTgzNDE0_634cf4a3-4160-4147-8502-c15bf7c989a5"
      unitRef="usd">-111092000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjc0ZmE0ZWY5NTQ0OTQwOWNhZDQ4YjU5NWIxYzVlZTFjL3RhYmxlcmFuZ2U6NzRmYTRlZjk1NDQ5NDA5Y2FkNDhiNTk1YjFjNWVlMWNfMTEtMjQtMS0xLTgzNDE0_3a8b2b85-ae57-49f0-9396-c2f281d16587"
      unitRef="usd">337558000</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ia42f738735254708b40f6633a2122e8e_I20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy0xLTEtMS04MzQxNA_d93a5fd4-a81d-4f6a-bcf2-79846171a71b"
      unitRef="shares">13174805</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ia42f738735254708b40f6633a2122e8e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy0zLTEtMS04MzQxNA_74f026fb-b1ac-4723-9525-dae8cf62ec7f"
      unitRef="usd">5494000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ie85bed107ca14c97901fe21cb7bb5dd8_I20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy01LTEtMS04MzQxNA_3dc86bbc-0b9f-4c1b-a97e-7d41ff3190d9"
      unitRef="shares">16836436</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ie85bed107ca14c97901fe21cb7bb5dd8_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy03LTEtMS04MzQxNA_b61d2c0c-4d5d-4a2c-b791-2eaad1e44964"
      unitRef="usd">27067000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i1335e9d7772048258994030cd2031c3f_I20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy05LTEtMS04MzQxNA_daa8f9e7-8532-4003-82f7-c4c3ae86deca"
      unitRef="shares">22164724</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i1335e9d7772048258994030cd2031c3f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy0xMS0xLTEtODM0MTQ_c8cebed6-c049-4e76-8ade-16e6bc0b38c7"
      unitRef="usd">75857000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i05843a43ee50491196307c78a95fc47c_I20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy0xNC0xLTEtODM0MTQ_4d3d6df8-8f33-4873-8fbc-7848e7307f40"
      unitRef="shares">33069513</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i05843a43ee50491196307c78a95fc47c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy0xNi0xLTEtODM0MTQ_69a009d1-e949-467b-8473-c2f19595d8a1"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8e040518794245b0863ec2f6444d3794_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy0xOC0xLTEtODM0MTQ_67fe4961-4b0a-4ba6-9c7c-21725fbd91c9"
      unitRef="usd">1936000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5202287c29e942c5b0cdac7690f742a4_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy0yMC0xLTEtODM0MTQ_8cd27a55-13ed-4bff-9e12-7128b9535c2a"
      unitRef="usd">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5bb0ce9e01b540f58814347806008b98_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy0yMi0xLTEtODM0MTQ_50b03d28-defb-4def-99df-e20ba1db08c8"
      unitRef="usd">-38734000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3c6985f8581548c2a524d21940747415_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy0yNC0xLTEtODM0MTQ_33d9f17d-bbec-4ecb-9ce3-4f325f3d3871"
      unitRef="usd">-36795000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i331a2564c2fd4ca8a141e5b7414f9560_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNC0xNC0xLTEtODM0MTQ_60d8abd0-bfc6-4ce0-9a1f-cda9cdbd83ff"
      unitRef="shares">65003</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic4c2e6f425d94a478aa350968a70941c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNC0xOC0xLTEtODM0MTQ_f3c86b3d-c919-4fc4-ae13-0adf43f9653a"
      unitRef="usd">46000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNC0yNC0xLTEtODM0MTQ_7324e612-566a-42ed-b173-c04e51871f0a"
      unitRef="usd">46000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <naut:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="i331a2564c2fd4ca8a141e5b7414f9560_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNS0xNC0xLTEtODQ0NzU_61e3aa2a-5c3e-494b-ae90-37291d77a75f"
      unitRef="shares">62772</naut:StockIssuedDuringPeriodSharesWarrantsExercised>
    <naut:ReclassificationsOfTemporaryToPermanentEquityShares
      contextRef="ia19895c7ccdf43c886000a1fe40ad74d_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi0xLTEtMS04NDQ2OA_20297a22-d73b-4327-b5ca-3ff135f493d7"
      unitRef="shares">-13174805</naut:ReclassificationsOfTemporaryToPermanentEquityShares>
    <us-gaap:ReclassificationsOfTemporaryToPermanentEquity
      contextRef="ia19895c7ccdf43c886000a1fe40ad74d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi0zLTEtMS04NDQ2OA_102faac5-abf5-4ce5-adc3-3549f86ea6a7"
      unitRef="usd">-5494000</us-gaap:ReclassificationsOfTemporaryToPermanentEquity>
    <naut:ReclassificationsOfTemporaryToPermanentEquityShares
      contextRef="i23ee12f309a94096b523c85c9c89ec41_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi01LTEtMS04NDQ2OA_9ce79aea-6f5a-4f20-b036-347ba96cdc23"
      unitRef="shares">-16836436</naut:ReclassificationsOfTemporaryToPermanentEquityShares>
    <us-gaap:ReclassificationsOfTemporaryToPermanentEquity
      contextRef="i23ee12f309a94096b523c85c9c89ec41_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi03LTEtMS04NDQ2OA_4f3c1bb2-2773-4c67-b7c6-a6922b8769b6"
      unitRef="usd">-27067000</us-gaap:ReclassificationsOfTemporaryToPermanentEquity>
    <naut:ReclassificationsOfTemporaryToPermanentEquityShares
      contextRef="ibb3fddc37cf84806bb3cb2eb9243e764_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi05LTEtMS04NDQ2OA_43ffdcfe-0fbb-4d42-9614-cfecfc6ff0c7"
      unitRef="shares">-22164724</naut:ReclassificationsOfTemporaryToPermanentEquityShares>
    <us-gaap:ReclassificationsOfTemporaryToPermanentEquity
      contextRef="ibb3fddc37cf84806bb3cb2eb9243e764_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi0xMS0xLTEtODQ0Njg_856aa965-04c9-4ef7-b35b-e73286357a4d"
      unitRef="usd">-75857000</us-gaap:ReclassificationsOfTemporaryToPermanentEquity>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i331a2564c2fd4ca8a141e5b7414f9560_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi0xNC0xLTEtODQ0NzU_57bc314f-834c-40f1-a242-997899b68f31"
      unitRef="shares">52175965</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i331a2564c2fd4ca8a141e5b7414f9560_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi0xNi0xLTEtODQ0NzU_6902c066-89ad-44c8-91f1-e34e3a9ac77f"
      unitRef="usd">7000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="ic4c2e6f425d94a478aa350968a70941c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi0xOC0xLTEtODQ0NzU_0df6904a-298a-48ae-91d8-89e0994e080b"
      unitRef="usd">108411000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi0yNC0xLTEtODQ0NzU_d41e32d7-7f35-47bc-ba02-39d7feb120d1"
      unitRef="usd">108418000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <naut:StockIssuedDuringPeriodSharesReverseRecapitalization
      contextRef="i331a2564c2fd4ca8a141e5b7414f9560_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNy0xNC0xLTEtODQ0NzU_05b2a09e-74fe-48ba-9927-bcbc1cebd63e"
      unitRef="shares">38721137</naut:StockIssuedDuringPeriodSharesReverseRecapitalization>
    <naut:StockIssuedDuringPeriodValueReverseRecapitalization
      contextRef="i331a2564c2fd4ca8a141e5b7414f9560_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNy0xNi0xLTEtODQ0NzU_749ccf7a-b4ed-41bf-9f19-1143f23fe77c"
      unitRef="usd">4000</naut:StockIssuedDuringPeriodValueReverseRecapitalization>
    <naut:StockIssuedDuringPeriodValueReverseRecapitalization
      contextRef="ic4c2e6f425d94a478aa350968a70941c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNy0xOC0xLTEtODQ0NzU_b88beadd-30cd-49c1-b641-f75fcda5cc86"
      unitRef="usd">327276000</naut:StockIssuedDuringPeriodValueReverseRecapitalization>
    <naut:StockIssuedDuringPeriodValueReverseRecapitalization
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNy0yNC0xLTEtODQ0NzU_facf65d2-b995-4a55-b2f4-9d5f83ecbd88"
      unitRef="usd">327280000</naut:StockIssuedDuringPeriodValueReverseRecapitalization>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic4c2e6f425d94a478aa350968a70941c_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi0xOC0xLTEtODM0MTQ_f4592e0f-7dd2-4fc5-8600-22741c841628"
      unitRef="usd">1820000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi0yNC0xLTEtODM0MTQ_d1ede71e-ec40-48f0-91f0-75f6f8603a59"
      unitRef="usd">1820000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i64c43e244ef8492fa7383bb02f49cad6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNy0yMC0xLTEtODM0MTQ_961c877f-50bd-4db6-8783-46b026a99904"
      unitRef="usd">-12000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNy0yNC0xLTEtODM0MTQ_ef7d39c7-8394-4d6a-9f7e-10aaebb8d5d3"
      unitRef="usd">-12000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="iaf5ead0636be44b29ce427b1dd08509d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOC0yMi0xLTEtODM0MTQ_588d2ae0-ca5b-4ba5-8f41-c64548e6703e"
      unitRef="usd">-10713000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOC0yNC0xLTEtODM0MTQ_dcd87651-b1b3-4552-a625-ea073a3e2145"
      unitRef="usd">-10713000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ie9e2d89185264884b8085af4b2cd97fc_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS0xLTEtMS04MzQxNA_034b4253-3fca-4b18-92d1-236a541cddfd"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ie9e2d89185264884b8085af4b2cd97fc_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS0zLTEtMS04MzQxNA_267b6689-b499-4049-a619-59cd0cc66bb3"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ic17b9d22c2764dd798b80f5dfc34b5cf_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS01LTEtMS04MzQxNA_33093a59-7f1b-49ac-a9c6-08437cf57263"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ic17b9d22c2764dd798b80f5dfc34b5cf_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS03LTEtMS04MzQxNA_35f2c7c1-5b02-4b2b-b2e5-fab204b3ffb5"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i91ec4082056644ceb4605ae97ee305ff_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS05LTEtMS04MzQxNA_6edd4567-16bd-4015-a577-62d71f192da8"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i91ec4082056644ceb4605ae97ee305ff_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS0xMS0xLTEtODM0MTQ_8412c177-d857-42d2-bbfd-774dd35e884f"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="ib5a3a46052d04721ae2a3b35284e5778_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS0xNC0xLTEtODM0MTQ_3f69f49b-df8f-49c3-be9b-43be5bd65607"
      unitRef="shares">124094390</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ib5a3a46052d04721ae2a3b35284e5778_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS0xNi0xLTEtODM0MTQ_a2f0552e-8620-45a6-b8e6-2def11706570"
      unitRef="usd">12000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1c20cf8954844243a311683aea4cdc51_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS0xOC0xLTEtODM0MTQ_294dfcf9-fdcc-4789-bed5-b77b6ba5f894"
      unitRef="usd">439489000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i93e671a07e70472fbbddd30300e8c88e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS0yMC0xLTEtODM0MTQ_f40f8d30-6991-476e-a77f-597396e4c082"
      unitRef="usd">-10000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5af05f6fd3814dfcbf23c51970fb91b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS0yMi0xLTEtODM0MTQ_d605b811-6bc0-4e3e-9ac3-650b83327e24"
      unitRef="usd">-49447000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibff31d711c89442ab7051c729b67d7e0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS0yNC0xLTEtODM0MTQ_cb3df700-d94e-4f41-869b-fd9741fc0429"
      unitRef="usd">390044000</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i7cc1b5792cf94105940e3332ea917424_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy0xLTEtMS04NDUwNg_4edba972-c1cb-4ffb-a57b-4e2ca9adfa57"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i7cc1b5792cf94105940e3332ea917424_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy0zLTEtMS04NDUwNg_1c2eb489-595e-40d3-ae48-0e34b7a340b4"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i36b1b43803b74d6f9880f7465fee5d9b_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy01LTEtMS04NDUwNg_b8bc7253-d81f-4b02-959a-8f5afd08a577"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i36b1b43803b74d6f9880f7465fee5d9b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy03LTEtMS04NDUwNg_d7762fa1-23e9-4cc2-96e8-a508cc22a36f"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ib4e23aef5312440092a0c722a7b14905_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy05LTEtMS04NDUwNg_2d8ba5f5-eee8-4e45-8c28-d31752cafccc"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ib4e23aef5312440092a0c722a7b14905_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy0xMS0xLTEtODQ1MDY_04303050-74ba-4699-a323-c9dc69e9aa7a"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="id40db1cc432e4a13bfe6f29d29443dfb_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy0xNC0xLTEtODQ1MDk_ffa78cf3-5d7a-4ce6-8f0a-89208842a501"
      unitRef="shares">124303083</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="id40db1cc432e4a13bfe6f29d29443dfb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy0xNi0xLTEtODQ1MDk_b7754c9d-40e0-4947-b931-f55d1c31a34c"
      unitRef="usd">12000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9fc487a3a7a14aa09b1841736e6b5f97_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy0xOC0xLTEtODQ1MDk_59770708-d6e2-499b-9545-c4aec1ad8b08"
      unitRef="usd">444388000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3b2bafa5e4ed4f35b82f303f9778746d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy0yMC0xLTEtODQ1MDk_6e64d513-844f-487b-9ca7-1da3e1665f1b"
      unitRef="usd">-184000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib76ca1b4c23944e7823ec12efb0e4440_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy0yMi0xLTEtODQ1MDk_ce7a83dc-bb01-4847-9b7f-f75e83dd990d"
      unitRef="usd">-80640000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy0yNC0xLTEtODQ1MDk_a625d7cd-8675-456f-808f-d3753bfe3099"
      unitRef="usd">363576000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i6a897b30f9ac4d8a98520fc12b077eb7_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfNC0xNC0xLTEtODQ1MDk_8f776fee-0955-4314-837d-e64b44ab36d0"
      unitRef="shares">211309</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ifd33588bc4814c39915e2771cc9556d1_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfNC0xOC0xLTEtODQ1MDk_2f2f6ef8-39a4-4a68-a5e8-cc6ea2dda780"
      unitRef="usd">188000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfNC0yNC0xLTEtODQ1MDk_9b0e5eff-5539-4836-87a3-c86c3bb13d32"
      unitRef="usd">188000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i6a897b30f9ac4d8a98520fc12b077eb7_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfOC0xNC0xLTEtODU2OTk_17cc78a9-285a-4683-b922-53ccbca07603"
      unitRef="shares">48353</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ifd33588bc4814c39915e2771cc9556d1_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfOC0xOC0xLTEtODU2OTk_63722114-c999-4aeb-ac6d-5c56ff437c76"
      unitRef="usd">153000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfOC0yNC0xLTEtODU2OTk_e0c8abe3-0047-4ad0-9578-2ed6806fe3bf"
      unitRef="usd">153000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifd33588bc4814c39915e2771cc9556d1_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfOC0xOC0xLTEtODQ1MDk_8a263ee5-d8d5-4c53-9d24-b9d02b802d39"
      unitRef="usd">4677000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfOC0yNC0xLTEtODQ1MDk_2505e360-7771-4710-aa47-9dc1535394fe"
      unitRef="usd">4677000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i6be3e094f3c24773ad3af2c5ef2aa634_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfOS0yMC0xLTEtODQ1MDk_fd8ce64c-742e-4851-bdd9-9642f969c064"
      unitRef="usd">-584000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfOS0yNC0xLTEtODQ1MDk_44a0817d-41bb-4f70-89bc-1f6d3cd32584"
      unitRef="usd">-584000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i149f021a272a4689a24162c8f8e7d768_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTAtMjItMS0xLTg0NTA5_98696552-f898-49fa-910d-ab81d7d26ff0"
      unitRef="usd">-30452000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTAtMjQtMS0xLTg0NTA5_81bdf90c-9fdd-475d-8397-dc84fe223de7"
      unitRef="usd">-30452000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i4472b9eda37d47c1a4d8adc7d6d2cd67_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtMS0xLTEtODQ1MDY_bffaae5a-9acd-4a32-96ff-e26d68de6ad5"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i4472b9eda37d47c1a4d8adc7d6d2cd67_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtMy0xLTEtODQ1MDY_49fbf8a3-d880-4a89-aba4-d976da0efe07"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ia8d4f89749114fff9f0cfa6384876a0b_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtNS0xLTEtODQ1MDY_22ceea25-8891-45fb-bfa7-d4ed0c4c76e5"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ia8d4f89749114fff9f0cfa6384876a0b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtNy0xLTEtODQ1MDY_391465c4-0a52-4802-89df-589019b17e0c"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i3734d525d0254e38ba1f10086eb40e63_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtOS0xLTEtODQ1MDY_210860ff-0daf-48e6-97d5-7d4e201f43f6"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i3734d525d0254e38ba1f10086eb40e63_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtMTEtMS0xLTg0NTA2_e6151c55-bf84-49e5-a3fe-d4974dfa5518"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i389999977661484882273df554199358_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtMTQtMS0xLTg0NTA5_26835d7a-7a99-4bda-887f-9ce027293260"
      unitRef="shares">124562745</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i389999977661484882273df554199358_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtMTYtMS0xLTg0NTA5_c6d78b3b-69e9-4182-9ead-64d085d1bfc9"
      unitRef="usd">12000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie314d916207a418aa13a6eac1ba0316b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtMTgtMS0xLTg0NTA5_b84c552c-c8d5-4ee5-83ca-ad5bb4e25bc5"
      unitRef="usd">449406000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i94e283e466604a8d91b96c149bce904f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtMjAtMS0xLTg0NTA5_8e4a9983-9b60-4044-a25e-b64d8cd40a34"
      unitRef="usd">-768000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0d2cd67fbecd458cba307172152eed68_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtMjItMS0xLTg0NTA5_bb452fe9-7b64-4778-a7e6-b3593c7594c7"
      unitRef="usd">-111092000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtMjQtMS0xLTg0NTA5_475be139-c8d3-4ac9-b249-8a2581c4081b"
      unitRef="usd">337558000</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ib1a4309f941040f286a32c33912b765f_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy0xLTEtMS04NDQ5Mg_851ca1e7-788c-4451-a018-d1ddcb4366c1"
      unitRef="shares">13174805</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ib1a4309f941040f286a32c33912b765f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy0zLTEtMS04NDQ5Mg_9acad75e-925f-49b0-82f7-7e2a822d6467"
      unitRef="usd">5494000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i72367460707f479b803532b3fb755692_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy01LTEtMS04NDQ5Mg_1d02e536-9978-4a12-9457-c9d32604020b"
      unitRef="shares">16836436</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i72367460707f479b803532b3fb755692_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy03LTEtMS04NDQ5Mg_2c1cc92d-3225-406a-ae35-43dcc870b071"
      unitRef="usd">27067000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i7d44af6f75f540d7b0ecbde2f40b4975_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy05LTEtMS04NDQ5Mg_e6eed32e-e8f9-4997-9df8-2ef2c264d55a"
      unitRef="shares">22164724</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i7d44af6f75f540d7b0ecbde2f40b4975_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy0xMS0xLTEtODQ0OTI_5473fab1-5d8c-49bb-9181-375cb21b2ba1"
      unitRef="usd">75857000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="ifde94ccddd2d45069a65f8843572a9ae_I20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy0xNC0xLTEtODQ0OTk_719f2a7b-ec0b-40ac-a508-a821cb3bd035"
      unitRef="shares">33069513</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ifde94ccddd2d45069a65f8843572a9ae_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy0xNi0xLTEtODQ0OTk_fe9faf56-eac0-4e2e-add6-1f6c6f88d799"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i35476aa1f20349a1b78904608e5b16ab_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy0xOC0xLTEtODQ0OTk_e522849a-bc2c-4406-bec1-01e03c485c1f"
      unitRef="usd">600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4ea49b1cdab94931bcc33becf8b06845_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy0yMC0xLTEtODQ0OTk_b1b80ac4-d0c5-4495-bc3a-a48a57547558"
      unitRef="usd">3000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i944a24eac2e246da8e69f0c1ac41391d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy0yMi0xLTEtODQ0OTk_d1834298-3088-410a-b0d4-a253983066d9"
      unitRef="usd">-30325000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i616643cbd31d47a686cf71385bb21573_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy0yNC0xLTEtODQ0OTk_d4c33bb7-53b9-452b-8486-87ad803fc7b7"
      unitRef="usd">-29721000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="iaec5179caeab4e28a0d89e51f7815911_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNC0xNC0xLTEtODQ0OTk_97d76318-92a5-4f80-b04a-d7b50d140d16"
      unitRef="shares">65003</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4ab559ce8be94eab9ca0ec550a426771_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNC0xOC0xLTEtODQ0OTk_78084ea5-c04e-44ef-8688-6c93d120997b"
      unitRef="usd">46000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNC0yNC0xLTEtODQ0OTk_f3320890-b48e-4e9f-a1a0-6fd6f90de80e"
      unitRef="usd">46000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <naut:StockIssuedDuringPeriodSharesWarrantsExercised
      contextRef="iaec5179caeab4e28a0d89e51f7815911_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNS0xNC0xLTEtODQ0OTk_80af0f86-b8df-4a3e-bed6-4d2862df830c"
      unitRef="shares">62772</naut:StockIssuedDuringPeriodSharesWarrantsExercised>
    <naut:ReclassificationsOfTemporaryToPermanentEquityShares
      contextRef="ieff8ab03765e4ac7b663c2cbfb8ab6f8_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi0xLTEtMS04NDQ5Mg_74f4ac74-240d-4f1b-9934-8cac77a2ebaf"
      unitRef="shares">-13174805</naut:ReclassificationsOfTemporaryToPermanentEquityShares>
    <us-gaap:ReclassificationsOfTemporaryToPermanentEquity
      contextRef="ieff8ab03765e4ac7b663c2cbfb8ab6f8_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi0zLTEtMS04NDQ5Mg_cf87a956-bfdf-4b1c-acb1-2fcde1ab4192"
      unitRef="usd">-5494000</us-gaap:ReclassificationsOfTemporaryToPermanentEquity>
    <naut:ReclassificationsOfTemporaryToPermanentEquityShares
      contextRef="i43f28fa225984e9bbd35f3d7ff3f55c6_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi01LTEtMS04NDQ5Mg_480e1859-325f-4374-ae5f-6d4318797597"
      unitRef="shares">-16836436</naut:ReclassificationsOfTemporaryToPermanentEquityShares>
    <us-gaap:ReclassificationsOfTemporaryToPermanentEquity
      contextRef="i43f28fa225984e9bbd35f3d7ff3f55c6_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi03LTEtMS04NDQ5Mg_d6efd2b6-3377-4720-a716-377752b79cea"
      unitRef="usd">-27067000</us-gaap:ReclassificationsOfTemporaryToPermanentEquity>
    <naut:ReclassificationsOfTemporaryToPermanentEquityShares
      contextRef="ice89ec8597d741e6a43e56fbdbb1915b_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi05LTEtMS04NDQ5Mg_7f9b9355-bce7-4582-bdf6-52f2251ca828"
      unitRef="shares">-22164724</naut:ReclassificationsOfTemporaryToPermanentEquityShares>
    <us-gaap:ReclassificationsOfTemporaryToPermanentEquity
      contextRef="ice89ec8597d741e6a43e56fbdbb1915b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi0xMS0xLTEtODQ0OTI_98fc30b1-3dc4-4681-9def-03b0da8fd9a2"
      unitRef="usd">-75857000</us-gaap:ReclassificationsOfTemporaryToPermanentEquity>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="iaec5179caeab4e28a0d89e51f7815911_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi0xNC0xLTEtODQ0OTk_52185f78-57f1-41ee-ba4a-19e2df199dea"
      unitRef="shares">52175965</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="iaec5179caeab4e28a0d89e51f7815911_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi0xNi0xLTEtODQ0OTk_bc572a92-eee0-49cc-910b-6bc5334be637"
      unitRef="usd">7000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i4ab559ce8be94eab9ca0ec550a426771_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi0xOC0xLTEtODQ0OTk_06b1f810-70c2-4749-ad84-dc234272d71a"
      unitRef="usd">108411000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi0yNC0xLTEtODQ0OTk_05b298ec-4839-4547-b48e-6e95c8f9ce35"
      unitRef="usd">108418000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <naut:StockIssuedDuringPeriodSharesReverseRecapitalization
      contextRef="iaec5179caeab4e28a0d89e51f7815911_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNy0xNC0xLTEtODQ0OTk_d5a07a5b-d731-47e5-a184-403b6951b5ac"
      unitRef="shares">38721137</naut:StockIssuedDuringPeriodSharesReverseRecapitalization>
    <naut:StockIssuedDuringPeriodValueReverseRecapitalization
      contextRef="iaec5179caeab4e28a0d89e51f7815911_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNy0xNi0xLTEtODQ0OTk_60e8fe84-9ac2-4391-afed-79f98c285342"
      unitRef="usd">4000</naut:StockIssuedDuringPeriodValueReverseRecapitalization>
    <naut:StockIssuedDuringPeriodValueReverseRecapitalization
      contextRef="i4ab559ce8be94eab9ca0ec550a426771_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNy0xOC0xLTEtODQ0OTk_fb4811cd-0928-4b8a-8f33-917085615e66"
      unitRef="usd">327276000</naut:StockIssuedDuringPeriodValueReverseRecapitalization>
    <naut:StockIssuedDuringPeriodValueReverseRecapitalization
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNy0yNC0xLTEtODQ0OTk_88d0a41b-c3bb-48d9-b8bf-9a66b6b70704"
      unitRef="usd">327280000</naut:StockIssuedDuringPeriodValueReverseRecapitalization>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4ab559ce8be94eab9ca0ec550a426771_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfOS0xOC0xLTEtODQ0OTk_5f9f1317-61a7-4f65-955c-9ce428be3782"
      unitRef="usd">3156000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfOS0yNC0xLTEtODQ0OTk_743a6a6e-809a-41db-88d0-0ed787a2bcb2"
      unitRef="usd">3156000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i5e556ea5dbff49d8b604228bf8cd44a0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTAtMjAtMS0xLTg0NDk5_cea37258-c576-42b4-8f4a-335eb5686ac9"
      unitRef="usd">-13000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTAtMjQtMS0xLTg0NDk5_16167b8e-1d9b-4a0a-91b1-34425899be40"
      unitRef="usd">-13000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i83eab16a45a34043b19482dba0424ebf_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTEtMjItMS0xLTg0NDk5_78014abc-8596-40ea-b022-3b697d5a8b19"
      unitRef="usd">-19122000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTEtMjQtMS0xLTg0NDk5_c4fd7fd6-8a8d-4b1e-906c-7ac3ccff49b9"
      unitRef="usd">-19122000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ie9e2d89185264884b8085af4b2cd97fc_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItMS0xLTEtODQ0OTI_4ca8e9cc-23bf-48c8-bb72-7c3582044e38"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ie9e2d89185264884b8085af4b2cd97fc_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItMy0xLTEtODQ0OTI_209568eb-7a26-462e-9dc6-cc053a729ac1"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ic17b9d22c2764dd798b80f5dfc34b5cf_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItNS0xLTEtODQ0OTI_46c2bf03-9c4c-49b2-937b-33031864d629"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ic17b9d22c2764dd798b80f5dfc34b5cf_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItNy0xLTEtODQ0OTI_cae89cae-8002-4d78-9a6a-0d87ceb98a85"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i91ec4082056644ceb4605ae97ee305ff_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItOS0xLTEtODQ0OTI_733722af-14c8-4290-8046-f9cba9551922"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i91ec4082056644ceb4605ae97ee305ff_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItMTEtMS0xLTg0NDky_87ce9ccd-25b5-4c40-bd74-6775e1b5c10e"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="ib5a3a46052d04721ae2a3b35284e5778_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItMTQtMS0xLTg0NDk5_ab958293-94be-428e-9d40-eb3216ad4fa3"
      unitRef="shares">124094390</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ib5a3a46052d04721ae2a3b35284e5778_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItMTYtMS0xLTg0NDk5_586c96f6-e7ba-49d7-b3e9-15cceb0e921b"
      unitRef="usd">12000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1c20cf8954844243a311683aea4cdc51_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItMTgtMS0xLTg0NDk5_b7388d6f-7e2f-4570-804c-31caa52e9ab9"
      unitRef="usd">439489000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i93e671a07e70472fbbddd30300e8c88e_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItMjAtMS0xLTg0NDk5_db106d43-dc1f-4b85-9f09-ea1d3175ea0c"
      unitRef="usd">-10000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5af05f6fd3814dfcbf23c51970fb91b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItMjItMS0xLTg0NDk5_3feee35e-6cb8-47f2-80e8-e9497ed7f9b4"
      unitRef="usd">-49447000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibff31d711c89442ab7051c729b67d7e0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItMjQtMS0xLTg0NDk5_8a2db744-4240-42f6-a49c-70ad427381b3"
      unitRef="usd">390044000</us-gaap:StockholdersEquity>
    <naut:RecapitalizationExchangeRatio
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMjMw_483b0f35-5b29-4fc6-ad61-ad8b13f4878f"
      unitRef="number">3.6281</naut:RecapitalizationExchangeRatio>
    <us-gaap:NetIncomeLoss
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMy0xLTEtMS04MzQxNA_600d069f-d81f-4c91-b70f-5a0aed3a47cf"
      unitRef="usd">-30452000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMy0zLTEtMS04MzQxNA_d9c51db2-b462-4c34-a40d-4975ef352a23"
      unitRef="usd">-19122000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfNS0xLTEtMS04MzQxNA_8146e581-fbe7-48ec-8b9a-aebcaf534136"
      unitRef="usd">562000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfNS0zLTEtMS04MzQxNA_578eec61-8721-4d0f-91c7-92a230f481fa"
      unitRef="usd">479000</us-gaap:Depreciation>
    <us-gaap:ShareBasedCompensation
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfNi0xLTEtMS04MzQxNA_6c929818-3ae9-4d9d-82b5-9956a319db85"
      unitRef="usd">4677000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfNi0zLTEtMS04MzQxNA_52264e69-6777-4241-aa13-735246dd08ce"
      unitRef="usd">3156000</us-gaap:ShareBasedCompensation>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfNy0xLTEtMS04MzQxNA_d793cb59-81a5-480d-a3ff-f766daabfc1a"
      unitRef="usd">147000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfNy0zLTEtMS04MzQxNA_fd570e9b-a6dd-471c-a0b7-2057ca57a442"
      unitRef="usd">-213000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfOC0xLTEtMS04MzQxNA_e1635090-a3c4-4898-9e39-0aa64881d9fa"
      unitRef="usd">1073000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfOC0zLTEtMS04MzQxNA_31adceff-eee2-4e07-b533-ff3f11973167"
      unitRef="usd">760000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTEtMS0xLTEtODM0MTQ_47bd58eb-2a31-4c58-8699-b38fb85f1387"
      unitRef="usd">503000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTEtMy0xLTEtODM0MTQ_14a93911-54be-44f1-86b8-85413d779378"
      unitRef="usd">331000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTItMS0xLTEtODM0MTQ_e4a3a7ba-f792-4821-b5a0-6e34e1c5d6c7"
      unitRef="usd">-643000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTItMy0xLTEtODM0MTQ_7aa60067-bf78-4e23-bdfe-754b95ddcc73"
      unitRef="usd">725000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTMtMS0xLTEtODM0MTQ_04e5017b-7f8e-4bc9-a3b1-5cc479ca2118"
      unitRef="usd">-11000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTMtMy0xLTEtODM0MTQ_35372ec9-ccc9-49dc-91cf-e12640ee1c40"
      unitRef="usd">410000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTQtMS0xLTEtODM0MTQ_2456ae6b-7ea3-40fe-ac3d-c6e875a5827d"
      unitRef="usd">-420000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTQtMy0xLTEtODM0MTQ_7c83a54a-1212-4e1e-85bd-3d5296bc1785"
      unitRef="usd">-835000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTUtMS0xLTEtODM0MTQ_accede5d-804f-45bb-8986-32cee20ac491"
      unitRef="usd">-25864000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTUtMy0xLTEtODM0MTQ_bc15a3e3-91a4-4167-9837-20bfb1d4d734"
      unitRef="usd">-14545000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTctMS0xLTEtODM0MTQ_76df7be7-a8a7-4339-a1a5-744d2eefc67d"
      unitRef="usd">105575000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTctMy0xLTEtODM0MTQ_7650a583-aa61-422f-bfa1-6e6696293c06"
      unitRef="usd">40000000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTgtMS0xLTEtODM0MTQ_cce6a304-0de5-41f4-80c0-40048b0a9acd"
      unitRef="usd">54185000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTgtMy0xLTEtODM0MTQ_19f2a705-75c7-4d20-94d4-1684e7ecbb74"
      unitRef="usd">100035000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTktMS0xLTEtODM0MTQ_3e27fdc8-34c2-4916-9122-9de6faf99baf"
      unitRef="usd">1132000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMTktMy0xLTEtODM0MTQ_a244b725-5ee5-4de7-bf84-f4d26afa7fbd"
      unitRef="usd">1013000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjAtMS0xLTEtODM0MTQ_870fea3e-ae44-489d-b8cf-a5ad8d2eefc6"
      unitRef="usd">50258000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjAtMy0xLTEtODM0MTQ_573aaaed-1a22-4c53-889a-cbe7104f0a33"
      unitRef="usd">-61048000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjMtMS0xLTEtODM0MTQ_ee0d63ba-9192-451f-ac8a-71cdb895b282"
      unitRef="usd">188000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjMtMy0xLTEtODM0MTQ_191b0b91-1302-4d95-a7c2-7fcfabbf4491"
      unitRef="usd">46000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjQtMS0xLTEtODY3MDg_9b41a4cc-6d7b-48d0-beab-78eead647dac"
      unitRef="usd">153000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjQtMy0xLTEtODY3MDg_f3193cd9-3b2e-484c-9d5c-a704406b1b18"
      unitRef="usd">0</us-gaap:ProceedsFromStockPlans>
    <naut:ProceedsFromReverseRecapitalizationTransaction
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjUtMS0xLTEtODY4NDk_bfdf561c-2153-4b46-b389-8747478eb19e"
      unitRef="usd">0</naut:ProceedsFromReverseRecapitalizationTransaction>
    <naut:ProceedsFromReverseRecapitalizationTransaction
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjUtMy0xLTEtODY4NDk_629ba895-7a18-4d41-85c8-9a731e2330f1"
      unitRef="usd">335409000</naut:ProceedsFromReverseRecapitalizationTransaction>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjQtMS0xLTEtODM0MTQ_a0e8fa06-5926-466f-87d3-b5036cad8c0f"
      unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjQtMy0xLTEtODM0MTQ_620d30a2-4717-4dbf-b437-50d5bccdb3d4"
      unitRef="usd">8082000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjYtMS0xLTEtODM0MTQ_e20df119-6bd9-4d7f-bff2-c00934c6e2c9"
      unitRef="usd">341000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjYtMy0xLTEtODM0MTQ_9d2daf5b-6758-4346-b70c-64bba17295cd"
      unitRef="usd">327373000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjctMS0xLTEtODM0MTQ_3be97e67-6466-4ddf-b2c1-b70ccd511385"
      unitRef="usd">24735000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjctMy0xLTEtODM0MTQ_bbc9a1d4-9871-4ea6-bebd-3daf764a63c2"
      unitRef="usd">251780000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjktMS0xLTEtODM0MTQ_ac931034-f281-4bff-bd2f-4a9aee94353a"
      unitRef="usd">186461000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i616643cbd31d47a686cf71385bb21573_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMjktMy0xLTEtODM0MTQ_4ce92016-0a11-428b-b7d1-1e9c2c756bb6"
      unitRef="usd">37219000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMzAtMS0xLTEtODM0MTQ_cdd5347b-51d4-4d61-a840-8015b90928d5"
      unitRef="usd">211196000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ibff31d711c89442ab7051c729b67d7e0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMzAtMy0xLTEtODM0MTQ_ddfbd8eb-22de-49e3-9bf2-43f4220bd7ec"
      unitRef="usd">288999000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMzMtMS0xLTEtODM0MTQ_f882cbd9-de3e-4220-afab-0140d7e8ec6d"
      unitRef="usd">413000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMzMtMy0xLTEtODM0MTQ_4a77210b-7943-428f-841f-1210746cd3e3"
      unitRef="usd">101000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <naut:DeferredStockIssuanceCosts
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMzQtMS0xLTEtODM0MTQ_5cef3cb5-e149-4aa1-9a25-c0372fcd2ccb"
      unitRef="usd">0</naut:DeferredStockIssuanceCosts>
    <naut:DeferredStockIssuanceCosts
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMzQtMy0xLTEtODM0MTQ_e406c941-93b2-453f-83ed-842a5d61617b"
      unitRef="usd">47000</naut:DeferredStockIssuanceCosts>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMzUtMS0xLTEtODM0MTQ_153b8946-656b-4199-8a81-306ff81815b6"
      unitRef="usd">0</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMzUtMy0xLTEtODM0MTQ_37913ac9-f786-4706-8ae1-de5cd6c2251d"
      unitRef="usd">108418000</us-gaap:ConversionOfStockAmountConverted1>
    <naut:DeferredStockIssuanceCostsReclassifiedToEquity
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMzYtMS0xLTEtODM0MTQ_5a75e9ec-b392-4d2b-82a6-635f4c37b774"
      unitRef="usd">0</naut:DeferredStockIssuanceCostsReclassifiedToEquity>
    <naut:DeferredStockIssuanceCostsReclassifiedToEquity
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMzYtMy0xLTEtODM0MTQ_856415d1-e8a3-491e-baae-7cfc0caac02b"
      unitRef="usd">8129000</naut:DeferredStockIssuanceCostsReclassifiedToEquity>
    <naut:ModificationToReduceRightOfUseAssetsAndLeaseLiability
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMzctMS0xLTEtODM0MTQ_0d76a80d-8ca9-4b09-bab2-02b8a58bf242"
      unitRef="usd">0</naut:ModificationToReduceRightOfUseAssetsAndLeaseLiability>
    <naut:ModificationToReduceRightOfUseAssetsAndLeaseLiability
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80MC9mcmFnOmJhNTZmMWU3NzVhZTRkMDE5YTYwNzM5NjhlNGQ2NTM1L3RhYmxlOmQ4NDlmMzI3ZjY2MTQ5MjU5ZWY2ODhjNWI3MjJiMDI2L3RhYmxlcmFuZ2U6ZDg0OWYzMjdmNjYxNDkyNTllZjY4OGM1YjcyMmIwMjZfMzctMy0xLTEtODM0MTQ_dfbce33c-7b77-4428-8205-230a5b018b68"
      unitRef="usd">3254000</naut:ModificationToReduceRightOfUseAssetsAndLeaseLiability>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80Ni9mcmFnOjljMTE1NDk3M2IzYTQzYzFhNDgzODhlN2M2YTg2NjI5L3RleHRyZWdpb246OWMxMTU0OTczYjNhNDNjMWE0ODM4OGU3YzZhODY2MjlfODY5Mg_41024118-f11e-44ba-a904-f9e359c8300c">Description of Business and Basis of Presentation&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Nautilus Biotechnology, Inc. (the &#x201c;Company&#x201d;) is a biotechnology company incorporated in 2016 and based in Seattle, Washington with laboratory operations in San Carlos, California. Since the Company&#x2019;s incorporation in 2016, the Company has devoted substantially all of its resources to research and development activities, including with respect to its proteomics platform, business planning, establishing and maintaining its intellectual property portfolio, hiring personnel, raising capital and providing general and administrative support for these operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 9, 2021 (the &#x201c;Closing Date&#x201d;), Nautilus Biotechnology, Inc. a Delaware corporation (f/k/a ARYA Sciences Acquisition Corp. III, a Cayman Islands exempted company and the Company&#x2019;s predecessor company (&#x201c;ARYA&#x201d;)), consummated the previously announced business combination (the &#x201c;Business Combination&#x201d;) pursuant to the terms of that certain Business Combination Agreement, dated as of February 7, 2021 (the &#x201c;BCA&#x201d;), by and among ARYA, Mako Merger Sub, Inc., a Delaware corporation and wholly-owned subsidiary of ARYA (&#x201c;Mako Merger Sub&#x201d;), and Nautilus Subsidiary, Inc., a Delaware corporation (f/k/a Nautilus Biotechnology, Inc.) (&#x201c;Legacy Nautilus&#x201d;). As a result of the Business Combination, ARYA changed its name to &#x201c;Nautilus Biotechnology, Inc.&#x201d; and Mako Me&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;rger Sub merged with and into Legacy Nautilus with Legacy Nautilus surviving as the surviving company and becoming a wholly-owned subsidiary of ARYA (the &#x201c;Merger&#x201d; and, collectively with the other transactions described in the BCA, the &#x201c;Reverse Recapitalization&#x201d;).  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, in conjunction with the completion of the Business Combination, certain investors (&#x201c;PIPE Investors&#x201d;) subscribed for the purchase of an aggregate of 20,000,000 shares of common stock of the Company (&#x201c;New Nautilus Common Stock&#x201d;) at a price of $10.00 per share for aggregate gross proceeds of $200.0&#160;million (&#x201c;PIPE Financing&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Please refer to Note 3 &#x201c;Reverse Recapitalization&#x201d; for further details of the Business Combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements and accompanying notes are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and regulations of the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) for interim financial reporting. All intercompany transactions and balances have been eliminated upon consolidation. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated financial statements were prepared on the same basis as the audited financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments necessary for a fair statement of the Company&#x2019;s financial position as of June&#160;30, 2022, the results of its operations for the three and six months ended June 30, 2022 and 2021 and its cash flows for the six months ended June 30, 2022 and 2021. The results of operations for the three and six months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022. These financial statements and accompanying notes should be read in conjunction with the consolidated financial statements and notes thereto in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 on file with the SEC. The Company&#x2019;s reporting currency is the U.S. dollar. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Going Concern&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s condensed consolidated financial statements have been prepared on the basis of continuity of operations, the realization of assets, and the satisfaction of liabilities in the ordinary course of business. Since inception, the Company has been engaged in developing its technology, raising capital, and recruiting personnel. The Company&#x2019;s operating plan may change as a result of many factors currently unknown and there can be no assurance that the current operating plan will be achieved in the time frame anticipated by the Company, and it may need to seek additional funds sooner than planned. If adequate funds are not available to the Company on a timely basis, it may be required to delay, limit, reduce, or terminate certain commercial efforts, or pursue merger or acquisition strategies, all of which could adversely affect the holdings or the rights of the Company&#x2019;s stockholders. The Company has incurred net operating losses and negative cash flows from operations in every year since &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;inception and expects this to continue for the foreseeable future. As of June&#160;30, 2022, the Company had an accumulated deficit of $111.1 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has funded its operations primarily with proceeds from the issuance of redeemable convertible preferred stock and common stock. In June 2021, the Company received gross proceeds of approximately $345.5 million from PIPE Investors and the Business Combination offset by approximately $18.2 million of transaction costs and underwriters&#x2019; fees relating to the closing of the Business Combination. The Company had cash, cash equivalents, and short-term investments of $299.3 million as of June&#160;30, 2022.  As of the date on which these condensed consolidated financial statements were available to be issued, the Company believes that its cash, cash equivalents, and short-term investments will be sufficient to fund its operations for the next twelve months following the issuance of the condensed consolidated financial statements. The Company&#x2019;s actual results could vary as a result of, and its near and long-term future capital requirements will depend on many factors, including its growth rate and the timing and extent of spending to support its research and development efforts. The Company has based its estimates on assumptions that may prove to be wrong, and it could use its available capital resources sooner than it currently expects. The Company may be required to seek additional equity or debt financing. Future liquidity and cash requirements will depend on numerous factors. In the event that additional financing is required, the Company may not be able to raise it on acceptable terms or at all. If the Company is unable to raise additional capital when desired, or if it cannot expand its operations or otherwise capitalize on its business opportunities because it lacks sufficient capital, its business, operating results, and financial condition would be adversely affected. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impact of the COVID-19 Coronavirus&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, COVID-19 was first reported to the World Health Organization (&#x201c;WHO&#x201d;), and in January 2020, the WHO declared the outbreak to be a public health emergency. In March 2020, the WHO characterized COVID-19 as a pandemic. Since then, the COVID-19 pandemic and efforts to control its spread have significantly curtailed the movement of people, goods, and services worldwide. As a result, the Company has taken certain measures in response to COVID-19. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the duration and extent of the COVID-19 pandemic depends on future developments that cannot be accurately predicted at this time, such as the extent and effectiveness of containment and mitigation actions, it has already had an adverse effect on the global economy, and the ultimate societal and economic impact of the COVID-19 pandemic remains unknown. Additionally, concerns over the economic impact of COVID-19 have caused extreme volatility in financial and other capital markets, which may adversely affect the Company&#x2019;s ability to access capital markets in the future. Furthermore, the impact of the COVID-19 pandemic could adversely impact the Company&#x2019;s cash flows and operations and delay the Company&#x2019;s research and development activities. &lt;/span&gt;&lt;/div&gt;While the Company has developed and continues to develop plans to help mitigate the potential negative impact of COVID-19, these efforts may not be effective, and any protracted economic downturn will likely limit the effectiveness of its efforts. Accordingly, it is not possible for the Company to predict the duration and ultimate extent to which this will affect its business, future results of operations, and financial condition at this time.</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ia44cc7d1aae94a61ab5ee6ba5904ea17_D20210609-20210609"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80Ni9mcmFnOjljMTE1NDk3M2IzYTQzYzFhNDgzODhlN2M2YTg2NjI5L3RleHRyZWdpb246OWMxMTU0OTczYjNhNDNjMWE0ODM4OGU3YzZhODY2MjlfMTgwNA_c17a509e-f218-470b-a2a1-c68fb8a23525"
      unitRef="shares">20000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="ibd18e99e03a84549a89394d3537245e4_I20210609"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80Ni9mcmFnOjljMTE1NDk3M2IzYTQzYzFhNDgzODhlN2M2YTg2NjI5L3RleHRyZWdpb246OWMxMTU0OTczYjNhNDNjMWE0ODM4OGU3YzZhODY2MjlfMTg4OQ_57c45ed4-f0ef-48f8-b3d8-8464e07aa700"
      unitRef="usdPerShare">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="ia44cc7d1aae94a61ab5ee6ba5904ea17_D20210609-20210609"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80Ni9mcmFnOjljMTE1NDk3M2IzYTQzYzFhNDgzODhlN2M2YTg2NjI5L3RleHRyZWdpb246OWMxMTU0OTczYjNhNDNjMWE0ODM4OGU3YzZhODY2MjlfMTkzNA_845709a4-6a15-406a-8bde-4ef5ac713fda"
      unitRef="usd">200000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80Ni9mcmFnOjljMTE1NDk3M2IzYTQzYzFhNDgzODhlN2M2YTg2NjI5L3RleHRyZWdpb246OWMxMTU0OTczYjNhNDNjMWE0ODM4OGU3YzZhODY2MjlfODY5Mw_8ca67fec-eef1-4a69-a79c-a1157e84e873">The condensed consolidated financial statements and accompanying notes are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and regulations of the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) for interim financial reporting. All intercompany transactions and balances have been eliminated upon consolidation. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. The condensed consolidated financial statements were prepared on the same basis as the audited financial statements and, in the opinion of management, reflect all adjustments, which include only normal recurring adjustments necessary for a fair statement of the Company&#x2019;s financial position as of June&#160;30, 2022, the results of its operations for the three and six months ended June 30, 2022 and 2021 and its cash flows for the six months ended June 30, 2022 and 2021. The results of operations for the three and six months ended June 30, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022. These financial statements and accompanying notes should be read in conjunction with the consolidated financial statements and notes thereto in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 on file with the SEC. The Company&#x2019;s reporting currency is the U.S. dollar.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80Ni9mcmFnOjljMTE1NDk3M2IzYTQzYzFhNDgzODhlN2M2YTg2NjI5L3RleHRyZWdpb246OWMxMTU0OTczYjNhNDNjMWE0ODM4OGU3YzZhODY2MjlfNTAyOQ_78762282-695c-486f-acd7-42d4727206f0"
      unitRef="usd">-111100000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <naut:ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction
      contextRef="i23369e4e61894856b3b29fd3dd2c1609_D20210601-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80Ni9mcmFnOjljMTE1NDk3M2IzYTQzYzFhNDgzODhlN2M2YTg2NjI5L3RleHRyZWdpb246OWMxMTU0OTczYjNhNDNjMWE0ODM4OGU3YzZhODY2MjlfNTMyMw_d5b5f06f-7d64-4046-8e02-3f4b63b806ca"
      unitRef="usd">345500000</naut:ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction>
    <naut:PaymentsOfReverseRecapitalizationTransactionCosts
      contextRef="i23369e4e61894856b3b29fd3dd2c1609_D20210601-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80Ni9mcmFnOjljMTE1NDk3M2IzYTQzYzFhNDgzODhlN2M2YTg2NjI5L3RleHRyZWdpb246OWMxMTU0OTczYjNhNDNjMWE0ODM4OGU3YzZhODY2MjlfNTM5OQ_bb864042-4766-425a-8ad3-22d331ed58a3"
      unitRef="usd">18200000</naut:PaymentsOfReverseRecapitalizationTransactionCosts>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80Ni9mcmFnOjljMTE1NDk3M2IzYTQzYzFhNDgzODhlN2M2YTg2NjI5L3RleHRyZWdpb246OWMxMTU0OTczYjNhNDNjMWE0ODM4OGU3YzZhODY2MjlfMTA5OTUxMTY0MDE0OQ_db5c0c84-874e-4493-b5a0-d940c12ec33e"
      unitRef="usd">299300000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80OS9mcmFnOmVjYjZiM2VmMmMyNjRjYjBiYmVhMWJjZmE5NDY5ODhmL3RleHRyZWdpb246ZWNiNmIzZWYyYzI2NGNiMGJiZWExYmNmYTk0Njk4OGZfMTQ4MDQ_228d34b5-9b2d-4340-9936-e84c5f565848">Significant Accounting Policies&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the condensed consolidated financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include determining the estimated lives of property and equipment, stock-based compensation including the estimated fair value per share of common stock prior to the date the Company became public, research and development accruals, and the valuation allowance for deferred tax assets. These estimates and assumptions are based on management&#x2019;s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk and Other Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Credit risk represents the accounting loss that would be recognized as of the reporting date if counterparties failed completely to perform as contracted. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments, which potentially subject the Company to concentration of credit risk, consist of cash balances maintained in excess of federal depository insurance limits and investments in U.S. Treasury securities that are not federally insured. The Company has not experienced any losses in such accounts and believes it is not exposed to significant credit risk on cash or investments. The Company relies, and expects to continue to rely, on a number of vendors to provide services, supplies and materials related to its research and development programs. The Company relies on single source suppliers for certain components and materials used in the Nautilus platform. The loss of any of these single source suppliers would require the Company to expend significant time and effort to locate and qualify an alternative source of supply for these components. The Company also relies, and expects to continue to rely, on third-party manufacturers and, in many cases, single third-party manufacturers for the production of certain reagents and antibodies. These programs could be adversely affected by a significant interruption in these services or the availability of materials.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to risks similar to those of&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; other&#160;pre-clinical&#160;stage companies in the biopharmaceutical industry, including dependence on key individuals, the need to develop commercially viable products, competition from other companies, many of whom are larger and better capitalized, the impact of the COVID-19 pandemic and the need to obtain adequate additional financing to fund the development of its products. There can be no assurance that the Company&#x2019;s research and development will be successfully completed, that adequate protection for the Company&#x2019;s intellectual property will be maintained, that any products developed will obtain required regulatory approval or that any approved products will be commercially viable. Even if the Company&#x2019;s development efforts are successful, it is uncertain when, if ever, the Company will generate significant revenue from the sale of its products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision m&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;arket (&#x201c;CODM&#x201d;) in deciding how to allocate resources and in assessing performance. The Company&#x2019;s Chief Executive Officer is its CODM. The Company&#x2019;s CODM re&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;views financial information presented on a consolidated basis for the purposes of making operating decisions, allocating resources and evaluating financial performance. As such, the Company has determined that it operates in one operating and one reportable segment. The Company&#x2019;s long-lived assets are entirely based in the United States. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all highly-liquid investments with an original maturity of three months or less as of the date of acquisition to be cash equivalents. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers investments with an original maturity greater than three months and remaining maturities less than one year to be short-term investments. The Company classifies those investments that are not required for use in current operations and that mature in more than 12 months as long-term investments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies its investments as available for sale and reports them at fair value, with unrealized gains and losses recorded in accumulated other comprehensive income (loss). For investments sold prior to maturity, the cost of investments sold is based on the specific identification method. Realized gains and losses on the sale of investments are recorded in other income (expense), net in the condensed consolidated statement of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other-than-temporary Impairment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluates its investments with unrealized losses for other-than-temporary impairment. When assessing investments for other-than-temporary declines in value, the Company considers factors such as, among other things, the extent and length of time the investment&#x2019;s fair value has been lower than its cost basis, the financial condition and near-term prospects of the investment, the Company&#x2019;s ability and intent to retain the investment for a period of time sufficient to allow for any anticipated recovery in fair value, and the expected cash flows from the security. If any adjustments to fair value reflects a decline in the value of the investment that the Company considers to be &#x201c;other than temporary,&#x201d; the Company reduces the investment to fair value through a charge to the condensed consolidated statement of operations and condensed consolidated statement of comprehensive loss. No such adjustments were necessary during the periods presented. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of cash and cash equivalents, prepaid expenses and other current assets, accounts payable and accrued expenses and other liabilities approximate their respective fair values due to their short-term nature.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement includes a lease at inception by assessing whether there is an identified asset and whether the contract conveys the right to control the use of the identified asset for a period of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;time in exchange for consideration. Operating leases with a term of more than one year are included in operating lease right-of-use (&#x201c;ROU&#x201d;) assets and operating lease liabilities on the Company's condensed consolidated balance sheets. ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments. Operating lease ROU assets and liabilities are recognized on the lease commencement date based on the present value of the future minimum lease payments over the lease term. The Company uses the incremental borrowing rate commensurate with the lease term based on the information available at the lease commencement date in determining the present value of the lease payments as the Company's leases generally do not provide an implicit rate. ROU assets initially equal the lease liability, adjusted for any prepaid lease payments and initial direct costs incurred, less any lease incentives received. Certain of the Company's leases include renewal options which allow the Company to, at its election, renew or extend the lease for a fixed or indefinite period of time. These renewal periods are included in the lease terms when the Company is reasonably certain the options will be exercised. Lease expense is recognized on a straight-line basis over the lease term when leases are operating leases. If it is considered a finance lease, expense is recognized over the lease term within &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;interest expense and amortization in the Company&#x2019;s condensed consolidated statements of operations. The Company also has lease arrangements with lease and non-lease components. The Company elected the practical expedient not to separate non-lease components from lease components for the Company's facility leases and to account for the lease and non-lease components as a single lease component. The Company also elected to apply the short-term lease measurement and recognition exemption in which ROU assets and lease liabilities are not recognized for leases with terms of 12 months or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comprehensive Loss &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive loss consists of net loss and other gains or losses affecting stockholders&#x2019; equity that, under U.S. GAAP are excluded from net loss. For the three and six months ended June 30, 2022 and 2021, unrealized losses on debt securities were included as components of comprehensive loss. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is provided the option to adopt new or revised accounting guidance as an &#x201c;emerging growth company&#x201d; under the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;) either (1) within the same periods as those &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;otherwise applicable to public business entities, or (2) within the same time periods as non-public business entities, including early adoption when permissible. With the exception of standards the Company elected to early adopt, when permissible, the Company has elected to adopt new or revised accounting guidance within the same time period as non-public business entities, as indicated below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU No. 2020-04, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Reference Rate Reform (Topic 848).&#x201d;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The amendments in ASU 2020-04 provide optional expedients and exceptions for ap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;plying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this ASU are effective for all entities as of March 12, 2020 through December 31, 2022. An entity may elect to apply the amendments for contract modifications by Topic or Industry Subtopic as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or prospectively from the date that the financial statements are available to be issued. Once elected for a Topic or an Industry Subtopic, the amendments must be applied prospectively for all eligible contract modifications for that Topic or Industry Subtopic. The Company adopted this guidance effective January 1, 2022 using the prospective method, which did not have a material impact on the Company&#x2019;s condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU No. 2016-13, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Financial Instruments- Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;, which amends existing guidance on the impairment of financial assets and adds an impairment model that is based on expected losses rather than incurred losses and requires an entity to recognize as an allowance its estimate of expected credit losses for its financial assets. An entity will apply this guidance through a cumulative-effect adjustment to retained earnings upon adoption (a modified-retrospective approach) while a prospective transition approach is required for debt securities for which an other-than-temporary impairment had been recognized before the effective date. This ASU is effective for the Company for its fiscal year ending December 31, 2023. Early adoption is permitted. The Company is in the process of evaluating the impact of the adoption of this ASU on its condensed consolidated financial statements and related disclosures. The Company does not anticipate adoption to have a material impact on its condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December&#160;2019, the FASB issued ASU No. 2019-12, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&#x201d;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as the elimination of exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, the recognition of deferred tax liabilities for outside basis differences, ownership changes in investments, and tax basis step-up&#160;in goodwill obtained in a transaction that is not a business combination. This ASU is effective for the Company for its fiscal year ending December&#160;31, 2022. Early adoption is permitted. The Company is in the process of evaluating the impact of the &lt;/span&gt;&lt;/div&gt;adoption of this ASU on its condensed consolidated financial statements and related disclosures. The Company does not anticipate adoption to have a material impact on its condensed consolidated financial statements.</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80OS9mcmFnOmVjYjZiM2VmMmMyNjRjYjBiYmVhMWJjZmE5NDY5ODhmL3RleHRyZWdpb246ZWNiNmIzZWYyYzI2NGNiMGJiZWExYmNmYTk0Njk4OGZfMTQ4MDU_44ea3b40-57a1-4b3a-a5c0-f880e27c892d">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the condensed consolidated financial statements, and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include determining the estimated lives of property and equipment, stock-based compensation including the estimated fair value per share of common stock prior to the date the Company became public, research and development accruals, and the valuation allowance for deferred tax assets. These estimates and assumptions are based on management&#x2019;s best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances. The Company adjusts such estimates and assumptions when facts and circumstances dictate. Changes in those estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods. As future events and their effects cannot be determined with precision, actual results could materially differ from those estimates and assumptions.</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80OS9mcmFnOmVjYjZiM2VmMmMyNjRjYjBiYmVhMWJjZmE5NDY5ODhmL3RleHRyZWdpb246ZWNiNmIzZWYyYzI2NGNiMGJiZWExYmNmYTk0Njk4OGZfMTQ4MDE_73016830-8dc7-4457-9bf2-3ef6864abc64">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Credit risk represents the accounting loss that would be recognized as of the reporting date if counterparties failed completely to perform as contracted. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments, which potentially subject the Company to concentration of credit risk, consist of cash balances maintained in excess of federal depository insurance limits and investments in U.S. Treasury securities that are not federally insured. The Company has not experienced any losses in such accounts and believes it is not exposed to significant credit risk on cash or investments. The Company relies, and expects to continue to rely, on a number of vendors to provide services, supplies and materials related to its research and development programs. The Company relies on single source suppliers for certain components and materials used in the Nautilus platform. The loss of any of these single source suppliers would require the Company to expend significant time and effort to locate and qualify an alternative source of supply for these components. The Company also relies, and expects to continue to rely, on third-party manufacturers and, in many cases, single third-party manufacturers for the production of certain reagents and antibodies. These programs could be adversely affected by a significant interruption in these services or the availability of materials.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to risks similar to those of&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; other&#160;pre-clinical&#160;stage companies in the biopharmaceutical industry, including dependence on key individuals, the need to develop commercially viable products, competition from other companies, many of whom are larger and better capitalized, the impact of the COVID-19 pandemic and the need to obtain adequate additional financing to fund the development of its products. There can be no assurance that the Company&#x2019;s research and development will be successfully completed, that adequate protection for the Company&#x2019;s intellectual property will be maintained, that any products developed will obtain required regulatory approval or that any approved products will be commercially viable. Even if the Company&#x2019;s development efforts are successful, it is uncertain when, if ever, the Company will generate significant revenue from the sale of its products.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80OS9mcmFnOmVjYjZiM2VmMmMyNjRjYjBiYmVhMWJjZmE5NDY5ODhmL3RleHRyZWdpb246ZWNiNmIzZWYyYzI2NGNiMGJiZWExYmNmYTk0Njk4OGZfMTQ4MDk_36c916a6-263f-4c93-b4f0-4accc86b8014">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision m&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;arket (&#x201c;CODM&#x201d;) in deciding how to allocate resources and in assessing performance. The Company&#x2019;s Chief Executive Officer is its CODM. The Company&#x2019;s CODM re&lt;/span&gt;views financial information presented on a consolidated basis for the purposes of making operating decisions, allocating resources and evaluating financial performance. As such, the Company has determined that it operates in one operating and one reportable segment. The Company&#x2019;s long-lived assets are entirely based in the United States.</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80OS9mcmFnOmVjYjZiM2VmMmMyNjRjYjBiYmVhMWJjZmE5NDY5ODhmL3RleHRyZWdpb246ZWNiNmIzZWYyYzI2NGNiMGJiZWExYmNmYTk0Njk4OGZfNDM4Mw_79587aec-06b7-4512-ab47-131106c91894"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80OS9mcmFnOmVjYjZiM2VmMmMyNjRjYjBiYmVhMWJjZmE5NDY5ODhmL3RleHRyZWdpb246ZWNiNmIzZWYyYzI2NGNiMGJiZWExYmNmYTk0Njk4OGZfNDQwMA_7de17a9c-9d17-449f-ae00-7ab29e16bc05"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80OS9mcmFnOmVjYjZiM2VmMmMyNjRjYjBiYmVhMWJjZmE5NDY5ODhmL3RleHRyZWdpb246ZWNiNmIzZWYyYzI2NGNiMGJiZWExYmNmYTk0Njk4OGZfMTQ4MDY_a53c4c96-2ada-4af2-a5d6-ca3ab293a288">The Company considers all highly-liquid investments with an original maturity of three months or less as of the date of acquisition to be cash equivalents.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80OS9mcmFnOmVjYjZiM2VmMmMyNjRjYjBiYmVhMWJjZmE5NDY5ODhmL3RleHRyZWdpb246ZWNiNmIzZWYyYzI2NGNiMGJiZWExYmNmYTk0Njk4OGZfMTQ4MDc_3378a9b3-18e6-40c9-93fb-66f901481458">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers investments with an original maturity greater than three months and remaining maturities less than one year to be short-term investments. The Company classifies those investments that are not required for use in current operations and that mature in more than 12 months as long-term investments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies its investments as available for sale and reports them at fair value, with unrealized gains and losses recorded in accumulated other comprehensive income (loss). For investments sold prior to maturity, the cost of investments sold is based on the specific identification method. Realized gains and losses on the sale of investments are recorded in other income (expense), net in the condensed consolidated statement of operations. &lt;/span&gt;&lt;/div&gt;Other-than-temporary ImpairmentThe Company evaluates its investments with unrealized losses for other-than-temporary impairment. When assessing investments for other-than-temporary declines in value, the Company considers factors such as, among other things, the extent and length of time the investment&#x2019;s fair value has been lower than its cost basis, the financial condition and near-term prospects of the investment, the Company&#x2019;s ability and intent to retain the investment for a period of time sufficient to allow for any anticipated recovery in fair value, and the expected cash flows from the security. If any adjustments to fair value reflects a decline in the value of the investment that the Company considers to be &#x201c;other than temporary,&#x201d; the Company reduces the investment to fair value through a charge to the condensed consolidated statement of operations and condensed consolidated statement of comprehensive loss. No such adjustments were necessary during the periods presented.</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80OS9mcmFnOmVjYjZiM2VmMmMyNjRjYjBiYmVhMWJjZmE5NDY5ODhmL3RleHRyZWdpb246ZWNiNmIzZWYyYzI2NGNiMGJiZWExYmNmYTk0Njk4OGZfMTQ4MDI_b0f8ae96-cff4-4399-9abc-be2bcdb56ac3">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of cash and cash equivalents, prepaid expenses and other current assets, accounts payable and accrued expenses and other liabilities approximate their respective fair values due to their short-term nature.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80OS9mcmFnOmVjYjZiM2VmMmMyNjRjYjBiYmVhMWJjZmE5NDY5ODhmL3RleHRyZWdpb246ZWNiNmIzZWYyYzI2NGNiMGJiZWExYmNmYTk0Njk4OGZfMTQ4MTA_a78b5c84-d122-4179-beb7-d152bc1bb88a">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement includes a lease at inception by assessing whether there is an identified asset and whether the contract conveys the right to control the use of the identified asset for a period of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;time in exchange for consideration. Operating leases with a term of more than one year are included in operating lease right-of-use (&#x201c;ROU&#x201d;) assets and operating lease liabilities on the Company's condensed consolidated balance sheets. ROU assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the obligation to make lease payments. Operating lease ROU assets and liabilities are recognized on the lease commencement date based on the present value of the future minimum lease payments over the lease term. The Company uses the incremental borrowing rate commensurate with the lease term based on the information available at the lease commencement date in determining the present value of the lease payments as the Company's leases generally do not provide an implicit rate. ROU assets initially equal the lease liability, adjusted for any prepaid lease payments and initial direct costs incurred, less any lease incentives received. Certain of the Company's leases include renewal options which allow the Company to, at its election, renew or extend the lease for a fixed or indefinite period of time. These renewal periods are included in the lease terms when the Company is reasonably certain the options will be exercised. Lease expense is recognized on a straight-line basis over the lease term when leases are operating leases. If it is considered a finance lease, expense is recognized over the lease term within &lt;/span&gt;interest expense and amortization in the Company&#x2019;s condensed consolidated statements of operations. The Company also has lease arrangements with lease and non-lease components. The Company elected the practical expedient not to separate non-lease components from lease components for the Company's facility leases and to account for the lease and non-lease components as a single lease component. The Company also elected to apply the short-term lease measurement and recognition exemption in which ROU assets and lease liabilities are not recognized for leases with terms of 12 months or less.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80OS9mcmFnOmVjYjZiM2VmMmMyNjRjYjBiYmVhMWJjZmE5NDY5ODhmL3RleHRyZWdpb246ZWNiNmIzZWYyYzI2NGNiMGJiZWExYmNmYTk0Njk4OGZfMTQ4MDg_18c8116e-e86b-4029-9a72-b4b2c84221d9">Comprehensive loss consists of net loss and other gains or losses affecting stockholders&#x2019; equity that, under U.S. GAAP are excluded from net loss. For the three and six months ended June 30, 2022 and 2021, unrealized losses on debt securities were included as components of comprehensive loss.</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV80OS9mcmFnOmVjYjZiM2VmMmMyNjRjYjBiYmVhMWJjZmE5NDY5ODhmL3RleHRyZWdpb246ZWNiNmIzZWYyYzI2NGNiMGJiZWExYmNmYTk0Njk4OGZfMTQ4MDM_f1aa784c-423c-4128-98b3-166d5b337e51">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is provided the option to adopt new or revised accounting guidance as an &#x201c;emerging growth company&#x201d; under the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;) either (1) within the same periods as those &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;otherwise applicable to public business entities, or (2) within the same time periods as non-public business entities, including early adoption when permissible. With the exception of standards the Company elected to early adopt, when permissible, the Company has elected to adopt new or revised accounting guidance within the same time period as non-public business entities, as indicated below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU No. 2020-04, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Reference Rate Reform (Topic 848).&#x201d;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The amendments in ASU 2020-04 provide optional expedients and exceptions for ap&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;plying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this ASU are effective for all entities as of March 12, 2020 through December 31, 2022. An entity may elect to apply the amendments for contract modifications by Topic or Industry Subtopic as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or prospectively from the date that the financial statements are available to be issued. Once elected for a Topic or an Industry Subtopic, the amendments must be applied prospectively for all eligible contract modifications for that Topic or Industry Subtopic. The Company adopted this guidance effective January 1, 2022 using the prospective method, which did not have a material impact on the Company&#x2019;s condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU No. 2016-13, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Financial Instruments- Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;, which amends existing guidance on the impairment of financial assets and adds an impairment model that is based on expected losses rather than incurred losses and requires an entity to recognize as an allowance its estimate of expected credit losses for its financial assets. An entity will apply this guidance through a cumulative-effect adjustment to retained earnings upon adoption (a modified-retrospective approach) while a prospective transition approach is required for debt securities for which an other-than-temporary impairment had been recognized before the effective date. This ASU is effective for the Company for its fiscal year ending December 31, 2023. Early adoption is permitted. The Company is in the process of evaluating the impact of the adoption of this ASU on its condensed consolidated financial statements and related disclosures. The Company does not anticipate adoption to have a material impact on its condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December&#160;2019, the FASB issued ASU No. 2019-12, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&#x201d;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which enhances and simplifies various aspects of the income tax accounting guidance, including requirements such as the elimination of exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, the recognition of deferred tax liabilities for outside basis differences, ownership changes in investments, and tax basis step-up&#160;in goodwill obtained in a transaction that is not a business combination. This ASU is effective for the Company for its fiscal year ending December&#160;31, 2022. Early adoption is permitted. The Company is in the process of evaluating the impact of the &lt;/span&gt;&lt;/div&gt;adoption of this ASU on its condensed consolidated financial statements and related disclosures. The Company does not anticipate adoption to have a material impact on its condensed consolidated financial statements.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <naut:ReverseRecapitalizationDisclosureTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMzg5Nw_d318d0c4-95f0-4709-93ed-de887af67974">Reverse Recapitalization&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 9, 2021, Mako Merger Sub merged with Legacy Nautilus, with Legacy Nautilus surviving as the surviving company and as a wholly-owned subsidiary of ARYA. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the Business Combination, Legacy Nautilus equity holders received an aggregate number of shares of New Nautilus Common Stock equal to (i) $900.0&#160;million plus $24.3&#160;million, which reflects the aggregate exercise price of all stock options (whether vested or unvested) of Legacy Nautilus at the consummation of the Business Combination, divided by (ii) $10.00 giving effect to the exchange ratio of approximately 3.6281 (&#x201c;Exchange Ratio&#x201d;) based on the terms of the Business Combination Agreement. For purposes of calculating the aggregate number of New Nautilus Common Stock issuable to each holder of Legacy Nautilus Common Stock pursuant to the Business Combination Agreement, all Legacy Nautilus Common Stock held by such holder was aggregated, and the Exchange Ratio was applied to that aggregate number of shares held by such holder, and not on a share-by-share basis, and the number of New Nautilus Common Stock issued was rounded down to the nearest whole share. At the Closing Date, (i) an aggregate of 18,721,137 shares of Class A and Class B ordinary shares of ARYA were exchanged for an equivalent number of Common Stock, (ii) an aggregate of 85,324,118 shares of Common Stock were issued in exchange for the shares of Nautilus outstanding as of immediately prior to the Business Combination and (iii) an aggregate of 20,000,000 shares of Common stock were issued to the PIPE Investors in the PIPE Financing with total gross proceeds of $200.0&#160;million. Moreover, at the Closing, all options to purchase shares of Nautilus were exchanged for comparable options to purchase shares of Common Stock based on an implied Legacy Nautilus equity value of $900.0&#160;million. Immediately after giving effect to the transactions, there were 124,045,255 shares of Common Stock outstanding and 7,106,767 shares of Common Stock subject to outstanding options under the 2017 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Business Combination is accounted for as a reverse recapitalization under U.S. GAAP. This determination is primarily based on Legacy Nautilus stockholders comprising a relative majority of the voting power of Nautilus and having the ability to nominate the members of the Board, Legacy Nautilus&#x2019;s operations prior to the acquisition comprising the only ongoing operations of Nautilus, and Legacy Nautilus&#x2019;s senior management comprising a majority of the senior management of Nautilus. Under this method of accounting, ARYA is treated as the &#x201c;acquired&#x201d; company for financial reporting purposes. Accordingly, for accounting purposes, the financial statements of Nautilus represent a continuation of the financial statements of Legacy Nautilus with the Business Combination being treated as the equivalent of Nautilus issuing stock for the net assets of ARYA, accompanied by a recapitalization. The net assets of ARYA are stated at historical costs, with no goodwill or other intangible assets recorded. Operations prior to the Business Combination are presented as those of Nautilus. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All periods prior to the Business Combination have been retrospectively adjusted using the Exchange Ratio for the equivalent number of shares outstanding immediately after the Business Combination to effect the reverse recapitalization. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Business Combination, the Company raised $335.4 million of net proceeds. This amount was comprised of $135.4&#160;million of cash held in ARYA&#x2019;s trust account from its initial public offering, net of ARYA&#x2019;s transaction costs and underwriters&#x2019; fees of $10.1&#160;million, and $200.0&#160;million of cash in connection with the PIPE Financing. The Company incurred $8.1&#160;million of transaction costs, consisting of banking, legal, and other professional fees which were recorded as a reduction to additional paid-in capital.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The number of shares of Common Stock issued immediately following the consummation of the Business Combination was:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.070%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common Stock of ARYA outstanding prior to the Business Combination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,186,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less redemption of ARYA shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(465,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common Stock of ARYA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,721,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issued in PIPE Financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business Combination and PIPE Financing shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,721,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legacy Nautilus shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,324,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total shares of Common Stock immediately after the Business Combination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,045,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</naut:ReverseRecapitalizationDisclosureTextBlock>
    <naut:StockConvertedValueReverseRecapitalization
      contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMzQ0_bea5d770-5551-428b-95e7-648426e4041e"
      unitRef="usd">900000000</naut:StockConvertedValueReverseRecapitalization>
    <naut:StockConvertedValueReverseRecapitalization
      contextRef="i4ff48ca2fc6c45e787116cf1deff00ca_D20210609-20210609"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMzUy_18f963f3-2c6d-4718-b73e-b996130c3890"
      unitRef="usd">24300000</naut:StockConvertedValueReverseRecapitalization>
    <naut:RecapitalizationExchangeRatioPerShare
      contextRef="i8cf39cfd7fd34311bc52d7c3ad8da2ff_I20210609"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfNTM0_6e3b3d2a-341d-4984-a0a9-d91e250c6a2b"
      unitRef="usdPerShare">10.00</naut:RecapitalizationExchangeRatioPerShare>
    <naut:RecapitalizationExchangeRatio
      contextRef="i8cf39cfd7fd34311bc52d7c3ad8da2ff_I20210609"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfNTkw_dfd85677-cca0-46db-a073-ed5e08469ca6"
      unitRef="number">3.6281</naut:RecapitalizationExchangeRatio>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic9aa3fe7e62449e8bd4ba541d238d058_I20210609"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMTE4NA_81faceb7-a92b-4905-a1e0-a1a053d4f504"
      unitRef="shares">18721137</us-gaap:CommonStockSharesOutstanding>
    <naut:StockConvertedReverseRecapitalization
      contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMTMxOQ_c8f6ff35-7a3d-4afa-8160-764c0511864c"
      unitRef="shares">85324118</naut:StockConvertedReverseRecapitalization>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ia44cc7d1aae94a61ab5ee6ba5904ea17_D20210609-20210609"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMTQ4Ng_739b79e6-6069-4128-9685-e68ad12bb32e"
      unitRef="shares">20000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="ia44cc7d1aae94a61ab5ee6ba5904ea17_D20210609-20210609"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMTU5Nw_e3b18136-da24-40e4-9152-6104194b1a8c"
      unitRef="usd">200000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:EquityFairValueDisclosure
      contextRef="i8cf39cfd7fd34311bc52d7c3ad8da2ff_I20210609"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMTc5NQ_51dfef58-0790-4070-a6e6-14ad92e523d9"
      unitRef="usd">900000000</us-gaap:EquityFairValueDisclosure>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i8cf39cfd7fd34311bc52d7c3ad8da2ff_I20210609"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMTg2Mw_c12bb021-4736-4a89-9b78-86ca4ddfdee8"
      unitRef="shares">124045255</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i8cf39cfd7fd34311bc52d7c3ad8da2ff_I20210609"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMTkwNQ_7491587c-cc9c-4f9d-931f-3a07bc1dff4f"
      unitRef="shares">7106767</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <naut:ProceedsFromReverseRecapitalizationTransaction
      contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMzM3MQ_b67e30f8-f995-4ac9-897b-bc1a6a7c5ae6"
      unitRef="usd">335400000</naut:ProceedsFromReverseRecapitalizationTransaction>
    <naut:CashAcquiredThroughReverseRecapitalization
      contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMzQyMA_b278a88a-616c-4b3e-8daf-155898339b8b"
      unitRef="usd">135400000</naut:CashAcquiredThroughReverseRecapitalization>
    <naut:ReverseRecapitalizationCashPaidToShareholders
      contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMzU1Mg_eb0f035e-3212-4fa7-9683-e0a771029ed8"
      unitRef="usd">10100000</naut:ReverseRecapitalizationCashPaidToShareholders>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMzU2MA_0be1a315-9ee1-4868-ac0f-745736c9c3a0"
      unitRef="usd">200000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <naut:PaymentsOfReverseRecapitalizationTransactionCosts
      contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMzYzMQ_6020a436-7a8e-48ee-ad53-8251154e68ba"
      unitRef="usd">8100000</naut:PaymentsOfReverseRecapitalizationTransactionCosts>
    <naut:ScheduleOfReverseRecapitalizationTableTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RleHRyZWdpb246ZDVhYTEwYjAxMmQ0NDA3NWJiNDZjMjY4M2Y3OWFiNGJfMzg5OA_684732f2-356d-4ab1-af41-0c280ff91717">The number of shares of Common Stock issued immediately following the consummation of the Business Combination was:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.070%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.936%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common Stock of ARYA outstanding prior to the Business Combination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,186,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less redemption of ARYA shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(465,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common Stock of ARYA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,721,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issued in PIPE Financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business Combination and PIPE Financing shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,721,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Legacy Nautilus shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,324,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total shares of Common Stock immediately after the Business Combination&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,045,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</naut:ScheduleOfReverseRecapitalizationTableTextBlock>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i95b304753b094f299b60dec3c082158f_I20210608"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RhYmxlOjg5NzQ4ZmU1NjU5OTRkZDRiNThmNzQ4ZjE2NTI4MWUwL3RhYmxlcmFuZ2U6ODk3NDhmZTU2NTk5NGRkNGI1OGY3NDhmMTY1MjgxZTBfMS0xLTEtMS04MzQxNA_56166a2e-ea5b-4018-8b7f-414c900e995e"
      unitRef="shares">19186500</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i565dd4757c4d4703a0e0f5fd3a984d8a_D20210609-20210609"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RhYmxlOjg5NzQ4ZmU1NjU5OTRkZDRiNThmNzQ4ZjE2NTI4MWUwL3RhYmxlcmFuZ2U6ODk3NDhmZTU2NTk5NGRkNGI1OGY3NDhmMTY1MjgxZTBfMi0xLTEtMS04MzQxNA_6cec7522-98a0-442b-90d9-5643f3cce2a2"
      unitRef="shares">465363</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RhYmxlOjg5NzQ4ZmU1NjU5OTRkZDRiNThmNzQ4ZjE2NTI4MWUwL3RhYmxlcmFuZ2U6ODk3NDhmZTU2NTk5NGRkNGI1OGY3NDhmMTY1MjgxZTBfMy0xLTEtMS04MzQxNA_1cd7f346-8012-4e1f-ab33-b3fde978a2b6"
      unitRef="shares">18721137</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RhYmxlOjg5NzQ4ZmU1NjU5OTRkZDRiNThmNzQ4ZjE2NTI4MWUwL3RhYmxlcmFuZ2U6ODk3NDhmZTU2NTk5NGRkNGI1OGY3NDhmMTY1MjgxZTBfNC0xLTEtMS04MzQxNA_c2e0a06f-dc2c-4c92-add4-606bf6e309a3"
      unitRef="shares">20000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <naut:StockIssuedDuringPeriodSharesReverseRecapitalization
      contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RhYmxlOjg5NzQ4ZmU1NjU5OTRkZDRiNThmNzQ4ZjE2NTI4MWUwL3RhYmxlcmFuZ2U6ODk3NDhmZTU2NTk5NGRkNGI1OGY3NDhmMTY1MjgxZTBfNS0xLTEtMS04MzQxNA_77b8ca19-ffd2-4ae8-940d-eabc79fda2e2"
      unitRef="shares">38721137</naut:StockIssuedDuringPeriodSharesReverseRecapitalization>
    <naut:StockConvertedReverseRecapitalization
      contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RhYmxlOjg5NzQ4ZmU1NjU5OTRkZDRiNThmNzQ4ZjE2NTI4MWUwL3RhYmxlcmFuZ2U6ODk3NDhmZTU2NTk5NGRkNGI1OGY3NDhmMTY1MjgxZTBfNi0xLTEtMS04MzQxNA_cdfb581e-2026-478e-a0f0-f9bda107a54d"
      unitRef="shares">85324118</naut:StockConvertedReverseRecapitalization>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i8cf39cfd7fd34311bc52d7c3ad8da2ff_I20210609"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81Mi9mcmFnOmQ1YWExMGIwMTJkNDQwNzViYjQ2YzI2ODNmNzlhYjRiL3RhYmxlOjg5NzQ4ZmU1NjU5OTRkZDRiNThmNzQ4ZjE2NTI4MWUwL3RhYmxlcmFuZ2U6ODk3NDhmZTU2NTk5NGRkNGI1OGY3NDhmMTY1MjgxZTBfNy0xLTEtMS04MzQxNA_70c596a8-cded-46b5-b446-185ee211c2f5"
      unitRef="shares">124045255</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RleHRyZWdpb246ZGRlYTM1M2E0ZTg0NGY4MmFkZmExMmI3ZGVkMTBlYzZfMzc5_2da7a186-b85d-44a5-a616-65ce16319420">Fair Value Measurements&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table details the assets carried at fair value and measured on a recurring basis within the three levels of fair value as of June&#160;30, 2022 and December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.797%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.797%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.797%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.797%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(246)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(246)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(207)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(561)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 1 and Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(807)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.814%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.814%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.814%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.814%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 1 and Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual maturities of short-term investments as of June&#160;30, 2022 and December&#160;31, 2021 are due in one year or less. Contractual maturities of long-term investments as of June&#160;30, 2022 and December&#160;31, 2021 are due &lt;/span&gt;&lt;/div&gt;after 1 year through 2 years.  There were no continuous unrealized loss positions in excess of twelve months as of June 30, 2022 and December 31, 2021.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RleHRyZWdpb246ZGRlYTM1M2E0ZTg0NGY4MmFkZmExMmI3ZGVkMTBlYzZfMzgw_3a6e149c-6924-496a-bca7-58507c2690ea">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table details the assets carried at fair value and measured on a recurring basis within the three levels of fair value as of June&#160;30, 2022 and December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.797%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.797%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.797%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.797%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(246)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(246)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(207)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(561)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 1 and Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(807)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.814%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.814%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.814%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.814%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.442%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Long-term investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mutual funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Agency bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;325,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Level 1 and Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i79037a7aa8bb452a9abe1acf155b0a38_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMy0yLTEtMS04MzQxNA_64f2bf90-2fa7-4349-91d3-42140c97fa20"
      unitRef="usd">1821000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i79037a7aa8bb452a9abe1acf155b0a38_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMy00LTEtMS04MzQxNA_8c22c44f-b9bb-4ec3-bb80-015d4d4d6462"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i79037a7aa8bb452a9abe1acf155b0a38_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMy02LTEtMS04MzQxNA_035c8baf-9683-4a58-894b-cfda157dfd8c"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i79037a7aa8bb452a9abe1acf155b0a38_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMy04LTEtMS04MzQxNA_eec404c8-2022-4439-9f85-66e7d79d267e"
      unitRef="usd">1821000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iec519f1b51a74b28a9f702bc1a15de30_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMy0xMC0xLTEtODM0MTQ_2f38ab1b-b6ea-42f8-9c75-d8cfa73595bd"
      unitRef="usd">1821000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2fc5af0cf1f14c46a0f276dc81c59884_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMy0xMi0xLTEtODM0MTQ_0e00c5cf-5535-4a48-94ee-a7395f2f3210"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0050fd4d6a3d46e2b3392794b3ad0b86_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMy0xNC0xLTEtODM0MTQ_2acde115-71bd-44b6-8a90-5bc77a711263"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1337c836c5934b6bac4f03a65db10d20_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNC0yLTEtMS04MzQxNA_98e380f1-b892-4a22-a382-eedecb57d9c0"
      unitRef="usd">39405000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1337c836c5934b6bac4f03a65db10d20_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNC00LTEtMS04MzQxNA_ce222e13-49d9-4be5-b89c-52a7086f8b48"
      unitRef="usd">18000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1337c836c5934b6bac4f03a65db10d20_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNC02LTEtMS04MzQxNA_d524ee02-7f9c-4784-8869-f2808e9072b9"
      unitRef="usd">246000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1337c836c5934b6bac4f03a65db10d20_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNC04LTEtMS04MzQxNA_cd07f28c-47f4-4770-9ea2-12f2132bbde8"
      unitRef="usd">39177000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3465ab1d6d8f48b68b3953bf87063529_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNC0xMC0xLTEtODM0MTQ_b497f25b-92f7-4f85-b7f2-441487508a91"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaaebac9cbb2145b1baef43c60057d70a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNC0xMi0xLTEtODM0MTQ_b8692970-fcab-4b00-a796-c8c0a0fb191c"
      unitRef="usd">14976000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2c2daae9584b48c397b73875dc06c78a_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNC0xNC0xLTEtODM0MTQ_8c50ca3b-264e-4f15-9c78-38585e7c7717"
      unitRef="usd">24201000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iadef21ee44e04221a04d477fe4115655_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNS0yLTEtMS04MzQxNA_cdb3f6aa-37c8-42c5-9f24-25886a4697d6"
      unitRef="usd">41226000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iadef21ee44e04221a04d477fe4115655_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNS00LTEtMS04MzQxNA_f8881d48-21de-4e3c-a711-864e1ab528ef"
      unitRef="usd">18000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iadef21ee44e04221a04d477fe4115655_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNS02LTEtMS04MzQxNA_9a04a892-8114-4d24-93f7-a2b9224bd31d"
      unitRef="usd">246000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iadef21ee44e04221a04d477fe4115655_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNS04LTEtMS04MzQxNA_81eeec6e-b3ac-4426-b0e0-2dad32430d3c"
      unitRef="usd">40998000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4a11f62dd1ef4191af3a81425e1797b7_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNS0xMC0xLTEtODM0MTQ_2ca459fa-927f-4391-8d04-d8655e653486"
      unitRef="usd">1821000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4d8fd5d7b0fa49a481c18d85c47bf96e_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNS0xMi0xLTEtODM0MTQ_b88fe632-5fca-4b47-83bc-12c501bb2b72"
      unitRef="usd">14976000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0728a8794dce4087b0492d0e4351e1e6_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNS0xNC0xLTEtODM0MTQ_9e04abb5-84f7-485e-bf33-16d99cfa1a3f"
      unitRef="usd">24201000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="idc43f21c31c5480eb0e220208d1cbaa6_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNy0yLTEtMS04MzQxNA_760074c6-e525-4946-a4a9-4a5f1bb3c84c"
      unitRef="usd">266695000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="idc43f21c31c5480eb0e220208d1cbaa6_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNy00LTEtMS04MzQxNA_a06e43f8-de3b-4bf0-93d8-440f85f635ca"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="idc43f21c31c5480eb0e220208d1cbaa6_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNy02LTEtMS04MzQxNA_db87c7aa-57a2-4b39-b88f-949a5fe38541"
      unitRef="usd">207000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idc43f21c31c5480eb0e220208d1cbaa6_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNy04LTEtMS04MzQxNA_c55ddafc-b896-436b-858e-7192a1d8672a"
      unitRef="usd">266490000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic726402929734cce8dbbe855f46e9393_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNy0xMC0xLTEtODM0MTQ_1b60265e-8ea2-4558-9221-eb6f4732f30f"
      unitRef="usd">208533000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id7a7db4799084f059a70fe68887a2222_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNy0xMi0xLTEtODM0MTQ_005ec957-dc65-4116-9edb-3fc01fa98183"
      unitRef="usd">57957000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i01ccc819c01f4da4bf182c10a26166db_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfNy0xNC0xLTEtODM0MTQ_20121dbd-ee67-4e37-a587-fec0cf48abfe"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib6d4c75d853d45118d52af84feb1c9ea_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOC0yLTEtMS04MzQxNA_97f9aa7d-7494-49f3-80f1-028078d71012"
      unitRef="usd">7365000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib6d4c75d853d45118d52af84feb1c9ea_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOC00LTEtMS04MzQxNA_11908b62-15e3-4363-9e5c-4ea0a5d15d78"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib6d4c75d853d45118d52af84feb1c9ea_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOC02LTEtMS04MzQxNA_02b839d3-86f4-4f99-96c2-a23f1a193604"
      unitRef="usd">135000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib6d4c75d853d45118d52af84feb1c9ea_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOC04LTEtMS04MzQxNA_6ef0d9f4-5f25-4b6a-b29e-bf73a15596e4"
      unitRef="usd">7230000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i72d1a4360cb049bcbd0a7a2c5d41cfeb_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOC0xMC0xLTEtODM0MTQ_84f0f369-6645-4a41-83a2-5025b4a847c1"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i43796c765a3b4a81a908d3053773a8d9_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOC0xMi0xLTEtODM0MTQ_fd0b784a-4253-48e3-9cdc-e1af47fb13b5"
      unitRef="usd">7230000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic56b289dcf7e46aa9e1028ca71a10d0b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOC0xNC0xLTEtODM0MTQ_73680037-27b4-4e44-8210-ef6e3294e985"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i642f3161862d43c3b6ae73200ecd113f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOS0yLTEtMS04MzQxNA_7e0de034-fc17-4bdd-86f2-9ce6fadfddf5"
      unitRef="usd">20378000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i642f3161862d43c3b6ae73200ecd113f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOS00LTEtMS04MzQxNA_bde2a6c4-d26d-454e-a38c-28172063c046"
      unitRef="usd">19000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i642f3161862d43c3b6ae73200ecd113f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOS02LTEtMS04MzQxNA_fd9d6c4f-1869-42e9-b047-277919fcceff"
      unitRef="usd">219000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i642f3161862d43c3b6ae73200ecd113f_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOS04LTEtMS04MzQxNA_03378622-a93a-43b7-8690-193582ec55a2"
      unitRef="usd">20178000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iea1db945b9d4412b88ca684b96485097_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOS0xMC0xLTEtODM0MTQ_0d9e9614-7340-4008-86dd-19413c199345"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibd637638870b48e1b476508b5f17a987_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOS0xMi0xLTEtODM0MTQ_fe8acfd3-37f7-4c83-9ccc-8373038ea823"
      unitRef="usd">8821000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic460f8db52ff40a98fc27d37b206e662_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfOS0xNC0xLTEtODM0MTQ_a6991195-4682-4150-a590-d87cf576a333"
      unitRef="usd">11357000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id56a7a2e33ba4a32a1d5145855a08542_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTAtMi0xLTEtODM0MTQ_09dd1862-75a9-4bbd-9a57-eb7ebafef668"
      unitRef="usd">294438000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id56a7a2e33ba4a32a1d5145855a08542_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTAtNC0xLTEtODM0MTQ_276b8128-e64b-4e83-bd05-bb22e6a129b9"
      unitRef="usd">21000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id56a7a2e33ba4a32a1d5145855a08542_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTAtNi0xLTEtODM0MTQ_ae03b583-faeb-46c8-9919-02dbfdf128b8"
      unitRef="usd">561000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id56a7a2e33ba4a32a1d5145855a08542_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTAtOC0xLTEtODM0MTQ_65f61591-9f8c-4de2-9a99-0724ff11ad97"
      unitRef="usd">293898000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie358eafdc46d4b668ba594dc1e5b18d6_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTAtMTAtMS0xLTgzNDE0_341f5fcf-acbd-46ce-b278-40b99ea632a8"
      unitRef="usd">208533000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i406e02c48601468ebc3605dcc7cc3a1d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTAtMTItMS0xLTgzNDE0_f3fcfaff-0bd3-48d0-894d-7422cb9bd72c"
      unitRef="usd">74008000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1239a3c41dbc40e1bbeff834e51c1aee_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTAtMTQtMS0xLTgzNDE0_d727ba3e-3101-4b68-8e28-e966815ce8f7"
      unitRef="usd">11357000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i65429cbc59dc44efba3731beff6b9dd1_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTEtMi0xLTEtODM0MTQ_02d883d3-62ee-4e5d-882f-8a0598f09f68"
      unitRef="usd">335664000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i65429cbc59dc44efba3731beff6b9dd1_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTEtNC0xLTEtODM0MTQ_b53aad2d-93c8-4918-8247-5057c0b522ae"
      unitRef="usd">39000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i65429cbc59dc44efba3731beff6b9dd1_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTEtNi0xLTEtODM0MTQ_5d995a4e-56db-4ddc-9bf6-7a5f57645f1f"
      unitRef="usd">807000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i65429cbc59dc44efba3731beff6b9dd1_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTEtOC0xLTEtODM0MTQ_c4858c06-7152-4bea-997a-9512d697b5c4"
      unitRef="usd">334896000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ice7fbda97984484fa4687feefa1e787c_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTEtMTAtMS0xLTgzNDE0_f84b7e62-1501-47b4-90d1-7ee21ee68add"
      unitRef="usd">210354000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i55132e2a8fbb44009e345287f535137b_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTEtMTItMS0xLTgzNDE0_de73cbb6-1c19-4bfb-bfd0-0d2b79857273"
      unitRef="usd">88984000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7dc0732a547c47a49a1c5860398b6fa2_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOjdiMWRjNGMwN2FhMDQ2ZjJhZTUzNTAwNjk3YWQ3YjBkL3RhYmxlcmFuZ2U6N2IxZGM0YzA3YWEwNDZmMmFlNTM1MDA2OTdhZDdiMGRfMTEtMTQtMS0xLTgzNDE0_65bf17c9-f6e4-43be-a263-f6b90e6fe8be"
      unitRef="usd">35558000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ibd1d463226d84aad9a1438d158e6eb23_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMy0yLTEtMS04MzQxNA_d30f4550-5609-4a05-9d60-7697222c4d27"
      unitRef="usd">21925000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibd1d463226d84aad9a1438d158e6eb23_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMy00LTEtMS04MzQxNA_1b5b550f-977d-406f-bc71-2752dc1dcbbd"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibd1d463226d84aad9a1438d158e6eb23_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMy02LTEtMS04MzQxNA_a9aaa5e9-a477-47ba-a24f-2dffe0f98046"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibd1d463226d84aad9a1438d158e6eb23_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMy04LTEtMS04MzQxNA_cc79cdfd-8144-4973-99f9-81a6e5d34d6a"
      unitRef="usd">21925000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i54b9d11dd5654d79a875c72b42d10b86_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMy0xMC0xLTEtODM0MTQ_b2b0d6c6-c54f-419a-ad25-116ee25dcb92"
      unitRef="usd">21925000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id7bad06e2afb4d469055e60478216c8e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMy0xMi0xLTEtODM0MTQ_858da950-56b8-46b2-b6c9-007c3358859d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1ad2ffe0c6c64a0f945e3af8721a487f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMy0xNC0xLTEtODM0MTQ_999a1d2a-5ed8-48b2-a20d-66df3d60408a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i950704d092364ff2b931f1d01449efb0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNC0yLTEtMS04MzQxNA_841c3edc-16da-4e22-861a-22d229b84308"
      unitRef="usd">15156000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i950704d092364ff2b931f1d01449efb0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNC00LTEtMS04MzQxNA_14a8ad2c-2448-45b4-aa63-a6688d38b804"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i950704d092364ff2b931f1d01449efb0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNC02LTEtMS04MzQxNA_09384a2a-2f87-4db5-bb39-703f237c0365"
      unitRef="usd">20000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i950704d092364ff2b931f1d01449efb0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNC04LTEtMS04MzQxNA_4e76a481-0125-4fb6-9735-bc65eb95aa08"
      unitRef="usd">15136000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib5acec1f8c5648f6b912abb5a8c70899_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNC0xMC0xLTEtODM0MTQ_6301a9d6-e614-4267-ba89-e075c7fe9b39"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i276d2f47485e4e31b420416f91c282aa_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNC0xMi0xLTEtODM0MTQ_859e8d2e-bc86-4e6f-a3eb-23e3a92302bc"
      unitRef="usd">15136000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2b4de2e6190b45178fbe6a57799d9ce1_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNC0xNC0xLTEtODM0MTQ_729f2beb-9741-4d53-9a0c-95ae2cce9ff6"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i0de8e6af07d84138b0e785102ca2f7f6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNS0yLTEtMS04MzQxNA_db3f19f6-792c-4e10-8ee0-ca4a44cd6576"
      unitRef="usd">37081000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0de8e6af07d84138b0e785102ca2f7f6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNS00LTEtMS04MzQxNA_42425e22-ab0c-498c-82ed-6676817fa7e4"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0de8e6af07d84138b0e785102ca2f7f6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNS02LTEtMS04MzQxNA_d29ce884-0391-405c-9967-01c9cc6b0e9b"
      unitRef="usd">20000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0de8e6af07d84138b0e785102ca2f7f6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNS04LTEtMS04MzQxNA_e4f087a4-6fb7-40fd-99ce-1df9c3e08aa0"
      unitRef="usd">37061000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i325c3c07c7f74c5f98e3c999c65b7441_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNS0xMC0xLTEtODM0MTQ_bb282b11-a080-4873-bace-1e0f9e90818a"
      unitRef="usd">21925000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idca49185e1c445cfa94d8d799ed53ce3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNS0xMi0xLTEtODM0MTQ_d968b131-ae40-4bc8-a1f3-487be748f00a"
      unitRef="usd">15136000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic6a86385f1054cff872febbcd6e2d2eb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNS0xNC0xLTEtODM0MTQ_c1d7bf1a-dc38-45dd-87e5-e10cb2145172"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if9cb68272c8244ea9919716328cc5ef2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNy0yLTEtMS04MzQxNA_353bdb69-cbe7-4360-98c2-1d44232fe331"
      unitRef="usd">301906000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if9cb68272c8244ea9919716328cc5ef2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNy00LTEtMS04MzQxNA_b075b65c-5e12-465d-acdd-3e09d378954d"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if9cb68272c8244ea9919716328cc5ef2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNy02LTEtMS04MzQxNA_bce3430b-465c-443e-9bd3-11ec09a7d8fa"
      unitRef="usd">90000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if9cb68272c8244ea9919716328cc5ef2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNy04LTEtMS04MzQxNA_bcf1ee65-e331-4a89-a99c-741f1c03c431"
      unitRef="usd">301818000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i70c36a3813d14058806f4eb11606f72e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNy0xMC0xLTEtODM0MTQ_90cf93a3-36cd-4069-9a0a-c08420e36007"
      unitRef="usd">163694000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icfd0acaaf2c04dbb8b67de884e3f27b8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNy0xMi0xLTEtODM0MTQ_b9eb62b4-8c49-45b4-a58e-5257e6ec8919"
      unitRef="usd">138124000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3b751c1b3c4a4f9d80dd9d109c372f81_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfNy0xNC0xLTEtODM0MTQ_f08df611-cd65-4cb1-8c8f-deac2e9a100e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ibe88c920880047c18b0c9cdf55c6e8df_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOC0yLTEtMS04MzQxNA_8aea0a80-2ef6-4e28-85ca-6bab75c646e0"
      unitRef="usd">14299000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibe88c920880047c18b0c9cdf55c6e8df_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOC00LTEtMS04MzQxNA_6a39cc3f-5294-44c7-8332-be3cfda1a944"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibe88c920880047c18b0c9cdf55c6e8df_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOC02LTEtMS04MzQxNA_8023e601-0a8e-4477-be81-7e8724d96fee"
      unitRef="usd">36000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibe88c920880047c18b0c9cdf55c6e8df_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOC04LTEtMS04MzQxNA_ed41807a-24c1-42cd-a4f1-660bbc1d5987"
      unitRef="usd">14263000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id158f09e96ab481f97e32c8613f97003_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOC0xMC0xLTEtODM0MTQ_41091993-6856-4170-bc29-ab18bba4cd73"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i82a7bcc7bc4d49e084d69fc0519a1f46_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOC0xMi0xLTEtODM0MTQ_1a91b658-1f66-40b3-af33-a7ec5ae13520"
      unitRef="usd">6850000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id14ac15267014aa398c2c76cac075a21_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOC0xNC0xLTEtODM0MTQ_3d58b081-a168-4098-a5a8-ef96e9de5606"
      unitRef="usd">7413000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ice46726bd5254e1d955ba67438fa7351_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOS0yLTEtMS04MzQxNA_a5265d1d-2651-4df4-a33f-e1ddfbe59aca"
      unitRef="usd">8998000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ice46726bd5254e1d955ba67438fa7351_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOS00LTEtMS04MzQxNA_df506322-a4dc-4ed4-933c-acf58ff6f6b8"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ice46726bd5254e1d955ba67438fa7351_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOS02LTEtMS04MzQxNA_d68d3b71-a1fe-4635-a4fd-55c53ebf0c8d"
      unitRef="usd">40000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ice46726bd5254e1d955ba67438fa7351_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOS04LTEtMS04MzQxNA_f8ff9876-c1ee-4c8f-b851-83ae1c6c136f"
      unitRef="usd">8958000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0677ff7a71e047b1b7f25782cf4ffe83_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOS0xMC0xLTEtODM0MTQ_8ac78066-b99b-4c75-bfe4-804b25ae4096"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id505c63953e54d2184cb7f771dec30b2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOS0xMi0xLTEtODM0MTQ_9c659b90-83b7-4eb3-8fcc-c0c0bd638ce1"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id3be0b06a9c94f3a9829bec818382447_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfOS0xNC0xLTEtODM0MTQ_8283eba3-ecc6-4716-a1f8-ca2259d29df9"
      unitRef="usd">8958000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i1375f50662564d9695c2f9a598ea96ff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTAtMi0xLTEtODM0MTQ_70fcbd83-f00f-4ccf-8e47-99463e6fb5d1"
      unitRef="usd">325203000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i1375f50662564d9695c2f9a598ea96ff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTAtNC0xLTEtODM0MTQ_72beb826-6aad-429b-904a-75c12942f0d3"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i1375f50662564d9695c2f9a598ea96ff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTAtNi0xLTEtODM0MTQ_c065696d-5ef2-4613-8e44-76ba18b1538d"
      unitRef="usd">166000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1375f50662564d9695c2f9a598ea96ff_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTAtOC0xLTEtODM0MTQ_1700da23-df80-4da0-965e-b4471060516c"
      unitRef="usd">325039000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i390387b0a67e446f8057dfcc678f0e57_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTAtMTAtMS0xLTgzNDE0_a96e3c4f-fac9-45a5-bbce-301ff51e78dd"
      unitRef="usd">163694000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5e8607b8fc264a58929288d5a7cae83f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTAtMTItMS0xLTgzNDE0_1061f845-55b1-4116-ba1c-eb0b3e8838a8"
      unitRef="usd">144974000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1ebedf34f1ba432d875df25f515ac771_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTAtMTQtMS0xLTgzNDE0_f2be1f37-bb64-47b3-b4fd-94117c32c4f4"
      unitRef="usd">16371000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic760bbad7d924910b0fc9c0598c7dd1c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTEtMi0xLTEtODM0MTQ_0c90a9a1-4b67-4a96-9979-4db33d83165d"
      unitRef="usd">362284000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic760bbad7d924910b0fc9c0598c7dd1c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTEtNC0xLTEtODM0MTQ_98e25287-2414-4bdc-b9ef-2ac67acf6103"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic760bbad7d924910b0fc9c0598c7dd1c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTEtNi0xLTEtODM0MTQ_ba5c0d03-4e5e-4c9b-8ab9-8c7ea63b6410"
      unitRef="usd">186000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic760bbad7d924910b0fc9c0598c7dd1c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTEtOC0xLTEtODM0MTQ_ce4e26d8-fbcd-480a-9481-4bc6a4524120"
      unitRef="usd">362100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0c35013b448d4f9a8ea202c0cc904312_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTEtMTAtMS0xLTgzNDE0_6ab9fd15-5c7d-4b10-92cb-a42e85c7e639"
      unitRef="usd">185619000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if6319ed6f43b45e59b873b4727e4b8df_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTEtMTItMS0xLTgzNDE0_fd3aac3d-5744-4a28-9c20-40c49d45ebd1"
      unitRef="usd">160110000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4671216a131e4e1a8c9dfea3bb76d2bd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81NS9mcmFnOmRkZWEzNTNhNGU4NDRmODJhZGZhMTJiN2RlZDEwZWM2L3RhYmxlOmMyNWViMWViZjBhNzRhY2ZhNDAwYTRiY2RmMzg3MGNkL3RhYmxlcmFuZ2U6YzI1ZWIxZWJmMGE3NGFjZmE0MDBhNGJjZGYzODcwY2RfMTEtMTQtMS0xLTgzNDE0_6e67b1e1-87ba-49a8-ba91-a385e0228dea"
      unitRef="usd">16371000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RleHRyZWdpb246Nzk2N2E5YjExYmIzNGMwMWI3ZGQ3NzQ2NzgyMTA4M2VfNjIz_77b7624c-031d-491e-a75d-fbeaa3dd2374">Composition of Certain Condensed Consolidated Financial Statement Line Items&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Property and Equipment, Net &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer hardware&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,994)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded depreciation expense of $0.3 million and $0.6 million for the three and six months ended June 30, 2022 and $0.3 million and $0.5 million for the three and six months ended June 30, 2021, respectively, which was primarily allocated to research and development expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Long Term Assets &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other long term assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Deposits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Accrued Expenses and Other Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses and other liabilities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional and consulting fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents and restricted cash consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash included in other long term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RleHRyZWdpb246Nzk2N2E5YjExYmIzNGMwMWI3ZGQ3NzQ2NzgyMTA4M2VfNjI0_4089f8fd-10ca-41ba-9525-79e79a2c326e">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer hardware&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,994)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i62504dcfdac144e7a5c3c6eb6862529d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfMS0xLTEtMS04MzQxNA_e9370e7c-d566-4d00-b21a-a6b92ad54e31"
      unitRef="usd">4460000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5f485413bc8146e3bbce6629c4dcd539_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfMS0zLTEtMS04MzQxNA_42092a65-8e8c-410f-9f02-056ab8b67dae"
      unitRef="usd">4032000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0083086336d845fdad111086bbba6da7_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfMi0xLTEtMS04MzQxNA_4f7156bd-ba9b-416e-b482-bf152953c91d"
      unitRef="usd">157000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9e22a0d731ef400b92b19e10336609cc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfMi0zLTEtMS04MzQxNA_0c8692a6-ba62-40e3-8d5c-6d4f78d4d935"
      unitRef="usd">157000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic2148fd953e942c9b5fa08720c4723a6_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfMy0xLTEtMS04MzQxNA_10cfbc11-5bdb-415f-99fd-5c59d3dcd019"
      unitRef="usd">26000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia89341e52be34f04b93a341be9170381_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfMy0zLTEtMS04MzQxNA_49e0dda9-251f-488f-ade7-aee5b1239d93"
      unitRef="usd">1000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iffc3dca386444731a94b2e7034cbfd79_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfNC0xLTEtMS04MzQxNA_6bccc6f3-c1d6-43d5-8f09-b2e0aaf50f79"
      unitRef="usd">8000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="idc0ee8f762314302abd9fa2688c27560_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfNC0zLTEtMS04MzQxNA_94866002-1f32-4828-8b04-9a0d50f03f42"
      unitRef="usd">8000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i69c8e273988d437082cf0d4dd215960d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfNS0xLTEtMS04MzQxNA_7fa61c55-f410-4f60-968c-4c3fe94bac39"
      unitRef="usd">1307000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i3e301c5918bb4924a1937829c187cbe6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfNS0zLTEtMS04MzQxNA_fc2e65c2-a7b2-4cf9-9943-4ca3bf85f764"
      unitRef="usd">279000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfNi0xLTEtMS04MzQxNA_816d0ca3-6806-4414-9dc3-e8afc8254d13"
      unitRef="usd">5958000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfNi0zLTEtMS04MzQxNA_997542b6-3bc9-4544-b40d-91a93c9422f2"
      unitRef="usd">4477000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfNy0xLTEtMS04MzQxNA_492615cb-e487-462b-8570-25a1fe83489d"
      unitRef="usd">2556000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfNy0zLTEtMS04MzQxNA_60b0c5cb-b9d0-447f-9590-8750a275746f"
      unitRef="usd">1994000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfOC0xLTEtMS04MzQxNA_99c74847-1415-45a5-8d0f-015cc95a6564"
      unitRef="usd">3402000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjI3M2U3YmY5MTVjYzQ4M2E4NzZjN2YzMDNlNmVmZjVlL3RhYmxlcmFuZ2U6MjczZTdiZjkxNWNjNDgzYTg3NmM3ZjMwM2U2ZWZmNWVfOC0zLTEtMS04MzQxNA_d52c8bad-5a87-49c2-8d60-4b768c872fcc"
      unitRef="usd">2483000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RleHRyZWdpb246Nzk2N2E5YjExYmIzNGMwMWI3ZGQ3NzQ2NzgyMTA4M2VfMjA5_37db1d66-530f-4112-8c64-27fe8a18f635"
      unitRef="usd">300000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RleHRyZWdpb246Nzk2N2E5YjExYmIzNGMwMWI3ZGQ3NzQ2NzgyMTA4M2VfNTQ5NzU1ODE0NTI2_d583959a-a06c-4747-b39c-cf985b1dc50c"
      unitRef="usd">600000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RleHRyZWdpb246Nzk2N2E5YjExYmIzNGMwMWI3ZGQ3NzQ2NzgyMTA4M2VfNTQ5NzU1ODE0NTE4_5d89be1e-41b0-434c-87ee-af0223530190"
      unitRef="usd">300000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RleHRyZWdpb246Nzk2N2E5YjExYmIzNGMwMWI3ZGQ3NzQ2NzgyMTA4M2VfNTQ5NzU1ODE0NTM0_8aa99ab8-e5d3-45e8-b94e-2248984a0099"
      unitRef="usd">500000</us-gaap:Depreciation>
    <us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RleHRyZWdpb246Nzk2N2E5YjExYmIzNGMwMWI3ZGQ3NzQ2NzgyMTA4M2VfNjI1_b7613b1b-6c10-4877-b46f-089f0e24f7ae">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other long term assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Deposits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjdiMWE4ZGE5YjAwYzRmZjc4ZTJhNGJmZTVlMzU4YmMxL3RhYmxlcmFuZ2U6N2IxYThkYTliMDBjNGZmNzhlMmE0YmZlNWUzNThiYzFfMS0xLTEtMS04MzQxNA_42e009f3-8be8-4d3e-882e-06007a44e1d6"
      unitRef="usd">842000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjdiMWE4ZGE5YjAwYzRmZjc4ZTJhNGJmZTVlMzU4YmMxL3RhYmxlcmFuZ2U6N2IxYThkYTliMDBjNGZmNzhlMmE0YmZlNWUzNThiYzFfMS0zLTEtMS04MzQxNA_6f5941a5-e528-492b-af2c-dc28c9e74616"
      unitRef="usd">842000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjdiMWE4ZGE5YjAwYzRmZjc4ZTJhNGJmZTVlMzU4YmMxL3RhYmxlcmFuZ2U6N2IxYThkYTliMDBjNGZmNzhlMmE0YmZlNWUzNThiYzFfMi0xLTEtMS04MzQxNA_ac37be93-51f3-4123-aefc-57b7a748ced2"
      unitRef="usd">155000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjdiMWE4ZGE5YjAwYzRmZjc4ZTJhNGJmZTVlMzU4YmMxL3RhYmxlcmFuZ2U6N2IxYThkYTliMDBjNGZmNzhlMmE0YmZlNWUzNThiYzFfMi0zLTEtMS04MzQxNA_c5ea6f63-bb19-40ed-831d-14c394e01331"
      unitRef="usd">155000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjdiMWE4ZGE5YjAwYzRmZjc4ZTJhNGJmZTVlMzU4YmMxL3RhYmxlcmFuZ2U6N2IxYThkYTliMDBjNGZmNzhlMmE0YmZlNWUzNThiYzFfNC0xLTEtMS04MzQxNA_4c5d7799-5787-4df5-be29-e128ac684ad9"
      unitRef="usd">997000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjdiMWE4ZGE5YjAwYzRmZjc4ZTJhNGJmZTVlMzU4YmMxL3RhYmxlcmFuZ2U6N2IxYThkYTliMDBjNGZmNzhlMmE0YmZlNWUzNThiYzFfNC0zLTEtMS04MzQxNA_c2bec689-7182-4ee3-b485-f50d1ed1be14"
      unitRef="usd">997000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RleHRyZWdpb246Nzk2N2E5YjExYmIzNGMwMWI3ZGQ3NzQ2NzgyMTA4M2VfNjI2_523ea789-8937-4e9c-b426-91859d0a5f00">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses and other liabilities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional and consulting fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RleHRyZWdpb246Nzk2N2E5YjExYmIzNGMwMWI3ZGQ3NzQ2NzgyMTA4M2VfNjI2_609e727e-7b5a-42b0-8989-46c40f67f531">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses and other liabilities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional and consulting fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued facilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjcyMjZkYTdjMWYxMDRiMGQ4N2ZhMmFiN2VjYmQ5Y2RmL3RhYmxlcmFuZ2U6NzIyNmRhN2MxZjEwNGIwZDg3ZmEyYWI3ZWNiZDljZGZfMS0xLTEtMS04MzQxNA_6ed37edd-48fb-4a3e-aa94-ccdedf0131f4"
      unitRef="usd">1299000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjcyMjZkYTdjMWYxMDRiMGQ4N2ZhMmFiN2VjYmQ5Y2RmL3RhYmxlcmFuZ2U6NzIyNmRhN2MxZjEwNGIwZDg3ZmEyYWI3ZWNiZDljZGZfMS0zLTEtMS04MzQxNA_982bdd0c-1d6d-44d9-8a4c-7f350c67ce93"
      unitRef="usd">1465000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <naut:AccruedResearchAndDevelopment
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjcyMjZkYTdjMWYxMDRiMGQ4N2ZhMmFiN2VjYmQ5Y2RmL3RhYmxlcmFuZ2U6NzIyNmRhN2MxZjEwNGIwZDg3ZmEyYWI3ZWNiZDljZGZfMi0xLTEtMS04MzQxNA_1977d45a-2b4a-417c-9c71-cda76d875624"
      unitRef="usd">874000</naut:AccruedResearchAndDevelopment>
    <naut:AccruedResearchAndDevelopment
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjcyMjZkYTdjMWYxMDRiMGQ4N2ZhMmFiN2VjYmQ5Y2RmL3RhYmxlcmFuZ2U6NzIyNmRhN2MxZjEwNGIwZDg3ZmEyYWI3ZWNiZDljZGZfMi0zLTEtMS04MzQxNA_d9e9fb44-b20f-42ee-97a2-5ec79efd3db7"
      unitRef="usd">518000</naut:AccruedResearchAndDevelopment>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjcyMjZkYTdjMWYxMDRiMGQ4N2ZhMmFiN2VjYmQ5Y2RmL3RhYmxlcmFuZ2U6NzIyNmRhN2MxZjEwNGIwZDg3ZmEyYWI3ZWNiZDljZGZfMy0xLTEtMS04MzQxNA_3c623e43-4a47-4ed9-b605-abf7849bf9f7"
      unitRef="usd">539000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjcyMjZkYTdjMWYxMDRiMGQ4N2ZhMmFiN2VjYmQ5Y2RmL3RhYmxlcmFuZ2U6NzIyNmRhN2MxZjEwNGIwZDg3ZmEyYWI3ZWNiZDljZGZfMy0zLTEtMS04MzQxNA_72a76501-93ef-438b-9ab5-c23692e30318"
      unitRef="usd">411000</us-gaap:AccruedProfessionalFeesCurrent>
    <naut:AccruedFacilities
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjcyMjZkYTdjMWYxMDRiMGQ4N2ZhMmFiN2VjYmQ5Y2RmL3RhYmxlcmFuZ2U6NzIyNmRhN2MxZjEwNGIwZDg3ZmEyYWI3ZWNiZDljZGZfNC0xLTEtMS04MzQxNA_5144b59b-faa5-44cc-8587-6adcef64aa48"
      unitRef="usd">0</naut:AccruedFacilities>
    <naut:AccruedFacilities
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjcyMjZkYTdjMWYxMDRiMGQ4N2ZhMmFiN2VjYmQ5Y2RmL3RhYmxlcmFuZ2U6NzIyNmRhN2MxZjEwNGIwZDg3ZmEyYWI3ZWNiZDljZGZfNC0zLTEtMS04MzQxNA_4ae9eca0-d32d-4865-a6fe-a98a040c5da4"
      unitRef="usd">337000</naut:AccruedFacilities>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjcyMjZkYTdjMWYxMDRiMGQ4N2ZhMmFiN2VjYmQ5Y2RmL3RhYmxlcmFuZ2U6NzIyNmRhN2MxZjEwNGIwZDg3ZmEyYWI3ZWNiZDljZGZfNS0xLTEtMS04MzQxNA_9d043ee0-e4d2-4bc6-bfd3-20c9db21333d"
      unitRef="usd">396000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjcyMjZkYTdjMWYxMDRiMGQ4N2ZhMmFiN2VjYmQ5Y2RmL3RhYmxlcmFuZ2U6NzIyNmRhN2MxZjEwNGIwZDg3ZmEyYWI3ZWNiZDljZGZfNS0zLTEtMS04MzQxNA_bd5dfe88-27b5-4250-bf2f-336c6a608b9c"
      unitRef="usd">388000</us-gaap:OtherSundryLiabilitiesCurrent>
    <naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjcyMjZkYTdjMWYxMDRiMGQ4N2ZhMmFiN2VjYmQ5Y2RmL3RhYmxlcmFuZ2U6NzIyNmRhN2MxZjEwNGIwZDg3ZmEyYWI3ZWNiZDljZGZfNi0xLTEtMS04MzQxNA_954719ab-9896-4c0f-aa09-64d1713ba9a4"
      unitRef="usd">3108000</naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent>
    <naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOjcyMjZkYTdjMWYxMDRiMGQ4N2ZhMmFiN2VjYmQ5Y2RmL3RhYmxlcmFuZ2U6NzIyNmRhN2MxZjEwNGIwZDg3ZmEyYWI3ZWNiZDljZGZfNi0zLTEtMS04MzQxNA_e7fb4f8a-3ec7-4828-869a-8d60f3aa23eb"
      unitRef="usd">3119000</naut:AccruedLiabilitiesAndOtherLiabilitiesCurrent>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RleHRyZWdpb246Nzk2N2E5YjExYmIzNGMwMWI3ZGQ3NzQ2NzgyMTA4M2VfNjI3_0304df85-f859-409b-ae84-1a6094096375">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents and restricted cash consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash included in other long term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RleHRyZWdpb246Nzk2N2E5YjExYmIzNGMwMWI3ZGQ3NzQ2NzgyMTA4M2VfNjI3_98918a9d-2f23-4ba7-ab3c-fdba2781f588">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash, cash equivalents and restricted cash consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash included in other long term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOmIzZTkzNDJmZDcxODRhODZiYzIxNGE1ODgxN2ExZjZmL3RhYmxlcmFuZ2U6YjNlOTM0MmZkNzE4NGE4NmJjMjE0YTU4ODE3YTFmNmZfMS0xLTEtMS04MzQxNA_ea5e3e43-3017-4aeb-a89c-38a0a7639dcb"
      unitRef="usd">210354000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOmIzZTkzNDJmZDcxODRhODZiYzIxNGE1ODgxN2ExZjZmL3RhYmxlcmFuZ2U6YjNlOTM0MmZkNzE4NGE4NmJjMjE0YTU4ODE3YTFmNmZfMS0zLTEtMS04MzQxNA_589dc11f-223d-4a1d-91dd-aea1caa5d9fe"
      unitRef="usd">185619000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOmIzZTkzNDJmZDcxODRhODZiYzIxNGE1ODgxN2ExZjZmL3RhYmxlcmFuZ2U6YjNlOTM0MmZkNzE4NGE4NmJjMjE0YTU4ODE3YTFmNmZfMi0xLTEtMS04MzQxNA_c444ebdc-a5f5-4a89-af77-d88d8ccff740"
      unitRef="usd">842000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOmIzZTkzNDJmZDcxODRhODZiYzIxNGE1ODgxN2ExZjZmL3RhYmxlcmFuZ2U6YjNlOTM0MmZkNzE4NGE4NmJjMjE0YTU4ODE3YTFmNmZfMi0zLTEtMS04MzQxNA_cfdfe8d8-5b08-4126-8132-3a5f8ec7d897"
      unitRef="usd">842000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOmIzZTkzNDJmZDcxODRhODZiYzIxNGE1ODgxN2ExZjZmL3RhYmxlcmFuZ2U6YjNlOTM0MmZkNzE4NGE4NmJjMjE0YTU4ODE3YTFmNmZfMy0xLTEtMS04MzQxNA_4fa1556d-b26a-4e4c-be0c-752a0d3b5077"
      unitRef="usd">211196000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV81OC9mcmFnOjc5NjdhOWIxMWJiMzRjMDFiN2RkNzc0Njc4MjEwODNlL3RhYmxlOmIzZTkzNDJmZDcxODRhODZiYzIxNGE1ODgxN2ExZjZmL3RhYmxlcmFuZ2U6YjNlOTM0MmZkNzE4NGE4NmJjMjE0YTU4ODE3YTFmNmZfMy0zLTEtMS04MzQxNA_a605691e-691f-4804-8842-bd2e2ff909bb"
      unitRef="usd">186461000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <naut:DisclosureOfRedeemableConvertiblePreferredStockTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82MS9mcmFnOmI4N2M3ODVkMmM2NTQ2ZjViOTI4MGJjNjgyZWQwNzFhL3RleHRyZWdpb246Yjg3Yzc4NWQyYzY1NDZmNWI5MjgwYmM2ODJlZDA3MWFfNTAz_e975e7e6-1161-4067-9438-4ab13f2109e4">Redeemable Convertible Preferred Stock On June 9, 2021, upon the closing of the Business Combination (as defined in Note 1 and further described in Note 3), all of the outstanding redeemable convertible preferred stock was converted to New Nautilus Common Stock pursuant to the Exchange Ratio effective immediately prior to the Business Combination and the remaining amount was reclassified to additional paid-in capital. As of June&#160;30, 2022 the Company had no issued and outstanding Preferred Stock shares.</naut:DisclosureOfRedeemableConvertiblePreferredStockTextBlock>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82MS9mcmFnOmI4N2M3ODVkMmM2NTQ2ZjViOTI4MGJjNjgyZWQwNzFhL3RleHRyZWdpb246Yjg3Yzc4NWQyYzY1NDZmNWI5MjgwYmM2ODJlZDA3MWFfNDUz_3e148d9b-1570-4264-a7d5-147add1a342f"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82MS9mcmFnOmI4N2M3ODVkMmM2NTQ2ZjViOTI4MGJjNjgyZWQwNzFhL3RleHRyZWdpb246Yjg3Yzc4NWQyYzY1NDZmNWI5MjgwYmM2ODJlZDA3MWFfNDUz_8d32fa7c-f0a8-4af4-afa2-06400f300d63"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RleHRyZWdpb246NWIxNzFmNjRkMWZlNDhiYjg4ZGVmY2E4Y2Q4NjYxOThfMTAzMw_e9ea60f2-8a90-4ce3-9d18-5bf5a107f6ff">Common Stock&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 9, 2021, the Business Combination (as defined in Note 1 and further described in Note 3) was consummated and the Company issued 38,721,137 shares for an aggregate purchase price of $327.3&#160;million, net of issuance costs of $8.1&#160;million. Immediately following the Business Combination, there were 124,045,255 shares of Common Stock outstanding. The holder of each share of Common Stock is entitled to one vote.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has retroactively adjusted the shares issued and outstanding prior to June 9, 2021 to give effect to the exchange ratio established in the Business Combination Agreement to determine the number of shares of Common Stock into which they were converted. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2021, pursuant to the Business Combination, the Company amended its certificate of incorporation to increase the number of authorized common stock shares to 1,000,000,000 shares. There were 124,562,745 shares issued and outstanding as of June&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Common Stock Reserved for Future Issuance&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares of common stock reserved for future issuance on an as-if converted basis, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options issued and outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,650,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,550,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares available for grant under 2021 Equity Incentive Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,384,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,481,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares available for grant under 2021 Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,439,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,244,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total shares of common stock reserved&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,474,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,276,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <naut:StockIssuedDuringPeriodSharesReverseRecapitalization
      contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RleHRyZWdpb246NWIxNzFmNjRkMWZlNDhiYjg4ZGVmY2E4Y2Q4NjYxOThfMTU0_1552cfbe-bb26-4360-b267-f00d35f7e07a"
      unitRef="shares">38721137</naut:StockIssuedDuringPeriodSharesReverseRecapitalization>
    <naut:StockIssuedDuringPeriodValueReverseRecapitalization
      contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RleHRyZWdpb246NWIxNzFmNjRkMWZlNDhiYjg4ZGVmY2E4Y2Q4NjYxOThfMTk5_2aec8d9c-e8ac-4002-932b-9302049e2243"
      unitRef="usd">327300000</naut:StockIssuedDuringPeriodValueReverseRecapitalization>
    <naut:PaymentsOfReverseRecapitalizationTransactionCosts
      contextRef="ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RleHRyZWdpb246NWIxNzFmNjRkMWZlNDhiYjg4ZGVmY2E4Y2Q4NjYxOThfMjI4_b518a006-25d0-4f72-b6b6-9b62cfd5caef"
      unitRef="usd">8100000</naut:PaymentsOfReverseRecapitalizationTransactionCosts>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i8cf39cfd7fd34311bc52d7c3ad8da2ff_I20210609"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RleHRyZWdpb246NWIxNzFmNjRkMWZlNDhiYjg4ZGVmY2E4Y2Q4NjYxOThfMjkx_bc3e8e73-a723-4d05-b324-5ca2658c750a"
      unitRef="shares">124045255</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ibff31d711c89442ab7051c729b67d7e0_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RleHRyZWdpb246NWIxNzFmNjRkMWZlNDhiYjg4ZGVmY2E4Y2Q4NjYxOThfODI2_e9f43092-8a5b-4c6c-8e7e-36d3d28c3704"
      unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RleHRyZWdpb246NWIxNzFmNjRkMWZlNDhiYjg4ZGVmY2E4Y2Q4NjYxOThfODQ4_48feafc3-d2d0-433a-84fe-35881e96d114"
      unitRef="shares">124562745</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RleHRyZWdpb246NWIxNzFmNjRkMWZlNDhiYjg4ZGVmY2E4Y2Q4NjYxOThfODQ4_5f077156-fec3-42ba-9153-14e7e0ea4e81"
      unitRef="shares">124562745</us-gaap:CommonStockSharesIssued>
    <naut:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RleHRyZWdpb246NWIxNzFmNjRkMWZlNDhiYjg4ZGVmY2E4Y2Q4NjYxOThfMTAzNA_bec09f08-c4e2-4ff7-9939-63e4c42e5b2d">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares of common stock reserved for future issuance on an as-if converted basis, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.374%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options issued and outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,650,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,550,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares available for grant under 2021 Equity Incentive Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,384,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,481,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares available for grant under 2021 Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,439,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,244,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total shares of common stock reserved&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,474,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,276,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</naut:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RhYmxlOmQ5NGRlOGU1YjVkNjRiMWJiZjM1MTJiODg3Y2ZhOWI2L3RhYmxlcmFuZ2U6ZDk0ZGU4ZTViNWQ2NGIxYmJmMzUxMmI4ODdjZmE5YjZfMS0xLTEtMS04MzQxNA_10ba635f-79bc-495c-abae-50606a3ee642"
      unitRef="shares">11650794</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RhYmxlOmQ5NGRlOGU1YjVkNjRiMWJiZjM1MTJiODg3Y2ZhOWI2L3RhYmxlcmFuZ2U6ZDk0ZGU4ZTViNWQ2NGIxYmJmMzUxMmI4ODdjZmE5YjZfMS0zLTEtMS04MzQxNA_ffd8512f-0d53-4bbf-b907-8b6d4463d947"
      unitRef="shares">8550076</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i4f3af80321e54f9fb93e4f4f432b503c_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RhYmxlOmQ5NGRlOGU1YjVkNjRiMWJiZjM1MTJiODg3Y2ZhOWI2L3RhYmxlcmFuZ2U6ZDk0ZGU4ZTViNWQ2NGIxYmJmMzUxMmI4ODdjZmE5YjZfMi0xLTEtMS04MzQxNA_23a633da-e7d3-4afa-8fad-62e25ca554b3"
      unitRef="shares">17384590</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i2f3067b2fe2743df8d892928fdb699d8_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RhYmxlOmQ5NGRlOGU1YjVkNjRiMWJiZjM1MTJiODg3Y2ZhOWI2L3RhYmxlcmFuZ2U6ZDk0ZGU4ZTViNWQ2NGIxYmJmMzUxMmI4ODdjZmE5YjZfMi0zLTEtMS04MzQxNA_c755fe2e-075f-4c8e-8d37-df11f51747be"
      unitRef="shares">14481463</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i787199e8a86147f2b16226c6baee76a4_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RhYmxlOmQ5NGRlOGU1YjVkNjRiMWJiZjM1MTJiODg3Y2ZhOWI2L3RhYmxlcmFuZ2U6ZDk0ZGU4ZTViNWQ2NGIxYmJmMzUxMmI4ODdjZmE5YjZfMy0xLTEtMS04MzQxNA_2e0a0764-48b3-4ce4-b46f-83b8dd3c6654"
      unitRef="shares">2439577</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i646596b1fd7f425b997adba08286e2c6_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RhYmxlOmQ5NGRlOGU1YjVkNjRiMWJiZjM1MTJiODg3Y2ZhOWI2L3RhYmxlcmFuZ2U6ZDk0ZGU4ZTViNWQ2NGIxYmJmMzUxMmI4ODdjZmE5YjZfMy0zLTEtMS04MzQxNA_786cd897-6f0b-4de9-acb6-c973e6fc8dc4"
      unitRef="shares">1244900</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RhYmxlOmQ5NGRlOGU1YjVkNjRiMWJiZjM1MTJiODg3Y2ZhOWI2L3RhYmxlcmFuZ2U6ZDk0ZGU4ZTViNWQ2NGIxYmJmMzUxMmI4ODdjZmE5YjZfNy0xLTEtMS04MzQxNA_fba358bd-e18a-4ffb-a0cd-2075496bede2"
      unitRef="shares">31474961</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82NC9mcmFnOjViMTcxZjY0ZDFmZTQ4YmI4OGRlZmNhOGNkODY2MTk4L3RhYmxlOmQ5NGRlOGU1YjVkNjRiMWJiZjM1MTJiODg3Y2ZhOWI2L3RhYmxlcmFuZ2U6ZDk0ZGU4ZTViNWQ2NGIxYmJmMzUxMmI4ODdjZmE5YjZfNy0zLTEtMS04MzQxNA_5e086589-65d2-429b-950f-fb68c61b26a1"
      unitRef="shares">24276439</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82Ny9mcmFnOmEyNzk3ZDc3MTM0ODQ5MmU4YmRmNzI4NzJhODhlMjMyL3RleHRyZWdpb246YTI3OTdkNzcxMzQ4NDkyZThiZGY3Mjg3MmE4OGUyMzJfNjMw_df6430b8-f5d3-41d4-92ab-de7bd1e58b72">Income Taxes The Company accounts for income taxes under the asset and liability method. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be realized. For the three and six months ended June 30, 2022 and 2021, no income tax expense or benefit was recognized, primarily due to a full valuation allowance recorded against its deferred tax asset.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82Ny9mcmFnOmEyNzk3ZDc3MTM0ODQ5MmU4YmRmNzI4NzJhODhlMjMyL3RleHRyZWdpb246YTI3OTdkNzcxMzQ4NDkyZThiZGY3Mjg3MmE4OGUyMzJfNDk2_1d96243e-dfd4-4f4d-a7bc-55b2f833e476"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82Ny9mcmFnOmEyNzk3ZDc3MTM0ODQ5MmU4YmRmNzI4NzJhODhlMjMyL3RleHRyZWdpb246YTI3OTdkNzcxMzQ4NDkyZThiZGY3Mjg3MmE4OGUyMzJfNDk2_7ad135ed-8cf6-4346-9c66-cad36e41efeb"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82Ny9mcmFnOmEyNzk3ZDc3MTM0ODQ5MmU4YmRmNzI4NzJhODhlMjMyL3RleHRyZWdpb246YTI3OTdkNzcxMzQ4NDkyZThiZGY3Mjg3MmE4OGUyMzJfNDk2_7d88d40f-8a5a-4e75-b41c-e918d366c13f"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV82Ny9mcmFnOmEyNzk3ZDc3MTM0ODQ5MmU4YmRmNzI4NzJhODhlMjMyL3RleHRyZWdpb246YTI3OTdkNzcxMzQ4NDkyZThiZGY3Mjg3MmE4OGUyMzJfNDk2_7f1838f1-6cc1-404e-9429-e60fe8431ba3"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfNzE4Mg_40457b60-d7f5-458c-8597-d9ac24b8166e">Stock Option Plan and Stock-based Compensation&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 8, 2021, the stockholders of the Company approved the 2021 Equity Incentive Plan (&#x201c;2021 Plan&#x201d;) and the 2021 Employee Stock Purchase Plan (&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;2021 ESPP&#x201d;). As of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;June&#160;30, 2022, 17,384,590 and 2,439,577 shares were available for grant under the 2021 Plan and 2021 ESPP, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2021 Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the 2021 ESPP, the Company can grant stock options to employees to purchase shares of Common Stock at a purchase price which equal to 85% of the fair market value of common stock on the enrollment date or on the exercise date, whichever is lower. Participants are permitted to purchase shares of the Company&#x2019;s Common Stock at 85% of the lower of the fair market value of the Company&#x2019;s Common Stock on the first trading day of an offering period or on the last trading date in each purchase period. Participants may end their participation at any time during an offering and will be paid their accrued contributions that have not yet been used to purchase shares. Participation ends automatically upon termination of employment with the Company. The number of shares of common stock available for issuance under the 2021 ESPP will be increased on the first day of each fiscal year beginning on January 1, 2022, in an amount equal to the least of (i) 3,734,500 shares of common stock, (ii) a number of s&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;hares of common stock equal to one percent (1%) of the total number of shares of all classes of common stock of the Company on the last day of the immediately preceding fiscal year, or (iii) such number of shares determined by the Administrator no later than the last day of the immediately preceding fiscal year. On January 1, 2022, the number of shares available under the ESPP increased by 1,243,030 shares pursuant to this feature.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The first offering period was from October 1, 2021 through June 1, 2022. For subsequent offering periods, the Company will be offering a six month purchase period. As of June&#160;30, 2022, 48,353 shares of common stock were purchased under the 2021 ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2021 Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the 2021 Plan, the Company can grant incentive stock options, nonstatutory stock options, stock appreciation rig&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;hts, restricted stock, restricted stock units and performance awards to employees, directors and consultants. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options generally expire ten years after the date of grant. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The number of shares available for issuance under the 2021 Plan will be increased on the first day of each fiscal year, beginning on January 1, 2022, in an amount equal to the least of (i) 18,672,200 shares, (ii) a number of shares equal to five percent (5%) of the total number of shares of all classes of common stock of the Company outstanding on the last day of the immediately preceding fiscal year, or (iii) such number of shares determined by the Administrator no later than the last day of the immediately preceding fiscal year&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. On January 1, 2022, the number of shares available under the 2021 Plan increased by 6,215,154 shares pursuant to this feature.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2017 Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At the time of adoption of the 2021 Plan and the 2021 ESPP, no further awards will be granted under the 2017 Equity Incentive Plan (&#x201c;2017 Plan&#x201d;) and 7,106,767 shares of common stock were initially reserved for outstanding awards issued under the 2017 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining the compensation cost of the option awards, the fair value for each option award has been estimated using the&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Black Scholes model&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The significant assumptions used in these calculations are summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.121%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.452%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.452%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.452%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.358%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3 - 6.1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6 - 6.1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3 - 6.1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5 - 6.6&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.2% - 109.1%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.0% - 93.7%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.2% - 110.0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.0% - 94.2%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.80% - 3.36%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.91% - 1.02%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.73% - 3.36%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.53% - 1.02%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2.70 - $4.72&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$10.10 - $11.16&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2.70 - $4.72&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$7.56 - $11.16&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected term: The expected term of stock options represents the weighted-average period the stock options are expected to remain outstanding. The Company does not have sufficient historical exercise and post-vesting termination activity to provide accurate data for estimating the expected term of options and has opted to use the &#x201c;simplified method,&#x201d; whereby the expected term equals the arithmetic average of the vesting term and the original contractual term of the option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected volatility: Historically, the Company has been a private company and lacked company&#x2011;specific historical and implied volatility information for its common stock. Therefore, the expected volatility of the Company&#x2019;s common stock was determined by using an average of historical volatilities of selected industry peers deemed to be comparable to the Company&#x2019;s business corresponding to the expected term of the awards and the Company expects to continue to do so until such time as the Company has adequate historical data regarding the volatility of its traded common stock price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected dividend yield: The expected dividend rate is zero as the Company has no history or expectation of declaring dividends on its common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for zero-coupon U.S. Treasury notes with maturities corresponding to the expected term of the awards. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value of common stock: Prior to the Business Combination, the fair value of the shares of common stock underlying the stock options has historically been determined by the Company&#x2019;s Board of Directors. Because there has been no public market for the common stock, the Board of Directors has determined the fair value of the common stock at the time of grant of the option by contemporaneous valuations performed by an unrelated third-party valuation firm as well as a number of objective and subjective factors including valuation of comparable companies, sales of convertible preferred stock to unrelated third parties, operating and financial performance, the implied equity value of the Company as contemplated by the Business Combination, the lack of liquidity of capital stock and general and industry specific economic outlook, among other factors. The fair value of common stock was determined in accordance with applicable elements of the American Institute of Certified Public Accountants Practice Aid, Valuation of Privately-Held-Company Equity Securities Issued as Compensation. Subsequent to the completion of the Business Combination (as defined in Note 1 and further described in Note 3) the fair value of the Company&#x2019;s common stock is determined based on its closing market price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The awards granted in late January 2021 had an exercise price equal to the grant date fair value of the Company&#x2019;s common stock. The Company&#x2019;s board of directors made a determination of the fair market value of the Company&#x2019;s common stock which contemplated the implied equity value of the Company per the Business Combination Agreement that was executed on February 7, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes option award activity during the six months ended June 30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Stock Option Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Contractual Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,550,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,037,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211,309)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(725,836)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,650,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and expected to vest as of June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,650,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and exercisable at June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,279,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, there was $31.0 million of total unrecognized compensation expense expected to be recognized over a weighted average-period of 2.94 years. Aggregate intrinsic value represents the difference between the fair market value of the common stock and the exercise price of outstanding, in-the-money options. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following sets forth the total stock-based compensation expense for the Company&#x2019;s stock options included in the Company&#x2019;s condensed consolidated statement of operations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.629%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i4f3af80321e54f9fb93e4f4f432b503c_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfMjIy_ad5f7c64-c059-4551-9a20-f424bd8a81d0"
      unitRef="shares">17384590</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i787199e8a86147f2b16226c6baee76a4_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfMjI5_fa44e145-10fb-4a1b-9309-99dee00f3ba9"
      unitRef="shares">2439577</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i233799cb44d44a66a5f2ab2cdc7ec56c_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfNDg4_46739f27-4466-4d6b-9e27-69b9557b3ffc"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i233799cb44d44a66a5f2ab2cdc7ec56c_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfNjc5_c0dcbdef-77d9-4532-b83a-9108dbaa5fd1"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i69902fa9a7884b429fd406f65655535f_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfMTMwMQ_b3c3464b-a45f-4657-a524-316c20f2b0f0"
      unitRef="shares">3734500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
      contextRef="i69902fa9a7884b429fd406f65655535f_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfMTM5MA_d09c0ac1-1ebc-494b-ac98-27bb0ab74a99"
      unitRef="number">0.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant
      contextRef="ie310279ce69747ab9825ced6a3fe78fc_I20220101"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfMTczOQ_d3002cf0-c6c0-4c5e-9a27-c3cb74c1379c"
      unitRef="shares">1243030</naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="i69902fa9a7884b429fd406f65655535f_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfNDk0NzgwMjMzMjI0MQ_a0ec90ff-b75c-4028-b134-cb279230ee78"
      unitRef="shares">48353</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i89b1c3e45f0b40979b88b450d15bcbfa_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfMjMwMg_fcf98d66-321b-4962-8643-adad552250ff">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i89b1c3e45f0b40979b88b450d15bcbfa_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfMjUxOQ_d53979ce-4692-4057-b4fe-730a1a3eb8eb"
      unitRef="shares">18672200</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
      contextRef="i89b1c3e45f0b40979b88b450d15bcbfa_D20220101-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfMjU3Nw_63815c44-9100-49ae-8c1a-ac263673bc60"
      unitRef="number">0.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant
      contextRef="ibed4c6e11d5d43c5806dbe2b925b0fea_I20220101"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfMjk0Mw_7afdb609-01c3-4765-af01-197b4163fcba"
      unitRef="shares">6215154</naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i47703b687f7846fcb57b2784db412643_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfMzE1NQ_1accdc8e-0fa2-4425-a4ac-1661a1fd135f"
      unitRef="shares">7106767</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfNzE3OQ_9b8f0718-7b58-4b62-82fb-471f27668dc4">The significant assumptions used in these calculations are summarized as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.237%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.121%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.452%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.452%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.452%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.358%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3 - 6.1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6 - 6.1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3 - 6.1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5 - 6.6&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.2% - 109.1%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.0% - 93.7%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105.2% - 110.0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.0% - 94.2%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.80% - 3.36%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.91% - 1.02%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.73% - 3.36%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.53% - 1.02%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2.70 - $4.72&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$10.10 - $11.16&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2.70 - $4.72&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$7.56 - $11.16&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i3e682fab2418499796c2bd51ca5f5d63_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMi0xLTEtMS04MzQxNC90ZXh0cmVnaW9uOjBkMjkzMjAyMDU0NTRmMDViZDJiOTVkYTI2ZmZmODhkXzQ_2f166912-21c7-4d4e-9807-09c0d090bc6c">P5Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i7b3c9d4006024ff3b3fc21d16c2ae7ec_D20220401-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMi0xLTEtMS04MzQxNC90ZXh0cmVnaW9uOjBkMjkzMjAyMDU0NTRmMDViZDJiOTVkYTI2ZmZmODhkXzk_df023184-0350-4e17-ad91-f91d02eb372d">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ic34352ef98754a5da0e85055bbc95472_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMi0zLTEtMS04MzQxNC90ZXh0cmVnaW9uOmQxMGQ5MTQ2NmE1ZDRkMzJhNGNhMTVjNmQwZTI1ZjdiXzU_fd0a1e39-bc91-45ed-b0ed-cda3172edcac">P5Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="id7ff0979e8484728b1b10937c3182077_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMi0zLTEtMS04MzQxNC90ZXh0cmVnaW9uOmQxMGQ5MTQ2NmE1ZDRkMzJhNGNhMTVjNmQwZTI1ZjdiXzEw_7ccb565f-16d3-4d20-a469-a822a673d5a4">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="idf9c413e24a54f04ad65558d7a7137db_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMi01LTEtMS04MzQxNC90ZXh0cmVnaW9uOmI2NDI2NDQzMWQ5NjQwZDM5NmExNzRmM2RhMjNjNzBiXzQ_77ee4654-1cd7-4530-86de-c761ef703bc6">P5Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i08e2f1e57e9b497f9d8298da3df3d6e6_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMi01LTEtMS04MzQxNC90ZXh0cmVnaW9uOmI2NDI2NDQzMWQ5NjQwZDM5NmExNzRmM2RhMjNjNzBiXzk_8fdc2717-f92c-44db-b3e1-c6363537a01c">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ifdb873a8ec034005806968a7270b26bd_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMi03LTEtMS04MzQxNC90ZXh0cmVnaW9uOjYyYmJmNThkZDVhNzRkZGU4Mzc3OTM2N2ViZmJhNTJjXzQ_faabdcdb-ea27-4a92-b1c8-53af2a952898">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i8caa73d19bf74f9fb01149e58ec6f2b8_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMi03LTEtMS04MzQxNC90ZXh0cmVnaW9uOjYyYmJmNThkZDVhNzRkZGU4Mzc3OTM2N2ViZmJhNTJjXzk_987fd745-c876-4212-bacf-c30eba0af356">P6Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="i49299c0b86364054a5d2222883ee3b39_D20220401-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMy0xLTEtMS04MzQxNC90ZXh0cmVnaW9uOjYwODIwNGM4ZjkzNTRlYmViM2UyYjE2NzMwYzAzZjAzXzQ_41825abb-bd28-49b7-913f-3ff7ebe3fe55"
      unitRef="number">1.052</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="i49299c0b86364054a5d2222883ee3b39_D20220401-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMy0xLTEtMS04MzQxNC90ZXh0cmVnaW9uOjYwODIwNGM4ZjkzNTRlYmViM2UyYjE2NzMwYzAzZjAzXzk_9f74d0f2-edca-4ca0-b51c-20ed7ea39546"
      unitRef="number">1.091</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="i0da319978bcb43ecb4461222b4a14066_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMy0zLTEtMS04MzQxNC90ZXh0cmVnaW9uOmFjZTEwMjM3MDQ5NzQyNjU4YjYzYzdhNGQzZjBhYzRhXzQ_07006857-b27d-40b8-8fde-0441a6a5ba1d"
      unitRef="number">0.930</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="i0da319978bcb43ecb4461222b4a14066_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMy0zLTEtMS04MzQxNC90ZXh0cmVnaW9uOmFjZTEwMjM3MDQ5NzQyNjU4YjYzYzdhNGQzZjBhYzRhXzk_4fcc0f65-6089-41cc-a894-4ce899c97861"
      unitRef="number">0.937</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="i74defcab308e430587503de9ccb5ac4a_D20220101-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMy01LTEtMS04MzQxNC90ZXh0cmVnaW9uOjc0YjNiYjcwNmI2MzRjZjFiZGQ3YTVkMTJlOWYzNWZjXzQ_fb8539b5-0546-436c-b454-6d09f4a20c20"
      unitRef="number">1.052</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="i74defcab308e430587503de9ccb5ac4a_D20220101-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMy01LTEtMS04MzQxNC90ZXh0cmVnaW9uOjc0YjNiYjcwNmI2MzRjZjFiZGQ3YTVkMTJlOWYzNWZjXzk_b8f4d21c-eea6-446d-bdad-ebc4923943d0"
      unitRef="number">1.100</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="i52460f4c2a9740b295d473a2341fa225_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMy03LTEtMS04MzQxNC90ZXh0cmVnaW9uOjM0MzBjNGYwMWEyNDQzZTJiZmIyOWQ1YmMzYmNlY2UzXzQ_78c800a9-8db6-4183-b8d1-60858753c12e"
      unitRef="number">0.920</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="i52460f4c2a9740b295d473a2341fa225_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfMy03LTEtMS04MzQxNC90ZXh0cmVnaW9uOjM0MzBjNGYwMWEyNDQzZTJiZmIyOWQ1YmMzYmNlY2UzXzk_43642f5a-e93d-45fd-863b-b4ed8a404ffc"
      unitRef="number">0.942</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i49299c0b86364054a5d2222883ee3b39_D20220401-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNC0xLTEtMS04MzQxNA_e3f450c5-6709-40f5-bcac-a8e0cedd086c"
      unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i0da319978bcb43ecb4461222b4a14066_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNC0zLTEtMS04MzQxNA_8a76c114-843c-42df-a081-ecb3146bdcc1"
      unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i74defcab308e430587503de9ccb5ac4a_D20220101-20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNC01LTEtMS04MzQxNA_ea28019f-4be9-4a1d-b925-1f26affda324"
      unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i52460f4c2a9740b295d473a2341fa225_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNC03LTEtMS04MzQxNA_6e9aafb8-1201-4306-b81c-44213b55664f"
      unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i49299c0b86364054a5d2222883ee3b39_D20220401-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNS0xLTEtMS04MzQxNC90ZXh0cmVnaW9uOjNmYjRjNDA2ZjAxZDQ5NzU4ZDMxZjkzZTFjMDAxNmRkXzQ_c21d78cf-119f-432c-9cfd-0dff0a4012a4"
      unitRef="number">0.0280</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i49299c0b86364054a5d2222883ee3b39_D20220401-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNS0xLTEtMS04MzQxNC90ZXh0cmVnaW9uOjNmYjRjNDA2ZjAxZDQ5NzU4ZDMxZjkzZTFjMDAxNmRkXzk_ee7ef472-1aa6-491f-a2c1-e4de29350b8b"
      unitRef="number">0.0336</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i0da319978bcb43ecb4461222b4a14066_D20210401-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNS0zLTEtMS04MzQxNC90ZXh0cmVnaW9uOjZmNWJkMjY5ZDI5OTRlYmZhOTg2NTI3NmUzMzJhYzE1XzQ_da704caf-78bd-4ee6-b657-7b9efb1bbc9e"
      unitRef="number">0.0091</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i0da319978bcb43ecb4461222b4a14066_D20210401-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNS0zLTEtMS04MzQxNC90ZXh0cmVnaW9uOjZmNWJkMjY5ZDI5OTRlYmZhOTg2NTI3NmUzMzJhYzE1Xzk_f2966fff-4ea5-4036-a136-be0123d049ed"
      unitRef="number">0.0102</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i74defcab308e430587503de9ccb5ac4a_D20220101-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNS01LTEtMS04MzQxNC90ZXh0cmVnaW9uOjdkNWM0MDg4MGNmOTQ3ZmE4ZTcxOGY4MWZlYTRhNzY2XzQ_8c099423-7dba-4c2c-bc31-3c8a6dbac82d"
      unitRef="number">0.0173</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i74defcab308e430587503de9ccb5ac4a_D20220101-20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNS01LTEtMS04MzQxNC90ZXh0cmVnaW9uOjdkNWM0MDg4MGNmOTQ3ZmE4ZTcxOGY4MWZlYTRhNzY2Xzk_a8d31dfb-fc13-4c3a-a530-e6ad51f68e36"
      unitRef="number">0.0336</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i52460f4c2a9740b295d473a2341fa225_D20210101-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNS03LTEtMS04MzQxNC90ZXh0cmVnaW9uOjIxNThmZDg5YjkxYjQ5N2M5OGFjMDdkYTcwZjUzMzRmXzQ_e57d778d-f9c8-4bab-9c1a-d9d9aa16274d"
      unitRef="number">0.0053</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i52460f4c2a9740b295d473a2341fa225_D20210101-20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNS03LTEtMS04MzQxNC90ZXh0cmVnaW9uOjIxNThmZDg5YjkxYjQ5N2M5OGFjMDdkYTcwZjUzMzRmXzk_771fb697-82e6-46b0-b262-ef26880f79f9"
      unitRef="number">0.0102</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice
      contextRef="i3e682fab2418499796c2bd51ca5f5d63_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNi0xLTEtMS04MzQxNC90ZXh0cmVnaW9uOmExM2IwZmUxNzMxZTQzZDVhYzc1MDEwYTU5NGMzYjViXzQ_beb15b7b-6f02-4b3e-b7b4-8065a2b0aa3c"
      unitRef="usdPerShare">2.70</naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice>
    <naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice
      contextRef="i7b3c9d4006024ff3b3fc21d16c2ae7ec_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNi0xLTEtMS04MzQxNC90ZXh0cmVnaW9uOmExM2IwZmUxNzMxZTQzZDVhYzc1MDEwYTU5NGMzYjViXzk_4aa36934-83b6-4b13-b608-f2dd95833e52"
      unitRef="usdPerShare">4.72</naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice>
    <naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice
      contextRef="ic34352ef98754a5da0e85055bbc95472_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNi0zLTEtMS04MzQxNC90ZXh0cmVnaW9uOjcwZDQwOTlhNTY0ZTQ4NWJiYWUxZjQ4ZjQ3NjEzNzQ1XzQ_afa2b3b8-3240-45d9-b3ed-f08b61e84c46"
      unitRef="usdPerShare">10.10</naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice>
    <naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice
      contextRef="id7ff0979e8484728b1b10937c3182077_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNi0zLTEtMS04MzQxNC90ZXh0cmVnaW9uOjcwZDQwOTlhNTY0ZTQ4NWJiYWUxZjQ4ZjQ3NjEzNzQ1Xzk_bde3d411-9c92-4142-9079-5bd7ed5e60fb"
      unitRef="usdPerShare">11.16</naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice>
    <naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice
      contextRef="idf9c413e24a54f04ad65558d7a7137db_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNi01LTEtMS04MzQxNC90ZXh0cmVnaW9uOjUzZWI0NWE4ZTQ5NjQ4ZWY4Mzg0YjQ5NjdhMzk1YWRlXzQ_8a17842b-3090-4afc-9a99-cbcb5e854df9"
      unitRef="usdPerShare">2.70</naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice>
    <naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice
      contextRef="i08e2f1e57e9b497f9d8298da3df3d6e6_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNi01LTEtMS04MzQxNC90ZXh0cmVnaW9uOjUzZWI0NWE4ZTQ5NjQ4ZWY4Mzg0YjQ5NjdhMzk1YWRlXzk_db308cc5-e6e9-489a-8450-270d4811723e"
      unitRef="usdPerShare">4.72</naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice>
    <naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice
      contextRef="ifdb873a8ec034005806968a7270b26bd_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNi03LTEtMS04MzQxNC90ZXh0cmVnaW9uOjgxNzZhNzBhMGU0ZDRlNDg5ZTM3OGZiZWZmOWUxODliXzQ_8ca0b053-eb3e-4b09-81d4-fb55df12d43f"
      unitRef="usdPerShare">7.56</naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice>
    <naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice
      contextRef="i8caa73d19bf74f9fb01149e58ec6f2b8_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmE2OGMzYzU0ZDAwYTQwNDhhZjQxNzk2OTVmMDFiNTM3L3RhYmxlcmFuZ2U6YTY4YzNjNTRkMDBhNDA0OGFmNDE3OTY5NWYwMWI1MzdfNi03LTEtMS04MzQxNC90ZXh0cmVnaW9uOjgxNzZhNzBhMGU0ZDRlNDg5ZTM3OGZiZWZmOWUxODliXzk_dfbe39c9-bf1f-4feb-96a3-cc07a3b01aee"
      unitRef="usdPerShare">11.16</naut:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice>
    <us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfNzE4MA_0bf93b1e-d8b7-4461-8cb1-3a3b4ba167c3">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes option award activity during the six months ended June 30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Stock Option Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Contractual Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,550,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,037,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(211,309)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(725,836)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,650,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options vested and expected to vest as of June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,650,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and exercisable at June&#160;30, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,279,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfMS0xLTEtMS04MzQxNA_e015d945-3cfa-4ee1-8f02-6dbc32b38492"
      unitRef="shares">8550076</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfMS0zLTEtMS04MzQxNA_1093445c-e4c5-4f6d-bb89-48a782b0eac8"
      unitRef="usdPerShare">4.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfMi0xLTEtMS04MzQxNA_82d631b6-137e-4d1f-95fb-3fcc1bd014ca"
      unitRef="shares">4037863</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfMi0zLTEtMS04MzQxNA_cf387e9a-be60-41a5-83ff-ace88de7646f"
      unitRef="usdPerShare">3.81</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfMy0xLTEtMS04MzQxNA_93fd8ef4-c252-4fab-a404-3283bd92f8b9"
      unitRef="shares">211309</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfMy0zLTEtMS04MzQxNA_12d323b9-aec7-4f45-99f1-526d4fe652ea"
      unitRef="usdPerShare">0.89</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfNC0xLTEtMS04MzQxNA_ccd7385c-d7b8-4a67-8f32-8bb67d0619a6"
      unitRef="shares">725836</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfNC0zLTEtMS04MzQxNA_50962208-c213-425b-9be5-b97d92296161"
      unitRef="usdPerShare">8.11</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfNS0xLTEtMS04MzQxNA_61e4dbb6-f969-4007-aa70-7e80600bfb71"
      unitRef="shares">11650794</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfNS0zLTEtMS04MzQxNA_fb651e7b-bcc7-437f-b644-d0bd971aec15"
      unitRef="usdPerShare">4.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfNS01LTEtMS04MzQxNA_6e62310b-4527-4edf-8103-a6ce00ca31d2">P8Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfNS03LTEtMS04MzQxNA_402a577d-242b-4610-ae12-67d380aa75d9"
      unitRef="usd">7964000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfNi0xLTEtMS04MzQxNA_49552d2d-d529-4209-82bc-13832d4ca032"
      unitRef="shares">11650794</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfNi0zLTEtMS04MzQxNA_7d5894ac-6bcb-4335-958a-9baf80225b42"
      unitRef="usdPerShare">4.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfNy0xLTEtMS04MzQxNA_a026f6c3-9d55-4241-9aae-1a19c7832e11"
      unitRef="shares">3279223</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfNy0zLTEtMS04MzQxNA_5a33217e-cd93-4356-b881-ad475d384f59"
      unitRef="usdPerShare">3.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfNy01LTEtMS04MzQxNA_13f6a648-a93f-474a-86ea-326f2a86d1b8">P7Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmY5Y2JmNThlYmIyYjQ1OWI5NDc3ZDAxMDNjMGNkNzNkL3RhYmxlcmFuZ2U6ZjljYmY1OGViYjJiNDU5Yjk0NzdkMDEwM2MwY2Q3M2RfNy03LTEtMS04MzQxNA_bb1dfa12-e3ac-497d-b5f5-6880e60d0b35"
      unitRef="usd">4474000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfNjY5NQ_fd97c280-4034-4a7f-9b8a-07d69ab739ab"
      unitRef="usd">31000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfNjgwMQ_b10dd62c-de6e-4355-9517-563b2584c24d">P2Y11M8D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RleHRyZWdpb246MzE5Nzg0ZDVkYjgyNDY0MjlhZTM2NWY3YTcxYWZlMmZfNzE4MQ_93147097-6360-412f-aa35-23dc204a36a3">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following sets forth the total stock-based compensation expense for the Company&#x2019;s stock options included in the Company&#x2019;s condensed consolidated statement of operations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.629%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib1706d23492b43b7a385b6224b7bb789_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmI5YmI1N2UxNGNhNTQwNzY4MDQ0MGZjMTIyZjMwYmI5L3RhYmxlcmFuZ2U6YjliYjU3ZTE0Y2E1NDA3NjgwNDQwZmMxMjJmMzBiYjlfMi0xLTEtMS04MzQxNA_59c5198f-f0d3-4fb8-980d-ba783deb8560"
      unitRef="usd">975000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie2cf87bc9d4c4ace9ed33c1df39f2e20_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmI5YmI1N2UxNGNhNTQwNzY4MDQ0MGZjMTIyZjMwYmI5L3RhYmxlcmFuZ2U6YjliYjU3ZTE0Y2E1NDA3NjgwNDQwZmMxMjJmMzBiYjlfMi0zLTEtMS04MzQxNA_9d5d6555-002d-4990-a253-2f762d18f4b4"
      unitRef="usd">666000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia22d009c3ac44aeb931bf7a56b79db92_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmI5YmI1N2UxNGNhNTQwNzY4MDQ0MGZjMTIyZjMwYmI5L3RhYmxlcmFuZ2U6YjliYjU3ZTE0Y2E1NDA3NjgwNDQwZmMxMjJmMzBiYjlfMi01LTEtMS04MzQxNA_9a77678a-72c0-4430-8d47-eea3e8d35541"
      unitRef="usd">1843000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1548f12c35584dfe86dfe82e4fc2766b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmI5YmI1N2UxNGNhNTQwNzY4MDQ0MGZjMTIyZjMwYmI5L3RhYmxlcmFuZ2U6YjliYjU3ZTE0Y2E1NDA3NjgwNDQwZmMxMjJmMzBiYjlfMi03LTEtMS04MzQxNA_ac6cf71c-ee76-4240-a0ec-85477d3d7c56"
      unitRef="usd">1163000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i95e307280f854c36abc9723392120e2d_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmI5YmI1N2UxNGNhNTQwNzY4MDQ0MGZjMTIyZjMwYmI5L3RhYmxlcmFuZ2U6YjliYjU3ZTE0Y2E1NDA3NjgwNDQwZmMxMjJmMzBiYjlfMy0xLTEtMS04MzQxNA_a8b30c9a-ba63-4544-af8e-477cb80ddab9"
      unitRef="usd">1592000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9f6592550bdb4e179558e3808e9fa8eb_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmI5YmI1N2UxNGNhNTQwNzY4MDQ0MGZjMTIyZjMwYmI5L3RhYmxlcmFuZ2U6YjliYjU3ZTE0Y2E1NDA3NjgwNDQwZmMxMjJmMzBiYjlfMy0zLTEtMS04MzQxNA_78411008-b4be-43fb-a444-dc21a3f6de05"
      unitRef="usd">1154000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6a590e5e314f4b95b05e281bd0d44db4_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmI5YmI1N2UxNGNhNTQwNzY4MDQ0MGZjMTIyZjMwYmI5L3RhYmxlcmFuZ2U6YjliYjU3ZTE0Y2E1NDA3NjgwNDQwZmMxMjJmMzBiYjlfMy01LTEtMS04MzQxNA_6c78c7a4-29a8-4e31-a489-db08952d3cba"
      unitRef="usd">2834000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0333ae88e1f147b9a495311e02ae01c5_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmI5YmI1N2UxNGNhNTQwNzY4MDQ0MGZjMTIyZjMwYmI5L3RhYmxlcmFuZ2U6YjliYjU3ZTE0Y2E1NDA3NjgwNDQwZmMxMjJmMzBiYjlfMy03LTEtMS04MzQxNA_c1ec8abd-eebd-4c80-bd71-031cce836c5e"
      unitRef="usd">1993000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i49299c0b86364054a5d2222883ee3b39_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmI5YmI1N2UxNGNhNTQwNzY4MDQ0MGZjMTIyZjMwYmI5L3RhYmxlcmFuZ2U6YjliYjU3ZTE0Y2E1NDA3NjgwNDQwZmMxMjJmMzBiYjlfNC0xLTEtMS04MzQxNA_da7c6123-9fd8-4ca6-abbc-8dfe6d35ff27"
      unitRef="usd">2567000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0da319978bcb43ecb4461222b4a14066_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmI5YmI1N2UxNGNhNTQwNzY4MDQ0MGZjMTIyZjMwYmI5L3RhYmxlcmFuZ2U6YjliYjU3ZTE0Y2E1NDA3NjgwNDQwZmMxMjJmMzBiYjlfNC0zLTEtMS04MzQxNA_9e794c11-7368-4bfd-a689-6a691139a97c"
      unitRef="usd">1820000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i74defcab308e430587503de9ccb5ac4a_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmI5YmI1N2UxNGNhNTQwNzY4MDQ0MGZjMTIyZjMwYmI5L3RhYmxlcmFuZ2U6YjliYjU3ZTE0Y2E1NDA3NjgwNDQwZmMxMjJmMzBiYjlfNC01LTEtMS04MzQxNA_345a4062-26a0-4538-beed-7b594af2665f"
      unitRef="usd">4677000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i52460f4c2a9740b295d473a2341fa225_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83MC9mcmFnOjMxOTc4NGQ1ZGI4MjQ2NDI5YWUzNjVmN2E3MWFmZTJmL3RhYmxlOmI5YmI1N2UxNGNhNTQwNzY4MDQ0MGZjMTIyZjMwYmI5L3RhYmxlcmFuZ2U6YjliYjU3ZTE0Y2E1NDA3NjgwNDQwZmMxMjJmMzBiYjlfNC03LTEtMS04MzQxNA_80b9d418-16cc-4387-9844-472c35848a49"
      unitRef="usd">3156000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfNTU4MQ_4f2a71fa-f169-4c1c-bf47-f397e82a8293">Commitments and Contingencies &lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Purchase Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Open purchase commitments are for the purchase of goods and services related to, but not limited to, research and development, facilities, and professional services under non-cancellable contracts. They were not recorded as liabilities on the condensed consolidated balance sheet as of June&#160;30, 2022 as the Company had not yet received the related goods or services. As of June&#160;30, 2022, the Company had open purchase commitments for goods and services of $2.0 million, which are expected to be received through the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company may become involved in litigation relating to claims arising from the ordinary course of business. Management believes that there are currently no claims or actions pending against the Company where the ultimate disposition could have a material adverse effect on the Company&#x2019;s results of operations, financial condition or cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is obligated under certain non-cancellable operating leases for office space and laboratory space. This space includes operating leases in Seattle, Washington, and San Carlos, California.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Seattle Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The operating lease in Seattle, Washington expired in April 2021 and continued to be renewed month to month until August 2021. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company entered into a 7-year non-cancellable operating lease, which commenced in August 2021, for an additional office space in Seattle, Washington. Total non-cancellable payments under this lease aggregate $4.5&#160;million through June 2028. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;San Carlos Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, the Company amended its existing facility lease contract in San Carlos, California which was executed to shorten the remaining term of the lease to expire in December 2021 and reduce monthly lease payments and was accounted for as a modification. The impact of this modification reduced the operating lease right-of-use asset and lease liability balance as a $3.3&#160;million non-cash adjustment. In September 2021, the Company further amended the facility lease contract in San Carlos, California to shorten the remaining term of the lease to expire in October 2021 and was also accounted for as a modification.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2020, the Company entered into a new lease in San Carlos, California for ten years which commenced in October 2021 and expiring in October 2031 with total minimum lease payments of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$40.7 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2020, the Company also entered into a temporary office space lease agreement in San Carlos, California which commenced in February 2021 and expired in October 2021 with total minimum lease payments of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1.2 million. The temporary office space lease agreement was recognized as a short-term lease due to the election of the short-term lease measurement and recognition exemption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, the Company entered into another lease in San Carlos, California for nine years expected to commence in December 2022 and expiring in October 2031. The Company can terminate this lease after five years from commencement date without bearing any significant termination penalties and therefore the Company concluded that the lease term is five years with total minimum lease payments of $7.2&#160;million. The Company may borrow funds from the landlord of up to $2.0&#160;million with an interest rate of 7% to finance its tenant improvements. No amounts have been borrowed as of June 30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease costs, which were included in operating expenses in condensed consolidated statements of operations, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.629%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the six months ended June 30, 2022 and 2021, cash paid for amounts included in the measurement of operating lease liabilities included in cash flows used in operating activities was $1.7 million and $0.8 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, the weighted-average remaining lease term and weighted-average discount rate for operating leases is 9.0 years and 8.9% respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's future principal contractual obligations for operating lease commitments as of June&#160;30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Lease Obligations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six months ending December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Guarantees and Indemnifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, the Company enters into agreements that may include indemnification provisions. Pursuant to such agreements, the Company may indemnify, hold harmless and defend an indemnified party for losses suffered or incurred by the indemnified party. Some of the provisions will limit losses to those arising from third-party actions. In some cases, the indemnifications will continue after the termination of the agreement. The maximum potential amount of future payments the Company could be required to make under these provisions is not determinable. The Company has never incurred material costs to defend lawsuits or settle claims related to these indemnification provisions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has also agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines and settlement amounts incurred by them in any action or proceeding to which any of them are, or are threatened to be, made a party by reason of their service as a director or officer. The Company maintains director and officer insurance coverage that would generally enable it to recover a portion of any future amounts paid. The Company may be subject to indemnification obligation by law with respect to the actions of its employees under certain circumstances and in certain jurisdictions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Letter of Credit&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with the San Carlos lease agreement entered in December 2020, the Company issued a cash-collateralized letter of credit in lieu of security deposit of $0.6 million. In conjunction with the San Carlos lease agreement entered in December 2021, the Company amended the existing cash-collateralized letter of credit and increased the amount to $0.8&#160;million. The cash amount is recorded as restricted cash under Other long-term assets on the Company&#x2019;s condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfNTU4MQ_5f8628b2-05cc-4a6d-bc4b-284934431bd7">Commitments and Contingencies &lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Purchase Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Open purchase commitments are for the purchase of goods and services related to, but not limited to, research and development, facilities, and professional services under non-cancellable contracts. They were not recorded as liabilities on the condensed consolidated balance sheet as of June&#160;30, 2022 as the Company had not yet received the related goods or services. As of June&#160;30, 2022, the Company had open purchase commitments for goods and services of $2.0 million, which are expected to be received through the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company may become involved in litigation relating to claims arising from the ordinary course of business. Management believes that there are currently no claims or actions pending against the Company where the ultimate disposition could have a material adverse effect on the Company&#x2019;s results of operations, financial condition or cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is obligated under certain non-cancellable operating leases for office space and laboratory space. This space includes operating leases in Seattle, Washington, and San Carlos, California.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Seattle Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The operating lease in Seattle, Washington expired in April 2021 and continued to be renewed month to month until August 2021. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company entered into a 7-year non-cancellable operating lease, which commenced in August 2021, for an additional office space in Seattle, Washington. Total non-cancellable payments under this lease aggregate $4.5&#160;million through June 2028. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;San Carlos Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, the Company amended its existing facility lease contract in San Carlos, California which was executed to shorten the remaining term of the lease to expire in December 2021 and reduce monthly lease payments and was accounted for as a modification. The impact of this modification reduced the operating lease right-of-use asset and lease liability balance as a $3.3&#160;million non-cash adjustment. In September 2021, the Company further amended the facility lease contract in San Carlos, California to shorten the remaining term of the lease to expire in October 2021 and was also accounted for as a modification.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2020, the Company entered into a new lease in San Carlos, California for ten years which commenced in October 2021 and expiring in October 2031 with total minimum lease payments of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$40.7 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2020, the Company also entered into a temporary office space lease agreement in San Carlos, California which commenced in February 2021 and expired in October 2021 with total minimum lease payments of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1.2 million. The temporary office space lease agreement was recognized as a short-term lease due to the election of the short-term lease measurement and recognition exemption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, the Company entered into another lease in San Carlos, California for nine years expected to commence in December 2022 and expiring in October 2031. The Company can terminate this lease after five years from commencement date without bearing any significant termination penalties and therefore the Company concluded that the lease term is five years with total minimum lease payments of $7.2&#160;million. The Company may borrow funds from the landlord of up to $2.0&#160;million with an interest rate of 7% to finance its tenant improvements. No amounts have been borrowed as of June 30, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease costs, which were included in operating expenses in condensed consolidated statements of operations, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.629%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the six months ended June 30, 2022 and 2021, cash paid for amounts included in the measurement of operating lease liabilities included in cash flows used in operating activities was $1.7 million and $0.8 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2022, the weighted-average remaining lease term and weighted-average discount rate for operating leases is 9.0 years and 8.9% respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's future principal contractual obligations for operating lease commitments as of June&#160;30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Lease Obligations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six months ending December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Guarantees and Indemnifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, the Company enters into agreements that may include indemnification provisions. Pursuant to such agreements, the Company may indemnify, hold harmless and defend an indemnified party for losses suffered or incurred by the indemnified party. Some of the provisions will limit losses to those arising from third-party actions. In some cases, the indemnifications will continue after the termination of the agreement. The maximum potential amount of future payments the Company could be required to make under these provisions is not determinable. The Company has never incurred material costs to defend lawsuits or settle claims related to these indemnification provisions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has also agreed to indemnify its directors and executive officers for costs associated with any fees, expenses, judgments, fines and settlement amounts incurred by them in any action or proceeding to which any of them are, or are threatened to be, made a party by reason of their service as a director or officer. The Company maintains director and officer insurance coverage that would generally enable it to recover a portion of any future amounts paid. The Company may be subject to indemnification obligation by law with respect to the actions of its employees under certain circumstances and in certain jurisdictions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Letter of Credit&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with the San Carlos lease agreement entered in December 2020, the Company issued a cash-collateralized letter of credit in lieu of security deposit of $0.6 million. In conjunction with the San Carlos lease agreement entered in December 2021, the Company amended the existing cash-collateralized letter of credit and increased the amount to $0.8&#160;million. The cash amount is recorded as restricted cash under Other long-term assets on the Company&#x2019;s condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LongTermPurchaseCommitmentAmount
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfNDkx_d67159d2-af90-4010-9404-400151d10479"
      unitRef="usd">2000000</us-gaap:LongTermPurchaseCommitmentAmount>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="iac74a2b58af547489b585fbc6f3a6dc4_I20210831"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMTMyNg_4d27a785-ef91-4ff5-b79f-e820d23c6929">P7Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="iac74a2b58af547489b585fbc6f3a6dc4_I20210831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMTUxMg_de3b5669-11e0-43a5-a9ac-683affd559e6"
      unitRef="usd">4500000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <naut:OperatingLeaseNoncashAdjustment
      contextRef="i22fffe12aeab41308245c99399a1f92b_D20210201-20210228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMTkzMA_ccfb2e54-3992-4bf3-b403-0546769e023b"
      unitRef="usd">3300000</naut:OperatingLeaseNoncashAdjustment>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i005d3c6634c744229bee47f60e02c564_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMjI1NQ_cad77cd3-f4c9-43a5-ab9d-eda4608770af">P10Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i005d3c6634c744229bee47f60e02c564_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMjM1Ng_3bb0f70e-1963-4a6e-8a05-978eec595997"
      unitRef="usd">40700000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i43cfc749a9134f95896a73a831e49eb6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMjU3Mw_a7fdb01c-c848-4495-b275-c32a76c43ebe"
      unitRef="usd">1200000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i7b12af6151364817bb6215130879f731_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMjgyNw_c857936f-e82d-4758-a404-aab08124650a">P9Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <naut:LesseeOperatingLeaseOptionToTerminateLeaseTerm
      contextRef="i7b12af6151364817bb6215130879f731_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMjk0MA_31a06968-022e-4814-936d-b3aedef94c4e">P5Y</naut:LesseeOperatingLeaseOptionToTerminateLeaseTerm>
    <naut:LesseeOperatingLeaseOptionToTerminateLeaseTerm
      contextRef="i7b12af6151364817bb6215130879f731_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMzA3Nw_5cc6e3c6-72f3-4ca6-b26b-cf5e3390a01d">P5Y</naut:LesseeOperatingLeaseOptionToTerminateLeaseTerm>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i7b12af6151364817bb6215130879f731_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMzExNw_c75f1818-79b8-4ae3-bab8-08efa7adb412"
      unitRef="usd">7200000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i5734f6007d394ffdba6338fcd01317d1_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMTY0OTI2NzQ0NzcwOA_ead81cbc-ef38-425a-99bd-1308322005dc"
      unitRef="usd">2000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5734f6007d394ffdba6338fcd01317d1_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMTY0OTI2NzQ0NzcyMg_6c5e703f-bc5b-4ca4-b55e-9b2b4fb5c604"
      unitRef="number">0.07</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding
      contextRef="i96e9f550a3474120bad073b9f8a36ac5_I20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMTY0OTI2NzQ0Nzg2MA_cc041529-ec0b-4937-8a84-80a76fe0ab3a"
      unitRef="usd">0</us-gaap:LineOfCreditFacilityFairValueOfAmountOutstanding>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfNTU3OA_7a640bd7-a7c2-41cf-a017-4bc7daf12b8e">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease costs, which were included in operating expenses in condensed consolidated statements of operations, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.629%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable operating lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfMi0xLTEtMS04MzQxNA_6f98cfe3-a7c9-457e-bdea-3463db5de74d"
      unitRef="usd">1182000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfMi0zLTEtMS04MzQxNA_09db455e-e9db-497b-b899-6591a5482a6b"
      unitRef="usd">362000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfMi01LTEtMS04MzQxNA_58d95042-8079-4fec-932e-f9984e5e7c92"
      unitRef="usd">2365000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfMi03LTEtMS04MzQxNA_3295e211-a37e-4cfd-b8cb-2630ad2d114a"
      unitRef="usd">863000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfMy0xLTEtMS04MzQxNA_2a69d058-3328-4cdd-b648-3f9a9b1532b5"
      unitRef="usd">380000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfMy0zLTEtMS04MzQxNA_1801215f-2ac4-4ae3-8ab4-f59f16bc4cc7"
      unitRef="usd">10000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfMy01LTEtMS04MzQxNA_c7a784a3-45ef-4a3d-98d4-16a609e77ba8"
      unitRef="usd">818000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfMy03LTEtMS04MzQxNA_86410e4d-9a00-49af-b4ea-705c113705b8"
      unitRef="usd">20000</us-gaap:VariableLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfNC0xLTEtMS04MzQxNA_4694502e-b902-49cd-81b7-777dc9901a54"
      unitRef="usd">6000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfNC0zLTEtMS04MzQxNA_c9064aa6-5bed-4de3-8b47-4098478cfb6f"
      unitRef="usd">440000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfNC01LTEtMS04MzQxNA_2676d5d9-2259-490a-b528-3772c0532ce3"
      unitRef="usd">11000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfNC03LTEtMS04MzQxNA_93d3918c-a223-4cec-8240-df4f87097582"
      unitRef="usd">619000</us-gaap:ShortTermLeaseCost>
    <us-gaap:LeaseCost
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfNi0xLTEtMS04MzQxNA_81fe4064-c32e-48b2-9c93-5d588ecac67c"
      unitRef="usd">1568000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfNi0zLTEtMS04MzQxNA_fcd93aa9-700c-4440-a307-fce909f1fd12"
      unitRef="usd">812000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfNi01LTEtMS04MzQxNA_73e0dd76-8ffe-4058-b8c4-19bca31f4531"
      unitRef="usd">3194000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmYyN2RmMjE3ZWQ4YjQyYmZhOTQ4MDcxZGE0NTdjZGVjL3RhYmxlcmFuZ2U6ZjI3ZGYyMTdlZDhiNDJiZmE5NDgwNzFkYTQ1N2NkZWNfNi03LTEtMS04MzQxNA_296de476-9706-429b-9663-ab66054dd604"
      unitRef="usd">1502000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMzQxNA_0f6d21c9-daf0-407a-a64c-62978c974953"
      unitRef="usd">1700000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMzQyMQ_adfcf638-35a8-430b-a21a-2b30caf576f3"
      unitRef="usd">800000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMzU1MA_e33b5074-db94-4062-939b-7254a687e978">P9Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfMzU1Nw_0117e48f-3bd3-41f9-9972-bf5939dd9a96"
      unitRef="number">0.089</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfNTU4MA_4011145c-0ff9-456a-8fe1-5c2ce31d0ac1">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the Company's future principal contractual obligations for operating lease commitments as of June&#160;30, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Lease Obligations&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Six months ending December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmE3YTk3ZDc3ZmEwOTQ1YTY4MWMxNjdmZjBkYjUyMDJhL3RhYmxlcmFuZ2U6YTdhOTdkNzdmYTA5NDVhNjgxYzE2N2ZmMGRiNTIwMmFfMi0xLTEtMS04MzQxNA_770a1ad7-2d72-4520-81dc-816aac0c8ee9"
      unitRef="usd">1812000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmE3YTk3ZDc3ZmEwOTQ1YTY4MWMxNjdmZjBkYjUyMDJhL3RhYmxlcmFuZ2U6YTdhOTdkNzdmYTA5NDVhNjgxYzE2N2ZmMGRiNTIwMmFfMy0xLTEtMS04MzQxNA_c8618f06-78be-4614-a8de-1b78c78ee675"
      unitRef="usd">4440000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmE3YTk3ZDc3ZmEwOTQ1YTY4MWMxNjdmZjBkYjUyMDJhL3RhYmxlcmFuZ2U6YTdhOTdkNzdmYTA5NDVhNjgxYzE2N2ZmMGRiNTIwMmFfNC0xLTEtMS04MzQxNA_fb811a7f-d8fd-4907-8dd0-f2d757d17986"
      unitRef="usd">4569000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmE3YTk3ZDc3ZmEwOTQ1YTY4MWMxNjdmZjBkYjUyMDJhL3RhYmxlcmFuZ2U6YTdhOTdkNzdmYTA5NDVhNjgxYzE2N2ZmMGRiNTIwMmFfNS0xLTEtMS04MzQxNA_d7595f48-7145-43b9-8dae-77cbc6a73b40"
      unitRef="usd">4701000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmE3YTk3ZDc3ZmEwOTQ1YTY4MWMxNjdmZjBkYjUyMDJhL3RhYmxlcmFuZ2U6YTdhOTdkNzdmYTA5NDVhNjgxYzE2N2ZmMGRiNTIwMmFfNi0xLTEtMS04MzQxNA_393ddade-97b0-4365-8f6e-2b3968b68cb6"
      unitRef="usd">4837000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <naut:LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmE3YTk3ZDc3ZmEwOTQ1YTY4MWMxNjdmZjBkYjUyMDJhL3RhYmxlcmFuZ2U6YTdhOTdkNzdmYTA5NDVhNjgxYzE2N2ZmMGRiNTIwMmFfNy0xLTEtMS04MzQxNA_7388492f-7bfe-4f08-bf4c-45456129593d"
      unitRef="usd">22942000</naut:LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmE3YTk3ZDc3ZmEwOTQ1YTY4MWMxNjdmZjBkYjUyMDJhL3RhYmxlcmFuZ2U6YTdhOTdkNzdmYTA5NDVhNjgxYzE2N2ZmMGRiNTIwMmFfOC0xLTEtMS04MzQxNA_31928329-c5db-44be-883e-56dfdaab6997"
      unitRef="usd">43301000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmE3YTk3ZDc3ZmEwOTQ1YTY4MWMxNjdmZjBkYjUyMDJhL3RhYmxlcmFuZ2U6YTdhOTdkNzdmYTA5NDVhNjgxYzE2N2ZmMGRiNTIwMmFfOS0xLTEtMS04MzQxNA_018847fd-53ea-4d25-8fe8-001c1298cd44"
      unitRef="usd">13689000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RhYmxlOmE3YTk3ZDc3ZmEwOTQ1YTY4MWMxNjdmZjBkYjUyMDJhL3RhYmxlcmFuZ2U6YTdhOTdkNzdmYTA5NDVhNjgxYzE2N2ZmMGRiNTIwMmFfMTAtMS0xLTEtODM0MTQ_2ce9063c-5066-4817-a22f-e810dbaf4cd7"
      unitRef="usd">29612000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i616643cbd31d47a686cf71385bb21573_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfNTI2Mw_7a63bfdf-11e7-48f1-887b-f72c4ccb8366"
      unitRef="usd">600000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i34e4a2a383364c848f4d73f961251253_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83My9mcmFnOjU3YjRmYWQ1NWY0NzQwZTU4MTVhOWNlMGJiODYyODhkL3RleHRyZWdpb246NTdiNGZhZDU1ZjQ3NDBlNTgxNWE5Y2UwYmI4NjI4OGRfNTQ0Mg_a9cc86fe-d3af-4b2b-b9f4-e919b3f22b4c"
      unitRef="usd">800000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RleHRyZWdpb246YTg0ZWQ5OTJjNWVmNDM0OTk4MTk0YWU1ZTg0Yzk4ZjBfOTc2_873dfd3c-e8c2-41bd-913f-00e0e4f4133f">Basic and Diluted Net Loss per Share&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth the computation of the Company&#x2019;s basic and diluted net loss per share attributable to common stockholders for the three and six months ended June 30, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.629%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands, except share and per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,452)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,494,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,070,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,456,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,130,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Less: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average unvested restricted shares and shares subject to repurchase&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,624)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares used in computing net loss per share attributable to common stockholders, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,494,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,070,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,456,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,096,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share attributable to common stockholders, basic and diluted:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the Business Combination, the Company has retroactively adjusted the weighted-average number of shares of Common Stock outstanding prior to the Closing Date by multiplying them by the Exchange Ratio of 3.6281 used to determine the number of shares of New Nautilus Common Stock into which they converted (as described in Note 3). The Common Stock issued as a result of the redeemable convertible preferred stock conversion on the Closing Date was included in the basic net loss per share calculation on a prospective basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have had an antidilutive effect were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.993%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.925%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three and Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,650,794&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,014,879&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,411&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total potentially dilutive common share equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,712,205&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,014,879&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RleHRyZWdpb246YTg0ZWQ5OTJjNWVmNDM0OTk4MTk0YWU1ZTg0Yzk4ZjBfOTc3_df8c3d90-8ceb-4c8d-81fa-bb2c107a4760">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth the computation of the Company&#x2019;s basic and diluted net loss per share attributable to common stockholders for the three and six months ended June 30, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.037%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.453%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.629%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%"&gt;(in thousands, except share and per share amounts)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,713)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,452)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19,122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,494,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,070,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,456,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,130,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Less: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average unvested restricted shares and shares subject to repurchase&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34,624)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares used in computing net loss per share attributable to common stockholders, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,494,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,070,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,456,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,096,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss per share attributable to common stockholders, basic and diluted:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfMy0xLTEtMS04MzQxNA_859f2b30-7529-47d2-bffe-c5e4529170a5"
      unitRef="usd">-14689000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfMy0xLTEtMS04MzQxNA_8f9f1de0-d46e-42f3-bdd1-d33475d8a2ab"
      unitRef="usd">-14689000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfMy0zLTEtMS04MzQxNA_0b2bc11c-cd6a-48a4-8b98-cb56140ae56d"
      unitRef="usd">-10713000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfMy0zLTEtMS04MzQxNA_815b4875-96ff-4a54-940d-c546e30fb780"
      unitRef="usd">-10713000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfMy01LTEtMS04MzQxNA_50254b1f-55c7-41d3-a4ed-3c6200631a74"
      unitRef="usd">-30452000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfMy01LTEtMS04MzQxNA_9bdaaf13-0028-4292-a334-ec35d9df39b9"
      unitRef="usd">-30452000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfMy03LTEtMS04MzQxNA_402525e8-f750-4de9-9cac-d4a559628e3b"
      unitRef="usd">-19122000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfMy03LTEtMS04MzQxNA_5d613926-fc5d-42ef-88c5-fb630470d6a6"
      unitRef="usd">-19122000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNS0xLTEtMS04MzQxNA_83cfc29f-2bee-474f-91bf-d43cb622e633"
      unitRef="shares">124494036</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNS0zLTEtMS04MzQxNA_12daccb3-f5a1-4caf-9734-623896950ace"
      unitRef="shares">55070480</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNS01LTEtMS04MzQxNA_0eb02c57-cedb-4d81-bb4e-7d3a95304fd1"
      unitRef="shares">124456518</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNS03LTEtMS04MzQxNA_48f29913-4d78-4c8b-8cf2-44a33307ce00"
      unitRef="shares">44130773</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <naut:WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNi0xLTEtMS04MzQxNA_3c8724e4-0662-41c9-9e0b-dabc883d5359"
      unitRef="shares">0</naut:WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase>
    <naut:WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNi0zLTEtMS04MzQxNA_dd5b83a2-9388-40a6-8b14-79407e111e1c"
      unitRef="shares">0</naut:WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase>
    <naut:WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNi01LTEtMS04MzQxNA_5a3f6333-1a7a-4833-88fa-0d3444294f4a"
      unitRef="shares">0</naut:WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase>
    <naut:WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNi03LTEtMS04MzQxNA_6bea5ed3-e3a0-401d-ba0a-c78fdf95c31d"
      unitRef="shares">34624</naut:WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNy0xLTEtMS04MzQxNA_9aeb7400-a419-4195-b421-676ec26997bc"
      unitRef="shares">124494036</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNy0xLTEtMS04MzQxNA_ef0c7e70-f2cb-433f-9355-4a4603462d78"
      unitRef="shares">124494036</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNy0zLTEtMS04MzQxNA_8f0a1768-1ea5-4ba4-a20b-ce303502cca8"
      unitRef="shares">55070480</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNy0zLTEtMS04MzQxNA_a9ef480e-dba9-4d6d-89f9-1752c34d743a"
      unitRef="shares">55070480</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNy01LTEtMS04MzQxNA_1d9e5481-06bb-49e7-9a03-eeaa8fb66e31"
      unitRef="shares">124456518</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNy01LTEtMS04MzQxNA_be06489a-40a8-4c3d-8006-0c08bbd277ae"
      unitRef="shares">124456518</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNy03LTEtMS04MzQxNA_3dc4e53b-4b25-4205-874f-7fed5ad44215"
      unitRef="shares">44096149</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfNy03LTEtMS04MzQxNA_77433fdb-bd38-466e-a0e6-6fa52ed87a9f"
      unitRef="shares">44096149</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfOC0xLTEtMS04MzQxNA_2652ef4f-1e94-47d0-a5af-ff948e77cf28"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfOC0xLTEtMS04MzQxNA_a4700d1f-b027-45af-a1fe-ff80aea88f2e"
      unitRef="usdPerShare">-0.12</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfOC0zLTEtMS04MzQxNA_c57145b1-46cb-4c30-a9c4-eee8e2cf27ea"
      unitRef="usdPerShare">-0.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfOC0zLTEtMS04MzQxNA_ed2d84ab-4341-4008-822b-fd2aca614876"
      unitRef="usdPerShare">-0.19</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfOC01LTEtMS04MzQxNA_98c262b3-0b5b-454c-bacc-3f021da456bb"
      unitRef="usdPerShare">-0.24</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfOC01LTEtMS04MzQxNA_c67517d8-7fac-466f-a1ba-d54b49438709"
      unitRef="usdPerShare">-0.24</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfOC03LTEtMS04MzQxNA_d0397406-0b9f-4dd0-a072-49ee7d4f3115"
      unitRef="usdPerShare">-0.43</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjlkNmVjYzY2ZWZhMzRiZWNiYzRjNGRjNmNmNDdjNzdhL3RhYmxlcmFuZ2U6OWQ2ZWNjNjZlZmEzNGJlY2JjNGM0ZGM2Y2Y0N2M3N2FfOC03LTEtMS04MzQxNA_dcbb6533-65da-4699-9a7c-79bab20716bc"
      unitRef="usdPerShare">-0.43</us-gaap:EarningsPerShareDiluted>
    <naut:RecapitalizationExchangeRatio
      contextRef="ie8b7caea51104b0fa022cb4d3c2b850d_I20220630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RleHRyZWdpb246YTg0ZWQ5OTJjNWVmNDM0OTk4MTk0YWU1ZTg0Yzk4ZjBfNDEw_672511a4-2bac-40ed-8c4d-ee5f077408f1"
      unitRef="number">3.6281</naut:RecapitalizationExchangeRatio>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RleHRyZWdpb246YTg0ZWQ5OTJjNWVmNDM0OTk4MTk0YWU1ZTg0Yzk4ZjBfOTc4_d3e68acd-8ccf-4e45-8b2b-49f262b956fb">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have had an antidilutive effect were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.993%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.925%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three and Six Months Ended&lt;br/&gt;June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,650,794&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,014,879&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,411&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total potentially dilutive common share equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,712,205&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,014,879&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7b0787d033534be8830b754832d12575_D20220401-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjI1NzRjNzBhMTVmNzRiYmE5OWJmZmIzMTFlMTA4NzVmL3RhYmxlcmFuZ2U6MjU3NGM3MGExNWY3NGJiYTk5YmZmYjMxMWUxMDg3NWZfMi01LTEtMS04MzQxNA_1aa16a70-35ac-4e6f-91de-b1d861e5abc5"
      unitRef="shares">11650794</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="idae2ad2a8fe44cc2ae26dfcfb3a80cf3_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjI1NzRjNzBhMTVmNzRiYmE5OWJmZmIzMTFlMTA4NzVmL3RhYmxlcmFuZ2U6MjU3NGM3MGExNWY3NGJiYTk5YmZmYjMxMWUxMDg3NWZfMi01LTEtMS04MzQxNA_a416729e-918a-4900-b3da-b4f2a7b9e57d"
      unitRef="shares">11650794</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id173ca79999149b0acf943a294060af6_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjI1NzRjNzBhMTVmNzRiYmE5OWJmZmIzMTFlMTA4NzVmL3RhYmxlcmFuZ2U6MjU3NGM3MGExNWY3NGJiYTk5YmZmYjMxMWUxMDg3NWZfMi03LTEtMS04MzQxNA_89c675cf-58f2-4a3f-86e5-569df6882791"
      unitRef="shares">8014879</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1193b3efa76e4883905243879462ee64_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjI1NzRjNzBhMTVmNzRiYmE5OWJmZmIzMTFlMTA4NzVmL3RhYmxlcmFuZ2U6MjU3NGM3MGExNWY3NGJiYTk5YmZmYjMxMWUxMDg3NWZfMi03LTEtMS04MzQxNA_ff8f82e7-ea1f-4af1-ac26-fe9d19d71141"
      unitRef="shares">8014879</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia851771fac4244bc9fcb9380f95e907a_D20220401-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjI1NzRjNzBhMTVmNzRiYmE5OWJmZmIzMTFlMTA4NzVmL3RhYmxlcmFuZ2U6MjU3NGM3MGExNWY3NGJiYTk5YmZmYjMxMWUxMDg3NWZfMy01LTEtMS04MzQxNA_52183eb6-4482-4ac4-b5bc-532867bbf9a3"
      unitRef="shares">61411</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0108800d07f0495691d5110222b35f25_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjI1NzRjNzBhMTVmNzRiYmE5OWJmZmIzMTFlMTA4NzVmL3RhYmxlcmFuZ2U6MjU3NGM3MGExNWY3NGJiYTk5YmZmYjMxMWUxMDg3NWZfMy01LTEtMS04MzQxNA_c0ab2a6b-6fd8-44f7-87ae-3a8701ce875c"
      unitRef="shares">61411</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i51a1bd721e3d4a4e91f03a5a2c31863b_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjI1NzRjNzBhMTVmNzRiYmE5OWJmZmIzMTFlMTA4NzVmL3RhYmxlcmFuZ2U6MjU3NGM3MGExNWY3NGJiYTk5YmZmYjMxMWUxMDg3NWZfMy03LTEtMS04MzQxNA_ee1e187f-f6d1-430d-9d84-3be065a06fa2"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic4fee951cce3455ca59554a17600d641_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjI1NzRjNzBhMTVmNzRiYmE5OWJmZmIzMTFlMTA4NzVmL3RhYmxlcmFuZ2U6MjU3NGM3MGExNWY3NGJiYTk5YmZmYjMxMWUxMDg3NWZfMy03LTEtMS04MzQxNA_fde881ec-fb34-4861-bcea-5bb6cdd8c21f"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i452786b7977748c0a94d775ecb931729_D20220401-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjI1NzRjNzBhMTVmNzRiYmE5OWJmZmIzMTFlMTA4NzVmL3RhYmxlcmFuZ2U6MjU3NGM3MGExNWY3NGJiYTk5YmZmYjMxMWUxMDg3NWZfNy01LTEtMS04MzQxNA_22bc5183-9d21-4d8b-9105-78e45a34494a"
      unitRef="shares">11712205</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjI1NzRjNzBhMTVmNzRiYmE5OWJmZmIzMTFlMTA4NzVmL3RhYmxlcmFuZ2U6MjU3NGM3MGExNWY3NGJiYTk5YmZmYjMxMWUxMDg3NWZfNy01LTEtMS04MzQxNA_2a8247ee-52ed-465a-a126-f52e5831d87f"
      unitRef="shares">11712205</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib6f2a0bb278145dbb243418e6b5940e0_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjI1NzRjNzBhMTVmNzRiYmE5OWJmZmIzMTFlMTA4NzVmL3RhYmxlcmFuZ2U6MjU3NGM3MGExNWY3NGJiYTk5YmZmYjMxMWUxMDg3NWZfNy03LTEtMS04MzQxNA_467d37da-9ab9-4336-be98-2cc58be46e81"
      unitRef="shares">8014879</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8cd61cb8b75946248e1c577819a5904d_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV83Ni9mcmFnOmE4NGVkOTkyYzVlZjQzNDk5ODE5NGFlNWU4NGM5OGYwL3RhYmxlOjI1NzRjNzBhMTVmNzRiYmE5OWJmZmIzMTFlMTA4NzVmL3RhYmxlcmFuZ2U6MjU3NGM3MGExNWY3NGJiYTk5YmZmYjMxMWUxMDg3NWZfNy03LTEtMS04MzQxNA_736fd814-85fe-4ca9-a863-4fc322954e99"
      unitRef="shares">8014879</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi0xNC0xLTEtODQ0NzU_57bc314f-834c-40f1-a242-997899b68f31"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi0xNC0xLTEtODQ0NzU_57bc314f-834c-40f1-a242-997899b68f31"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNS0xNC0xLTEtODQ0OTk_80af0f86-b8df-4a3e-bed6-4d2862df830c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNS0xNC0xLTEtODQ0OTk_80af0f86-b8df-4a3e-bed6-4d2862df830c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy0xNC0xLTEtODQ0OTk_719f2a7b-ec0b-40ac-a508-a821cb3bd035"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy0xNC0xLTEtODQ0OTk_719f2a7b-ec0b-40ac-a508-a821cb3bd035"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy01LTEtMS04NDUwNg_b8bc7253-d81f-4b02-959a-8f5afd08a577"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy01LTEtMS04NDUwNg_b8bc7253-d81f-4b02-959a-8f5afd08a577"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNC0xNC0xLTEtODQ0OTk_97d76318-92a5-4f80-b04a-d7b50d140d16"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNC0xNC0xLTEtODQ0OTk_97d76318-92a5-4f80-b04a-d7b50d140d16"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi0xLTEtMS04NDQ5Mg_74f4ac74-240d-4f1b-9934-8cac77a2ebaf"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi0xLTEtMS04NDQ5Mg_74f4ac74-240d-4f1b-9934-8cac77a2ebaf"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi01LTEtMS04NDQ5Mg_480e1859-325f-4374-ae5f-6d4318797597"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi01LTEtMS04NDQ5Mg_480e1859-325f-4374-ae5f-6d4318797597"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi05LTEtMS04NDQ2OA_43ffdcfe-0fbb-4d42-9614-cfecfc6ff0c7"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi05LTEtMS04NDQ2OA_43ffdcfe-0fbb-4d42-9614-cfecfc6ff0c7"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi0xNC0xLTEtODQ0OTk_52185f78-57f1-41ee-ba4a-19e2df199dea"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi0xNC0xLTEtODQ0OTk_52185f78-57f1-41ee-ba4a-19e2df199dea"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtMS0xLTEtODQ1MDY_bffaae5a-9acd-4a32-96ff-e26d68de6ad5"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtMS0xLTEtODQ1MDY_bffaae5a-9acd-4a32-96ff-e26d68de6ad5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS0xNC0xLTEtODM0MTQ_3f69f49b-df8f-49c3-be9b-43be5bd65607"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS0xNC0xLTEtODM0MTQ_3f69f49b-df8f-49c3-be9b-43be5bd65607"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS01LTEtMS04MzQxNA_33093a59-7f1b-49ac-a9c6-08437cf57263"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS01LTEtMS04MzQxNA_33093a59-7f1b-49ac-a9c6-08437cf57263"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItMS0xLTEtODQ0OTI_4ca8e9cc-23bf-48c8-bb72-7c3582044e38"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItMS0xLTEtODQ0OTI_4ca8e9cc-23bf-48c8-bb72-7c3582044e38"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItOS0xLTEtODQ0OTI_733722af-14c8-4290-8046-f9cba9551922"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItOS0xLTEtODQ0OTI_733722af-14c8-4290-8046-f9cba9551922"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNy0xNC0xLTEtODQ0NzU_05b2a09e-74fe-48ba-9927-bcbc1cebd63e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNy0xNC0xLTEtODQ0NzU_05b2a09e-74fe-48ba-9927-bcbc1cebd63e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS05LTEtMS04MzQxNA_6edd4567-16bd-4015-a577-62d71f192da8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS05LTEtMS04MzQxNA_6edd4567-16bd-4015-a577-62d71f192da8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi0xLTEtMS04NDQ2OA_20297a22-d73b-4327-b5ca-3ff135f493d7"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi0xLTEtMS04NDQ2OA_20297a22-d73b-4327-b5ca-3ff135f493d7"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtMTQtMS0xLTg0NTA5_26835d7a-7a99-4bda-887f-9ce027293260"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtMTQtMS0xLTg0NTA5_26835d7a-7a99-4bda-887f-9ce027293260"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS0xLTEtMS04MzQxNA_034b4253-3fca-4b18-92d1-236a541cddfd"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS0xLTEtMS04MzQxNA_034b4253-3fca-4b18-92d1-236a541cddfd"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItNS0xLTEtODQ0OTI_46c2bf03-9c4c-49b2-937b-33031864d629"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItNS0xLTEtODQ0OTI_46c2bf03-9c4c-49b2-937b-33031864d629"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNS0xNC0xLTEtODQ0NzU_61e3aa2a-5c3e-494b-ae90-37291d77a75f"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNS0xNC0xLTEtODQ0NzU_61e3aa2a-5c3e-494b-ae90-37291d77a75f"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi01LTEtMS04NDQ2OA_9ce79aea-6f5a-4f20-b036-347ba96cdc23"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi01LTEtMS04NDQ2OA_9ce79aea-6f5a-4f20-b036-347ba96cdc23"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy0xNC0xLTEtODQ1MDk_ffa78cf3-5d7a-4ce6-8f0a-89208842a501"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy0xNC0xLTEtODQ1MDk_ffa78cf3-5d7a-4ce6-8f0a-89208842a501"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNC0xNC0xLTEtODM0MTQ_60d8abd0-bfc6-4ce0-9a1f-cda9cdbd83ff"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNC0xNC0xLTEtODM0MTQ_60d8abd0-bfc6-4ce0-9a1f-cda9cdbd83ff"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNy0xNC0xLTEtODQ0OTk_d5a07a5b-d731-47e5-a184-403b6951b5ac"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNy0xNC0xLTEtODQ0OTk_d5a07a5b-d731-47e5-a184-403b6951b5ac"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy0xNC0xLTEtODM0MTQ_4d3d6df8-8f33-4873-8fbc-7848e7307f40"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy0xNC0xLTEtODM0MTQ_4d3d6df8-8f33-4873-8fbc-7848e7307f40"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy05LTEtMS04NDUwNg_2d8ba5f5-eee8-4e45-8c28-d31752cafccc"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy05LTEtMS04NDUwNg_2d8ba5f5-eee8-4e45-8c28-d31752cafccc"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy0xLTEtMS04MzQxNA_d93a5fd4-a81d-4f6a-bcf2-79846171a71b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy0xLTEtMS04MzQxNA_d93a5fd4-a81d-4f6a-bcf2-79846171a71b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy05LTEtMS04MzQxNA_daa8f9e7-8532-4003-82f7-c4c3ae86deca"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy05LTEtMS04MzQxNA_daa8f9e7-8532-4003-82f7-c4c3ae86deca"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy0xLTEtMS04NDUwNg_4edba972-c1cb-4ffb-a57b-4e2ca9adfa57"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy0xLTEtMS04NDUwNg_4edba972-c1cb-4ffb-a57b-4e2ca9adfa57"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItMTQtMS0xLTg0NDk5_ab958293-94be-428e-9d40-eb3216ad4fa3"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItMTQtMS0xLTg0NDk5_ab958293-94be-428e-9d40-eb3216ad4fa3"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy05LTEtMS04NDQ5Mg_e6eed32e-e8f9-4997-9df8-2ef2c264d55a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy05LTEtMS04NDQ5Mg_e6eed32e-e8f9-4997-9df8-2ef2c264d55a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy0xLTEtMS04NDQ5Mg_851ca1e7-788c-4451-a018-d1ddcb4366c1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy0xLTEtMS04NDQ5Mg_851ca1e7-788c-4451-a018-d1ddcb4366c1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy01LTEtMS04MzQxNA_3dc86bbc-0b9f-4c1b-a97e-7d41ff3190d9"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy01LTEtMS04MzQxNA_3dc86bbc-0b9f-4c1b-a97e-7d41ff3190d9"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy01LTEtMS04NDQ5Mg_1d02e536-9978-4a12-9457-c9d32604020b"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy01LTEtMS04NDQ5Mg_1d02e536-9978-4a12-9457-c9d32604020b"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi05LTEtMS04NDQ5Mg_7f9b9355-bce7-4582-bdf6-52f2251ca828"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi05LTEtMS04NDQ5Mg_7f9b9355-bce7-4582-bdf6-52f2251ca828"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtNS0xLTEtODQ1MDY_22ceea25-8891-45fb-bfa7-d4ed0c4c76e5"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtNS0xLTEtODQ1MDY_22ceea25-8891-45fb-bfa7-d4ed0c4c76e5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtOS0xLTEtODQ1MDY_210860ff-0daf-48e6-97d5-7d4e201f43f6"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtOS0xLTEtODQ1MDY_210860ff-0daf-48e6-97d5-7d4e201f43f6"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">(1)&#160;&#160;&#160;&#160;The shares of the Company&#x2019;s common and redeemable convertible preferred stock, prior to the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 3.6281 established in the Business Combination as described in Note 3.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi0xNC0xLTEtODQ0NzU_57bc314f-834c-40f1-a242-997899b68f31"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNS0xNC0xLTEtODQ0OTk_80af0f86-b8df-4a3e-bed6-4d2862df830c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy0xNC0xLTEtODQ0OTk_719f2a7b-ec0b-40ac-a508-a821cb3bd035"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy01LTEtMS04NDUwNg_b8bc7253-d81f-4b02-959a-8f5afd08a577"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNC0xNC0xLTEtODQ0OTk_97d76318-92a5-4f80-b04a-d7b50d140d16"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi0xLTEtMS04NDQ5Mg_74f4ac74-240d-4f1b-9934-8cac77a2ebaf"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi01LTEtMS04NDQ5Mg_480e1859-325f-4374-ae5f-6d4318797597"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi05LTEtMS04NDQ2OA_43ffdcfe-0fbb-4d42-9614-cfecfc6ff0c7"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi0xNC0xLTEtODQ0OTk_52185f78-57f1-41ee-ba4a-19e2df199dea"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtMS0xLTEtODQ1MDY_bffaae5a-9acd-4a32-96ff-e26d68de6ad5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS0xNC0xLTEtODM0MTQ_3f69f49b-df8f-49c3-be9b-43be5bd65607"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS01LTEtMS04MzQxNA_33093a59-7f1b-49ac-a9c6-08437cf57263"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItMS0xLTEtODQ0OTI_4ca8e9cc-23bf-48c8-bb72-7c3582044e38"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItOS0xLTEtODQ0OTI_733722af-14c8-4290-8046-f9cba9551922"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNy0xNC0xLTEtODQ0NzU_05b2a09e-74fe-48ba-9927-bcbc1cebd63e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS05LTEtMS04MzQxNA_6edd4567-16bd-4015-a577-62d71f192da8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi0xLTEtMS04NDQ2OA_20297a22-d73b-4327-b5ca-3ff135f493d7"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtMTQtMS0xLTg0NTA5_26835d7a-7a99-4bda-887f-9ce027293260"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfOS0xLTEtMS04MzQxNA_034b4253-3fca-4b18-92d1-236a541cddfd"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItNS0xLTEtODQ0OTI_46c2bf03-9c4c-49b2-937b-33031864d629"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNS0xNC0xLTEtODQ0NzU_61e3aa2a-5c3e-494b-ae90-37291d77a75f"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNi01LTEtMS04NDQ2OA_9ce79aea-6f5a-4f20-b036-347ba96cdc23"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy0xNC0xLTEtODQ1MDk_ffa78cf3-5d7a-4ce6-8f0a-89208842a501"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfNC0xNC0xLTEtODM0MTQ_60d8abd0-bfc6-4ce0-9a1f-cda9cdbd83ff"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNy0xNC0xLTEtODQ0OTk_d5a07a5b-d731-47e5-a184-403b6951b5ac"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy0xNC0xLTEtODM0MTQ_4d3d6df8-8f33-4873-8fbc-7848e7307f40"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy05LTEtMS04NDUwNg_2d8ba5f5-eee8-4e45-8c28-d31752cafccc"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy0xLTEtMS04MzQxNA_d93a5fd4-a81d-4f6a-bcf2-79846171a71b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy05LTEtMS04MzQxNA_daa8f9e7-8532-4003-82f7-c4c3ae86deca"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMy0xLTEtMS04NDUwNg_4edba972-c1cb-4ffb-a57b-4e2ca9adfa57"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMTItMTQtMS0xLTg0NDk5_ab958293-94be-428e-9d40-eb3216ad4fa3"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy05LTEtMS04NDQ5Mg_e6eed32e-e8f9-4997-9df8-2ef2c264d55a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy0xLTEtMS04NDQ5Mg_851ca1e7-788c-4451-a018-d1ddcb4366c1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjBkMDQwODUxNzYwYTRjY2NiYjI4ODkxMDcxYzhjMmZlL3RhYmxlcmFuZ2U6MGQwNDA4NTE3NjBhNGNjY2JiMjg4OTEwNzFjOGMyZmVfMy01LTEtMS04MzQxNA_3dc86bbc-0b9f-4c1b-a97e-7d41ff3190d9"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfMy01LTEtMS04NDQ5Mg_1d02e536-9978-4a12-9457-c9d32604020b"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOmM1MjQxNTViZTE3OTRjYWNhNzI3OWZlMjgyNTc5OWZlL3RhYmxlcmFuZ2U6YzUyNDE1NWJlMTc5NGNhY2E3Mjc5ZmUyODI1Nzk5ZmVfNi05LTEtMS04NDQ5Mg_7f9b9355-bce7-4582-bdf6-52f2251ca828"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtNS0xLTEtODQ1MDY_22ceea25-8891-45fb-bfa7-d4ed0c4c76e5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RhYmxlOjQwYThkYzA3ZTE2ZDRmY2I4NmUyNDFkMzZhZjIzM2YwL3RhYmxlcmFuZ2U6NDBhOGRjMDdlMTZkNGZjYjg2ZTI0MWQzNmFmMjMzZjBfMTEtOS0xLTEtODQ1MDY_210860ff-0daf-48e6-97d5-7d4e201f43f6"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkyYjNjOTdjZTg5MzRiYjdiN2FiNmNhNWUwOGIzMTIxL3NlYzo5MmIzYzk3Y2U4OTM0YmI3YjdhYjZjYTVlMDhiMzEyMV8zNC9mcmFnOjgwZWFjY2EzNmU5ODQ1MDFhYTA3OWE3NTE3YTZmNDE4L3RleHRyZWdpb246ODBlYWNjYTM2ZTk4NDUwMWFhMDc5YTc1MTdhNmY0MThfMzk0_66c68fac-2e21-4f8f-84ea-ad090fe05d5d"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>63
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MC0#\OI92/VW,Q61[$;WZ#U!+ P04    " !6@ )5<AJE9$ $  "R$   &
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M(-<-R8KJ!KAF$NZ3U6M,"4R$ L#O6\;D2T,-T/Z;8OXW4$L#!!0    ( %:
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MV=IY4U4WNQ&/GV5+9\XW6_Z2?6;E/*]VWWYB5?UPIEULF]/EJN]"44_E'7,
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M>T/B_A ";78"I:50&D71Y.<4"V,D&/L,K;'3PIX*NAXK#,VX@M)F4%H,I9%
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M('#<#WYS$)B82XU6-9*60FD419-5+7R7\"F9+GHE0_V44,T240;*WI"X/X1
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M  !M"@  &    'AL+W=O<FMS:&5E=',O<VAE970W+GAM;*U6:V_3,!3]*U9
M:)-&XR1];;21MDX(D)"J5< 'Q <WN6VL.7:PW7;PZ[E.NM!NZ6O0#XT?]QR?
M8U\G=[!2^MYD )8\Y$*:H9=96USYODDRR)EIJ0(DSLR4SIG%KI[[IM# TA*4
M"S^DM.OGC$LO'I1C8QT/U,(*+F&LB5GD.=._;D"HU= +O,>!.S[/K!OPXT'!
MYC !^Z48:^SY-4O*<Y"&*TDTS(;>=7 U"J@#E!%?.:S,1ILX*U.E[EWG8SKT
MJ%,$ A+K*!@^EC "(1P3ZOBY)O7J-1UPL_W(_KXTCV:FS,!(B6\\M=G0ZWLD
MA1E;"'NG5A]@;:CC^!(E3/E/5E5LM^>19&&LRM=@5)!S63W9PWHC-@!!>P<@
M7 /"8P'1&A"51BMEI:U;9ED\T&I%M(M&-M<H]Z9$HQLNW3%.K,99CC@;CY1,
M\5 @)=@R2O"46>S<,,%D F3BB TY&S,-TF9@><+$.7E+7A.?F Q'S<"WJ,.Q
M^<EZS9MJS7#'FI\6LD4B>D%"&H8-\-%^^"TD" ]*>+ -]]%]O05AO05AR1?M
MX)M8M(R9:8F:D?=<HG'.!!DKP\M,^WX]-59COOUHLEIQMYNYW26\,@5+8.CA
M+3.@E^#%;UX%7?JNR?A_(MO:AJC>AF@?>SS&^P-:X^%CTB7W%Z1@FBR96  Y
MXY*D2@BF#2E 5P=_WK0;U1+]<@GW!EG&M$4IQ6-:;OH\&+;EH%T[:)_FH$I0
MPA8V4YK_Q@GGI!IME%_Q=S9TX>NP^CUQ<$SDEHE.;:+S(A/<F,5A YUGLIX*
MWQ>Q);A;"^Z^2#!^,XQE,N5R?DAU]Z#J?1%;JGNUZMY>U2.5YWBW_R'5>\>E
M^L&P+?G]6G[_!/DGYWG_V78&=$>B'Q6ZY>&R]G!YNH?CTOSRN:BPW>F&O7;G
MB?S&R(A&M!\UJP_HWR\G/5W_"5F_IC_&17-HHPU_HQ9PA=AGIN=<&B)@AEC:
MZB&)KFJ;JF-5498'4V6QV"B;&=:#H%T SL^4LH\=5W'4%6;\!U!+ P04
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MCR%87T#GI3&X2_R\]<]K]@=02P,$%     @ 5H "55CQ5RW-#0  \20  !@
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MUMK16KSWUAA5C823VM.K0C8Z8!>)Q<Z-9FU7RL#E\:TL@7R:RHL@'-YI2+"
MMN1!KP;A&8L/1@ @E'C!^##=SQN$C(0#*E5.GM'#:2?%&U7)K71*#$/X[?+T
M]E2*V<=_SL1-H96AF,R*/UO8Q OF6#P65U=7(XB8RUV-G+GR<&CIA;I3=4-Q
MSDE*1AY+&Q13J2#9P]*\]MMD"QV=;8 1!8RGQDIB212V;K1M/>6/,;:%@F4?
M60A; ,6B*0,'=44Z[Q=T5=:TSK?(2DH>VA.4J[F(PUH&42#B2 AQ3(28K9QB
MH!R)DE64O/&=6K@67$!\?R18E_-9'Z-%=)*L+<)'IH_$>WEKQ7OE5LJ)FW81
MXS6Z+V"T>[NVJ*<G=FM2C2'5Z'1HPH',KCV0W&M!0KILN>D$_,71*5<>2K/O
MNK/_H5:RV'6+\]EC,2.,0_F";D2?JZ.N'D53BK4T*\(WU*:1M:*8I1,>TB,=
MQX8F+XCL!E&31\J(([0 -6_%@;[QT\.7OG4;(!)AAV?-^Q?#$E@H//&JOP[5
M(%%BI :J4S4P& $MD/^L$JVW^ >0X:3QLHAH7G*36L1.P#Z=SR(N)^$?@:L.
M$/-1)9Q*1*$/S!62JRQU=#ZDH!+_0+EQZ+NCR<Q*Y5YX?_!R%6FS >9:Y[O$
MN+ZZ?HNSTNNN*,DWR8*$AU2G"#_!XA+>$'*%XENAZNCY;#*:3/@_X==(5"Y#
M*(>Z$A!<W&;UY@=P\PL(=A?/>=QP0QLZ38 !$K"C"S[HZ^EDC$, S/$@UJY7
M9>6LY_93*%6R$E]CCAA/P'&KBHMF:'9B7&;5>_VZ4F0B.#R%U(I?D,OB_ NC
MQLHL6\?Y4"IXO/(/Q65\#V'YE2,+6FL\HWEFCA2,CB3ZGB0RA!4IY2G1#;3&
M:[BG-1)MFJ$1B]82?6ZAE"$<;_ YYR=M=:4DDA&+$,\M6 +U57370B/%?.Z<
M!/Q%H9K0Y_9OA@]@ULK&S%#2NI"=LW\;WXS%WV:SZSZH4 8A:ZO$?I*3>.&-
M*EK'-(.7O;V+H,/9H;T_["TW;^>=6/(_40:GZX&G8"KZ.LP!VH'S\(*,#WM5
M&_E;);GK]KY2E:XI8K"Q;:P9!(1C..]J*PZSN2TLK0T4"%%J7X AM%06AI:0
M$R.!BDX\&M2'(M0Y=*!EGS!P O ND+[#WNI;<#K75LFO _>/'YUQ6^54KZ&-
M>>"I(2PXHQ,>Y]R[+VM'.85L R8600R,!F-[;.HH0\);IJJR_ -S*V\= <<U
MC$D^Q/EP:/0LMB![F!,.-@C#=(>0GO%"+*5VO2X'X-3QI%[MQB;^%0D&,\$\
M*D9<CRW49T8]8/89/\,:9(5=[_6=J./PJFAXW9?'2YBV<#>$L (3A%A6=ML+
M^T(1,;(#W?XGO1!S)'3G3,UI7*+2F3\G)^;#F+W5<H?L!#.EZ6#02W:8,.@,
M9LT05R^ F.?3>! K#91]#-;YM6TK:O6"[I >Z)=?@J51)*&XHH'&'$V.F3$T
ME'QD<*$2H.L<,9T\^7MGY1*%CR796!QY:.N4-BYUI7H5@6<Q:H<'=C F*,,Q
M&NQH0.U@LP0WD0ZP8&G)W (LG#DJZ#&%?J1CI&I?Y-8%(="JU6&WGV"Y+KHN
MR<3!>T4%G$<3CT_\,@(P?5YIN=!51/^,#0YI0J6+KN0B_<@#1YZ-Z9\F,IW#
MV3<BN%G)5832--#F 7/(5 \FQU&"R<+!MKTA\WA\DN6T$"V$4S]U+KG/L6O2
MC6PF'A9C&5!*K;DU(*;9-<3V(69!-4=N:YV,UP H*T[EN/'PV"V(#FV2Q5K#
MU*Y)!PUP7CJ":+H!0%/GH&, &GALE""'E3>*9C[T#:5N.RJ*[%BV-&QZ:PU1
M)%@8!WI5@K,BP*7ZLR4J%I=ES) ;D"',^BI/>3E&A*FL'#S *37*YW,M8_)U
M48T2,Q 4I%[,G:%L"S6B7D?S(K?GCN42\42+IU162Q0C)1P6<C-4<=YP]$(.
M!FN^!E KOMQ(-R.QR10,++)DYD?L9[GDFP[8@&&"$,R+5.^.[FK]?=V$>3!M
M@:"]#.(\10I30 $^:AA3\ :?&K8ABDM .VP'SM8'MTA$47<1<_Q^<;"4",6$
M&YIO>U+UJAZT+%%1Q;%:M@&LA8?$XUVOMZ#DF: HVII8A:*;HR6R+$32/IV.
MIYF#?VX[I4H:*@>V@'O6L<DP-G:DGFVFPT$&6ZX)'$$W&JIFI6$17! T_=TP
MD2>WQBF$/# <2WC,8KL(C/=M0N4K317T^5 A&SS=:;H6@7I?GS]]-G[6C1BL
MW_Y8U<'=T5L,NUP"%/DN8E_N](?Q62>6LJHGJ[#"IVY%SG-;,&85YS<DFU@J
M10VCBDF42JY(UU0/3B2_'D25DFT44XZ*<2.KR,"8+ZQ16T^H_M)@&7L&3UTO
M7HS/.]V/L*:<5*1)R5.D2047[]X>S4;W$&81LT.5^R%=@,JC/A(YR=3JD>9E
MA/7MDC)<179-.7P?\S/J#FNVJD+Q)GZU1+>V6P[.02:'QU'QX[U(QAO3S,4B
MAFVHB>[WHE'',0T!!CU4UJRBT;'ZNXO4!,8#)Y2J :VAR U;VO!RF"2C?+9T
M14Q!SG40=)VO?.&;1,%]DQ@A#ROQ,C;=3A^_D$[@_CF@I$MX[$74N)P\-QJX
MN6YB;#IZ2G?#.6>VSM*U=&J"T6LMDI$D]?G5.R3?F@^;(6WL>GI"VWT-CS2W
MPQY+'Q&?HFN$1<B!IPGV70Q*I;&BI#4,:92_#\7'M.AZMO4Y1HQ[% AXD_*7
MG#%L\?D\8IA9S_U28H: QDY4(Q4=\2?R%;N:[PCB)_$^U_%-3E4Q2QA*PA&M
MV9<Q4"4[>[M61-Y\U(3F_"6[FFZA _E9?EY_- @3D]J2S.[&AJ&&5G;7UI9S
MK361=BY4(6/0126+6S\L](X:#O>/!OTZ55S,H;Y>J: CS]CF.>6043!_@D>*
M?AS]\/O5FR?3%W3I#U]LM$, $;=NB#B;3%^,^F5;:J7:^9!&A9A:).F3=3CT
M)U!Q%.+P>\GNBN;33Q_V[Z/!)'Z6AF_1 =>3&'RL0@R*BN< YN9M6(#AWZ;Z
MD>!8BTH78AV/4LRU,*EPOKWG(MZ7!H9,WVXJA[B4O2F,4A125>MB\ U8)OAY
M75X2D23"068USE8<IOBS@CC)>+TR&L&47)VH4[JC2[;4P(%\&] HV]!W=RMK
MR]P-E-MH*O8M.7.K2[5W>?[YY!'D+5W+)$Y:*QEO@+3A;\N0GYSPV92Q^+2F
M.9#[83OX=J''Q^.6QR)G?$N /8#(A'.I2G@L*$@XI1U]"Z1Y*N>)@N@@:/@H
MWA.E"YQT>/)NO/J.)1/G/EA6YP7@Y7HENQ]%\ 2(&B)7R(I"T-/$F/I)9!XH
M5Y5=$/1!KJUW_8@(YS*$ V51A/DKO;@,]NOC-=/Y!X@(+7T>KQ"T#ERJ'7_!
M18,R+-JHV*V/2.ZD<A(Q/'!@"&W%QA+-J@B+]^[R2,OXU4#&,-#96]5?7Q&$
M'ITK/NOFBR@>Z4*X2E^T[4O,0U[FZ^_B'70-*A_S\J^<=#CDI/7'E!E,'VQA
M#[>Q/6-*.[KO"[Y6'HMCOTLX'?P,A?&$?FS#G,:$^(N4[FWW>YY9_!E+OSS^
M& @(M*)<J-026R?C[Y^=Q*$M/P3;\(]:%C8$6_.?@#+P:UJ S^E.-S_0 =VO
MG"[^"U!+ P04    " !6@ )5D!/;+*,5  "#/@  &0   'AL+W=O<FMS:&5E
M=',O<VAE970Q,"YX;6RU6VF/W#:V_2M"#S!C ]75BSW.X@5H=YSW'"1QX(X3
M/#R\#RJ)5<6Q2JR(4B_Y]>^<>TF*JJ63##!?["Z52-[UW(WUZLYUG_W:F+ZX
MWS2M?WVR[OOMUV=GOEJ;3>GG;FM:?+-TW:;L\;%;G?EM9\I:%FV:L\OS\Q=G
MF]*V)V]>R;.?NC>OW- WMC4_=84?-INR>WAK&G?W^N3B)#[X:%?KG@_.WKS:
MEBMS8_I/VY\Z?#I+N]1V8UIO75MT9OGZY.KBZ[?/^;Z\\(LU=S[[NR G"^<^
M\\/[^O7).0DRC:EZ[E#BOUMS;9J&&X&,W\*>)^E(+LS_CKM_*[R#ET7IS;5K
M?K5UOWY]\N5)49ME.33]1W?WWR;P\T_N5[G&R[_%G;[[[/*DJ ;?NTU8# HV
MMM7_R_L@AVS!E^='%ER&!9="MQXD5'Y3]N6;5YV[*SJ^C=WXA[ JJT&<;:F4
MF[[#MQ;K^C<W=M7:I:W*MB^NJLH-;6_;5?&3:VQEC7]UUN,0OGI6A0W?ZH:7
M1S9\4?S@VG[MBW=M;>KI^C,0ERB\C!2^O7QTP^^&=EX\.Y\5E^>7EX_L]RQQ
M_$SV>W9DOP-<%O][M?!]!POYOT,,ZW[/#^]'K_G:;\O*O#Z!6WC3W9J3-W__
MV\6+\Y>/4/L\4?O\L=W_'?T\NN%A<O_@E.*3-X5;%N]\;^$(>/#SVA18OBV[
M4IP+7_9X5#DHO?6FYE\>JVN\71=+VY9M9<NF\#T>P*=[7]B6+Q%6;/\ J^_7
MQ:?YS;SXKZNKG^#NOPT6Y,'46V #5Q2]PZ?/IC")BK*MB](#3[8DPH.$LB_*
MY1(>+^2 0->1@')#ECS)Q/NFUZ6-+1>VL;T-6]765XWS \_%FZ".4N#1QQ;Y
MR#CY_#>$,),MCY%J[K?<QQ?UT%$=XWO\M#6==?4<^NH'; JB 40>9PX-68$4
MNF+9N0V6.9]);5[DVAZ%:=NJ&6JP8GH#G;3QQ/@&6;]5R6P[!(4.6B/UU-26
MW,S F*L^GQ(DR?N&U*MYZ-[[.RY+VQ6W93,8LE/X==D9%?UF@V6R'TZSKJ/V
MDZ#YQS7V+]N'8F&J<H/EPP*V.J,83-E5:U6HN474$>( _U4'.64BY[E*7MD@
M-D$YIH Y$M--UX&ZOKP/FI_3X/UCID?"E7'L-QKMW__VY>7%%R\]R/3]SO)_
M#?6*[\R+'T8C-TH5]0%E'C^/5,/MVI6C5'&R]<7@^??:0FP=M-N( 776D#&N
M=^ :-@&8<QWD,%5*-8!G$@"C=1M;%::]M9UK5;-W:PN99LZX,(TU- ?H94&S
M++UKRT5CB@'6W^F6MJN&#:P=!*@(D];*^E^(;1ZY +8]SN7=VK1"L'XUV1 V
M7M&1YL7UNH2;"J+LV'KP"O(HKJ N/?!SE2\R!]D&*#6-<K=D%@'EAK>/ =IR
MZ($>P37!\I6/CR"K-G"!#6#U1F *_EJVK:,\D^/A&$%#X&MEF?S,F+OL^S@Y
M[$!#\_"8N^_*%.)R$%_;*W*+/U_#VFU??+3^L[S^00R%'W7Y)RSH>F1X@GKA
M[8YO X[H<62-<BG'V $@#8!\)]2*&"L'Y/F=*)>0<P0T<6U+Y\<6ID-LD>.
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MA^5 *<:@)MP2VR/=H*$/?8MHX;LGT0P;IB7,#%)&'H\90U+<&L*/G$7")-/
M^T%J 5T(,ZL!4,5X56Z)NSA!J C[Z$.\F#:,QQZPD7GQ#BC.P'Z(BUQ$"E6:
M2X]BFH5H-,0D1++"&3?$VFXV 4.A RZ/R-B;B==VS," 12%'PI=E8_95?F,D
M)R\^IK3DPY:;\2^OWRF!J!(DX$L&DH* P'G!-(.Z$/-A5=E!QUG2:%OMI@F
M^)3S1\%WD!U01U+HM35P_D1"'5+"@A[TV?3%$TKR\OSE]8=O?I _+UX^)1+P
M17'TM;NCP;/$$?B'@0K*Q\Q#*ASO0T4I=$'0$Y!*RKH6:M[=(R.1>/%A">'"
M;:U6*Z3AR$)\@Y-A$>;.'Q%$2"2U@BJGM;/6-PGKAXY)B5=8_4S2]R7$<*0\
M\^F4ZR!P*0L2+1/NK[0TF1H74ZHL21=W@&WJV0K ,(.,%BFZVICC"F &&SHL
MI@;UW"FK[#IU'%@ZP)H8/D-]&6#^4VLIF9M>:_IK9F \3_YX!T<&CV*2>;21
M#+:68 L_6=O5NGG @7A[FH1*_<'ZLK,K2_"$CIB$AD2E,P 8[?)!)0VSW?U6
M2%EA6Z\!08M$R1+-2-J\>)^=>9C./T?5"H&^EZJS;*?T422=(1I2(6$!HZ50
M+>]30P]&XRT!>@U=G5++Q]/9JH%^@"R2DS-"YV1.LO2$J33>0=Y,I78P%&D?
MM,&>A$)Y:^,DT0.!%Y>)FV C?YHZVT]%B U"8M)HLT-04(6T%?"%"H$M?=::
MF:G@AQ9"EM!<K"#.T W3:H*575>K<:*B&#:#IN!C#M"9-3OYMV0-GTWQA$N?
MHF2;E@W(09MZ;/E$#<]"9TVKK[WW 0ZI^2+8CAR4P%_ B. ]# %BAQL#=:%0
M^GB4D[A!# ZY[#HS8529B^R$9MW3&7*1/CKID59@:AI(9I>L8*Z%]RF5#A4C
MJ'0E0O![:-5V\GJNY6FG:,]/,G4%UJAN=^@ FPZ8%[^RXS*&A'S;H^L!N>PR
M"P &B^D/.G-H/87*DP@-NUX%02+';U<A]33WO?3LJ!?3KL .P84EC22%B:B$
MG%DCD2B],."B<7<1$JPT36 \$DAF.ST<:DEQB@>V@ )U,&0%7HN9 &WCP;.#
MR4Q,]S6R]J%IC>!?!GL8-Q!IEJ%3E+CS R.J#0NE+:DO,NF"(5=V&_*$"OF7
MM!,FCAK382W":':$W"6V\5GBHPV%!\"O%I_:C O@Y7)9AL87.(M*CI:MW^_)
M92\QSK2O\!KRE:ASXG4TI%E(8";K@9U#9?S>.1,Z ?EN6*V9-JQ95,1N\5_S
M/^TQ_HDE4T"C>\V+'UTPZTR8=\S_6L-$5OQD;..'#N&8]  (R<XO4:QC)^O]
MV,G2=Y1EZ_,45$M@&RN3O.5F))](6*\9JJ07#-[P?/VR1V'CE]IU*=.40VI&
MC;G0(7MO?*W4R@1%VQT=;:.IJ#3L:*$"EFH%&VEBJ>!J:=:.,QZH$F'(^C6S
M,HW:IPC-W<29\9GEU$-JXC$RP%E_3R:Q'?JQW:+G26*7-M'@F'8J5C+&Z.79
M:LV^?-A4>BE#JQHT[)*X7HH<J>MM'"$'?A40-<"PR@X9&Q.B;$3TY'L6.,5%
M+@G_-#DJ,6J/ +=@,T%"=& O[/)LNDML8_16,R69WWQ=A!-GN7WL;QDP>(?)
M*4M9$W6?_9?AH,O)06'WS+W_2(HI73)6%M5(EZH>IB:)P?AIY. XZ;%S\BCA
MW/@QKH_OLT<R,SS=_*6H-*AI(I%#^I0BEN8,*^GIE!W;"\&/X"<E$-SZ7B,5
M0-A)ZL%,4LN*6&%FW1F&.'?7YJW^69)4&G41-#H%!(:#<036FVK=HA P&7%2
MS'2:B$X;8*KC;O)4';;F[ITF2SGGS/61JVUVID*S/2=FTJ=&GN/ AI<KM(;H
MS0J^\GN8DK#4E>$'$::A+%*T/@0C0D9,V2<TY(=EH&7]Y$BKN8269/U#F@<=
M.&J:D09'%PJ5WU _^FG;UCU"C )957;=@YC!."FN8O6W6V+-=$IOZW&8/$X"
M8QVBR#4;9P';\D&L5;JFG)N:@^LGHW"VA.YEY!0&7(AL3$+H>",[G&7'Z&R[
MO-9JI?"9PX78^9UDNJGF]FSZ,'IU'8=WJB"%/8:0ADL9>?#,:'N6S=N4S-ZM
M38 EQF5+5E*!$$MN82][,8V7^,>M>=# T8DYAA9WYQIY./@Q(=K=]6"VI[,B
MF4/J4"&D2N*1\ZSQU*A,M/XM1%QL?:0",56PI92.(A M4:9;*-VG;GE*6F/K
MZ..'3ZESE%UTV%V;:SL8=5#0/_RQK"E,R JYGX0D"4?%(]+D<&>G)%J2"-YD
MG-RHP2=1BD<)52(,K1-VB9R>X)!JK,K8C9"+)+H$QAYJZ!V!Y]3NW?SH)N/,
MZ.2R3'J@X#HE/5,DB$1-,N@P)>:UB\VPV:&L8*Z_P_.TXA]\2H<JQ0K$L87K
M.G<GW2\2H62Q@8T/8DH[4IQ0F7?FQHY!R.J.\2E]Q^GMD8/<[K 7\M?1!H*]
M:Q]7YMM.0FT< =)O-UO>3>J%MXEAX>PPY&4OO<D.S)+:E./%ZBK"Y"YI4LG)
MAB$QD3I2LBVB9ST+[2].5F6IE0FRI)@Q^9X7UZ%S[9:'.8UW;P#'YHXI2+K_
MP#BL=>!TYC<3G&,H"O<;9[J845FJYSIC7-%G:>^I7\FJF)[8WNP@4DPH(QFQ
M2MF%E:GAA&L:.7W6CS="'M(T3MPP<A8&!N:>XP)/(0GRQSBC6^0.5A:\HB<
M)H6H]H0/N(:2$R0K%XIV@%0*7QTJ1,@E4(>.0-AJ=HR20P=J(B*#0;GG$U9*
M_-QPCO![F4T+]_H&?U1S^MT^T=X$EDV/$/[&V!@B1GC.UH9K3Y/O'ASGFG#/
M15V7J6V\1U1+5X)>R*L >O//'-Q14\O]I],YUC^D':3]DJBK5M*_D(;L /TQ
M^J6E&>?$.U\>$%1BT#%E:73*DJ4AND.> 6IS5/0O.H3%;M+L5QUT-U#LA:*Q
M&YSL:"F=\S&NJR=!SV.W-_36Y\+!V&_XGO<&KO=:$/%ZBFS"'J0\'+,U;75R
M3VT'ZH!;YEJ\9K=V#;LTP28EAV2!@1QU%JYTC96[5&OW 0]$V_$\[>=2IMJ%
M+^5:PGWDB"/GNOAN@/O&&[WR"OZXF!UH63H&E$6?WX&1GDH"H[WIVZ'63'ZC
MM7.M&T+0\KN3^!!?Z@RIQ%!J_%T$<.W,+>$JO^JT&N"P<LE.4LJ05N&(;B5?
M(PI#P=7H].QQC=?DOD.]!E?O^N+#T!5O>8N/(>6&CX:MYP5/<G9Y#LMXP@7A
M@.\^O+WAEREY"P7TDXNG$9&TE;T9^TUE'%B(3=Q9.A:OF%02WGG+1NY1%HM(
MA12:,KX'[T\N]W>63#;;GCYZ?)/Q H*1,:>(EF(6S-XR=4"N+O7BKS%%X7VJ
M;;S9P9JM+KMZDC+D7IWM.]O;=7^>E^/!GU7S(R+X8PE(CZ3F0,+(A2MWQW$$
M<P:0?442\#RSV)O$,"K7'^1J ;SE7#GY]NKF+0S7LT"[NOE4_.CF\NWI^?-9
M-)./1JICT/V1B/W1R,6Y)S^[+0C\\OF73^?1).D-X*>M4\.#>X;]4O*E"LNC
M0ABJ1C4IU)?;8JMI^YC&09A&^,NDNNU@$W;;F'1EB&$'@EJ;>J6CVT;#WMIN
MPQVCT%T:6Y%^<EVG2QQW.O$6CNUX+:@"EO RC@#9QH0X,64=*O;"OX"=8N5M
M2*60ND2%AL&G*N;B4C#M//6COX%BY2K;LPM%.X!1:MYLRF"XTV"4D1&*0JT_
M-ZY.@RQ/-E6#>.5]N-]3W R+7AZ6Z6*9Y.6I];\P$*GDYMH&EHS%;J+Q:D<B
M%M2N"[>3/()!Z+E/^110B%,22(<WQN)1X:)VJ!@.7IBE9,?:0L<#:LRHQ:B^
MZ)R:OR9^0?@>R[-=V6T&+PTC@3>]JI*3&=6(HI# <$S,RWCMY;BP=R\VJP>+
M^23$&.WGN[(=. L(]A#N;&NZE0@,<\K8\ZYM+=G#NL179;I)EBY'_:6D\I F
M,@1Z'\#D:,C\$83\#Z)]A"J@DL1SA*<7CX'2Q8O3BV<)E Z.-T[CU>+O-?H'
MC'IV^>+IU\4/64HV7EG^/N4)AP<F =JB),4^O#97)Y >J]YQU,KKNVG+++DK
MZ]J' C2^"I,Q36KGI3(Z#>'BD+P<F^*Q?$S)6)LN=_II?S>EC"&[&'^KD/]
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MA[M2<TRE9^,D M.=1SO#Z54X TZUPQ-E6"[Q"*^,#\#]N=9N8_@;]'\*)O\
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MPU8>-/3!0/8;Y_A^$AS,3^3V/U!+ P04    " !6@ )5TIUA4(0-  ![)@
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M+$W&'S<*"<[2!JRO#,H _T 7-+\W>_5?4$L#!!0    ( %:  E4"7EMUD0L
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M?5"]ZQ^^&TV'/Q]0X:16X>00]<,J[!/V#Y 3=Z6-5@"]:"[[C(P@\NI-U"0
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M,<?"3YH5\'ZE0+%[8 ?]OQ"+?P%02P,$%     @ 5H "5:?:]-[U%0  0$$
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MTO!^VB=A:RW7U&+FFMM58Y<;>XH(T&Y#>4H XQ2H8/.^*)*1)79WGWH*Y)0
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M"0(.N74,%!]/< F<.R*4\7O#&;0I'7!WO66_]K5C+0MJX%+Q[ZRPY3#H!Z2
M):VYG:GU9]C4TW5\N>+&_Y-U$YN=!R2OC55B T8%@LGF29\W?=@!].,#@'0#
M2+WN)I%7^8E:.AIHM2;:12.;6_A2/1K%,>D.96XU>AGB[&@&3Z -D!GDM&*6
M<O:'^G:=/- %!W,ZB"RF<<%1OJ&<-)3I <H>N5/2EH9<R0**M_@(Y;4:TZW&
M27J4\$LMST@6AR2-T_0(7];6G'F^[']K_CE>&*OQ1?FUK^J&M+.?U%V>"U/1
M'(8!W@X#^@F"T?MW22_^>$1RIY7<.<8^FN-E+&H.1"W)(?G[-!]EW:_YH00B
M:[$ [9*9DJ+'K2Z5$-BCN57Y(V'&U% 0)@04C%K@+V2I.-YP)E?$(D.NI+_G
MOJ^(=K9);5" ,8YJP63C6U-S0>[;?/,FWYMD:![/?HP)SA1CJ2Q<CDHSI8E5
MAXF3#V'2[X7=.":WSJ>A %%M]7C"37$GG5XWS'K9Z?ZT23\\3Y,PR<ZWZK;5
M2S*]F5Z1:TPI<Z<JC<,X]K_]FE#\OY"-ANPUR2VL:/Y"[FEM&:_--J*/&M-.
MF"1]\J#PU \>S<Z9T*7%MAYN$?+%G6Z8=KMDWTL:[<P5 7KEIZ?!LZVE;49,
M:VT']+B92Z_AS72_HWK%I"$<E@B-S\Z[ ='-Q&PV5E5^2BV4Q9GGER5^9$"[
M /0OE;+;C4O0?K9&?P%02P,$%     @ 5H "5?+OKIFA!   :@L  !D   !X
M;"]W;W)K<VAE971S+W-H965T,C(N>&ULS59M;]LV$/XK![<H;("+^2+)4FH;
M2-*UW=  05ZZ#\,^T#)M"Y5$EZ3B9K]^1\J6[<S)MF_[(O&.=P^?.]Y)-]YH
M\\VNE'+PHRIK.^FMG%N?#X<V7ZE*VC.]5C7N++2II$/1+(=V;92<!Z>J'')*
MDV$EB[HW'0?=C9F.=>/*HE8W!FQ35=(\7:I2;R8]UMLI;HOERGG%<#I>RZ6Z
M4^YA?6-0&G8H\Z)2M2UT#48M)KT+=GX9>?M@\+50&WNP!A_)3.MO7OAE/NE1
M3TB5*G<>0>+K45VILO1 2./[%K/7'>D=#]<[](\A=HQE)JVZTN5OQ=RM)KVT
M!W.UD$WI;O7FL]K&$WN\7)<V/&'3VH[B'N2-=;K:.B.#JJC;M_RQS<.!0TI?
M<.!;!QYXMP<%EA^DD].QT1LPWAK1_"*$&KR17%'[2[ES!G<+]'/3C[(P\%66
MC8)K)6UC%&;<6>C?RUFI[& \='B*MQWF6\3+%I&_@)C M:[=RL+/]5S-C_V'
MR*ZCR'<4+_FK@+\V]1D(2H!3SE_!$UW((N")?P[Y0V'S4ONH+?Q^,;/.8)7\
M<2KF%C(Z#>D[Y]RN9:XF/6P-J\RCZDW?O6$)??\*X:@C'+V&/KW#3IPWI0*]
M@ MK%5[/E32F4'.0#@["D?5\=XMS\"4/MRIOT+)>PJ6TA3T5V:MGGX[L?J5@
MH4ML:(_L?*5@)SA9E!8<[LF69+XGN? D'SN2U1%)TY&<>9+8 6Y5U ')K8Q2
M4*I'A= 8_B%.4&!QJ*XX O8'E:MJI@P(%K3L'/H!33<6]^T /AEM+3S4^!$K
MBS^1Q:U::^,\4WO^#/&BPIU@=*6M@T_XF;/P!?VQ8@XR?R7M*IR>^X7ZWA1(
M,C32W0H!?G+*5%#4C\JZMK^^Z'IY0NL#!0;7C6MD"8L&^<);8"3E#-_OWN";
MOS]:[?9>MGDXNSL#9T+*G\#Z9!>N0/XB(Q&-@:70YU$R\#(;C3H_%I%LE "/
M"*<,[K5#1CN"$2.<)WO7B)(L2[<DCAU;%X[YJRIE\@)1UG*-]\.3A"19C%M]
M3D>#($<9Q;RG)!8"XA')XCV=*VWPEJ3SI39SAW&,B$CBSJ[/1#Q '1>TTQU+
M%TM5YT\PTSZ[G!(Q0N89LF#9P,L,Y9UMVD;$B$ JASG@P+.(1"(%W._'"4/7
M3) 4L[ +8!012M-3SBS4R@[H+0@1DR2)_"K#1S_U^?#J" $37'&&-&-OD*8D
M2X-E3.(X_6^U_;?>^'_4-V<DX_$+!=YMOF+U8HFSF+ XV=<&IX.@$WO=,_'X
MFL2(T)0=^WM=PG9TGKF_6.V"HCU-?+5G'@3%%-N')0*;( (F4L)X]"^J';N+
M9]F>DL#V\[I$=+J$I#'%HH^8."[V-'1IYQHA$53%>]6^[+WVN-X%C[&AA8^
M)?YS@3+%>NU"B'S?XSO!CGK^P7A6[PDG/%2QE_HL309;+:/4?\Q2[ ?F6P%_
MH82QH&MA3_U/AP?S#V9]&:8\_/_HIG;M*-1INT'RHIV?]N;M%'HMS=*W0*D6
MZ$K/_-QFVLFN%9Q>AVEJIAW.9F&YPF%8&6^ ^PNMW4[P!W3C]?0O4$L#!!0
M   ( %:  E4(_BIUB 0  )P.   9    >&PO=V]R:W-H965T<R]S:&5E=#(S
M+GAM;.U776_;-A3]*Q=N4"2 $.O3EM+$0#ZQ#BEJ)-GV,.R!EJXLHI*HDE2<
M[-?ODK(5KU.$#-W>"L,6*9&'YYYS>66>;H3\H@I$#4]56:NS2:%U<S*=JK3
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M>SRGOP.R.PMU'2T:>_Y8"4VG&=LLZ/B(T@R@Y[D0>M<Q"_0'TL5?4$L#!!0
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MXITKRJ"FFZ0QJI*%X$,A@=CNXJ1-H3>D[BZ(_WL-_) %NVZ%2]H;H?/2Z:'
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MDY)EYC$!HJS4 >K]CC'Y7- )FJ.[Y;]02P,$%     @ 5H "57%?7/XS @
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MS$5U%4I#6HP=VQI-AK5Y #2OUY!W;-N6-7)J\P!4VFJ/3RPR;.SQ>Z;03O"
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M>K'?*:(;!2A+]N*B]D&>/:997*C@5MT4'4\"NK4.G1A?VG0? )23\^*II%?
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M7NWQYL!)2@&B6BU -+H8(#(08(A&K<)[!CE1+SC7L+%6#A"=6@\0&1X":A9
M-PG9[CCU6L@=Q9#M&[/7ECH-UK;+)!9:+:N7*Q[#A+VVUJ<3MZ?3("<DLTUG
MO2)P1TE@\W(U=$_6T<OP,LE3Y$5PO10QGA<5ACW7-)ZFJ'&]JK&[\F]GW'<G
M<-PR#<-JV*&C9+ UX =LR-Q=#)^L*6@P7"]4C.=%A&'/]8^G*8!<KX#LKA+<
M&>UMFDNT2[Z8Q*P!7P,5'16&K0'??P/F[F'X=$V1-L+UDL9X7E08=M=8'N[
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MG7LD@R5=<_,@MY^@KL<)3"77[DFV=6[@D72MC2QJ,"HHF*C>]*7VH04(AV\
MHAH0_2M@4 ,&KM!*F2MK2@U-1DINB;+9R&8'SAN'QFJ8L*<X-PI7&>),,I%%
M*35SELHEF8 R>/1D(D6&1P69'6G)648-!C=,4)$RRLG<X 2>IB%WR$AN,=#D
MF-R;'!2YDV)U;$ 5Y$IK,)H<3@%IN?Z *4_S*3D\^$ .".[SF,NUIB+3(]]@
M-5:3G];*KROET1O*/Z_%"1D$1R0*HJ@#/NF'3R%%>.C@X3[<1P\;(Z/&R,CQ
M#=[@NU<K*MAO:IT\:KGF[JK(R$R!1KOHSND.*S7Y?K701N'5_M'E1R5@V"W
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M69TCMD'&]-=?;-_ZK4U;G61SG62A3K)()]E"$]E!A R:"!ETL4\_<EY $B-
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M*#)\!:?2_J)C:YO$#BH:J7C5@74$5<G:?_*Y$^($X.,7 $$'"%X+"#M ^%H
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M]C#L@9$86Z@DNB05Q\-^_$A)D4Q%9J*505X2??">>WE(7=Y#\VQ'V5>^(42
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M?"L+)WR=D2H%K"7E I2RY&& U/-ZJRJQ1Y:5^8,$#T-WYOESIY=9C2&-96_
MJ^?-H!>XP\L*=+I*U#%R\ZG,KR4#<I7%25(E1)PU_0>X%!O*JHSZ""N-$RW
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M^D;0;75JX9H*0?/J<D.P+%Q5 _G^AE)Q?Z,<M"=E%O\!4$L#!!0    ( %:
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MZQ?Z+WGP,IA'Q/&*QG^12.P6QLP $=Z@?2SNZ?%77 ;D*MZ:QCS_"XZEK66
M]9X+FI3.<@4)28O_Z+D4HN9@NQT.=NE@MQVF'0Y.Z> ,G6%:.DR'SN"6#GGH
M9A%[+ER !%K.&3T"IJPE35WDZN?>4B^2JHWR()C\ED@_L7P0=/T$OF5YUNYB
M)%.71B ?O5 )B,"*)G)7<I1;7( 'LDW)AJQ1*L UE_LK=^7@4X %(C'_+&V^
ME6,7X$=@ KY##/.Y*>1RU:3FNES:3;$TNV-I#KBEJ=AQ$*81CC3^0;^_U^-O
M2IDJK>P7K6[L7N!O^W0"'.L+L"W;UJQG-=P=ZL+Y?[.''YZ](893;1PGYSE=
M&T=E5;=%KAE#Z1;+8B+ XPG4[>[0*1^^/B(6@;]_ETCP5>"$_Z/;'<7\4_W\
MJH!>\0RM\<*0%9)C=L#&\J<?H&?]K$O-F+!@3%@X$JR1Q&F5Q&D??1D^9[)@
MR\P<:"RS%Q-Q^J*J#$GVB2XE!0T6Q40]@PY+.+%<N1T/=;%+,ZMF9DTNG:95
M, P6ZF%GJT;@;A6X^X' T7-7X*YVK9>P%;C&3 7N6[5/RR=P7\<')RVC4 ^>
MPLOZ1R^)5TGB#9,D(@<28?D48$A@G1B>)B,M(=XV"=XV"7M-&D'Z59!^;Y#W
MA#^!#<,8D%1@^8,2>92]F][7:6_9LU;(>K-7>R30VT&_]?,(.WBNHU=@5BDP
M^Z "W;M_IEV*XW@M"?1VT&K]I(.!O/!M7D."RTJ"RUX);KMSW>OXWF?.F+!@
M3%@X$JRA/K3.KYS6=WYU*!<P4AY'I06CTL*Q:,U4UKH'..RA(4M) CZ1%)PP
M8ORS-BG]*+=P!0Y(BM=V. ,1.ND:A]5 E/^"\KI(P7B+"@>BO!+5I[]]UM_N
MA1;M6\;(&N?J1S2.U2099D7?I<]$ ?5K==6>^*UBKC&"5OO%)!B""C5&_L3U
M]%4<GCL0V/MNO+SM?F+U>[Z[ (S:/8Q*"\>B-7-P;B#@]'O7\MX6YMVI'),6
MC$H+QZ(U4WENB># GFA(+>]'>66M@T6MZZZ_J[% P5B@<""H]]G2S,"Y X/]
M+=@'J[GWJKI.)WZ[)]=80=EG>NUZ/@06O@DK!#!KYY()9MO\0)B#-=VGHCAI
MJD:K0^?K_*BU-7X#KU90,QZH0^K\'/2,+TZX;Q';DI2#&&_D5-;$EUEEQ:%Q
M<2-HEI^*/E(A:))?[C"*,%,&\OL-I>+E1DU0'=TO_P-02P,$%     @ 5H "
M50!]7.D\!   ]P\  !D   !X;"]W;W)K<VAE971S+W-H965T-#,N>&ULM5=M
M;^,H$/XKR+<ZM5(;&Q*_I)=$ZLO>F[2WT?:Z^YG8)$&U30YPTO[[ ^S8[L8F
M[JVN'QK S,PS,_ ,,SLP_BRVA$CPDJ6YF#M;*7<WKBOB+<FP&+$=R=67->,9
MEFK*-Z[8<8(3(Y2E+O*\P,TPS9W%S*PM^6+&"IG2G"PY$$668?YZ1U)VF#O0
M.2Y\H9NMU ON8K;#&_)(Y--NR=7,K;4D-".YH"P'G*SGSBV\N4-("Y@=7RDY
MB-88:%=6C#WKR1_)W/$T(I*26&H56/WLR3U)4ZU)X?BG4NK4-K5@>WS4_JMQ
M7CFSPH+<L_0;3>1V[D0.2,@:%ZG\P@Z_D\HA7^N+62K,?W"H]GH.B LA658)
M*P09S<M?_%(%HB6 _!X!5 F80+BE(8/R 4N\F'%V %SO5MKTP+AJI!4XFNNL
M/$JNOE(E)Q>/DL7/X//.A&B98A6G/ %F]5I[FX![EJDC(+#9<0W>"-SJF%+Y
M"BX>B,0T%9=JQ]/C [CX< D^ !>(+>9$ )J#IYQ*<:46U?CO+2N$LB-FKE0^
M:"1N7.&]*_&B'KP!^,1RN17@8YZ0Y*V\JWRO X". ;A#5H5_%OD(C+TK@#R$
M+/K&=4#'1M^X1]]?1;8B'+#U=Y$Z8-[M;ZENTJU.7\H;L<,QF3OJU@G"]\19
M_/P3#+Q?+& G-=B)3?OB<R&%5(F@^0:LR(;FN1EA=0YB BY4JLH$7G8!+U7[
M1K6^_/M%Y/N>%P8S=]^!R:\Q^59,OW&<2W7NSECW3ZQ/O'$8!>-NZT%M/;!:
M__A">$S%>?O!B?UK!.'8FW;;#VO[H=6^HIHUH0/\#T_MA\B/QCW1CVK[T> 3
M0:J#,>PX1"> ( Q\+YQ.NA%-:T13.R)S@038$Z'#HNF)O.P4J:N)9&;Y'+3I
M.Z%!KV%/SPKN:QN4.3EXE9X-5:6T#6B,PBE"/8<7MM@<6MGGFZE""M'MGG!5
M5<'Q/(,EIS'I! /_!P*"J$&,?I""$I:FF NP4[1J@MH=T]),V":$4=!S&V##
MYM#*OV_8:""04B%$[>R.(MB#I*%J:.?JM\PT$,OD%(LWBGHX"C84#>T<_9:E
M!F+Q3[%$(^A-VW\]P!KVAG;Z/D-? Y$&IT@G(]27P8;:H9W;AS+90)3ANU V
M!0#:*X"%T@8"BTYNXGCD]Z6V*0-P6!U@38JOP.'(=[CB.TYT*Z+S'JMW(E>/
M_@*G(*7K;NZSFXS *]'^3D%6/CIA!!+\*FS/SJ9TH/]2.G[8I3-6P\JEJ'8)
MG76IJ3[(6BNZ4X0W&TXV6!+U\I><JGXN!GN<%MWH2P-!Z^R$TZ"G3*.FR"![
MD>F+]?NPH1-LDTGX/3:WU8MEA&],QRE4ZHI<EFU9O5IWM;=E+]=L+UOB3YBK
M>BA 2M9*U!N%BD%YV666$\EVIK-;,:GZ1#/<JLZ<<+U!?5\S)H\3;:#N]1?_
M E!+ P04    " !6@ )5YD-@L)L#  #R$   &0   'AL+W=O<FMS:&5E=',O
M<VAE970T-"YX;6S%F&UOFT@0@/_*BJM.K70-[]C.V4BQH6]J52M)KQ^J^["!
ML4$!ENZN[>3?W^Y""&!BI3VJ?K'W9>:9G9EES'A^(/26)0 <W>59P19:PGEY
MKNLL2B#'[(R44(B=#:$YYF)*MSHK*>!8*>69;AF&I^<X+31_KM;6U)^3'<_2
M M84L5V>8WJ_A(P<%IJI/2Q<IMN$RP7=GY=X"U? OY1K*F9Z0XG3' J6D@)1
MV"RT"_,\- VIH"3^2>' 6F,D7;DAY%9.WL<+S9 G@@PB+A%8?.UA!5DF2>(<
MWVNHUMB4BNWQ _V-<EXX<X,9K$CV-8UYLM"F&HIA@W<9OR2'=U [Y$I>1#*F
M/M&AEC4T%.T8)WFM+$Z0IT7UC>_J0+04!&=8P:H5K+Z"\X2"72O8S[7@U K.
M<RVXM8)R7:]\5X$+,,?^G)(#HE):T.1 15]IBWBEA;PH5YR*W53H<?^*D^@6
M?2Y5UM89%JDK8J167\L$Q&A%<G$K&582KZLMM#S>"N_D&-#+ #A.,_9*"%=<
M)D9?K@+T\L4K] *E!;I.R(X).VRN<^&#/(D>U>==5N>UGCBOC3Z1@B<,A44,
M\8!^<%K?.Z&OB]@U ;0> KBT3@(_[(HS9!M_(<NPK('SK)ZO;@ZY\_^LAS]M
MO1,,N[E-MN+93]VF!%,8NC<7E.)B"Z+"<'1SC]IR:WROEB\.F,;HVT>!1.\Y
MY.S?H=M1V7>&[<NJ>LY*',%"$V63 =V#YO_YA^D9?P^E9DQ8,"8L' G62:+3
M)-$Y1?>O"<<98JT2$+53"=5S/I2<BNLIKOR%VON6ZTWF^KX=]&,A<VH97:'@
M6,CQ)CU2>"QDFZ[7"'6<=QOGW9/.7XIP8AHEJ@S&L!>_I*6\GD/NGB3]Z%T<
M$Q:,"0M'@G72X37I\'YS0?'&3.*8L&!,6#@2K)/$29/$R2\J*!77;3WALXG;
MJR?',I[G]<K)L8PY=>Q>.1D0,CU[N)Q,&]>G)UU_"P50X;RL)C@6[V\IXQ3+
M=^,A=T^R?O0NC@D+QH2%(\$Z"9DU"9G]YH(R&S.)8\*",6'A2+!.$DWCL6LQ
M?E%)J<&=]P]W9O6*RI"4Z3J]LC(@94WMGE0XQ)K-^H5%;_5P.="M:IZ9<&M7
M\.H%O%EM&O0+U9;VUI?F^<H<6 ]D0Z]ZQD=\]6_ )TRWJ>C2,M@(4\;91-1
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M] KJ^P?.Y?,'/4#Y9/3T/U!+ P04    " !6@ )5@O>L-"D#  "Y"@  &0
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M4_^K-7>G'#*UZ"<JUZQ02+Q">>]TB*F6V_)NV]"BM!720FBLM^QKAB4Q2#,
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M,@,  -03   -    >&PO<W1Y;&5S+GAM;-U8T6[:,!3]E<A=IU::&B!K2E9
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M$<#\#J((0^!IQ!', 7C D"BJWH,[[Z-P_9X*-__'&ST#4$L#!!0    ( %:
M E67BKL<P    !,"   +    7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] A
MB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:
MU;@!2+8ECVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]
MVR]/06^ KSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::
M1<G3HAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$
M%     @ 5H "5:=W-L;S P  ("$   \   !X;"]W;W)K8F]O:RYX;6S%FL%N
MVS@00'^%T&E[R-H2&;<-Z@)MC.X&Z*:&'>2ZH*5Q3$0B!9)*NOGZ#N6Z(5MD
ML!=6)TN43#V-I7D<TN\>C;W?&7//OG:M=LOBX'U_,9NY^@"=='^:'C0>V1O;
M28^[]F[F>@NR<0< W[6S:CY?S#JI=/'^W:FOM9W%.\9#[971V!@:;A4\NN?C
M89<]**=VJE7^OV4Q;K=0L$YIU:DG:);%O&#N8![_-E8]&>UENZVM:=ME41X/
MW(+UJOZE>1L@;^3.C2U>[C8209;%8HX=[I5U?CQC[%\BXP/@R<>]P9M/JO5@
M5]+#7]8,O=)WH1N\BUET&V,<3I_'(%[8_Q-&L]^K&E:F'CK0_AA'"VT U.Z@
M>E<P+3M8%I?F 6RX'[S 57.\-X]04:3LA<(#]JH9\7*BZ :T@X;AEC.M:I"C
M81]E*W4-+(*L",AJ$LAMP,&O1I"<@.030OY;19""@!130O((\IR /)\24D20
M"P)R,>&+D_S<KPG(UU-&\CR"?$- OLD+N0)76]6'=F;V[./@E ;GF-0AG"Z"
M?$M OLT+N55W6N&Y4GOVH:[-H#W:@ZTQIK6"&+*<4]E\GA=S V@6!VP#M>P5
M6E4]C2?%?*1M,NOFDU26W<IV /8/2#?8D+]]$C[*,V5VT72]<>KT*%[B& 3'
M0>ST&L68E&G*S*K90 /8"5XTH#V$D5+87EO8@[4))N6:,KMLN@X#N?6FOH^9
M*+64F=URI6O3 ;N17].7EC))F5DE8X#8EV,&7*,_QM0WMI[MD@184BXIL\ND
MZY0/)XU\^.2%% CZY_Q'J:3,[!+TA:I'O)5JA^"Z:[S29X,ZZ<'&P]F2DDDY
MI4V2P4-%V:2:R";LCQLYDCQC4E*III'*=\KXV:S((F9*N:0_.B67*GL=\YRU
M3R%\%<-12JDR*X5,E6D,*<M4V2N8EU,EQC3&I,13918/F2W3:%+BJ3*+ARP0
M4DS*/55F]]!)/:ZM*\H]56;WO)C4S]BUM/&T%*?<PZ=RSQG;'F2"2;F'3^6>
M%6!V;V-,RCU\4O?$SR8GI]#RNX? C&=^.&4AGK^P(3#C:15.68CGMQ"!N8@Q
M*0OQS!8BJ]DDO7/*0OPWE#\_QD7'7"G#^L+W5SW&I"S$,UOH)\QD=Y,,ACEE
M(9[90G$=3D=34!82F2U$CS?CO"DH"XG,%J(QX[PI* N)S!:B,>.\*2@+B<P6
MHC'CO"G(I9S?,+WV8I%Q%L]U",I"8LI:*%T7HRPDLJ_G4)C)FTY92&2V$%VR
M)9B4A<24\W!I0J(L)$8+S4XK\@WLL?)KKO$2#MMKV=9KR\+'<>5 G(=9O?W0
MMI?8]D5_-K(Y+?"?_ISP_AM02P,$%     @ 5H "58YA./J] 0  >AT  !H
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M;IY)=3Z_&V^?ORRO-Q'GX07G $>M[[]02P,$%     @ 5H "59PKTP^] 0
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M/V5]-V;YU[\"VWM:Z[(YY+/N?^OT$U!+ 0(4 Q0    ( %:  E4'04UB@0
M +$    0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#
M%     @ 5H "55B=,Y+M    *P(  !$              ( !KP   &1O8U!R
M;W!S+V-O<F4N>&UL4$L! A0#%     @ 5H "59E<G",0!@  G"<  !,
M         ( !RP$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " !6
M@ )5H;3 D^P%  "Y'P  &               @($,"   >&PO=V]R:W-H965T
M<R]S:&5E=#$N>&UL4$L! A0#%     @ 5H "5:C"7NR)!0  E!8  !@
M         ("!+@X  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0
M   ( %:  E5R&J5D0 0  +(0   8              " @>T3  !X;"]W;W)K
M<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " !6@ )5W)<UQ%@#  !<#
M&               @(%C&   >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L!
M A0#%     @ 5H "5=8Z<0S%$0  4=(  !@              ("!\1L  'AL
M+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( %:  E5.@RW9#0<
M '\>   8              " @>PM  !X;"]W;W)K<VAE971S+W-H965T-BYX
M;6Q02P$"% ,4    " !6@ )56;/.G  #  !M"@  &               @($O
M-0  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ 5H "53IN
MRE59 @  :@4  !@              ("!93@  'AL+W=O<FMS:&5E=',O<VAE
M970X+GAM;%!+ 0(4 Q0    ( %:  E58\5<MS0T  /$D   8
M  " @?0Z  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " !6
M@ )5D!/;+*,5  "#/@  &0              @('W2   >&PO=V]R:W-H965T
M<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( %:  E619S6B)@@  #@6   9
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M970Q-2YX;6Q02P$"% ,4    " !6@ )57;'#<2H#   N!P  &0
M    @(&?>   >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    (
M %:  E72G6%0A T  'LF   9              " @0!\  !X;"]W;W)K<VAE
M971S+W-H965T,3<N>&UL4$L! A0#%     @ 5H "50)>6W61"P  4C@  !D
M             ("!NXD  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"
M% ,4    " !6@ )5=']83@H%  !.#   &0              @(&#E0  >&PO
M=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( %:  E6GVO3>]14
M $!!   9              " @<2:  !X;"]W;W)K<VAE971S+W-H965T,C N
M>&UL4$L! A0#%     @ 5H "52806]SG @  P@8  !D              ("!
M\+   'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " !6@ )5
M\N^NF:$$  !J"P  &0              @($.M   >&PO=V]R:W-H965T<R]S
M:&5E=#(R+GAM;%!+ 0(4 Q0    ( %:  E4(_BIUB 0  )P.   9
M      " @>:X  !X;"]W;W)K<VAE971S+W-H965T,C,N>&UL4$L! A0#%
M  @ 5H "563)/#[G @  508  !D              ("!I;T  'AL+W=O<FMS
M:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " !6@ )52?.M] 8%   S#
M&0              @('#P   >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+
M 0(4 Q0    ( %:  E66);8,Q0,  .4(   9              " @0#&  !X
M;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%     @ 5H "5: [;R]<
M!    0L  !D              ("!_,D  'AL+W=O<FMS:&5E=',O<VAE970R
M-RYX;6Q02P$"% ,4    " !6@ )5!3MR)A0$  #&$P  &0
M@(&/S@  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( %:
M E5Q7US^,P(  "L%   9              " @=K2  !X;"]W;W)K<VAE971S
M+W-H965T,CDN>&UL4$L! A0#%     @ 5H "5<SG%YV]!@  KC8  !D
M         ("!1-4  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4
M    " !6@ )53<^A*<8#  !*$P  &0              @($XW   >&PO=V]R
M:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( %:  E597R<\3PL  /EL
M   9              " @37@  !X;"]W;W)K<VAE971S+W-H965T,S(N>&UL
M4$L! A0#%     @ 5H "589>KE16!0  O2<  !D              ("!N^L
M 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " !6@ )517 *
MEIP"  ">!@  &0              @(%(\0  >&PO=V]R:W-H965T<R]S:&5E
M=#,T+GAM;%!+ 0(4 Q0    ( %:  E6?<-X@' ,  *X(   9
M  " @1OT  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @
M5H "5<$@F2 2 P  [0D  !D              ("!;O<  'AL+W=O<FMS:&5E
M=',O<VAE970S-BYX;6Q02P$"% ,4    " !6@ )517A(IBX"  #\!   &0
M            @(&W^@  >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4
M Q0    ( %:  E4B%MRGW@,  ,<3   9              " @1S]  !X;"]W
M;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ 5H "58)/S&EO P
M?0X  !D              ("!,0$! 'AL+W=O<FMS:&5E=',O<VAE970S.2YX
M;6Q02P$"% ,4    " !6@ )5ZSWG9G<"  "I!P  &0              @('7
M! $ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( %:  E7K
MIT>-L04  #4C   9              " @84' 0!X;"]W;W)K<VAE971S+W-H
M965T-#$N>&UL4$L! A0#%     @ 5H "58PKNMZ'!   QA<  !D
M     ("!;0T! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %:  E6QV:(,00,  ' +   9              "
M@?,D 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @ 5H "
M51'7GI&L!   V14  !D              ("!:R@! 'AL+W=O<FMS:&5E=',O
M<VAE970T."YX;6Q02P$"% ,4    " !6@ )5J(G99I$#   B$0  &0
M        @(%.+0$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0
M   ( %:  E4E3,?Z,@,  -03   -              "  18Q 0!X;"]S='EL
M97,N>&UL4$L! A0#%     @ 5H "59>*NQS     $P(   L
M ( !<S0! %]R96QS+RYR96QS4$L! A0#%     @ 5H "5:=W-L;S P  ("$
M  \              ( !7#4! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (
M %:  E6.83CZO0$  'H=   :              "  7PY 0!X;"]?<F5L<R]W
M;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( %:  E6<*],/O0$  '<=   3
M              "  7$[ 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     Y
- #D A@\  %\] 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>203</ContextCount>
  <ElementCount>248</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>40</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1003003 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1004004 - Statement - Condensed Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1005005 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders??? Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit</Role>
      <ShortName>Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders??? Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1007006 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1402401 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1406402 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders??? Equity (Deficit) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficitParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders??? Equity (Deficit) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Description of Business and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentation</Role>
      <ShortName>Description of Business and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2106103 - Disclosure - Reverse Recapitalization</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/ReverseRecapitalization</Role>
      <ShortName>Reverse Recapitalization</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2110104 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2113105 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItems</Role>
      <ShortName>Composition of Certain Condensed Consolidated Financial Statement Line Items</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2119106 - Disclosure - Redeemable Convertible Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/RedeemableConvertiblePreferredStock</Role>
      <ShortName>Redeemable Convertible Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2121107 - Disclosure - Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CommonStock</Role>
      <ShortName>Common Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2125108 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2127109 - Disclosure - Stock Option Plan and Stock-based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensation</Role>
      <ShortName>Stock Option Plan and Stock-based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2133110 - Disclosure - Commitment and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CommitmentandContingencies</Role>
      <ShortName>Commitment and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2138111 - Disclosure - Basic and Diluted Net Loss per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/BasicandDilutedNetLossperShare</Role>
      <ShortName>Basic and Diluted Net Loss per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.nautilus.bio/role/SignificantAccountingPolicies</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2307301 - Disclosure - Reverse Recapitalization (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/ReverseRecapitalizationTables</Role>
      <ShortName>Reverse Recapitalization (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nautilus.bio/role/ReverseRecapitalization</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2311302 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nautilus.bio/role/FairValueMeasurements</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2314303 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsTables</Role>
      <ShortName>Composition of Certain Condensed Consolidated Financial Statement Line Items (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItems</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2322304 - Disclosure - Common Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CommonStockTables</Role>
      <ShortName>Common Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nautilus.bio/role/CommonStock</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2328305 - Disclosure - Stock Option Plan and Stock-based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationTables</Role>
      <ShortName>Stock Option Plan and Stock-based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensation</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2334306 - Disclosure - Commitment and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CommitmentandContingenciesTables</Role>
      <ShortName>Commitment and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nautilus.bio/role/CommitmentandContingencies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2339307 - Disclosure - Basic and Diluted Net Loss per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/BasicandDilutedNetLossperShareTables</Role>
      <ShortName>Basic and Diluted Net Loss per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.nautilus.bio/role/BasicandDilutedNetLossperShare</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2402403 - Disclosure - Description of Business and Basis of Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails</Role>
      <ShortName>Description of Business and Basis of Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentation</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2405404 - Disclosure - Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails</Role>
      <ShortName>Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2408405 - Disclosure - Reverse Recapitalization - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails</Role>
      <ShortName>Reverse Recapitalization - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2409406 - Disclosure - Reverse Recapitalization - Shares Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/ReverseRecapitalizationSharesReconciliationDetails</Role>
      <ShortName>Reverse Recapitalization - Shares Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2412407 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.nautilus.bio/role/FairValueMeasurementsTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2415408 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items - Property, Plant and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails</Role>
      <ShortName>Composition of Certain Condensed Consolidated Financial Statement Line Items - Property, Plant and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2416409 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items - Other Long-term Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsOtherLongtermAssetsDetails</Role>
      <ShortName>Composition of Certain Condensed Consolidated Financial Statement Line Items - Other Long-term Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2417410 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items - Accrued Expenses and Other Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsAccruedExpensesandOtherLiabilitiesDetails</Role>
      <ShortName>Composition of Certain Condensed Consolidated Financial Statement Line Items - Accrued Expenses and Other Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2418411 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items - Cash, Cash Equivalents and Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsCashCashEquivalentsandRestrictedCashDetails</Role>
      <ShortName>Composition of Certain Condensed Consolidated Financial Statement Line Items - Cash, Cash Equivalents and Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2420412 - Disclosure - Redeemable Convertible Preferred Stock - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/RedeemableConvertiblePreferredStockNarrativeDetails</Role>
      <ShortName>Redeemable Convertible Preferred Stock - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2423413 - Disclosure - Common Stock - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CommonStockNarrativeDetails</Role>
      <ShortName>Common Stock - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2424414 - Disclosure - Common Stock - Common Stock Reserved for Future Issuance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CommonStockCommonStockReservedforFutureIssuanceDetails</Role>
      <ShortName>Common Stock - Common Stock Reserved for Future Issuance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2426415 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2429416 - Disclosure - Stock Option Plan and Stock-based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails</Role>
      <ShortName>Stock Option Plan and Stock-based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2430417 - Disclosure - Stock Option Plan and Stock-based Compensation - Significant Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails</Role>
      <ShortName>Stock Option Plan and Stock-based Compensation - Significant Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2431418 - Disclosure - Stock Option Plan and Stock-based Compensation - Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockOptionActivityDetails</Role>
      <ShortName>Stock Option Plan and Stock-based Compensation - Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2432419 - Disclosure - Stock Option Plan and Stock-based Compensation - Stock Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock Option Plan and Stock-based Compensation - Stock Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2435420 - Disclosure - Commitment and Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails</Role>
      <ShortName>Commitment and Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2436421 - Disclosure - Commitment and Contingencies - Components of Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CommitmentandContingenciesComponentsofLeaseCostDetails</Role>
      <ShortName>Commitment and Contingencies - Components of Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2437422 - Disclosure - Commitment and Contingencies - Lease Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails</Role>
      <ShortName>Commitment and Contingencies - Lease Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2440423 - Disclosure - Basic and Diluted Net Loss per Share - Basic and Diluted Not Loss per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/BasicandDilutedNetLossperShareBasicandDilutedNotLossperShareDetails</Role>
      <ShortName>Basic and Diluted Net Loss per Share - Basic and Diluted Not Loss per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="naut-20220630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2441424 - Disclosure - Basic and Diluted Net Loss per Share - Antidilutive Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.nautilus.bio/role/BasicandDilutedNetLossperShareAntidilutiveSecuritiesDetails</Role>
      <ShortName>Basic and Diluted Net Loss per Share - Antidilutive Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="naut-20220630.htm">naut-20220630.htm</File>
    <File>exhibit101-offerletter_god.htm</File>
    <File>exhibit102-changeincontrol.htm</File>
    <File>exhibit311-2022q210xq.htm</File>
    <File>exhibit312-2022q210xq.htm</File>
    <File>exhibit321-2022q210xq.htm</File>
    <File>exhibit322-2022q210xq.htm</File>
    <File>naut-20220630.xsd</File>
    <File>naut-20220630_cal.xml</File>
    <File>naut-20220630_def.xml</File>
    <File>naut-20220630_lab.xml</File>
    <File>naut-20220630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="683">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>68
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "naut-20220630.htm": {
   "axisCustom": 0,
   "axisStandard": 16,
   "contextCount": 203,
   "dts": {
    "calculationLink": {
     "local": [
      "naut-20220630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "naut-20220630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "naut-20220630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "naut-20220630_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "naut-20220630_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "naut-20220630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 370,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 5
   },
   "keyCustom": 29,
   "keyStandard": 219,
   "memberCustom": 13,
   "memberStandard": 26,
   "nsprefix": "naut",
   "nsuri": "http://www.nautilus.bio/20220630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.nautilus.bio/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Significant Accounting Policies",
     "role": "http://www.nautilus.bio/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "naut:ReverseRecapitalizationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106103 - Disclosure - Reverse Recapitalization",
     "role": "http://www.nautilus.bio/role/ReverseRecapitalization",
     "shortName": "Reverse Recapitalization",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "naut:ReverseRecapitalizationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110104 - Disclosure - Fair Value Measurements",
     "role": "http://www.nautilus.bio/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113105 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items",
     "role": "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItems",
     "shortName": "Composition of Certain Condensed Consolidated Financial Statement Line Items",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "naut:DisclosureOfRedeemableConvertiblePreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119106 - Disclosure - Redeemable Convertible Preferred Stock",
     "role": "http://www.nautilus.bio/role/RedeemableConvertiblePreferredStock",
     "shortName": "Redeemable Convertible Preferred Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "naut:DisclosureOfRedeemableConvertiblePreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121107 - Disclosure - Common Stock",
     "role": "http://www.nautilus.bio/role/CommonStock",
     "shortName": "Common Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2125108 - Disclosure - Income Taxes",
     "role": "http://www.nautilus.bio/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127109 - Disclosure - Stock Option Plan and Stock-based Compensation",
     "role": "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensation",
     "shortName": "Stock Option Plan and Stock-based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133110 - Disclosure - Commitment and Contingencies",
     "role": "http://www.nautilus.bio/role/CommitmentandContingencies",
     "shortName": "Commitment and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2138111 - Disclosure - Basic and Diluted Net Loss per Share",
     "role": "http://www.nautilus.bio/role/BasicandDilutedNetLossperShare",
     "shortName": "Basic and Diluted Net Loss per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ie8b7caea51104b0fa022cb4d3c2b850d_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ie8b7caea51104b0fa022cb4d3c2b850d_I20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - Significant Accounting Policies (Policies)",
     "role": "http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "naut:ScheduleOfReverseRecapitalizationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2307301 - Disclosure - Reverse Recapitalization (Tables)",
     "role": "http://www.nautilus.bio/role/ReverseRecapitalizationTables",
     "shortName": "Reverse Recapitalization (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "naut:ScheduleOfReverseRecapitalizationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311302 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.nautilus.bio/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2314303 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items (Tables)",
     "role": "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsTables",
     "shortName": "Composition of Certain Condensed Consolidated Financial Statement Line Items (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "naut:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322304 - Disclosure - Common Stock (Tables)",
     "role": "http://www.nautilus.bio/role/CommonStockTables",
     "shortName": "Common Stock (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "naut:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2328305 - Disclosure - Stock Option Plan and Stock-based Compensation (Tables)",
     "role": "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationTables",
     "shortName": "Stock Option Plan and Stock-based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2334306 - Disclosure - Commitment and Contingencies (Tables)",
     "role": "http://www.nautilus.bio/role/CommitmentandContingenciesTables",
     "shortName": "Commitment and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2339307 - Disclosure - Basic and Diluted Net Loss per Share (Tables)",
     "role": "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareTables",
     "shortName": "Basic and Diluted Net Loss per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ie8b7caea51104b0fa022cb4d3c2b850d_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402403 - Disclosure - Description of Business and Basis of Presentation (Details)",
     "role": "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails",
     "shortName": "Description of Business and Basis of Presentation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i23369e4e61894856b3b29fd3dd2c1609_D20210601-20210630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "naut:ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405404 - Disclosure - Significant Accounting Policies (Details)",
     "role": "http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails",
     "shortName": "Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i452786b7977748c0a94d775ecb931729_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003003 - Statement - Condensed Consolidated Statements of Operations",
     "role": "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i452786b7977748c0a94d775ecb931729_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "naut:StockConvertedValueReverseRecapitalization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408405 - Disclosure - Reverse Recapitalization - Narrative (Details)",
     "role": "http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails",
     "shortName": "Reverse Recapitalization - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "naut:StockConvertedValueReverseRecapitalization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i8cf39cfd7fd34311bc52d7c3ad8da2ff_I20210609",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409406 - Disclosure - Reverse Recapitalization - Shares Reconciliation (Details)",
     "role": "http://www.nautilus.bio/role/ReverseRecapitalizationSharesReconciliationDetails",
     "shortName": "Reverse Recapitalization - Shares Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i65429cbc59dc44efba3731beff6b9dd1_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412407 - Disclosure - Fair Value Measurements (Details)",
     "role": "http://www.nautilus.bio/role/FairValueMeasurementsDetails",
     "shortName": "Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i65429cbc59dc44efba3731beff6b9dd1_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ie8b7caea51104b0fa022cb4d3c2b850d_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415408 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items - Property, Plant and Equipment (Details)",
     "role": "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails",
     "shortName": "Composition of Certain Condensed Consolidated Financial Statement Line Items - Property, Plant and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i34e4a2a383364c848f4d73f961251253_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ie8b7caea51104b0fa022cb4d3c2b850d_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416409 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items - Other Long-term Assets (Details)",
     "role": "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsOtherLongtermAssetsDetails",
     "shortName": "Composition of Certain Condensed Consolidated Financial Statement Line Items - Other Long-term Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ie8b7caea51104b0fa022cb4d3c2b850d_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ie8b7caea51104b0fa022cb4d3c2b850d_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417410 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items - Accrued Expenses and Other Liabilities (Details)",
     "role": "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsAccruedExpensesandOtherLiabilitiesDetails",
     "shortName": "Composition of Certain Condensed Consolidated Financial Statement Line Items - Accrued Expenses and Other Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ie8b7caea51104b0fa022cb4d3c2b850d_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ie8b7caea51104b0fa022cb4d3c2b850d_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418411 - Disclosure - Composition of Certain Condensed Consolidated Financial Statement Line Items - Cash, Cash Equivalents and Restricted Cash (Details)",
     "role": "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsCashCashEquivalentsandRestrictedCashDetails",
     "shortName": "Composition of Certain Condensed Consolidated Financial Statement Line Items - Cash, Cash Equivalents and Restricted Cash (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ie8b7caea51104b0fa022cb4d3c2b850d_I20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ie8b7caea51104b0fa022cb4d3c2b850d_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420412 - Disclosure - Redeemable Convertible Preferred Stock - Narrative (Details)",
     "role": "http://www.nautilus.bio/role/RedeemableConvertiblePreferredStockNarrativeDetails",
     "shortName": "Redeemable Convertible Preferred Stock - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ie8b7caea51104b0fa022cb4d3c2b850d_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "naut:StockIssuedDuringPeriodSharesReverseRecapitalization",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423413 - Disclosure - Common Stock - Narrative (Details)",
     "role": "http://www.nautilus.bio/role/CommonStockNarrativeDetails",
     "shortName": "Common Stock - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ic5713d0ce55a4f2bb6146e67b25c7a96_D20210609-20210609",
      "decimals": "-5",
      "lang": "en-US",
      "name": "naut:StockIssuedDuringPeriodValueReverseRecapitalization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ie8b7caea51104b0fa022cb4d3c2b850d_I20220630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424414 - Disclosure - Common Stock - Common Stock Reserved for Future Issuance (Details)",
     "role": "http://www.nautilus.bio/role/CommonStockCommonStockReservedforFutureIssuanceDetails",
     "shortName": "Common Stock - Common Stock Reserved for Future Issuance (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i452786b7977748c0a94d775ecb931729_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004004 - Statement - Condensed Consolidated Statements of Comprehensive Loss",
     "role": "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss",
     "shortName": "Condensed Consolidated Statements of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i452786b7977748c0a94d775ecb931729_D20220401-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i452786b7977748c0a94d775ecb931729_D20220401-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426415 - Disclosure - Income Taxes - Narrative (Details)",
     "role": "http://www.nautilus.bio/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i452786b7977748c0a94d775ecb931729_D20220401-20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "naut:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ie8b7caea51104b0fa022cb4d3c2b850d_I20220630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429416 - Disclosure - Stock Option Plan and Stock-based Compensation - Narrative (Details)",
     "role": "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails",
     "shortName": "Stock Option Plan and Stock-based Compensation - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ie8b7caea51104b0fa022cb4d3c2b850d_I20220630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i49299c0b86364054a5d2222883ee3b39_D20220401-20220630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430417 - Disclosure - Stock Option Plan and Stock-based Compensation - Significant Assumptions (Details)",
     "role": "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails",
     "shortName": "Stock Option Plan and Stock-based Compensation - Significant Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i49299c0b86364054a5d2222883ee3b39_D20220401-20220630",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "naut:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i34e4a2a383364c848f4d73f961251253_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431418 - Disclosure - Stock Option Plan and Stock-based Compensation - Stock Option Activity (Details)",
     "role": "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockOptionActivityDetails",
     "shortName": "Stock Option Plan and Stock-based Compensation - Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i49299c0b86364054a5d2222883ee3b39_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432419 - Disclosure - Stock Option Plan and Stock-based Compensation - Stock Based Compensation Expense (Details)",
     "role": "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockBasedCompensationExpenseDetails",
     "shortName": "Stock Option Plan and Stock-based Compensation - Stock Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i49299c0b86364054a5d2222883ee3b39_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermPurchaseCommitmentAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435420 - Disclosure - Commitment and Contingencies - Narrative (Details)",
     "role": "http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails",
     "shortName": "Commitment and Contingencies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermPurchaseCommitmentAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i452786b7977748c0a94d775ecb931729_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436421 - Disclosure - Commitment and Contingencies - Components of Lease Cost (Details)",
     "role": "http://www.nautilus.bio/role/CommitmentandContingenciesComponentsofLeaseCostDetails",
     "shortName": "Commitment and Contingencies - Components of Lease Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i452786b7977748c0a94d775ecb931729_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ie8b7caea51104b0fa022cb4d3c2b850d_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437422 - Disclosure - Commitment and Contingencies - Lease Maturity (Details)",
     "role": "http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails",
     "shortName": "Commitment and Contingencies - Lease Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ie8b7caea51104b0fa022cb4d3c2b850d_I20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i452786b7977748c0a94d775ecb931729_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440423 - Disclosure - Basic and Diluted Net Loss per Share - Basic and Diluted Not Loss per Share (Details)",
     "role": "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareBasicandDilutedNotLossperShareDetails",
     "shortName": "Basic and Diluted Net Loss per Share - Basic and Diluted Not Loss per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i452786b7977748c0a94d775ecb931729_D20220401-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i452786b7977748c0a94d775ecb931729_D20220401-20220630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441424 - Disclosure - Basic and Diluted Net Loss per Share - Antidilutive Securities (Details)",
     "role": "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareAntidilutiveSecuritiesDetails",
     "shortName": "Basic and Diluted Net Loss per Share - Antidilutive Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i452786b7977748c0a94d775ecb931729_D20220401-20220630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ib1a4309f941040f286a32c33912b765f_I20201231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005005 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders\u2019 Equity (Deficit)",
     "role": "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
     "shortName": "Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders\u2019 Equity (Deficit)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ib1a4309f941040f286a32c33912b765f_I20201231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007006 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ie8b7caea51104b0fa022cb4d3c2b850d_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1402401 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ie8b7caea51104b0fa022cb4d3c2b850d_I20220630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "ie8b7caea51104b0fa022cb4d3c2b850d_I20220630",
      "decimals": "4",
      "first": true,
      "lang": "en-US",
      "name": "naut:RecapitalizationExchangeRatio",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1406402 - Statement - Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders\u2019 Equity (Deficit) (Parenthetical)",
     "role": "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficitParenthetical",
     "shortName": "Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders\u2019 Equity (Deficit) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Description of Business and Basis of Presentation",
     "role": "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentation",
     "shortName": "Description of Business and Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "naut-20220630.htm",
      "contextRef": "i39efc08f0cd54de7aaf38659dec72585_D20220101-20220630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 40,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails",
      "http://www.nautilus.bio/role/ReverseRecapitalizationSharesReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails",
      "http://www.nautilus.bio/role/ReverseRecapitalizationSharesReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.nautilus.bio/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "naut_A2017EquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2017 Equity Incentive Plan",
        "label": "2017 Equity Incentive Plan [Member]",
        "terseLabel": "2017 Equity Incentive Plan"
       }
      }
     },
     "localname": "A2017EquityIncentivePlanMember",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "naut_A2021EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Employee Stock Purchase Plan",
        "label": "2021 Employee Stock Purchase Plan [Member]",
        "terseLabel": "2021 Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "A2021EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockCommonStockReservedforFutureIssuanceDetails",
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "naut_A2021EquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Equity Incentive Plan",
        "label": "2021 Equity Incentive Plan [Member]",
        "terseLabel": "2021 Equity Incentive Plan"
       }
      }
     },
     "localname": "A2021EquityIncentivePlanMember",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockCommonStockReservedforFutureIssuanceDetails",
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "naut_AccruedFacilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsAccruedExpensesandOtherLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Facilities",
        "label": "Accrued Facilities",
        "terseLabel": "Accrued facilities"
       }
      }
     },
     "localname": "AccruedFacilities",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsAccruedExpensesandOtherLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Liabilities and Other Liabilities, Current",
        "label": "Accrued Liabilities and Other Liabilities, Current",
        "terseLabel": "Accrued expenses and other liabilities",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccruedLiabilitiesAndOtherLiabilitiesCurrent",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsAccruedExpensesandOtherLiabilitiesDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "naut_AccruedResearchAndDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsAccruedExpensesandOtherLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Research and Development",
        "label": "Accrued Research and Development",
        "terseLabel": "Accrued research and development"
       }
      }
     },
     "localname": "AccruedResearchAndDevelopment",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "naut_AryaSciencesAcquisitionCorpIIIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arya Sciences Acquisition Corp III",
        "label": "Arya Sciences Acquisition Corp III [Member]",
        "terseLabel": "Arya Sciences Acquisition Corp III"
       }
      }
     },
     "localname": "AryaSciencesAcquisitionCorpIIIMember",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails",
      "http://www.nautilus.bio/role/ReverseRecapitalizationSharesReconciliationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "naut_CashAcquiredThroughReverseRecapitalization": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Acquired Through Reverse Recapitalization",
        "label": "Cash Acquired Through Reverse Recapitalization",
        "terseLabel": "Cash acquired through reverse recapitalization"
       }
      }
     },
     "localname": "CashAcquiredThroughReverseRecapitalization",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "naut_DeferredStockIssuanceCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Stock Issuance Costs",
        "label": "Deferred Stock Issuance Costs",
        "terseLabel": "Deferred offering costs in accounts payable and accrued expenses and other liabilities"
       }
      }
     },
     "localname": "DeferredStockIssuanceCosts",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "naut_DeferredStockIssuanceCostsReclassifiedToEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Stock Issuance Costs Reclassified To Equity",
        "label": "Deferred Stock Issuance Costs Reclassified To Equity",
        "terseLabel": "Deferred offering costs reclassified to equity"
       }
      }
     },
     "localname": "DeferredStockIssuanceCostsReclassifiedToEquity",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "naut_DisclosureOfRedeemableConvertiblePreferredStockTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of Redeemable Convertible Preferred Stock",
        "label": "Disclosure of Redeemable Convertible Preferred Stock [Text Block]",
        "terseLabel": "Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "DisclosureOfRedeemableConvertiblePreferredStockTextBlock",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/RedeemableConvertiblePreferredStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "naut_EmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan",
        "label": "Employee Stock Purchase Plan [Member]",
        "terseLabel": "Employee stock purchase plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanMember",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "naut_February2021ToOctober2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "February 2021 To October 2021",
        "label": "February 2021 To October 2021 [Member]",
        "terseLabel": "February 2021 to October 2021"
       }
      }
     },
     "localname": "February2021ToOctober2021Member",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "naut_FurnitureFixturesAndOfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Furniture, Fixtures And Office Equipment",
        "label": "Furniture, Fixtures And Office Equipment [Member]",
        "terseLabel": "Furniture, fixtures and office equipment"
       }
      }
     },
     "localname": "FurnitureFixturesAndOfficeEquipmentMember",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "naut_LaboratoryEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Laboratory Equipment",
        "label": "Laboratory Equipment [Member]",
        "terseLabel": "Laboratory equipment"
       }
      }
     },
     "localname": "LaboratoryEquipmentMember",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "naut_LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, to be Paid, Due after Year Four",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Due after Year Four",
        "terseLabel": "2027 and thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityToBePaidDueAfterYearFour",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "naut_LesseeOperatingLeaseOptionToTerminateLeaseTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Option to Terminate, Lease Term",
        "label": "Lessee, Operating Lease, Option to Terminate, Lease Term",
        "terseLabel": "Lease term with option to terminate"
       }
      }
     },
     "localname": "LesseeOperatingLeaseOptionToTerminateLeaseTerm",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "naut_LongTermInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long Term Investments",
        "label": "Long Term Investments [Member]",
        "terseLabel": "Long-term investments"
       }
      }
     },
     "localname": "LongTermInvestmentsMember",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "naut_ModificationToReduceRightOfUseAssetsAndLeaseLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Modification To Reduce Right-Of-Use Assets And Lease Liability",
        "label": "Modification To Reduce Right-Of-Use Assets And Lease Liability",
        "terseLabel": "Modification to reduce right-of-use assets and lease liability"
       }
      }
     },
     "localname": "ModificationToReduceRightOfUseAssetsAndLeaseLiability",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "naut_October2022ToOctober2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 2022 to October 2031",
        "label": "October 2022 to October 2031 [Member]",
        "terseLabel": "October 2022 to October 2031"
       }
      }
     },
     "localname": "October2022ToOctober2031Member",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "naut_OperatingLeaseNoncashAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Noncash Adjustment",
        "label": "Operating Lease, Noncash Adjustment",
        "terseLabel": "Operating lease, noncash adjustment"
       }
      }
     },
     "localname": "OperatingLeaseNoncashAdjustment",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "naut_PaymentsOfReverseRecapitalizationTransactionCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments of Reverse Recapitalization Transaction Costs",
        "label": "Payments of Reverse Recapitalization Transaction Costs",
        "terseLabel": "Payments of transaction costs"
       }
      }
     },
     "localname": "PaymentsOfReverseRecapitalizationTransactionCosts",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockNarrativeDetails",
      "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails",
      "http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "naut_ProceedsFromReverseRecapitalizationTransaction": {
     "auth_ref": [],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Reverse Recapitalization Transaction",
        "label": "Proceeds From Reverse Recapitalization Transaction",
        "terseLabel": "Net proceeds from reverse recapitalization and PIPE financing"
       }
      }
     },
     "localname": "ProceedsFromReverseRecapitalizationTransaction",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "naut_ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Sale Of Stock And Reverse Recapitalization Transaction",
        "label": "Proceeds From Sale Of Stock And Reverse Recapitalization Transaction",
        "terseLabel": "Proceeds from sale of stock and reverse recapitalization transaction"
       }
      }
     },
     "localname": "ProceedsFromSaleOfStockAndReverseRecapitalizationTransaction",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "naut_RecapitalizationExchangeRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recapitalization Exchange Ratio",
        "label": "Recapitalization Exchange Ratio",
        "terseLabel": "Recapitalization exchange ratio"
       }
      }
     },
     "localname": "RecapitalizationExchangeRatio",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareBasicandDilutedNotLossperShareDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficitParenthetical",
      "http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "naut_RecapitalizationExchangeRatioPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recapitalization Exchange Ratio, Per Share",
        "label": "Recapitalization Exchange Ratio, Per Share",
        "terseLabel": "Recapitalization exchange ratio, per share (in dollars per share)"
       }
      }
     },
     "localname": "RecapitalizationExchangeRatioPerShare",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "naut_ReclassificationsOfTemporaryToPermanentEquityShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares subject to possible redemption reclassified from temporary equity to permanent equity.",
        "label": "Reclassifications of Temporary to Permanent Equity, Shares",
        "terseLabel": "Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization (in shares)"
       }
      }
     },
     "localname": "ReclassificationsOfTemporaryToPermanentEquityShares",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "naut_ReverseRecapitalizationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reverse Recapitalization",
        "label": "Reverse Recapitalization [Abstract]"
       }
      }
     },
     "localname": "ReverseRecapitalizationAbstract",
     "nsuri": "http://www.nautilus.bio/20220630",
     "xbrltype": "stringItemType"
    },
    "naut_ReverseRecapitalizationCashPaidToShareholders": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reverse Recapitalization, Cash Paid To Shareholders",
        "label": "Reverse Recapitalization, Cash Paid To Shareholders",
        "terseLabel": "Reverse recapitalization, cash paid to shareholders"
       }
      }
     },
     "localname": "ReverseRecapitalizationCashPaidToShareholders",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "naut_ReverseRecapitalizationDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reverse Recapitalization Disclosure",
        "label": "Reverse Recapitalization Disclosure [Text Block]",
        "terseLabel": "Reverse Recapitalization"
       }
      }
     },
     "localname": "ReverseRecapitalizationDisclosureTextBlock",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/ReverseRecapitalization"
     ],
     "xbrltype": "textBlockItemType"
    },
    "naut_SanCarlosLeaseImprovementsLineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "San Carlos Lease Improvements Line of Credit",
        "label": "San Carlos Lease Improvements Line of Credit [Member]",
        "terseLabel": "San Carlos Lease Improvements Line of Credit"
       }
      }
     },
     "localname": "SanCarlosLeaseImprovementsLineOfCreditMember",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "naut_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Common Stock Reserved For Future Issuance",
        "label": "Schedule Of Common Stock Reserved For Future Issuance [Table Text Block]",
        "terseLabel": "Schedule of Common Stock Reserved for Future Issuance"
       }
      }
     },
     "localname": "ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "naut_ScheduleOfReverseRecapitalizationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Reverse Recapitalization [Line Items]",
        "label": "Schedule Of Reverse Recapitalization [Line Items]",
        "terseLabel": "Schedule Of Reverse Recapitalization [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfReverseRecapitalizationLineItems",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails",
      "http://www.nautilus.bio/role/ReverseRecapitalizationSharesReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "naut_ScheduleOfReverseRecapitalizationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Reverse Recapitalization [Table]",
        "label": "Schedule Of Reverse Recapitalization [Table]",
        "terseLabel": "Schedule Of Reverse Recapitalization [Table]"
       }
      }
     },
     "localname": "ScheduleOfReverseRecapitalizationTable",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails",
      "http://www.nautilus.bio/role/ReverseRecapitalizationSharesReconciliationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "naut_ScheduleOfReverseRecapitalizationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Reverse Recapitalization",
        "label": "Schedule Of Reverse Recapitalization [Table Text Block]",
        "terseLabel": "Schedule of Reverse Recapitalization"
       }
      }
     },
     "localname": "ScheduleOfReverseRecapitalizationTableTextBlock",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/ReverseRecapitalizationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "naut_September2021ToSeptember2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "September 2021 To September 2031",
        "label": "September 2021 To September 2031 [Member]",
        "terseLabel": "September 2021 to September 2031"
       }
      }
     },
     "localname": "September2021ToSeptember2031Member",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "naut_SeriesSeedRedeemableConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series Seed Redeemable Convertible Preferred Stock",
        "label": "Series Seed Redeemable Convertible Preferred Stock [Member]",
        "terseLabel": "Series Seed"
       }
      }
     },
     "localname": "SeriesSeedRedeemableConvertiblePreferredStockMember",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Share Price",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Share Price",
        "terseLabel": "Stock price (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "naut_ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Increase in Number of Shares Available for Grant",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Increase in Number of Shares Available for Grant",
        "terseLabel": "Increase in shares available for grant under equity plan (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardIncreaseInNumberOfSharesAvailableForGrant",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "naut_StockConvertedReverseRecapitalization": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Converted, Reverse Recapitalization",
        "label": "Stock Converted, Reverse Recapitalization",
        "terseLabel": "Stock converted, reverse recapitalization (in shares)",
        "verboseLabel": "Legacy Nautilus shares (in shares)"
       }
      }
     },
     "localname": "StockConvertedReverseRecapitalization",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails",
      "http://www.nautilus.bio/role/ReverseRecapitalizationSharesReconciliationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "naut_StockConvertedValueReverseRecapitalization": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Converted, Value, Reverse Recapitalization",
        "label": "Stock Converted, Value, Reverse Recapitalization",
        "terseLabel": "Stock converted, value, reverse recapitalization"
       }
      }
     },
     "localname": "StockConvertedValueReverseRecapitalization",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "naut_StockIssuedDuringPeriodSharesReverseRecapitalization": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Shares, Reverse Recapitalization",
        "label": "Stock Issued During Period, Shares, Reverse Recapitalization",
        "terseLabel": "Issuance of common stock upon the reverse recapitalization, net of issuance costs (in shares)",
        "verboseLabel": "Business Combination and PIPE Financing shares (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesReverseRecapitalization",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockNarrativeDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://www.nautilus.bio/role/ReverseRecapitalizationSharesReconciliationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "naut_StockIssuedDuringPeriodSharesWarrantsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Shares, Warrants Exercised",
        "label": "Stock Issued During Period, Shares, Warrants Exercised",
        "terseLabel": "Issuance of common stock upon exercise of warrants (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesWarrantsExercised",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "naut_StockIssuedDuringPeriodValueReverseRecapitalization": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, Reverse Recapitalization",
        "label": "Stock Issued During Period, Value, Reverse Recapitalization",
        "terseLabel": "Issuance of common stock upon the reverse recapitalization, net of issuance costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueReverseRecapitalization",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockNarrativeDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "naut_WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase": {
     "auth_ref": [],
     "calculation": {
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareBasicandDilutedNotLossperShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Number Of Shares, Unvested Restricted Stock And Shares Subject To Repurchase",
        "label": "Weighted Average Number Of Shares, Unvested Restricted Stock And Shares Subject To Repurchase",
        "negatedTerseLabel": "Less: Weighted-average unvested restricted shares and shares subject to repurchase (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesUnvestedRestrictedStockAndSharesSubjectToRepurchase",
     "nsuri": "http://www.nautilus.bio/20220630",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareBasicandDilutedNotLossperShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r178",
      "r179",
      "r180",
      "r181",
      "r197",
      "r209",
      "r241",
      "r242",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r386",
      "r412",
      "r413",
      "r427",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r178",
      "r179",
      "r180",
      "r181",
      "r197",
      "r209",
      "r241",
      "r242",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r386",
      "r412",
      "r413",
      "r427",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r173",
      "r178",
      "r179",
      "r180",
      "r181",
      "r197",
      "r209",
      "r232",
      "r241",
      "r242",
      "r270",
      "r271",
      "r272",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r386",
      "r412",
      "r413",
      "r427",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r173",
      "r178",
      "r179",
      "r180",
      "r181",
      "r197",
      "r209",
      "r232",
      "r241",
      "r242",
      "r270",
      "r271",
      "r272",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r386",
      "r412",
      "r413",
      "r427",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r22",
      "r355"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedTerseLabel": "Amortization of premiums on securities, net"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsAccruedExpensesandOtherLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Accrued professional and consulting fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r9",
      "r170"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Less: Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r17",
      "r34",
      "r35",
      "r36",
      "r402",
      "r418",
      "r419"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r33",
      "r36",
      "r43",
      "r44",
      "r45",
      "r77",
      "r78",
      "r79",
      "r307",
      "r352",
      "r414",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r15",
      "r355"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r77",
      "r78",
      "r79",
      "r282",
      "r283",
      "r284",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r244",
      "r285",
      "r286"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r275"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Total potentially dilutive common share equivalents"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r11",
      "r72",
      "r127",
      "r135",
      "r139",
      "r156",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r304",
      "r308",
      "r328",
      "r353",
      "r355",
      "r390",
      "r400"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r4",
      "r21",
      "r72",
      "r156",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r304",
      "r308",
      "r328",
      "r353",
      "r355"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r148"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r149"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r146",
      "r163"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r143",
      "r147",
      "r163",
      "r392"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r145",
      "r163"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-Sale, Current",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails",
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails",
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails",
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r310",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r2",
      "r76",
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "terseLabel": "Description of Business and Basis of Presentation"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r3",
      "r6",
      "r63"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsCashCashEquivalentsandRestrictedCashDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      },
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsCashCashEquivalentsandRestrictedCashDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "auth_ref": [
      "r21"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
        "label": "Cash, Cash Equivalents, and Short-Term Investments",
        "terseLabel": "Cash, cash equivalents, and short-term investments"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r58",
      "r63",
      "r68"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsCashCashEquivalentsandRestrictedCashDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsCashCashEquivalentsandRestrictedCashDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r58",
      "r329"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r12",
      "r13",
      "r14",
      "r70",
      "r72",
      "r94",
      "r95",
      "r100",
      "r103",
      "r105",
      "r113",
      "r114",
      "r115",
      "r156",
      "r185",
      "r189",
      "r190",
      "r191",
      "r194",
      "r195",
      "r207",
      "r208",
      "r212",
      "r216",
      "r223",
      "r328",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockCommonStockReservedforFutureIssuanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r28",
      "r393",
      "r406"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r175",
      "r176",
      "r177",
      "r182",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CommonStockCommonStockReservedforFutureIssuanceDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Shares of common stock reserved (in shares)",
        "totalLabel": "Total shares of common stock reserved (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockCommonStockReservedforFutureIssuanceDetails",
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r77",
      "r78",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockNarrativeDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockNarrativeDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r14",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockNarrativeDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails",
      "http://www.nautilus.bio/role/ReverseRecapitalizationSharesReconciliationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r14",
      "r355"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "#REF!"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r39",
      "r41",
      "r42",
      "r47",
      "r395",
      "r408"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer hardware"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r118",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentrations of Credit Risk and Other Risks and Uncertainties"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConversionOfStockAmountConverted1": {
     "auth_ref": [
      "r65",
      "r66",
      "r67"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Amount Converted",
        "terseLabel": "Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization"
       }
      }
     },
     "localname": "ConversionOfStockAmountConverted1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r233",
      "r240",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r27",
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate on borrowings to finance tenant improvements"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DepositsAssetsNoncurrent": {
     "auth_ref": [
      "r10"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsOtherLongtermAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.",
        "label": "Deposits Assets, Noncurrent",
        "terseLabel": "Deposits"
       }
      }
     },
     "localname": "DepositsAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsOtherLongtermAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r61",
      "r168"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r246",
      "r247",
      "r276",
      "r277",
      "r279",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stock Option Plan and Stock-based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r48",
      "r82",
      "r83",
      "r84",
      "r85",
      "r86",
      "r90",
      "r94",
      "r103",
      "r104",
      "r105",
      "r109",
      "r110",
      "r316",
      "r317",
      "r396",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per share attributable to common stockholders, basic (in dollars per share)",
        "verboseLabel": "Net loss per share attributable to common stockholders, basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareBasicandDilutedNotLossperShareDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r48",
      "r82",
      "r83",
      "r84",
      "r85",
      "r86",
      "r94",
      "r103",
      "r104",
      "r105",
      "r109",
      "r110",
      "r316",
      "r317",
      "r396",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "verboseLabel": "Net loss per share attributable to common stockholders, diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareBasicandDilutedNotLossperShareDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r106",
      "r107",
      "r108",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Basic and Diluted Net Loss per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsAccruedExpensesandOtherLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Employee compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r278"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized compensation expense, period for recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee Stock"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Options",
        "verboseLabel": "Options to purchase common stock"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareAntidilutiveSecuritiesDetails",
      "http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails",
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails",
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r43",
      "r44",
      "r45",
      "r77",
      "r78",
      "r79",
      "r81",
      "r87",
      "r89",
      "r112",
      "r157",
      "r223",
      "r230",
      "r282",
      "r283",
      "r284",
      "r293",
      "r294",
      "r315",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r352",
      "r414",
      "r415",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityFairValueDisclosure": {
     "auth_ref": [
      "r318"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the entity's equity.",
        "label": "Equity, Fair Value Disclosure",
        "terseLabel": "Equity value"
       }
      }
     },
     "localname": "EquityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r318",
      "r319",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r318",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Assets Carried at Fair Value and Measured on a Recurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r198",
      "r201",
      "r202",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r319",
      "r359",
      "r360",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r318",
      "r319",
      "r320",
      "r321",
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r198",
      "r233",
      "r234",
      "r239",
      "r240",
      "r319",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r198",
      "r201",
      "r202",
      "r233",
      "r234",
      "r239",
      "r240",
      "r319",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r198",
      "r201",
      "r202",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r359",
      "r360",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r322",
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r325",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r164",
      "r165",
      "r166",
      "r167",
      "r200",
      "r221",
      "r313",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r172",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Taxes [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r73",
      "r290",
      "r291",
      "r292",
      "r295",
      "r297",
      "r299",
      "r300",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r74",
      "r88",
      "r89",
      "r126",
      "r289",
      "r296",
      "r298",
      "r411"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "terseLabel": "Accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r60",
      "r345"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r155",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "verboseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseContractualTermAxis": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Axis]",
        "terseLabel": "Lease Contractual Term [Axis]"
       }
      }
     },
     "localname": "LeaseContractualTermAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseContractualTermDomain": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Domain]",
        "terseLabel": "Lease Contractual Term [Domain]"
       }
      }
     },
     "localname": "LeaseContractualTermDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r348",
      "r350"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CommitmentandContingenciesComponentsofLeaseCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease costs"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesComponentsofLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Components of Lease Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Summary of Future Principal Contractual Obligations for Operating Lease Commitments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r349"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "terseLabel": "Total minimum lease payments",
        "totalLabel": "Total future minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails",
      "http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r349"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r349"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r349"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r349"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r349"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Six months ending December 31, 2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r349"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: Imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Term of contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r24",
      "r72",
      "r136",
      "r156",
      "r185",
      "r186",
      "r187",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r305",
      "r308",
      "r309",
      "r328",
      "r353",
      "r354"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r20",
      "r72",
      "r156",
      "r328",
      "r355",
      "r391",
      "r404"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r5",
      "r26",
      "r72",
      "r156",
      "r185",
      "r186",
      "r187",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r305",
      "r308",
      "r309",
      "r328",
      "r353",
      "r354",
      "r355"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the amount outstanding under the credit facility.",
        "label": "Line of Credit Facility, Fair Value of Amount Outstanding",
        "terseLabel": "Outstanding borrowings"
       }
      }
     },
     "localname": "LineOfCreditFacilityFairValueOfAmountOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r23"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity to finance tenant improvements"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermInvestments": {
     "auth_ref": [
      "r7"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).",
        "label": "Long-Term Investments",
        "terseLabel": "Long-term investments"
       }
      }
     },
     "localname": "LongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum amount the entity agreed to spend under the long-term purchase commitment.",
        "label": "Long-Term Purchase Commitment, Amount",
        "terseLabel": "Open purchase commitment"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MutualFundMember": {
     "auth_ref": [
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulated investment instrument that pools funds from multiple investors to invest principally in a portfolio of securities and money market instruments to match the investment objective.",
        "label": "Mutual Fund [Member]",
        "terseLabel": "Mutual funds"
       }
      }
     },
     "localname": "MutualFundMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r58",
      "r59",
      "r62"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r37",
      "r40",
      "r45",
      "r46",
      "r62",
      "r72",
      "r80",
      "r82",
      "r83",
      "r84",
      "r85",
      "r88",
      "r89",
      "r101",
      "r127",
      "r134",
      "r137",
      "r138",
      "r140",
      "r156",
      "r185",
      "r186",
      "r187",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r317",
      "r328",
      "r394",
      "r407"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r82",
      "r83",
      "r84",
      "r85",
      "r90",
      "r91",
      "r102",
      "r105",
      "r127",
      "r134",
      "r137",
      "r138",
      "r140"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net loss attributable to common stockholders, basic"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareBasicandDilutedNotLossperShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r93",
      "r96",
      "r97",
      "r98",
      "r99",
      "r102",
      "r105"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "terseLabel": "Net loss attributable to common stockholders, diluted"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareBasicandDilutedNotLossperShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1": {
     "auth_ref": [
      "r65",
      "r66",
      "r67"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Fixed Assets Acquired",
        "terseLabel": "Acquisitions of property and equipment included in accounts payable"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r342",
      "r350"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CommitmentandContingenciesComponentsofLeaseCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Fixed operating lease costs"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesComponentsofLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r337"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r337"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r337"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liability, net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r338",
      "r345"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Cash paid for lease liabilities included in operating activities"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r336"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Amortization of operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r347",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r346",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r10"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsOtherLongtermAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long term assets",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsOtherLongtermAssetsDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r302",
      "r303",
      "r306"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Available-for-Sale Securities Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Unrealized loss on securities available-for-sale"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive loss:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r38",
      "r41",
      "r302",
      "r303",
      "r306"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive loss",
        "totalLabel": "Total other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofComprehensiveLoss",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other current liabilities.",
        "label": "Other Current Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "auth_ref": [
      "r25",
      "r183"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsAccruedExpensesandOtherLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "naut_AccruedLiabilitiesAndOtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.",
        "label": "Other Sundry Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsAccruedExpensesandOtherLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedLabel": "Payments of offering costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r52",
      "r54",
      "r144"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-Sale",
        "negatedTerseLabel": "Purchases of securities"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockCommonStockReservedforFutureIssuanceDetails",
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockCommonStockReservedforFutureIssuanceDetails",
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r13",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r13",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r13",
      "r355"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.0001 par value, 200,000,000 authorized as of June 30, 2022 and December 31, 2021; 0 shares issued and outstanding as of June 30, 2022 and December 31, 2021"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrivatePlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.",
        "label": "Private Placement [Member]",
        "terseLabel": "Private Placement"
       }
      }
     },
     "localname": "PrivatePlacementMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails",
      "http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "auth_ref": [
      "r56"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.",
        "label": "Proceeds from Issuance of Private Placement",
        "terseLabel": "Gross proceeds from private placement"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r52",
      "r53",
      "r144"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale",
        "terseLabel": "Proceeds from maturities of securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r56",
      "r281"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockPlans": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period.",
        "label": "Proceeds from Stock Plans",
        "terseLabel": "Proceeds from issuance of common stock under employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromStockPlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r8",
      "r169"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r171",
      "r355",
      "r398",
      "r405"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationsOfTemporaryToPermanentEquity": {
     "auth_ref": [
      "r204",
      "r312"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2.",
        "label": "Reclassifications of Temporary to Permanent Equity",
        "terseLabel": "Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization"
       }
      }
     },
     "localname": "ReclassificationsOfTemporaryToPermanentEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r288",
      "r387",
      "r429"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r6",
      "r63",
      "r68",
      "r389",
      "r401"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsCashCashEquivalentsandRestrictedCashDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents",
        "terseLabel": "Restricted cash included in other long term assets"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r10",
      "r68",
      "r425"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsOtherLongtermAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsOtherLongtermAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r16",
      "r230",
      "r355",
      "r403",
      "r417",
      "r419"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "negatedTerseLabel": "Accumulated deficit",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets",
      "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r77",
      "r78",
      "r79",
      "r81",
      "r87",
      "r89",
      "r157",
      "r282",
      "r283",
      "r284",
      "r293",
      "r294",
      "r315",
      "r414",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Consideration received on transaction"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails",
      "http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails",
      "http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Shares issued in transaction (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails",
      "http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Price per share (in dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Potential Shares of Common Stock Excluded from the Computation of Diluted Net Loss Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents.",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of Cash and Cash Equivalents"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Schedule of Stock Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of noncurrent assets.",
        "label": "Schedule of Other Assets, Noncurrent [Table Text Block]",
        "terseLabel": "Schedule of Other Long Term Assets"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsPropertyPlantandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "auth_ref": [
      "r68",
      "r389",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.",
        "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of Restricted Cash"
       }
      }
     },
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItemsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r243",
      "r245",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails",
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails",
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Significant Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r12",
      "r13",
      "r14",
      "r70",
      "r113",
      "r114",
      "r203",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r212",
      "r216",
      "r221",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockCommonStockReservedforFutureIssuanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in stock options.",
        "label": "Schedule of Stock Options Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [
      "r12",
      "r13",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A preferred stock.",
        "label": "Series A Preferred Stock [Member]",
        "terseLabel": "Series A"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "auth_ref": [
      "r12",
      "r13",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B preferred stock.",
        "label": "Series B Preferred Stock [Member]",
        "terseLabel": "Series B"
       }
      }
     },
     "localname": "SeriesBPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "terseLabel": "Expected volatility, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "terseLabel": "Expected volatility, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Risk free interest rate, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk free interest rate, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails",
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails",
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Number of additional shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r280"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CommonStockCommonStockReservedforFutureIssuanceDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for grant under equity plan (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockCommonStockReservedforFutureIssuanceDetails",
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r280"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Options outstanding, aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r250",
      "r251"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CommonStockCommonStockReservedforFutureIssuanceDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding ending balance (in shares)",
        "periodStartLabel": "Outstanding beginning balance (in shares)",
        "terseLabel": "Stock options issued and outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStockCommonStockReservedforFutureIssuanceDetails",
      "http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails",
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Stock Option Awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r250",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding ending balance (in dollars per share)",
        "periodStartLabel": "Outstanding beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "terseLabel": "Vested and exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Vested and exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Options vested and expected to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Options vested and expected to vest (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum",
        "terseLabel": "Percentage of outstanding stock maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period",
        "terseLabel": "Shares of common stock issued in period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails",
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails",
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails",
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Award expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationSignificantAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r280"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Vested and exercisable, aggregate intrinsic value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options outstanding, weighted average remaining contractual life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Vested and exercisable, weighted average remaining contractual life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Purchase price of common stock, percent"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r421",
      "r422",
      "r423",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short-Term Investments [Member]",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r343",
      "r350"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CommitmentandContingenciesComponentsofLeaseCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-Term Lease, Cost",
        "terseLabel": "Short-term lease costs"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesComponentsofLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r69",
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r12",
      "r13",
      "r14",
      "r70",
      "r72",
      "r94",
      "r95",
      "r100",
      "r103",
      "r105",
      "r113",
      "r114",
      "r115",
      "r156",
      "r185",
      "r189",
      "r190",
      "r191",
      "r194",
      "r195",
      "r207",
      "r208",
      "r212",
      "r216",
      "r223",
      "r328",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r31",
      "r43",
      "r44",
      "r45",
      "r77",
      "r78",
      "r79",
      "r81",
      "r87",
      "r89",
      "r112",
      "r157",
      "r223",
      "r230",
      "r282",
      "r283",
      "r284",
      "r293",
      "r294",
      "r315",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r352",
      "r414",
      "r415",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r77",
      "r78",
      "r79",
      "r112",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r13",
      "r14",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Common Stock of Arya (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/ReverseRecapitalizationSharesReconciliationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r30",
      "r199",
      "r223",
      "r224",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r13",
      "r14",
      "r223",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock under employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r13",
      "r14",
      "r223",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Shares issued in PIPE Financing (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/ReverseRecapitalizationSharesReconciliationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r13",
      "r14",
      "r223",
      "r230",
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)",
        "terseLabel": "Issuance of common stock upon exercise of vested stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://www.nautilus.bio/role/StockOptionPlanandStockbasedCompensationStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r31",
      "r223",
      "r230"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r13",
      "r14",
      "r223",
      "r230"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock under employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r31",
      "r223",
      "r230"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of common stock upon exercise of vested stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r13",
      "r14",
      "r223",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedTerseLabel": "Less redemption of Arya shares (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/ReverseRecapitalizationSharesReconciliationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r14",
      "r18",
      "r19",
      "r72",
      "r142",
      "r156",
      "r328",
      "r355"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r71",
      "r208",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r222",
      "r230",
      "r231",
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommonStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails",
      "http://www.nautilus.bio/role/ReverseRecapitalizationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "terseLabel": "Subsidiary, Sale of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/DescriptionofBusinessandBasisofPresentationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Composition of Certain Condensed Consolidated Financial Statement Line Items"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CompositionofCertainCondensedConsolidatedFinancialStatementLineItems"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplementary cash flow information on non-cash activities"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity [Abstract]"
       }
      }
     },
     "localname": "TemporaryEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r185",
      "r189",
      "r190",
      "r191",
      "r194",
      "r195"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Issued",
        "terseLabel": "Redeemable convertible preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "verboseLabel": "Redeemable convertible preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofRedeemableConvertiblePreferredStockandStockholdersEquityDeficit",
      "http://www.nautilus.bio/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r200",
      "r221",
      "r313",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r75",
      "r233",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "Agency bonds"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r75",
      "r233",
      "r240",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "U.S. treasury securities"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r116",
      "r117",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r344",
      "r350"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/CommitmentandContingenciesComponentsofLeaseCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable operating lease costs"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/CommitmentandContingenciesComponentsofLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r93",
      "r105"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareBasicandDilutedNotLossperShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)",
        "verboseLabel": "Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareBasicandDilutedNotLossperShareDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesIssuedBasic": {
     "auth_ref": [
      "r90",
      "r92"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareBasicandDilutedNotLossperShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).",
        "label": "Weighted Average Number of Shares Issued, Basic",
        "terseLabel": "Weighted average common shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesIssuedBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareBasicandDilutedNotLossperShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r90",
      "r105"
     ],
     "calculation": {
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareBasicandDilutedNotLossperShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "totalLabel": "Weighted average shares used in computing net loss per share attributable to common stockholders, basic (in shares)",
        "verboseLabel": "Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.nautilus.bio/role/BasicandDilutedNetLossperShareBasicandDilutedNotLossperShareDetails",
      "http://www.nautilus.bio/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90193-114008"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "https://asc.fasb.org/topic&trid=2122208"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r430": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r431": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r432": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r433": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r434": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r435": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r436": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r437": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r438": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r439": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r440": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r441": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r442": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r443": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3151-108585"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2646-109256"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>69
<FILENAME>0001808805-22-000081-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001808805-22-000081-xbrl.zip
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M'T.)M!DE%Q/ORC%;U12-=S$1[Y,78P-859O*(,O>P H;<5Y\N&'0U\;K4[U
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MU<!3=6<T*^*<.I R-]-$3ELW6G<_-2CMA@,!PO#!8[^5A/VR;5723_+JCKH
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M:4EG%GGG9,\&BF_V&O_OAMC[_"<:Z8]%OOPW4$L#!!0    ( %:  E7B!_D
M^C$  'M, 0 >    97AH:6)I=#$P,BUC:&%N9V5I;F-O;G1R;VPN:'1M[7UI
M<]M&UN[W^ROP)C7S2E60+-&+O.1-E2QK$M]*9%];F=SY=*L)-,F.08"#11+G
MU]^S=:.Q292CF CC^3"Q2!"]G3[K<\[Y[K_>O#N[_-?[\V!1+I/@_2^O?WI[
M%GQS\.C1KX_/'CUZ<_DF^/'RYY^")X='Q\%EKM+"E"9+5?+HT?G%-\$WB[)<
MO7STZ/KZ^O#Z\6&6SQ]=?GB$KWKR*,FR0A_&9?S-]]_A)_#_6L7?_Z_O_NO@
M('B31=52IV40Y5J5.@ZJPJ3SX-=8%Y^"@P-YZBQ;K7,S7Y3!Y&@R"7[-\D_F
M2O'WI2D3_;U]SW>/^._O'M$@WTVS>/W]=[&Y"DS\/]^8HQ,U>?[XZ73RXMG3
M)R].X!_'DUC-CJ?Z9'*L'ZO_]W0"LWP$S_./BG*=Z/_Y9FG2@X7&";Q\<7+X
M8K(J7UV;N%R\/#XZ^MLWS4=5/H>GRVSU\AB?*_5->: 2,T]?T@KX Y/&,-F7
MCY^M2OCY+(,-D-]'69+E+[\]HO^]PF\.9FIIDO7+_[XT2UT$%_HZ^) M5?K?
M80''<%#HW,SXP<+\1\.48%3Z\YIG? +O24RJ[0J.CR<PY_.;A9F:,C@^.IQ\
M]PB?M^ONK-Y;0@2SUOF#3WERUY1IFR].?[E\^],O'X/7;]]=GI_]>/'NIW<_
M_"L,WEZ<'3:7L,'D@33R[^_]JR^]Y+,?3R]^.(<5!F?O+BX_O/LI.+UX$WP\
M_^?YA].+L_/@](</Y^<_GU]<=E9RSU7^5A6EF:W_>.ILK_M)[[HO%Z8(SA8J
MG>O I'#_TS+/DD"E<?!17VG@/Y$.3N>YUL0\]LJ%#O[^[?/)Y.B57>TVCLO-
MZ,M,HG_O:!^.7^T'L(5+%>M@NJ:-F^KR6NLTN%!5:9*J"%Z;K-31(H5YS=?!
MVS0Z# ,5O-&)NE:Y#J(L7V6Y0C8_F@T^RY8KE:['L+TA;>K/*E\'/V3Q-5#I
MW@@VZ/Q&1W"\5WH<6Z1G,QWA= )5!-DL0#**0<[#/X ZZPL,?VB:.6@ 0*[3
MK%S0LW+>M-5N::.AQG.WNC>PIC'L^!URL,O8_]0"HJ:?59Y=&= 9@TCGI8*[
M"!^4>#996@1EYM$.?!=E:<K?!=<&"$VE\.E5EE1IB;<9I#WH>\SW@&3=3W&/
MCT]> :4N5TFVIG'I]SZA5K S.7T2F1Q4TJ)$454$,+<H-U,@;YA D_A#^"A*
MJACUWK[9!9&3@Y'(0;E),NAA$)S)LB.U,B4<V']@(%Q' ?ITWY@!,OA8SV!?
MZ=N//.+?OSU^=O3J!$1%DEW_A6AIB-$HW"]D7;,L@1TI_O[MT^>O@L_2M<0N
M ,Y69LN.:3"R'3D^W!Y;?;52,=Z%@T3/RI>3$]R$2R!E)/I1Z%=PW5K<Y]HD
M2;!02##(2L R5@E=/[ZH2$-[C_>#M58Y<*AL"3^*\+9G*5WCIA@9C71[*PO!
MS1^%; N"=[QAS2V%34]A\_("F;=PQN:6AFWN1P>6ZQ0F",HP3+$TD4J2-=QS
M>!V0'_LV0C@A&.=8QF&&NJ=5M$#E;PQG=.KF.IIC A&8Z *D) @O$(4KE9?K
M6C[CX63>%R3BKG-3EF"9I!F<@\8S3+.4C@?6I<H@T:HH@Q2&A%_LO3C:!QUR
M7<!+#1P72'>G5<(OW7D&\@(@FXNLQ'%0%I.4Q>?AI/4\@[] _,*O>HS-+(HJ
MN*][:I_%XO5"$_F!Y$3I.=/7).F!$,"N2E M/9[L!TOX]:* P9<@CW&PN,KM
MF/Z-"F#J>U-YM3P#KVH=*%*N%J)W_*1+RB U- BN)BW#+<FJ^<+7N15IVCQ=
M'MF?,PLY.UF[H:1HM#<'-O6MIQJ!P@!L#8X79H3NM]B>RA3.8&;*0O2BAIKQ
MN+L:;[FM%0)I.,5,P]O @@U@E7:"V13$J&)U3SY"^C(P)3PPF T16JZ+%4R!
M9]?81N+>4S2/"WA-,3,Z'M9__E2R?#(R67Y:'OR*)WKNM.BM"_-!]2_ZE&;7
M0,YSN3RWV@) 3_AS(E=4U$U:::2T*;P(9@$?AZA*6JV;;X1:K1*XK]-$!XFZ
M)EX%E$LO+$)W?4+D%L1#"R)Q:V5T.0$,/(.OJA7H%MY"8&GL/X?YN+G=R[()
MX0KF/ 9\N@9> -=QALR0GH3O$K,T)?(('.U:K>G7/&K37L&'Z[GA7707NZ@B
MO*4)7^6%62'[QY^4<.BA&PK_FU4EF#M@WH26V1 7!%L0WU:*)Z&YO\6.W.G'
M([O3M4_VM5#LEN_T Q[SR62+QZQ&<]#'SP^?/<>=^#\5[-5LC6K"I><I>5>5
M!6AX@QI#\![FD,5;IHNWK%P N:;$E50PL!QB]Z(!LKY*FIZGS VM,/1XF]@9
MD29&1UJG5;$LDQ?7O*A)LSQ;-KEN44U_<RH+\%/][\KDFG_:T9_(/_& M/_\
M\>&SDRV2__&AV>(% +ZF$C0J'7O;,O6>!A@<3T#B)=5R!:0!]D&DBH4EI@"(
M ST/63 S,[2Z=!Y1>.SIT=_V^WV9O,*'%(O/CPX?/]DNS6R7:,[>O?YP.AJ:
M^5CS#T_G@D' 0M0)VF/ C$0E9-8793CSN?9\V<#ABBPQ,2$TWBU3,\7P805Z
M<1E\ -,OC4QB^->G$3'6XQ?/GY*ZJX P8_C5&()C=#*C\)$@TY]5.0D6C\,W
M[..GAX_#AMI,TF0EBC6KZNA'R7(;JB"S%X2#J9:%E10Q^;2LSA_7I[L"T5:I
ME,9EDO7/FT9T7&*>9]4*+&F5E(LPP&NN.!C/!@DP(; #5@GL#(WF&QXQJ>_]
M<13@(08U\UBO-#&/@DG&Z>QARR<Q(*S9'4"[HO($C'XD0?;5H_L&N.9-L/=L
M S]'__M#=-1XSZ;!]<* G=)<YD;K@^GXZ]L7QPF?"IS.(!\6,D)E]-4J8_#5
M2S:4KO0@&$G8]E']$S6%BUR5W9\,QC#\_U_D]LTK(*&#::[5IP,U _OMI4K
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MYRR-K4X%5H MYX0"$LC9!%=:8B>&W,<MS=0$Y<ZJS&[-(!:^,(;K.9E,^)W
MO$MC&MP+X RFC)S*P!QDX$L-50&S&-WA22 TFXVE/V8FI9_'_C.A13X(+6 B
M303Y04IF)NT8"S2)\)V#-&X"UU2 94[1+6##^7(8?A $UK\?! H6RA@Y)K@\
MYK0(^,$<S7JI7<8AJ(23]L7??I0&&!.X64I@$9B31#\)TDZ()21'T2,D<S28
M)U,#]8$3U46R2",8 (<*8''3&>>/S\V8A9&:F05(M1A)8Z'(+>-T,_,;7A:7
ML&86SJQY^X/ K;%S<!NLY.:=R:&4:P:B!A6&$I<N7WW&M7#(0*;E,!*4028
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M4*C[0_;V1G>NY3<U\W7OY"]02P,$%     @ 5H "5:%,7X1IKP( F'X: !$
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M=_-5^^#3A\OZIYVS^N9[5+]L-@_:6_SP3>UR=[/>VFWLM78W:U_\F^W"OOD
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M2)Q\*WSZ'HO0R\H.A7OCB]<[_W,;[MQ]^.7DI]NMGY8"/?D&H4)OD'Q7J67
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M)QRBI",Z *,<,,IYXZ30*$I&S JQ:<Y@?(HLL\"DH /"E@/.XTIA1IE42"!
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M$:X$J(+\BRW $*MZGBI'1,.T80H[K+SBCDD;M0B5 %>H>X'%%TFB3#KAVKO
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MX(0)%)6WG,3($.A.=$1Z*BUH3Q!B">81YQB<5#I<:=%H-IZ+E%(.E%K##"4
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M2'K%,%46!:DX1B2=!RYCE0->5.E=% &BA*=3G*6343+'HU:!.JVU$]Q*QI;
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MMPW\ DJD)^_?O+T7^B'5_-@ DJ6:'MUR&>S6^2FT%E8.=LW%6P?BHI(VS3>
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M4TDT]A"O2EY%J]^- .[B*HEU) ;"T^ 0^"J4Y@ X4CF@5.PLM1[1:A+P>SE
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M+OMG,OCQXGI&9WQ.0,^<%A[Z6^9_4ENA\Z7H=3NC==A)4$?D@N9[:9*GG"4
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M4"B B_A0R)OKLMD]&0Z&:74G4ZJLG06O'6\M"[F1)O,6 ?4.&4AV /%)SD0
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M#,ARBI'@C@!67"<@3JP)VD)-)GH]N-/S4H1/"L@5D'L2?TX!N3F!W+B#)Y#
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M>1V)],C:X! $9Y/Q&1B"R)+QR3Q3DB1\$VVI)X_7- S?'GQ*,%;_W/C=!-^
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M*0N!T,BP-AJP%I;3I.[<::=T<$#*KKZ,JD[&5%V[(+4)!HG(#8)(,;*8"<1
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M(ZC(R-H&3]PA84K"G0:=,"H$HMZ3\S.J_</."4ZA]H4I/$RS.V.9D1I3AX5
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M;NH'[58X=2&OUGP>LF6JD]J#B4R61P'*(X)-ES>?>SAS2J"H#HFV+F>CUA'
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MR)',9L*Z3-FT52JV5%)Q&[QT<RQL>6F;P2 _#"ZN!-X?@!;_\R.(?PNB[Q*
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M$,4D=H8E@B1IEC$&FXUE2:J<Y,[1),U[46S'H.-H113CE')"5(XP,P(Q(A,
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MA-VFO ?+K<SV)G'S#V;)\+WCBS59>?/<PC&?^V-^D)>3L\%DZKR:#QI+L N
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M<G;F&[(%20(FZ<J!.YN.)A?.U1].:Y_A8#I2?7_8'RAD>,=!7U+E=@C5K5P
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MNC^WO$RDXWD:R/E\/YYN]</KCNN#U9;KBSVQ1=S^7B1]!:P(ND#<JC%IY0.
MTW+6BJ?,R#72XN5;O<&<8OP)#MM)6;5L].>K/U_"CJX_;B',D[->]/H@]*@&
MS.+/P]S;^]0)0-4)8)3_^U(O0G4*3%ZM.!(48\9PBY5RDJD,*YTZEVF5@C3M
M%.:U(R%+)&I^Z3H27AW^OJK"O%$C5X<P@R"L70E_A#?[.!7?H.UXL:%NYD-(
M'IF.<W!\<GZX_]Y@KM)$.I034'083S121&%D,I%KH0A-B:_HF0QA\_M_U_P
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M#T;*?*RZC-XZ.;KW#SN6YYKCXAY:\*MGZ&@Q/V_<GJNV<>\)V$FE[I:NOU=
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M$8(61C#D<5U%.K[5AS;Z%U]TRDDO)KIB!AA5DUM1=W9:E!9Y./(Q>>.YMPW
M[BT7A5M";";LJ$#BN!R7W]36^2PG=M[6%VC( SQTLBCJ :/1$UNXUAC4[(!:
M7-H8Y!;R'):6-A3Z*>?3IFYY3;@F\J<>4!U^&2,<0CF >FO<\TRHHEJ YR0
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M<X=K3UVOS=,5IF^Z]ZY8@NM7(,0V69] Z4(9W<GY-F,-O\>^NF7BS&OGK8%
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MWD]/D_O& 0O+5/\2#!BV;!1<"P9N<EDFEZU0BT"7"8#0 A]3U[L,B*X*0?P
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M"IK_WA<XV#[MK;VDGP6P+'/(Q 4?BS:0B.?:$*#>VN048KU9& -IQ8*GA05
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M!J\,USP8#I"<M<QJI@0W(<B4><WV:+VF-D]P+Z3PT2M+ AIG!(2BQ)K "8L
M7*#V+7 Y5P1E74L79:X]4J.L2O<]IFY4J;Z)5,^F:'BJI5<R$)D8)Z!D)"Z@
M#282M5%H8R7$I15>Y?F1R?--$BT>6J!KHL4M!'HVT<*')$!07V0Y$ "1B/51
M$,92H-;I:+);6K$+2+2HPOR,#N<:(;D'69Y-FO ALY24)$6W)E!*0'%! ]'
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M\'0%O;4OLSH3VBO)(@F*V\ RXSU8#HY9H0VW@1D=?%)5;W@(89W5&W+@2<G
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M!PQDQ%_PMLPDY7$;T$3'R\[JLM_1LJ_3S\8Y:YTW),DHT,Q-AG@+B7"40FO
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M\K W-9#IKMR?<:WE[D$GR_OU7+(%U%-0+6MA& N-I):&K5;MQ[P&4GROES4
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M%8N0QBN0+>4:*2ECV"N6,\2^[S7=Q'7V^Q4\>*V*UYS6\,:RI9"OK6ZA[8W
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M.-L;/A='4B%A8*^[IX5J5;JRAVV8+PS2'ZL:!29<^F/"L'>AB#5_UH"!!H=
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MD3&PD0K8G@;89F/%31!!"B$0QC0@;@Q&E@J&:%*2!J(3=WSMC7Q=K7PK8*N
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M=NT-7=>L8NT7S-J8,6:CUI$DPI4SEAO!"(F8VHB)%Y4S8?59>]:9X$GTVKJ
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ME'726Q&Q=HQ0LJ_8VFTJ=CTZ "TNAT7P14FW7__X,565S5PIVQ#%.CQNT2W
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M55J@F Q!/"6!G#()14UQH,Q+0T$'G>O9B/**W0308^TT6S&Y:T[)>I?LLUX
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M\7C#ODGN)L16Q"2MXJ:B_F%L(HKR*%M4*;8O%K=IHK![F#5-2NW%41T431G
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M9V7]Z3JQFX1NM&$2@68O\=S9[,$9'AQMHP/[(R?9<H.%'Y4.IS@6C?S6,WN
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M4U:-H%-3E2T%\0O!/]3JK[.!XTJG:L* @4@CQFW5",7G'=2T_D%VYR,^RX@
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MUJ);JVQ]EATEX/1;&6P=AZVLQ^VRD%]NI G:$*F<RLJ=.K2]DS2XI9;XQ4%
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M6MQ5&F&@:["],ZS<[V#6>(G6=I2IVEM@L,%!R#)T$!F[OXZHZW]>J9_T?[Q
MULRBQ4]I3MNB'[WP'W<*9T#(P7&420R9SIT_EK#KY>7QR> "(Z]U"?\_T2^6
MH.PQ!67_5B?+GPW[QZ<7ERL_/CGNK?QLW6-[_>/A9?^S'KO^L^'P_+#8_5KL
M<*/'_HTHUR0A-(</F9N0>S-DO__]P^ 'FZ@@#):?3H(>?4N_PWSU<NFK_?DG
M_/)R1J;-8\Q>#RW1+NY36R<LT%;*:".#VEO=XE3@J^!(K?K97IS02[+7*6'T
M_-F/AT-Q#B7@4_D/_U16<%?_2[C+?E7T6UW,?X+O!J1E [W?O3I#-)4V(*>-
M-KSYP8FJ7W[4DSK8WC<\V,ZO?@TFN'R"3/"<PJ?@8&*U]4-)UPTN9B51+ 76
MXEBI\7C=J2(NV[<YT_N]E!._'$ [ZC]MP@^KMOY@$NCION"PR)6+W)KA))+=
M8KB _O=RQSEO58%'F_VVV?Q)L \RY]D7;='=&@&F[=3>+L*+TS/&Z_J276HJ
MWF*W6[%HZY5M-C_0W#[1W%DXN#@YT-R!YK[AWOKA\'S_Y9QY1G\[(Z.3_G;O
MD@:7CW)#C['5_^B**WVIY[8?AN3J K"5GMPZ<N\XBCTA][/PK+>M3%IS\5]+
M)FWJ8CW-2QJ&@][YX9)V^Y+Z8?]R6]UQN*1O?$FG@T>YH3W4[FO,FL'YCFOW
M#T5MX6.=,.UGZ78YB(US GO"";U3\$;ZGV?K;I,?V1=7Y<G=[TEX=KFMT7"X
MW[VYWV%X?GYZN-Y[][27=_O0%_L=VB_[F%=>78S^)5&)IR;YSB\^TXC?&;GW
M@#[84[O<Y[VSI3*5P[WNN3X[_]S R%=3:(=K?0A>'5Y>#A^.6[]#(V7;((LW
MM/7D^*2WW%'RJ,?QFZJI5^TS#5<IGAW $21%@UTW6U?//M$L]P,>T&XSU//>
M,#R[N-Q<JCSX >UX2<>!50ZLHEGE)#SO#0ZL\O ;/?#)YJ>SXTPR""_/MW I
M'_9P]B^ VKWCI^6W#+XL+?)%1[2_?LW?J*6]HV?^@,;Z<__T@,:Z,[BENPD+
M\H7 I31%X-G%\:4%.A=TBYI:S&<%M9BK9;B04,8-,';4L[/CX;:/Z(4\^% C
M2HZ#9WV+N$YSV0:7_\&#Q\VW<'*#!<Z1H:M1\*QW?&'>[P)!K@9170^TAU.!
MGIVL>"A#FXX+?T2CAF/BZD_\]6GGKY=15VEB'..L6=!X_P$T/%(&T[":N1>J
M5=_RGL%#?2Y>Y&,!KFVYD3T4(YO 6K(@.3L^^U)!,CP>/(@@&;B"A#GF=+"Y
M-.E]#6G2+0\,-)PS_8&^/MA(?#P)]OYNT-\VY0J$9W/Y8A,V,+/$EDA:UD+S
M$:(8:*D3O#L@2O-!Y5JX='M&;)MBH]VDGS9 1EO[K0,NVE[BHH$#A&.\/@L8
M;7#<&ZS^^ L0L09GGPO1M1Z^Z_-^>5CLHRWV (QF1-IFP#0K1?0! 6P9 >R
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M@-=5J.C&T6U1\M= 1?&"@4^SC'-M+!@7:YXA[XH2N/<*4R+,KUB'LW#XYJZ
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M7\,1E)/V1L\LD$<HA4IVNUQC!.]\-G0@+;$Z:P6\'"W^F8,4TP+U&KMW1R=
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M.(,H\LK14WK$&R[1=K=2T-&6UG)EDV^1'0>O;,*-Y5GHRS*2%Z$OL^Z*\F.
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MU<RK=/IN;Z,TT[6-\"V<0D3=-P8,$HT=:NC7 Z8UC%9D6S#@V:,T%V0]1I)
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M$<M$:K&5Z)P%\EPSS<:?6ME:CH%#YIH=&S->^=@=I,P=2S"T<7>[ ':E:8,
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M] 8AAI2H( U/4*GNI\O$;6,-&Q/XF"[$EP9.!;:3"F;8/AR5!K:.I#=SC%/
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M]#[SA'I)6B-W^9QHOCOKCO6'3"4>MNE=GR9SJOTR-6+9FB&#P8N";2>-@MK
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MG=;/L1U$>L8Y11AV O1&.(B5#4$_%@$%+%U()PKU]O@7F%>-HI/]ICN@YU-
M XJ_DGH0]*(K#7\ M]FL+F]Y\1NP>?VB;GOL,H&+B+9)J3W=@H1K_-_3:T;>
M7C(?V;<^7,_^VM[ZS=H);;IW:.%J=66#D5#;09$O&'1[-&Q_F-QP]2'Z4O;U
MP*_S]YN_P4F:!O F\,-WSNTP(2LGB.B;&7\K5RJTI <;41BMA&9Y>LD+ VLQ
M4NRF]]Q_L_? _/7&5Y$?!/1\,"AFZ!/!^(@*T^CCC.E,8P(J;O34?;5P;HF^
MO="'[7WXN2//&%C?;AP:!UE3"3(G7_0)'O2?6NZ8QSF9/K4MM/[ 1*DC9<\E
M6%#H@QC8HX&$Y(T_)DMR7"CU[^B( O6P>"P^C&][6JG2QQH.'!,,3S$JJ["E
M23<F=(N].G9G+%M'-X20 NA8+^";(^";;SX[\,TCS20:#.Y:2!B)1")27(0B
M^@#87-E*QYK?\'ZCWW\B1WWV%V\3N=D2+4"YTWY5LI QA0/U+:\ <E*NF:Y4
M$"O'"GC^(MT-&!1Z&\\ 'NQT5DX4, W0Q7-%%-=:-<2"KI^@)VA;7^/M-/*<
MB-\G\I^:9<R:".F6MN--TUO_*N>E6U^9'.S\(O"UB5W&DDM"@4&'*^<M&'I>
MW>Q7'Y93&[M5Y:"E1H311+0O[M#08!\L-=5"I MV/"$7'S%1H^\'V^^ H01_
M6\:'X@,4I:TF>Y.#F)[;6L?1>%TTI>,RM8R@(IITF(_,!B4PZ/NH]UG<I?';
M^"6"%&$'#LL14FY889(>@H?U&_9?*&>$U^W);X)](7FA&AKZ:@=.W>S7P=^O
MPDV <VX)!M@E6U6U4TL!]7R'PH.-@[U<$H_ TO45);7&IH,R%K)!"YY4>B3O
M.X,",!IZF'FE#!'FU;*/AFG@%B_\?A)UZZ)9\X>W(>\-?NK'GKSWJSVL*Y(O
M><O;8U.@T*PCO$YFEES^E8P5O[!D0HH@Q#A!N#WLO=7S$PN9&^#-J6 _>Z\4
M?))PF$>!SO7L!_\'+>Y.TTZO(6W$ZZXA13@:6W^@VV5F7VG:-KQ,M 4P082Y
M0<PF<V:K:VNV_]"94-+M0HB/:).P 9K:#M!0*R9+OX,..&^#0#0T%RL(JI78
M9,ZY?1-'8%#@Q]>P[2/F@]2,ILER^ECT( F\9!AHCLWH[0G1 [$TUH+2L-2(
M&D4ZN"-Y*V(?98]3PT. WN:>,BL08NA^DGO]"5YY49AFW KU;D9L]2,2))BW
MX"'X$Y.RHA1,%HRI3S2^'#)C;IKC\'\.@-=7-H)-V1,?#XSI#&NB__9G'\;^
MZJ@,O86-9"+7JI%<_<';&>":":S7KMH39:].-20PV.[ASO*GUE"AV0]E[W$-
MDR.#B4=@62'8FK8ND'Z=B(9CRD'T2[@SFS70BQD&B<C]I3&BX0(S-WKT=?P2
M;$!RS#EBX&/;WK1->$;@VT^M%5T @9./RX'F9CUV.:-9N/%;K5KQ7]J3$(R)
M!JE,J[AJ[Y(+79E)\=\/_$%U3-C'9,V(;(V_:>B#C<RF>^3:1ONKY0<__J:$
M,BB51#FR+[GXE)AD?YDLO+W#;R46-[1S_K;VD2 .GQ!_>N//T;60AZL]K1JS
MTK*?;=,]_R:_T+$59K@\E$?\9FF%44.H)MK0:LS?QI:<O('P.C>(I!I;>;R@
M!KQI)*5\Q#DE$B7YH*Z<283A(D'2ZRTSJF/)^+:A*1K=<&9KJO\WOK^B%247
M2MX:O'V<WHKEAXY1^%A0)]]YH5#E_PQV-.?MD@7,C,R;"'J(?(%=87VLA@[\
MK)0P5>P2S4\-WJ @!N!0N?<EW!*%:$[29D:$JDE-*=,#[^]J+\18F\@QX!YI
MM[2)J12E3/@"PXDO9C>7CK1YR#X*CO7"DP"1$Y1P[BB-*XYUQBK*(L"72-G:
M3&FX,"1#O)+/9M<>3$/!+$8U9P'XMV1ID+G!)F-U.X652G.UA6:PO7/C.MHR
MTD:.+[W'$$9HKFC&$O<[3/H+$@Q%*@KO0%-UF>G,/UD%=)JWZ!/Z:P_ACGQ@
MS1!V],_7;Z_!=[!"UV8KZ2GR9IX9[*#MHA&)!_SHI/NGG+95GU#@I5Q;EI(T
MA40P'173Y!CSDQ2JHMA+!T<F\8DMY%&_\HZ^HG44Y0S=Q5>$>SKC+C(:BFWE
MF)J1[\0>+]L.YX>IT>X036I"DJV?B%OAU40EFMAEPT@1]QXP-"W=H@1"87R?
MMT#<N$9B-+R[^EOGD/E0E;):,P]4^.Q[&>L+?Z?[42'W->RB%W[_??'BU8O?
MX070.Z-/ T!$*%!N6T";H*$MR/.AAX5[SQO)K1^_O#_R'$&RD(]:O 1O0O[U
M)ZUAOH8"N9M]\?/;-S^]_IV_]SKCZ=KYI19*FTWPOA=)SJ67A;T42WF6OX?P
M.[0/$^G[O"^VOR+DF+G<+(V4^81WJRIW6] 61)?*]?Q#SJ=TU8W)1]/#Z(*5
MV9TC7F[/3)OHE/JU>?4BT+C.B:1Q3[GD&NJOO8)C8#$X1?,)-JRYBC]PTV(D
M%6U<W"%! _M<4#R7JMF?O_[#9U<U._NK[!\,>_;'H(MIZ?;BF[P==M D[8VZ
M_TC!Z&',G6 .O"'68'\#5#TA-(P.8H1,NHM# Z>WZK'J5[D^\HDB7.TA36:L
MV[*&\,X?,\3K(?LFY2 ?DW@Y3 O.FW'6ZX.)>]CFS=69@CF,^_F$3K$;:C5F
M_@G.GUL,TE>(JEA41"D%*D0#=/3O-J[Q 5,#!@IN6S_M^"M2-9WWB+*!C'QY
M/?O>+["WVP :P8H47ACDN""8G%^E\)$V<$M]ZS?!=NYOF*^^?/:UW/UP<T%F
M<#?,:XH?::$(S$EW/_T*;R1X>= > %"UZTVU!4-,_[.N#[485 ^DGZ,[01-C
M_P8G Z?P6JYQ_I3=22+JZV^"==MY#P[PP_,*<PNX<Z[PAG00DWAKT]C\/RD_
ME/4!4P[ACZ3!R!3M)/VX1?E)/A@#G)<:8>&G]S.Q2QI8\MYZ0$\PE_U"4%P^
ML&W$JT K(RZCOUO=$KDHR"3AO,BVNN$Z%E%3MO3_FDC+&)L(V*7\G\ WPZ8G
MAOU2H@;&QH\+<3P_#U)&B-G1)_A[=Y#,RUO.0(D3%3CKT1'V[UL.?AM)2T36
MSX]P65@M"PQRP7TZ2"$8<@=B'>\8BA6:8L)!+A CE'NV%IFCY+3Z44@P)TC2
M:V\.)/_;-N8Z&+^TM-I$KUUP,'$KRF=KE/R!)Y#&H0T]66($7P 57BSF@5IX
M-!EZ-]=N/'6-W_$V285J Y"GLT6J?&2,+I\MPVHO"3_[OB+C!^SMX!0NT'%[
M&W5HAT FK/6I;K]JZZJEJXNS7XU;EXQ%3 R;)H]#HJ+?*\TO[HT"5P4- ]R#
MF-^+%4M5QZ;M;.C%(0#0E*M@IDV@MAC=]9+*AJ_#-@M_)Y*].<OZ5C""Q:2[
MQKR?D4TMQF97Y.#(TB)'+9TN-*K>/"Z]G>E'7EQAN$%L-*O59V](3N6H)!%K
MC5(A67G)Z<NI-4L]RKFL<N:TB",\V7Z:V;I39!?T,OZ7)BKSD);3P'3!(U#W
M'602PM%Z6A-V]"!^/Z;JX$3+*BJ):K/BF*:7(34!Z)6;LX#R]=^T\9XN6U)%
M](46BZ/K :85JBCAV_S7 "-U)AOF#3U"1\!(:+9GAGJVU!::2V-^3HO[D_@E
M4)V!68.T%M0]P^RQ'(2<A^-G@=RIOMPJ1)QT9_1+1K.I0+@)4&.BH1*)\1@L
MXVA3HL4-6T+>*W%'8Q6>$Z,860BJ\&:*NSL(/*N%=*3'10V<9[@"HB,QN4GQ
MNB"$FY]XX9?<BN:*:2+"DKUJ-&8JOP8B&@^)V21R">,\O@-F+G10A;#P:.,&
MMD.,B8.34@#U[-P:V3)MZ!K'/4$F2XK>1U"24CM$%!^T$G1[I-6H2)#%EM;]
M5NLJ5G*)!Y3I,II[,V:SM-QWYG=^O^\@?5]*XBAG33CS'S6#195]"V,ET.L)
M^*\M8ITD2;([6YMI$!<2R3Z$S>ZVM!NYG-VLDV8;C3YU:^.\P<<'/_'=P0#M
MT"I@UH SUF44BRH0 ;ZJKJGQ(VDQAZ"&VW084A)E>K8$7I&A8$^43:N;C)U&
M.+82'C!_(7L8W.P99% 6W =O?BP=7J MS+6DWMQ($=0MO"G.DW1M@9^[- (_
MY.D9+9T\NLJ@9#^G>^H'P2 1WD\4H!XS^ZGJ4Y8I ?*<-63*CEU-I]R7B;L*
M[VH$+DHZCAHK#B,</5_92",PKB&MHEC^F(6(6RGM+DQE/2%S2 B3?N]M,7SG
MMNH#?CY"L-Q4;1T0AG=PZ.3@L;%V5K;29($HR))9R$V838[I;.F50/.%<?D5
M=-M[8\6P'=IU1&0F6]"52Y92)OA9Z'U(+C1J"S1#O?NTTSN4\]ZQ</FF]':M
M ;F#T]@_S3<%LV[W 2QB/Q9G;3#G8<#'DBH+J>BX'[8X^3Z2: 0<9"!X0!1C
M@OFL,M@\ =@GWI=-4B40IM@)H629W8S:?9WIKJ4[NK76^E+7/%;7_./_NKKF
M0TWM&P/T2S;\"><^!NI-W2@C7&2*MF-^V]\,M),TU6X0=;2[^:_E7GM[YX[L
M?X 26Q22_R<52EC4_NY?DD NPA>"M6$"*LN( M#H%EAF8Q/3(G-_%_A)32?Z
MM,-N -<.ZC<4B1W0< ^5R:]/_7T%U"\:(VJSCOQX:<8QL644T#);EEN2J0V:
M6.2 SLK;LEL"]J5"][*P$4,$+@<* C]?JZ%.0X(XL0FE6NSLPKLYJJ9P76RR
M8W"<GL#;F\L=V5I'I@%]Q#U2* K>QK)I[)CQI*8:&1:+%L4[12;32!W9<WST
MODSS]4H3$GKJS5M&;JAM;51M-.51RG^K;#:-I[7E\X& LD^8*NCC,LYSAW!O
M[DXB<6H]^J$B9[T:@;J3F<$-&%SBXLX^]P1G0Q<EOKO36[5 FY+@S>;.YFRQ
MC!VWP Z-A8E+5D8R#(AQJ\O#'55,^62=Y[XX>K__+8#[^62'?MD03V40^RDC
MCMB+9OGOM(1+!]QD_@L#; #N8&8;2.M9!"XUC /)@Z]G9J2M)#,$^*&=<GB)
MU2[PY2L^FQ.\I/FK#3>,^A'TC ]UTH$CE)4'&?*5VN)*S:>M7G=<FNY$>E4[
MVI@#,NJ<\+>.C]1"?99J@SBV8VX175DKIP!/^&@,?.++* )LV,JQ">Y>^*BS
M.'(1\+80K U$U\;()UHFU"NM"V5?EB@'>].J,FYE >M[1?BC4K&^P##'C9CV
M>9F&G5$'"SHR1]M7(-2K&DBN(MHN4;%'2 %[&0EA9.B=MQ]*>,EL@M"$=W++
M"3F?"MQ3+MN@*FKH03N$Y',)\*Q%/6")2)K254\V"B AL[^J7+WTT_(=M_;U
MU*3)@P(WC9[,3!8;=XAJ#(KGR36O4]L<[KT(BWR*W:AK#V6-O7"'H$0<R#KE
M3=E1B#J>K8$W, ?C>:W]%0WN&%A;RGI2&:[L)>%I=D<]LGUHZH!( NR>))BC
M%K@R.4)N&;%BZ9288I'*K;"C!^>,_DN[S-%"**&E^2C+?0@=!+?2UTBYC0=.
M4'.& O4)WD*1HR[$E7U+_0-D[G;3@>CQA$_F,@H&*( K+ _.M']J+4AZ]>DM
M5@C:5 >L/LE\\%%,@WLR(HHIM/L6,DVNT]J>/X%/<#TGF/BP9XX4H!(ROJ9M
MKM+$JNT_;J=F/.GD_?O@OQ.@;_:.RB\E(I8L@I#-@318H&-05^\<TB8&JE1D
M>=!/SMW^EMHT&**&)'R(;&,?P* #8X2.",TV2V/[.9:D0#X OJ0N)W,$CZM.
MA6X]3S'TOBA?JVA>,,>_6](9,NVL?L*[@U1BVUX4<?%V30NK=J!,SNFVN[H]
M2 5X(L$)-44 7C!PD=QH2E, :ABQP^RC(7EBYP1A9L4F(P@@)1UPGD5L#6TT
M, GW=!.FZ/5;^W5^F@0WB< MFRC''\ >Q:[TGAJ/XJQ-#SN.;KA?H+^^6>_]
MWOZY@<Q5+]2+,+B_E]RX],I[+]5^(/S=7YVWZIN"BJT<61&7'#USL2FAEN>/
MX[]DEPG)"U]+;7W8.7^#+$FIO'F*#)[1/9"PD86D2!\<)&,?B%S1P#Y3B*[$
M>#B[C!4//4RC(]9SC*&^Y0M2+VEO'!T...7")3UB7QDG=\ UVL[1=4A, WIE
M\J3H5,$9'Q=L<F%7R+$ABR@1<0*>AGOUT(!B;"LGTQQS.P "!H9GP%W[GGH8
MHAA$"9&6&8^.N 7.<P-^*.MPS*-!C3/!N-&>T?N=V"2G>"3A?@]\!N<Y/2?O
M=>)TR&:#S3R507[DK&KXQZ@F3(@[1?'":0]."0A!(,6=PA,3-9LR#,<[$!*U
ME7BFJKW G[QIVU2[$;F,27V5TG!SJ0$>J0'^QV=7 SPW_(ME=OF$Y"V0J=,4
M3V%ZIR$;9))!Q7WW&4[>#/GIL,W?YVGKI$U]U+FN.0?)2FI<:RA^0MOZQ_#=
M$/.1EOQ&>;<TP4G-ZQ_";&,)-6I7+DTKEWO4CM1C)#O%XW3%SS(9EGPQ-M1S
M,XD7<3/+* PSZ1B]][)^$B5&J*14JOP0)\J,6VY9-"<>!!XJ&1Q,75::5Y8*
M1.1XX?N/Z8QR%=XB'I^.#'@W_808! !OT-&F+3LJ2;?-KBX7#IT#CF$;24^0
M7>AGPPXX(!EU:N<4F@(X##CQ=<;;N)[]%S\7FVB#+Q%.:2!J;NB%(-5:5O5
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MT$QF"F/FK@1WX.]A)G3K739?$GF0XSL5"#GWV75DIA[S>1&^X=JU!;&JJ#;
M2CI$&22 [%[JB$-':DC2A879VF5%9&7 -70!6]^[=JD$(QP#1SJ-;)YMBQMG
MSR)-@4B'@I,BICLW*\;5Q#I<X0^AK>])5B5%?G/CRIN*9#BCB1."O%@),XA?
M)T0K/H;!H^J-TKNFO;W:M+=%2J<S+L2;K%%$&EMVH1?I+/, (Z:4QW0I"V$"
M4]&=*<DYJT Z6FQ9-[GLHNY27FO."4N_+!-OJ'-!D*:,%E@<"Y+-SX]@!B/
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M5@B,R[F?R)9Z?$!: 4<>\YUD61LE@4 =293/*VL1G*PA*R&MZ2-MMX@BR_;
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MP^$!9 5FN&UILFZ;M>*#A#T\/[V/;D3_!H#YFHG.L2B5BACXN!G2LE")W(H
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MK\S;+7CJU*+@WU#\U)YE45#&B^]%%Y\>:7H'NYHICL8TZ/@S>X6XUD 8I@"
MO+/^D\P\SQ/S?L7-Y_@SK0_%?D.H%'6"".*ZD^VGQK>" @<&E]P;+!0F\!)2
M+)P:9=5/?H^5AZ9GP?U<;=IVB2@^M%W(\EWV?;NHT,4 6U'88<U %6+-WY=
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M2@[- (KL;9!SVF81%"6M@>&QL7$'\!Z!6Y:NKPB8&@B3(JT-P <T#%%-OT(
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ME(T.TW_=KEP@EPBO"O)\I4OSW[,7( OP%W]GN.Y :Y%.?Y0"538I@]RA/X[
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MH J12\3$$3ETAH]#DN\MY5T'*#M!I\P6H;/PF')*$<?X2FT7!VVO5B&1+]]
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MM\U_4GK, WQ$#VL(I?I"O)#?D@ZS8@F?3VKL#HPJ92J19;7V8IFL+MYO.7P
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M][D30]!Q>F!81[.S,W]>FIBX@'V0"+U=>A;8\@N$"P(D(84_-CHWKX164GA
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M.E;/!,(?Z.24%#4;0^G5@7%*'993,_G4S#'3T16L8CTLN;!0<QS/4SGD=DL
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M%/DDP-'XO/5E<.V<M'[Y\.[=^[\YSF\7#[?@BOCQ%$4<7%($.0K ,^83\#5
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MIKJ29P-66V&#NI3^-G^'2L/[S@4.WZV2K[85,Z'9%'YX]W]02P,$%     @
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M#IUDA9Q%'<#+@*"D5."""8!<9%42Q<-AF "T;1P=3,0BC06I$ZG6G"PI65L
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M1[M7 #3;CO@LKL(XNBSI>:OG395$LN2,9K:HR'PDR5%TN5_]?J>V@T$9O;W
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MP&#F+"MG\O4CV2T*<*_%,B8SV)X/320P>LMWGAMR494YG">&7,H'>6!#N#G
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M*6""Y&3M"5AWNY)/P+1%3"DJQ5JKA,\W;UM.;S4<Y4HPF7A<=,W(#T)"T#I
M\N0JD\L<<_/S>U^C&),!WD[2MU>\N_=,-S.)_PC=M!KF+S",]"D2!(C2>5"8
M:A6L>C+-9F02,]GJUBM)7X$8DTEJ(^_=YKFA![3HEF^Q.[Y$NZQ9DHQLE*B]
M5IB/X(61Y)B56'@(1N361^B_1C&&7<RV M]QIA_(.5B!O2@],HA3L/8.PSH#
M=P^JF1/0]X@W%,B]*(KP[!0GEIACA+3DJC**?K31X"4ZX*:(8+P4[5L4;(IM
M5PVSZ7W^&T/W?'':303+4NMZEL073F:OMI0RN79]0BV$3Q)EZR-5]\4X+O=C
M (Y=5UZ#"K&9,;L/RK=$'9RDP@2OG9"*JQHX,P&Q=KJ(+HG$B@ZZ>?'Y>X,<
ME^\S,K+=7XS[9=MK/ Y3LB3=R_)\VI/P*N@).J]DS@J<L[6:8ZQK%,+6+//:
M9RD4[EO'4-NC'9<K-A;^[2[8AU%['Q83);WG63A(:%)-HLP0:D%1D4LV/!>;
M9>O",O>$.(:LMO%1;DL1MDEJO!7AV\43?%5KV)[B85EB]]D-"#;(DI0#5$@!
MDU,(CCD&(G+-I% \7:]:?4/BXU:W'T/:VUYHM"<)[5UC_4YQV-L/.'N/OU'\
M=M1/BBKHZ@Z]XJ*V>; !G)$<6,D>/07AN;1.XMD6ZYCJZ(]*A^TDU!$M@TRN
M/1=#+(30/?:_%')]8/M>#"DB.9E+ A.=!"5= H?UI <7,F0IF$T/]9 /JOC^
MF.?S=FWU+&"BKQX>UU<3R8HE&^] ZT#!M# >8LX9** V42!]%ENGG6P%])M<
M%KD/V^ZE\IJ(<Z#&6%^Z=,ELK.3" S)C*&+Q"H)' Y[5'JU.<MN\GM\.S=1&
MM\ZQ"WM:B&10>UB+P"6R&,_H;2+Q[[BLQ=D(]442Q)5/%U<^W6&OH,5M6UC-
MYL-O9$C_N7H",!^^)_Z\PXO,JG,@9_DQES)1)I['PM0JP;56?;11UO(#1%F%
M7KA<2L+6"^KWA+BK<KOA=F?WJ9E!F%?BFDA'_B3/$41)I'IC9N!K/V,T43.7
M16#73WP/-15?81N3\1R28=>UX""R:[/F<2NT/U8UTO%2ZOHJ2^UP?CX_;T[C
MOS$MWRY>X\EIEXY(Q4]DL5:P@,!#IB&XVH;.1@&20BXNF<S*^[NTXR#(1M7Z
M8!_L>WCY-O/L;AW%I7DZ>XH"/2S>H00C72&(,8&/T8 0H; L: I3ZVR>>P'<
MFRE(6:"V(=8&*:NE^@*>IP"H?,I8G3C>NA7)7\@4-&#7UH;@/I(;J2&(.0E4
MI?9&YC1/BM,\*8;@M$"4R2=S_2#)_QN"(;CW\-+=,( [?[_^B'2+G[[[/U!+
M P04    " !6@ )5P"+4;8$P  "U#P( %0   &YA=70M,C R,C V,S!?9&5F
M+GAM;.U]6W=32Y+F>_T*AGF=*/)^J=6G>G$YU+ 6!2R@NGJ>M/(2B=5E2[0D
M<Z!__41NR=C8EBQ9N24A\P!8LM#^,N++S(B,2_[;OW\].WWT!2?3X7CTVV/^
M9_;X$8[2. ]'GWY[_(^/+\$]_O>__NE/__:_ /[SV?O7CUZ,T_D9CF:/GD\P
MS# _^F,X.WGTSXS3?STJD_'9HW^.)_\:?@D ?^W^T_/QYV^3X:>3V2/!A+C^
MV\E??$HR\)+!HC"@N$O@M720&(O<*2PAEO_SZ2\A^BB28F #=Z",*1"*Y\ 8
ME\DFF:**W9>>#D?_^DO]*X8I/J+!C:;=R]\>G\QFG__RY,D??_SQYZ]Q<OKG
M\>33$\&8?'+QZ<>+CW^]\?D_9/=I[KU_TOWV^T>GP]L^2%_+G_SGWU]_2"=X
M%F XFL["*%T^@!Z?9]__XU4T^LG\E_31Z? OT^[_OQZG,.O4<^<0'BW]1'T%
M%Q^#^A9P 9+_^>LT/_[KGQX]FDLN3-)D?(KOL3Q:_/B/]Z]N(AV.9D_R\.S)
MXC-/PNDI(>Z^8?;M,_[V>#H\^WR*%^^=3+ L17\QY I*5SC_NW[;DZTQG1"0
M23J/"/0NCBK!&V*\[=NWQ_S]NR 3\\]/9PT1W_SNIGC'9V'84L WOKH!VNZ+
MX S/(DY:0OWA>Z_@O !Y'6']RE$XGPU/SZ=_CL/QDP[>\_$HTY QTP_3\>DP
MU_7UPXS^K@ON=%S>8T9:#^(ITB=HS9X-Z<=WA!4GD_K)<?I7&,W_/1F?9EK4
M?__O\^'LVPLLPS1<@TL5$]1UFAG)NJ'UCNF*M(B6P]&PKG2OZ>4"6)7,0<D-
MO\Z0GI<?/QKFWQX/?>$\&*EX$4$99J)A24J5G;4NF5@&O:.K KP0X>DX_0#V
MM&X=X^]</PT13[MW!^=3^!3"Y\%W)"1S?$4_3@<F,J9D*9 +TI;L..VUR2E@
M0MNL3*&=.=R<*=.+F5?"-'9S9?&()Y503_!T-KUXIZ-81Z_E*.;$N/^X7HT2
M&2A3?('S?U^-/N+9Y_$D3+[-Q?=^?'KZ<CSY(TSR0/B<0HD9G$T:5$@,?)$*
MI),L&:XMB:3QB#?!]Z,L+J?)T\F%5!8KW#V7P&JW-67%;+PC9<S90(-[_&@\
MH:GQVV.V+7&N(?MP$B8X?7L^JR9<M8H'QB@6I=4@1&"@=$@08S"@BS J:\PL
ME<9DN0O3[@G2GT;'/:KC)EUX8[H\#Y/)-X+U]&Q\/IH]G<TFPW@^JXO[Q_$[
M@CZ:#4)&P8J0P*(G5X;V#W A6RC,).:]S2:J?OES-\B'0ZC&"KO),'%?AE5#
M9_ >TVF83H>TU7<^X/1M^3X  HB3LS BC%<GQT"D8J11BESJR$DZA#RX$"$K
M3(X,$^6#N<ONN^_#CY X.]'#3=[(;5>FC2 /9'3&TFH)6DL)2D8+WM8]'IEV
M+CJ>2FL3:". 1TBL_A5UDU6J=_-(2>')%,R@LB=)Z!PA"DD6HQ1D.-JLO6KM
M/6QF'NUDCU?%\)0RF*)%59(#GU" ,U$(AY%E3(>UQ[?PL&[ZJ%>G"#-!,!LX
M30R30%E!Q,B:?F)""46S17K1NY.U$N(1^EGM5-*#[7QS\4@AE1)IW1!,15!>
M:8A>,#!:.F><")G)UD</A^A,-53;N*7,^R#!C:$.(H:8<G"0%.%0GM;1D+@'
M*W,NW(JDDV]^ '4=Q9'38#NI-W1S?D#T:CH]Q_SB?$+$),-G.,YSOG:_?/NY
MLXY^_XJ3-)QB'D3GE;"&/+'JCBG-+3BGR<I&KE$FP["T/ZC<%.4#X%%_6NO!
M+5J"^#_"Z3G>#IAYY@AO!(D):4>6#EQR'J37WCF5LH]Z-S1;#O)!LJR1SGKP
MDE9.B]_//I^.O^$<^;OS23HA\;T[#:/I@'&;5! !N#4*% H%7CL)TF;:CJ5P
M6K<^&[PGU =)N*;ZNTD[W>?:MA3UH*0@R"WG8%4U $6BN>*,![+[M!1&!"MW
MN;XM!?H@*==0=S<)9[8ZFUXY2?X9)I,PFEU9DCEZ@1DE)$F;OTK,0]3:@R<7
M0RN5M+=VK6/IS9Y[G*SI6P$WN6)[W1/GJ0\UW>=MN9(&\0$3?70VK*?II@2;
M<R+,DG;TI#(X7SADS;/710NTK<.NVR$^3N+M09LWN>CZW"CO!I]<1)T%@G&Q
M2T;-X+-,X'V)WG++1&A]DKD5X ?)Q!YT>9.(OK\-]#U6Y/@>4_@\G(73X?]T
MP:&!CLH5'LC$C,AJD(7<9R$+1*5CBJ(ZU67[;73)TX^32;M1QBUGI_=.5EJ%
MN"/^,L"**18YK;:",[(!) ;P@L03I<8L1?1%N&W8L^KA#X\\S51Q"W>V/GA_
MFO_K?#KKDE _CI_FW.DBG+X+P_QJ]'R.M6-_K1C(S\=GGW$T[:"_1Y+<=#BC
M=73R99AP/E@:X/C37*/=N =%*^=ME, E^<$J:P:.Y@-$I]'$E%(QO/$VV?>8
MCI/"!\F(6RB_=8SA[>P$)Q7W!$]J<<$7$F<:G^'K\73Z!F=OR\?P]=UXTFGT
MMK"^X(22BP0T3\EJE2E48T&#0IX,C2V5T#H\N27DXR;L+O5Y"Q^WCD40QDO
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MN)&VMD:BFO><1]J_@7M.BR]CY"ZP8LE #)QSIJ-4;"T3?+/G'A>3^A9\ZTL
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MB_*WXT53,3<LH][D3-PK[H(+ KSE9&(%YR%Z=$ DU0JS*\R9-D[>06;6WI\
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M$IN;Y=NC/MAS/58R#ZAXO<Z-T[R7'%PV 8JHW:]C2MFVKKXZGG.]';-Y9X>
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MI]&P#%/MLS>=GI_->S7MH#QP]8-W6"NX@02N%0X&E)%Q4WP626%@CMPO64Q
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MZ<SF,NE%5;.9^JR,O+8>Z;JVZ6]J>:>_L!\?%U7C-%T:!?GCLDFC7WQDS1L
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M:/0>H8<G^-UC-9\N'ROU;OK#_F%#9>^TG@JU+EW6.=^4%H@348*T5 R00FM
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M6R=V*JG9"ES5,XM4'V!G J[R*5X'ZPOZ#UO%;Y)MU0=*[S^&UA!9_3MRQ^
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MI5B67.;$MNNA(FU;A)>9% !**%,J2IGBPB\(^(+$L='<;G.Y[>*C.U5'?0.
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MFOBRR0?WQ Z/]*..*QMU?IC.U?NENC>;!88990@#I!@#)%<Y*'G* 2FDEI!
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MM.?%C-=L.-ZKQ,(X^KK0]M?MNG[LHOUI"^TO#FC[WV3T02W41827[&'O$?K
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M@,U=C>W[UZGT%;>_[F=Z5B5UF5:_;A=J]7KE;H8K*&G!4X!T9G?N0D- <\B
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MDLB"%-![^6GO:VKK3"U@XL1UZ\SA=P0#.*P#8(_E(AYL0UNT+8AU5V@)ABZ
MY^-!.!*A]WKYPNC:#Y-67NYH8CP"]M/EA&D]'^EW*O#.&J7SS4<N2WZNTW (
MBABA2 '&4FO*:\,!-1(!@83*,\(9*X(2(U_K9&HD6LF8[(3LF>/D*IQ^IP&W
M@C0P90;C$[SW;P,@TI;_:A>C[O3;E#S?X+=^-[QLS(?%QC;SX8\RRTGI0%^%
M=<TPS+(BI060"#K3"7' "59 "(D* F&!"J]LFVV=3&VZ5W(F'_Y(#I(FE:C^
M56,:$6V?\;%P&GC&]X$HJ&A,%P:]BL8T-CI:T9@NM8Z+QG1^-T[2[[_R]5S:
M><Y1RHH<I((R@!G&@!54@ARRC!M1$%'0D&7]:B]3F^A]DWT+I\P@J;ZKP>"%
M,80H[2J&9@!S60#*- 1YCO)<0\ZX-K?E7P\>CFEG7Q]Z0/RLM)M!'IJTK^1=
M+V4<+NOZ"00#Y5RO^GC3C.LG:G;E6S_]<H_3KGTZ*:W>;UUJM&I=*!WF&FH>
MS[3.=9%K#C F$&!99-:.HP*@G%EZEYP;Y.5]W5> J5'_/CO:TIQ02K)]<1<R
M/W1C*?N[9&%9RCXVWS41D)BN]_AYG+ -/"H#D],A:9U6225_;5#>[<HE-U5=
M'QCZ@!.Z@8=@I&.[(88B[%3O!AQ;C_KZM#O>^=\-6I\<"M[23H_EZ-[B##\\
MOSPM7[4N^WZT;^(/OM:/]K6JC[EA+B V2 $HH5N$4 %$X8X-F> ZE:F1F?!>
M?WQZG-J"XT1.=C+7*3IW4B=.[  6\T+<8\6(C>/ 2T0GA'VN9[RP#%@"8F,Z
M$N?W?SW#F#T$GE8J]VIH/.X.T>N$K(,>'"&ZQ8*N9[1 4/,<@50CR]:*YH!K
ME@)I%%(4:Z:9UX5Y;PDFR-YDP B7$G2_0X9!H1R8P/M%N3@EWBC.Y1B_MXAT
M*?N?;JS+,3PW1;N<-'1#)/M%LL++6$-Q'FOXX8^7^8H?7=!D3 J*BP)HQC'
MUFX%S/ 4P$QHG6=V(8+A!>9B2#8U4BR%=#EG:RG=H:OW'5G\<?/CSS<9C:'/
M3FX/(#]H%^T:;S#$8\9]1Y%K_+#NF'!>C=J.VD%/]Z/EZF7ITCJ]UV+S5<OM
MJ@QBJ+=D..,$I]IR<R9<.A&" *?V+Y)*3HV0$G.O P6OWJ;&O'MA$V6E3=9[
M<0,]DEH1]N/3:+@-S)$'R)R@R4'2[D.#<&\E'TQBN2VU]C6N_Y*/VA>.3%X/
M3:HF\8<_]$K.U^Y&NJY"RU/F(IL0T-I=V"M$ !>L "9GE"IL4,K'22D=*/C4
M>.VHT*P^R#JY,L27+T" [3FQ89V^:>I7AO@(A#]-&>+&@7OKS$:A8O\Y\AKU
M'(R1RA W]S^!U'Y7,Q#6F=TR0^W:QW- 6<'LXF<D8!!"D(L<X33E$)L@2WPL
MP:>V^#4GM7WSU'YMPS_PTC?@H$Y_Z0M/:COIK'X>X_;6*U^HV'^.E:_G8(R?
MU/:F;'Z5\XO\H=76%>]M<'7Y5I9O3(NB,(930+E +B,%!LPN5H K9;)4IKGD
M_B'!?GU.;;W929T\F$9_KN2W4O00APK/ ?!P3XD/Z]",_Z:(AO@I1D=V+-?$
M& @'^B(&8=7N?NC7U(@>AT&ZG3H9ACTZ@.?*W_G&'1:^EAT=Y39,69IIS0"D
MW&Y'C(& (E8 D@O$3($Y)$&13#UDF!S3;Y^?^>K5.:U_W&Y<*K_'U7PAYR_\
MR5JFB\V*R\W6_OP@GN;?R\%;ES4GS_PTG!7[/*^*!D9TAFD8QPCN,+>/S@0<
M8G9*U+26#)*$\088Q_"+:9!@.IXQ[1 %^<9T--4WMOM>*?OFKNM_/L\7&LY2
M71"LD0**Y\9%!DG N:$ YBHO%%.2Z2(LN/M*+U,CPSITN1;Q;O=#XH1-'A:>
MQ9/;@6WGKFAP#<Q.O9'J$>G=@L0-H=[76ATYUKM%L<M@[[8O]SP%/C+3UIO5
MW)TWO^/K'_>+\I\/_[&=_^1/;D4_K+Q(%M 0EMN]<2H!SG0!.)+6EB(X3ZV5
METL25J4L7(:ID<9^W[%T^XZ=$HD3/_!8ML=X>)ZP#HORP%RSD[FT/>T>SHE<
MWO25/QP)/Z@9= .&L0XN>T@P[AED?X@NCA-O:*HG&QYE#7#-NSR;6+-,$V$W
MB;FP-E"! 17$ %7@(C5*(21D2!'7RRZ"N&RT(J['"13^ZW^F&2S^-=&EO(&$
M=@FI82P56#"@*$D!SNW2046: 5(0@](<:XKYK/(5_KKAJ\T8P)YW-QR\?]7?
MYPL7\)\(_N3BPV_&,Z,99Q9&D&4I KBP+RM/,06%1II F0O)48WGAX4:#\U=
M9T-:H"HFD)X+Z4W0#'W$?"3<?TLJ\9+[LQPICSQNYO5F1&*M>I<=C+NH-2IX
ML68U?[/O$:?=_!\=PGW3J^?[/^;K&<P11BFCED5391<F2.T295P1!B@PERGF
M(@T[Q[S>T=1,[=U1X^%8TDF:_.9D#<RXV(BM[]GB[8@-?H#8!ZP>QX/M2$0[
M VSH9N2#OG9E+T_S.K[?,_SAB:_7#Z8DG%WN5::5SH3C &H-JP([J]5((&%:
MI )1:<)*J%YV,34R*"5TF^XJ(KUGXM5+)/T(X#9\!I[ZH="$1S$T:A\K=.&R
M@W'C%1H5O A2:/YFO\F]=X@YU'):WXMU22$SHG&6(9(!K:@!.%,*4(YS4!#"
M&<^TG>E!YV]MG4UMPA]YO!U):Q>T6M[ J=^*LQ\)Q$)O8#KH#UPP,?@@$HDB
M6KL:E2Q\E#ZG#:]G;CW7+TFI=BW_LGQZ^KA<.9>[L]MTRC"4*)> :YT!3.Q?
M+),(,(4,E0A!G9-^9_I>_4^-9H[/\ZOUL](@N9>;^<_P0[# T0@]T8^.\="G
M% WPKA,G?5*+/])1?A!XT8_Q_7I_HR/\(&B:C^_#FNE)>%NQGJLY7[U^Y?L^
MW0WIIXU^7L\HAYQ0;(!">6ZW1ID[(X4,<,Q2S)$14@>=EK1W-SDZVTM[ESAY
MC[8%3N:D%#K0=.H W)/"HL$X-&/=AF X/7D!$XN-VCL;EWR\%+_@&K^G^CI'
ME3$(W"W]^CW?\%VI5E(02R>X +F&UF@2(@6"YAP4&NLT,ZG=BGF12E='4Z.3
MVO'G2-C$2=M9TC4,W78&B8G9P-S1%ZX>;E+M6-S@*=70\,C.4NWJ7?I+=7R_
MIZ5Q8)@J$-?^4B8?J%+J?EJ4!3EXZ:OBRF%A)% &)%,,8$05X(10D$*:*U(8
M90DCR.X(Z'QJM%$)6N9%URJ9+Y+-0=8;<CB$#(>G53(0R$/;*,=VR2[)0?E!
M!?RG/?!'\D<T67J@%LN ">EZ7'.F!R@7QDV?-F*4]"OO0G/*B"8L RD7$. T
MMPR6,0$,(2A/.50J#XJ7N>QB:CQU4:ZNQ]7R%2 ][Y1N@F?H.Z4P9&XLXS?
M#?*5#MZPA%_;K7'+-V\]$7Y<+5_T:O/J$DAO7)Z1_]C.7US45A4G"@65@D$(
MC,O2@3.A ,5, D5P1B1A6INPHQ+/CJ=& SMI[\K\YILJK]!.XK PW> Q"#T
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M<+V/4>=^JYKGL[[]RSU#<W8)VDLOQEW*X]=?K?AUT5V::ZT8,R G.;7&!,:
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M\4Y?8N!P<A@3I<$;4A:Y8YY/SR^KY<]RE[XK_&0X5-QD!$@N[:I%60&8R#,
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MB?[AKEG[1/\0ZNX@37X/IS]&?3"56$),D'@=5R2<!">D *%%+B7P*)JW;#Y
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M&OOZKN<#\C"U]0#":SOUHNXB^F;]>NCF3?M7-]HRHL^TJTH!7HH#57(FWI(
MEH/.W,0<L'EES![T=7AR'HB+!X[/IDKJ"X!DUM>/P*]YF^1@3"Q*01;HZX4#
M U^G5W+Z.7<^<)^:QP9;:.G%\@T)K,.%WQ>(:G@_S>LQ:?/9.TPX_8+YS8T=
MDD)PT@2$*+,$%:TCB0D+I23)(Q.:B=:=!'L1.'8MPRG@UEA-'6#P7<W#SC#_
M'A:SZ>SC\EE*%^<79[7[Z_+]VDDT+I#?JT$(44?UH8*0:&N%E+3VD7N16Q?.
M/$[5V&4.@Z&ML4+&'V!SIY/V>HA>*[4?[:N5J9:<T6Z2T64*NI2$4"B0+\5+
MYDF8+MZR?#OT.>]+Q=C%#LT!=UJ]C%U?<]53^SACFP)(##D:Y%C+.$BF(I4Z
MEM>",3D6P4+@MU]!VH:Z?9<>N6]C**@-JH$.CM)[^E)H'[W_-%^LR(J>7W]R
M"0-GS)8:OY.WJFC_0#0F0"K9$8N^1-'Z;=;=J1NY96.XHW4@!?5::_!^^G&V
MKF&;K2Y?5B!_XNW\C'P(/*BLX.$/;%)!L ?-C8H%[BYS;?*;,FB, VMJR6"4
MELZW3'^$:*S3(139.I;?3LW1P>9#DKTJLC$V!Q%%KM/NB.?$JEN)M \X_4#+
MH%AL[>SO1MG(;Z&V0<F=T+*]4IZD-1K,*IW0.HUEI>K#3(ZQ=;FQIS_J@"M+
M6$DQEA*"MC*WGC8VG)6Z+ "\M<"WS9_7-@2+12I?Z[B9K-GB %$E!%&4%DD6
M96)NS/-NE'5KI?9!R9U:S?9*Z<!=__N2O,O?EZOI>5C5-WJ(<H;)0V:N-HLH
M <YYHAXS1NL5FM2Z4NTF!2._P#P,=(X0<@<0>3Z?)9+=9;IWNOS'<Z)ANJI?
M3:RR*7*>@==7=)3W%)PJKH$YZ91U1@PPV&<[.2._A#P,>%J)OP,DO<>/-;!\
MAY_KJ[7;+&B4)6EG"H@@:IF[E!!$H3^016DLT<6:5\ON0MC([Q(/@Z[V*ND
M9Y?C3V[/H[K%E$;:)=HI()O+07''(1:3(/.84DQ*1#M$^NE1PD9^2'@@*]9<
M)1W@["I7=F?#H$.%@4,)F8[X5-^9XR$ 2D-B(VYL:/^>ZA9BQDVD#X2G-J(_
M&$-?<!'GC5#T,DP7_R.<7>"U#H97,Y+1Q?G5'IF0B%BJ TJ,C1&42JD^ \O
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MZ7)*4A8*-:.SGM')3S(@:03D=2Q#Q! -:EY:UQ<-P<?(.<'#876[TFUL'7>
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MP>PNKOCPZN_ M]E03K^\+HM/P@HEB@4G-(DPLP">)U_?T$F268'.M1ZR>(.
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M3H/"4B"6>O3H%&4B+RB4UIOE%G)>RK378P[T5MKJ%W@;VY2NWFA$!GE3)VF
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M>J$Y2.\UDUJIG%L_!1MJU[F=Q'I_A;787]V(_=Z$#X/%Y=IM-+/:%=1Y22)
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M='1E<E]G;V0N:'1M4$L! A0#%     @ 5H "5>('^0#Z,0  >TP! !X
M         ( !%!8  &5X:&EB:70Q,#(M8VAA;F=E:6YC;VYT<F]L+FAT;5!+
M 0(4 Q0    ( %:  E6TVG(DC @  +PI   9              "  4I(  !E
M>&AI8FET,S$Q+3(P,C)Q,C$P>'$N:'1M4$L! A0#%     @ 5H "5=?%V=6,
M"   NRD  !D              ( !#5$  &5X:&EB:70S,3(M,C R,G$R,3!X
M<2YH=&U02P$"% ,4    " !6@ )5I"3I&QH%   [%   &0
M@ '060  97AH:6)I=#,R,2TR,#(R<3(Q,'AQ+FAT;5!+ 0(4 Q0    ( %:
M E7)-TT^& 4  #@4   9              "  2%?  !E>&AI8FET,S(R+3(P
M,C)Q,C$P>'$N:'1M4$L! A0#%     @ 5H "5:%,7X1IKP( F'X: !$
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7;%!+!08     #  , #X#   %>@0    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
